     Using dna-methylation to inform the exposome-health
                          relations
                                             Solène Cadiou



      To cite this version:
    Solène Cadiou. Using dna-methylation to inform the exposome-health relations. Human health and
    pathology. Université Grenoble Alpes [2020-..], 2020. English. �NNT : 2020GRALS038�. �tel-03438103�




                                   HAL Id: tel-03438103
                 https://tel.archives-ouvertes.fr/tel-03438103
                                      Submitted on 21 Nov 2021




    HAL is a multi-disciplinary open access               L’archive ouverte pluridisciplinaire HAL, est
archive for the deposit and dissemination of sci-     destinée au dépôt et à la diffusion de documents
entific research documents, whether they are pub-     scientifiques de niveau recherche, publiés ou non,
lished or not. The documents may come from            émanant des établissements d’enseignement et de
teaching and research institutions in France or       recherche français ou étrangers, des laboratoires
abroad, or from public or private research centers.   publics ou privés.


THÈSE
Pour obtenir le grade de
DOCTEUR DE L’UNIVERSITÉ GRENOBLE ALPES
Spécialité : Modèles, méthodes et algorithmes en biologie, santé
et environnement
Arrêté ministériel : 25 mai 2016

Présentée par

Solène CADIOU
Thèse dirigée par Rémy SLAMA, Université Grenoble Alpes


préparée au sein du lnstitute for Advanced Biosciences (IAB),
lnserm U1209, CNRS UMR 5309, Université Grenoble Alpes
dans l'École Doctorale Ingénierie pour la Santé la Cognition et
l'Environnement

Influence de l'exposome sur la santé : apport
des données de haute dimension de
méthylation de l'ADN
Using DNA-methylation to inform the
exposome-health relations
Thèse soutenue publiquement le 20 novembre 2020,
devant le jury composé de :
Monsieur REMY SLAMA
DIRECTEUR DE RECHERCHE, INSERM DELEGATION AUVERGNE-
RHÔNE-ALPES, Directeur de thèse
Monsieur ARTHUR TENENHAUS
PROFESSEUR, CENTRALE SUPELEC - PARIS-SACLAY, Rapporteur
Madame JULIE HERBSTMAN
PROFESSEUR ASSOCIE, UNIVERSITE COLUMBIA A NEW YORK -
USA, Rapporteure
Monsieur RODOLPHE THIEBAUT
PROFESSEUR DES UNIV - PRATICIEN HOSP., UNIVERSITE DE
BORDEAUX, Président
Monsieur XAVIER BASAGANA
PROFESSEUR ASSOCIE, INS DE BARCELONE POUR LA SANTE
MONDIALE, Examinateur








     "Chacun a le droit de vivre dans un environnement équilibré et respectueux de la santé."
          "Toute personne a le devoir de prendre part à la préservation et à l’amélioration de
                                                                              l’environnement."
                                                          Charte de l’environnement, articles 1 et 2

                                                                "La fumée fait mal à mon ami."
                                                              Marcel Proust, Le côté de Guermantes

"Les événements n'appartiennent au hasard que tant qu'on ne connait pas les lois générales de
                                                                              leur catégorie."
                                   Guy-Ernest Debord, dans Le mal du Dehors, Rémy Slama

         "C’était l’austère simplicité de la fiction plutôt que la trame embrouillée de la réalité."
                                                              Raymond Chandler, Le grand sommeil

                                            "L'égarement de la vérité entre le beau et le réel"
                                      Mahmoud Darwich, Comme des fleurs d'amandiers ou plus loin

                                                   "Où t'en vas-tu pensée où t'en vas-tu rebelle"
                                                                   Louis Aragon, Cantique à Elsa




Acknowledgments
Je veux remercier ici les nombreuses personnes qui ont contribué à l’aboutissement de ma thèse.
I would like to thank all the members of my jury: Rodolphe Thiebaut, who did me the honor to
chair the jury, Julie Herbstman and Arthur Tenenhaus, who carefully reviewed my manuscript, and
Xavier Basagana, also member of my PhD committee, who kindly shared his expertise and his
advice during the three years of my PhD. I also thank the members of my PhD committee: Olivier
François, Xavier Basagana again, Andrea Baccarelli, and François Mariotti, who all contributed to
the progression of my thesis.
Je souhaite également remercier tous les autres chercheurs des laboratoires extérieurs avec qui j’ai
collaboré et qui m’ont fait bénéficier de leur expérience et leur expertise au cours de discussions
passionnantes ; je pense en particulier à mes collègues de l’ISGlobal à Barcelone, notamment
Mariona Bustamante, à Michaël Blum du TIMC ainsi qu’à Simon Barthelme et Florent Chatelain
du Gipsa Lab.
Je remercie aussi Alexandre Péry, pour son suivi attentif, et par son intermédiaire, le Ministère de
l’Agriculture et de l’Alimentation et le Corps des Ponts, Eaux et Forêts, qui ont financé cette thèse.
J’ai eu la chance d’être accueillie dans l’équipe d’épidémiologie environnementale de l’Institut pour
l’Avancée des Biosciences (IAB) de Grenoble, une équipe dont l’excellence scientifique,
l’atmosphère conviviale et le dynamisme – mais aussi la localisation avec vue sur la chaîne de
Belledonne – m’ont permis d’accomplir ma thèse dans les meilleures conditions. Je veux remercier
en premier lieu mon directeur de thèse et directeur d’équipe, Rémy Slama : ma thèse doit
énormément à son excellence et sa rigueur scientifique, sa hauteur de vue et son esprit de synthèse
face à des problèmes complexes à l’interface de plusieurs disciplines. Plus que cela, son humanité,
sa patience pleine de détermination face à mon propre entêtement lors de nos points réguliers, et
la grande autonomie, toujours alliée à un encadrement rigoureux, qu’il me laissait (sans oublier ses
habituels retards qui me permettaient de finir mes présentations à temps) ont rendu ces trois années
de thèse très agréables à vivre, qu’il en soit ici vivement remercié.
Plus largement, je souhaite remercier tous les membres de l’équipe, pour leur apport scientifique
comme pour les moments plus conviviaux : les chercheuses de l’équipe, en particulier Valérie
Siroux et ses conseils avisés dans la dernière ligne droite et Claire Philippat, pour son expertise
gentiment partagée tant sur les perturbateurs endocriniens que sur les spots de grimpe ; tous les
autres permanents de l’équipe : en particulier Sarah Lyon-Caen, pour sa gentillesse et sa
disponibilité, et Maïlys Barbagallo et Karine Supernant si aidantes ; enfin tous les stagiaires,
thésards, post-doctorants ou ingénieurs de passage, en particulier Lydiane Agier, qui m’a apporté
une aide et une amitié précieuse pendant la première année de thèse et avec qui je partage le
souvenir d’un agréable séjour barcelonais, et Matthieu Rolland, pour son aide en R (ggplot !), mais
aussi pour son enthousiasme à faire vivre l’équipe et ses talents de brasseur.
Enfin j’ai un mot particulier pour les membres du bureau 103 que j’ai vu défiler durant ces trois
ans, qui ont vraiment rendu cette thèse si agréable au quotidien : je remercie Dorothy bien sûr pour
son soutien, ses contributions majeures au dialecte endémique du bureau et ses photos de Willa ;
Stephan, pilier du bureau 103 avec son grand cœur, son expertise et ses qualités d’esthète, avec qui
je déchiffrais les hiéroglyphes de Rémy (et nos verres au Groove avec Hubert, parfois
déraisonnables mais toujours passionnants, resteront sans aucun doute parmi mes meilleurs
souvenirs de thèse !) ; Hubert donc, membre honoraire du bureau 103, ses rires un peu trop


sonores, son optimisme réfléchi, sa solidité et son immense gentillesse ; Alicia, avec qui les
discussions statistiques étaient toujours éclairantes, les séances de bloc sympathiques (malgré les
chevilles tordues et les démotivations de dernier moment) et les discussions sur ses exs
passionnantes ; Ian, toujours si gentil et aussi toujours prêt à aller visiter un buffet gratuit, dont
l’expertise en Unix a sans doute divisé mon temps passé sur Ciment par 2 ; Pau, with our
memorable memories of Utrecht and our (attempt of) record du monde ; enfin André, je garde un
très bon souvenir de ces deux semestres où nos horaires étaient variables, de sa générosité, de ses
conseils en bloc, et de nos débats aux déjeuners.
Je remercie également Florent Chuffart, si aidant et disponible pour m’empêcher de faire planter
Ciment et grâce à qui j’ai pu mener mes études de simulations à terme.
Je tiens aussi à remercier les amis, les nouveaux grenoblois comme les anciens, fidèles et lointains,
grâce auxquels ce furent de belles années grenobloises. Au moment où j’achève cette thèse, j’ai une
pensée particulière pour mes colocs, Antoine et Claire, compagnons quotidiens aux thèses
parallèles.
Enfin, c’est bien sûr ma famille que je veux remercier, mes chers parents, mes petites sœurs Jeanne
et Camille, mon frère Erwan, avec Mathilde et Augustine. Vous avez joué un rôle inestimable dans
l’achèvement de cette thèse comme dans les choix qui m’y ont conduite, par les valeurs transmises
et partagées, par votre joie de vivre, et bien sûr par votre soutien plein d’humour, vos
encouragements et votre affection.
Et je termine en remerciant mon Jean-Gabriel, que ma thèse a également amené à Grenoble et qui
a rendu bien plus mouvementées et belles ces trois années de vie alpine.


Abstract
Context: The exposome is defined as encompassing all the life-course environmental exposures
from the prenatal period onwards. Challenges in the characterization of its effects on health include
a limited statistical power and a possibly high rate of false positive signals of current studies. False
positives findings may correspond to reverse causality. To cope with such challenges, refinement
in statistical methods may be needed. In addition, using (a priori) biological information, e.g. from
intermediary layers such as DNA methylation, may help to reduce the problem dimensionality and
possibly false positive signals due to reverse causality.
Aims: We aimed to identify strategies to limit the false positive rate in exposome studies, in
particular by integrating a priori information from the methylome and to apply these strategies to
the question of the exposome’s influences on child health. We also aimed to illustrate issues of
exposome studies related to models’ stability.
Methods: We first implemented two “oriented Meet-in-the-Middle” (oMITM) approaches to
characterize the link between the exposome and child health outcomes (Body Mass Index, BMI
and lung function) in the Helix cohorts (1173 mother-child pairs); the approach relied on 3 steps:
a) identification of CpGs loci (i.e. methylation sites) independently associated with exposures and
the outcome using a priori information and/or univariate linear regressions; b) identification by
linear regression of the exposures associated with at least one of these CpGs, thus constituting a
reduced exposome; c) test of their association with the outcome. We then performed a Monte-Carlo
simulation study to characterize the performance of the oMITM design under various causal
assumptions. We simulated realistic exposome, intermediary layer and outcome relying on data
from the Helix BMI study and assuming linear relationships between components of the three
layers. The magnitude of links was allowed to vary, leading to 2281 scenarios under 5 different
causal structures, including a structure corresponding to reverse causality. For each scenario, we
generated 100 datasets and tested 6 methods: 3 ignoring the methylome data (“agnostic
approaches”: ExWAS; DSA; LASSO) and 3 using methylome data (two implementations of
oMITM and a mediation analysis). Methods’ performance was assessed by sensitivity and
specificity. We further performed a two-layer simulation study to assess the instability of some
agnostic methods, with a focus on LASSO.
Results: The oMITM approaches performed on Helix data identified one exposure, copper post-
natal blood level, associated with higher BMI and with lower lung function. An ExWAS relating
exposome to BMI identified in the same data 18 additional (lipophilic) exposures, whose
association with BMI could possibly be due to reverse causality. The simulation study showed that,
compared to the other approaches, the oMITM design may allow to discard some false positive
findings in at least one situation of reverse causality and to increase specificity when the
intermediate layer mediates part of the effect of the exposome on the outcome, at a cost in terms
of sensitivity loss. The oMITM – DSA implementation showed better performances (sensitivity,
specificity) than the oMITM – ExWAS. The second simulation study showed that the stabilization
step changes model performance thus illustrating its importance when using agnostic machine
learning algorithms such as LASSO.
Discussion and perspectives: The use of complex statistical methods tailored for intermediate
or high dimensional data, or the consideration of biological information, could help tackle the
question of false positives in exposome studies. We developed a design, oMITM, which was less
prone to reverse causation bias than agnostic approaches ignoring intermediate layers between the
exposome and health, at a cost in terms of sensitivity.

                                                   1


Résumé
Contexte : L'exposome est défini comme l’ensemble des expositions environnementales reçues au
cours de la vie (dont la vie prénatale). La puissance statistique limitée et le taux élevé de faux positifs
des études actuelles sont deux défis majeurs pour la caractérisation de ses effets sur la santé. Les
faux-positifs peuvent notamment être dus à de la causalité inverse. Pour faire face à ces défis, affiner
les méthodes statistiques est utile, mais l'utilisation d'information biologique, par exemple
provenant de couches intermédiaires telle la méthylation de l'ADN, peut aussi contribuer à réduire
la dimension du problème, et les faux positifs liés à la causalité inverse.
Objectifs : Notre objectif principal est d’identifier des stratégies pour limiter les faux positifs dans
les études sur l’exposome, en particulier en intégrant des informations a priori provenant du
méthylome, et d’appliquer ces stratégies à l’étude de l’influence de l'environnement sur la santé de
l’enfant. Nous avons également cherché à illustrer d’autres enjeux des études sur l’exposome liés à
l’instabilité des modèles.
Méthodes : Nous avons d'abord mis en œuvre deux approches "Meet-in-the-Middle orientées"
(oMITM) pour caractériser le lien entre exposome et santé de l'enfant (indice de masse corporelle,
IMC et fonction pulmonaire) dans les cohortes Helix (1173 mères-enfants) ; l'approche comprenait
3 étapes : a) identification de CpG indépendamment associés aux expositions et à la santé en
utilisant des connaissances a priori et/ou des régressions linéaires univariées ; b) identification par
régression linéaire des expositions associées à au moins un de ces CpG, constituant un exposome
réduit ; c) test de leur association avec la santé. Nous avons ensuite réalisé une simulation de Monte-
Carlo pour caractériser la pertinence du design oMITM sous différentes structures causales. Nous
avons simulé un exposome, une couche intermédiaire et un évènement de santé à partir des
données Helix en postulant des relations linéaires entre les couches. La magnitude des liens variait,
générant 2281 scénarios sous 5 structures causales différentes, dont une de causalité inverse. Pour
chaque scénario, 100 jeux de données étaient générés et 6 méthodes testées : 3 ignorant le
méthylome ("approches agnostiques" : ExWAS ; DSA ; LASSO) et 3 l’utilisant (deux
implémentations d’oMITM et une analyse de médiation). Les performances étaient évaluées par
leur sensibilité et spécificité. Nous avons aussi effectué une étude de simulation pour évaluer
l'instabilité de certaines méthodes agnostiques, en particulier le LASSO.
Résultats : Les approches oMITM sur les données Helix ont identifié une exposition, le niveau
postnatal de cuivre dans le sang, associé à un IMC accru et à une fonction pulmonaire diminuée.
Une ExWAS entre exposome et IMC dans HELIX a identifié 18 autres expositions (lipophiles),
dont l'association avec l'IMC pourrait de ce fait être due à de la causalité inverse. L'étude de
simulation a montré que, par rapport aux autres approches, le design oMITM peut éviter certains
faux positifs dans au moins une situation de causalité inverse et augmenter la spécificité lorsque la
couche intermédiaire médie une partie de l'effet de l'exposome sur la santé, ceci à un coût en terme
de sensibilité. L’implémentation oMITM-DSA montrait de meilleures performances qu’oMITM-
ExWAS. La deuxième simulation a montré que l'étape de stabilisation du modèle est cruciale lors
de l'utilisation d'algorithmes d'apprentissage agnostique tels LASSO, car elle en modifie les
performances.
Discussion et perspectives : L'utilisation de méthodes statistiques complexes adaptées à des
données de dimensions intermédiaires ou élevées, ou la prise en compte de connaissances
biologiques, pourraient aider à limiter les faux positifs dans les études sur l’exposome. Nous avons
proposé un design, oMITM, qui est moins sujet au biais de causalité inverse que les approches
agnostiques avec un coût en termes de sensibilité.

                                                    2


Large audience abstract
The exposome includes all the life-course environmental exposures. However, its application to
find causal predictors of a health outcome raise challenges, due to limited statistical power and high
false positive rate in current exposome projects. Reducing the exposome dimension, e.g. using a
priori knowledge, can be a solution. We proposed a new design, the oriented Meet-in-the-Middle
(oMITM): it relied on an intermediary biological layer to restrict to exposures associated with
relevant intermediary features, whose association with health is then tested. In Helix data, oMITM
with methylome pointed copper post-natal blood level as associated with higher child body mass
index. We performed a simulation study to compare oMITM to existing methods: oMITM allowed
to discard some associations due to reverse causality and to increase specificity in case of an effect
of exposome on health. We also provided new insights on the use of unstable machine learning
algorithms in epidemiology.


Résumé grand-public
L'exposome est l'ensemble des expositions environnementales au long de la vie. Y identifier des
prédicteurs causaux de la santé pose des défis, de par la puissance statistique limitée et le taux élevé
de faux positifs des projets exposome actuels. Réduire a priori la dimension de l'exposome peut
être une solution. On propose un nouveau design, le "Meet-in-the-Middle orienté" (oMITM), qui
restreint l’exposome aux expositions associées à des variables biologiques intermédiaires
pertinentes avant de tester son association avec la santé. Dans les données Helix, oMITM a pointé
le niveau sanguin postnatal de cuivre comme associé à un IMC plus élevé de l'enfant. Une
simulation a montré qu’oMITM écartait des associations dues à la causalité inverse et augmentait
la spécificité par rapport à des méthodes existantes. Ce travail permet de mieux comprendre dans
quelles situations certaines approches statistiques ou l’intégration des données intermédiaires
rendent les études exposome performantes.


Keywords
Exposome; cohort; methylome; biological a priori; false-discovery; causality; high-dimension;
Body-Mass-Index; stability.


Mots-clefs
Exposome ; cohorte ; methylome ; a priori biologique ; faux-positifs ; causalité ; haute dimension ;
Indice de Masse Corportelle ; stabilité.




                                                   3


List of acronyms
BMI: Body Mass Index
BPA: bisphenol A
BPF: bisphenol F
BPS: bisphenol S
BUPA: butyl paraben
CI: Confidence Interval
cxMiNP: Mono-4-methyl-7-carboxyoctyl-phthalate
CpG: Cytosine phosphate Guanine
DAG: Directed Acyclic Graph
DDE: 4,4′dichlorodiphenyl dichloroethylene
DMR: Differentially methylated regions
DNA: Deoxyribonucleic acid
DOHaD: Developmental Origins of Health and Disease
DSA: Deletion Substitution Addition
ETPA: ethyl paraben
ExWAS: Exposome wide association study
FDP: False discovery proportion
FDR: False discovery rate
FEV1: Forced Expiratory Volume in 1 second
HCB: Hexachlorobenzene
HELIX: Human Early Life Exposome
LASSO: Least Absolute Shrinkage and Selection Operator
LOD: Limit of Detection
LOQ: Limit of Quantification
LUR: Land use regression
MBzP: mono benzyl phthalate
MECPP: mono-2-ethyl 5-carboxypentyl phthalate
MEHHP: mono-2-ethyl-5-hydroxyhexyl phthalate
MEHP: Mono(2-éthylhexyl) phthalate
MEOHP: mono-2-ethyl-5-oxohexyl phthalate
MEP: monoethyl phthalate
MEPA: methyl paraben
MiBP: mono-iso-butyl phthalate
MITM: Meet-in-the-Midle
MLR: Multivariate Linear Regression
MMCHP: Mono-2-carboxymethyl hexyl-phthalate
MnBP: mono-n-butyl phthalate
MWAS: Methylome-Wide Association Study
NDVI: Normalized Differential Vegetation Index
ohMiNCH: 2-(((Hydroxy-4-methyloctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid
OHMiNP: mono-4-methyl-7-hydroxyoctyl phthalate
ohMPHP: 6-Hydroxy Monopropylheptyl-phthalate
oMITM: oriented Meet-in-the-Middle
OXBE: oxybenzone (benzophenone-3)
oxoMiNCH: 2-(((4-Methyl-7-oxyooctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid
OXOMiNP: mono-4-methyl-7-oxooctyl phthalate
PBDE: Polybrominated diphenyl ethers
PCA: Principal components analysis
PCB: Polychlorinated biphenyl
PLS: Partial Least Square
PM: Particulate Matter
PRPA: propyl paraben
RMSE: Root Mean Squared Error
RNA: Ribonucleic acid

                                                4


SD: Standard deviation
VEMS: volume expiratoire maximal en 1 seconde
VIF: Variance inflation factor
WQS: Weighted Quantile Sum




                                                5


Table of contents



Acknowledgments                                                                       1

Abstract                                                                              1

Résumé                                                                               2

List of acronyms                                                                     4

Table of contents                                                                    6

Detailed table of contents                                                           7

Lists of figures and tables                                                          11

CHAPTER I:         Introduction                                                      17

CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle
approach using preselected methylation marks                                  45

CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-
Middle approach using preselected methylation marks                              101

CHAPTER IV: Performance of approaches relying on intermediate high-dimension
data to decipher causal relationships between the exposome and health: a simulation
study under various causal structures                                               111

CHAPTER V: Some insights regarding the instability of variable-selection algorithms
used for causal inference purposes in epidemiology                                167

CHAPTER VII: Discussion                                                            203

References                                                                         217

APPENDIX I: Oral communications and publications; curriculum vitae                 239

APPENDIX II: Prenatal exposures and birthweight in SEPAGES mother-child study, an
adapted oriented Meet-in-the-Middle approach                                   243

APPENDIX III: Large supplementary materials                                        263




                                          6


Detailed table of contents




Acknowledgments

Abstract                                                                                             1

Résumé                                                                                               2

List of acronyms                                                                                     4

Table of contents                                                                                    6

Detailed table of contents                                                                           7

Lists of figures and tables                                                                         11

  Main figures:                                                                                     11
  Supplementary Figures:                                                                            12
  Main tables:                                                                                      13
  Supplementary tables:                                                                             14
  Other supplementary materials:                                                                    15
CHAPTER I:           Introduction                                                                   17

            Challenges of the use of the exposome concept in environmental epidemiology             17
                The exposome concept                                                                17
                Assessing the exposome                                                              18
                Relevance of the exposome concept for public health                                 19
                Relating the exposome to health                                                     20
                Considering the false positive rate issue in a structural causal framework          26
            Statistical techniques to address false positive and false negative challenges in exposome
  studies                                                                                            29
                Multiple testing correction                                                         29
                Curse of dimensionality and dimension reduction techniques                          30
                Multivariate variable selection methods                                             31
            Adding biological information                                                           34
                Focusing a priori on a single exposure                                              34
                Information from intermediate biological layers                                     34
                Mediation analysis                                                                  37
           Using intermediate biological layer to find true predictors of health within the
    exposome                                                                                        39

                                                    7


        Environmental effects on child weight                                            40
            Environmental effects on child Body Mass Index                                40
            Environmental effects on birth weight                                         41
        PhD project’s aim                                                                 41
CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle
approach using preselected methylation marks                                  45

          Abstracts                                                                       46
            English abstract                                                              46
            French abstract                                                               47
          Published article                                                               49
          Supplementary materials                                                         65
CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-
Middle approach using preselected methylation marks                              101

          Abstracts                                                                      102
              English abstract                                                           102
              French abstract                                                            103
          Background                                                                     104
          Methods                                                                        104
          Results                                                                        107
          Discussion                                                                     108
CHAPTER IV: Performance of approaches relying on intermediate high-dimension
data to decipher causal relationships between the exposome and health: a simulation
study under various causal structures                                               111

          Abstracts                                                                      112
              English abstract                                                           112
              French abstract                                                            113
          Introduction                                                                   114
          Materials and methods                                                          116
              Overview of the simulation                                                 116
              Causal structures considered                                               116
               Generation of independent realistic exposome, methylome and outcome data,
    and addition of causal relations within them                                       117
              Methods to relate the exposome and health compared                         121
              Assessing scenarios’ characteristics and methods’ performances             122
                Comparisons between oMITM, mediation and direct association test using
    structural causal modelling theory in a three-variable scheme                        123

                                                8


              Results                                                                             125
                  Causal structures assuming an effect of the exposome on health                  125
                  Causal structures without effect of the exposome on health                      134
                  Comparisons between methods using causal inference theory                       138
              Discussion                                                                          140
                  Strengths and limitations                                                       140
                  Summary of methods’ performances                                                141
               Consistency between our structural causal modelling analysis and experimental
    simulation-based                                                                       143
                  The need to rely on causal knowledge                                            144
              Supplementary materials                                                             146
CHAPTER V: Some insights regarding the instability of variable-selection algorithms
used for causal inference purposes in epidemiology                                167

              Abstracts                                                                           168
                English abstract                                                                  168
                French abstract                                                                   169
              Introduction                                                                        170
              Methods                                                                             173
                Simulation study of LASSO, DSA and ExWAS under various correlation structures
                                                                                         173
                Simulation study of stabilizations methods for LASSO in a realistic exposome
    setting                                                                                       175
                Indicators of stability and performance                                           177
                Application: using LASSO to relate the exposome to child body mass index          178
              Results                                                                             180
                Stability and performances of the models’ default implementations                 180
                Effectiveness of stabilization methods                                            181
                Relation between stabilization and model performance                              182
                Application: using LASSO to relate exposome to child body mass index in Helix
    data        185
              Discussion                                                                          187
                Strengths and limitations                                                         188
                Stability selection, a relevant approach when selecting true predictors is the aim 189
                Importance of the calibration of model averaging approaches                       191
                Practical consequences and conclusion                                             191
              Supplementary Materials                                                             193


                                                   9


CHAPTER VII: Discussion                                                                      203

           Overview of results                                                               203
           Dimension reduction approaches in the context of exposome studies                 204
                Which dimension reduction approaches when selection of variable(s) of interest
    is the aim?                                                                            205
                Which dimension reduction approaches when information concentration is the
    aim?                                                                                 207
           Multilayer designs to identify causal predictors                                  210
                Infer causality in exposome studies                                          210
                Multiple layers design as a clue to overcome the challenges of data-driven causal
    modelling                                                                                 211
           Perspectives and conclusion                                                       213
References                                                                                   217

APPENDIX I: Oral communications and publications; curriculum vitae                           239

APPENDIX II: Prenatal exposures and birthweight in SEPAGES mother-child study, an
adapted oriented Meet-in-the-Middle approach                                   243

APPENDIX III: Large supplementary materials                                                  263




                                                10


Lists of figures and tables
   Main figures:

Figure I.1: Median absolute correlation within exposure groups (diagonal) and between
             exposure groups (off-diagonal) for the prenatal exposome assessed in the Helix
             Project (Figure from Tamayo et al., 2019).                                         20
Figure I.2: Sensitivity and FDP of 6 differents statistical methods assessed from a Monte-Carlo
             simulation assuming a causal relationship between predictors drawn from a
             realistic exposome and a health outcome.                                           32
Figure I.3 : Schematic representation of links between exposome, intermediate biological
             layers and health effects. Figure from (Vrijheid, 2014).                           35
Figure I.4: Implementation of Meet-in-the-Middle. Adapted from (Chadeau-Hyam et al.,
             2011).                                                                             36
Figure I.5: Causal graph of mediation.                                                          38
Figure III.1: Manhattan plot of the step b) of the MITM approach: adjusted-values of adjusted
             association tests between preselected CpG and exposome.                           108
Figure IV.1: Causal structures considered in the simulation study of the efficiency of studies
             relating a layer of predictors E (e.g., the exposome) to a layer of possibly
             intermediary parameters (e.g. biological parameters such as DNA methylation) M
             and a health outcome or parameter Y.                                              117
Figure IV.2: A. 1- FDP and B. Sensitivity under causal structure A (see Figure IV.1) for all
             compared methods; performances were averaged across scenarios according to
             categories of variabilities of Y explained by E (x-axis) and by M (color) and
             categories of mean variability of a covariate from M affected by E by E.          127
Figure IV.3: Comparisons between oMITM-ExWAS and control methods (oMITM-steps 1 and
             2 and ExWAS on subsample) performance (1-Average FDP and sensitivity) for
             causal structures A, B and C.                                                     128
Figure IV.4: A. 1- FDP; B. sensitivity under causal structure B (see Figure IV.1).             132
Figure IV.5: A. 1- FDP; B. Sensitivity under causal structure C.                               133
Figure IV.6: A. Proportion of exposures influenced by Y wrongly identified, and B. number
             of hits under causal structure D.                                                 136
Figure IV.7: Average number of covariates selected per method under causal structure E. 137
Figure V.1: Stability index (mean Sorensen index) of ExWAS, default LASSO, Elastic-Net and
             DSA for 3 different structures of pairwise correlations within the tested
             predictors.                                                                       181
Figure V.2: Performance and stability of various stabilization methods of LASSO.               182
Figure V.3: Dependence of performance measures on stability (mean Sorensen index).             184
Figure Appendix II.1: Distribution of the weight of CpGs in the selected PLS component. 251




                                                11


       Supplementary Figures:


Supplementary Figure IV.1: Causal structure A, average sensitivity (A), 1- FDP (B) and
                          number of hits (C) according to the variability of Y explained by
                          E, method by method.                                                 157
Supplementary Figure IV.2: Causal structure B, average sensitivity (A), 1- FDP (B) and
                          number of hits (C) according to the variability of Y explained by
                          E methods by methods.                                                158
Supplementary Figure IV.3: Causal structure C, average sensitivity (A), 1- FDP (B) and
                          number of hits (C) according to the variability of Y explained by
                          E, method by method.                                                 160
Supplementary Figure IV.4: causal structure D, average number of hits (A), and sensitivity
                          to detect exposures affected by Y (B) according to the variability
                          of one exposure affected by Y explained by Y, methods by
                          methods, in causal structure D (reverse causality).                  161
Supplementary Figure IV.5: Example of a causal situation in which a classical Meet-in-the-
                          Middle framework without our additional adjustment would
                          conclude to causal associations between E1 and Y3 whereas
                          there is no causal influence of E1 on Y3 through M.                  162
Supplementary Figure V.1: Performance and stability of some common algorithms as a
                          function of the total outcome variability explained by the
                          predictors in situations in which 10 predictors explained the
                          outcome.                                                             193
Supplementary Figure V.2: Performance and stability of the LASSO stabilization methods as
                          a function of the total outcome variability explained by the
                          predictors (log scale).                                              196
Supplementary Figure V.3: Average number of predictors selected in 20% (A.) and 60% (B.)
                          of the runs on a same dataset for unstable methods, as a function
                          of the total variability of the outcome explained by the true
                          predictors.                                                          197
Supplementary Figure V.4: Occurrence of selection for each exposure when applying 10
                          times default LASSO and all tested stabilized LASSO to relate an
                          exposome of 173 prenatal and postnatal quantitative exposures
                          (A) or only the smaller exposome of 74 prenatal quantitative
                          variables (B), to zBMI in 1301 mother-child pairs of the Helix
                          cohorts.                                                             198




                                               12


       Main tables:


Table I.1: Exposome project funded by the European Commission. All cited text comes from
             the website of Community Research and Development Information Service
             (CORDIS) resources.                                                                 22
Table III.1: Preselected genes related to FEV1 according to (Li et al., 2013) and corresponding
             number of enhancers CpGs available in Helix data.                                  106
Table III.2: Agnostic ExWAS corrected for relevant potential confounders and corrected for
             multiple testing relating the exposome and child FEV1.                             107
Table IV.1: Details of the methods compared in the simulation study.                            119
Table IV.2: Performance for every method under each causal structure.                           131
Table IV.3: Number of hits (average mean and standard error across scenarios), sensitivity to
             find the exposures predicted by Y (average mean and standard error across
             scenarios) under causal structures D and E.                                        134
Table IV.4: Number of true causal links detected, false causal links detected, true causal links
             non-detected, false causal links non-detected by different designs among the 25
             causal structures considering all possible links between 3 unidimensional layers. 139
Table V.1: Implementation details for ExWAS, Elastic-Net and DSA.                               174
Table V.2: Details of the implemented LASSO methods.                                            176
Table V.3: Results of the application of default LASSO and various LASSO stabilization
             methods to relate an exposome of 173 prenatal and postnatal quantitative
             exposures to zBMI in 1301 mother-child pairs of the Helix cohorts.                 186
Table VI.1: Possible strategies of dimension reduction for the exposome and methylome layers
              ..........                                                                        209
Table Appendix II.1: Exposome components assessed in Sepages cohort during pregnancy,
             with mean and standard deviation for quantitative variables and frequency for
             qualitative variables, and amount of missing data.                                 245
Table Appendix II.2: Characteristics of the 438 mother-child pairs included in the exposome
             analysis based on Sepages study.                                                   250
Table Appendix II.3: Step b) of the oMITM approach: estimates, confidence intervals,
             uncorrected and corrected for multiple comparisons p-values of the tests of
             association between exposome and PLS component adjusted on relevant
             covariates and birth weight (434 mother-child pairs from the Sepages cohort). 253
Table Appendix II.4: Agnostic multiple regression relating the exposome to the birth weight:
             estimates, confidence intervals, uncorrected and corrected for multiple
             comparisons p-values of the tests of association between exposome and
             birthweight adjusted on relevant covariates                                        256




                                                13


       Supplementary tables:

Supplementary Table IV.1: Meaning and ranges of parameters used in each causal structure to
                          simulate the link between layers.                                    146
Supplementary Table IV.2: Characteristics of scenarios for structure A, B and C.               149
Supplementary Table IV.3: Characteristics of the scenarios simulated for structure D           150
Supplementary Table IV.4: DAG analysis for different designs when considering all possible
                          links between 3 unidimensional layers (e.g. an exposure, a CpG
                          site, and BMI) according to causal inference theory.                 151
Supplementary Table IV.5: Details of causal inference analysis for the oMITM design applied
                          to 3 variables (e.g. an exposure, a CpG site, and BMI) according
                          to causal inference theory in all possible causal structures.        154
Supplementary Table V.1: Distribution of stability index, sensitivity and False Discovery
                          Proportion (FDP), across all scenarios and categorized according
                          to the total variability explained by the true predictors (>1 and ≤1)
                          for different stabilization methods of LASSO.                        200
Supplementary Table V.2: Results of the application of default LASSO and LASSO
                          stabilization methods to relate an exposome of 74 prenatal
                          quantitative exposures to zBMI in 1301 mother-child pairs of the
                          Helix cohorts.                                                       200
 Supplementary Table V.3: List of variables selected by default LASSO and all tested stabilized
                          LASSO for each of the 10 runs applied to relate an exposome of
                          173 prenatal and postnatal quantitative exposures (A) or only the
                          smaller exposome of 74 prenatal quantitative variables (B), to
                          zBMI in 1301 mother-child pairs of the Helix cohorts.                201




                                                14


         Other supplementary materials:

Supplementary Material II.1: Exposure levels in 1,173 mother-child pairs from the HELIX
                           cohort.                                                              65
Supplementary Material II.2: Pathways identified as relevant for zBMI relying on KEGG
                           database, and corresponding numbers of genes and enhancer CpGs
                                                                                                82
Supplementary Material II.3: Boxplot of child zBMI in HELIX data, by cohorts.                   83
Supplementary Material II.4: Population characteristics by cohort                               84
Supplementary Material II.5: Distribution of pairwise coefficients of correlation within
                           quantitative variables of the full exposome assessed in 1,173
                           mother-child pairs from HELIX cohort                                 87
Supplementary Material II.6: Adjusted associations between the reduced methylome (2284
                           CpGs) and zBMI in 1,173 children from the HELIX cohort
                           (ExWAS model, step b) of the Meet-in-the-Middle approach).           88
Supplementary Material II.7: Adjusted associations between exposures and CpGs associated
                           with childhood zBMI in 1,173 children from HELIX cohort
                           (ExWAS model, step c) of the Meet-in-the-Middle approach).
                           Results are presented only for CpGs with a (FDR-corrected for
                           multiple hypothesis testing) p-value below 0.05 in ExWAS.            91
Supplementary Material II.8: Sensitivity Analysis I: adjusted associations between the whole
                           exposome and zBMI in 1,173 children from the HELIX cohort (2
                           multivariate agnostic approaches, one prenatal, one postnatal,
                           ignoring the methylome).                                             94
Supplementary Material II.9: Characteristics of the CpG selected by a methylome wide analysis
                           on the whole methylome (row percentages).                            94
Supplementary Material II.10: Sensitivity analysis III - adjusted association between the whole
                           methylome and zBMI in 1,173 children from the HELIX cohort
                           (ExWAS model, step b of the Meet-in-the-Middle approach applied
                           to the whole methylome).                                             95
Supplementary Material II.11: Sensitivity analysis III, Meet-in-the-Middle without CpGs
                           preselection: adjusted associations between the exposome and
                           CpGs associated with zBMI in 1,173 children from the HELIX
                           cohort (ExWAS model adjusted on zBMI, step c of the Meet-in-
                           the-Middle approach applied on the whole methylome).                 96
Supplementary Material II.12: Sensitivity analysis IV: Meet-in-the-Middle approach considering
                           the cell-types as the intermediate layer. Adjusted associations at
                           steps b),c) and d).                                                  98
Supplementary Material IV.1: Detailed simulation methods                                       163
Supplementary Material IV.2: Commented simulation script                                       166
Supplementary Material V.1: Commented simulation script                                        201
Supplementary Material V.2: Application: using LASSO to relate pregnancy exposome to child
                           body mass index in Helix data                                       201




                                                 15


16


                                                                         CHAPTER I: Introduction


CHAPTER I: Introduction


                Challenges of the use of the exposome concept in environmental

            epidemiology

             The exposome concept

The exposome concept acknowledges that individuals are simultaneously exposed to a multitude

of different factors from conceptions onwards (Wild, 2005) and can be defined as the totality of

the individual environmental (i.e. non-genetic) factors. Since the 2000s, environmental

epidemiology has progressively embraced it and evolved from studies considering the association

of one exposure with one specific disease (e.g. (Hill and Doll, 1950)) to studies including various

long term or short term measures of different exposures (see for example (Agier et al., 2019;

Lenters et al., 2016)).

The exposome was originally defined as consisting in three main categories (Siroux et al., 2016;

Wild, 2012): 1. A large set of external individual exposures, including air pollutants, meteorological

factors, radiation, chemical exposures, as well as diet, physical activity and tobacco and other life-

style factors; 2. A wider general exposome, including the urban-rural environmental, the education

and the socio-economical and climate factors; 3. An internal exposome, consisting in endogenous

processes internal to the body (such as metabolic factors, gut microflora, inflammation or

oxidative stress). The inclusion of the internal exposome in exposome studies which has been

sometimes advocated (Rappaport, 2012; Vermeulen et al., 2020) can be discussed: indeed, if

biomarkers of exposures (for example levels of a given phthalate in urine) can be useful to assess

the individual exposures, components of the internal exposome can be considered to be

biomarkers of effects, whose levels and variations result from a wide range of exogenous and

genetic factors (Chadeau-Hyam et al., 2013). Last, the infectious factors, the “infectome”, are also

sometimes recognized as a part of the exposome (Bogdanos et al., 2015; Damiani et al., 2020).


                                                 17


                                                                           CHAPTER I: Introduction

Since 2010, numerous ambitious studies have been built in order to describe the exposome at the

individual level and its links with the health (see for example the 12 exposome projects funded by

the European Commission from 2012 to 2024, Table I.1).

             Assessing the exposome

Assessing the exposome involves many challenges: the first one is to know what to measure.

Exposome studies most often assessed an a priori defined set of exposures (see for example the

Helix project (Vrijheid et al., 2014)). An alternative or a complement is to screen for exogenous

chemicals using metabolomic biomarkers (Vermeulen et al., 2020) in an untargeted approach (see

for example (Bonvallot et al., 2013)). In targeted studies, the individual exposome is sometimes

assessed both by environmental models, for outdoors exposures such as air pollutants and

meteorological data, which often have the advantages to document the source of exposures, and

by biomarkers for individuals exposures to chemicals, such as phthalates or phenols (in urine) or

metals (in blood or other matrices), which allowed a more personal assessment (Maitre et al., 2018;

Vineis et al., 2017).

The measurement error (Armstrong, 1998) traditionally encountered in environmental

epidemiology is an important challenge for exposome assessment, as the exposome is dynamic

throughout time and as some chemicals components of interest have high within-subjects

variability (Agier et al., 2020b; Casas et al., 2018; Vernet et al., 2018): this includes in particular

short half-life compounds, such as phenols, phthalates and organophosphate pesticides (Casas et

al., 2018). Some studies, like the French SEPAGES cohort (Lyon-Caen et al., 2019), aim at

decreasing measurement error by increasing the number of measurement points in each subject,

e.g. relying on the so-called within-subject biospecimens pooling approach (Vernet et al., 2019). Whereas

the exposome encompasses all exposures from conceptions, it appears relevant for some exposome

studies to reduce measurement time window to focus on early life, as the early-life environment




                                                   18


                                                                        CHAPTER I: Introduction

may be critical for later health, as stated by the Developmental Origins of Health and Disease

(DOHaD) paradigm (Heindel et al., 2015); this is done by many exposome projects (see Table I.1).

            Relevance of the exposome concept for public health

The relevance of the application of the exposome concept in environmental epidemiology first lies

in such ambitious assessments: they allow to describe the correlations between exposures (see for

example (Tamayo-Uria et al., 2019) and Figure I.1). Such a description is crucial for environmental

justice (Brulle and Pellow, 2006), but also to better relate the environment to health and help

assessing the environmental burden of disease: indeed, the exposome may explain an important

part of chronic diseases (Manrai et al., 2017; Rappaport, 2016) and deaths (Gakidou et al., 2017),

which genetic factors are not sufficient to account for (Rappaport, 2016). Simultaneously

considering numerous exposures allows to limit selective reporting and publication bias in etiologic

studies (Slama and Vrijheid, 2015), to reckon with multiple testing and to help discarding

confounding by co-exposures. Moreover, an exposome approach may, at least in principle, enable

to identify mixture effects (Slama and Vrijheid, 2015), i.e. combinations and interactions between

multiple environmental exposures on their causal path to an health effect (Patel, 2017) (an

operational definition of interactions corresponds to departure from additivity in a linear setting

(Rothman et al., 2012)).




                                                19


                                                                      CHAPTER I: Introduction




Figure I.1: Median absolute correlation within exposure groups (diagonal) and between exposure
groups (off-diagonal) for the prenatal exposome assessed in the Helix Project (Figure from Tamayo
et al., 2019). Between-exposure correlations in a given exposure family can reach 0.8 (Tamayo-Uria
et al., 2019).




            Relating the exposome to health

The number of environmental factors assessed in such studies are typically in the order of a few

hundred (216 in HELIX (Tamayo-Uria et al., 2019)); after the assessment of the exposome, the

second main challenge of exposome studies, on which we will focus, is to manage to identify

causal predictors of health outcomes among these exposures, and assessing their effect.



                                               20


                                                                            CHAPTER I: Introduction

The first method used to do this was the ExWAS (for exposome-wide association studies), i.e.

univariate regressions (adjusted for confounders) relating independently each exposure to the

health outcome of interest and possibly corrected for multiple testing (Patel et al., 2010). Patel first

assessed the relationship between 266 exposures and type 2 diabetes (Patel et al., 2010). Since then,

ExWAS studies have been conducted to relate exposures to birth weight and foetal growth (Agier

et al., 2020a; Govarts et al., 2018, 2016; Lenters et al., 2016; Nieuwenhuijsen et al., 2019; Woods et

al., 2017), fecundity (Chung et al., 2019; Lenters et al., 2015; Louis et al., 2013), respiratory function

(Agier et al., 2019), mortality (Patel et al., 2013), child obesity (Vrijheid et al., 2020) and blood

pressure (Warembourg et al., 2019). Note that many exposome-type or so-called “mixtures” studies

have also been conducted, considering a few dozen exposures, typically for a couple of exposures

families (Lenters et al., 2016; Philippat et al., 2019; Woods et al., 2017).

These ExWAS studies probably suffer from a lack of power: indeed, assessing numerous exposures

implies costs which make these studies difficult to be performed on a number of individuals

sufficient to have enough statistical power (Patel et al., 2017) and to avoid spurious correlation

between exposures. This is expected to lead to false negative (low sensitivity) and false positive

findings. Moreover, the use in ExWAS of the classical tool of the low-dimension epidemiology, i.e.

univariate linear regression, can dramatically increase the “statistical” false-positive rates. This is

known as the ‘multiple comparison issue’: the higher the number of inferences made using an

acceptance threshold for type I error (usually 5%), the more likely erroneous inferences are to occur

(Benjamini and Hochberg, 1995). Moreover, some exposures are intrinsically correlated,

which makes true predictors of health outcomes difficult to differentiate from correlated

exposures (Slama and Vrijheid, 2015), which are thus predictors but not causal predictors : a

simulation study under a realistic exposome setting showed that ExWAS (understood as an

exposome-wide study using multiple univariate linear regression) false discovery proportion (FDP)

increases with correlation (Agier et al., 2016).



                                                   21


                                                                                                                              CHAPTER I: Introduction

Table I.1: Exposome project funded by the European Commission. All cited text comes from the website of Community Research and Development
Information Service (CORDIS) resources.
 European       Exposome            Aim                                          Which exposome           Population                   Assessing
 Funding        Project                                                                                                                biomarkers
 Programm
 FP7   (2012-   HELIX - The “To exploit novel tools and methods                  9      groups       of   31 472 mother-child          Yes,      on    a
 2017)          Human Early Life (remote sensing/GIS-based spatial               individuals exposures    pairs from 6 cohorts         subcohort of 1301
                Exposome          methods, omics-based approaches,               assessed            by   (Maitre et al., 2018).       individuals:
                (Vrijheid et al., biomarkers of exposure, exposure               biomarkers; and 5        2      windows          of   methylome,
                2014)             devices and models [..]), to characterize      groups of outdoor        exposures : pregnancy        transcriptome,
                                  early-life exposure to a wide range of         exposures, assessed      and            childhood.    proteome,
                                  environmental hazards, and integrate           by     models     (216   (Vrijheid et al., 2014).     metabolome
                                  and link these with data on major child        exposures in total)                                   (Vrijheid et al.,
                                  health outcomes”.                                                                                    2014)

 FP7   (2012- EXPOSOMICS            “To predict individual disease risk          An            external   Subpopulation        of      Yes: metabolome
 2017)                              related to the environment, by               exposome focusing        various        cohorts,      (“internal
                                    characterizing the external and internal     on air pollutants and    including both prenatal,     exposome”),
                                    exposome for common exposures (air           water contaminants,      child and later life         methylome,
                                    and drinking water contaminants)             and an “internal         cohorts.                     transcriptome
                                    during critical periods of life, including   exposome”,         the                                (Vineis et al., 2017)
                                    in utero”.                                   metabolome. (Vineis
                                                                                 et al., 2017)

 FP7   (2012- HEALS - Health        “To [refine] an integrated methodology       Both internal (135 Children              cohorts, No intermediate
 2017)        and Environment-      and       [apply]     analytical   and       biomarkers)          and including twin cohorts biomarkers
              wide Associations     computational tools for elucidating          external              (64
              based on Large        human exposome through the                   exposures) exposome
              population Surveys    integrated use of advanced statistical       (Steckling et al., 2018)
                                    tools for environment-wide association
                                    studies in support of EU-wide
                                    environment and health assessments”

                                                                         22


                                                                                                                    CHAPTER I: Introduction



H02020        ATHLETE         “To develop a toolbox of advanced,        “multiple                 “15 cohorts in 10          Yes:
(2020-2024)   Advancing Tools next-generation, exposome tools and a     environmental      risk   European countries »,      “metagenomic,
              for Human Early prospective exposome cohort, which        factors                   during the “20 first       metabolomic,
              Lifecourse      will be used to systematically quantify   (external/urban,          years of life”             epigenetic »
              Exposome        the effects of a wide range of            chemical,     physical,
              Research    and community-level and individual-level      behavioral, social)”
              Translation     environmental risk factors on mental,
                              cardiometabolic, and respiratory health
                              outcomes and associated biological
                              pathways during the first 2 decades of
                              life, to implement acceptable and
                              feasible exposome interventions, and
                              to translate the resulting evidence to
                              policy      recommendations        and
                              prevention strategies. »

H02020        EXPANSE           To “study the impact of the Urban       Outdoor exposome,         Existing exposome data     Yes: metabolome
(2020-2024)   EXposome          Exposome on [..] Cardio-Metabolic       diet and individual       on      “2       million   to         assess
              Powered tools for and Pulmonary Disease”                  exposome assessed by      Europeans,          and    individual
              healthy living in                                         untargeted screening      personalized               exposome
              urbAN SEttings                                            for       exogenous       Exposome assessment
                                                                        chemicals                 for 5,000 individuals”

H02020        HEAP - Human To build an exposome assessment Not yet described          Not yet described    Yes: epigenome
(2020-2024)   Exposome     platform                                                                        and metagenome
              Assessment
              Platform
H02020        REMEDIA      To     “expose   the    impact     of “exposures from the Existing cohorts, not No
(2020-2024)                environmental factors on debilitating environment,   diet, yet described
                           lung disease”                         behavior        and
                                                                 endogenous
                                                                 processes”

                                                                 23


                                                                                                               CHAPTER I: Introduction



H02020        HEDIMED         To “identify exposomic determinants Not yet described           “A combination of data Not yet described
(2020-2024)   Human           which are driving” immune-mediated                              and biological samples
              Exposomic       diseases.                                                       from large clinical
              Determinants of                                                                 cohorts,      including
              Immune Mediated                                                                 350.000        pregnant
              Diseases                                                                        women,           28.000
                                                                                              children prospectively
                                                                                              followed from birth
                                                                                              and 6.600 children
                                                                                              from     cross-sectional
                                                                                              studies
H02020        EXIMIOUS            “To construct ‘immune fingerprints’ Not yet described       Not described yet        Yes
(2020-2024)   Mapping             that reflect a person’s lifetime
              Exposure-Induced    exposome and identify ‘immune
              Immune Effects:     fingerprints’ that are early signs of poor
              Connecting    the   health and predictors of disease at the
              Exposome and the    individual level”
              Immunome

H02020        EPHOR          - To “develop a working-life exposome The       working-life Not yet described           Not yet described
(2020-2024)   Exposome project toolbox”                            exposome, defined as
              for health and                                       “all occupational and
              occupational                                         related          non-
              research                                             occupational factors
                                                                   (general and socio-
                                                                   economic
                                                                   environment, lifestyle,
                                                                   behavior)”

H02020        Equal-Life - Early “To utilize the exposome concept in an External exposome “A combination of Yes              (not    yet
(2020-2024)   Environmental      integrated study of the external and           physiological birth-cohort data with described)
              quality and life- exposome and its social aspects and of factor

                                                                 24


                                                                                                                CHAPTER I: Introduction


              course       mental measurable internal physiological                         new sources of data”
              health effects      factors and link those to a child's                       (N=>250.000)
                                  development and life course mental
                                  health”

H02020        LONGITOOLS            To “study and measure how exposures Not described yet   Not described yet         Yes:         DNA
(2020-2024)   Dynamic               to [the environment such as air and                                               methylation, RNA
              longitudinal          noise pollution and the built                                                     expression    and
              exposome              environment, and individual’s lifestyle,                                          read    outs   of
              trajectories     in   psychological and social situation]                                               metabolic
              cardiovascular and    contribute to the risk of developing                                              pathways.
              metabolic     non-    [diseases such as obesity, type 2
              communicable          diabetes and cardiovascular diseases]
              diseases              through a person’s life




                                                                   25


                                                                          CHAPTER I: Introduction

             Considering the false positive rate issue in a structural causal framework

The problem of false positive findings, central in exposome studies, may gain to be considered

within a structural causal framework. Indeed, a part of epidemiology is interested in finding the

causal predictors of health, i.e. not factors which allow to predict an outcome, but factors which

have a causal effect on the outcome. This distinction between risk prediction and causal inference,

i.e. between risk predictors and causal factors (or “true predictors”), is crucial for later use of

epidemiological findings in public health, as only causal predictors are relevant targets for clinical

or public health interventions.

Identifying with accuracy true predictors of an event means avoiding false-positive as well as

false-negative results, i.e. requires to be both specific and sensitive. When epidemiologists

identify statistical associations between factors and an outcome in a sample to try to identify true

predictors of this outcome in a population, they are likely to encounter two types of false-positive

associations. The first type is the false positive due to sampling variability, the “random error”. The

second type occurs when a structural association which truly exists in the population is

identifiable in the sample, but has no causal meaning. Indeed, as described by Hernán et al.

(2004), an association between two variables can occur in five cases:

    a. One is cause of the other, i.e.:

                a1. The variable of interest (typically the outcome) is influenced by the a priori

                explanatory variable (typically an exposure): if detected, the association corresponds

                to a true positive.

                a2. The variable of interest causes the a priori explanatory variable: possibly leading

                to a false-positive finding due to reverse causality.

    b. They share a common cause: this leads to a confounding bias, potentially creating false

        positive (or also false-negative) finding.




                                                     26


                                                                          CHAPTER I: Introduction

    c. They share a common consequence. If one controls for this consequence, a selection bias

        occurs, and can lead to false positive (or also false-negative) findings.

    d. By chance, due to sampling variability.

All situations a, b, and c correspond to structural associations but only case a1 corresponds to the

identification of a causal predictor. Case e corresponds to a false positive “by-chance”: in this case,

the observed association, has not only no meaning of causal association, but does not correspond

to a structural association. The association then depends on the size of the study sample: chance

associations become smaller with increased sample size whereas structural associations remain

unchanged (Hernán et al., 2004). In the classical framework of statistical tests, this type of false

positive association by chance corresponds to the type I error, i.e. rejecting as false the null

hypothesis of independence whereas it is true in the source population. To this classification made

by Hernan inside the causal framework, we must add the measurement error (Armstrong, 1998).

Thus, identifying the true predictors of a health outcome without false positive means, for the

epidemiologist, to identify structural associations without false-positives (i.e. avoiding case d) and

being able to point among these associations the ones which correspond to a causal link (i.e.

distinguishing case a1 from the other cases a2, b and c).

Cases a2, b and c are biases and thus cannot be cured by increases in the sample size, but by options

related to study design and statistical modeling (e.g., adjustment for confounding factors),

supported by information on the causal structure or a priori information. Situation a2 of reverse

causality is generally considered to be avoidable by external knowledge on the data generation

process (e.g., the underlying biological mechanisms and the study design, including in particular the

timing of assessment of E and Y).

Additionally, one should symmetrically avoid also false-negative findings, i.e. be able to identify a

causal association when it exists. False negative associations can also occur by random fluctuations,



                                                  27


                                                                          CHAPTER I: Introduction

which, in the framework of statistical tests, correspond to type II error, which is linked to the power

of the method of identification.




                                                  28


                                                                        CHAPTER I: Introduction




               Statistical techniques to address false positive and false negative challenges

            in exposome studies

             Multiple testing correction

To face the above-mentioned challenges of the exposome related to the simultaneous

consideration of multiple and possibly correlated exposures, relying on statistical methods more

suitable to intermediate and high dimensional data than the classical regression model typically used

in “single exposure” analysis (the ExWAS) can be seen as a solution.

Statistical methods have been developed to tackle the problem of by-chance findings. These

techniques include correction for multiple testing and dimension reduction, in particular variable

selection (Chadeau-Hyam et al., 2013).

Various multiple testing correction techniques have been developed to solve the multiple

comparison problem, proposing to adapt the significance threshold of 5% most often used in

univariate regression, making it stricter to compensate for the number of inferences being made.

Two strategies can be distinguished: False-Discoveries-Rate (FDR) controlling procedures and

Family-Wise error Rate (FWER) controlling procedures. FDR-controlling procedures control the

expected proportion of "discoveries" (rejected null hypotheses) that are false, whereas FWER-

controlling procedures control the probability of at least one Type I error, which is more

conservative. They are widely used, and all the ExWAS studies that we cited in paragraph I.1.4

applied one of these controlling procedures. Three of the most common strategies of

implementation are Benjamini and Hochberg (Benjamini and Hochberg, 1995) and Benjamini and

Yekutieli (Benjamini and Yekutieli, 2001) for FDR-controlling techniques and Bonferroni (Dunn,

1961) for FWER-controlling techniques. The simulation by Agier et al. (2016) in realistic exposome

settings showed that the addition of a FDR controlling procedure to independent linear regression

(which is the most common implementation of the ExWAS method) allowed to decrease the FDP

                                                 29


                                                                           CHAPTER I: Introduction

from always more than 0.89 (without correction) to values between 0.67 and 0.93 (with correction).

This decrease in FDP came together a strong decrease in sensitivity: indeed, the Benjamini-

Yekutieli procedure used to adjust for multiple testing as well as the other procedures cited above

assume that the tests are independent, which is in practical never the case in exposome studies, as

exposures are often correlated. Correlation, additionally to create false-positive findings, also makes

the number of effective tests performed lower than the number of associations tested, which

decreases ExWAS power when a multiple comparisons correction technique is applied. Thus,

adaptation of Bonferroni or Benjamini-Hochberg procedures taking into account a computed

effective number of tests have been proposed (see for example (Li et al., 2012)) to target the

decreased in power, but they also enhance the lack of specificity linked to correlation that we

described in I.1.4.

             Curse of dimensionality and dimension reduction techniques

To address the issue of false-positive hits linked to correlation and confounding, multiple

regression appears as a relevant option: however, the size of current exposome studies prevents its

use, as it is expected to be biased in such dimension (Sur and Candès, 2019). Here, an option is to

use “dimension reduction techniques”. In fact, some problems encountered when dealing with

intermediate or high dimensional data such as the exposome, known as the “curse of

dimensionality” (a term first used by Bellman in 1961 (Bellman, 1961)), were the motivation of the

development of dimension reduction techniques. Indeed, when the number of variables (and so

the dimensionality of the features space) increases, the number of possible configurations increases

too, making the configuration covered by an observation smaller compared to all possibilities. In

other words, for a defined number of individuals, with more variables, the information may be

richer, but it is also more diluted. In practice, this leads to several challenges when trying to extract

information from the data: for example, the "vastness" of high-dimensional space often prevents

algorithms based on similarity measures (k-neighbors, decision trees…) to work (Houle et al., 2010)

and the number of samples needed to estimate an arbitrary function with a given level of accuracy

                                                   30


                                                                         CHAPTER I: Introduction

grows with the dimensionality. This explained why the classical maximum-likelihood estimator may

be biased when the ratio of the number of independent variables to the number of individuals is

typically of 0.2 or more (Sur and Candès, 2019), a ratio which is expected to be even lower if

variables are correlated, which explains the difficulty to use multiple regression in current

exposome studies. Overall when the number of observations is small compared to the number of

features (intermediate or high dimension), dimension reduction may be needed to build good

models, in particular for selection of causal predictors. Dimension reduction techniques belong to

two major categories: selection techniques, which eliminate some variables while keeping the

others, or extraction techniques, which create a set of new variables (Guyon and Elisseeff, 2003).

Methods such as sparse Partial Least Squared Regression (sPLS) (Chun and Keleş, 2010) or

Regularized Generalized Canonical Correlation Analysis (RGCCA) (Tenenhaus et al., 2017) are for

example extraction techniques: they restrict to a small number of new covariates with low or null

collinearity whose association with the outcome is assessed. Even if they allow to handle at least

partially some of the challenges of false positive association in high dimension, their main drawback

is their lack of interpretability (Lazarevic et al., 2019).

              Multivariate variable selection methods

Multivariate variable selection methods could be more suitable to the exposome problem, as they

may be able to handle correlation and interactions while allowing easy interpretability. Some

simulation studies (Agier et al., 2016; Barrera-Gómez et al., 2017; Lazarevic et al., 2019; Lenters et

al., 2018) have shown that under specific assumptions, methods such as LASSO (Least Absolute

Shrinkage and Selection Operator) (Tibshirani, 1996), ElasticNet (Zou and Hastie, 2005), Deletion-

Substitution-Addition algorithm (DSA) (Sinisi and van der Laan, 2004), Weighted Quantile Sum

regressions (WQS) (Carrico and Gennings, 2013) may allow to identify the true predictors of an

health outcome among a set of exposures with good sensitivity and improved specificity (lower

FDP) compared to ExWAS (see Figure I.2).



                                                     31


                                                                          CHAPTER I: Introduction

These methods are becoming more common in exposome studies and to some extent tend to

replace the ExWAS. Since 2015, (Agier et al., 2020a, 2019; Forns et al., 2016; Lenters et al., 2016;

Philippat et al., 2019; Vrijheid et al., 2020) for example, used at least one of the methods cited

above.

Figure I.2: Sensitivity and FDP of 6 different statistical methods assessed from a Monte-Carlo
simulation assuming a causal relationship between predictors drawn from a realistic exposome and
a health outcome. Each predictor explained 3% of the variance of the outcome. DSA,
Deletion/substitution/addition; ENET, elastic net; EWAS, environment-wide association study;
EWAS-MLR, EWAS- multiple linear regression; GUESS, Graphical Unit Evolutionary Stochastic
Search; sPLS, sparse partial least-squares (Agier et al., 2016).




However, these methods have some limits which should be acknowledged. First, none of them

allows an accurate balance between sensitivity and specificity when detecting structural

associations: the simulation by Agier et al. (2016) showed that, under specific hypotheses,

regression-based selection methods have sensitivity that do not exceed 81% and false discovery

proportion (FDP) rate which were at least at 34 %. Methods with the best sensitivity were also

those with the highest FDP. More generally, in realistic settings, it appears very difficult to reach a

FDP of about 5% without having a null sensitivity.

Moreover, stability is also a concern for most of these methods. In machine learning theory,

stability is the notion that a small perturbation in the training dataset(s) will not change the learned

                                                  32


                                                                                CHAPTER I: Introduction

model, and thus the prediction of the learning algorithm (Poggio et al., 2004). Stability is directly

linked to the generalization property of the algorithm (Poggio et al., 2004): intuitively, predictions

robust to small perturbations are more likely to be good on a similar dataset. Whereas machine

learning often focuses on prediction accuracy, environment epidemiologists, as already stated, are

more interested in feature selection, as they want to identify causal predictors of health. In our case,

stability should therefore be discussed considering the stability of the subset of selected predictors, defined

in the machine learning field by Nogueira et al. (2017), rather than prediction stability. These may

not be equivalent since it is possible that the predicted outcome (or risk) does not always change

as the set of selected predictors changes. Instability lowers confidence in results and, as underlined

previously (Lee et al., 2013; Nogueira et al., 2017), generalizability. This notion of stability is

intrinsically linked to the problem of true predictors: a non-reproducible algorithm which will give

non-identical results in term of selection in all different subsamples of a population has necessarily

identified false positives, but a stable prediction can in some cases be achieved using different

actors correlated with the true predictors, which is often the case in a high dimension setting.

In addition to showing the limits of such algorithms to avoid false positive associations, this also

highlights a fundamental difference between prediction and feature selection: whereas

accurate prediction can be achieved with appropriate data, sample size and learning algorithm,

selection of causal predictors (or counterfactual prediction, i.e. prediction using causal predictor)

requires additional information. Hernán et al. (2019) underlined that only an expert using a priori

knowledge can be able to differentiate a causal predictor from a variate perfectly correlated: “causal

analyses typically require not only good data and algorithms, but also domain expert knowledge”

(Hernán et al., 2019).

Methods developed in epidemiology to avoid bias and reverse causality all imply a priori knowledge:

for example, structural causal modelling (Pearl, 2009) assumes that the epidemiologist knows the




                                                      33


                                                                         CHAPTER I: Introduction

underlying causal structure; the assumption of lack of reverse causality in longitudinal studies comes

from the additional information about the causal meaning of the time variable.

However, some methods try to infer causal structure from the data: for example, Bayesian

structural learning, also known as causal probabilistic networks (Uusitalo, 2007), which uses

Bayesian theory to find the causal structure which better fits the data. However, at least some prior

knowledge is most often needed for Bayesian modelling, and as underlined by (Uusitalo, 2007),

“theories about causal connections generally result in better models.”




                               Adding biological information

             Focusing a priori on a single exposure

An additional way to cope with the challenges of exposome studies related to the high false positive

and false negative rate could be the use of a priori information. One way to do so would be to

focus a priori on an exposure or a set of exposure of interest for example using knowledge from

the toxicological field. For many health outcomes relevant to humans, however, a good animal

model is lacking (e.g. asthma, autism...). Such studies could be nested in an exposome project, but

such an approach is limited by available toxicological knowledge and does not take advantage of

biological information at the level of the exposome. One option would be to use a priori

information about intermediate biological layer.

             Information from intermediate biological layers

Several intermediary biological layers can be measured between the exposures and the health

outcome considered: epigenome (DNA methylation), transcriptome (RNA), proteome and

metabolome. They can show physiological responses to external exposures, thus constituting

internal signatures of health outcomes. These ‘omics data, as potential biomarkers of exposures

early effect, or biomarkers of disease risk, are possibly a precious but complex additional

information about the link between exposures and health (Chadeau-Hyam et al., 2013; Crews and

                                                   34


                                                                          CHAPTER I: Introduction

Gore, 2011). Assessing the association between these biomarkers and the variation in exposures

levels/health outcome may give some insight about how the health effect of one or more given

exposure is biologically mediated (Ho et al., 2012).

DNA methylation, which is the addition of a methyl group in cytosine-guanine context (CpG

site) on a DNA chain, depends both on genetic and environmental influences (Feil and Fraga, 2012;

Marioni et al., 2018). At a biological level, DNA methylation is essential to control DNA

transcription and thus cell differentiation, phenotype and functioning (Michalowsky and Jones,

1989). The influence of various early-life environmental factors on interindividual variation in

methylation on specific loci (CpG sites) has been demonstrated (Baccarelli et al., 2009; Joubert et

al., 2016). These epigenetic alterations can result in modified disease risk (Ho et al., 2012), even if

there is so far little convincing estimates of the share of the effect of environmental factors on

health mediated by epigenetic changes.




Figure I.3 : Schematic representation of links between exposome, intermediate biological layers

and health effects. Figure from (Vrijheid, 2014).




                                                  35


                                                                        CHAPTER I: Introduction

Different strategies were developed to integrate these methylation, and more generally omics, data

in epidemiology and use them to better understand mechanisms of environmental effect on health

(Blum et al., 2020; Chadeau-Hyam et al., 2013). Due to their high dimension (for one individual,

current methylation measures based on commercial arrays assess between 450,000 and 850,000

CpG sites) and their correlation structure, discovering biomarkers of interest for specific exposures

and/or diseases is challenging. Dimension reduction techniques and multivariate analyses have,

again, been used (see for example (Parkhomenko et al., 2007)).

A Meet-in-the-Middle framework has been developed by Chadeau-Hyam and colleagues in the

context of studies considering a single exposure and single outcome to point intermediate

biomarkers. The approach is often followed by a mediation analysis for these biomarkers: overlap

between omics associated with exposure and outcome are considered as putative mediators

(Chadeau-Hyam et al., 2011; Vineis and Perera, 2007).

Figure I.4: Implementation of Meet-in-the-Middle. Adapted from (Chadeau-Hyam et al., 2011).




Nowadays, these complex layers are paradoxically fairly well-known from biological studies and

annotated; large database are now available about the functionality of genes/proteins/metabolites

and the biological pathways, i.e. the biological network, in which they are involved, such as KEGG

(http://www.genome.ad.jp/kegg/) (Tanabe and Kanehisa, 2012) or Gene Ontology (http://www.

geneontology.org/ (Pavlidis et al., 2004).

                                                 36


                                                                         CHAPTER I: Introduction




                Mediation analysis

The concept of biological mechanism can be framed in epidemiology with the notion of mediation

(Vanderweele and Vansteelandt, 2009).

Mediation analysis aims at identifying the mechanisms (or pathways) through which an exposure

E can influence an outcome Y (Figure I.5), and quantifying the importance of these pathways.

More precisely, the theory of mediation (VanderWeele, 2011) assumes that there is a causal link

between E and Y and that a potential mediator M of this effect is identified. The effect of E on Y

which is not mediated by M is called the direct effect whereas, if M is indeed a mediator, the

proportion of the association between E and Y that occurs through M is called the indirect (or

mediated) effect of E (see Figure I.5).

In the case where M and Y are quantitative variables and residuals are normally distributed, two

linear models representing these effects can be written (Baron and Kenny, 1986):


        𝔼(Y)=0 + 1E + 2M + 3C (Exposure-outcome model)

where 𝔼 is the mathematical expectation, E the exposure variable and C a vector including all
potential confounders of the exposure-outcome, exposure-mediator and mediator-outcome
associations.

        𝔼(M)=b0 + b1E + b2C’         (Exposure-mediator model)

where C’ is a vector including all potential confounders of the exposure mediator association.

The estimation of direct and indirect effect, requires, beside the postulate that the effect from E to

Y is causal, major assumptions (Vanderweele and Vansteelandt, 2009):


       the lack of uncontrolled confounders for all three mediator-outcome / exposure-mediator

        / exposure-outcome associations,

       the lack of mediator-outcome confounder affected by the exposure and of interaction

        between exposure and mediator.

                                                 37


                                                                         CHAPTER I: Introduction


If these hypotheses are met, 1 is an estimate of the direct effect, and b1 x2 is an estimate of the

indirect effect (Baron and Kenny, 1986; MacKinnon et al., 2002; Vanderweele and Vansteelandt,

2009).

A well-known test for mediation is the causal inference test, which successively tests the

significance of the overall exposome-outcome association not adjusted for M, b1 and 2 (Baron and

Kenny, 1986; MacKinnon et al., 2002).




Figure I.5: Causal graph of mediation.




CpGs sites are good candidate mediators between exposures and health. For example,

Fasanelli and colleagues, estimated by ExWAS that in adults smoking reversibly caused

hypomethylation on two specific CpGs, and that the total effect of smoking on lung cancer risk is

mediated by more than 35% by methylation variation at these specific marks (Fasanelli et al., 2015).

However, considering the methylome layer instead of only some specific targeted CpGs

complexifies a lot the mediation analysis. Among the challenges of the mediation analysis in high

dimension (Barfield et al., 2017; Blum et al., 2020), the a priori causal knowledge on the relation

between covariates, which is required for mediation analysis, is expected to be more difficult to

decipher, in particular when the relations between potential mediators are complex, which is the

case in the methylome layer (Blum et al., 2020).




                                                   38


                                                                        CHAPTER I: Introduction

            Using intermediate biological layer to find true predictors of health within the

            exposome

Omics layers could provide an additional information source to study associations between the

exposome and health and to overcome some challenges of the exposome and not only as a way to

understand some already known associations. This is one of the key assumptions underpinning this

PhD project. In particular, information from epigenetic marks could be used to reduce the

dimension of the exposome with the hope to overcome some of the limits of purely agnostic

exposome approaches: performing informed dimension reduction using the methylome, for

example considering only exposures having influence on biological mechanisms relevant for the

outcome of interest, could be a way to increase the power of exposome studies or decrease the

false discovery proportion as well as to avoid some false positives due to structural association

without causal meaning.

At another level, the restriction to candidate genes in studies of the association between the

methylome and an outcome (see for example (Richmond et al., 2016)) can be seen as a similar

strategy: using information from the genomic layer is expected to increase power as well as to test

only the most a priori plausible CpGs.

Due to the complexity of the methylome layer and its high dimension, challenges encountered with

the exposome can be even compounded when relying on methylome data to reduce the exposome

dimension. Indeed, it could seem paradoxical to aim to use a high dimension layer (the methylome)

in order to reduce the dimension of a low dimension layer (the exposome). However, it must be

underlined that part of the difficulties rising for the exposome do not hold when the aim of

the use of the methylome is not the identification of causal relevant CpGs but only to

inform the relation between exposome and health. In particular, one can here adopt a risk

prediction rather than a causal analysis logic, contrarily to what is sometimes aimed for in a Meet-

in-the-Middle approach.


                                                39


                                                                         CHAPTER I: Introduction

                 Environmental effects on child weight

Such strategies can be used to better understand the causal relationship between early-life

exposome and child health outcomes. During this PhD, we focused on child body mass index as

our main outcome of interest, and also considered another measure of child growth, birth weight,

as well as child lung function.

             Environmental effects on child Body Mass Index

Childhood greater Body Mass Index (BMI), defined as the weight in kilogram divided by the

squared height in centimeters, is associated with future risk of obesity as well as other risks of

diseases, including type 2 diabetes, some cancers and cardiovascular diseases, lack of school

achievement, and mental health problems (Han et al., 2010; Park et al., 2012; Quek et al., 2017;

Singh et al., 2008).

Childhood obesity and overweight, which have increased rapidly in the three last decades (Finucane

et al., 2011), are multifactorial conditions. Changes in the most important risk factors, genetic

predisposition and energy imbalance (McAllister et al., 2009), are not sufficient to fully explain the

magnitude and speed of the recent increase (Park et al., 2017). Other environmental factors

influencing child obesity and adiposity have been identified. They include prenatal exposures, such

as maternal smoking (Von Kries et al., 2002) and traffic noise exposure during pregnancy (Weyde

et al., 2018) but also exposures occurring during early-life: exposures to some endocrine disruptors

during first years of life (Agay-Shay et al., 2015; Holtcamp, 2012; Thayer et al., 2012), exposures to

metals (Shao et al., 2017) and life-style factors such as physical activity and thus built environment

characteristics like green spaces which contributes to it (Gascon et al., 2016; Lachowycz and Jones,

2011). Overall, the environmental obesogenic hypothesis states that these early exposures play a

role in future obesity development by altering metabolic programming (Janesick and Blumberg,

2011; Park et al., 2017).




                                                 40


                                                                          CHAPTER I: Introduction

             Environmental effects on birth weight

Birth weight is also a determinant of later health condition and is considered as a marker of the

intrauterine environment (Belbasis et al., 2016); low birth weight has been associated with various

later comorbidities, including metabolic diseases, cardiovascular diseases and cardiovascular risk

factors (Belbasis et al., 2016) and respiratory health (Kindlund et al., 2010). Some evidence exists

about the impact of prenatal exposures on birth weight: besides maternal tobacco (Windham et al.,

2000) and alcohol consumption (Little, 1977; Mills et al., 1984; Strandberg-Larsen et al., 2017),

higher temperature during pregnancy (Strand et al., 2011) and maternal exposure to air pollutants

(Bell et al., 2010; Parker et al., 2005; Pedersen et al., 2013; Stieb et al., 2012) have been associated

with lower birth weight. An effect of mother undernutrition has also been suggested (Stein and

Lumey, 2000). Exposures to some phthalates (MEHHP and MOiNP), a perfluoroalkyl acid

(PFOA), and an organochlorine (p,p´‑DDE) have also been related with decreased birth weight

in an exposome study (Lenters et al., 2016). Last, a study on Helix exposome data (Vrijheid et al.,

2014) relying on both DSA and ExWAS method pointed the prenatal exposure to green area

(NDVI, Normalized Difference Vegetation Index) as significantly associated with an increased

birth weight (Nieuwenhuijsen et al., 2019), an association which has already been suggested by

Dadvand et al. (2014) .




                PhD project’s aim

Overall, we identified research needs both regarding the understanding of early environmental

drivers of child growth and obesity and regarding efficient methods to identify them from the

exposome and to improve exposome studies in general. In particular, even if some statistical

methods have been pointed as being possibly more efficient than the classical ExWAS, methods

currently used most often provide discouraging false-discovery rate when trying to detect the causal

predictors of a health outcome (Agier et al., 2016). They are also expected to be prone to reverse


                                                  41


                                                                         CHAPTER I: Introduction

causality, especially when exposures biomarkers are assessed in a cross-sectional design. Last, the

possibilities offered by the intermediary biological layers and the a priori knowledge available about

them are for the moment not exploited in exposome studies as resources allowing to help pointing

new causal predictors of a health outcome.

In this research, we aim at building novel strategies to inform the association between the

exposome and a health outcome, and to propose insights about how exposome studies could better

tackle the challenges related to high false positive rates and low sensitivity of exposome studies.

We aim to do so by considering both “purely statistical” approaches and approaches incorporating

(more) a priori biological information, considering specifically biological knowledge related to

DNA methylation.

The objectives are both methodological, with the development of specific methods, and applied,

aiming at informing the early environmental influences on child birthweight and later BMI.

In the second chapter of this report, we present an exposome study on the environmental

determinants of BMI based on Helix data (Vrijheid et al., 2014), which used methylome data using

a modified “Meet-in-the-Middle” (oMITM) approach that we developed. In the third chapter, we

present a short study where this method is repeated on Helix data considering another child

outcome, the lung function. We also provided in an appendix the preliminary results of an ongoing

study on Sepages cohort (Lyon-Caen et al., 2019), repeating an oMITM design with a different

implementation to study the relationship between prenatal exposome and birthweight, taking

advantage of methylome data. After these studies based on real data, we present in the two last

results chapters two simulations studies (chapters IV and V) aiming at validating the original

approach we proposed in chapter II under various causal structure and to identify the most relevant

implementation(s). Chapter IV focuses on the performance of the oMITM design under various

causal structures and aims at understanding how the use of methylome data can help limiting the

false positive rate. Chapter V presents a simulation study emphasizing the problem of instability


                                                 42


                                                                         CHAPTER I: Introduction

when using complex machine learning algorithms in epidemiology. In our last chapter, we discuss

what insights our work can give about how environmental epidemiologists should deal with the

dimension and the causality challenges of exposome studies.



 A note on terminology: in the article detailed in chapter II (Cadiou et al., 2020), we proposed
 an innovative design adapted from an existing design usually called “Meet-in-the-Middle” in the
 literature (Chadeau-Hyam et al., 2011). In our published article reproduced in chapter II, we kept
 the term “Meet-in-the-Middle” (MITM) to call our adapted design. Later, we chose to rather use
 the term “oriented Meet-in-the-Middle” (oMITM) to underline the differences between our
 design and the classical Meet-in-the-Middle, a term which is used in all the other chapters of this
 thesis.




                                                 43


44


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks

CHAPTER II:       Early-life Exposures and child Body Mass Index: a Meet-in-the-
  Middle approach using preselected methylation marks
The work presented in this chapter is a study on the relationship between the exposome and child Body Mass
Index on the data of the Helix project. To inform this relationship, methylome data are used in an innovative
oriented Meet-in-the-Middle design, implemented with ExWAS-type methods. It has been published in
Environment International:

Cadiou, S., Bustamante, M., Agier, L., Andrusaityte, S., Basagaña, X., Carracedo, A., Chatzi, L.,
Grazuleviciene, R., Gonzalez, J.R., Gutzkow, K.B., Maitre, L., Mason, D., Millot, F.,
Nieuwenhuijsen, M., Papadopoulou, E., Santorelli, G., Saulnier, P.-J., Vives, M., Wright, J.,
Vrijheid, M., Slama, R., 2020. “Using methylome data to inform exposome-health association
studies: An application to the identification of environmental drivers of child body mass
index.” Environment International. 138, 105622, doi:10.1016/j.envint.2020.105622




                                                       45


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
               Abstracts

             English abstract

Background: The exposome is defined as encompassing all environmental exposures one

undergoes from conception onwards. Challenges of the application of this concept to

environmental-health association studies include a possibly high false-positive rate.

Objectives: We aimed to reduce the dimension of the exposome using information from DNA

methylation as a way to more efficiently characterize the relation between exposome and child body

mass index (BMI).

Methods: Among 1,173 mother–child pairs from HELIX cohort, 216 exposures (“whole

exposome”) were characterized. BMI and DNA methylation from immune cells of peripheral

blood were assessed in children at age 6–10 years. A priori reduction of the methylome to preselect

BMI-relevant CpGs was performed using biological pathways. We then implemented a tailored

Meet-in-the-Middle approach to identify from these CpGs candidate mediators in the exposome-

BMI association, using univariate linear regression models corrected for multiple testing: this

allowed to point out exposures most likely to be associated with BMI (“reduced exposome”).

Associations of this reduced exposome with BMI were finally tested. The approach was compared

to an agnostic exposome-wide association study (ExWAS) ignoring the methylome.

Results: Among the 2284 preselected CpGs (0.6% of the assessed CpGs), 62 were associated with

BMI. Four factors (3 postnatal and 1 prenatal) of the exposome were associated with at least one

of these CpGs, among which postnatal blood level of copper and PFOS were directly associated

with BMI, with respectively positive and negative estimated effects. The agnostic ExWAS identified

18 additional postnatal exposures, including many persistent pollutants, generally unexpectedly

associated with decreased BMI.

Discussion: Our approach incorporating a priori information identified fewer significant

associations than an agnostic approach. We hypothesize that this smaller number corresponds to

                                                 46


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
a higher specificity (and possibly lower sensitivity), compared to the agnostic approach. Indeed, the

latter cannot distinguish causal relations from reverse causation, e.g. for persistent compounds

stored in fat, whose circulating level is influenced by BMI.

             French abstract

Contexte : L'exposome est défini comme l’ensemble des expositions environnementales

auxquelles on est exposé dès la conception. L'application de ce concept à l’étude des liens entre

l'environnement et la santé pose des défis, notamment en raison d'un taux de faux positifs

potentiellement élevé.

Objectifs : Nous avons cherché à réduire la dimension de l'exposome en utilisant les informations

provenant de la méthylation de l'ADN, comme une façon de caractériser plus efficacement la

relation entre l'exposome et l'indice de masse corporelle (IMC) de l'enfant.

Méthodes : Parmi 1 173 paires mère-enfant de la cohorte HELIX, 216 expositions ("exposome

entier") ont été caractérisées. L'IMC et la méthylation de l'ADN des cellules immunitaires du sang

périphérique ont été évalués chez les enfants à l’âge de 6 à 10 ans. Une réduction a priori du

méthylome par préselection des CpG pertinents pour l'IMC à partir de banques de données de

pathways a été effectuée. Nous avons ensuite mis en œuvre une approche Meet-in-the-Middle adaptée

pour identifier au sein de ces CpG de potentiels médiateurs de relations entre expositions et IMC,

en utilisant des modèles de régression linéaire univariés corrigés pour les tests multiples : cela a

permis d’identifier les expositions les plus susceptibles d'être liées à l'IMC ("exposome réduit").

L’association de cet exposome réduit avec l'IMC a finalement été testé. L'approche a été comparée

à une étude d'association agnostique à l'échelle de l'exposome (ExWAS) ignorant le méthylome.

Résultats : Parmi les 2284 CpG présélectionnés (0,6 % des CpG évalués), 62 étaient associés à

l'IMC. Quatre facteurs (3 postnataux et 1 prénatal) de l'exposome étaient associés à au moins un

de ces CpG, parmi lesquels les taux sanguins postnataux de cuivre et de PFOS étaient directement

associés à l'IMC, avec des effets estimés respectivement positif et négatif. L'ExWAS agnostique a

                                                 47


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
identifié 18 expositions postnatales supplémentaires, dont de nombreux polluants persistants,

généralement associés, de manière non attendue, à une diminution de l'IMC.

Discussion : Notre approche intégrant des informations a priori a identifié moins d'associations

significatives qu'une approche agnostique. Nous émettons l'hypothèse que ce nombre plus faible

correspond à une spécificité plus élevée (et peut-être à une sensibilité plus faible), par rapport à

l'approche agnostique. En effet, cette dernière ne peut distinguer les relations causales de la

causalité inverse, par exemple pour les composés persistants stockés dans les graisses, dont le

niveau de circulation est influencé par l'IMC.




                                                 48


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks
            Published article




                                           49


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           50


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           51


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           52


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           53


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           54


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           55


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           56


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           57


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           58


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           59


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           60


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           61


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           62


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           63


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks




                                           64


                   CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks



                 Supplementary materials

Supplementary Material II.1: Exposure levels in 1,173 mother-child pairs from the HELIX cohort.
 Exposure name             Exposure    Group        Unit -      Modality        Mean      n (%)   Assessment      Detailed exposure name
                           window                   transform                   +- SE
                                                    ation
 Arsenic                   Postnatal   Metals       μg/L –                      0.6 ± 0           By biomarkers
                                                    Log2
 Arsenic                   Pregnancy   Metals       μg/L –                      0.5 ± 0           By biomarkers
                                                    Log2
 Cadmium                   Postnatal   Metals       μg/L –                      -3.4 ±            By biomarkers
                                                    Log2                        0
 Cadmium                   Pregnancy   Metals       μg/L –                      -1.3 ±            By biomarkers
                                                    Log2                        0
 Cobalt                    Postnatal   Metals       μg/L –                      -1.5 ±            By biomarkers
                                                    Log2                        0
 Cobalt                    Pregnancy   Metals       μg/L –                      -1.4 ±            By biomarkers
                                                    Log2                        0
 Caesium                   Postnatal   Metals       μg/L –                      1.3 ± 0           By biomarkers
                                                    Log2
 Caesium                   Pregnancy   Metals       μg/L –                      1.5 ± 0           By biomarkers
                                                    Log2
 Copper                    Postnatal   Metals       μg/L –                      10.8 ±            By biomarkers
                                                    Log2                        0
 Copper                    Pregnancy   Metals       μg/L –                      11.4 ±            By biomarkers
                                                    Log2                        0
 Mercury                   Postnatal   Metals       μg/L –                      0.4 ± 0           By biomarkers
                                                    Log2
 Mercury                   Pregnancy   Metals       μg/L –                      1.6 ± 0           By biomarkers
                                                    Log2
 Manganese                 Postnatal   Metals       μg/L –                      4 ± 0             By biomarkers
                                                    Log2
 Manganese                 Pregnancy   Metals       μg/L –                      4.3 ± 0           By biomarkers
                                                    Log2

                                                                           65


             CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Molybdenum           Postnatal   Metals       μg/L –                       0.5 ± 0              By biomarkers
                                              Log2
Molybdenum           Pregnancy   Metals       μg/L –                       0.2 ± 0              By biomarkers
                                              Log2
Lead                 Postnatal   Metals       μg/L –                       3.9 ± 0              By biomarkers
                                              Log2
Lead                 Pregnancy   Metals       μg/L –                       4.1 ± 0              By biomarkers
                                              Log2
Thallium             Postnatal   Metals                  Undetected                  1087       By biomarkers
                                                                                     ( 0.93 )
Thallium             Postnatal   Metals                  Detected                    86         By biomarkers
                                                                                     ( 0.07 )
Thallium             Pregnancy   Metals                  Undetected                  1134       By biomarkers
                                                                                     ( 0.97 )
Thallium             Pregnancy   Metals                  Detected                    39         By biomarkers
                                                                                     ( 0.03 )
DDE                  Postnatal   OCs          ng/g                         5.4 ± 0              By biomarkers   Dichlorodiphenyldichloroethylene
                                              lipids –
                                              Log2
DDE                  Pregnancy   OCs          ng/g                         6.6 ± 0              By biomarkers   Dichlorodiphenyldichloroethylene
                                              lipids –
                                              Log2
DDT                  Postnatal   OCs          ng/g                         0.1 ± 0              By biomarkers   Dichlorodiphenyltrichloroethane
                                              lipids –
                                              Log2
DDT                  Pregnancy   OCs          ng/g                         1.5 ± 0              By biomarkers   Dichlorodiphenyltrichloroethane
                                              lipids –
                                              Log2
HCB                  Postnatal   OCs          ng/g                         4 ± 0                By biomarkers   Hexachlorobenzene
                                              lipids –
                                              Log2
HCB                  Pregnancy   OCs          ng/g                         3.9 ± 0              By biomarkers   Hexachlorobenzene
                                              lipids –
                                              Log2
PCB 118              Postnatal   OCs          ng/g                         1.9 ± 0              By biomarkers   Polybrominated diphenyl ether-
                                                                                                                47,Dichlorodiphenyldichloroethylene
                                              lipids –
                                              Log2                                                              ether-118
PCB 118              Pregnancy   OCs          ng/g                         2.1 ± 0              By biomarkers   Polybrominated diphenyl ether-
                                                                                                                47,Dichlorodiphenyldichloroethylene
                                              lipids –
                                              Log2                                                              ether-119


                                                                      66


             CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

PCB 138              Postnatal   OCs             ng/g                  3.2 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether-138
PCB 138              Pregnancy   OCs             ng/g                  4 ± 0           By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether-138
PCB 153              Postnatal   OCs             ng/g                  4.3 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether- 153
PCB 153              Pregnancy   OCs             ng/g                  4.8 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether- 154
PCB 170              Postnatal   OCs             ng/g                  0.9 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether-170
PCB 170              Pregnancy   OCs             ng/g                  2.7 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether-171
PCB 180              Postnatal   OCs             ng/g                  2.5 ± 0         By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether- 180
PCB 180              Pregnancy   OCs             ng/g                  4 ± 0           By biomarkers      Polybrominated diphenyl ether-
                                                 lipids –                                                 153,Dichlorodiphenyldichloroethylene
                                                 Log2                                                     ether- 181
PCBs (sum)           Postnatal   OCs             ng/g                  6.4 ± 0         By biomarkers
                                                 lipids –
                                                 Log2
PCBs (sum)           Pregnancy   OCs             ng/g                  7.3 ± 0         By biomarkers
                                                 lipids –
                                                 Log2
DEP                  Postnatal   OP Pesticides   μg/L –                1.2 ±           By biomarkers      Diethyl phosphate (DEP)
                                                 Log2                  0.1
DEP                  Pregnancy   OP Pesticides   μg/L –                2.5 ± 0         By biomarkers      Diethyl phosphate (DEP)
                                                 Log2
DETP                 Postnatal   OP Pesticides   μg/L –                -0.7 ±          By biomarkers      Diethyl thiophosphate (DETP)
                                                 Log2                  0.1
DETP                 Pregnancy   OP Pesticides   μg/L –                -0.1 ±          By biomarkers      Diethyl thiophosphate (DETP)
                                                 Log2                  0.1



                                                                  67


           CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

DMDTP              Postnatal   OP Pesticides            Undetected                  960        By biomarkers   Dimethyldithiophosphate
                                                                                    ( 0.82 )
DMDTP              Postnatal   OP Pesticides            Detected                    213        By biomarkers   Dimethyldithiophosphate
                                                                                    ( 0.18 )
DMP                Postnatal   OP Pesticides   μg/L –                     0.7 ±                By biomarkers   Dimethyl phosphate
                                               Log2                       0.1
DMP                Pregnancy   OP Pesticides   μg/L –                     3.7 ± 0              By biomarkers   Dimethyl phosphate
                                               Log2
DMTP               Postnatal   OP Pesticides   μg/L –                     2.2 ± 0              By biomarkers   Dimethyl thiophosphate
                                               Log2
DMTP               Pregnancy   OP Pesticides   μg/L –                     3 ± 0                By biomarkers   Dimethyl thiophosphate
                                               Log2
PBDE 153           Postnatal   PBDEs           μg/L –                     -2.6 ±               By biomarkers   Polybrominated diphenyl ether 153
                                               Log2                       0
PBDE 153           Pregnancy   PBDEs           μg/L –                     -0.8 ±               By biomarkers   Polybrominated diphenyl ether 153
                                               Log2                       0.1
PBDE 47            Postnatal   PBDEs           μg/L –                     -1.3 ±               By biomarkers   Polybrominated diphenyl ether 47
                                               Log2                       0
PBDE 47            Pregnancy   PBDEs           μg/L –                     0.1 ± 0              By biomarkers   Polybrominated diphenyl ether 47
                                               Log2
PFHXS              Postnatal   PFASs           μg/L –                     -1.6 ±               By biomarkers   Perfluorohexane sulfonate
                                               Log2                       0
PFHXS              Pregnancy   PFASs           μg/L –                     -0.2 ±               By biomarkers   Perfluorohexane sulfonate
                                               Log2                       0
PFNA               Postnatal   PFASs           μg/L –                     -1.1 ±               By biomarkers   Perfluorononanoate
                                               Log2                       0
PFNA               Pregnancy   PFASs           μg/L –                     0.2 ± 0              By biomarkers   Perfluorononanoate
                                               Log2
PFOA               Postnatal   PFASs           μg/L –                     0.6 ± 0              By biomarkers   Perfluorooctanoate
                                               Log2
PFOA               Pregnancy   PFASs           μg/L –                     1.9 ± 0              By biomarkers   Perfluorooctanoate
                                               Log2
PFOS               Postnatal   PFASs           μg/L –                     1.1 ± 0              By biomarkers   Perfluorooctanoate
                                               Log2
PFOS               Pregnancy   PFASs           μg/L –                     3.4 ± 0              By biomarkers   Perfluorooctanoate
                                               Log2


                                                                     68


         CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

PFUNDA           Postnatal   PFASs        μg/L –                   -4.6   ± 0      By biomarkers      Perfluoroundecanoate
                                          Log2
PFUNDA           Pregnancy   PFASs        μg/L –                   -1.8 ±          By biomarkers      Perfluoroundecanoate
                                          Log2                     0
BPA              Postnatal   Phenols      μg/g –                   2.9 ± 0         By biomarkers      Bisphenol A
                                          Log2
BPA              Pregnancy   Phenols      μg/g –                   2.4 ± 0         By biomarkers      Bisphenol A
                                          Log2
BUPA             Postnatal   Phenols      μg/g –                   -2.7 ±          By biomarkers      N‐Butyl paraben
                                          Log2                     0
BUPA             Pregnancy   Phenols      μg/g –                   1.7 ±           By biomarkers      N‐Butyl paraben
                                          Log2                     0.1
ETPA             Postnatal   Phenols      μg/g –                   0.5 ± 0         By biomarkers      Ethyl paraben
                                          Log2
ETPA             Pregnancy   Phenols      μg/g –                   3.3 ±           By biomarkers      Ethyl paraben
                                          Log2                     0.1
MEPA             Postnatal   Phenols      μg/g –                   4.1 ±           By biomarkers      Methyl paraben
                                          Log2                     0.1
MEPA             Pregnancy   Phenols      μg/g –                   7.8 ±           By biomarkers      Methyl paraben
                                          Log2                     0.1
OXBE             Postnatal   Phenols      μg/g –                   1.5 ±           By biomarkers      Oxybenzone
                                          Log2                     0.1
OXBE             Pregnancy   Phenols      μg/g –                   3.4 ±           By biomarkers      Oxybenzone
                                          Log2                     0.1
PRPA             Postnatal   Phenols      μg/g –                   -1.3 ±          By biomarkers      Propyl paraben
                                          Log2                     0.1
PRPA             Pregnancy   Phenols      μg/g –                   5.9 ±           By biomarkers      Propyl paraben
                                          Log2                     0.1
TRCS             Postnatal   Phenols      μg/g –                   -0.3 ±          By biomarkers      Triclosan
                                          Log2                     0.1
TRCS             Pregnancy   Phenols      μg/g –                   3.8 ±           By biomarkers      Triclosan
                                          Log2                     0.1
MBzP             Postnatal   Phthalates   μg/g –                   3.2 ± 0         By biomarkers      Mono benzyl phthalate
                                          Log2
MBzP             Pregnancy   Phthalates   μg/g –                   3.8 ± 0         By biomarkers      Mono benzyl phthalate
                                          Log2

                                                              69


           CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

MECPP              Postnatal   Phthalates   μg/g –                   6 ± 0           By biomarkers      Mono-2-ethyl 5-carboxypentyl phthalate
                                            Log2
MECPP              Pregnancy   Phthalates   μg/g –                   6 ± 0           By biomarkers      Mono-2-ethyl 5-carboxypentyl phthalate
                                            Log2
MEHHP              Postnatal   Phthalates   μg/g –                   5.2 ± 0         By biomarkers      Mono-2-ethyl-5-hydroxyhexyl phthalate
                                            Log2
MEHHP              Pregnancy   Phthalates   μg/g –                   5 ± 0           By biomarkers      Mono-2-ethyl-5-hydroxyhexyl phthalate
                                            Log2
MEHP               Postnatal   Phthalates   μg/g –                   2.4 ± 0         By biomarkers      Mono-2-ethylhexyl phthalate
                                            Log2
MEHP               Pregnancy   Phthalates   μg/g –                   3.7 ± 0         By biomarkers      Mono-2-ethylhexyl phthalate
                                            Log2
MEOHP              Postnatal   Phthalates   μg/g –                   4.5 ± 0         By biomarkers      Mono-2-ethyl-5-oxohexyl phthalate
                                            Log2
MEOHP              Pregnancy   Phthalates   μg/g –                   4.6 ± 0         By biomarkers      Mono-2-ethyl-5-oxohexyl phthalate
                                            Log2
MEP                Postnatal   Phthalates   μg/g –                   5.3 ± 0         By biomarkers      Mono-2-ethyl-5-oxohexyl phthalate
                                            Log2
MEP                Pregnancy   Phthalates   μg/g –                   8.2 ± 0         By biomarkers      Mono-2-ethyl-5-oxohexyl phthalate
                                            Log2
MiBP               Postnatal   Phthalates   μg/g –                   5.4 ± 0         By biomarkers      Mono-iso-butyl phthalate
                                            Log2
MiBP               Pregnancy   Phthalates   μg/g –                   6.1 ± 0         By biomarkers      Mono-iso-butyl phthalate
                                            Log2
MnBP               Postnatal   Phthalates   μg/g –                   4.6 ± 0         By biomarkers      Mono-n-butyl phthalate
                                            Log2
MnBP               Pregnancy   Phthalates   μg/g –                   5.7 ± 0         By biomarkers      Mono-n-butyl phthalate
                                            Log2
OH-MiNP            Postnatal   Phthalates   μg/g –                   2.6 ± 0         By biomarkers      Mono-4-methyl-7-hydroxyoctyl phthalate
                                            Log2
OH-MiNP            Pregnancy   Phthalates   μg/g –                   0.7 ± 0         By biomarkers      Mono-4-methyl-7-hydroxyoctyl phthalate
                                            Log2
oxo-MiNP           Postnatal   Phthalates   μg/g –                   1.7 ± 0         By biomarkers      Mono-4-methyl-7-oxooctyl phthalate
                                            Log2
oxo-MiNP           Pregnancy   Phthalates   μg/g –                   0.9 ± 0         By biomarkers      Mono-4-methyl-7-oxooctyl phthalate
                                            Log2

                                                                70


                       CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

DEHP (sum of metabolites)        Postnatal   Phthalates      μg/g –                          7 ± 0                By biomarkers            Sum of DEHP metabolites
                                                             Log2
DEHP (sum of metabolites)        Pregnancy   Phthalates      μg/g –                          7.8 ± 0              By biomarkers            Sum of DEHP metabolites
                                                             Log2
Cotinine                         Postnatal   Tobacco Smoke                 Undetected                  957        By biomarkers
                                                                                                       ( 0.82 )
Cotinine                         Postnatal   Tobacco Smoke                 Detected                    216        By biomarkers
                                                                                                       ( 0.18 )
Cotinine                         Pregnancy   Tobacco Smoke   μg/L –                          1.5 ± 0              By biomarkers
                                                             None
PMabsorbance (preg)              Pregnancy   Air Pollution   10-5 m-1                        1 ± 0                By environmental models or questionnaires
                                                             – Log
NO2 (preg)                       Pregnancy   Air Pollution   μg/m3 –                         3.5 ± 0              By environmental models or questionnaires
                                                             Log
PM10 (preg)                      Pregnancy   Air Pollution   μg/m3 –                         23.9 ±               By environmental models or questionnaires
                                                             None                            0.2
PM2.5 (preg)                     Pregnancy   Air Pollution   μg/m3 –                         15.1 ±               By environmental models or questionnaires
                                                             None                            0.1
NO2 (year)                       Postnatal   Air Pollution   μg/m3 –                         3.5 ± 0              By environmental models or questionnaires
                                                             Log
PM10 (year)                      Postnatal   Air Pollution   μg/m3 –                         25.9 ±               By environmental models or questionnaires
                                                             None                            0.2
PM2.5 (year)                     Postnatal   Air Pollution   μg/m3 –                         13.7 ±               By environmental models or questionnaires
                                                             None                            0.1
PMabsorbance (year)              Postnatal   Air Pollution   10-5 m-1                        0.8 ± 0              By environmental models or questionnaires
                                                             – Log
Accessibility (bus lines 300m)   Pregnancy   Built           m / km2 -                       0.7 ± 0              By environmental models or questionnaires
                                             Environment     Dic


Accessibility (bus stops 300m)   Pregnancy   Built           m / km2 -                       2.5 ± 0              By environmental models or questionnaires
                                             Environment     Dic


Built density (300m)             Pregnancy   Built           m2 built /                      418.9 ±              By environmental models or questionnaires
                                             Environment     km2                             4.3
Connectivity (300m)              Pregnancy   Built           number of                       12.2 ±               By environmental models or questionnaires
                                             Environment     intersectio                     0.1
                                                             ns / km2


                                                                                        71


                       CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Facility richness (300m)          Pregnancy   Built         -                    0.1 ± 0         By environmental models or questionnaires
                                              Environment
Land use (300m)                   Pregnancy   Built         -                    0.4 ± 0         By environmental models or questionnaires
                                              Environment
Population density                Pregnancy   Built         people /             77.2 ±          By environmental models or questionnaires
                                              Environment   km2                  1.3
Walkability                       Pregnancy   Built         -                    0.3 ± 0         By environmental models or questionnaires
                                              Environment
Accessibility (bus lines 300m)    Postnatal   Built         m / km2 -            0.7 ± 0         By environmental models or questionnaires
                                              Environment   Dic


Accessibility (bus lines 300m -   Postnatal   Built         m / km2 -            0.7 ± 0         By environmental models or questionnaires
school)                                       Environment   Dic


Accessibility (bus stops 300m     Postnatal   Built         m / km2-             2.5 ± 0         By environmental models or questionnaires
- school)                                     Environment   Log


Built density (300m)              Postnatal   Built         m2 built /           390.3 ±         By environmental models or questionnaires
                                              Environment   km2 –                4.6
                                                            Square
                                                            root
Built density (300m - school)     Postnatal   Built         m2 built /           409.8 ±         By environmental models or questionnaires
                                              Environment   km2 –                4.3
                                                            Square
                                                            root
Connectivity density (300 m)      Postnatal   Built         number of            5.3 ± 0         By environmental models or questionnaires
                                              Environment   intersectio
                                                            ns / km2 -
                                                            Log
Connectivity density (300m -      Postnatal   Built         number of            5.4 ± 0         By environmental models or questionnaires
school)                                       Environment   intersectio
                                                            ns / km2 -
                                                            Log
Facility density (300m -          Postnatal   Built         n / km2-             3.4 ± 0         By environmental models or questionnaires
school)                                       Environment   Log
Facility richness                 Postnatal   Built         - - None             0.1 ± 0         By environmental models or questionnaires
                                              Environment
Facility richness (300m -         Postnatal   Built         - - None             0.1 ± 0         By environmental models or questionnaires
school)                                       Environment
Land use (300m)                   Postnatal   Built         - - None             0.4 ± 0         By environmental models or questionnaires
                                              Environment


                                                                            72


                      CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Land use (300m - school)         Postnatal   Built         - - None             0.4 ± 0              By environmental models or questionnaires
                                             Environment
Population density               Postnatal   Built         people /             69.4 ±               By environmental models or questionnaires
                                             Environment   km2 –                1.3
                                                           Square
                                                           root
Population density (school)      Postnatal   Built         people /             69.8 ±               By environmental models or questionnaires
                                             Environment   km2 –                1.1
                                                           Square
                                                           root
Walkability index                Postnatal   Built         - - None             0.3 ± 0              By environmental models or questionnaires
                                             Environment
Facility density (300m)          Pregnancy   Built         n / km2 -            3.4 ± 0              By environmental models or questionnaires
                                             Environment   Log
Facility density (300m)          Postnatal   Built         n / km2 -            3.3 ± 0              By environmental models or questionnaires
                                             Environment   Log
Accessibility (bus stops 300m)   Postnatal   Built         m / km2 -            2.7 ± 0              By environmental models or questionnaires
                                             Environment   Log


Indoor PMabsorbance              Postnatal   Indoor air    10-5 m-1             0.4 ± 0              By environmental models or questionnaires
                                                           – Log
Indoor benzene                   Postnatal   Indoor air    μg/m3 –              1.2 ± 0              By environmental models or questionnaires
                                                           Log
Indoor NO2                       Postnatal   Indoor air    μg/m3 –              4.3 ± 0              By environmental models or questionnaires
                                                           Log
Indoor PM2.5                     Postnatal   Indoor air    μg/m3 –              3 ± 0                By environmental models or questionnaires
                                                           Log
Indoor BTEX                      Postnatal   Indoor air    μg/m3 –              3.6 ± 0              By environmental models or questionnaires
                                                           Log
Alcohol intake                   Pregnancy   Lifestyle                      0             811        By environmental models or questionnaires
                                                                                          ( 0.69 )
Alcohol intake                   Pregnancy   Lifestyle                      1             362        By environmental models or questionnaires
                                                                                          ( 0.31 )
Cereals intake                   Pregnancy   Lifestyle                      1             459        By environmental models or questionnaires
                                                                                          ( 0.39 )
Cereals intake                   Pregnancy   Lifestyle                      2             393        By environmental models or questionnaires
                                                                                          ( 0.34 )
Cereals intake                   Pregnancy   Lifestyle                      3             321        By environmental models or questionnaires
                                                                                          ( 0.27 )
Dairy intake                     Pregnancy   Lifestyle                      1             399        By environmental models or questionnaires
                                                                                          ( 0.34 )


                                                                           73


                      CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Dairy intake                      Pregnancy   Lifestyle                        2        404        By environmental models or questionnaires
                                                                                        ( 0.34 )
Dairy intake                      Pregnancy   Lifestyle                        3        370        By environmental models or questionnaires
                                                                                        ( 0.32 )
Fast-food intake                  Pregnancy   Lifestyle                        1        257        By environmental models or questionnaires
                                                                                        ( 0.22 )
Fast-food intake                  Pregnancy   Lifestyle                        2        127        By environmental models or questionnaires
                                                                                        ( 0.11 )
Fast-food intake                  Pregnancy   Lifestyle                        3        789        By environmental models or questionnaires
                                                                                        ( 0.67 )
Fish and seafood intake           Pregnancy   Lifestyle                        1        482        By environmental models or questionnaires
                                                                                        ( 0.41 )
Fish and seafood intake           Pregnancy   Lifestyle                        2        358        By environmental models or questionnaires
                                                                                        ( 0.31 )
Fish and seafood intake           Pregnancy   Lifestyle                        3        333        By environmental models or questionnaires
                                                                                        ( 0.28 )
Folic acid supplementation        Pregnancy   Lifestyle                        0        524        By environmental models or questionnaires
                                                                                        ( 0.45 )
Folic acid supplementation        Pregnancy   Lifestyle                        1        649        By environmental models or questionnaires
                                                                                        ( 0.55 )
Fruits intake                     Pregnancy   Lifestyle                        1        447        By environmental models or questionnaires
                                                                                        ( 0.38 )
Fruits intake                     Pregnancy   Lifestyle                        2        357        By environmental models or questionnaires
                                                                                        ( 0.3 )
Fruits intake                     Pregnancy   Lifestyle                        3        369        By environmental models or questionnaires
                                                                                        ( 0.31 )
Legumes intake                    Pregnancy   Lifestyle                        1        277        By environmental models or questionnaires
                                                                                        ( 0.24 )
Legumes intake                    Pregnancy   Lifestyle                        2        509        By environmental models or questionnaires
                                                                                        ( 0.43 )
Legumes intake                    Pregnancy   Lifestyle                        3        387        By environmental models or questionnaires
                                                                                        ( 0.33 )
Meat intake                       Pregnancy   Lifestyle                        1        381        By environmental models or questionnaires
                                                                                        ( 0.32 )
Meat intake                       Pregnancy   Lifestyle                        2        384        By environmental models or questionnaires
                                                                                        ( 0.33 )
Meat intake                       Pregnancy   Lifestyle                        3        408        By environmental models or questionnaires
                                                                                        ( 0.35 )
Moderate physical activity (t3)   Pregnancy   Lifestyle          None or                565        By environmental models or questionnaires
                                                                 sometimes              ( 0.48 )
Moderate physical activity (t3)   Pregnancy   Lifestyle          Often                  283        By environmental models or questionnaires
                                                                                        ( 0.24 )
Moderate physical activity (t3)   Pregnancy   Lifestyle          Very Often             325        By environmental models or questionnaires
                                                                                        ( 0.28 )


                                                                              74


                        CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Vigorous physical activity (t3)   Pregnancy   Lifestyle            Low                        514        By environmental models or questionnaires
                                                                                              ( 0.44 )
Vigorous physical activity (t3)   Pregnancy   Lifestyle            Medium-High                659        By environmental models or questionnaires
                                                                                              ( 0.56 )
Vegetables intake                 Pregnancy   Lifestyle                          1            375        By environmental models or questionnaires
                                                                                              ( 0.32 )
Vegetables intake                 Pregnancy   Lifestyle                          2            411        By environmental models or questionnaires
                                                                                              ( 0.35 )
Vegetables intake                 Pregnancy   Lifestyle                          3            387        By environmental models or questionnaires
                                                                                              ( 0.33 )
Bakery products intake            Postnatal   Lifestyle                          1            409        By environmental models or questionnaires
                                                                                              ( 0.35 )
Bakery products intake            Postnatal   Lifestyle                          2            451        By environmental models or questionnaires
                                                                                              ( 0.38 )
Bakery products intake            Postnatal   Lifestyle                          3            313        By environmental models or questionnaires
                                                                                              ( 0.27 )
Soda intake                       Postnatal   Lifestyle                          1            460        By environmental models or questionnaires
                                                                                              ( 0.39 )
Soda intake                       Postnatal   Lifestyle                          2            418        By environmental models or questionnaires
                                                                                              ( 0.36 )
Soda intake                       Postnatal   Lifestyle                          3            295        By environmental models or questionnaires
                                                                                              ( 0.25 )
Breakfast cereals intake          Postnatal   Lifestyle                          1            408        By environmental models or questionnaires
                                                                                              ( 0.35 )
Breakfast cereals intake          Postnatal   Lifestyle                          2            384        By environmental models or questionnaires
                                                                                              ( 0.33 )
Breakfast cereals intake          Postnatal   Lifestyle                          3            381        By environmental models or questionnaires
                                                                                              ( 0.32 )
Caffeinated drinks                Postnatal   Lifestyle                          1            746        By environmental models or questionnaires
                                                                                              ( 0.64 )
Caffeinated drinks                Postnatal   Lifestyle                          2            163        By environmental models or questionnaires
                                                                                              ( 0.14 )
Caffeinated drinks                Postnatal   Lifestyle                          3            264        By environmental models or questionnaires
                                                                                              ( 0.23 )
Dairy products intake             Postnatal   Lifestyle                          1            396        By environmental models or questionnaires
                                                                                              ( 0.34 )
Dairy products intake             Postnatal   Lifestyle                          2            402        By environmental models or questionnaires
                                                                                              ( 0.34 )
Dairy products intake             Postnatal   Lifestyle                          3            375        By environmental models or questionnaires
                                                                                              ( 0.32 )
Sleep duration                    Postnatal   Lifestyle                              10.3 ±              By environmental models or questionnaires
                                                                                     0
Fast-food intake                  Postnatal   Lifestyle                          1            651        By environmental models or questionnaires
                                                                                              ( 0.55 )


                                                                             75


                      CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Fast-food intake              Postnatal   Lifestyle                         2             382        By environmental models or questionnaires
                                                                                          ( 0.33 )
Fast-food intake              Postnatal   Lifestyle                         3             140        By environmental models or questionnaires
                                                                                          ( 0.12 )
KIDMED score                  Postnatal   Lifestyle                             2.8 ±                By environmental models or questionnaires
                                                                                0.1
Moderate and vigorous PA      Postnatal   Lifestyle                             40.3 ±               By environmental models or questionnaires
                                                                                0.7
Organic food intake           Postnatal   Lifestyle                         1             409        By environmental models or questionnaires
                                                                                          ( 0.35 )
Organic food intake           Postnatal   Lifestyle                         2             468        By environmental models or questionnaires
                                                                                          ( 0.4 )
Organic food intake           Postnatal   Lifestyle                         3             296        By environmental models or questionnaires
                                                                                          ( 0.25 )
Cat at home                   Postnatal   Lifestyle                         0             967        By environmental models or questionnaires
                                                                                          ( 0.82 )
Cat at home                   Postnatal   Lifestyle                         1             206        By environmental models or questionnaires
                                                                                          ( 0.18 )
Dog at home                   Postnatal   Lifestyle                         0             1006       By environmental models or questionnaires
                                                                                          ( 0.86 )
Dog at home                   Postnatal   Lifestyle                         1             167        By environmental models or questionnaires
                                                                                          ( 0.14 )
Other pets at home            Postnatal   Lifestyle              No                       728        By environmental models or questionnaires
                                                                                          ( 0.62 )
Other pets at home            Postnatal   Lifestyle              Yes                      445        By environmental models or questionnaires
                                                                                          ( 0.38 )
Processed meat intake         Postnatal   Lifestyle                         1             427        By environmental models or questionnaires
                                                                                          ( 0.36 )
Processed meat intake         Postnatal   Lifestyle                         2             484        By environmental models or questionnaires
                                                                                          ( 0.41 )
Processed meat intake         Postnatal   Lifestyle                         3             262        By environmental models or questionnaires
                                                                                          ( 0.22 )
Readymade food intake         Postnatal   Lifestyle                         1             581        By environmental models or questionnaires
                                                                                          ( 0.5 )
Readymade food intake         Postnatal   Lifestyle                         2             293        By environmental models or questionnaires
                                                                                          ( 0.25 )
Readymade food intake         Postnatal   Lifestyle                         3             299        By environmental models or questionnaires
                                                                                          ( 0.25 )
Sedentary behaviour           Postnatal   Lifestyle                             239.6 ±              By environmental models or questionnaires
                                                                                3.8
Bread intake                  Postnatal   Lifestyle                         1             531        By environmental models or questionnaires
                                                                                          ( 0.45 )
Bread intake                  Postnatal   Lifestyle                         2             360        By environmental models or questionnaires
                                                                                          ( 0.31 )


                                                                           76


                     CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Bread intake                 Postnatal   Lifestyle                         3           282        By environmental models or questionnaires
                                                                                       ( 0.24 )
Cereals intake               Postnatal   Lifestyle                         1           395        By environmental models or questionnaires
                                                                                       ( 0.34 )
Cereals intake               Postnatal   Lifestyle                         2           394        By environmental models or questionnaires
                                                                                       ( 0.34 )
Cereals intake               Postnatal   Lifestyle                         3           384        By environmental models or questionnaires
                                                                                       ( 0.33 )
Fish and seafood intake      Postnatal   Lifestyle                         1           468        By environmental models or questionnaires
                                                                                       ( 0.4 )
Fish and seafood intake      Postnatal   Lifestyle                         2           356        By environmental models or questionnaires
                                                                                       ( 0.3 )
Fish and seafood intake      Postnatal   Lifestyle                         3           349        By environmental models or questionnaires
                                                                                       ( 0.3 )
Fruits intake                Postnatal   Lifestyle                         1           386        By environmental models or questionnaires
                                                                                       ( 0.33 )
Fruits intake                Postnatal   Lifestyle                         2           396        By environmental models or questionnaires
                                                                                       ( 0.34 )
Fruits intake                Postnatal   Lifestyle                         3           391        By environmental models or questionnaires
                                                                                       ( 0.33 )
Total fat intake             Postnatal   Lifestyle                         1           467        By environmental models or questionnaires
                                                                                       ( 0.4 )
Total fat intake             Postnatal   Lifestyle                         2           323        By environmental models or questionnaires
                                                                                       ( 0.28 )
Total fat intake             Postnatal   Lifestyle                         3           383        By environmental models or questionnaires
                                                                                       ( 0.33 )
Meat intake                  Postnatal   Lifestyle                         1           444        By environmental models or questionnaires
                                                                                       ( 0.38 )
Meat intake                  Postnatal   Lifestyle                         2           329        By environmental models or questionnaires
                                                                                       ( 0.28 )
Meat intake                  Postnatal   Lifestyle                         3           400        By environmental models or questionnaires
                                                                                       ( 0.34 )
Potatoes intake              Postnatal   Lifestyle                         1           417        By environmental models or questionnaires
                                                                                       ( 0.36 )
Potatoes intake              Postnatal   Lifestyle                         2           506        By environmental models or questionnaires
                                                                                       ( 0.43 )
Potatoes intake              Postnatal   Lifestyle                         3           250        By environmental models or questionnaires
                                                                                       ( 0.21 )
Sweets intake                Postnatal   Lifestyle                         1           382        By environmental models or questionnaires
                                                                                       ( 0.33 )
Sweets intake                Postnatal   Lifestyle                         2           394        By environmental models or questionnaires
                                                                                       ( 0.34 )
Sweets intake                Postnatal   Lifestyle                         3           397        By environmental models or questionnaires
                                                                                       ( 0.34 )


                                                                          77


                       CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Vegetables intake              Postnatal   Lifestyle                         1             594        By environmental models or questionnaires
                                                                                           ( 0.51 )
Vegetables intake              Postnatal   Lifestyle                         2             224        By environmental models or questionnaires
                                                                                           ( 0.19 )
Vegetables intake              Postnatal   Lifestyle                         3             355        By environmental models or questionnaires
                                                                                           ( 0.3 )
Yogurt intake                  Postnatal   Lifestyle                         1             525        By environmental models or questionnaires
                                                                                           ( 0.45 )
Yogurt intake                  Postnatal   Lifestyle                         2             264        By environmental models or questionnaires
                                                                                           ( 0.23 )
Yogurt intake                  Postnatal   Lifestyle                         3             384        By environmental models or questionnaires
                                                                                           ( 0.33 )
Humidity (preg)                Pregnancy   Meteorological   % - None             76 ±                 By environmental models or questionnaires
                                                                                 0.3
Humidity (t1)                  Pregnancy   Meteorological   % - None             76 ±                 By environmental models or questionnaires
                                                                                 0.3
Pressure (preg)                Pregnancy   Meteorological   Bar -                995.1 ±              By environmental models or questionnaires
                                                            None                 0.4
Pressure (t1)                  Pregnancy   Meteorological   Bar -                994.7 ±              By environmental models or questionnaires
                                                            None                 0.4
Temperature (preg)             Pregnancy   Meteorological   °C - None            11.4 ±               By environmental models or questionnaires
                                                                                 0.1
Temperature (t1)               Pregnancy   Meteorological   °C - None            10.8 ±               By environmental models or questionnaires
                                                                                 0.2
Blue spaces (300 m)            Pregnancy   Natural Spaces   m - Log          0             1085       By environmental models or questionnaires
                                                                                           ( 0.92 )
Blue spaces (300 m)            Pregnancy   Natural Spaces   m - Log          1             88         By environmental models or questionnaires
                                                                                           ( 0.08 )
Green spaces (300 m)           Pregnancy   Natural Spaces   m - Log          0             292        By environmental models or questionnaires
                                                                                           ( 0.25 )
Green spaces (300 m)           Pregnancy   Natural Spaces   m - Log          1             881        By environmental models or questionnaires
                                                                                           ( 0.75 )
NDVI (100 m)                   Pregnancy   Natural Spaces   NDVI -               0.4 ± 0              By environmental models or questionnaires
                                                            None
Blue spaces (300 m)            Postnatal   Natural Spaces   m - Log          0             1077       By environmental models or questionnaires
                                                                                           ( 0.92 )
Blue spaces (300 m)            Postnatal   Natural Spaces   m - Log          1             96         By environmental models or questionnaires
                                                                                           ( 0.08 )
Blue spaces (300m - school)    Postnatal   Natural Spaces   m - Log          0             1092       By environmental models or questionnaires
                                                                                           ( 0.93 )
Blue spaces (300m - school)    Postnatal   Natural Spaces   m - Log          1             81         By environmental models or questionnaires
                                                                                           ( 0.07 )
Green spaces (300 m)           Postnatal   Natural Spaces   m - Log          0             245        By environmental models or questionnaires
                                                                                           ( 0.21 )


                                                                            78


                        CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Green spaces (300 m)            Postnatal   Natural Spaces   m - Log          1             928        By environmental models or questionnaires
                                                                                            ( 0.79 )
Green spaces (300m - school)    Postnatal   Natural Spaces   m - Log          0             263        By environmental models or questionnaires
                                                                                            ( 0.22 )
Green spaces (300m - school)    Postnatal   Natural Spaces   m - Log          1             910        By environmental models or questionnaires
                                                                                            ( 0.78 )
NDVI (100 m)                    Postnatal   Natural Spaces   NDVI -               0.4 ± 0              By environmental models or questionnaires
                                                             None
NDVI (100 m - school)           Postnatal   Natural Spaces   NDVI -               0.4 ± 0              By environmental models or questionnaires
                                                             None
Traffic noise (24h)             Pregnancy   Noise                             1             551        By environmental models or questionnaires
                                                                                            ( 0.47 )
Traffic noise (24h)             Pregnancy   Noise                             2             207        By environmental models or questionnaires
                                                                                            ( 0.18 )
Traffic noise (24h)             Pregnancy   Noise                             3             259        By environmental models or questionnaires
                                                                                            ( 0.22 )
Traffic noise (24h)             Pregnancy   Noise                             4             156        By environmental models or questionnaires
                                                                                            ( 0.13 )
Traffic noise (night)           Pregnancy   Noise                             1             911        By environmental models or questionnaires
                                                                                            ( 0.78 )
Traffic noise (night)           Pregnancy   Noise                             2             152        By environmental models or questionnaires
                                                                                            ( 0.13 )
Traffic noise (night)           Pregnancy   Noise                             3             72         By environmental models or questionnaires
                                                                                            ( 0.06 )
Traffic noise (night)           Pregnancy   Noise                             4             24         By environmental models or questionnaires
                                                                                            ( 0.02 )
Traffic noise (night)           Pregnancy   Noise                             5             14         By environmental models or questionnaires
                                                                                            ( 0.01 )
Traffic noise (24h)             Postnatal   Noise                             1             616        By environmental models or questionnaires
                                                                                            ( 0.53 )
Traffic noise (24h)             Postnatal   Noise                             2             190        By environmental models or questionnaires
                                                                                            ( 0.16 )
Traffic noise (24h)             Postnatal   Noise                             3             250        By environmental models or questionnaires
                                                                                            ( 0.21 )
Traffic noise (24h)             Postnatal   Noise                             4             117        By environmental models or questionnaires
                                                                                            ( 0.1 )
Traffic noise (24h - school)    Postnatal   Noise            dB - None            54.1 ±               By environmental models or questionnaires
                                                                                  0.2
Traffic noise (night)           Postnatal   Noise                             1             934        By environmental models or questionnaires
                                                                                            ( 0.8 )
Traffic noise (night)           Postnatal   Noise                             2             94         By environmental models or questionnaires
                                                                                            ( 0.08 )
Traffic noise (night)           Postnatal   Noise                             3             86         By environmental models or questionnaires
                                                                                            ( 0.07 )


                                                                             79


                        CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Traffic noise (night)           Postnatal   Noise                                        4             59         By environmental models or questionnaires
                                                                                                       ( 0.05 )
Family affluence score          Postnatal   Socio-eco capital           Low                            134        By environmental models or questionnaires
                                                                                                       ( 0.11 )
Family affluence score          Postnatal   Socio-eco capital           Middle                         469        By environmental models or questionnaires
                                                                                                       ( 0.4 )
Family affluence score          Postnatal   Socio-eco capital           High                           570        By environmental models or questionnaires
                                                                                                       ( 0.49 )
Contact with family and         Postnatal   Socio-eco capital           Less than once                 50         By environmental models or questionnaires
friends                                                                 a week                         ( 0.04 )
Contact with family and         Postnatal   Socio-eco capital           Once a week                    338        By environmental models or questionnaires
friends                                                                                                ( 0.29 )
Contact with family and         Postnatal   Socio-eco capital           (almost) Daily                 785        By environmental models or questionnaires
friends                                                                                                ( 0.67 )
House crowding                  Postnatal   Socio-eco capital   -   N                        4.3 ± 0              By environmental models or questionnaires
                                                                    o
                                                                    n
                                                                    e
Social participation            Postnatal   Socio-eco capital           None                           667        By environmental models or questionnaires
                                                                                                       ( 0.57 )
Social participation            Postnatal   Socio-eco capital           1 organisation                 332        By environmental models or questionnaires
                                                                                                       ( 0.28 )
Social participation            Postnatal   Socio-eco capital           2 or more                      174        By environmental models or questionnaires
                                                                        organisations                  ( 0.15 )
Cigarette                       Pregnancy   Tobacco Smoke       -   N                        0.6 ±                By environmental models or questionnaires
                                                                    o                        0.1
                                                                    n
                                                                    e
Active smoking (preg)           Pregnancy   Tobacco Smoke               no                             998        By environmental models or questionnaires
                                                                                                       ( 0.85 )
Active smoking (preg)           Pregnancy   Tobacco Smoke               yes                            175        By environmental models or questionnaires
                                                                                                       ( 0.15 )
ETS                             Postnatal   Tobacco Smoke               no exposure                    745        By environmental models or questionnaires
                                                                                                       ( 0.64 )
ETS                             Postnatal   Tobacco Smoke               exposure                       428        By environmental models or questionnaires
                                                                                                       ( 0.36 )
Parental smoking                Postnatal   Tobacco Smoke               neither                        722        By environmental models or questionnaires
                                                                                                       ( 0.62 )
Parental smoking                Postnatal   Tobacco Smoke               one                            325        By environmental models or questionnaires
                                                                                                       ( 0.28 )
Parental smoking                Postnatal   Tobacco Smoke               both                           126        By environmental models or questionnaires
                                                                                                       ( 0.11 )
Maternal smoking (active and    Pregnancy   Tobacco Smoke               no exposure                    624        By environmental models or questionnaires
ETS)                                                                                                   ( 0.53 )


                                                                                        80


                       CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

 Maternal smoking (active and      Pregnancy   Tobacco Smoke                   only passive                   374        By environmental models or questionnaires
 ETS)                                                                          exposure                       ( 0.32 )
 Maternal smoking (active and      Pregnancy   Tobacco Smoke                   smoker                         175        By environmental models or questionnaires
 ETS)                                                                                                         ( 0.15 )
 Inverse distance to nearest       Pregnancy   Traffic            m-1 - None                       -2.5 ±                By environmental models or questionnaires
 road                                                                                              0
 Road traffic load (100 m)         Pregnancy   Traffic            Vehm./da                         71.9 ±                By environmental models or questionnaires
                                                                  y.m -cube                        1.9
                                                                  root
 Traffic density on nearest road   Pregnancy   Traffic            veh/day.m                        12.5 ±                By environmental models or questionnaires
                                                                  -cube root                       0.2
 Inverse distance to nearest       Postnatal   Traffic            m-1 - None                       -3.5 ± 0              By environmental models or questionnaires
 road
 Road traffic load (100 m)         Postnatal   Traffic            veh/day.m                        71.7 ±                By environmental models or questionnaires
                                                                  -cube root                       2
 Inverse distance to nearest       Pregnancy   Traffic            m-1 - None                       16.2 ±                By environmental models or questionnaires
 road (school)                                                                                     0.3
 Traffic load of major roads       Pregnancy   Traffic                                         0              915        By environmental models or questionnaires
 (100 m)                                                                                                      ( 0.78 )
 Traffic load of major roads       Pregnancy   Traffic                                         1              258        By environmental models or questionnaires
 (100 m)                                                                                                      ( 0.22 )
 Traffic load of major roads       Pregnancy   Traffic                                         0              884        By environmental models or questionnaires
 (100 m - school)                                                                                             ( 0.75 )
 Traffic load of major roads       Pregnancy   Traffic                                         1              289        By environmental models or questionnaires
 (100 m - school)                                                                                             ( 0.25 )
 Water Brominated THMs             Pregnancy   Water              ng/L -                           1.6 ±                 By environmental models or questionnaires
                                               disinfection by-   None                             0.1
                                               products
 Water Chloroform                  Pregnancy   Water              ng/L -                           1.5 ± 0               By environmental models or questionnaires
                                               disinfection by-   None
                                               products
 Water THMs                        Pregnancy   Water              ng/L -                           3 ± 0                 By environmental models or questionnaires
                                               disinfection by-   None
                                               products
OCs : Organochlorine compounds Brominated ; PFAS: Perfluorinated alkylated substances; PBDEs: Brominated compounds Ops: Organophosphate
pesticide metabolites




                                                                                              81


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
Supplementary Material II.2: Pathways identified as relevant for zBMI relying on KEGG
database, and corresponding numbers of genes and enhancer CpGs


        Pathway                            Number of genes          Number of enhancer
                                                                    CpGs
 Fat digestion and absorption                      41                      84
 Fatty acid elongation                              30                      93
 Fatty acid degradation                            44                      79
 Biosynthesis of unsaturated fatty acids           23                      66
 Vitamin digestion and absorption                  24                      80
 Bile secretion                                    71                      304
 PPAR signalling pathway                           74                      202
 Insulin resistance                                107                     478
 Regulation of lipolysis in adipocytes              54                     299
 Adipocytokine signalling pathway                  69                      194
 Type II diabetes mellitus                          46                     269
 Ribosome biogenesis in eukaryotes                 105                     52
 Thyroid hormone signalling pathway                116                     524
 Fanconi anemia pathway                            54                      51
 GnRH signalling pathway                           93                      518
 Prolactin signalling pathway                      70                      271




                                              82


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
Supplementary Material II.3: Boxplot of child zBMI in HELIX data, by cohorts.




                                             83


 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                        using preselected methylation marks
Supplementary Material II.4: Population characteristics by cohort
 Cohorts                  BIB              EDEN           INMA            KANC          MOBA            RHEA
 (number of
 individuals)

 Characteristic   Mean           n     Mean     n     Mean     n      Mean     n     Mean     n     Mean     n
                  (SD)          (%)    (SD)    (%)    (SD)    (%)     (SD)    (%)    (SD)    (%)    (SD)    (%)

 Child BMI        16.0                 17.9           18.1            16.4           16.3           16.8
                  (2.0)                (2.7)          (3.1)           (2.3)          (1.9)          (2.6)

 Child sex

   Female                       91             63             98              91             98             88
                                (45)           (43)           (46)            (46)           (46)           (44)

   Male                         112            83             117             107            114            111
                                (55)           (57)           (54)            (54)           (54)           (56)

 Child age        6.6                  10.7           8.82            6.5            8.5            6.5
 (year)           (0.2)                (0.5)          (0.6)           (0.5)          (0.5)          (0.3)

 Maternal
 education

   low                          95             10             50              12             0              9 (5)
                                (47)           (7)            (23)            (6)            (0)

   middle                       36             53             91              69             43             110
                                (18)           (36)           (42)            (35)           (20)           (55)

   high                         72             83             74              117            169            80
                                (35)           (57)           (34)            (59)           (80)           (40)

 Maternal pre-    28.2                 23.3           24              27.6           22.7           24.1
 pregnancy        (5.3)                (4.2)          (4.7)           (5)            (3.3)          (4.3)
 BMI (kg/m2)

 Parity before
 index
 pregnancy

   0                            86             70             116             85             97             76
                                (42)           (48)           (54)            (43)           (46)           (38)

   1                            57             51             90              57             88             87
                                (28)           (35)           (42)            (29)           (42)           (44)

   2 or more                    60             25             9 (4)           56             27             36
                                (30)           (17)                           (28)           (13)           (18)

 Trimester of
 conception

  January-                      73             51             46              63             75             60
 March                          (36)           (35)           (21)            (32)           (35)           (30)

   April-June                   20             30             48              28             43             65
                                (10)           (21)           (22)            (14)           (20)           (33)

   July-                        34             24             60              64             35             43
 September                      (17)           (16)           (28)            (32)           (17)           (22)

  October-                      76             41             61              43             59             31
 December                       (37)           (28)           (28)            (22)           (28)           (16)

 Maternal                       73
 smoking                        (36)
 status during
 pregnancy

   no                           137            99             78              102            190            18
 exposure                       (67)           (68)           (36)            (52)           (90)           (9)



                                                              84


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks
  only                  39             16             84              84              12             139
passive                 (19)           (11)           (39)            (42)            (6)            (70)
exposure

 smoker                 27             31             53              12              10             42
                        (13)           (21)           (25)            (6)             (5)            (21)

Postnatal
tobacco
smoke
exposure

 not exposed            145            108            146             115             171            60
                        (71)           (74)           (68)            (58)            (81)           (30)

 exposed                58             38             69              83              41             139
                        (29)           (26)           (32)            (42)            (19)           (70)

Maternal age    28.7           30.8            31.9           29.1            32.7           30.9
(years)         (5.8)          (4.9)           (4)            (4.9)           (3.7)          (4.8)

Birthweight

 < 2500g                13             5 (3)          5 (2)           5 (3)           6              6 (3)
                        (6)                                                           (3)

  2500 to               114            92             141             75              97             143
3500g                   (56)           (63)           (66)            (38)            (46)           (72)

  3500 to               56             36             62              84              76             43
4000g                   (28)           (25)           (29)            (42)            (36)           (22)

 ≥ 4000g                20             13             7 (3)           34              33             7 (4)
                        (10)           (9)                            (17)            (16)

Breastfeeding
duration

 < 10.8                 68             81             60              32              32             88
weeks                   (33)           (55)           (28)            (16)            (15)           (44)

  10.8 to               87             52             98              61              42             79
34.9 weeks              (43)           (36)           (46)            (31)            (20)           (40)

 > 34.9                 48             13             57              105             138            32
weeks                   (24)           (9)            (27)            (53)            (65)           (16)

Parents born
in the
country of
inclusion

 None                   81             0 (0)          1 (0)           8 (4)           42             2 (1)
                        (40)                                                          (20)

 Only one               31             10             10              0 (0)           1              6 (3)
                        (15)           (7)            (5)                             (0)

 Both                   91             136            204             190             169            191
                        (45)           (93)           (95)            (96)            (80)           (96)

Ethnicity

 African                7              0 (0)          0 (0)           0 (0)           0              0 (0)
                        (3)                                                           (0)

 Asian                  13             0 (0)          0 (0)           0 (0)           6              0 (0)
                        (6)                                                           (3)

 European               87             146            215             198             203            199
ancestry                (43)           (100)          (100)           (100)           (96)           (100)

 Native                 0              0 (0)          0 (0)           0 (0)           2              0 (0)
American                (0)                                                           (1)




                                                      85


CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach
                                                       using preselected methylation marks
Pakistani       79           0 (0)         0 (0)          0 (0)         0            0 (0)
                (39)                                                    (0)

Other           17           0 (0)         0 (0)          0 (0)         1            0 (0)
                (8)                                                     (0)




                                           86


                  CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.5: Distribution of pairwise coefficients of correlation within quantitative variables of the full exposome assessed in 1,173
mother-child pairs from HELIX cohort




                                                                           87


                CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.6: Adjusted associations between the reduced methylome (2284 CpGs) and zBMI in 1,173 children from the HELIX cohort
(ExWAS model, step b) of the Meet-in-the-Middle approach). Results are presented only for CpGs with a (FDR-corrected for multiple hypothesis
testing) p-value below 0.05 in ExWAS.

     CpG site               Gene                 Effect estimate          95% CI           Uncorrected p-Value      FDR-corrected p-Value
                                                                                                         -6
cg23098018                        PIK3CD                     3.64      2.12   5.16                2.80x10                   3.20x10-3
cg01943221                        PIK3CD                     4.16      2.47   5.85                1.51x10-6                 3.20x10-3
cg06695691                       SPATA5                     -3.99     -5.70   -2.27               5.65x10-6                 4.30x10-3
cg03781224                          MGLL                    -5.79     -8.38   -3.20               1.29x10-5                 5.96x10-3
cg25905215                         NFKB1                     5.23      2.88   7.57                1.31x10-5                 5.96x10-3
cg09706586                        PIK3CD                     3.37      1.81   4.93                2.46x10-5                 8.19x10-3
cg11947782                        PIK3CD                     3.05      1.63   4.48                2.80x10-5                 8.19x10-3
cg18288462                       ELOVL3                     -3.70     -5.43   -1.96               3.14x10-5                 8.19x10-3
cg12228229                          DLG4                    -9.94    -14.63   -5.24               3.58x10-5                 8.19x10-3
cg27110374                          GRB2                     2.68      1.41   3.94                3.48x10-5                 8.19x10-3
cg15526535                     TNFRSF1B                      2.31      1.18   3.44                6.48x10-5                    0.01
cg09900893                      RPS6KA1                     -4.54     -6.78   -2.31               7.10x10-5                    0.01
cg05805445                       SPATA5                      2.64      1.29   4.00                1.31x10-4                    0.02
cg09035699                         ACSL6                     2.55      1.23   3.86                1.56x10-4                    0.02
cg14841483                         ACSL6                     2.80      1.37   4.24                1.35x10-4                    0.02
cg14003265                         TRAF2                     2.74      1.33   4.15                1.51x10-4                    0.02
cg02423534                        ADCY6                     -2.69     -4.08   -1.31               1.37x10-4                    0.02
cg00810292                       TBC1D4                      1.66      0.81   2.50                1.28x10-4                    0.02
cg12085119                           IRS2                    3.31      1.63   4.99                1.12x10-4                    0.02
cg16702014                         ABCC1                    -2.13     -3.23   -1.04               1.38x10-4                    0.02
cg01312837                       CREBBP                     -4.14     -6.27   -2.01               1.44x10-4                    0.02
cg22435313                        PRKCA                      2.00      0.97   3.04                1.52x10-4                    0.02
cg22284398                         PRKCE                    -2.98     -4.53   -1.43               1.73x10-4                    0.02
cg02105211                          ITPR1                   -1.57     -2.39   -0.75               1.74x10-4                    0.02
cg02099877                         NCEH1                    -3.07     -4.68   -1.46               1.89x10-4                    0.02
cg11010552                         ACSL6                    -2.44     -3.72   -1.15               2.08x10-4                    0.02


                                                                     88


                CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks


     CpG site              Gene                  Effect estimate          95% CI           Uncorrected p-Value      FDR-corrected p-Value
cg05004855                      CAMK2A                      -3.84    -5.86   -1.82               2.03x10-4                    0.02
cg09365147                         REV3L                    -1.18    -1.80   -0.56               2.09x10-4                    0.02
cg19791262                            HK3                   -3.22    -4.94   -1.49               2.68x10-4                    0.02
cg18681426                       ELOVL5                     -4.29    -6.61   -1.98               2.78x10-4                    0.02
cg13941235                          RXRA                    -2.13    -3.27   -0.98               2.72x10-4                    0.02
cg04056757                          GRB2                     3.12     1.45   4.78                2.53x10-4                    0.02
cg07298473                         NR1H3                    -2.34    -3.61   -1.06               3.28x10-4                    0.02
cg09877009                        PRKCQ                     -3.72    -5.76   -1.69               3.44x10-4                    0.02
cg13832670                      CREB3L2                     -1.98    -3.08   -0.88               4.18x10-4                    0.03
cg23875758                        SREBF1                    -5.80    -9.02   -2.59               4.14x10-4                    0.03
cg00793946                         PRKCE                    -9.05   -14.07   -4.02               4.35x10-4                    0.03
cg04730825                         ABCC1                    -2.47    -3.85   -1.10               4.41x10-4                    0.03
cg07217499                     CACNA1C                      -3.87    -6.07   -1.67               5.87x10-4                    0.03
cg19542445                     CACNA1C                      -2.98    -4.68   -1.28               5.96x10-4                    0.03
cg07382687                      CREB3L2                     -2.32    -3.65   -0.99               6.30x10-4                    0.03
cg12978800                       PRKAG2                     -2.49    -3.93   -1.06               6.75x10-4                    0.03
cg13487983                          RXRA                    -4.39    -6.91   -1.86               6.75x10-4                    0.03
cg16401207                         PRKG1                    -3.91    -6.15   -1.66               6.67x10-4                    0.03
cg25338454                          ITPR2                   -1.43    -2.26   -0.61               6.45x10-4                    0.03
cg27340723                        ADCY9                     -1.91    -3.02   -0.81               7.21x10-4                    0.04
cg09265397                      NOTCH3                      -2.55    -4.02   -1.07               7.54x10-4                    0.04
cg23257225                      ADORA1                      -3.82    -6.04   -1.60               7.72x10-4                    0.04
cg19782686                       SPATA5                     -1.43    -2.26   -0.59               8.33x10-4                    0.04
cg18912768                       ABCB11                     -2.14    -3.41   -0.87               9.64x10-4                    0.04
cg18390025                       ELOVL3                     -1.57    -2.50   -0.64               9.75x10-4                    0.04
cg00536939                         NR1H3                    -1.62    -2.59   -0.66               9.59x10-4                    0.04
cg16942632                      CAMKK2                      -1.19    -1.89   -0.49               8.96x10-4                    0.04
cg19982668                      MAP3K3                      -2.32    -3.70   -0.95               9.56x10-4                    0.04
cg24961795                         PLCG1                     1.67     0.68   2.66                9.29x10-4                    0.04
cg13092108                      RPS6KA1                     -2.97    -4.74   -1.20               1.03x10-3                    0.04

                                                                     89


                CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks


     CpG site              Gene                  Effect estimate          95% CI           Uncorrected p-Value      FDR-corrected p-Value
cg18537222                       PPARG                      -1.08    -1.73   -0.43               1.08x10-3                    0.04
cg05379597                      CAMK2G                      -2.04    -3.26   -0.81               1.12x10-3                    0.04
cg09473249                       ABCC1                      -6.15    -9.84   -2.46               1.11x10-3                    0.04
cg12005026                        PTEN                      -2.37    -3.80   -0.94               1.22x10-3                    0.05
cg04885396                       ABCC1                      -1.71    -2.76   -0.67               1.28x10-3                    0.05
cg23369234                     CACNA1C                      -5.80    -9.34   -2.26               1.35x10-3                    0.05




                                                                     90


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.7: Adjusted associations between exposures and CpGs associated with childhood zBMI in 1,173 children from HELIX
cohort (ExWAS model, step c) of the Meet-in-the-Middle approach). Results are presented only for CpGs with a (FDR-corrected for multiple
hypothesis testing) p-value below 0.05 in ExWAS.

                                                                     Effect                                      Uncorrected FDR corrected
     CpG sites               Gene              Exposure             estimate              CI 95%                  p-Value      p –Value
cg09035699                         ACSL6       Copper - Postnatal            0.01    8.77x10-3            0.02       4.23x10-11      5.66x10-7
cg12085119                           IRS2      Copper - Postnatal       9.30x10-3    6.42x10-3            0.01       3.40x10-10      1.87x10-6
cg22435313                         PRKCA       Copper - Postnatal            0.01         0.01            0.02       4.19x10-10      1.87x10-6
cg07217499                      CACNA1C        Copper - Postnatal      -6.85x10-3   -9.05x10-3      -4.65x10-3        1.39x10-9      4.64x10-6
cg09365147                         REV3L       Copper - Postnatal           -0.02        -0.03           -0.02        1.19x10-8      3.19x10-5
cg04056757                          GRB2       Copper - Postnatal       8.37x10-3    5.46x10-3            0.01        2.14x10-8      4.77x10-5
cg05004855                       CAMK2A        Copper - Postnatal      -6.79x10-3   -9.19x10-3      -4.39x10-3        3.58x10-8      5.99x10-5
cg24961795                         PLCG1       Copper - Postnatal            0.01    9.02x10-3            0.02        3.42x10-8      5.99x10-5
cg05805445                        SPATA5       Copper - Postnatal            0.01    6.50x10-3            0.01        4.23x10-8      6.29x10-5
cg18537222                         PPARG       Copper - Postnatal           -0.02        -0.03           -0.01        5.71x10-8      6.96x10-5
cg07298473                         NR1H3       Copper - Postnatal           -0.01        -0.01      -6.81x10-3        5.70x10-8      6.96x10-5
cg23098018                        PIK3CD       Copper - Postnatal       8.54x10-3    5.36x10-3            0.01        1.59x10-7      1.64x10-4
cg18681426                        ELOVL5       Copper - Postnatal      -5.66x10-3   -7.76x10-3      -3.56x10-3        1.53x10-7      1.64x10-4
cg19782686                        SPATA5       Copper - Postnatal           -0.02        -0.02      -9.68x10-3        2.05x10-7      1.96x10-4
cg12005026                          PTEN       Copper - Postnatal      -8.98x10-3        -0.01      -5.59x10-3        2.51x10-7      2.24x10-4
cg02105211                          ITPR1      Copper - Postnatal           -0.02        -0.02      -9.68x10-3        2.79x10-7      2.34x10-4
cg11010552                         ACSL6       Copper - Postnatal      -9.91x10-3        -0.01      -6.13x10-3        3.17x10-7      2.49x10-4
cg27110374                          GRB2       Copper - Postnatal       1.00x10-2    6.16x10-3            0.01        3.60x10-7      2.68x10-4
cg04730825                         ABCC1       Copper - Postnatal      -9.05x10-3        -0.01      -5.51x10-3        5.99x10-7      4.22x10-4
cg18390025                        ELOVL3       Copper - Postnatal           -0.01        -0.02      -8.08x10-3        6.80x10-7      4.55x10-4
cg00536939                         NR1H3       Copper - Postnatal           -0.01        -0.02      -7.71x10-3        8.67x10-7      5.53x10-4
cg01943221                        PIK3CD       Copper - Postnatal       7.16x10-3    4.30x10-3            0.01        1.00x10-6      5.64x10-4
cg15526535                      TNFRSF1B         BPA - Postnatal       -8.70x10-3        -0.01      -5.23x10-3        1.01x10-6      5.64x10-4
cg05379597                       CAMK2G        Copper - Postnatal      -9.99x10-3        -0.01      -6.01x10-3        9.92x10-7      5.64x10-4
cg14003265                         TRAF2         BPA - Postnatal       -6.92x10-3   -9.70x10-3      -4.14x10-3        1.16x10-6      6.22x10-4


                                                                        91


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks


                                                                     Effect                                      Uncorrected FDR corrected
     CpG sites               Gene              Exposure             estimate              CI 95%                  p-Value      p –Value
cg14841483                          ACSL6      Copper - Postnatal       8.41x10-3    5.02x10-3            0.01        1.28x10-6      6.60x10-4
cg22284398                          PRKCE      Copper - Postnatal      -7.72x10-3        -0.01      -4.59x10-3        1.53x10-6      7.61x10-4
cg25338454                           ITPR2     Copper - Postnatal           -0.01        -0.02      -8.58x10-3        1.77x10-6      8.18x10-4
cg04885396                          ABCC1      Copper - Postnatal           -0.01        -0.02      -6.79x10-3        1.72x10-6      8.18x10-4
cg16942632                       CAMKK2        Copper - Postnatal           -0.02        -0.02           -0.01        1.92x10-6      8.56x10-4
cg19982668                       MAP3K3        Copper - Postnatal      -8.60x10-3        -0.01      -5.06x10-3        2.17x10-6      9.36x10-4
cg01312837                        CREBBP       Copper - Postnatal      -5.52x10-3   -7.80x10-3      -3.23x10-3        2.45x10-6      1.03x10-3
cg11947782                         PIK3CD      Copper - Postnatal       8.19x10-3    4.78x10-3            0.01        2.68x10-6      1.09x10-3
cg09706586                         PIK3CD      Copper - Postnatal       7.41x10-3    4.30x10-3            0.01        3.30x10-6      1.30x10-3
cg02423534                         ADCY6       Copper - Postnatal      -8.34x10-3        -0.01      -4.82x10-3        3.79x10-6      1.45x10-3
cg16401207                          PRKG1      Copper - Postnatal      -5.13x10-3   -7.30x10-3      -2.96x10-3        3.92x10-6      1.46x10-3
cg27340723                         ADCY9       Copper - Postnatal           -0.01        -0.01      -5.78x10-3        6.42x10-6      2.33x10-3
cg22284398                          PRKCE        BPA - Postnatal        5.79x10-3    3.26x10-3       8.33x10-3        8.19x10-6      2.89x10-3
cg02099877                          NCEH1      Copper - Postnatal      -6.81x10-3   -9.84x10-3      -3.78x10-3        1.14x10-5      3.93x10-3
cg15526535                      TNFRSF1B       Copper - Postnatal       9.64x10-3    5.33x10-3            0.01        1.23x10-5      4.12x10-3
cg18912768                        ABCB11       Copper - Postnatal      -8.58x10-3        -0.01      -4.72x10-3        1.38x10-5      4.50x10-3
cg18390025                        ELOVL3         BPA - Postnatal        9.34x10-3    5.11x10-3            0.01        1.63x10-5      5.07x10-3
cg16702014                          ABCC1      Copper - Postnatal      -9.82x10-3        -0.01      -5.37x10-3        1.63x10-5      5.07x10-3
cg19982668                       MAP3K3          BPA - Postnatal        6.30x10-3    3.43x10-3       9.17x10-3        1.78x10-5      5.42x10-3
cg13832670                       CREB3L2       Copper - Postnatal      -9.75x10-3        -0.01      -5.30x10-3        1.83x10-5      5.43x10-3
cg07298473                          NR1H3        BPA - Postnatal        6.77x10-3    3.67x10-3       9.87x10-3        1.94x10-5      5.65x10-3
cg13092108                       RPS6KA1       Copper - Postnatal      -6.00x10-3   -8.76x10-3      -3.24x10-3        2.19x10-5      6.12x10-3
cg09035699                          ACSL6        BPA - Postnatal       -6.50x10-3   -9.49x10-3      -3.51x10-3        2.19x10-5      6.12x10-3
cg00810292                        TBC1D4       Copper - Postnatal            0.01    6.54x10-3            0.02        3.01x10-5      8.01x10-3
cg04056757                           GRB2        BPA - Postnatal       -5.05x10-3   -7.41x10-3      -2.68x10-3        3.05x10-5      8.01x10-3
cg24961795                          PLCG1        BPA - Postnatal       -8.54x10-3        -0.01      -4.54x10-3        3.04x10-5      8.01x10-3
cg23369234                      CACNA1C        Copper - Postnatal      -2.94x10-3   -4.33x10-3      -1.56x10-3        3.14x10-5      8.08x10-3
cg03781224                           MGLL      Copper - Postnatal      -3.93x10-3   -5.81x10-3      -2.06x10-3        4.04x10-5      9.89x10-3
cg12085119                            IRS2       BPA - Postnatal       -4.94x10-3   -7.29x10-3      -2.59x10-3        3.92x10-5      9.89x10-3

                                                                        92


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks


                                                                     Effect                                      Uncorrected FDR corrected
     CpG sites               Gene              Exposure             estimate              CI 95%                  p-Value      p –Value
cg09265397                        NOTCH3       Copper - Postnatal      -6.95x10-3        -0.01      -3.64x10-3        4.06x10-5      9.89x10-3
cg07382687                        CREB3L2       PFOS - Postnatal        8.85x10-3    4.62x10-3            0.01        4.38x10-5           0.01
cg09900893                        RPS6KA1      Copper - Postnatal      -4.54x10-3   -6.72x10-3      -2.36x10-3        4.74x10-5           0.01
cg18537222                          PPARG        BPA - Postnatal             0.01    6.61x10-3            0.02        4.66x10-5           0.01
cg22435313                          PRKCA       PFOS - Postnatal            -0.01        -0.02      -5.86x10-3        4.79x10-5           0.01
cg04730825                          ABCC1       PFOS - Postnatal        8.37x10-3    4.28x10-3            0.01        6.34x10-5           0.01
cg14841483                          ACSL6        BPA - Postnatal       -5.61x10-3   -8.36x10-3      -2.86x10-3        6.52x10-5           0.01
cg13092108                        RPS6KA1       PFOS - Postnatal        6.43x10-3    3.24x10-3       9.61x10-3        7.88x10-5           0.02
cg05004855                        CAMK2A        PFOS - Postnatal        5.59x10-3    2.81x10-3       8.37x10-3        8.41x10-5           0.02
cg06695691                         SPATA5      Copper - Postnatal      -5.67x10-3   -8.50x10-3      -2.84x10-3        8.89x10-5           0.02
cg07382687                        CREB3L2      Copper - Postnatal      -7.35x10-3        -0.01      -3.67x10-3        9.41x10-5           0.02
cg05379597                        CAMK2G         BPA - Postnatal        6.41x10-3    3.18x10-3       9.64x10-3        1.05x10-4           0.02
cg19791262                            HK3      Copper - Postnatal      -5.59x10-3   -8.42x10-3      -2.76x10-3        1.14x10-4           0.02
cg19791262                            HK3       PFOS - Postnatal        6.35x10-3    3.09x10-3       9.61x10-3        1.38x10-4           0.03
cg23875758                         SREBF1      Copper - Postnatal      -2.98x10-3   -4.50x10-3      -1.45x10-3        1.37x10-4           0.03
cg22284398                          PRKCE       PFOS - Postnatal        7.05x10-3    3.43x10-3            0.01        1.43x10-4           0.03
cg01312837                         CREBBP       PFOS - Postnatal        5.11x10-3    2.47x10-3       7.75x10-3        1.53x10-4           0.03
cg13832670                        CREB3L2        BPA - Postnatal        6.90x10-3    3.30x10-3            0.01        1.77x10-4           0.03
cg19782686                         SPATA5       PFOS - Postnatal             0.01    6.16x10-3            0.02        1.81x10-4           0.03
cg19542445                       CACNA1C       Copper - Postnatal      -5.49x10-3   -8.37x10-3      -2.60x10-3        2.01x10-4           0.04
cg27340723                          ADCY9        BPA - Postnatal        6.80x10-3    3.22x10-3            0.01        2.01x10-4           0.04
cg25905215                          NFKB1      Copper - Postnatal       3.94x10-3    1.86x10-3       6.01x10-3        2.08x10-4           0.04
                                                Humidity (preg) -
cg23098018                          PIK3CD                                   0.03        0.01            0.04         2.16x10-4          0.04
                                                      Pregnancy
cg24961795                         PLCG1        PFOS - Postnatal           -0.01        -0.02       -4.99x10-3        2.46x10-4          0.04
cg03781224                         MGLL         PFOS - Postnatal       4.00x10-3    1.84x10-3        6.16x10-3        2.93x10-4          0.05
cg19982668                        MAP3K3        PFOS - Postnatal       7.59x10-3    3.50x10-3             0.01        2.89x10-4          0.05




                                                                        93


                  CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.8: Sensitivity Analysis I: adjusted associations between the whole exposome and zBMI in 1,173 children from the HELIX
cohort (2 multivariate agnostic approaches, one prenatal, one postnatal, ignoring the methylome). Results are presented only for exposures with a
(FDR-corrected for multiple hypothesis testing) p-value lower than 0.05.

 Exposure group       Exposure          Unit          Transfor-        Effect                   95%CI           Uncorrected      FDR-corrected
                      variable                        mation           estimate*                                 p -value          p –value
                      Copper -
Metals                                  μg/L               Log2        0.18             0.10      0.27            2.48x10-5        3.16x10-3
                      Postnatal
Organochlorines       HCB - Postnatal   ng/g lipids        Log2        -0.44            -0.57     -0.31          5.65x10-11        1.44x10-8
* Adjusted change in mean zBMI for each increase by 1 in transformed exposure level. Models were adjusted for all (respectively prenatal and postnatal
exposome variables) and maternal BMI, maternal education, maternal smoking during pregnancy, parental country, cohort, parity, trimester of
conception, ethnicity, child age and child sex and additionally only for the postnatal model for birth weight, passive smoking during childhood,
breastfeeding duration.


Supplementary Material II.9: Characteristics of the CpG selected by a methylome wide analysis on the whole methylome (row percentages).

 CpGs                                                      Number of CpGs                       Number (%) of CpGs selected by
                                                                                                MWAS on the whole methylome -
                                                                                                Benjamini Hochberg correction
 All                                                              386,518                                      1788 (0.46%)
 Belonging to a pathway AND enhancer                                2,284                                        28 (1.22%)
 Neither belonging to a pathway nor                               384,234                                      1760 (0.46%)
 being an enhancer




                                                                                   94


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.10: Sensitivity analysis III - adjusted association between the whole methylome and zBMI in 1,173 children from the
HELIX cohort (ExWAS model, step b of the Meet-in-the-Middle approach applied to the whole methylome). Results are presented only for CpGs
with a (FDR - corrected for multiple hypothesis testing) p-value below 0.05 in ExWAS.

This supplementary is provided in the appendix III due to its large size.




                                                                            95


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.11: Sensitivity analysis III, Meet-in-the-Middle without CpGs preselection: adjusted associations between the exposome and
CpGs associated with zBMI in 1,173 children from the HELIX cohort (ExWAS model adjusted on zBMI, step c of the Meet-in-the-Middle approach
applied on the whole methylome). Results are presented only for exposures associated with a (stringently corrected for multiple hypothesis testing) p-
value of less than 0.05 in exposure-CpGs ExWAS, with CpGs being previously selected in a CpGs-zBMI ExWAS.
 Exposure                                            Number of CpGs associated with the                    Number of corresponding genes
                                                         exposure and with zBMI

 Copper - postnatal                                                 1110                                               677
 Bisphenol A (BPA) -postnatal                                        449                                               293
 Perfluorooctanesulfonic acid (PFOS) -
 postnatal                                                           180                                               133
 Humidity - Pregnancy                                                 47                                                38
 PCBs (sum) - Pregnancy                                               10                                                10
 PCB 170 - Pregnancy                                                   9                                                  7
 MEHP - Postnatal                                                      8                                                  7
 MiBP - Postnatal                                                      7                                                  7
 DETP - Pregnancy                                                      3                                                  3
 DDT - Postnatal                                                       2                                                  1
 PBDE 153 - Postnatal                                                  2                                                  2
 PCB 138 - Pregnancy                                                   2                                                  2
 PFHXS - Postnatal                                                     2                                                  2
 Thallium - Postnatal                                                  2                                                  2



                                                                           96


                CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Traffic noise (24h) - Postnatal                                   2                                               2
Caesium - Postnatal                                               1                                               1
Fast-food intake - Pregnancy                                      1                                               1
Green spaces (300 m) - Pregnancy                                  1                                               1
HCB - Postnatal                                                   1                                               1
MBzP - Postnatal                                                  1                                               1
OH-MiNP - Pregnancy                                               1                                               1
PM2.5 - Pregnancy                                                 1                                               1
Population density - Postnatal                                    1                                               1
PRPA - Pregnancy                                                  1                                               1
Social participation - Postnatal                                  1                                               1
Soda intake - Postnatal                                           1                                               1
Vegetables intake - Pregnancy                                     1                                               1
Yogurt intake - Postnatal                                         1                                               1




                                                                      97


                  CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

Supplementary Material II.12: Sensitivity analysis IV: Meet-in-the-Middle approach considering the cell-types as the intermediate layer. Adjusted
associations at steps b),c) and d).
A.
       Cell types            Effect estimate*              95%CI                 Unadjusted p-Value                   FDR adjusted p –Value

 NK-cells                            0.87          -0.82       2.56                                       0.31                                      0.38
 B-cells                            -0.33          -2.19       1.53                                       0.72                                      0.72
                                                                                                             -5
 CD4+ T-cells                       -2.22          -3.31       -1.13                                 7.00x10                                    4.20x10-4
 CD8+ T-cells                       -1.91          -3.35       -0.47                                 9.20x10-3                                      0.02
                                                                                                             -3
 Granulocytes                       0.87           0.23        1.51                                  7.86x10                                        0.02
 Monocytes                           3.11          0.70        5.53                                       0.01                                      0.02
* Adjusted change in mean zBMI for each increase by 1 in cell-type level. Models were adjusted for maternal BMI, maternal education, maternal
smoking during pregnancy, parental country, cohort, parity, trimester of conception, ethnicity, child age and child sex and additionally only for
postnatal exposures birth weight, passive smoking during childhood, breastfeeding duration.
B.

                                                         Effect                                    Unadjusted p-
     Cell types     Exposure variable                                           95%CI                                     FDR adjusted p –Value
                                                       estimate*                                      Value

 CD4+ T-cells       Copper - Postnatal                         -0.01      -0.02 -8.76x10-3                 6.56x10-9                           5.67x10-6
 Granulocytes       Copper - Postnatal                          0.02       0.01 0.03                       8.50x10-8                           3.67x10-5
 CD8+ T-cells       Copper - Postnatal                    -7.68x10-3      -0.01 -4.27x10-3                 1.09x10-5                           3.13x10-3
 Granulocytes       BPA - Postnatal                            -0.01      -0.02 -6.96x10-3                 3.36x10-5                           7.26x10-3
 CD4+ T-cells       Humidity - Pregnancy                       -0.04      -0.06 -0.02                      2.36x10-4                                0.04
* Adjusted change in transformed exposure for each increase by 1 in cell-type level. Models were adjusted for maternal BMI, maternal education,
maternal smoking during pregnancy, parental country, cohort, parity, trimester of conception, ethnicity, child age and child sex and additionally only
for postnatal exposures birth weight, passive smoking during childhood, breastfeeding duration.



                                                                           98


                 CHAPTER II: Early-life Exposures and child Body Mass Index: a Meet-in-the-Middle approach using preselected methylation marks

C.

                     Exposure                                                                                 Unadjusted p-      FDR adjusted p –
Exposure group                        Unit     Transformation Effect estimate*               95%CI
                                                                                                                 Value               Value
                     variable
                     Copper -
Metals                                   μg/L        Log2                0.22            0.14 0.30                     3.57x10-7               1.07x10-6
                     Postnatal
 Phenols             BPA - Postnatal μg/g            Log2                -0.07          -0.14 2.83x10-4                     0.05                   0.08
                     Humidity -
 Meteorological                              %       None                0.05           -0.34 0.44                          0.81                   0.81
                     Pregnancy
* Adjusted change in mean zBMI for each increase by 1 in transformed exposure level. Models were adjusted for maternal BMI, maternal education,
maternal smoking during pregnancy, parental country, cohort, parity, trimester of conception, ethnicity, child age and child sex and additionally only
for postnatal exposures birth weight, passive smoking during childhood, breastfeeding duration.




                                                                          99


100


     CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-Middle
                                                approach using preselected methylation marks


CHAPTER III:      Early-life Exposures and child lung function: a modified Meet-in-the-
  Middle approach using preselected methylation marks
The work presented in this small chapter is a study performed on Helix data similar to the one presented in Chapter
II, but considering another child health outcome: the child lung function, measured with FEV1 (see below). We used
the same oMITM design, but with one major modification: we followed through its logical next step the strategy
initiated in our first study to preselect a part of the methylome according to possible pathways from the exposome to
the outcome; for the first step of our oMITM design, a drastic preselection of the methylome was performed according
to MWAS studies about lung function available in the literature, instead of a test of association between the
methylome and the outcome.

This work was the topic of an oral communication presented at the annual congress of the International Society of
Environmental Epidemiology in Utrecht in 2019:

Cadiou, S., Agier, L., Bustamante, M., Maitre, L., Basagana, X., Vrijheid, M., Siroux, V., Slama, R.,
“Using DNA methylation to characterize more efficiently associations between the
exposome and child lung function”, ISEE 2019 congress, Utrecht, Netherlands




                                                        101


     CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-Middle
                                                approach using preselected methylation marks

               Abstracts

             English abstract

Background: Early environmental exposures may influence lung function. Most pollutants have
small effect sizes and some are correlated, potentially limiting the statistical power of agnostic
exposome-wide association study (ExWAS). DNA methylation, which may act as a mediator for
some exposures, could be used in exposome-health studies to increase power by reducing the
exposome to exposures with biologically plausible mechanisms.
Aim: To assess the relations between the exposome and child lung function (FEV1, forced
expiratory volume in one second) with a method consisting in reducing the exposome dimension
using DNA methylation.
Methods: Among 919 mother-child pairs from Helix cohorts, exposures to 216 environmental
factors were assessed during pregnancy or at age 6-10 years. Genome-wide DNA methylation levels
in peripheral blood at 6–10 years were measured using HumanMethylation450 BeadChip, filtered
and corrected for batch effects. An oriented Meet-in-the-Middle, consisting in a 3-step statistical
approach, was applied: (i) selecting a priori relevant DNA CpG sites for FEV1 according to a review
of the literature; (ii) selecting exposures significantly associated with at least one of these CpGs,
using an ExWAS approach adjusted for FEV1 and confounders; (iii) identifying by linear regression
the exposures from this reduced set associated with FEV1.
Results: 314 CpGs enhancers from 23 candidate genes were selected at step 1. Step 2 identified a
single exposure, postnatal blood copper level, which was associated with one CpG site located on
ARMC2 gene. In step 3, copper was found significantly associated with lower FEV1. A classical
ExWAS analysis on FEV1 corrected for multiple comparisons did not identify statistically
significant association; copper was among the 6 exposures associated with FEV1 when no multiple
testing correction was applied.
Conclusion: Our 3-steps approach identified one exposure associated with lower FEV1, postnatal
blood copper level, while an agnostic ExWAS reported no significant association. Further research
is needed to quantify the efficiency of this approach.




                                                102


     CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-Middle
                                                approach using preselected methylation marks



             French abstract

Contexte : Les expositions environnementales précoces peuvent influencer la fonction
pulmonaire. La plupart des polluants ont des effets de faible ampleur et certains sont corrélés, ce
qui peut limiter la puissance statistique des études d'association à l'échelle de l'exposome (ExWAS).
La méthylation de l'ADN, qui peut agir comme médiateur pour certaines expositions, pourrait être
utilisée dans les études exposome-santé pour augmenter la puissance en restreignant l'exposome à
un ensemble d’expositions avec des mécanismes d’effets biologiquement plausibles.

Objectif : tester une méthode consistant à réduire la dimension de l'exposome en utilisant la
méthylation de l'ADN dans le cadre d'une étude d'association exposome-VEMS (Volume
Expiratoire Maximal par seconde).

Méthodes : L’exposition à 216 facteurs environnementaux a été évaluée pour 919 paires mère-
enfant des cohortes du projet Helix, pendant la grossesse ou à l'âge de 6-10 ans. Les niveaux de
méthylation de l'ADN à l'échelle du génome dans le sang périphérique à 6-10 ans ont été mesurés
à l'aide de la puce HumanMethylation450 BeadChip, filtrés et corrigés des effets batch. Une
approche statistique « Meet-in-the-Middle orientée », consistant en 3 étapes, a été appliquée : (i)
sélectionner a priori les sites CpG pertinents pour le VEMS à partir d'une revue de la littérature
existante ; (ii) sélectionner les expositions significativement associées à au moins un de ces CpG,
en utilisant une approche ExWAS ajustée sur le VEMS et les facteurs de confusion pertinents; (iii)
identifier par régression linéaire les expositions associées au VEMS au sein de cet exposome réduit.

Résultats : 314 CpGs enhancers provenant de 23 gènes candidats ont été sélectionnés à l'étape 1.
L'étape 2 a identifié une seule exposition, le taux de cuivre dans le sang postnatal, qui a été associée
à un site CpG situé sur le gène ARMC2. À l'étape 3, on a constaté que le cuivre était associé de
manière significative à un VEMS plus faible. Une analyse classique ExWAS sur le VEMS corrigé
pour les comparaisons multiples n'a pas identifié d'association statistiquement significative ; le
cuivre figurait parmi les 6 expositions associées au VEMS lorsqu'aucune correction pour les
comparaisons multiples n’était appliquée.

Conclusion : Notre approche en 3 étapes a identifié une exposition associée à un VEMS plus
faible, le niveau de cuivre dans le sang postnatal, alors qu'une analyse ExWAS agnostique n'a révélé
aucune association significative. Des travaux supplémentaires sont nécessaires pour quantifier
l'efficacité de l’approche oMITM.



                                                  103


     CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-Middle
                                                approach using preselected methylation marks

               Background

Early environmental exposures may influence lung function (Vernet et al., 2017; Vrijheid et al.,

2016). Effects of smoking and air pollution exposures are well known: maternal prenatal as well as

postnatal smoking is associated with child asthma (Hofhuis et al., 2003; Wang and Pinkerton, 2008),

and prenatal exposure to air pollution is associated with both decreased lung function and asthma

(Latzin et al., 2009). There is also moderate evidence of the effect of persistent organic compounds

on lung function (Gascon et al., 2014; Hansen et al., 2014), as well as emerging concerns for other

man-made substances (Qin et al., 2017; Vernet et al., 2017). However, exploring the effects of the

exposome on lung function involves the challenges of limited power and specificity that we

discussed earlier: most pollutants are expected to have small effect sizes and some are correlated.

A previous ExWAS study on HELIX data did not find any association between the exposome and

child lung function (Agier et al., 2019). As differential DNA methylation in blood cells can be

associated with decreased lung function, it seems relevant to use our oMITM design on Helix data

of exposome, blood methylome and lung function, to study causal environmental predictors of

child respiratory health. In this short report, we aimed to apply an oriented Meet-in-the-Middle

approach to exposome and lung function, strongly relying on a priori knowledge about the link

between methylome and lung function.




               Methods

Among 1031 mother-child pairs from Helix cohorts, exposures to 216 environmental factors were

assessed during pregnancy or at age 6-10 years, as previously done and detailed in Cadiou et al.

(2020) (see Chapter II). The forced expiratory volume in one second, expressed in % (FEV1) was

measured with standardized spirometry tests during a clinical examination at age 6-10 years. FEV1

predicted values were computed after filtering and according to reference equations from the

Global Lung Initiative (Agier et al., 2019; Quanjer et al., 2012). Genome-wide DNA methylation


                                                104


     CHAPTER III: Early-life Exposures and child lung function: a modified Meet-in-the-Middle
                                                approach using preselected methylation marks

levels in peripheral blood sampled at the time of the clinical examination were measured using

HumanMethylation450 BeadChip, filtered and corrected for batch effects (see Chapter II). They

were available for 919 children. Relevant potential confounders for the exposome-FEV1 association

were a priori selected: child sex, child age, child height, parental country of birth, breast feeding

duration, season of conception, presence of older siblings, parental education level, maternal age,

maternal pre-pregnancy body-mass index (BMI), postnatal passive smoking status, prenatal

maternal active and passive smoking status and ethnicity. An oriented MITM adapted from (Cadiou

et al., 2020) was applied. It consists in a 3-step statistical approach: a) selecting a priori enhancers

CpG sites on genes relevant for FEV1 according to the literature (Li et al., 2013) (but without direct

test of association between them and the outcome, differently from (Cadiou et al., 2020)) ; b)

selecting exposures significantly associated with at least one of these CpGs, using an ExWAS

approach adjusted for FEV1 and confounders; b) identifying by linear regression the exposures

from this reduced set associated with FEV1. All the ExWAS-type analyses were corrected for

multiple testing using Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995). An

agnostic ExWAS as well as a simplified MITM without step a) were performed as sensitivity

analyses.




                                                  105


Table III.1: Preselected genes related to FEV1 according to (Li et al., 2013) and corresponding
number of enhancers CpGs available in Helix data.
 Genes        Number of
              corresponding
              enhancer
              CpGs
 ADAM19                     6
 ARMC2                      8
 C10orf11                  37
 CCDC38                     1
 CDC123                     2
 CFDP1                      8
 DAAM2                     11
 FAM13A                     9
 GPR126                     7
 HDAC4                     67
 HHIP                       2
 HTR4                       2
 LRP1                      10
 MECOM                     31
 MFAP                       2
 MMP15                      9
 PID1                       1
 PTCH1                      5
 RARB                      16
 SPATA9                     1
 TGFB2                      4
 THSD4                     57
 TNS1                      18




                                               106


               Results

314 CpGs enhancers from 23 candidate genes were selected at step a) (see Table III.1). Step b)

identified a single exposure, postnatal blood copper level, which was associated with one CpG site

(cpg04642300, coefficient -0.301 (CI: -0.414; -0.187), adjusted p-value: 0.016) located on gene

ARMC2 (Figure III.1). ARMC2 (Armadillo Repeat Containing 2) is a protein encoding gene. Some

variants have been identified as significantly associated with low FEVs (in non-asthmatic adults

(Yamada et al., 2016)); in 7-year-old children with asthma (Kreiner-Møller et al., 2014). Some CpGs

on this gene have been identified as significantly associated with bronchopneumopathy in smoking

adults (Busch et al., 2016). In step c) copper was found significantly associated with lower FEV1

(coefficient of -5.72, p-value, 0.0412). No CpG were associated with the outcome in the sensitivity

analysis considering the whole methylome (minimum corrected p-value: 0.342).

A classical ExWAS analysis on FEV1 corrected for multiple comparisons did not identify any

statistically significant association. Copper was among the 6 exposures associated with FEV1 when

no correction for multiple testing was applied (see Table III.2).

Table III.2: Agnostic ExWAS corrected for relevant potential confounders and corrected for
multiple testing relating the exposome and child FEV1.
 Exposures                Effect         95%Confidence              Uncorrected   FDR
                          estimate          Interval                 p-Value    corrected
                                                                                p –Value
 Alcohol intake -              1.96          0.44         3.48           0.0118          1
 Pregnancy
 ETPA - Postnatal             -0.62         -1.11        -0.14           0.0122          1
 PFOA - Pregnancy             -1.39         -2.68        -0.11           0.0336          1
 House crowding -             -0.78         -1.51        -0.06           0.0342          1
 Postnatal
 Copper - Postnatal           -5.72        -11.22        -0.23           0.0412          1
 Vegetables intake -           0.81          0.01         1.61           0.0475          1
 Postnatal




                                                107


Figure III.1:Manhattan plot of the step b) of the MITM approach: adjusted-values of adjusted
association tests between preselected CpG and exposome. Each color represents a different
exposure. The vertical black line is the significant threshold at 0.05.




              Discussion

Our 3-step oMITM approach identified one exposure associated with lower FEV1, postnatal blood

copper level, while an agnostic ExWAS reported no significant association. Copper exposure has

not been found previously associated with respiratory outcomes in the literature besides Helix

(Agier et al., 2019) but is known for its role in inflammatory diseases, as we discussed in the

previous chapter (Cadiou et al., 2020). The fact that copper was a hit in both oMITM approaches

on BMI and FEV1 on Helix data may mean that it is linked to a general inflammation process

which can be observed at the methylome. With our 3-step approach, we preselected the pathways

whereby the exposures could act on lung function: this was a way to add external knowledge

without performing a priori selection on the exposome itself, which would not be relevant in a

                                              108


 discovery study. Interestingly, in this case, assuming that copper is a true predictor of FEV1 (which

 as we discussed is plausible), the oMITM approach was more sensitive than the ExWAS agnostic

 approach: indeed, while no exposure was associated with FEV1 when corrected with multiple

 testing, one exposure was associated with one CpG relevant for FEV1, allowing to select a non-

 empty reduced exposome. This highlights the gain in power allowed by the dimension reduction

 of the exposome: the association with copper was not significant due to the correction for multiple

 comparisons in the ExWAS but was significant in the oMITM approach due to the decreased size

 of the reduced exposome. Thus, we can hypothesize that a relevant dimension reduction using the

 oMITM approach can increase sensitivity compared to its agnostic counterpart.




Note: In an ongoing study based on Sepages cohort, we applied a modified oMITM implementation to
relate the prenatal exposome to birth weight, taking advantage of the maternal methylome. The
preliminary results are presented in Appendix II.




                                                 109


110


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health

CHAPTER IV:                Performance of approaches relying on intermediate high-dimension

    data to decipher causal relationships between the exposome and health: a simulation

    study under various causal structures

In the two previous chapter and in Appendix II, we presented three studies on real data relating the exposome to
child outcomes, relying on an innovative oMITM design. Considering the results and their comparison with the results
of the agnostic counterparts of our oMITM, we made the hypotheses that: 1. our oMITM may be more specific, and
possibly even more sensitive, than an agnostic design if the methylome lies on the pathway from some exposures to the
outcome, at a cost in sensitivity in cases of exposures effects not involving the methylome; 2. that the adjustment on
the outcome that we proposed in the second step of our MITM may help to get rid of some reverse causal associations.
We chose to perform a simulation study in a realistic setting similar to our first study (chapter II) and under various
causal structures to compare the performance of our MITM design to other methods involving or not the use of the
methylome, which is presented in this chapter.

Cadiou, S., Basagana, X., González, JR., Lepeule, J., Siroux, V., Vrijheid, M., Slama, R.,
“Performance of approaches relying on intermediate high-dimensional data to decipher
causal relationships between the exposome and health: a simulation study under various
causal structures”, submitted




                                                         111


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
               Abstracts

            English abstract

Challenges in the assessment of the health effects of the exposome, defined as encompassing all

environmental exposures from the prenatal period onwards, include a possibly high rate of false

positive signals. It might be overcome using data dimension reduction techniques. Data on

biological layers lying between the exposome and its possible health consequences, such as the

methylome, may help reducing exposome dimension. We aimed to quantify the performances of

approaches relying on the incorporation of an intermediary biological layer to relate the exposome

and health, and compare them with agnostic approaches ignoring the intermediary layer. We

performed a Monte-Carlo simulation, in which we generated realistic exposome and intermediary

layer data by sampling with replacement real data from the Helix exposome project. We generated

a Gaussian outcome assuming linear relationships between the three data layers, in 2381 scenarios

under five different causal structures, including mediation and reverse causality. We tested 3

agnostic methods considering only the exposome and the health outcome: ExWAS (for

Exposome-Wide Association study), DSA, LASSO; and 3 methods relying on an intermediary

layer: two implementations of our new oriented Meet-in-the-Middle (oMITM) design, using

ExWAS and DSA, and a mediation analysis using ExWAS. Methods’ performances were assessed

through their sensitivity and FDP (False-Discovery Proportion). The oMITM-based methods

generally had lower FDP than the other approaches, possibly at a cost in terms of sensitivity; FDP

was in particular lower under a structure of reverse causality and in some mediation scenarios. The

oMITM–DSA implementation showed better performances than oMITM–ExWAS, especially in

terms of FDP. Among the agnostic approaches, DSA showed the highest performance. Integrating

information from intermediary biological layers can help lowering FDP in studies of the exposome

health effects; in particular, oriented-MITM seems less sensitive to reverse causality than agnostic

exposome-health association studies.



                                                112


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
            French abstract

Les nombreux défis dans l'évaluation des effets sur la santé de l'exposome, défini comme

l’ensemble des expositions environnementales subies à partir de la période prénatale, incluent un

taux éventuellement élevé de faux positifs. Ce défi pourrait être surmonté en utilisant des

techniques de réduction de la dimension. Les données sur les couches biologiques situées entre

l'exposome et ses éventuelles conséquences sur la santé, telles que le méthylome, peuvent aider à

réaliser une telle réduction de la dimension de l'exposome. Nous avons cherché à quantifier les

performances des approches reposant sur l'incorporation d'une couche biologique intermédiaire

pour mettre en relation l'exposome et la santé, et à les comparer avec des approches agnostiques

ignorant la couche intermédiaire. Nous avons réalisé une simulation de Monte-Carlo, dans laquelle

nous avons généré des données réalistes d'exposome et de couche intermédiaire en échantillonnant

des données réelles du projet HELIX. Nous avons généré un outcome gaussien en postulant des

relations linéaires entre les trois couches de données, dans 2381 scénarios sous cinq structures

causales différentes, y compris la médiation et la causalité inverse. Nous avons testé 3 méthodes

agnostiques ne considérant que l'exposome et l’outcome de santé : ExWAS (étude d'association à

l’échelle de l’exposome), DSA, LASSO ; et 3 méthodes reposant sur des données intermédiaires :

deux implémentations de notre nouveau design « Meet-in-the-Middle orienté » (oMITM), utilisant

ExWAS et DSA, et une analyse de médiation utilisant ExWAS. Nous avons évalué la sensibilité

des méthodes et le taux de faux positifs (FDP). Les méthodes oMITM avaient généralement un

FDP plus faible que les autres approches ; c'était notamment le cas dans une structure de causalité

inverse et dans certains scénarios de médiation (parfois à un coût en termes de sensibilité).

L’implémentation oMITM-DSA a montré de meilleures performances qu’oMITM-ExWAS. Parmi

les approches agnostiques, DSA a montré les meilleures performances. L'utilisation d'informations

provenant de couches biologiques intermédiaires peut contribuer à réduire le FDP dans les études

des effets de l'exposome sur la santé ; en particulier, oMITM semble moins sensible à la causalité

inverse que les études agnostiques d'association exposome-santé.

                                               113


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
                Introduction

The exposome concept acknowledges that individuals are exposed simultaneously to a multitude

of environmental factors from conceptions onwards (Wild, 2005). The exposome, understood as

the totality of the individual environmental (i.e. non-genetic exogenous) factors, may explain an

important part of the variability in chronic diseases risk (Manrai et al., 2017; Sandin et al., 2014;

Visscher et al., 2012). During the last decade, environmental epidemiology started embracing the

exposome concept (see e.g. (Agier et al., 2019; Lenters et al., 2016; Patel et al., 2010)). Such studies

typically face an issue encountered in many fields (Runge et al., 2019), that of efficiently identifying

the causal predictors of an outcome among a set of possibly correlated variables of intermediate to

high dimension (currently, a few hundred to a few thousand variables). The correlation within the

exposome (Tamayo-Uria et al., 2019) was shown to entail a possibly high rate of false positive

findings, in particular when using ExWAS (exposome-wide association study), i.e. parallel

univariate models with correction for multiple testing (Agier et al., 2016). Recent studies, typically

conducted among a few hundred or thousand subjects, are also expected to have limited power

(Chung et al., 2019; Siroux et al., 2016; Slama and Vrijheid, 2015; Vermeulen et al., 2020). In

addition, they can suffer from reverse causality: if exposures are measured by biomarkers at the

same time as the outcome, this opens the possibility of the health outcome influencing some

components of the exposome. For example, the serum concentration of persistent compounds can

be influenced by the amount of body fat, which is related to health outcomes such as obesity or

cardiovascular disorders (Cadiou et al., 2020). The potential for reverse causality is even stronger if

biomarkers of effect (e.g. biomarkers of oxidative stress or inflammation) are considered to be part

of the exposome, as sometimes advocated (Rappaport, 2012; Vermeulen et al., 2020). Indeed, these

may also be consequences of the considered health outcome.

Benchmark studies and reviews tried to identify which statistical methods could help to face some

of these issues (Agier et al., 2016; Barrera-Gómez et al., 2017; Lazarevic et al., 2019; Lenters et al.,

2018). Dimension reduction tools were a relevant option to consider (Chadeau-Hyam et al., 2013).

                                                  114


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Dimension reduction can be achieved by purely statistical approaches, or rely on external (e.g.,

biological) information. Past simulation studies focused on statistical dimension reduction

techniques and generally assumed a simple causal structure and that the variability of the outcome

explained by the exposome was higher than 5% (Agier et al., 2016; Barrera-Gómez et al., 2017;

Lenters et al., 2018): within this framework, they showed that dimension reduction techniques such

as regression-based variable selection methods simultaneously considering multiple variables were

more efficient than the ExWAS to control the false positive rate (Agier et al., 2016). When it comes

to non-purely statistical dimension reduction approaches, it may be relevant to try relying on

biological parameters, including ‘omic (methylome, transcriptome, metabolome…), inflammatory

or immunologic markers, possibly acting as intermediary factors between the exposome and health.

This logic is embodied in the Meet-in-the-Middle (MITM) design (Chadeau-Hyam et al., 2011;

Jeong et al., 2018), which detects “intermediary” biomarkers associated with both exposures and

the health outcome. We recently applied a tailored MITM design (Cadiou et al., 2020), named

hereafter “oriented Meet-in-the-Middle” (oMITM), with a dimension reduction aim, and using

methylation data to reduce exposome dimension.

Here, we make the hypothesis that oMITM could 1) allow lowering the high FDP reported for

agnostic ExWAS, and 2) could be less sensitive to reverse causality than agnostic dimension

reduction methods. This might be obtained at a cost of a decreased sensitivity, in particular as the

proportion of exposures whose health effect is not mediated by the considered layer increases

(Cadiou et al., 2020). Specifically, we aimed to test if methods relying on intermediary

multidimensional biological data allow to more efficiently identify the causal predictors of a health

outcome among a large number of environmental factors. We both considered methods making

use of information on potential mediators of the health effects of exposures and agnostic methods

ignoring the intermediate layer, and compared their sensitivity and false positive rate. Data were

generated assuming five different possible causal models, including reverse causality, for realistically

low values of the share of the outcome variability explained by the exposome. After comparing the

                                                  115


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
methods using simulated data, in a second section, we use causal inference theory to discuss which

designs may be most adapted under each possible causal structure.




                Materials and methods

             Overview of the simulation

We relied on a Monte-Carlo simulation to compare the efficiency of methods aiming at identifying

which components of the exposome influenced a health outcome under various causal models and

hypotheses (altogether defining a total of 2381 scenarios). Exposome, intermediary layer and

outcome data were generated under these various scenarios. For each scenario, 100 datasets were

simulated (see below). The 6 methods compared, as well as two control methods (see below), were

applied to each dataset and their performances were assessed, and synthesized over all datasets

related to a given scenario.

             Causal structures considered

Five different causal structures were considered (see Figure IV.1): in structures A, B, C the

exposome (E) affects the outcome (Y) directly or indirectly. In A, there is no direct effect from E

to Y, all the effect being mediated by the intermediary layer (i.e. “indirect effect” in the mediation

analysis terminology (Vanderweele and Vansteelandt, 2009)). B assumed a causal link from M to Y

and a direct effect from E to Y, without mediation through M. C assumed both a direct and an

indirect effect of E on Y. Structure D is a situation with reverse causal links from Y to M and from

Y to E. Structure E assumed total independence between the three layers.




                                                 116


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.1: Causal structures considered in the simulation study of the efficiency of studies relating a layer

of predictors E (e.g., the exposome) to a layer of possibly intermediary parameters (e.g. biological parameters

such as DNA methylation) M and a health outcome or parameter Y.




              Generation of independent realistic exposome, methylome and outcome data, and

              addition of causal relations within them

To build datasets according to these causal structures, we first generated independent variables

corresponding to a set of exposures (our exposome) and a biological layer (e.g., corresponding to

metabolomic signals or methylation levels at various sites on the DNA) by independently sampling

with replacement real data on the exposome and DNA methylome from 1173 individuals of

HELIX project (Cadiou et al., 2020; Maitre et al., 2018; Vrijheid et al., 2014). For the exposome,

173 quantitative variables corresponding to the exposures were obtained from the real prenatal and

postnatal child exposome data of Helix, selecting only the quantitative exposures and covariates.

Variables were then standardized and bounded (each standardized value greater than 3 in absolute

value were replaced by a value lower than 3 in absolute value randomly drawn in the distribution).

For the intermediary layer, 2284 quantitative variables corresponding to the CpGs were obtained

                                                     117


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
from the real methylome data of Helix and the a priori selection of CpGs performed in Cadiou et

al. (2020) by selecting only enhancers CpGs belonging to selected pathways. These variables were

standardized.

From this sampled dataset, in which the exposure and the methylome were, by construction,

independent, we used linear models to possibly add an hypothesized effect of some exposures on

the methylome, and to generate a health outcome possibly related to E and/or M according to the

above-mentioned causal structures (Figure IV.1): in causal structures A, B and C, assuming a causal

effect of the exposome or the methylome on the outcome, the outcome (Y) was drawn from a

normal distribution to which potential effects of E and M were added. The variance of this

distribution was set to ensure that the total variability explained by E and M was that defined by

the desired scenario. To simulate a reverse causal link (structure D, Figure IV.1) and a situation

without causal link between the three layers (structure E), we generated the outcome by

bootstrapping the real child BMI data of HELIX cohorts; a linear effect of the outcome was added

to the exposome and to the methylome for causal structure D. BMI was standardized according to

WHO guidelines (Cadiou et al., 2020; de Onis et al., 2007).

For each structure, different scenarios varying the intensity of the hypothesized associations and

the number of predictors from the different layers were generated: in particular, for the structures

displaying an effect of E on Y, the total variability of Y explained by E and M, fixed within a

scenario, varied between 0.01 and 0.4 and the number of true predictors of Y within E varied

between 1 and 25; the number of elements of M with an effect on Y varied between 10 and 100 in

the causal structures assuming such an effect. The parameters of the different scenarios are detailed

in Supplementary Table V.1. For each scenario considered, 100 datasets were simulated.

The simulation (detailed in Supplementary Material V.1) additionally made the following

assumptions:


       All direct effects of a variable on another were assumed to be linear.

                                                118


 CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                         to decipher causal relationships between the exposome and health
       The magnitude (i.e., slope) of all effects from the predictor variables of a given layer (e.g.

        E) on the predicted variables of another layer were identical within a given scenario.

       A variable from M could not be affected by more than one exposure. In consequence,

        when multiple exposures were assumed to affect the intermediary layer, the number of

        variables affected was a multiple of the number of exposures.

  Table IV.1: Details of the methods compared in the simulation study.
Name               Description                                                                References            Name
                                                                                                                    used in
                                                                                                                    figure
Agnostic methods
ExWAS with         Independent linear regressions corrected for multiple testing using        (Benjamini and        ExWAS
Benjamini-         Benjamini-Hochberg correction. The output corresponds to exposures         Hochberg, 1995)
Hochberg           associated with the outcome.
correction

Lasso              Penalized regression model relying on a generalized linear framework       (Tibshirani, 1996)    LASSO
                   developed by Tibshirani (Tibshirani, 1996). The LASSO penalty (L1)         (Friedman et al.,
                   added to the loss function promotes sparsity and performs variable         2010).
                   selection through shrinkage: the lowest regression coefficients,
                   corresponding to the least informative predictors, are attributed a zero
                   value, according to a penalty parameter λ. As advised by Tibshirani
                   (Tibshirani, 1996) and implemented in the glmnet package (Friedman et
                   al., 2010), λ is determined by minimizing the prediction root mean
                   squared error (RMSE) using 10-fold cross-validation. λ sequences
                   tested in the cross-validation process is a sequence of 100 values
                   deterministically determined from the data (Friedman et al., 2010).
                   Exposures with non-zero coefficients in the final model using optimal
                   lambda are the output of this selection method.




DSA (Deletion      DSA is an iterative linear regression model search algorithm (Sinisi and   (Sinisi and van der   DSA
Substitution       van der Laan 2004) following three constraints: maximum order of           Laan 2004)
Addition)          interaction amongst predictors, the maximum power for a given
algorithm          predictor, and the maximum model size. At each iteration, the
                   following three steps are allowed: a) removing a term, b) replacing one
                   term with another, and c) adding a term to the current model. The
                   search for the best model starts with the intercept model and identifies
                   an optimal model for each model size. The final model is selected by
                   minimizing the value of the RMSE using 5-fold cross-validated data.
                   We allowed no polynomial or interaction terms, and made no
                   restriction on the number of predictors. Exposures selected by DSA
                   are the output of this selection method.




                                                      119


 CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                         to decipher causal relationships between the exposome and health
Methods incorporating information from an intermediary layer
Oriented Meet     Design of the Meet in the Middle approach from (Cadiou et al., 2020),         (Cadiou et al., 2020)   oMITM-
in the Middle -   using ExWAS-type corrected for multiple testing using Benjamini-              (Benjamini and          ExWAS
ExWAS             Hochberg correction for all three steps. 3 steps: a. tests of association     Hochberg, 1995)
                  between the intermediary layer and the outcome with an ExWAS type
                  approach corrected for multiple comparisons using Benjamini and
                  Hochberg procedure; b. tests of association between each exposure and
                  the intermediary variables found associated with the outcome in step,
                  adjusted on the outcome, corrected for multiple testing using the
                  Benjamini-Hochberg procedure. Correction for multiple testing takes
                  into account all the tests performed at this step (i.e. number of
                  exposures x number of intermediary variables found associated with
                  the outcome in step a); c. Test of the associations between exposures
                  found associated with at least one intermediary variable at step b and
                  the outcome, using an ExWAS design corrected for multiple
                  comparisons. Correction for multiple testing takes into account all the
                  tests performed at this step (i.e. number of exposures found associated
                  with at least one CpG at step b.). Exposures found associated with the
                  outcome in step c. are the output of this selection method.

Oriented Meet     Design of the oriented Meet in the Middle approach from (Cadiou et            (Cadiou et al., 2020)   oMITM-
in the Middle -   al., 2020), using ExWAS-type corrected for multiple testing using             (Benjamini and          DSA
DSA               Benjamini-Hochberg correction for the two first steps and DSA for the         Hochberg, 1995)
                  last steps. 3 steps: a. tests of association between the intermediary layer   (Sinisi and van der
                  and the outcome with an ExWAS type approach corrected for multiple            Laan 2004)
                  comparisons using Benjamini and Hochberg procedure; b. tests of
                  association between each exposure and the intermediary variables
                  found associated with the outcome in step, adjusted on the outcome,
                  corrected for multiple testing using the Benjamini-Hochberg
                  procedure. Correction for multiple testing takes into account all the
                  tests performed at this step (i.e. number of exposures x number of
                  intermediary variables found associated with the outcome in step a); c.
                  DSA algorithm (implemented as described above) is applied to select
                  exposures associated with the outcome among the exposures found
                  associated with at least one intermediary variable at step b. Exposures
                  found associated with the outcome in step c. are the output of this
                  selection method.

Mediation         Mediation analysis in 3 causal steps: a. ExWAS using Benjamini-               (MacKinnon et al.,      Mediation
                  Hochberg correction; b. Tests of the associations between the                 2002; Vanderweele
                  exposures selected in step a. and each intermediary variable, corrected       and Vansteelandt,
                  for multiple comparisons using Benjamini-Hochberg correction; c.              2009)
                  tests of the association of each intermediary variable with the outcome
                  adjusted on each exposure found associated with the outcome at step
                  a., corrected for multiple testing using Benjamini Hochberg procedure.
                  Exposures for which corrected p-values are significant for at least one
                  intermediary variable site in both step b and c are the output of this
                  selection method.




                                                       120


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
 Control methods

 Steps 1 and 2 of   2 first steps of the design of the oriented Meet in the Middle approach    (Cadiou et al., 2020)   oMITM –
 the oriented       using ExWAS-type, corrected for multiple testing with Benjamini-                                   steps 1 and
 Meet-in-the-       Hochberg correction (Cadiou et al., 2020). a. tests of association                                 2
 Middle             between the intermediary layer and the outcome with an ExWAS type
                    approach corrected for multiple comparisons using Benjamini and
                    Hochberg procedure; b. tests of association between each exposure and
                    the intermediary variables found associated with the outcome in step a,
                    adjusted on the outcome, corrected for multiple testing using
                    Benjamini-Hochberg procedure. Correction for multiple testing takes
                    into account all the tests performed at step b (i.e. number of exposures
                    x number of intermediary variables found associated with the outcome
                    in step a). Exposures found associated with at least one intermediary
                    variable in step b. are the output of this selection method.

 ExWAS on a         ExWAS with FDR correction on a set of nR random exposures, where           (Benjamini and          ExWAS on
 random             nR is the number of exposures in the reduced exposome when applying        Hochberg, 1995)         subsample
 subsample          oMITM -ExWAS on the same dataset. Exposures found associated
                    with the outcome are the output of this selection method.




              Methods to relate the exposome and health compared

For each generated dataset, we applied 8 different statistical methods, detailed in Table IV.1:

- three “agnostic” methods ignoring the intermediary layer: ExWAS with Benjamini-Hochberg

correction (Benjamini and Hochberg, 1995), Lasso (Friedman et al., 2019; Tibshirani, 1996),

Deletion Substitution Addition (DSA) algorithm (Sinisi and van der Laan, 2004);

- three methods using the intermediary layer to reduce the dimension of the exposome: two

implementations of our oMITM-design (Cadiou et al., 2020) and a mediation analysis using parallel

simple linear regressions (Küpers et al., 2015; MacKinnon et al., 2002);

- two “control” methods: “ExWAS steps 1 and 2” and “ExWAS on subsample”, meant to inform

the comparison between the results of the previous methods (see below and Table IV.1).

The oMITM design, detailed in Table IV.1 and implemented by Cadiou et al. (2020), consists in

three series of association tests: a) between the intermediary layer M and the outcome Y, allowing

to identify components of M associated with Y; b) between the components of the intermediary

layer selected at step a) and the exposures E, with an adjustment on the outcome; c) between the


                                                       121


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
exposures selected at step b) and the outcome (see (Cadiou et al., 2020) for details). Various

statistical methods can be used at steps a, b, c). We tested two different implementations of the

oMITM design: the first one (oMITM-ExWAS) used ExWAS-type methods at all steps, i.e. a series

of parallel linear regression models (one per tested predictor) corrected for multiple testing using

Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995); the second oMITM

implementation used an ExWAS-type approach at steps a) and b) and DSA algorithm at step c).

DSA (Sinisi and van der Laan, 2004) is is an iterative linear regression model search algorithm,

which has been shown to provide the best performance (assessed as the compromise between

sensitivity and FDP) in studies relating the exposome to health, compared to other common

methods including ExWAS (Agier et al., 2016). It performs data-adaptive estimation through loss-

based cross-validated estimator selection. DSA was not considered for step a) and b) as, as a

wrapper method, it is not computationally feasible to use it on a set of covariates of dimension

higher than a few hundred. The third “agnostic” method used, LASSO, is a regularized linear

regression, adding a penalty term (L1) to the loss function (Tibshirani, 1996). For the mediation

design, using the 3 causal steps defined by the seminal article of Baron and Kenny (1986), we

implemented ExWAS-type analysis at each step, in order to allow comparison with MITM-

ExWAS.

             Assessing scenarios’ characteristics and methods’ performances

To assess the characteristics of each scenario, variabilities of Y explained by the true predictors of

E, by the true predictors of M and by both were measured and their mean and standard deviation

were computed over the 100 runs. For causal structures A and C, the variability explained by E for

each variable of M affected by E was also measured and averaged. Then mean and standard

deviation of this averaged variability were computed over the 100 runs. For structures D and E,

the variability explained by Y was measured for each variable of M or exposure predicted and

means and standard deviations were computed across the exposome and the intermediary layer.



                                                 122


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
To compare methods, for each scenario of causal structures A, B and C, false discovery proportion

(FDP) and sensitivity to identify true predictors within the exposome were measured and mean

and standard deviation were computed. FDP was defined as the proportion of exposures that were

not causal predictors among the exposures selected. When no exposure was selected, FDP was set

to 0. Sensitivity was defined as the proportion of exposures selected among the true causal

predictors. For scenario from structures D and E, for which there were no true predictors of Y,

the mean and standard deviations of the number of predictors found were computed over the 100

runs. The “sensitivity” to detect exposures affected by Y was also computed. In causal structures

A, B and C, methods’ performances were compared in term of FDP, sensitivity and accuracy

(defined as the sum of sensitivity and 1 – FDP).

The script, developed in R, is provided in Supplementary Material V.2.

             Comparisons between oMITM, mediation and direct association test using structural

             causal modelling theory in a three-variable scheme

We used the theory of structural causal modelling (Pearl, 2009, 1995) to identify in which causal

situations a causal association could be expected to be identified using the-Middle design in the

simpler situation of three unidimensional variables (i.e. one exposure, one CpG, one outcome,

ignoring the higher dimension of E and M in our simulation). Twenty-five Directed Acyclic Graphs

(DAG) were assessed, corresponding to the 27 theoretical possibilities combining 3 variables with

3 modalities (no causal link, causal link, reverse causal link) without the two diagrams

corresponding to cyclic graphs (E->M->Y->E and Y->M->E->Y). For each causal structure,

potential bias were identified for each association test through the existence of spurious association

between two variables because of a backdoor path not controlled for or because of adjustment for

a collider (Pearl, 2009, 1995). This allowed to determine if oMITM would be able to show an

association, assuming that statistical power was sufficient. We determined for each causal structure

if the design was expected to provide a false-positive, false-negative, true-positive or true negative


                                                 123


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
finding, according to the theoretical output (exposure selected or not) and the presence of a direct

causal link from the exposure to the outcome in the causal structure considered. Similar analyses

were done for the mediation design (see Table IV.1), for a design similar to the oMITM but without

adjustment on the outcome in the second step b) (which corresponds to the MITM design most

commonly implemented in the literature (Chadeau-Hyam et al., 2011)), and for the basic association

test between E and Y ignoring M.




                                                124


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
               Results

            Causal structures assuming an effect of the exposome on health

The characteristics of the scenarios under causal structures assuming an effect of the exposome on

health (structures A, B and C) are summarized in Supplementary Table V.2. On average over these

three structures, DSA and oMITM-DSA provided the highest accuracy; FDP was lower for

oMITM-DSA and sensitivity higher for DSA (Table IV.2). When we considered the three causal

structures separately, the method most accurate differed between causal structures.

When we assumed that the totality of the effect of E on Y was mediated by M (structure A), the

variability of Y explained by E was necessarily lower than under the other causal structures with

direct E-Y relation (Supplementary Table V.2). Overall, the method maximizing the accuracy was

oMITM-DSA (Table IV.2). It was immediately followed by the oMITM-ExWAS and then the

mediation analysis. Average sensitivity was higher than 0.095 for all the agnostic and non-agnostic

methods and it increased with the variability of E explained by Y. The method displaying the lowest

FDP was oMITM-DSA (average FDP across scenarios, 0.038), which also showed one of the

lowest sensitivities on average (0.095); however, as soon as the variability explained by the

exposome was above 0.1, its sensitivity was above 0.70 while its FDP remained below 0.20 (see

Figure V.2). In a few scenarios (when the variability explained by the exposome was between 0.05

and 0.1, see Figure 2 and Supplementary Figure 1), oMITM-DSA even showed a better sensitivity

than its agnostic counterpart, DSA, with a similar FDP. When the variability explained by the

exposome was low (below 0.01), oMITM-DSA did not select any predictor, contrarily to DSA,

which showed a non-null FDP in this range of variabilities. oMITM-ExWAS and mediation had

an average FDP and an average sensitivity that were both of 0.1. Overall, the reduced exposome

selected by the two oMITM designs (after steps 1 and 2 of oMITM) contained more true predictors

than a random set of exposures of the same dimension; this can be seen by comparing the

sensitivity of oMITM-ExWAS to the sensitivity of ExWAS on subsample (Figure IV.3A), which was

lower in all scenarios. Interestingly, the FDP of oMITM-ExWAS and ExWAS on subsample were

                                               125


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
similar and lower than the FDP of ExWAS. This shows the influence of the dimension on the

FDP for ExWAS-based methods and illustrates the benefit of the dimension reduction steps

provided by oMITM.

Coming to the agnostic methods, DSA and ExWAS displayed similar global performances (Table

IV.2), but DSA showed better (lower) FDP in the few scenarios for which the variability explained

by E was higher than 0.1 (Figure IV.2A and B). LASSO displayed the highest FDP (average, 0.41)

and had a high FDP even when the variability explained by the predictors was low (Figure IV.2B),

as, contrarily to the other methods, it most often selected a non-null number of variables in these

situations (Supplementary Figure V.1C).




                                               126


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.2: A. 1- FDP and B. Sensitivity under causal structure A (see Figure IV.1) for all
compared methods; performances were averaged across scenarios according to categories of
variabilities of Y explained by E (x-axis) and by M (color) and categories of mean variability of a
covariate from M affected by E by E. Values were smoothed to give the trend according to
averaged categories of variabilities of Y explained by E and by M. (in color)




                                                127


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.3: Comparisons between oMITM-ExWAS and control methods (oMITM-steps 1 and 2
and ExWAS on subsample) performance (1-Average FDP and sensitivity) for causal structures A, B
and C. Performances were averaged across scenarios according to categories of variabilities of Y
explained by E (x-axis) and by M (color). Values were smoothed to give the trend according to
averaged categories of variabilities of Y explained by E and by M.




                                              128


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                        to decipher causal relationships between the exposome and health




                                         129


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
When we assumed that the exposome directly influenced health (without mediation by the

intermediate layer, structure B), all methods relying on information from the intermediary layer

unsurprisingly showed very low sensitivity (lower than 0.010); they also had very low FDP (lower

than 0.013, Table IV.2), as they did not select any exposure in most scenarios (see Supplementary

Figure V.2C). Coming to the agnostic methods, their sensitivity increased with the variability of Y

explained by E (Figure IV.4B). Among both types of methods, the one maximizing accuracy was

DSA, which performed far better than the other methods (Table IV.2). oMITM-DSA ranked

second in terms of accuracy: there were some scenarios (when both variabilities explained by E

and M were higher than 0.1) in which oMITM methods selected some exposures that were true

predictors (Figure IV.4B and Supplementary Figure V.2A). In these scenarios, oMITM-DSA

showed good sensitivity (average, 50%) and very good FDP (lower than 15%). Indeed, counter-

intuitively, for these scenarios, the reduced exposome selected by oMITM design was non-empty

and contained more true predictors than would be selected by chance (this can be seen in Figure

IV.3B by comparing the sensitivity of oMITM-ExWAS to the sensitivity of ExWAS on subsample,

which was always lower). On the contrary, mediation provided a null sensitivity, always failing to

detect true predictors (Figure IV.4B). This relatively good behavior of oMITM under causal

structure B can be explained by the selection bias (Hernán et al., 2004) induced in step b) of the

oMITM design when adjusting on Y: a spurious link between E and Y is created, leading to add

some causal predictors of Y in the reduced exposome.

For structure C, the situation with both direct and indirect effects of the exposome on health,

performances ranged between those observed in scenarios A and B; oMITM-DSA and DSA were,

again, the methods with the highest accuracy (Figure IV.5).




                                               130


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
Table IV.2: Performance for every method under each causal structure. For structures A, B and C, FDP (average mean and standard error across
scenarios), sensitivity (average mean and standard error across scenarios) and accuracy, defined as 1 - FDP + sensitivity (average mean across
scenarios). For structure D, number of hits (average mean and standard error across scenarios) and sensitivity to find the exposures predicted by Y
(average mean and standard error across scenarios). For structure E, number of hits (average mean and standard error across scenarios). For each
performance indicator and for each structure, an * indicates the method with the best performance for a given causal structure. a: Proportion of
exposures influenced by Y identified by the approach.
                               Causal structure A                          Causal structure B                        Causal structure C               Causal structure D           Causal
                                                                                                                                                                                structure E

 Methods              FDP       Sensitivity     Accuracy         FDP         Sensitivity        Accuracy   FDP        Sensitivity     Accuracy     Number     Sensitivity to    Number of
                      (SD)        (SD)                           (SD)          (SD)                        (SD)         (SD)                        of hits    predicted         hits (SD)
                                                                                                                                                     (SD)      exposures
                                                                                                                                                                 (SD)a

 Agnostic methods

                      0.132                                      0.388                                      0.361                                    6.622
 ExWAS                          0.126 (0.048)       0.994                    0.363 (0.077)       0.975
                     (0.199)                                    (0.188)                                    (0.222)    0.288 (0.105)       0.927     (1.242)    0.554 (0.052)    0.32 (0.909)

 DSA                  0.123                                      0.169                                      0.172                                    5.935
                                0.113 (0.054)        0.99                    0.279 (0.082)       1.110*
                     (0.308)                                    (0.284)                                    (0.306)    0.216 (0.087)       1.044*    (2.625)    0.182 (0.022)    0.13 (0.661)

 LASSO                0.413                                      0.528                                      0.540                                    41.4
                               0.158 (0.098)*       0.745                   0.395 (0.106)*       0.8671
                     (0.430)                                    (0.317)                                    (0.341)   0.320 (0.127)*       0.780    (17.483)    0.463 (0.124)    2.56 (5.472)

 Methods incorporating information from an intermediary layer

 oMITM-ExWAS          0.094                                      0.012                                      0.109                                    0.014
                                0.105 (0.043)       1.011                    0.010 (0.010)       0.998
                     (0.065)                                    (0.032)                                    (0.085)    0.088 (0.051)       0.979     (0.128)    0.001 (0.008)       0 (0)*

 oMITM-DSA            0.038                                                                                 0.043
                                                                 0.009
                     (0.102)    0.095 (0.049)       1.057*                   0.010 (0.010)       1.001     (0.108)                                  0.003
                                                                (0.046)
                        *                                                                                     *       0.073 (0.045)        1.03    (0.022)*    2x10-4 (0.002)      0 (0)*

 Mediation            0.097                                      0.003                                      0.098                                   1.214
                                0.105 (0.055)       1.008                    0.000 (0.003)       0.997
                     (0.081)                                    (0.020)*                                   (0.083)    0.068 (0.044)       0.970     (0.4)       0.13 (0.034)       0 (0)*

 Control methods

 ExWAS on             0.091                                      0.014                                      0.110                                    0.002
                                0.041 (0.047)       0.959                    0.001 (0.005)       0.987                0.043 (0.040)       0.932
 subsample           (0.091)                                    (0.039)                                    (0.100)                                  (0.015)    8x10-5 (0.001)      0 (0)

 oMITM steps 1        0.177                                      0.028                                      0.164                                    0.026
                                0.176 (0.058)       0.999                    0.010 (0.011)       0.982                0.132 (0.062)       0.968
 and 2               (0.158)                                    (0.110)                                    (0.151)                                  (0.219)    0.001 (0.013)       0 (0)



                                                                                                 131


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.4: A. 1- FDP; B. sensitivity under causal structure B (see Figure IV.1). Performances were
averaged across scenarios according to categories of variabilities of Y explained by E (x-axis) and
by M (color). Values were smoothed to give the trend according to averaged categories of
variabilities of Y explained by E and by M.




                                                132


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.5: A. 1- FDP; B. Sensitivity under causal structure C. Performances were averaged across
scenarios according to categories of variabilities of Y explained by E (x-axis) and by M (color) and
of mean variability of an element of M affected by E by E. Values were smoothed to give the trend
according to performance averaged categories of variabilities of Y explained by E and by M.




                                                133


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health


             Causal structures without effect of the exposome on health

In a situation with a causal link from Y to E (corresponding to reverse causality, structure D,
scenarios described in Supplementary Table V.3), all agnostic methods displayed a non-null number
of hits, with the number of hits increasing when the variability of E explained by Y increased
(Figure IV.6B and Supplementary Figure V.4A). This is consistent with the fact that these methods
cannot distinguish an influence of E on Y from an influence of Y on E: as shown in Figure IV.6,
as the variability of exposures explained by Y increased, exposures were more often selected as
hits. This proportion of hits had values similar to the sensitivity displayed by these agnostic
methods in structures A, B and C.

Table IV.3: Number of hits (average mean and standard error across scenarios), sensitivity to find
the exposures predicted by Y (average mean and standard error across scenarios) under causal
structures D and E. For each performance indicator and for each causal structure, an * indicates
the method minimizing the indicator.
 Structure                          Causal structure D                         Causal structure E

 Methods                Number of hits        Sensitivity to     Number of hits          Sensitivity to
                           (SD)                predicted            (SD)                  predicted
                                             exposures (SD)                             exposures (SD)

 Agnostic methods
 ExWAS                    6.622 (1.242)        0.554 (0.052)       0.32 (0.909)                -

 DSA                      5.935 (2.625)        0.182 (0.022)       0.13 (0.661)                -

 LASSO                    41.4 (17.483)        0.463 (0.124)       2.56 (5.472)                -

 Methods incorporating information from the intermediary layer
 oMITM-ExWAS              0.014 (0.128)        0.001 (0.008)          0 (0)*                   -

 oMITM-DSA                0.003 (0.022)       2x10-4 (0.002)          0 (0)*                   -

 Mediation                  1.214 (0.4)        0.13 (0.034)           0 (0)*                   -

 Control methods
 ExWAS on subsample      0.002 (0.015)*       8x10-5(0.001)*          0 (0)*                   -

 oMITM steps 1 and 2      0.026 (0.219)        0.001 (0.013)          0 (0)*                   -




Both oMITM methods selected no exposure most of the time (Figure IV.6 and Table IV.2Table
IV.3). On the contrary, the mediation analysis showed a non-null number of hits as soon as the
mean variability of E explained by Y was higher than 0.05 and the mean variability of M explained
by Y was higher than 0.3.



                                                   134


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
The structure without any causal link (structure E) can be seen as the limit of all four precedent
structures when the strength of all associations approaches zero. All methods using methylome
information selected no exposure, while agnostic methods erroneously selected some exposures,
with LASSO showing the highest error rate (Table IV.2 and Figure IV.7).




                                               135


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.6: A. Proportion of exposures influenced by Y wrongly identified, and B. number of hits
under causal structure D. Values were averaged across scenarios according to categories of
variabilities of one exposure explained by Y (x-axis) and one element of M explained by Y (color).




                                               136


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Figure IV.7: Average number of covariates selected per method under causal structure E.




                                             137


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
             Comparisons between methods using causal inference theory

Applying causal inference theory, we compared the number of possible causal structures under
which various analytical strategies would be able to identify a true effect of an exposure on health
in ideal situations of large sample size. The results are synthesized in Table IV.4, while details of
results for each causal situation are displayed in Supplementary Table 4. In Supplementary Table
5, the step-by-step results for oMITM are detailed.

A test of association between E and Y ignoring M was expected to properly identify all situations
in which E influenced Y (0 false negative, 9 true positive results, Table IV.4), but also identified
associations corresponding to reverse causality (10 false positive results, Table IV.4). Among the
methods using the intermediary variable M, oMITM and MITM without adjustment on Y both
displayed 2 false negatives (structures J and K, Supplementary Table V.4). The mediation test
showed 2 additional false negatives (Table IV.4): in particular, contrarily to oMITM, it was not able
to detect the structure A in which E affects Y indirectly through M (structure A, Supplementary
Table V.4, Figure IV.1). Coming to false positives, oMITM was the design minimizing the false
positive findings (6 versus at least 8 for any other design). MITM method led to false positives in
two situations of reverse causality to which oMITM was not sensitive (structures D and Q,
Supplementary Table 4). The mediation method displayed similarly to MITM 8 false positives.

Overall, oMITM was the design giving true results (true positive or true negative) in the highest
number of causal structures (17, versus 15 for tests of association ignoring M and for MITM not
adjusted for Y, and 13 for mediation, Table IV.4).




                                                138


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
Table IV.4: Number of true causal links detected, false causal links detected, true causal links non-detected, false causal links non-detected by different
designs among the 25 causal structures considering all possible links between 3 unidimensional layers. The analysis has been made using causal inference
theory and the results for each of all 25 causal structures are detailed in Supplementary Table V.4 The columns giving true results (i.e. true positive or
true negative) are displayed in bold. *: a design similar to our oMITM design but without adjusting on Y at step b). This design corresponds to Meet-in-
the-Middle commonly implemented in the literature.
                            True causal link                               No causal link                                       Total
                                                                                                             True results       False            All
                   Association                                                                                  (true          results
   Methods                           No association              Association         No association
                    detected                                                                                  negative          (false
                                     detected (false            detected (false      detected (true
                      (true                                                                                   and true        negative
                                       negative)                   positive)           negative)
                    positive)                                                                                 positive)       and false
                                                                                                                              negative)
     Test of
                     9 (36%)              0 (0%)                   10 (40%)              6 (24%)               15 (60%)        10 (40%)       25 (100%)
   association
    oMITM            7 (28%)              2 (8%)                    6 (24%)              10 (40%)              17 (68%)        8 (32%)        25 (100%)
   Mediation         5 (20%)             4 (16%)                    8 (32%)              8 (32%)               13 (52%)        12 (48%)       25 (100%)
     MITM
    without
                     7 (28%)              2 (8%)                    8 (32%)              8 (32%)               13 (52%)        12 (48%)       25 (100%)
  adjusting on
       Y*




                                                                           139


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
                Discussion

Our simulations highlighted that the oMITM design has high accuracy under various causal
structures. In particular, it allows to avoid false-positive associations in some structures
corresponding to reverse causality more efficiently than all other tested designs which detected the
spurious association, in particular those not making use of the intermediary layer. Moreover, in the
causal structures with a direct effect of the exposome on the outcome for which other methods
sometimes suffer from a low specificity, it allows increasing specificity while conserving a good
accuracy compared to other methods.

             Strengths and limitations

We implemented a simulation considering five different causal structures to identify in which
contexts specific methods making use of information from an intermediary biological layer could
be more efficient than specific agnostic algorithms to identify components of the exposome
influencing health. Former simulations about the performance of statistical methods to assess
exposome-health associations generally considered simpler causal structures, without any
intermediate layer nor reverse causality (Agier et al., 2016; Barrera-Gómez et al., 2017; Lenters et
al., 2018). Other simulations considered multi-layered data, but often with an aim distinct from
ours, such as the quantification of the share of the effect of an exposure on an outcome mediated
by a high dimension intermediate layer (Barfield et al., 2017; Tobi et al., 2018).

We only studied experimentally 5 of the 25 possible causal structures theoretically possible,
deferring the discussion about the remaining causal structures to the qualitative assessment of the
simplified DAGs (which did not assume that either E or M had a dimension larger than one). We
selected the 5 structures that we thoroughly tested so as to cover what we considered to be the
most realistic situations in an exposome setting; the reader interested in another specific structure
may modify our code to study it more deeply. We considered separately these causal structures,
while in reality, with multidimensional exposures and intermediary layers, several causal structures
are expected to co-exist: for example, an exposure may only act directly on Y while another
exposure could act directly and via an indirect effect mediated by M. Models performances
estimated for different causal structures should not be compared one with another as the weight
of scenarios with high or low variability explained by predictors were not the same across different
causal structures. Within-structure comparisons/reasonings are more relevant.

In some of the considered situations, the variability of Y explained by E was very low, which
seemed realistic to us. This corresponds to a situation of “rare and weak” event (Donoho and Jin,
2008), which may be more plausible than higher values of explained outcome variability assumed
                                                 140


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
in previous simulations (Agier et al., 2016; Barrera-Gómez et al., 2017). Thus, we chose to include
these scenarios even if most methods showed very low power, as it may represent the performance
encountered in real studies. This led to point to major difference in terms of specificity between
methods. Situations in which E explained a large share of the variability of Y (above 20%) were
hard to reach in the causal model corresponding to mediation (structure A), which should be seen
as a realistic feature of our simulation rather than a limitation thereof. This was a consequence of
our choice not to simulate scenarios with strong effects of E on M (maximum average share of
variability in M explained by E, 20%).

We assumed that the dimension of our intermediary layer was 2284; this value corresponded to the
dimension of a set of variables representing DNA methylation sites selected on the basis of their a
priori relevance for the considered outcome (Cadiou et al., 2020); this is also a realistic size for
biological information of other nature, such as metabolomic or immunological markers. The
dimension of the intermediary layer in which the information is diluted is expected to impact the
efficiency of approaches relying on this layer.

Coming to our causal inference analysis, the main limitation is that we analyzed only low-
dimensional DAGs (with three variables), whereas the analyzed designs are meant to be used in
higher dimension.

             Summary of methods’ performances

Our oMITM is an innovative design, used here in two flavors (oMITM-ExWAS and oMITM-
DSA). It shows similarities with a mediation design and especially with the Meet-in-the-Middle
framework described in the literature (Chadeau-Hyam et al., 2011; Jeong et al., 2018; Vineis et al.,
2013). It is notably distinguished from the classical Meet-in-the-Middle by that: 1) it does not aim
to discover intermediary biomarkers but to reduce exposome dimension in the context of an
exposome-outcome association; this explains the order chosen for the different steps; 2) we added
an adjustment on the outcome in the test of association between the exposure and the potential
mediators. Overall, our oMITM design showed good performance compared to agnostic methods.
Due to our adjustment on the outcome (leading to what corresponds to a “selection bias”, as
defined by Hernán et al. (2004)), oMITM can identify some true predictors even in structures under
which there is no indirect effect of E on Y through M (causal structure B). We explained why this
can happen in the theoretical part of our work (see paragraph 3.3). In situations of reverse causation
without link between E and M, the additional adjustment on Y of our oMITM design also allowed
to avoid false positives due to reverse causality. In situations of mediation without any direct effect
of the exposures, the reduced exposome was relevant; under this causal structure, oMITM allowed

                                                  141


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
to decrease FDP in most scenarios, and in some scenarios to increase sensitivity. The replacement
of ExWAS by DSA in the last step of the oMITM design increases performance, in particular in
term of FDP when the effect of the exposures on the outcome was high. oMITM could be further
enhanced by replacing the ExWAS-type methods used at step b) and c) by selection methods more
adapted to the high dimension (see for example the reviews of (Fan and Lv, 2010; Lazarevic et al.,
2019)).

We used an ExWAS-based implementation of mediation analysis (Küpers et al., 2015) to allow
comparisons with the oMITM design (through the oMITM-ExWAS). However, alternative
mediation implementation, more adapted to multidimensional mediators, have been proposed
(Barfield et al., 2017; Blum et al., 2020; Chén et al., 2018).

Moving now to the agnostic methods, Deletion-Addition-Substitution algorithm was the best
agnostic method in situations involving a causal effect of the exposome on the health outcome. As
shown before by Agier et al. (2016), DSA provided a better compromise between sensitivity and
specificity than ExWAS. However, it is prone to suffer from reverse causality, like all other agnostic
methods. Our results on ExWAS are consistent with those from Agier et al. (2016) when R2 was
higher than 0.1. When R2 was lower than 0.01, ExWAS often selected no exposures and thus
exhibited a FDP of 0 whereas the two other agnostic methods (DSA and LASSO) showed non-
null FDP and null or very low sensitivity. LASSO was the worst performing agnostic method; in
particular, it displayed a very high FDP. In a case of correlation between a true predictor and other
variables, LASSO is known to select one variable among a set of correlated variables (Leng et al.,
2006). The high rate of false positive findings that we observed may be explained by our choice of
a penalty parameter (the parameter which minimizes the error of prediction during the cross-
validation process (Tibshirani, 1996)) optimized for prediction. Elastic-Net (Friedman et al., 2010),
which was designed to improve the performance of Lasso when predictors are correlated, could
have been tested here. However, Agier et al. (Agier et al., 2016) already showed that DSA provided
better performance than Elastic-Net in the context of a realistic exposome.




                                                  142


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health



             Consistency between our structural causal modelling analysis and experimental

             simulation-based

Although simplified in its design, our analysis based on DAGs yield results consistent with the
more elaborate simulation study, which considered an exposome of dimension 173 and an
intermediate layer of dimension 2284. In particular, in the causal structure of reverse causality (Y
influencing E and M) without link between E and M (structure D), the oMITM method provided
no hit (Figure IV.6), as predicted by the analyses of DAGs (Supplementary Table IV.4). Similarly,
in structure B, we observed a non-null sensitivity of oMITM due to selection bias when the
variabilities in Y explained by both E and M were above a certain level.

Moreover, the behavior of oMITM in a structure of reverse causality is also consistent with the
results of a previous study using oMITM-ExWAS to relate the exposome and child BMI in Helix
data using methylome (Cadiou et al., 2020). Indeed, as detailed in Cadiou et al (2020), an agnostic
ExWAS applied on the same data resulted in 20 significant associations, with the majority likely to
be due to reverse causality: most of these hits corresponded to lipophilic substances (such as
polychlorobiphenyls (PCB)), measured in blood at the same time as the outcome. They were
negatively associated with BMI, whereas toxicological studies based on a prospective design
suggested obesogenic effect of such components (Heindel & vom Saal, 2009; Thayer et al., 2012).
As they are stored in fat, a plausible explanation is that these associations are due to increased fat
levels in obese subjects, entailing a higher amount of PCBs stored in fat and, conversely, a lowering
of circulating PCB levels in blood (Cadiou et al., 2020). The reduced exposome obtained with
oMITM, which consisted of 4 exposures, did not contain any of these hits of the agnostic analysis
suspected to be due to reverse causality, except PFOS level. Thus, we can hypothesize that for
these exposures, this situation corresponded to one of the cases of reverse causality situations
discussed above, in which the oMITM design is not expected to identify exposures influenced by
the outcome. This is consistent with the simulation results and highlights that the benefit of
oMITM may come from the dimension reduction performed in the two first steps. The fact that
blood postnatal level of PFOS, another compound suspected of reverse causality, was selected by
the oMITM-ExWAS approach may be a consequence of the fact that oMITM is not expected to
avoid all situations of reverse causality (as shown by our causal discovery analysis (Supplementary
Table IV.4)).




                                                 143


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
               The need to rely on causal knowledge

We illustrated under which causal structures the results from previous exposome-health
simulations (Agier et al., 2016) are expected to be true and that methods always imply underlying
causal assumptions which are difficult to verify in an exposome setting. We showed that the use of
additional information through the use of methylome layer can help to deal with reverse causality
and thus decrease the false positive findings. This illustrates the affirmation of Hernan (2019) that
“causal analyses typically require not only good data and algorithms, but also domain expert
knowledge.” In our case, the use of an intermediate layer and our design, which itself relies on the
assumption of three distinctive biological layers, added some a priori information. However,
oMITM is still expected to lead to false positive findings in several causal structures corresponding
to reverse causality. Further knowledge, for example on the causal link between the exposome and
the intermediate layer, could help discarding these non-causal associations. Our work also illustrates
that classical designs, such as mediation and classical Meet-in-the-Middle procedure, are not robust
to violations of the strong assumptions they make about the underlying causal structure. Especially,
a significant mediation or classical Meet-in-the-Middle result should not be interpreted as a causal
clue supplementing the association between a factor or an outcome, unless strong knowledge about
the intermediary variables a priori makes their mediating role very likely: as we demonstrated, in
the causal structure D, which featured (reverse) causal links from the outcome to the potential
mediators and to the exposure, both mediation test and basic association test can result in
significant associations. Similarly (see theoretical results for structure D), a classic Meet-in-the-
Middle framework without adjustment on the outcome at the second step would also lead to
significant associations. Interestingly, in such a situation, even a longitudinal design may not be
sufficient to get rid of reverse causality (see the DAG provided in Supplementary Figure 5 for an
example). Thus, the statement about the Meet-in-the-Middle procedure that “If the same set of markers
is robustly associated with both ends of the exposure-to-disease continuum, this is a validation of a causal hypothesis
according to the pathway perturbation paradigm. » (Vineis et al., 2020) must be interpreted cautiously:
associations rising from an epidemiological study should be supplemented by toxicological and
biological knowledge. Overall, our work confirms that the uncertainty about the causal framework
deserves to be taken in consideration when applying statistical methods to exposome and health
data: first, it is of course crucial to understand the underlying causal assumptions behind the existing
model, and to take them into account when interpreting epidemiologic results; secondly, multilayer
approaches such as our oMITM design can be more robust than agnostic approaches when the
causal model is uncertain.



                                                         144


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
From a practical point of view, in an exposome health study where intermediary data are available,
if strong prior knowledge about the outcome or the nature of the intermediary layer makes one
specific causal structure very likely, one may choose the method(s) with a design adapted to this
causal structure according to a comparative causal analysis such as the one we performed. The
oMITM should in particular be preferred if there are reasons to expect associations due to reverse
causality (e.g. in the case of a cross-sectional design). A multilayer design should be preferred to an
agnostic one if both are adapted to the hypothesized underlying structure as the first one could
help increase the specificity. Once the design is chosen, the statistical methods (e.g. DSA, ExWAS)
for the implementation of this design should be chosen according to the dimensions of the
considered layer(s), relying on simulations studies. For example, in an exposome settings and with
an intermediary layer of intermediate dimension, our own simulations showed that respectively
DSA and ExWAS may be adapted for the implementation of the different steps of an oMITM
design.

If little a priori knowledge is available about the underlying causal structure, one could use either
an agnostic approach (if one tends to favor sensitivity over specificity, e.g. in a rather exploratory
study) or oMITM, which proved to be robust, if one tends to favor specificity.




                                                 145


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
                    Supplementary materials

Supplementary Table IV.1: Meaning and ranges of parameters used in each causal structure to
simulate the link between layers. *When a scenario did not fulfil the ‘multiplicity constraint’ (see
Supplementary Material V.1), it was ignored.
                                                                                                   Effective
                                                                                     Theoretical    number
                                                                  Range of
 Structure    Parameters        Meaning of parameters                                number of         of
                                                                 parameters
                                                                                      scenarios    scenarios
                                                                                                    tested*
                                 Numbers of exposures
                              having an effect on at least
 A            n_EE->M->Y
                               one intermediary variable
                                                                  1, 3, 10, 25          384          384
                                which has an effect on Y
                             Number of exposures having a
                   n_EE->Y                                             0
                                    direct effect on Y
                              Numbers of exposures having
                                 an effect on at least one
                   n_EE->M                                             0
                              intermediary variable having
                                      no effect on Y
                                 Number of intermediary
                                 variables affected by an
                   n_M-E>M                                             0
                              exposure having no effect on
                                             Y
                                Number of intermediary
                                variables affected by an
             n_ME->M->Y                                         10, 18, 25 ,100
                                exposure and having an
                                       effect on Y
                                 Number of intermediary
                               variables non-affected by an
                   n_MM->Y                                             0
                              exposure having an effect on
                                             Y
                                  Total variability of Y
                     R2                                       0.01, 0.05, 0.1, 0.4
                                 explained by E and M
                             Coefficient of the effect of
                                                                0.0001, 0.001,
             β               an exposure on an
                                                                0.01, 0.1, 0.5
                             intermediary variable
                             Coefficient of the effect of
             β'              an intermediary variable on             0.01
                             Y
                             Coefficient of the effect of
             β’’                                                       0
                             an exposure on Y

                             Numbers of exposures having
                             an effect on at least one
 B           n_EE->M->Y
                             intermediary variable which
                                                                       0                320          180
                             has an effect on Y
                             Number of exposures
             n_EE->Y                                              1, 3, 10, 25
                             having a direct effect on Y
                             Numbers of exposures having
                             an effect on at least one
             n_EE->M                                                   0
                             intermediary variable having
                             no effect on Y
                             Number of intermediary
                             variables affected by an
             n_M-E>M                                                   0
                             exposure having no effect on
                             Y

                                                   146


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                        to decipher causal relationships between the exposome and health
                      Number of intermediary
                      variables affected by an
        n_ME->M->Y                                               0
                      exposure and having an effect
                      on Y
                      Number of intermediary
                      variables non-affected by an
        n_MM->Y                                           10, 18, 25, 100
                      exposure having an effect
                      on Y
                      Total variability of Y
        R2                                              0.01, 0.05, 0.1, 0.4
                      explained by E and M
                      Coefficient of the effect of
                                                          0.0001, 0.001,
        β             an exposure on an
                                                          0.01, 0.1, 0.5
                      intermediary variable
                      Coefficient of the effect of
        β'            an intermediary variable on              0.01
                      Y
                      Coefficient of the effect of an
        β’’                                                      0
                      exposure on Y

                      Numbers of exposures
                      having an effect on at least
C       n_EE->M->Y
                      one intermediary variable
                                                            1, 3, 10, 25       1600   900
                      which has an effect on Y
                      Number of exposures
        n_EE->Y                                             1, 3, 10, 25
                      having a direct effect on Y
                      Number of exposures
                      having both a direct effect
        n_EE->Y U     on Y and an effect on at
                                                             n_EE->Y
        n_EE->M->Y    least one intermediary
                      variable which has an effect
                      on Y
                      Numbers of exposures having
                      an effect on at least one
        n_EE->M                                                  0
                      intermediary variable having
                      no effect on Y
                      Number of intermediary
                      variables affected by an
        n_M-E>M                                                  0
                      exposure having no effect on
                      Y
                      Number of intermediary
                      variables affected by an
        n_ME->M->Y                                        10, 18, 25, 100
                      exposure and having an
                      effect on Y
                      Number of intermediary
                      variables non-affected by an
        n_MM->Y                                                  0
                      exposure having an effect on
                      Y
                      Total variability of Y
        R2                                              0.01, 0.05, 0.1, 0.4
                      explained by E and M
        n_MY->M       Number of intermediary
                                                          10, 18, 25, 100
                      variables affected by Y
                      Coefficient of the effect of
                                                          0.0001, 0.001,
        β             an exposure on an
                                                          0.01, 0.1, 0.5
                      intermediary variable
                      Coefficient of the effect of
        β'            an intermediary variable on              0.01
                      Y
                      Coefficient of the effect of        0.0001, 0.001,
        β’’
                      an exposure on Y                    0.01, 0.1, 0.5

                                             147


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                        to decipher causal relationships between the exposome and health


        n_MM->Y       Number of intermediary                                      576
D                     variables having an effect on Y
                                                               0            576
        n_EY->E       Number of exposures
                                                          1, 3, 10, 25
                      affected by Y
        β’            Coefficient of the effect of an
                      intermediary variable on the             0
                      outcome
        γ             Coefficient of a non-zero
                                                        0.0001, 0.001,
                      effect of the outcome on an
                                                        0.01, 0.1, 0.5,2
                      intermediary variable
        γ'            Coefficient of the effect of       0.0001, 0.001,
                      the outcome on an exposure        0.01, 0.1, 0.5, 2

E       None          N.A.                                   N.A.           1     1




                                             148


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health



Supplementary Table IV.2: Characteristics of scenarios for structure A, B and C.

Causal
                                  Causal structure A                              Causal structure B                             Causal structure C
structure
Descriptive Min. 25                  75th                                 25th                75th                        25th                75th
                    th
                        Median Mean                      Max.    Min.            Median Mean              Max.    Min.           Median Mean             Max.
statistics*     centile             centile                              centile             centile                     centile             centile

Total
                 3.46    6.49                                    4.34
variability of                   0.004   0.016   0.010   0.289            0.004   0.015   0.073   0.069   0.409   7.570
                 x10-4   x10-4                                   x10-4                                                  0.004    0.013   0.062   0.059   0.406
Y explained                                                                                                       x10-4
by E
Total
variability of   0.014 0.054     0.098   0.157   0.206   0.428   0.004    0.011   0.043   0.087   0.100   0.428   0.005 0.020    0.057   0.112   0.111   0.427
Y explained
by M
Mean
variability of
one
                 3.87    5.07
intermediary                     0.009   0.041   0.013   0.189   0.000    0.000   0.000   0.000   0.000   0.000   3.869 5.073
                 x10-4   x10-4                                                                                                   0.009   0.041   0.013   0.189
variable                                                                                                          x10-4 x10-4
affected by E
explained by
E
*For each structure, various scenarios were simulated using the range of parameters detailed in Supplementary Table 1. Variabilities of Y explained by
respectively E and M and mean variability of one intermediary variable affected by E explained by E were measured for each scenario, and descriptive
statistics for these measures were computed across structure.




                                                                                  149


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
Supplementary Table IV.3: Characteristics of the scenarios simulated for structure D
                          Min.         25thcentile   Median     Mean        75th.centile   Max.
 Average variability of 4.18Ex10-       4.48 x10-4      0.006       0.170         0.204       0.804
                                4
       an intermediary
 variable affected by Y
       explained by Y*
 Average variability of   3.72 x10-4    4.94 x10-4      0.019       0.295         0.628       0.988
 an exposure affected
 by Y explained by Y*
*Various scenarios were simulated under structure D using the range of parameters detailed in Supplementary Table 1. Average variability of an
intermediary variable affected by Y explained by Y and Average variability of an exposure affected by Y explained by Y were measured for each
scenario, and descriptive statistics for these measures were computed across structure.




                                                                         150


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
Supplementary Table IV.4: DAG analysis for different designs when considering all possible links between 3 unidimensional layers (e.g. an exposure, a
CpG site, and BMI) according to causal inference theory.
                                                                                                                                                     Wanted to
                                                                                                                        Detected by                  detect (i.e.
                                                        Causal                                                            MITM         Detected by    direct or
                                 DAG                  link from    Mediation     Association between E   Detected by
                                                                                                                         (without       mediation     indirect
                                                        E to Y    from E to Y            and Y            oMITM
                                                                                                                       correcting on     analysis    causal link
                                                                                                                            Y)                       between E
                                                                                                                                                       and Y)
       A
                                                         Yes         No                  Yes                Yes            Yes            Yes           Yes

       B
                                                         No          Yes                 Yes                Yes             No            No            Yes

       C
                                                         Yes         Yes                 Yes                Yes            Yes            Yes           Yes

       D
                                                         No          No                  Yes                No             Yes            Yes            No

       E
                                                         No          No                  No                 No             No             No             No

       F
                                                         Yes         No                  Yes                Yes            Yes            Yes           Yes

       G
                                                         Yes         No                  Yes                Yes            Yes            No            Yes




                                                                           151


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
       H
                                                      Yes         No               Yes             Yes          Yes          Yes        Yes

       I
                                                      Yes         No               Yes             Yes          Yes          No         Yes

       J
                                                      Yes         No               Yes              No          Yes          Yes        Yes

       K
                                                      Yes         No               Yes              No          No           No         Yes

       L
                                                       No         No               Yes             Yes          Yes          Yes         No

       M
                                                       No         No               Yes             Yes          Yes          No          No

       N
                                                       No         No               Yes             Yes          Yes          Yes         No

       O
                                                       No         No               Yes             Yes          Yes          Yes         No

       P
                                                       No         No               Yes              No          No           Yes         No

       Q
                                                       No         No               Yes              No          Yes          Yes         No




                                                                       152


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
       R
                                                       No         No               Yes              No          No           No          No

       S
                                                       No         No               No               No          No           No          No

       T
                                                       No         No               No               No          No           No          No

       U
                                                       No         No               Yes             Yes          Yes          Yes         No

       V
                                                       No         No               Yes             Yes          Yes          Yes         No

       W
                                                       No         No               No               No          No           No          No

       X
                                                       No         No               No               No          No           No          No

       Y
                                                       No         No               No               No          No           No          No




                                                                       153


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
Supplementary Table IV.5: Details of causal inference analysis for the oMITM design applied to 3 variables (e.g. an exposure, a CpG site, and BMI)
according to causal inference theory in all possible causal structures.

                                                                                                                                             Wanted
                                                                                                                                            to detect
                                                                                                                  Selected as
                                                      Causal                                                                     Detected      (i.e.
                                                                                                                 to be tested
                                                        link                                         Bias in                    in oMITM    direct or
                                 DAG                             Mediation        Bias in oMITM                    in oMITM
                                                      from E                                         oMITM                      (assuming    indirect
                                                                 from E to Y          step 1                      (assuming
                                                        to Y                                          step 2                      perfect     causal
                                                                                                                     perfect
                                                                                                                                  power)       link
                                                                                                                     power)
                                                                                                                                            between
                                                                                                                                             E and Y)
       A
                                                         Yes         No                No           No n bias)       Yes           Yes        Yes

       B                                                                                                Yes           Yes
                                                         No          Yes               No           (selection    (selection       Yes        Yes
                                                                                                       bias)         bias)
       C
                                                                                 Yes (uncorrected
                                                         Yes         Yes                            No n bias)       Yes           Yes        Yes
                                                                                 for confounder)
       D
                                                         No          No                No              No            No            No          No

       E
                                                         No          No                No              No            No            No          No

       F
                                                                                 Yes (uncorrected
                                                         Yes         No                                No            Yes           Yes        Yes
                                                                                 for confounder)



                                                                           154


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
       G
                                                                             Yes (uncorrected
                                                      Yes         No                               No          Yes           Yes        Yes
                                                                             for confounder)
       H                                                                                            Yes
                                                      Yes         No               No           (selection     Yes           Yes        Yes
                                                                                                   bias)
       I
                                                      Yes         No               No              No          No            Yes        Yes

       J
                                                      Yes         No               No              No          No            No         Yes

       K
                                                      Yes         No               No              No          No            No         Yes

       L
                                                       No         No               No              No          Yes           Yes         No

       M
                                                       No         No               No              No          Yes           Yes         No

       N
                                                       No         No               No              No          Yes          Yes          No

       O
                                                       No         No               No              No          Yes           Yes         No

       P
                                                       No         No               No              No          No            No          No




                                                                       155


CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data to decipher causal relationships between the exposome
                                                                                                                                      and health
       Q
                                                       No         No              No              No           No            No          No

       R
                                                       No         No              No              No           No            No          No

       S
                                                       No         No              No              No           Yes           No          No

       T
                                                       No         No              No              No           No            No          No

       U
                                                       No         No              No              No           Yes           Yes         No

       V
                                                       No         No              No              No           Yes           Yes         No

       W
                                                       No         No              No              No           No            No          No

       X
                                                       No         No              No              No           No            No          No

       Y
                                                       No         No              No              No           No            No          No




                                                                       156


      CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                              to decipher causal relationships between the exposome and health

A Supplementary Figure IV.1: Causal structure A, average sensitivity (A), 1- FDP (B) and number
. of hits (C) according to the variability of Y explained by E, method by method. Color scale gives
  the magnitude of variability of Y explained by M.




B
.




                                                  157


     CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
C.                           to decipher causal relationships between the exposome and health




 Supplementary Figure IV.2: Causal structure B, average sensitivity (A), 1- FDP (B) and number
 of hits (C) according to the variability of Y explained by E methods by methods. Color scale
 gives the magnitude of variability of Y explained by M.
A.




                                               158


     CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                             to decipher causal relationships between the exposome and health
B.




C.




                                              159


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Supplementary Figure IV.3: Causal structure C, average sensitivity (A), 1- FDP (B) and number
of hits (C) according to the variability of Y explained by E, method by method. Color scale gives
the magnitude of variability of Y explained by M.




                                               160


          CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
     C.                           to decipher causal relationships between the exposome and health




      Supplementary Figure IV.4: causal structure D, average number of hits (A), and sensitivity to
      detect exposures affected by Y (B) according to the variability of one exposure affected by Y
      explained by Y, methods by methods, in causal structure D (reverse causality). Color scale gives
      the magnitude.

A.




                                                     161


     CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                             to decipher causal relationships between the exposome and health
B.




Supplementary Figure IV.5: Example of a causal situation in which a classical Meet-in-the-Middle
framework without our additional adjustment would conclude to causal associations between E1
and Y3 whereas there is no causal influence of E1 on Y3 through M. This causal situation
corresponds to a longitudinal design, with 3 different measurement times for exposure (E), a
potential mediator (M) and outcome (Y). The underlined variables are those included in the
analysis. A classical MITM design would find, assuming perfect power, an association between E1
and M2 (due to Y1 confounding), an association between M2 and Y3 (due to Y2 confounding) and
an association between E1 and Y3 (due to Y1 confounding).




                                              162


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Supplementary Material IV.1: Detailed simulation methods

In these paragraphs, a variable of the intermediary layer M is called a CpG.
2 similar implementations were used to simulate in one hand causal structures A, B and C, and in
the other hand structures D and D.
    1. Causal structures A, B and C:
Generation of links between E and M
An effect of the exposures on the methylome was generated according to

For each CpG i affected by E, 𝑚 = 𝑚            + ∑         𝛽 𝐸 (1)
where mbooti is the vector containing all values of methylation at the CpG i in the matrix M
bootstrapped from the real data, mi is the vector containing all new simulated values for this CpG
site after the addition of an effect of the exposome, and Ek is the vector containing all values for
the predictor k of the exposome. Regressions coefficients were all set to zeros except for the
exposures randomly exposures variables for which we created a causal link. The number of CpGs
affected by E, the number of exposures affecting each CpG and the values of the non-zero
regressions coefficients were fixed as described in the “definition of each scenario” section.
Generation of the health outcome
The health outcome Y was generated as a function of the exposome and the methylome according
to: 𝑌 = ∑       𝛽′ 𝑚 + ∑         𝛽′′ 𝐸 + 𝜀, 𝜀 ~ 𝒩(0, 𝜎 ) (2)

 where Y is the vector of the generated outcome, mj is the vector containing all values of the
predictor j from the methylome, Ek is the vector containing all values for the predictor k of the
exposome, and represents the residuals of the regression models, computed from a residual
variance σ2. The number and the values of non-zero regression coefficients were defined as
described in the “definition of each scenario” section below.
The value of σ2 is computed to ensure that the total variability of Y explained by E and M is equal
to the parameter R2 which varies between scenarios.
Implementation of each causal structure:
In order to easily define different causal situations, we define in the methylome matrix M 4 matrices,
with no intersection: M0, MM->Y,ME->M->Y,ME->M.
ME->M->Y contains all the methylome variable which are both affected by E and affecting Y, i.e. for
a methylation variable j belonging to ME->M->Y, at least one βi=j,k is non-zero in the equation (1) and
𝛽’j is non-zero in equation (2).
MM->Y contains all the methylome variables which are not affected by E but affecting Y, i.e. for a
methylation variable j belonging to MM->Y, all 𝛽 i=j,k are zero in the equation (1) and at least 𝛽’j is
non-zero in equation (2).
ME->M contains all the methylome variables which are affected by E but not affecting Y, i.e. for a
methylation variable j belonging to EE->M, at least one 𝛽 i=j,k is non-zero in the equation (1) and 𝛽’j
is zero in equation (2).


                                                 163


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
M0 contains all the methylome variables which are neither affected by E nor affecting Y, i.e. for a
methylation variable j belonging to M0, all 𝛽 i=j,k are zero in the equation (1) and 𝛽’j is zero in
equation (2).
M can therefore be seen as the concatenation of ME->M->Y,MM->Y,ME->M and M0, which we will now
called our M submatrices.
We also defined 3 submatrices in E with possible intersections: EE->M->Y, EE->M and EE->Y.
EE->M->Y contains all the exposome variables which affect at least one CpG site belonging to ME->M-
>Y, i.e. for an exposure variable k belonging to EE->M->Y, there is at least one methylation variable i

for which 𝛽 k,i is non-zero in the equation (1) and 𝛽’j=i is non-zero in equation (2).
EE->M contains all the exposome variables which affect at least one CpG site belonging to ME->M,
i.e. for an exposure variable k belonging to EE->M, there is at least one methylation variable i for
which 𝛽 k,i is non-zero in the equation (1) and 𝛽’j=i is zero in equation (2).
Therefore, EE->M U EE->M->Y contains all the exposome variables affecting at least one CpG Site.
EE->Y contains all the exposome variables which affect directly M i.e., for an exposure variable k
belonging to EE->Y, 𝛽’’k is non-zero in equation (2).
To model the influence of exposures via some pathways, we constrained the size of ME->M and ME-
>M->Y (i.e. the two sets of CpGs affected by E) to be a multiple of the size of respectively EE->M and
EE->M->Y. Each exposure of EE->M has a non-zero effect only on nME->M/nEE->M CpGs (i.e. the
number of CpGs belonging to ME->M divided by the number of exposures belonging to YEE->M).
Similarly, each exposure of EE->M has a non-zero effect only on nMEY/nEE->M->Y CpGs (i.e. the
number of CpGs belonging to ME->M divided by the number of exposures belonging to YEE->M).
We call this further this constraint the “multiplicity constraint”.
Moreover, to simplify the simulations, we set that in each M submatrices all the effects from the
methylome are identical, i.e. for two methylome variables i and j belonging to the same submatrix,
β’i=β’j in (2). We also set that the effect of one exposure of EE->M (respectively EE->M->Y) is identical
for all the CpGs affected by a non-zero effect of EE->M (respectively EE->M->Y), i.e. ∀𝑘 𝑡𝑞 β , ≠
0 and β , ≠ 0, βj,k=βi,k in (1).
Last, we can control the recovering between the different set of predictors from E, i.e. recovering
between EE->M->Y, EE->M and EE->Y.
Therefore the 3 causal structure A, B, and C can be defined by:
       Situation A: MM->Y=ME->M=EE->Y=EE->M=∅ and ME->M->Y≠ ∅ and EE->M->Y ≠ ∅.
       Situation B: MM->Y≠ ∅, EE->Y≠ ∅ and ME->M=EE->M=EE->M->Y= ME->M->Y=∅.
       Situation C: MM->Y=ME->M=∅ and ME->M->Y≠ ∅, EE->Y≠ ∅ and EE->M->Y ≠ ∅, and EE->Y U
        EE->M->Y = EE->Y=EE->M->Y
The values of parameters used can be found in table 1.
    2. Causal structures D and E:
Reverse causality links:
A linear causal effect from Y was added to E and M:


                                                  164


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
For each CpG i affected by Y, 𝑚 = 𝑚 + 𝛾 𝑌 (3)
 where m is the vector containing all values of methylation at the CpG i in the matrix M
bootstrapped from the real data, mi is the vector containing all new simulated values for this CpG
site after the addition of an effect of the outcome, and Y is the vector of the simulated outcome.
Regressions coefficients were all set to zeros except for the CpGs sites selected for which we
created a causal link. The number of CpGs affected by Y, and the values of the non-zero
regressions coefficients were fixed as described in the “definition of each scenario” section.
Similarly, for each exposure Ek affected by Y, 𝐸 = 𝐸           + 𝛾′ 𝑌 (4)
where Ekboot is the vector containing all exposure k values in the matrix M bootstrapped from the
real data, Ek is the vector containing all new simulated values for this exposure after the addition
of an effect of the outcome, and Y is the vector of the simulated outcome. Regressions coefficients
were all set to zeros except for the exposures randomly selected for which we created a causal
link. The number of exposures affected by Y, and the values of the non-zero regressions
coefficients were fixed as described in the “definition of each scenario” section.
Definition of each scenario
In order to easily define different causal situations, we define in the methylome matrix M 3 matrices,
with no intersection: M0, MM->Y and MY->M.
MY->M is the matrix containing all CpGs affected by Y, i.e. γi is non-zero in (3).
Similarly, we defined in E a subset EY->E, which is a matrix containing all exposures affected by Y,
i.e. 𝛾′ is non-zero in (4).
Thus, causal structures are defined:

       Causal structure D : EY->E= ∅, MY->M = ∅.
       Causal structure E: EY->E≠ ∅, MY->M≠ ∅
The values of parameters used can be found in Supplementary Table IV.1.




                                                 165


  CHAPTER IV: A simulation study of approaches relying on intermediate high-dimension data
                          to decipher causal relationships between the exposome and health
Supplementary Material IV.2: Commented simulation script

Due to its size, Supplementary Material IV.2 is provided in Appendix III.
This script will also be available on github (https://github.com/SoCadiou) once the corresponding
draft will be published.




                                              166


    CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                     causal inference purposes in epidemiology

CHAPTER V:                 Some insights regarding the instability of variable-selection
    algorithms used for causal inference purposes in epidemiology

In this last chapter, we focused on a practical question encountered when we tried to use some machine learning
algorithms: the instability of some selected subset. In the simulation study presented in this chapter, we studied the
performance and the stability of some algorithms commonly used to relate the exposome with an outcome and took
the example of LASSO to show that applying a stabilization step can modify performance.

This work is currently under review in Epidemiology journal:

Cadiou S., Slama R., “Some insights regarding the instability of variable-selection algorithms
used for causal inference purposes in epidemiology”, under review




                                                        167


    CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                     causal inference purposes in epidemiology
                 Abstracts

               English abstract

Background: Machine-learning algorithms are increasingly used in epidemiology to identify true

predictors of a health outcome when many potential predictors are measured. However, these

algorithms can provide different outputs when repeatedly applied on the same dataset. Such

instability can compromise research reproducibility. We aimed to illustrate that commonly-used

algorithms are unstable and, with the example of LASSO, that the stabilization method choice is

crucial.

Methods: In a simulation study, we tested the stability and performance of widely-used machine-

learning algorithms (LASSO, Elastic-Net and DSA). We then assessed the effectiveness of six

methods to stabilize LASSO, and their impact on performance. We assumed that a linear

combination of factors drawn from a simulated set of 173 quantitative variables assessed in 1301

subjects influenced to varying extents a continuous health outcome. Model stability, sensitivity and

False-Discovery-Proportion (FDP) were assessed.

Results: All tested algorithms were unstable. For LASSO, stabilization methods improved stability

without ensuring perfect stability, a finding confirmed by an application to an exposome study.

Stabilization methods also affected performance. Specifically, stabilization based on

hyperparameter optimization, frequently implemented in epidemiology, increased dramatically the

FDP when predictors explained a low share of outcome variability. In contrast, stabilization based

on stability selection procedure often decreased the FDP, while sometimes simultaneously lowering

sensitivity.

Discussion: Epidemiologists wishing to rely on machine-learning methods for variable selection

should care about instability. Stabilizing a model can impact its performance. For LASSO,

addressing estimation stability rather than prediction stability should be preferred when one aims

to identify true predictors.

                                                168


    CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                     causal inference purposes in epidemiology
                French abstract

Contexte : Les algorithmes d'apprentissage automatique sont de plus en plus utilisés en

épidémiologie pour identifier les prédicteurs causaux d'un outcome de santé lorsque de nombreux

prédicteurs potentiels sont disponibles. Toutefois, ces algorithmes peuvent fournir des résultats

différents lorsqu'ils sont appliqués de manière répétée sur le jeu de données. Une telle instabilité

compromet la reproductibilité de la recherche. Nous avons voulu illustrer que les algorithmes

couramment utilisés sont instables et, avec l'exemple de LASSO, que le choix d'une méthode de

stabilisation est crucial.

Méthodes : Nous avons réalisé une étude de simulation pour tester la stabilité et les performances

d'algorithmes de sélection de variables largement utilisés (LASSO, Elastic-Net et DSA). Nous

avons évalué l'efficacité de six méthodes de stabilisation et leur impact sur les performances de

LASSO. Nous avons supposé qu'une combinaison linéaire de facteurs tirés d'un exposome simulé

de 173 variables quantitatives évaluées chez 1301 sujets influençait à des degrés divers un outcome

de santé continu. La stabilité, la sensibilité et la proportion de faux positifs (FDP) du modèle ont

été évaluées.

Résultats : Tous les algorithmes testés étaient effectivement instables. Pour LASSO, les méthodes

de stabilisation ont amélioré la stabilité sans assurer une stabilité parfaite, un résultat confimé par

une application à une étude exposome réelle. Elles ont également affecté les performances. En

particulier, la stabilisation basée sur l'optimisation des hyperparamètres, fréquemment mise en

œuvre en épidémiologie, a augmenté de façon spectaculaire le FDP lorsque la variabilité de

l’outcome expliquée par les prédicteurs était faible. En revanche, la stabilisation basée sur la

procédure de ‘stability selection’ a souvent réduit le FDP, tout en diminuant parfois simultanément

la sensibilité.

Discussion : Les épidémiologistes qui souhaitent s'appuyer sur des méthodes d’apprentissage

automatique pour la sélection des variables doivent se préoccuper de la stabilité des modèles. La

stabilisation d'un modèle peut avoir un impact sur ses performances. Pour LASSO, les méthodes

traitant de la stabilité de l'estimation plutôt que de la stabilité de la prédiction doivent être préférées

lorsque l'objectif est l’identification de prédicteurs causaux.

                                                   169


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
                Introduction

Thanks to the development of high throughput sensitive biochemical assays and the wider

availability of environmental models, exposome studies now allow considering several hundred or

thousand exposures in a given study population. Such exposome studies raise many issues, in terms

of exposure assessment, handling of measurement error and missing data and consideration of

possible mixture effects (Agier et al., 2020b; Siroux et al., 2016; Slama and Vrijheid, 2015;

Vermeulen et al., 2020). They also raise more statistical challenges, encountered in other areas

relying on ‘omics data, such as genomic, epigenomic or metabolomic studies. Specifically, as the

ratio of the number of potential predictors of a health outcome to the number of observations

increases, the efficiency of multiple regression models to identify true predictors decreases

(Courvoisier et al., 2011; Fan et al., 2019): for example, the classical maximum-likelihood estimator

may be biased when the ratio of the number of variables to the number of individuals is typically

of 0.2 or more(Sur and Candès, 2019). More complex machine learning algorithms, such as LASSO

(Least Absolute Shrinkage and Selection Operator), which performs variable selection through

shrinkage, according to a penalty parameter λ (Tibshirani, 1996), ElasticNet, a penalized regression

algorithm relying on both the LASSO and ridge penalties (Zou and Hastie, 2005), or Deletion-

Substitution Addition algorithm (DSA) (Sinisi and van der Laan, 2004) may be more adapted for

variable selection in this setting of intermediate to high dimension, as underlined by recent

simulations (Agier et al., 2016; Tibshirani, 1996; Zou and Hastie, 2005). Although they can be used

for purely predictive approaches (consisting in predicting the outcome probability or expected

value without identifying its true predictors), they are increasingly used in epidemiology in multi-

exposures (or exposome) studies (Agier et al., 2019; Forns et al., 2016; Gängler et al., 2019; Huang

et al., 2019; Lenters et al., 2016; Mustieles et al., 2017; Nieuwenhuijsen et al., 2019; Philippat et al.,

2019; Vrijheid et al., 2020) and in studies relying on omics data (Benton et al., 2017; Cho et al.,

2010; Zhou and Lo, 2018), in order to select predictors whose associations with an outcome are

often interpreted as in favor of an underlying causal relationship.

                                                  170


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
A feature limiting the use of these methods relates to their possible lack of stability. In machine

learning, stability is the property that a small perturbation in the input does not change the learned

model, and thus the model prediction (Bousquet and Elisseeff, 2002; Poggio et al., 2004). Here, we

will focus on the instability corresponding to a variation in the model output in the absence of

modification in the observations. An example is when applying a model to a dataset would select

covariates A, E and G as associated with the outcome and applying again the same model to exactly

the same data would this time select covariates A and B. This type of instability relates to the fact

that some machine-learning algorithms have a random component (Elisseeff, 2005), for example

if they use bootstrap or cross-validation. LASSO and ElasticNet are unstable when their

hyperparameter(s) are determined by a cross-validation approach minimizing the prediction error

(Bach, 2008; Lazarevic et al., 2019; Lenters et al., 2016; Meinshausen and Bühlmann, 2010), as done

in their default implementation (Friedman et al., 2019) (see Table V.1). DSA has been reported to

be unstable in real exposome studies (Agier et al., 2019; Nieuwenhuijsen et al., 2019; Warembourg

et al., 2019), but its instability has only been mentioned in one simulation study (Agier et al., 2020b).


Instability limits results generalizability and research reproducibility (Bousquet and Elisseeff, 2002;

Lee et al., 2013; Nogueira et al., 2017; Poggio et al., 2004). It might be perceived as a fatal drawback

of machine-learning methods and hinder their diffusion among epidemiologists used to the stability

of classical regression models and concerned with the possibility of researchers cherry-picking the

most “convincing” results if models are unstable.

Instability has little been studied in epidemiology. Lazarevic et al. (2019) expressed concerns about

the reproducibility of results due to the instability of ElasticNet (Lazarevic et al., 2019). In machine

learning research, different strategies were developed to address instability. Some strategies address

the estimation stability, which is the stability of the model estimates (selected variables and the

associated parameters) (Lim and Yu, 2016), while other strategies address prediction stability, i.e. they

focus on the stability of the predicted value of the dependent variable, for example the disease risk.


                                                  171


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Both approaches can lead to different results, because the predicted disease risk or outcome

expected value can remain quite stable in the presence of changes in the selected variables, e.g. by

replacing a variable by another one strongly correlated to it or by adding a variable not associated

with the outcome. Methods relying on prediction stability are often based on prediction error

minimization by cross-validation. Lazarevic et al. (2019) advised to consider methods relying on

estimation stability, a strategy supported by theoretical work in the statistical field (Lim and Yu,

2016). However, to our knowledge, in the cases of Elastic-Net and LASSO, most multi-exposures

studies aiming at selecting relevant explanatory variables (supposed to possibly causally influence

the outcome) relied on hyperparameters optimization by repeated cross-validation to stabilize

results, which corresponds to prediction stability approaches (Forns et al., 2016; Gängler et al.,

2019; Huang et al., 2019; Lenters et al., 2016; Mustieles et al., 2017; Philippat et al., 2019).

We aimed to highlight the existence of instability in algorithms commonly-used for variable

selection (LASSO, DSA and Elastic-Net) and contrast it with the stability of the traditional linear

model. We also aimed to compare several stabilization methods in the case of LASSO; we focused

on LASSO as an algorithm with a wide array of proposed stabilization methods. With this example,

we point that model stability cannot be considered independently of model performance

dimensions such as sensitivity and false discovery proportion (FDP, the proportion of selected

variables not genuinely related to the outcome) and thus that the implementation of a stabilization

method is crucial and cannot be considered as a free add-on by epidemiologists who intend to use

an originally instable algorithm.




                                                  172


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology


                Methods

             Simulation study of LASSO, DSA and ExWAS under various correlation structures

We first performed a Monte-Carlo simulation to assess the stability and performance of LASSO,

DSA, Elastic-NET and ExWAS. ExWAS (Exposome-Wide Associations Study) corresponds to

parallel univariate regressions corrected for multiple testing (Nieuwenhuijsen et al., 2019). The

implementation of these variable selection algorithms is detailed in Table V.1.

We simulated an exposome of 173 Gaussian quantitative variables among 1301 subjects (as in the

Helix exposome project) (Haug et al., 2018; Tamayo-Uria et al., 2019) from three different

correlation matrices representing the correlation structure within the exposome: no correlation

between the covariates; a realistic correlation structure, computed from Helix project data

(Tamayo-Uria et al., 2019), with a median coefficient of correlation between any pair of exposures

of 0.12; and an identical correlation of 0.5 between all covariates pairs. We generated an outcome

according to a multivariate linear regression model, with the number of true predictors fixed to 10.

Scenarios considered three different values of R2, the variance explained by the true predictors of

the exposome (0.001, 0.1, 0.4), as well as the three different correlation structures.

LASSO was implemented using default LASSO, in which the hyperparameter λ is chosen so as to

minimize the root mean squared error (RMSE) of prediction derived from 10-fold cross-validation;

after this cross-validation step, the model’s result are obtained by fitting a single LASSO model

with this optimal value of the hyperparameter (Tibshirani, 1996). Similarly, we used the default

implementation of Elastic-Net, corresponding to an RMSE-based cross-validation to choose

hyperparameters followed by a single model run using these hyperparameters (see Table V.1 for

details) (Friedman et al., 2019). A stabilized version of Elastic-Net, using repeated cross-validation,

was also implemented (see Supplementary Figure V.1). We quantified stability, sensitivity and FDP

of each method (see below).


                                                 173


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Table V.1: Implementation details for ExWAS, Elastic-Net and DSA.
 Method         Description of the method                                    References
 name
 ExWAS          Univariate regressions corrected for multiple testing,       (Agier  et    al.,      2016;
                known as ExWAS (Exposome-Wide Association                    Nieuwenhuijsen et al., 2019)
                Study). Benjamini-Hochberg procedure (Benjamini and
                Hochberg, 1995) was used to correct multiple testing.
                Variable selection is performed by selecting all the
                variable for which the association test -p-value was
                below the significance threshold of 5%, after correction
                for multiple testing, as usually done (Agier et al., 2019,
                2016; Vrijheid et al., 2020).
 ElasticNet     Penalized regression model using a weighted mixture of       Elastic_Net method (Zou
                LASSO (Tibshirani, 1996) and ridge (Hoerl and                and Hastie, 2005)
                Kennard, 1970) penalties. The ridge penalty                  glmnet package(Friedman et
                accommodates correlated variables and ensures                al., 2010)
                numerical stability, but does not shrink coefficients        Two-dimensional         cross-
                exactly to zero, and thus cannot perform variable            validation implementation
                selection. Penalty is calibrated with a parameter λ, and     was similar to the one used in
                an other tuning parameter α controlled the mixing            a simulation study (Agier et
                proportion of the two penalties. As advised by Zou           al., 2016).
                &Hastie, 2005(Zou and Hastie, 2005) , the two
                hyperparameters are determined by two-dimensional
                cross-validation, implemented using the glmnet
                package.(Friedman et al., 2010)
 DSA            DSA (Deletion Substitution Addition) algorithm is an         (Sinisi and van der Laan,
                iterative linear regression model search algorithm(Sinisi    2004)
                and Van Der Laan, 2004) following three constraints:
                maximum order of interaction amongst predictors, the
                maximum power for a given predictor, and the
                maximum model size. At each iteration, the following
                three steps are allowed: a) removing a term, b) replacing
                one term with another, and c) adding a term to the
                current model. The search for the best model starts with
                the intercept model and identifies an optimal model for
                each model size. The final model is selected by
                minimizing the value of the RMSE using 5-fold cross-
                validated data. We allowed no polynomial or interaction
                terms, and made no restriction on the number of
                predictors.




                                              174


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
            Simulation study of stabilizations methods for LASSO in a realistic exposome setting

To compare some stabilizations methods for LASSO, we performed a second Monte-Carlo

simulation: we expanded the number of simulation scenarios, considering between 1 and 25 true

predictors and letting R2 vary from 0.0001 to 0.8. In this second simulation, the exposome was

realistically simulated by sampling with replacement quantitative variables of Helix exposome

dataset (Haug et al., 2018; Tamayo-Uria et al., 2019), which had been beforehand normalized,

standardized and bounded (i.e., a value greater than 3 in absolute value was replaced by a value

lower than 3 in absolute value randomly drawn in the distribution). In addition to default LASSO

(Tibshirani, 1996), we implemented six variants with different stabilization methods: LASSO–1 SE,

which is similar to default LASSO, but uses the largest λ located within one RMSE of the λ value

which minimizes the RMSE; this strategy is known to be more parsimonious, as increasing λ values

more strongly penalize the model and tend to select fewer variables (Krstajic et al., 2014) ; two

methods (CV1 and CV2) optimizing the hyperparameter λ by repeating the cross-validation

procedure 100 times and averaging the results using two different procedures (Table V.2); two

implementations of the stability selection proposed by Meinshausen and Bühlman (Meinshausen1 and

Meinshausen2), which repeatedly ran the algorithm on subsamples of the observations while

varying λ over large ranges and finally provided as outputs the covariates most frequently selected

across all these runs (Meinshausen and Bühlmann, 2010). A conceptual difference is that, in

contrast to CV1 and CV2, these two methods do not rely on cross-validation and do not fix an

optimal hyperparameter but follow a logic of model averaging (Claeskens and Hjort, 2008). We finally

tested an approach (Mix) that we developed as a mixture of the principles of the two previous

stabilization procedures (Table V.2): empirical selection probability was derived for each variable

from repeated runs on random subsamples as in stability selection, but using the optimal λ

parameter determined by cross-validation instead of varying λ on a large range of values. We

quantified stability, sensitivity and FDP of each method (see below).




                                                175


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Table V.2: Details of the implemented LASSO methods.
 LASSO           Description of the method and of the stabilization References
 method          process
 Default         A penalized regression model relying on a generalized linear                LASSO          method
 LASSO           framework (Tibshirani, 1996). The LASSO penalty promotes                    (Tibshirani, 1996)
                 sparsity and performs variable selection through shrinkage: the             glmnet         package
                 lowest regression coefficients, corresponding to the least                  (Friedman et al., 2019)
                 informative predictors, are attributed a zero value, according to a
                 penalty parameter λ. As advised by Zou et al. (Tibshirani, 1996) and
                 implemented in glmnet package (Friedman et al., 2019), λ was
                 determined by minimizing the prediction root mean squared error
                 (RMSE) using 10-fold cross-validation (i.e., the data were partitioned
                 into 10 subsets; for each subset, models were trained on the other 9
                 partitions and fitted on the left-out subset, over which the RMSE
                 was estimated). λ sequences tested in the cross-validation process
                 were sequences of 100 values deterministically determined from the
                 data (Friedman et al., 2019, 2010).
 LASSO_1SE       Similar to default LASSO, with the difference that the penalty              LASSO          method
                 parameter λ chosen after 10-fold cross-validation was the largest           (Tibshirani, 1996)
                 among the λ values giving an error within 1 standard error of the           glmnet         package
                 minimum RMSE, (Friedman et al., 2019) instead of the value                  (Friedman et al., 2019)
                 minimizing the RMSE.
 CV1             LASSO with 10-fold cross-validation was repeated 100 times on the           LASSO          method
                 same dataset. Penalty parameter minimizing the RMSE averaged                (Tibshirani, 1996)
                 across the 100 runs was used to fit the final LASSO model. The              glmnet         package
                 principle is similar to the one of bootstrap averaging (“bagging”)          (Friedman et al., 2019)
                 (Breiman, 2004), but considers always the same dataset with a
                 different seed for cross-validation instead of bootstrapped samples.
                 A similar stabilization method was used with ElasticNet (Huang et
                 al., 2019; Lenters et al., 2016; Philippat et al., 2019).
 CV2             LASSO with 10-fold cross-validation was repeated 100 times on the           LASSO          method
                 same dataset. RMSE curves as a function of λ were averaged over             (Tibshirani, 1996)
                 the 100 runs. The averaged curve allowed to determine the optimal           glmnet         package
                 λ optimizing the RMSE, which was used to fit the final LASSO                (Friedman et al., 2019)
                 model. The principle is similar to bootstrap averaging (“bagging”)
                 (Breiman, 2004), but considers always the same dataset with a
                 different seed for cross-validation, instead of bootstrapped samples.
 Meinshausen1    Implementation of the stability selection on LASSO (Meinshausen             LASSO           method
                 and Bühlmann, 2010): LASSO was run on 100 subsamples of half                (Tibshirani, 1996)
                 the size of the initial dataset on a range of 100 different values of the   glmnet          package
                 penalty parameter. A probability to be selected was derived                 (Friedman et al., 2019)
                 empirically for each variable. Variables having an empirical                Stability      selection
                 probability greater than a selection threshold T (T=0.85) were              (Meinshausen        and
                 retained in the final model. For all subsamples, the range of λ values      Bühlmann, 2010)
                 used was the one deterministically computed by glmnet package on
                 the complete dataset.
 Meinshausen2    Alternative implementation of the stability selection (Meinshausen          LASSO           method
                 and Bühlmann, 2010). Similar to Meinshausen1 above, with two                (Tibshirani, 1996)
                 differences: T=0.95 and the range of λ used was different for each          glmnet          package
                 subsample and deterministically computed by glmnet package on each          (Friedman et al., 2019)
                 subsample.                                                                  Stability      selection
                                                                                             (Meinshausen        and
                                                                                             Bühlmann, 2010)
 Mix             Implementation of the stability selection (Meinshausen and                  LASSO           method
                 Bühlmann, 2010) on the cross-validated LASSO. In Meinshausen et             (Tibshirani, 1996)
                 al. (Meinshausen and Bühlmann, 2010), empirical probabilities of            glmnet          package
                 selection for each covariate were derived from results of the               (Friedman et al., 2019)
                 algorithm run on a range of penalty parameters on different                 Stability      selection
                 subsamples. Here, we derived empirical probabilities from runs on a         (Meinshausen        and
                 range of subsamples but only from the model fitted with the optimal         Bühlmann, 2010)

                                                     176


    CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                     causal inference purposes in epidemiology
                        penalty parameter obtained by cross-validation. More precisely,
                        LASSO with 10-fold cross-validation was run on 100 random
                        subsamples each having half of the observations of the initial dataset.
                        Empirical probabilities to be selected in the model optimizing RMSE
                        in a subsample were then derived for each variable. Variables having
                        an empirical probability of selection greater than T= 0.5 were
                        retained in the final model. This original implementation is in
                        principle similar to stability selection (Meinshausen and Bühlmann,
                        2010), but considers always the same dataset with a different seed
                        for cross-validation instead of subsamples.
The code is provided in Supplementary Material V.1.



                Indicators of stability and performance

In both simulations, for each scenario, we generated 30 datasets (Efron and Tibshirani, 1993) upon

which each performance indicator was assessed. In order to assess stability, defined as the presence

of variations in the model output in the absence of modification in the observations, each method

was run 15 times on each of the 30 datasets generated for each scenario. The stability of the set of

variables selected as predictors in each of the 15 runs of each dataset was quantified using averaged

Sorensen index. Sorensen index is one of the most commonly-used measure of similarity

(Magurran, 2004). For two runs based on datasets with similar covariates, Sorensen index is defined

as twice the number of selected covariates common to both runs divided by the sum of the number

of covariates selected for each run (Boulesteix and Slawski, 2009). The index was averaged over all

pairs of runs done with a given dataset. Averaged Sorensen index has a value of 0 when there is no

intersection between the sets of selected variables in all runs based on the same dataset (total

instability) and of 1 when the selected variables are the same in all runs based on the same dataset,

or when no covariate is selected in any of the runs (Boulesteix and Slawski, 2009). As an alternative

measure of stability, we also counted the number of variables selected in at least 20% and 60% of

the runs on a same dataset.

We assessed two dimensions of model’s performance: FDP (the proportion of false-positive

among the predictors selected by the algorithms) and sensitivity (the proportion of true predictors

selected by the algorithm among the true predictors). Averaged FDP and sensitivity were computed



                                                           177


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
for each dataset by averaging respectively FDP and sensitivity across repeated runs, allowing to

estimate FDP and sensitivity for each scenario.

All simulations were performed with R software using glmnet (Friedman et al., 2019, 2010) and DSA

(Sinisi and van der Laan, 2004) packages.

             Application: using LASSO to relate the exposome to child body mass index

We illustrated instability in the context of an exposome study. Previous studies (Cadiou et al., 2020;

Vrijheid et al., 2020) tried to identify components of the prenatal and postnatal exposomes

associated with child body mass index (BMI, the mass in kilograms divided by the squared height

in meters). Within Helix project, this has been done using ExWAS and DSA (Cadiou et al., 2020;

Vrijheid et al., 2014). We repeated this analysis by using default LASSO and the different stabilized

LASSO presented in Table V.2. BMI, the outcome considered, was measured between 6 and 10

year of life in 1301 children from the 6 European cohorts (Chatzi et al., 2017; Grazuleviciene et al.,

2015; Guxens et al., 2012; Heude et al., 2016; Magnus et al., 2016; Wright et al., 2013) involved in

the Helix project. 216 prenatal (measured during mother pregnancy) and postnatal exposures

(measured at the time of the child clinical examination) were considered, measured by biomarkers

in urine or blood or by environmental models. Exposures belonged to 15 families: metals,

organochlorines, organophosphate pesticides, polybrominated diphenyl ethers (PBDE),

perfluorinated alkylated substances (PFAS), phenolic compounds, phthalates, built environment

exposures, indoor air exposures, lifestyle factors, meteorological data, natural spaces quantification,

noise, traffic, socio-economic capital and concentrations of disinfection by-products in drinking

water. Among them, we retained the 173 variables corresponding to quantitative exposures. Details

of exposome and covariates assessment (Tamayo et al., 2018), as well as relevant adjustment factors

selection (Cadiou et al., 2020) have been published elsewhere. In statistical analysis, an age-and-

sex-standardized z-score (de Onis et al., 2007), named hereafter zBMI, was used to take into

account the age-related shift in BMI in childhood. Adjustment factors were taken into account by


                                                  178


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
preliminarily computing residuals of zBMI in a multivariate model considering all relevant

covariables. We applied default LASSO as well as all studied stabilized LASSO algorithms to relate

the full (i.e. prenatal and postnatal) exposome to zBMI. We then applied the methods to relate only

the prenatal exposome to zBMI, as we expected the magnitude of link between prenatal exposome

and zBMI to be lower than that between the postnatal exposome and zBMI (Vrijheid et al., 2020).

In both cases, we computed averaged Sorensen index by repeating 15 times each method and

counted the average number of variables selected. As default LASSO and stabilized LASSO are

variable selection algorithms that do not estimate the model's coefficients, we ran in a second step

a multivariate linear model including for each run all selected exposures as well as the relevant

covariates to assess the direction of associations.




                                                 179


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
               Results

             Stability and performances of the models’ default implementations

The simulation highlighted ExWAS as the only stable model (Sorensen index, 1; Figure V.1).

Elastic-Net, DSA and LASSO default implementations were unstable (Figure V.1, Supplementary

Figure V.1): default LASSO had an average Sorensen index between 0.77 and 0.95 when the

correlation among predictors was the realistic structure from Helix exposome project, with a mean

correlation of 0.12 (Figure V.1). For all three algorithms, instability was stronger when the

variability explained was 0.001 than when it was 0.1 or 0.4. Elastic-Net was slightly less stable than

default LASSO, in particular when the correlation was high. DSA was more stable than default

LASSO when the variability of the outcome explained by the true predictors (R2) was below 0.1,

but less stable than default LASSO when R2 was above 0.1. The correlation among potential

predictors influenced stability (Figure V.1): for LASSO and Elastic-Net, a higher correlation was

associated with higher stability in most cases. For DSA, Sorensen stability index was highest in the

absence of correlation among covariates.

Coming to sensitivity and FDP (Supplementary Figure V.1A and B), DSA was the method with

the lowest FDP, with FDP levels always lower than 70%; FDP was lower than 35% when

correlation was not high (i.e., not 0.5); DSA did not select any predictor when R2 was 0.001 but,

when R2 was higher, DSA had a non-null sensitivity (higher than 15%). Elastic-Net and LASSO

showed considerably higher FDP than DSA (FDP higher than 40% in all scenarios for LASSO

and higher than 68% for Elastic-Net). Elastic-Net showed higher FDP and sensitivity than LASSO,

as theoretically expected (Zou and Hastie, 2005). Elastic-Net had a FDP of more than 90% when

R2 was 0.001. ExWAS showed high sensitivity (higher than 60% when R2 was higher than 0.001)

but was the algorithm with the highest FDP when the correlation was non-zero, reaching a FDP

of 95% when the correlation was high (Supplementary Figure V.1A).




                                                 180


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Figure V.1: Stability index (mean Sorensen index) of ExWAS, default LASSO, Elastic-Net and
DSA for 3 different structures of pairwise correlations between the predictors. Simulations
assumed the existence of 10 true predictors in a set of 173 tested predictors. Stability is reported as
a function of R2, the share of the outcome variability explained by the true predictors.




*: null corresponds to an absence of correlation between true predictors; intermediate corresponds to the
realistic correlation observed within real data from Helix project exposome (Vrijheid et al., 2014); high
corresponds to an identical pairwise correlation of 0.5 among all pairs of covariates.

             Effectiveness of stabilization methods

The application of stabilization methods generally increased the stability of LASSO, compared to

default LASSO, but without allowing perfect stability (Figure V.2C). Comparing stabilization

methods, mean Sorensen index was lowest for Meinshausen2 and highest for CV2 (Supplementary

Table V.1, Supplementary Figure V.3C).

For methods using cross-validation (CV1 and CV2) and for Meinshausen1 method, stability

increased with the outcome variability explained by the predictors (Figure V.2C, Supplementary

Figure V.2C). For LASSO-1SE and Mix, stability index followed a U-shaped curve: when R2 was

very small, both methods tended not to select any variable, leading to very good stability, after

which, as methods began to select some predictors, stability decreased when R2 increased; stability

increased again for higher R2.




                                                  181


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Figure V.2: Performance and stability of various stabilization methods of LASSO. Values are
averages of various scenarios with 1 to 25 true predictors of the health outcome. Performance is
reported as a function of the total variability explained by the predictors (log scale). A. False
discovery proportion. B. Sensitivity. C. Sorensen stability index. D. Number of hits (covariates
selected by the model).




FDP: False Detection Proportion. See Table V.2 for explanations regarding the compared methods.

Regarding Elastic-Net, the comparison between the performance of default Elastic-Net and of an

Elastic-Net with repeated cross-validation showed that this stabilization method effectively allowed

to stabilize the model with a pattern similar to that observed for LASSO-CV1: repeating the cross-

validation-process allowed to increase stability (Supplementary Figure V.1).

             Relation between stabilization and model performance

Stabilization generally influenced LASSO model’s performance. For R2 lower than 0.1, stability

obtained from repeated cross-validation came at a cost of a strongly increased FDP (mean FDP,

0.83 and 0.85 for CV1 and CV2, respectively, versus 0.58 for default LASSO; Supplementary Table

V.1). When R2 was greater than 0.1, CV1 and CV2 provided a clear stability gain with very small



                                                182


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
impacts on sensitivity and FDP compared to default LASSO (Figure V.2A and B). However, in

this R2 range, all three methods had a very high FDP (mean of 0.70-0.71).

Regarding stabilization methods based on stability selection principle, Meinshausen1 and

Meinshausen2 showed excellent performances when R2 was greater than 0.1 (FDP of 0.04 and 0.01,

respectively, sensitivity of 0.78 and 0.53, respectively) but mixed performances when R2 was lower.

Specifically, Meinshausen2 showed lower FDP than Meinshausen1 and default LASSO, at a cost of

a lower sensitivity (Figure V.2A and B). The Mix method showed the best performances when R2

was lower than 0.1 (average FDP, 0.17; average sensitivity, 0.23; average Sorensen index, 0.93, see

Supplementary Table V.1), followed by LASSO-1SE, which had slightly lower sensitivity and FDP

than the Mix method. The very good stability and FDP of LASSO-1SE when R2 was below 0.01

were linked to a lack of sensitivity; when sensitivity was non-null and R2 was lower than 0.1,

LASSO-1SE showed limited stability.

An interesting pattern of the two stability selection methods Meinshausen1 and Meinshausen2 was

that when the method was stable (Sorensen index above 0.95), performance was excellent both in

terms of sensitivity and FDP (Figure V.3). For the Mix method and LASSO-1SE, a high stability

always corresponded to a low FDP and either to a null (no exposures selected) or a very high

sensitivity. Such a relationship between stability and FDP was not observed for default LASSO and

for methods based on RMSE minimization by repeated cross-validation, for which high levels of

the stability index were observed for low values of sensitivity and high FDP values.

Regarding Elastic-Net, stabilization by repeated cross-validation (a logic similar to LASSO-CV1)

showed again similarities with what was observed for LASSO: it modified the average number of

predictors selected compared to the default Elastic-Net when R2 was low (Supplementary Figure

V.1D). When R2 was lower than 0.1, FDP, which was already extremely high (higher than 90%) for

default Elastic-Net, was also slightly increased (reaching 98% when correlation was high,

Supplementary Figure V.1A) after stabilization by repeated cross-validation.


                                               183


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Figure V.3: Variation of performance according to stability. A. False discovery proportion as a
function of model stability. B. Sensitivity as a function of model stability (mean Sorensen index).
Performance values were smoothed using LOESS method. Values are averages over 15 model
runs.




                                                184


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
             Application: using LASSO to relate exposome to child body mass index in Helix

             data

When relying on Helix real data, default LASSO identified in average 58.3 exposures (out of 173

candidate covariates) as related to zBMI and was unstable (Table V.3, Supplementary Table V.3

and Supplementary Figure V.4). CV1 and CV2 displayed very similar results, with a slightly lower

number of variables selected than by default LASSO and a higher stability (CV2 even ensuring

perfect stability). This similar behavior between default LASSO, CV1 and CV2, as well as the relative

stability of default LASSO make it plausible, from the simulation results (Figure V.1 and

Supplementary Figure V.1), that the share of outcome variability explained by the true predictors

be larger than 0.08. In this situation, one would expect (Figure V.1 and Supplementary Figure V.1)

a sensitivity between 0.7 and 1 for the three methods, but also a large FDP (higher than 0.75),

which may explain the high number of selected variables. The three methods based on stability

selection selected much fewer variables: the Mix method selected on average 21.5 variables. The

lower number of variables selected by the Mix method is consistent which what is expected from

our simulation (Figure V.1): for this range of scenarios (R2 above 0.08) the Mix method has a

sensitivity similar to default LASSO but a lower FDP. Meinshausen2 selected on average less than

1 predictor and was far less stable. Last, Meinshausen1 was perfectly stable and selected on average

5 predictors. For the expected range of scenarios, Meinshausen2 is expected to show an almost null

FDP (a situation generally observed in our simulation in all scenarios in which Meinshausen2 was

almost perfectly stable, Figure V.2) and a non-null sensitivity. We could thus hypothesize that all

the 5 exposures selected by Meinshausen2 are truly associated with zBMI. This hypothesis is

coherent with toxicological and epidemiological literature, as discussed in previous studies on the

same data (Cadiou et al., 2020; Vrijheid et al., 2020). Indeed, the highlighted positive association of

blood post-natal copper level with higher BMI (see Supplementary Table V.2) is a plausible

association, as copper toxicity and ability to induce oxidative stress is well-known in human

(Brewer, 2010; Uriu-Adams and Keen, 2005) and from animal models (Galhardi et al., 2004; Pereira

                                                 185


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
et al., 2016). The link between zBMI and the four other variables selected by Meinshausen2

(postnatal blood levels of DDE, PBDE, HCB and PCB170, all negatively associated with zBMI,

see Supplementary Table V.2) may also correspond to true structural associations. As discussed

previously, they may be caused by reverse causality: these lipophilic compounds are stored in fat

and therefore a low blood circulating level can be caused by a high BMI causing higher fat storage,

even if these compounds are generally expected to have harmful effects (Cadiou et al., 2020), which

would be identified in prospective studies possibly relying on other biological matrices to assess

PCBs. Additional results for the analysis on the pregnancy exposome are detailed in Supplementary

Material V.1, Supplementary Table V.3 and Supplementary Figure V.4.

Table V.3: Results of the application of default LASSO and various LASSO stabilization methods
to relate an exposome of 173 prenatal and postnatal quantitative exposures to zBMI in 1301
mother-child pairs of the Helix cohorts.
                         Number of             Computation          Number of
Stabilization    Sorense
                         selected              time (in             exposures selected
method           n index
                         exposures*            seconds)*            at least once
None (default
LASSO)             0.957            58.3                 1.16                     68
LASSO_1SE          0.752            12.3                 1.32                     20
CV1                0.998            58.1               194.34                     59
CV2                1.000            58.0               114.64                     58
Meinshausen1       1.000             5.0                14.32                      5
Meinshausen2       0.492             1.0                14.58                      2
Mix                0.910            21.5               172.21                     28
* computed after repetition of each method 15 times.




                                               186


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
                Discussion

Our simulation study brings practical insights on issues related to the stability of some algorithms

sometimes referred to as belonging to the field of machine learning used in epidemiology. First, we

confirmed that the default implementation of LASSO, ElasticNet and DSA were not stable (Agier

et al., 2019; Meinshausen and Bühlmann, 2010; Nieuwenhuijsen et al., 2019; Warembourg et al.,

2019). On the contrary, EXWAS, which relies on parallel simple (i.e., considering each covariate

one at a time) regression models estimated by the least squares approach, was as expected stable,

but had a large proportion of false positive signals as soon as there was some correlation between

the potential predictors, as previously reported (Agier et al., 2016). With the data structures that we

explored, LASSO and DSA, in spite of their instability, showed relatively low FDP, which makes

them attractive for epidemiologists aiming to identify true predictors of an outcome. In contrast,

Elastic-Net had a higher FDP, especially when the influence of the explanatory variable on the

outcome was low, making this algorithm not adapted to this true predictors selection problem – in

many situations, FDP was above 50%, meaning that less than half of the selected variables were

true predictors. Second, although all stabilization methods did improve LASSO stability, none of

them, including stabilizing hyperparameter based on repeated cross-validation as usually done

(Huang et al., 2019; Lenters et al., 2016; Philippat et al., 2019), allowed ensuring perfect stability of

the set of selected variables. This conclusion was illustrated with our application based on real Helix

data, in which some stabilization methods even showed less stable results than for the default

LASSO. Third, stabilizing LASSO affected its specificity and sensitivity, showing that the choice

of a stabilization method bears strong consequences on performance. To our knowledge, this

important feature has not been clearly described in the literature. Thus, this example of LASSO

suggests that selecting an algorithm on the basis of its expected performance should be done

considering simultaneously its stabilization method, as different stabilization methods can be

expected to differently alter performances.




                                                  187


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
             Strengths and limitations

Some limitations need to be acknowledged. We considered a narrow definition of stability, which

is more generally understood as the robustness to small perturbations in the observations or other

input parameters (Bousquet and Elisseeff, 2002; Poggio et al., 2004). Here we only considered

instability due to the random process in algorithms, thus without changes in the dataset. We

considered this to be the form of instability most worrying and least familiar to the epidemiologists,

who are used to seeing results change when data change, even slightly, but not when re-running a

model on the same data. We focused on sensitivity and FDP as indicators of models’ performances;

bias in the effect estimates is another relevant indicator, but we considered the issue of bias in a

parameter affecting an outcome to be secondary in the context of many models showing high FDP

or low sensitivity, that is, being unable to identify the true predictors. Although we considered a

large number of scenarios with ample variations in model predictive ability and number of true

predictors, we focused on a continuous outcome (whereas methods that we considered could also

be used for example with binary outcomes) (Lenters et al., 2018) and did not consider possible

non-linear relations or interactions between exposures. We chose an “intermediate” dimension

corresponding to current exposome studies, which were our motivating example. Last, we did not

test all possible stabilization methods suggested for LASSO: other existing approaches, possibly

relevant for epidemiologists, also rely on cross-validation but consider other metrics in addition to

error prediction in the cross-validation process, in a logic similar to LASSO-1SE (Lim and Yu,

2016; Roberts and Nowak, 2014), or adapt the LASSO algorithm itself by adding another penalty

term (Ternès et al., 2016; Zou, 2006). The methods we chose are the most commonly-used for

variable selection in epidemiology and give an insight on the two main categories of stabilization

methods: methods based on the optimization and the stabilization of the hyperparameter and

methods relying on a logic of model averaging. For DSA, there is to our knowledge no stabilization

method validated in the literature, which would be an interesting development given the relatively

good performances of the non-stabilized version of model.

                                                 188


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
             Stability selection, a relevant approach when selecting true predictors is the aim

Regarding the modification of the performance coming with the stabilization process, our results

offer new insights as to which stabilization methods are the most adapted. Stability selection

methods, which pick up the variables most often selected over a large number of model runs with

different values of the hyperparameter, can be seen as a model averaging approach, while default

LASSO relies on repeated cross-validation to define the hyperparameter optimal for prediction,

followed by a single model run with the selected “optimal” hyperparameter value. Stability selection

methods often provided increased performance compared to the default LASSO (and to the two

LASSO stabilized with repeated cross-validations), with a considerably lowered FDP; this result

was consistent with a study on survival models (Khan et al., 2016). In particular, when the variability

explained by the true predictor was higher than 0.2, the Mix method was able to show similar

sensitivity than default LASSO with a considerably lower FDP (and yet a non-null sensitivity);

Meinshausen2 stabilization method provided extremely low FDP (lower than 5%, compared to

about 70% for default LASSO), with a sensitivity above 50%. When R2 was low, both methods

also provided strong improvement for FDP almost without loss in sensitivity. Overall, on a realistic

range of low R2 values, the Mix method that we developed offered the best compromise between

sensitivity and FDP. Similarly, LASSO-1SE allowed to improve performance compared to default

LASSO. In our real data example, stability-selection based stabilization methods also seemed to

perform better than default LASSO. Thus, some stabilized versions of LASSO also have an added

value in terms of improvement (decrease) of the false detection rate. This pattern can be

understood by recalling that machine learning typically focuses on prediction accuracy, the ability

to correctly predict (disease) risk given a subject’s characteristics, which is what cross-validation-

based approaches rely on. In contrast, epidemiologists wishing to identify causal predictors of

health are rather interested in feature selection (Hernán et al., 2019), the ability to select causal

predictors of the outcome. However, prediction performance and selection performance are not

equivalent, in particular in a high-dimension setting (Hernán et al., 2019; Leng et al., 2006). In high

                                                 189


    CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                     causal inference purposes in epidemiology
dimension, a stable and accurate prediction (e.g., of disease risk) can be obtained by different sets

of predictors that may contain false positives (for example, variables correlated with a true

predictor, which are to some extent “exchangeable” from a prediction perspective). A model

switching between these different predictors in successive runs or adding unnecessary variables

with little influence on the predicted risk may have a good predictive power while being unstable

and of limited value when it comes to identifying true (causal) predictors of the outcome. Thus,

models aiming at optimizing predictive ability, like default LASSO, are not always the most

effective in terms of feature selection: (Hernán et al., 2019; Zou, 2006) for default LASSO,

hyperparameter optimization of RMSE with cross-validation (which focuses on the accuracy of

risk prediction), even if it allows high predictive performance, leads to selecting models including

the true model rather than selecting the true model itself (Leng et al., 2006; Zou, 2006). These

models also have tendency to select predictors even when there is no signal in the data (Belloni et

al., 2011), i.e. in our case when no covariate is associated with the outcome. In our realistic

exposome settings, we additionally showed that stabilization by repeating the cross-validation

process (LASSO-CV1 and LASSO CV2) suffered from strongly inflated FDP even compared to

default LASSO. This is of practical importance as, in environmental epidemiology, so far, most

publications using LASSO or Elastic-Net relied on repeated cross-validation for stabilization.

Overall, the stabilization methods which take into account other criteria than the prediction

accuracy are likely to be appropriate to the “true predictor selection” problem faced by

epidemiologists. Moreover, a relationship between FDP and stability was observed for these

methods: for stability selection methods (including the Mix method) as well as for LASSO–1SE,

when stability was good, FDP was low. This relation between FDP and stability (Figure V.3B)

makes it tempting to consider stability as an indicator of a low FDP; if general, this feature is

interesting since, while FDP cannot be estimated on one’s real data, stability can. For example, it

allowed us to choose when to trust the results provided by Meinshausen2 method in our application

to real data.

                                                190


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
             Importance of the calibration of model averaging approaches

These remarks are in favor of the use of stability selection-type methods, which follow a logic of

model averaging, rather than methods stabilizing the hyperparameters, when the aim is variable

selection. The rationale behind Meinshausen stability selection, i.e. picking the predictors most

often selected among various runs in a logic of model averaging, involves the choice of a threshold

(the proportion of runs containing a variable for this variable to be selected by the final model). In

practice, the performance of Meinshausen LASSO strongly depended on the implementation

chosen: in particular, Meinshausen1 showed extremely high FDP when the variability explained by

the true predictors was low, while the more stringent threshold chosen for Meinshausen2 provided

better performance. The strong impact of the choice of the threshold advocates in favor of

performing simulations taking into account the stabilization step to fine-tune it. More generally,

when running several times an algorithm in order to select the variables selected in a proportion T

of the runs, the choice of the threshold T may have major consequences on results (see

Supplementary Figure V.3).

             Practical consequences and conclusion

The practical consequences of this work can be summarized in five points: 1) Many commonly-

used algorithms used for high- or intermediary-dimension data are unstable, a finding previously

reported that we illustrated in a realistic exposome setting. 2) As we illustrated with LASSO, not

all stabilization methods provide effective stabilization; epidemiologists should therefore assess the

results’ stability after having used a stabilization method, e.g. by simply re-running the model 10

times. 3) Adding a stabilization step to an existing variable-selection algorithm is likely to change

its performance, and not all stabilization methods allow to simultaneously increase stability and

model performance. A practical consequence is that if one had chosen a method based on its

expected performance according to a simulation study conducted ignoring stability, this expected

performance is likely to change if a stabilization step is added. 4) In particular, for LASSO,

stabilization methods based on the averaging of optimal hyperparameters obtained by cross-

                                                 191


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
validation (CV1 and CV2) dramatically increased the false-discovery rate when the variability of the

outcome explained by the predictors was low, which may correspond to many epidemiological

studies. With these common stabilization methods, scientists are left with the poor alternative

between a stable result likely to include many false positives, and results with a lower false positive

rate but selecting different variables in successive runs. 5) When searching for true predictors of an

outcome, implementation of stability selection (Meinshausen and Bühlmann, 2010) or of similar

methods that do not use the prediction accuracy as the only criterion may be more appropriate

than hyperparameters optimization.

In conclusion, stabilization methods are worth applying and may make some complex machine

learning algorithms more attractive to epidemiologists, but should be seen as something that

inherently modifies the model considered and, in particular, its performance, rather than a small

add-on that comes for free.




                                                 192


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
               Supplementary Materials



Supplementary Figure V.1: Performance and stability of some common algorithms as a function
of the total outcome variability explained by the predictors in situations in which 10 predictors
explained the outcome. Colors show the level of correlation within the simulated exposome. A.
Average false discovery proportion. B. Average sensitivity. C. Average (Sorensen) stability index.
D. Average number of hits. E. Average number of hits, with a zoom between 0 and 10 *: null
corresponds to an absence of correlation between true predictors; intermediate corresponds to
the realistic correlation observed within real Helix exposome; high corresponds to a pairwise
correlation of 0.5. Elastic-Net CV-stabilized corresponds to Elastic-Net stabilized with a
methodology similar as LASSO-CV1: a cross-validation process selecting the value of the
parameter α minimizing the RMSE is repeating 100 times. The average value obtained for α is
then used to repeat 100 times the cross-validation process selecting the optimal λ parameter
minimizing RMSE: the average value of λ is used to fit the final model (this second step is exactly
similar to LASSO-CV1).




                                               193


CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                 causal inference purposes in epidemiology




                                          194


CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                 causal inference purposes in epidemiology




                                          195


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Supplementary Figure V.2: Performance and stability of the LASSO stabilization methods as a
function of the total outcome variability explained by the predictors (log scale). Colors also show
the total variability explained by the predictors. Each line corresponds to a different number of
true predictors, in contrast with Figure V.1, in which results from scenarios with different
numbers of true predictors were averaged. A. Average false discovery proportion. B. Average
sensitivity. C. Average stability index. D. Average number of hits.




                                                196


   CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                    causal inference purposes in epidemiology
Supplementary Figure V.3: Average number of predictors selected in 20% (A.) and 60% (B.) of
the runs on a same dataset for unstable methods, as a function of the total variability of the
outcome explained by the true predictors. Colors show the level of correlation within the
simulated exposome. *: null corresponds to an absence of correlation between true predictors;
intermediate corresponds to the realistic correlation observed within real Helix exposome; high
corresponds to a pairwise correlation of 0.5.




                                              197


     CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                      causal inference purposes in epidemiology
Supplementary Figure V.4: Occurrence of selection for each exposure when applying 10 times
default LASSO and all tested stabilized LASSO to relate an exposome of 173 prenatal and
postnatal quantitative exposures (A) or only the smaller exposome of 74 prenatal quantitative
variables (B), to zBMI in 1301 mother-child pairs of the Helix cohorts.
A.




                                               198


     CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for
                                                      causal inference purposes in epidemiology

B.




                                               199


                       CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for causal inference purposes in epidemiology

Supplementary Table V.1: Distribution of stability index, sensitivity and False Discovery Proportion (FDP), across all scenarios and categorized
according to the total variability explained by the true predictors (>1 and ≤1) for different stabilization methods of LASSO.

                                             All scenarios                                                                Scenarios with R2≤0.1                                                                      Scenarios with R2 >0.1
                        FDP                        Sensitivity              Stability index                  FDP                        Sensitivity              Stability index                       FDP                      Sensitivity                 Stability index
                Mean   SD     Min    Max    Mean    SD     Min    Max    Mean   SD     Min    Max    Mean   SD     Min    Max    Mean    SD     Min    Max    Mean   SD     Min    Max      Mean    SD     Min    Max    Mean   SD     Min    Max    Mean     SD     Min      Max

Default LASSO   0.64   0.11   0.38   0.76   0.63    0.42   0.00   1.00   0.85   0.09   0.71   0.98   0.58   0.12   0.38   0.76   0.34    0.38   0.00   1.00   0.80   0.07   0.71   0.94     0.70    0.06   0.61   0.76   0.97   0.06   0.77   1.00   0.92     0.05   0.84     0.98

LASSO – 1 SE    0.14   0.18   0.00   0.43   0.51    0.46   0.00   1.00   0.95   0.09   0.69   1.00   0.05   0.11   0.00   0.42   0.15    0.30   0.00   1.00   0.93   0.12   0.69   1.00     0.25    0.18   0.00   0.43   0.94   0.12   0.53   1.00   0.97     0.02   0.91     1.00

CV1             0.78   0.11   0.61   1.00   0.63    0.42   0.00   1.00   0.97   0.03   0.91   1.00   0.83   0.11   0.62   1.00   0.35    0.38   0.00   1.00   0.96   0.03   0.91   0.99     0.71    0.06   0.61   0.77   0.97   0.06   0.77   1.00   0.99     0.01   0.98     1.00

CV2             0.78   0.12   0.61   1.00   0.63    0.42   0.00   1.00   0.99   0.01   0.96   1.00   0.85   0.12   0.62   1.00   0.35    0.38   0.00   1.00   0.98   0.01   0.96   1.00     0.71    0.06   0.61   0.77   0.97   0.06   0.77   1.00   0.99     0.00   0.98     1.00

Mix             0.27   0.17   0.01   0.49   0.55    0.45   0.00   1.00   0.93   0.04   0.80   1.00   0.17   0.16   0.01   0.43   0.23    0.36   0.00   1.00   0.93   0.05   0.80   1.00     0.40    0.08   0.28   0.49   0.95   0.11   0.59   1.00   0.93     0.01   0.91     0.94

Meinshausen1    0.39   0.40   0.00   1.00   0.50    0.41   0.00   1.00   0.91   0.08   0.80   1.00   0.69   0.32   0.02   1.00   0.26    0.33   0.00   1.00   0.85   0.05   0.80   0.99     0.04    0.04   0.00   0.14   0.78   0.28   0.21   1.00   0.98     0.03   0.90     1.00

Meinshausen2    0.05   0.05   0.00   0.18   0.31    0.39   0.00   1.00   0.88   0.08   0.68   1.00   0.08   0.06   0.00   0.18   0.13    0.29   0.00   0.99   0.87   0.06   0.68   1.00     0.01    0.02   0.00   0.05   0.53   0.40   0.02   1.00   0.90     0.09   0.72     1.00




Supplementary Table V.2: Results of the application of default LASSO and LASSO stabilization methods to relate an exposome of 74 prenatal
quantitative exposures to zBMI in 1301 mother-child pairs of the Helix cohorts.
                                                                                       Number of selected                           Computation time (in                                           Number of exposures selected at least one
Stabilization method                           Sorensen index
                                                                                       exposures*                                   seconds)*                                                      time
None (default LASSO)                                                     1.000                                            0.00                                                            0.17                                                                                  0
LASSO_1SE                                                                1.000                                            0.00                                                            0.17                                                                                  0
CV1                                                                      1.000                                            1.00                                                        13.92                                                                                     1
CV2                                                                      1.000                                            1.00                                                        15.40                                                                                     1
Meinshausen1                                                             0.467                                            1.67                                                            0.98                                                                                  4
Meinshausen2                                                             1.000                                            0.00                                                            0.96                                                                                  0
Mix                                                                      1.000                                            0.00                                                        11.86                                                                                     0
* computed after repetition of each method 15 times.

                                                                                                                                         200


              CHAPTER V: Some insights regarding the instability of variable-selection algorithms used for causal inference purposes in epidemiology

Supplementary Table V.3: List of variables selected by default LASSO and all tested stabilized LASSO for each of the 10 runs applied to relate an
exposome of 173 prenatal and postnatal quantitative exposures (A) or only the smaller exposome of 74 prenatal quantitative variables (B), to zBMI in
1301 mother-child pairs of the Helix cohorts. For each run, the direction of association with zBMI in a multivariate model including all exposures
selected in the run and adjusted for relevant covariates is also given.
Due to its size, this supplementary is provided as a separated file in Appendix III.




Supplementary Material V.1: Commented simulation script

Due to its size, this supplementary is provided as a separated file in Appendix III.
This script will also be available on github (https://github.com/SoCadiou) once the corresponding draft will be published.




Supplementary Material V.2: Application: using LASSO to relate pregnancy exposome to child body mass index in Helix data

In the analysis relating only the prenatal exposures to zBMI, default LASSO did not select any exposure and was stable (Supplementary Table V.2). CV1
and CV2 displayed different results: they both selected one exposure (not the same for the two methods) and were stable (Supplementary Table V.3 and
Supplementary Figure V.4). This difference of behavior between default LASSO and the cross-validation based methods made it plausible that the true
predictors from the prenatal exposome explained less than 8% of zBMI (see Figure V.1), which is consistent with the fact that the pregnancy maternal
exposome may show links of lower magnitude with child zBMI than the exposome assessed during the year before the child examination. For this range
of scenarios, CV1 and CV2 are expected to show a very high FDP and should not be trusted, despite their stability. This is also the case for Meinshausen2,
which selected on average more than one exposure, and which is also expected to show high FDP (high FDP is more largely expected for Meinshausen2,
as soon as it is unstable, according to Figure V.3). The two other stability-selection-based methods did not select any exposure, which is consistent with
an expected very low FDP in this range of scenarios.




                                                                           201


202


                                                                                         Discussion

CHAPTER VII:           Discussion

In this PhD report we tried to provide news insights on the way to relevantly reduce the dimension

of the exposome in the context of exposome-health studies; we focused on a strategy consisting in

using information from intermediate layers between exposome and health to help performing this

dimension reduction. We applied this strategy to the study of the effects of the early-life exposome

on child health (growth and lung function).

In this discussion, after briefly summarizing our main results, we will question such a strategy and

our choices regarding its implementation. We will first discuss the central question of dimension

reduction, in exposome studies and within our particular context involving the use of a high-

dimensional intermediate layer: how to relevantly choose among the possible approaches to reduce

the dimension of a layer, according to the study objective? Then we will discuss the possible designs

combining multiple layers in the context of studies aiming at selecting causal predictors of a health

outcome. Last, we will replace our work within the larger challenges encountered today in

environmental epidemiology and exposome research.

               Overview of results

We performed three different studies on real data, using different implementation of our oMITM

design (chapters II, III and Appendix II). All three studies share the main characteristics of our

oMITM: they used an intermediary layer (the methylome), whose dimension was reduced

borrowing information from to the outcome of interest; then this reduced methylome was related

to the exposome conditionally to the outcome, in order to build a reduced exposome. In a last step,

a selection of exposures related to the outcome was performed within this reduced exposome. The

methods chosen for the implementation of oMITM differed between the three studies. In our two

studies on Helix data (chapters II and III), a priori information on the methylome was used by

selecting CpG related to the outcome according to external databases. The two studies identified

copper as related with the outcomes (respectively BMI and FEV1 at 6-10 years), a finding which


                                                203


                                                                                        Discussion

may be relevant giving the role of copper in the regulation of inflammation and which is extensively

discussed in chapters II and III. Compared to their agnostic counterparts ignoring the methylome,

the oMITM design implementations possibly allowed to discard associations likely to be due to

reverse causality, such as lipophilic compounds assessed at the same time at the outcome (chapter

II) and to increase sensitivity by identifying copper, which an agnostic approach failed to do

(chapter III). In the study on SEPAGES cohort (Appendix II), no a priori information about the

methylome was used: as the relevance of pathways databases may be discussed (Mubeen et al.,

2019), we chose a supervised dimension reduction without a priori, the PLS method, in order to

try to relevantly summarize the needed information from the methylome layer. The whole oMITM

did not identify any significant association between the (smaller) exposome and birth weight in this

study of 438 mother-child pairs.

In chapters IV and V, we performed simulations to strengthen our choice of design and

implementations. In a first simulation, we tested the relevance of our oMITM design compared to

other designs, either “agnostic” or using an intermediary layer. We showed that our oMITM design

allowed improved specificity compared to its agnostic counterpart (at a cost in sensitivity, when

the methylome is not involved on the path from exposures to the outcome) and is less prone to

suffer from reverse causality bias (chapter IV). In our second simulation (chapter V), we studied

the stability algorithms commonly-used to select exposures related to health, and showed with the

example of LASSO that methods taking into account the stability of selection seems to be more

adapted in the context of a study aiming at minimizing the false discoveries than methods aiming

at optimizing prediction, which are currently the most used.




               Dimension reduction approaches in the context of exposome studies

A motivation of this PhD work was related to the challenges of limited specificity and power of

exposome studies previously identified by our team (Agier et al., 2016; Slama and Vrijheid, 2015).


                                                204


                                                                                        Discussion

As we detailed in the introduction, relevant dimension reduction of the exposome may be a way to

address them (see I.2.1). Dimension reductions techniques can also be necessary to visualize high

dimensional data and thus better understand the model; or for computational reasons, to reduce

algorithmic costs (Van Der Maaten et al., 2009). All these objectives are encountered in

environmental epidemiology at different levels according to the aim of the study and the layers

considered. Different methods can be used depending on the objectives: in particular, we illustrated

that the dimension reduction can be done using a priori knowledge on the structuration of the data

or without it (for example with agnostic variable selection algorithms, as described in chapter V).

When it is data-driven, it can be supervised (using another layer, which is a more subtle way to

incorporate a priori information) or unsupervised (Guyon and Elisseeff, 2003).

With our oMITM design, we chose to rely on the information coming from an intermediate layer

of high dimension to perform this dimension reduction, and thus we also had to perform

dimension reduction on this intermediary layer. What are the possible dimension reduction

techniques that can be applied to these layers and in which situations are they relevant?

            Which dimension reduction approaches when selection of variable(s) of interest is the

            aim?

In exposome studies, as selection of variable is a key aim, extraction techniques are a priori not

relevant. However, not all selection methods are adapted to our problem. Indeed, epidemiologists

aim at selecting variables with causal biological meaning, with an ultimate public health aim to be

able to operate on these variables to modify the outcome. Thus, a supervised selection method

must be applied. But beforehand, another dimension reduction method can be applied to the

exposome to “simplify the problem”: this is what we did with the primary implementation of our

oriented Meet-in-the-Middle (chapters II and IV) design which allowed to build a reduced exposome,

on which a basic selection method, ExWAS, was then applied. What are the other dimension

reductions techniques that we could have considered? A summary is provided in Table VII.1, but


                                                205


                                                                                                  Discussion

it is important to notice that in an exposome study, using directly a priori knowledge to focus on

one (or a few more) a priori chosen exposure(s) is an option which does not take directly into

account the potential of the exposome in the sense that the interest of the exposome approach lies

in the ability to consider 1) potential predictors simultaneously; 2) potential predictors whose effect

on health is currently not well known. Thus, focusing on specific compounds whose harmfulness

is known would not be a strategy in an exploratory exposome study, whereas on the contrary it

would be relevant in specific confirmatory studies or studies aiming at precisely quantifying known

effects. However, some a priori knowledge on the exposome can be used for example to discard

exposures with no possibility of effects (for example irrelevant exposure windows).

Various data-driven selection techniques are available. They can be divided in three categories. The

first one are filtering methods: they select features on the basis of their scores in various statistical tests

(for example, their correlation with the outcome variable), usually as a pre-processing step before

applying a learning algorithm. Multiple linear regression (MLR) as well as ExWAS-type methods

can be considered as data-driven filtering methods, and we used them to perform a selection on

the exposome by relating it with the outcome of interest on our three real-data studies (chapters

II, III and Appendix II). Indeed, in the context of exposome studies, such methods can be used as

the main analysis if they have sufficient specificity, and rather as a pre-processing step if there are

sensitive but with low specificity. Thus, for example, ExWAS without correction for multiple

comparison could be used as a pre-processing filtering method, whereas ExWAS with correction

can be used for the main analysis (as soon as the correlation is not too high, which would have a

strong negative impact on the specificity, as we showed in chapter V). With our MITM design, we

used also such methods as a pre-processing step involving an intermediate layer: indeed, at the

second step of our original MITM design (chapter II, IV and Appendix II) or in our lung function

study at the first step (chapter III), we ran univariate tests involving another layer allowing to rank

and to select some variables to build our reduced exposome, on which a more stringent selection

method was then applied.

                                                     206


                                                                                          Discussion

A second category of selection techniques are the wrapper methods, which consist of iterative

searches of a subset of variables: at each iteration, some variables are added or remove to try to

strengthen the inference (Guyon and Elisseeff, 2003). These methods are usually very

computationally demanding, but may be adapted to the intermediate dimension of the exposome.

DSA is an example of such a method: it has been used in exposome studies (Agier et al., 2019;

Nieuwenhuijsen et al., 2019) in spite of its lack of stability, which we studied in chapter V.

Last, the embedded methods are methods which have inbuilt feature-selection methods, like for

example Elastic-Net and LASSO, which we have studied in chapter V.

The three categories could be used to tackle exposome studies challenges. However, embedded

methods may be not specific enough, as most of them were designed in the machine learning field

to optimize the predictive ability of models, which may imply the selection of too many variables,

as we showed with LASSO and discussed in chapter V. Indeed, as demonstrated by Guyon and

Elisseeff (2003) , for learning tasks, “noise and reduction and consequently better class separation

may be obtained by adding variables that are presumably redundant.” This may explain why, in our

simulation study of the stabilization methods of LASSO (chapter V), the stabilization method

aiming at optimizing the prediction showed lower performance in term of specificity than stability

selection (Meinshausen and Bühlmann, 2010), a method focusing on selection of variables of

interest in a logic of model averaging. Overall, the wrapper methods may be the most adapted for

the main analysis in exposome studies, whereas filtering methods should be potentially used as a

preprocessing step.

             Which dimension reduction approaches when information concentration is the aim?

When the aim is not selection of relevant variables but concentration of a diluted information,

other methods can be envisaged (see Table VII.1). In a strategy aiming at using a layer to inform

the structure of another layer, extraction methods may be well suited, in particular when the layer

is of high dimension, which was the case of the methylome. More generally, all methods reducing


                                                 207


                                                                                              Discussion

dimension can be used as soon as they are not too specific, i.e. if they do not restrict too much the

quantity of information. In other words, in this case, the compromise between sensitivity and

specificity (here in the sense of detection of available information) is in favor of sensitivity, as it is

a pre-processing step, whereas in the case of selection that we discussed in the previous paragraph,

specificity may be favored. As soon as the dimension is reduced enough to make the information

usable, the presence of redundant variables is not a problem. This was one the motivations of the

use of ExWAS-type method (MWAS) to reduce the dimension of the methylome (chapters II and

IV). Lack of biological interpretability is not a problem either: for example, in our MITM design,

selecting a CpG correlated with a causal CpG on the pathway from exposures to health is not an

issue as soon as it still enables to select the relevant exposures. This also explains why extraction

methods may be adapted in this context. Thus, in the Sepages study (Appendix II), we chose to

modify our MITM design by using PLS in the first step, which enabled to perform a huge

supervised dimension reduction by building one summary new variable. In the same logic,

interestingly, in chapter II, when we performed a sensitivity analysis of our MITM analysis by using

6 variables describing cell-types instead of our methylome of 2284 CpG as our intermediary

variables, we found the same results: the cell types can be considered as a smaller number of

variables carrying the same information for our problem than our high-dimensional methylome,

which made us hypothesize that the information that we obtained from the methylome was majorly

due to an inflammation process also observable from the cell-types counts. This also illustrated

that this step of information concentration can be performed using a priori external knowledge.

This was also what we did when we chose to focus on enhancers CpGs belonging to relevant

biological pathways (chapters II and III). Following the same logic of extraction dimension

reduction and reliance on external knowledge, we could also have considered a strategy aiming at

summarizing the methylation information pathway by pathway.




                                                  208


                                                                                            Discussion

Overall, multiple methods exist to deal with high dimensional layer when interpretability is not

necessary. They could be used to optimize prediction but also to concentrate information in order

to perform supervised dimension reduction on another layer.

Table VII.1: Possible strategies of dimension reduction for the exposome and methylome layers
                               Exposome layer                      Methylome (or another
                                                                   intermediate layer)
 Dimension                     Intermediate (~102)                 High (~106)
 Average correlation           Intermediate (~0.1)                 Intermediate (>0.1)
 Objective within our          Understand its causal link with     Provide information to help
 strategy                      an outcome                          dimension reduction of the
                                                                   exposome
 Why reducing dimension?       To select relevant variables of     To make information usable
                               interest
 Direct use of a priori        No direct a priori selection in a   Yes, if domain knowledge is
 knowledge in dimension        discovery exposome approach         available
 reduction?                    (but useful to discard totally
                               irrelevant variables, e.g.
                               variables in an irrelevant
                               exposure window, before the
                               analysis)
 Use of selection methods      Yes                                 Yes
 for dimension reduction?
           Filtering methods With a priori knowledge on the        With a priori on the layer: yes, for
                             layer: no                             example preselection of relevant
                             Without a priori: yes, for            features according to domain
                             example ExWAS (chap. II and           knowledge (chap. II, chap. III)
                             III), MLR (appendix II)               Without a priori: yes, for example
                                                                   MWAS (chap II, chap IV)
           Wrapper methods Yes, for example DSA (chap. IV          No, they are often computationally
                             and V)                                not feasible in high dimension
         Embedded methods Yes, for example LASSO or                Yes, for example high dimensional
                             Elastic-Net (chap. V)                 LASSO or random forest
 Use of extraction methods   No, selection is the aim              Yes
 for dimension reduction
                Unsupervised /                                     Without a priori: yes, for example
                                                                   ACP
                                                                   With a priori: yes, for example
                                                                   summary variables by biological
                                                                   pathway
                  Supervised /                                     Yes, for example PLS (appendix II)
 Favouring sensitivity or    Specificity (with non-null            Sensitivity (as well information is
 specificity?                sensitivity)                          usable)




                                                209


                                                                                          Discussion

                Multilayer designs to identify causal predictors

In the previous paragraphs, we discussed which methods could be adapted to perform dimension

reduction on the layers that we considered in this PhD project. Assuming the question of the

dimension reduction solved, the design of the statistical analysis would still be a major question:

how to combine the information from the two layers? As we showed in our simulation study under

various causal structures (chapter IV), the choice of the design is essential if the aim is to select

causal predictors.

             Infer causality in exposome studies

In epidemiology, the first condition to select causal variables is to choose a relevant design of data

collection (for example a longitudinal design). Then, knowledge-based adjustment on relevant

confounders is necessary. However, it is still impossible to distinguish between correlated variables

on which no previous information is available or be sure to discard reverse causality (as we show

in chapter IV (see Supplementary Figure IV.5), even with a longitudinal design, reverse causality

can still lead to spurious association). Some selection methods among those we discussed in

paragraph VI.2.2. have been built reckoning the causal inference theory and consider estimators

derived from counterfactuals inference in order to perform selection of causal predictors: for

example, in DSA, a derivative-based importance measure aiming at measuring the ‘causal’ effect of

a variable can be implemented (Sinisi and van der Laan, 2004). The ‘targeted learning’ proposed by

Van der Laan (van der Laan et al., 2007; van der Laan and Starmans, 2014) also considers inference

theory to choose the parameters to estimate. These methods, which can be considered “data-driven

causal modelling”, like the Bayesian networks that we discussed in the introduction (paragraph

I.2.3), may be adapted to our problem, as selection methods aiming at inference rather than

prediction should be preferred in the context of discovery exposome studies.




                                                 210


                                                                                            Discussion

             Multiple layers design as a clue to overcome the challenges of data-driven causal

             modelling

However, the possibility of inferring causality solely from data has been contested in the literature

on causal discovery, in the line of the idea of ‘no causes in, no causes out’ first introduced by

Cartwright: it states that “old causal knowledge must be supplied for new causal knowledge to be

had” when trying to decipher causality of an observed phenomenon (Cartwright and Nancy, 1994).

Big data (defined as available datasets characterized by their high volume, high velocity of

acquisition and high variety (Canali, 2016)) had once been considered a solution (Canali, 2016): the

abundance of meaningful correlations was supposed to allow to get rid of the need of prior causal

theory or knowledge (Mayer-Schönberger and Cukier, 2013). But these claims have later been

contradicted (Leonelli, 2014; Titiunik, 2014) and the indispensable use of hypotheses in research

based on Big Data highlighted (Ratti, 2015). Hernan underlined that a real causal assignation always

involves expert knowledge: this is what makes the difference between prediction and counterfactual

prediction (Hernán et al., 2019), i.e. causal selection. This can be linked to the fact that theoretical

conditions needed to make causal inference possible using only data (e.g. when using Bayesian

networks) seem impossible to reach in reality: for example, it is only under the faithfulness

condition (i.e. that all probabilistic dependencies and independencies characterizing the variables

studied should be considered) that a learned Bayesian network can be used for inference (Ghiara,

2019). More generally, all the causal theory used in DAG and underlying the causal learning

methods involves the absence of external confounders. In practice, this seems unreachable in

observational studies, unless the ‘whole system’ is considered, which would make the complexity

infinite. In particular, we can hypothesize that in most biological systems studied, the faithfulness

condition involves to consider a number of features which makes the curse of dimensionality a

problem. Thus, as we discussed before, dimension reduction techniques would be needed; but they

would be incompatible with the concept of purely data-driven causal modeling: indeed, selection

of variables involves a priori knowledge (even supervised selection techniques involve previous

                                                  211


                                                                                          Discussion

knowledge as a link with an outcome is postulated) and variables extraction prevents the causal

interpretation, as it provides new variables without biological meaning. Thus, even when using big

data, data-driven causal modelling cannot be enough to infer causality, expert knowledge is

additionally needed and we suggest here that this could be explained using the faithfulness

condition.

More precisely, the Russo-Williamson thesis suggests that to infer causality, a mechanism must be

supplied in addition to an observed association (i.e. a probabilistic dependency) (Russo and

Williamson, 2007). Such a mechanism generally means an external explanation of how, and

corresponds to the expert knowledge advocated by Hernan (2019). However, we must recall here

that all human knowledge derives solely from experience (Hume, 1740): in particular, what is

considered as external expert knowledge used for causality always derives from previous

observation(s). For example, it is interesting to note that information from biological databases

(e.g. pathways or genetic database) is discussed by Canali as a supplementary knowledge enabling

to infer causality in exposome studies (Canali, 2016), whereas Leonelli discussed it as part of data-

driven sciences (Leonelli, 2014). Thus, the notion of « mechanism » proposed by Russo &

Williamson must rather be interpreted as probabilistic dependencies observed at a different scale:

for example, toxicological observations at the level of the cell to support an adverse observed effect

at the population level. Thus, working with multiple biological layers as we did in this PhD work

may be a step on the path to causality: this is what Canali suggested when he considered the Meet-

in-the-Middle design proposed by Chadeau-Hyam and Vineiss (similar to our oMITM but without

our additional adjustment on the outcome) as a way to investigate disease causation by searching

for intermediate biomarkers (Canali, 2016; Chadeau-Hyam et al., 2011). Considering the

structuration of our data in different layers from different scales is a way to add expert knowledge.

However, we showed both with theoretical and simulated works (chapter IV) that the Meet-in-the-

Middle design advocated by Chadeau-Hyam et al. (2011) is not sufficient to affirm causality. In


                                                 212


                                                                                                  Discussion

particular, it is prone to reverse causality, similarly to the mediation design. On the contrary, our

oMITM design seems to be more robust to the variety of underlying causal structures, in the sense

that we developed in chapter IV. But, even considering an implementation with perfect power, it

is still not sufficient to get rid of all situations of reverse causality and it is not able to detect all true

causal associations. Combining results of different designs (for example running a mediation test

and a oMITM test and compare results according as in Table IV.4 and Supplementary Table IV.4)

could increase the probability of deciphering the true causal structures, but overall, causality could

not be affirmed but only discussed with more or less likeliness. Overall, data-driven causal

modelling is not enough and adding knowledge is always delicate, but working with structured

layers and adequate robust designs may help.




                 Perspectives and conclusion

Thus, our results show that to perform a causal discovery exposome study, one may rely on

intermediate layer and choose adapted dimension reduction method(s), design(s) and

implementation(s), according to the structure of data and the aim of study: in particular choosing

whether high sensitivity or specificity should be favored is needed. In this chapter, we discussed

the dimension reduction methods (VI.2.) as well as the most adequate analytical designs (VI.3); the

possible implementations of our proposed designs were extensively discussed in chapters IV and

V. One question remaining is the choice of the intermediate layer. We chose to focus on the

methylome layer, but other ‘omics’ (or non ‘omics’) layers could have been considered and may be

helpful to inform the exposome health relations. For example, transcriptome may also contain

biomarkers of exposures and diseases, making mediation or oMITM analyses relevant

(Winckelmans et al., 2017a, 2017b). Microbiome, whose causal relationship with health outcome is

complex, would also be a potentially relevant intermediate layer (Sohn and Li, 2019), as well as

inflammatory or immunological markers.


                                                     213


                                                                                          Discussion

Overall, this PhD work can give us insights of a possible future for exposome studies. Our work

supports the assessment of omics intermediate layers, as done by most of recent exposome studies

(see Table I.1): indeed, we demonstrated that these layers are not only useful to better understand

mechanisms of effect of exposures on health as often suggested, but also offer possibilities to

improve the detection of causal predictors of health among the exposome compared to “agnostic

exposome studies”. However, our work also illustrated the curse of dimensionality, which

constitutes a threat for exposome studies, as we underlined the systematic gain in term of specificity

obtained by dimension reduction for intermediate or high dimension data (see in particular in

Chapter IV the evolution of FDP according to the size of the reduced exposome, Figure IV.3).

Thus, the development of omics assessment in exposome studies should go together the

enhancement of dimension reduction tools. This is becoming crucial as novel analytical techniques

make it easier to measure omics by millions in one sample at low-cost. As we discussed previously

(see VI.I.1.), when the aim is to use intermediate layer to inform the exposome-health relation,

many statistical methods can be used, including the powerful extraction methods. But, we also

showed (see Chapter II and III) the relevance of dimension reduction relying on a priori knowledge,

especially from the toxicological field: if for the moment, information from toxicological databases

are not always reliable (Mubeen et al., 2019), consolidated and usable pathways database would be

promising tools for the exposome research. A novel application, in the line of our work, could be

to use such tools to build summary variables by pathways and use them to relevantly reduce the

exposome dimension.

On the contrary, less dimension reduction strategies are relevant for the exposome than for the

intermediary layer, as we discussed above (see VI.1.2), whereas current sample size of exposome

projects limit the specificity and power of exposome studies to detect causal predictors of health

(see chapters IV and V and Appendix II). As we showed, informed dimension reduction and

relevant statistical variable selection methods can help lower FDP and even in some cases increase

sensitivity, if an adequate analytical design is chosen. However, both of these strategies would still

                                                 214


                                                                                        Discussion

be limited by a too high dimension: an increase in the components of the exposome assessed should

come together with an increase in sample size to make strategies that we pointed applicable and to

provide sufficient power. Indeed, as we developed in appendix II, the oMITM cannot for example

be more sensitive than the corresponding agnostic approach without correction for multiple

testing. This is of particular importance as the assessment of exposures by biomarkers also makes

a wider assessment of exposome easier. Such an increase in the factors assessed would of course

be valuable to better describe the personal environment, but it could lead to assessing of thousands

to billions of factors in a few individuals, which will result in datasets unexploitable for causal

inference of environmental effects on health.

To conclude, we provided new insights on how the use of intermediate layers may help to inform

exposome health study and in particular to help to tackle the challenge of reverse causality and low

specificity, with the aim of detecting the causal predictors of a health outcome. To replace our

problematic among the challenges of the environmental epidemiology field, if omics are assessed

conjointly with a minimized measurement error on the exposome, the use of methods such as

those we proposed to identify with increased specificity causal predictors of health may help to

focus on relevant compounds and to build adequate analytical designs to estimate measures of

association and then perform health impact assessment, with an ultimate aim to help public

policies.




                                                215


216


References
Agay-Shay, K., Martinez, D., Valvi, D., Garcia-Esteban, R., Basagaña, X., Robinson, O., Casas,
    M., Sunyer, J., Vrijheid, M., 2015. Exposure to endocrine-disrupting chemicals during
    pregnancy and weight at 7 years of age: A multi-pollutant approach. Environ. Health
    Perspect. 123, 1030–1037. https://doi.org/10.1289/ehp.1409049
Agier, L., Basagaña, X., Hernandez-Ferrer, C., Maitre, L., Tamayo Uria, I., Urquiza, J.,
     Andrusaityte, S., Casas, M., de Castro, M., Cequier, E.M., Chatzi, L., Donaire, D., Giorgis-
     Allemand, L., Ramon Gonzalez, J., Grazuleviciene, R., Gützkow, K.B., Haug, L.S., Sakhi,
     A.K., McEachan, R.R.C., Meltzer, H.M., Nieuwenhuijsen, M., Robinson, O., Roumeliotaki,
     T., Sunyer, J., Thomsen, C., Vafeiadi, M., Valentin, A., West, J., Wright, J., Siroux, V.,
     Vrijheid, M., Slama, R., 2020a. Association Between the Pregnancy Exposome and Fetal
     Growth [WWW Document]. Int. J. Epidemiol. https://doi.org/10.2139/ssrn.3258668
Agier, L., Basagaña, X., Maitre, L., Granum, B., Bird, P.K., Casas, M., Oftedal, B., Wright, J.,
     Andrusaityte, S., de Castro, M., Cequier, E., Chatzi, L., Donaire-Gonzalez, D.,
     Grazuleviciene, R., Haug, L.S., Sakhi, A.K., Leventakou, V., McEachan, R., Nieuwenhuijsen,
     M., Petraviciene, I., Robinson, O., Roumeliotaki, T., Sunyer, J., Tamayo-Uria, I., Thomsen,
     C., Urquiza, J., Valentin, A., Slama, R., Vrijheid, M., Siroux, V., 2019. Early-life exposome
     and lung function in children in Europe: an analysis of data from the longitudinal,
     population-based HELIX cohort. Lancet Planet. Heal. 3, e81–e92.
     https://doi.org/10.1016/S2542-5196(19)30010-5
Agier, L., Portengen, L., Chadeau-Hyam, M., Basagaña, X., Giorgis-Allemand, L., Siroux, V.,
     Robinson, O., Vlaanderen, J., González, J.R., Nieuwenhuijsen, M.J., Vineis, P., Vrijheid, M.,
     Slama, R., Vermeulen, R., Hyam, M.C., Basagaña, X., Allemand, L.G., Siroux, V., Robinson,
     O., Vlaanderen, J., González, J.R., Nieuwenhuijsen, M.J., Vineis, P., Vrijheid, M., Slama, R.,
     Vermeulen, R., 2016. A Systematic Comparison of Linear Regression-Based Statistical
     Methods to Assess Exposome-Health Associations. Environ. Health Perspect. 124, 1848–
     1856. https://doi.org/10.1289/EHP172
Agier, L., Slama, R., Basagaña, X., 2020b. Relying on repeated biospecimens to reduce the effects
     of classical-type exposure measurement error in studies linking the exposome to health.
     Environ. Res. 186, 109492. https://doi.org/10.1016/j.envres.2020.109492
Armstrong, B.G., 1998. Effect of measurement error on epidemiological studies of
    environmental and occupational exposures. Occup. Environ. Med. 55, 651–656.
    https://doi.org/10.1136/oem.55.10.651
Baccarelli, A., Wright, R.O., Bollati, V., Tarantini, L., Litonjua, A.A., Suh, H.H., Zanobetti, A.,
    Sparrow, D., Vokonas, P.S., Schwartz, J., 2009. Rapid DNA Methylation Changes after
    Exposure to Traffic Particles. Am. J. Respir. Crit. Care Med. 179, 572–578.
    https://doi.org/10.1164/rccm.200807-1097OC
Bach, F., 2008. Bolasso: model consistent Lasso estimation through the bootstrap.
    https://doi.org/10.1145/1390156.1390161
Barfield, R., Shen, J., Just, A.C., Vokonas, P.S., Schwartz, J., Baccarelli, A.A., VanderWeele, T.J.,
     Lin, X., 2017. Testing for the indirect effect under the null for genome-wide mediation
     analyses. Genet. Epidemiol. 41, 824–833. https://doi.org/10.1002/gepi.22084
Baron, R.M., Kenny, D.A., 1986. The moderator-mediator variable distinction in social
    psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc.
    Psychol. 51, 1173–82.

                                                 217


Barrera-Gómez, J., Agier, L., Portengen, L., Chadeau-Hyam, M., Giorgis-Allemand, L., Siroux,
     V., Robinson, O., Vlaanderen, J., González, J.R., Nieuwenhuijsen, M., Vineis, P., Vrijheid,
     M., Vermeulen, R., Slama, R., Basagaña, X., 2017. A systematic comparison of statistical
     methods to detect interactions in exposome-health associations. Environ. Heal. A Glob.
     Access Sci. Source 16, 74. https://doi.org/10.1186/s12940-017-0277-6
Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., 2016. Birth weight in relation
     to health and disease in later life: An umbrella review of systematic reviews and meta-
     analyses. BMC Med. 14, 147. https://doi.org/10.1186/s12916-016-0692-5
Bell, M.L., Belanger, K., Ebisu, K., Gent, J.F., Lee, H.J., Koutrakis, P., Leaderer, B.P., 2010.
      Prenatal exposure to fine particulate matter and birth weight: Variations by particulate
      constituents and sources. Epidemiology 21, 884–891.
      https://doi.org/10.1097/EDE.0b013e3181f2f405
Bellman, R.E., 1961. Adaptive Control Processes: A Guided Tour [WWW Document]. Princeton,
     NJ. URL
     https://books.google.fr/books?hl=fr&lr=&id=iwbWCgAAQBAJ&oi=fnd&pg=PR9&ots=
     bDK5XqD25i&sig=KBl_vhNG67fA26OW4b0WF2JLSRU&redir_esc=y#v=onepage&q&
     f=false (accessed 5.28.20).
Belloni, A., Chernozhukov, V., Hansen, C.B., 2011. Inference for high-dimensional sparse
     econometric models. Adv. Econ. Econom. Tenth World Congr. Vol. 3, Econom. 245–295.
     https://doi.org/10.1017/CBO9781139060035.008
Benjamini, Y., Hochberg, Y., 1995. Controlling the False Discovery Rate: A Practical and
     Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B.
     https://doi.org/10.2307/2346101
Benjamini, Y., Yekutieli, D., 2001. The Control of the False Discovery Rate in Multiple Testing
     under Dependency. Ann. Stat. https://doi.org/10.2307/2674075
Benton, M.C., Sutherland, H.G., Macartney-Coxson, D., Haupt, L.M., Lea, R.A., Griffiths, L.R.,
    2017. Methylome-wide association study of whole blood DNA in the Norfolk Island isolate
    identifies robust loci associated with age. Aging (Albany. NY). 9, 753–768.
    https://doi.org/10.18632/aging.101187
Blum, M.G.B., Valeri, L., François, O., Cadiou, S., Siroux, V., Lepeule, J., Slama, R., 2020.
    Challenges Raised by Mediation Analysis in a High-Dimension Setting. Environ. Health
    Perspect. 128, 055001. https://doi.org/10.1289/EHP6240
Bogdanos, D.P., Smyk, D.S., Rigopoulou, E.I., Sakkas, L.I., Shoenfeld, Y., 2015. Infectomics and
    autoinfectomics: a tool to study infectious-induced autoimmunity. Lupus 24, 364–73.
    https://doi.org/10.1177/0961203314559088
Bonvallot, N., Tremblay-Franco, M., Chevrier, C., Canlet, C., Warembourg, C., Cravedi, J.-P.,
    Cordier, S., 2013. Metabolomics Tools for Describing Complex Pesticide Exposure in
    Pregnant Women in Brittany (France). PLoS One 8, e64433.
    https://doi.org/10.1371/journal.pone.0064433
Boulesteix, A.-L., Durif, G., Lambert-lacroix, S., Peyre, J., Strimmer, K., 2018. Package ‘
    plsgenomics .’
Boulesteix, A.-L., Slawski, M., 2009. Stability and aggregation of ranked gene lists. Brief.
    Bioinform. 10, 556–568. https://doi.org/10.1093/bib/bbp034
Bousquet, O., Elisseeff, A., 2002. Stability and Generalization. J. Mach. Learn. Res. 2, 499–526.

                                                 218


Breiman, L., 2004. Bagging predictors. Mach. Learn. 24, 123–140.
     https://doi.org/10.1007/bf00058655
Brewer, G.J., 2010. Copper toxicity in the general population. Clin. Neurophysiol. 121, 459–460.
    https://doi.org/10.1016/j.clinph.2009.12.015
Brulle, R.J., Pellow, D.N., 2006. ENVIRONMENTAL JUSTICE: Human Health and
     Environmental Inequalities. Annu. Rev. Public Health 27, 103–124.
     https://doi.org/10.1146/annurev.publhealth.27.021405.102124
Bunin, A., Sisirak, V., Ghosh, H.S., Grajkowska, L.T., Hou, Z.E., Miron, M., Yang, C., Ceribelli,
    M., Uetani, N., Chaperot, L., Plumas, J., Hendriks, W., Tremblay, M.L., Häcker, H., Staudt,
    L.M., Green, P.H., Bhagat, G., Reizis, B., 2015. Protein Tyrosine Phosphatase PTPRS Is an
    Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells. Immunity 43,
    277–288. https://doi.org/10.1016/j.immuni.2015.07.009
Burling, T.A., Bigelow, G.E., Robinson, J.C., Mead, A.M., 1991. Smoking during pregnancy:
     Reduction via objective assessment and directive advice. Behav. Ther. 22, 31–40.
     https://doi.org/10.1016/S0005-7894(05)80241-2
Busch, R., Qiu, W., Lasky-Su, J., Morrow, J., Criner, G., DeMeo, D., 2016. Differential DNA
    methylation marks and gene comethylation of COPD in African-Americans with COPD
    exacerbations. Respir. Res. 17, 143. https://doi.org/10.1186/s12931-016-0459-8
Buschdorf, J.P., Ong, M.L., Ong, S.X., MacIsaac, J.L., Chng, K., Kobor, M.S., Meaney, M.J.,
    Holbrook, J.D., 2016. Low birth weight associates with hippocampal gene expression.
    Neuroscience 318, 190–205. https://doi.org/10.1016/j.neuroscience.2016.01.013
Buuren, S. van, Groothuis-Oudshoorn, K., 2011. mice : Multivariate Imputation by Chained
    Equations in R. J. Stat. Softw. 45, 1–67. https://doi.org/10.18637/jss.v045.i03
Cadiou, S., Bustamante, M., Agier, L., Andrusaityte, S., Basagaña, X., Carracedo, A., Chatzi, L.,
    Grazuleviciene, R., Gonzalez, J.R., Gutzkow, K.B., Maitre, L., Mason, D., Millot, F.,
    Nieuwenhuijsen, M., Papadopoulou, E., Santorelli, G., Saulnier, P.J., Vives, M., Wright, J.,
    Vrijheid, M., Slama, R., 2020. Using methylome data to inform exposome-health association
    studies: An application to the identification of environmental drivers of child body mass
    index. Environ. Int. 138, 105622. https://doi.org/10.1016/j.envint.2020.105622
Canali, S., 2016. Big Data, epistemology and causality: Knowledge in and knowledge out in
    EXPOsOMICS. Big Data Soc. 3, 205395171666953.
    https://doi.org/10.1177/2053951716669530
Carrico, C., Gennings, C., 2013. Characterization of a Weighted Quantile Score Approach for
     Highly Correlated Data in Risk Analysis Scenarios. Dep. Biostat. Ph.D., 150.
     https://doi.org/10.1007/s13253-014-0180-3.Characterization
Cartwright, Nancy, 1994. Nature’s Capacities and Their Measurement. OUP Cat.
Casas, M., Basagaña, X., Sakhi, A.K., Haug, L.S., Philippat, C., Granum, B., Manzano-Salgado,
    C.B., Brochot, C., Zeman, F., de Bont, J., Andrusaityte, S., Chatzi, L., Donaire-Gonzalez,
    D., Giorgis-Allemand, L., Gonzalez, J.R., Gracia-Lavedan, E., Grazuleviciene, R.,
    Kampouri, M., Lyon-Caen, S., Pañella, P., Petraviciene, I., Robinson, O., Urquiza, J.,
    Vafeiadi, M., Vernet, C., Waiblinger, D., Wright, J., Thomsen, C., Slama, R., Vrijheid, M.,
    2018. Variability of urinary concentrations of non-persistent chemicals in pregnant women
    and school-aged children. Environ. Int. 121, 561–573.
    https://doi.org/10.1016/J.ENVINT.2018.09.046

                                               219


Cervantes, S., Fontcuberta-Pisunyer, M., Servitja, J.M., Fernandez-Ruiz, R., Garciá, A., Sanchez,
    L., Lee, Y.S., Gomis, R., Gasa, R., 2017. Late-stage differentiation of embryonic pancreatic
    β-cells requires Jarid2. Sci. Rep. 7, 1–14. https://doi.org/10.1038/s41598-017-11691-2
Chadeau-Hyam, M., Athersuch, T.J., Keun, H.C., De Iorio, M., Ebbels, T.M.D., Jenab, M.,
    Sacerdote, C., Bruce, S.J., Holmes, E., Vineis, P., 2011. Meeting-in-the-middle using
    metabolic profiling-a strategy for the identification of intermediate biomarkers in cohort
    studies. Biomarkers 16, 83–88. https://doi.org/10.3109/1354750X.2010.533285
Chadeau-Hyam, M., Campanella, G., Jombart, T., Bottolo, L., Portengen, L., Vineis, P., Liquet,
    B., Vermeulen, R.C.H., 2013. Deciphering the complex: Methodological overview of
    statistical models to derive OMICS-based biomarkers. Environ. Mol. Mutagen. 54, 542–557.
    https://doi.org/10.1002/em.21797
Chamberlain, P.P., Qian, X., Stiles, A.R., Cho, J., Jones, D.H., Lesley, S.A., Grabau, E.A., Shears,
    S.B., Spraggon, G., 2007. Integration of inositol phosphate signaling pathways via human
    ITPK1. J. Biol. Chem. 282, 28117–28125. https://doi.org/10.1074/jbc.M703121200
Chatzi, L., Leventakou, V., Vafeiadi, M., Koutra, K., Roumeliotaki, T., Chalkiadaki, G.,
    Karachaliou, M., Daraki, V., Kyriklaki, A., Kampouri, M., Fthenou, E., Sarri, K., Vassilaki,
    M., Fasoulaki, M., Bitsios, P., Koutis, A., Stephanou, E.G., Kogevinas, M., 2017. Cohort
    Profile: The Mother-Child Cohort in Crete, Greece (Rhea Study). Int. J. Epidemiol. 46,
    1392-1393k. https://doi.org/10.1093/ije/dyx084
Chén, O.Y., Crainiceanu, C., Ogburn, E.L., Caffo, B.S., Wager, T.D., Lindquist, M.A., 2018.
    High-dimensional multivariate mediation with application to neuroimaging data.
    Biostatistics 19, 121–136. https://doi.org/10.1093/biostatistics/kxx027
Chersich, M.F., Urban, M., Olivier, L., Davies, L.A., Chetty, C., Viljoen, D., 2012. Universal
    prevention is associated with lower prevalence of fetal alcohol spectrum disorders in
    Northern cape, South africa: A multicentre before-after study. Alcohol Alcohol. 47, 67–74.
    https://doi.org/10.1093/alcalc/agr145
Cho, S., Kim, K., Kim, Y.J., Lee, J.-K., Cho, Y.S., Lee, J.-Y., Han, B.-G., Kim, H., Ott, J., Park,
    T., 2010. Joint Identification of Multiple Genetic Variants via Elastic-Net Variable Selection
    in a Genome-Wide Association Analysis. Ann. Hum. Genet. 74, 416–428.
    https://doi.org/10.1111/j.1469-1809.2010.00597.x
Chun, H., Keleş, S., 2010. Sparse partial least squares regression for simultaneous dimension
    reduction and variable selection. J. R. Stat. Soc. Ser. B Stat. Methodol. 72, 3–25.
    https://doi.org/10.1111/j.1467-9868.2009.00723.x
Chung, M.K., Buck Louis, G.M., Kannan, K., Patel, C.J., 2019. Exposome-wide association study
    of semen quality: Systematic discovery of endocrine disrupting chemical biomarkers in
    fertility require large sample sizes. Environ. Int. 125, 505–514.
    https://doi.org/10.1016/j.envint.2018.11.037
Claeskens, G., Hjort, N.L., 2008. Model Selection and Model Averaging. Cambridge Books.
Courvoisier, D.S., Combescure, C., Agoritsas, T., Gayet-Ageron, A., Perneger, T. V., 2011.
    Performance of logistic regression modeling: Beyond the number of events per variable, the
    role of data structure. J. Clin. Epidemiol. 64, 993–1000.
    https://doi.org/10.1016/j.jclinepi.2010.11.012
Crews, D., Gore, A.C., 2011. Life imprints: living in a contaminated world. Environ. Health
    Perspect. 119, 1208–10. https://doi.org/10.1289/ehp.1103451

                                                220


Dadvand, P., Ostro, B., Figueras, F., Foraster, M., Basagaña, X., Valentín, A., Martinez, D.,
    Beelen, R., Cirach, M., Hoek, G., Jerrett, M., Brunekreef, B., Nieuwenhuijsen, M.J., 2014.
    Residential proximity to major roads and term low birth weight: The roles of air pollution,
    heat, noise, and road-adjacent trees. Epidemiology.
    https://doi.org/10.1097/EDE.0000000000000107
Damiani, G., Bragazzi, N.L., McCormick, T.S., Pigatto, P.D.M., Leone, S., Pacifico, A.,
   Tiodorovic, D., Di Franco, S., Alfieri, A., Fiore, M., 2020. Gut microbiota and nutrient
   interactions with skin in psoriasis: A comprehensive review of animal and human studies.
   World J. Clin. Cases 8, 1002–1012. https://doi.org/10.12998/wjcc.v8.i6.1002
de Onis, M., Onyango, A.W., Borghi, E., Siyam, A., Nishida, C., Siekmann, J., 2007.
    Development of a WHO growth reference for school-aged children and adolescents. Bull.
    World Health Organ. 85, 660–7.
DeSocio, J.E., 2018. Epigenetics, maternal prenatal psychosocial stress, and infant mental health.
    Arch. Psychiatr. Nurs. 32, 901–906. https://doi.org/10.1016/j.apnu.2018.09.001
Donoho, D., Jin, J., 2008. Higher criticism thresholding: Optimal feature selection when useful
   features are rare and weak. Proc. Natl. Acad. Sci. U. S. A. 105, 14790–14795.
   https://doi.org/10.1073/pnas.0807471105
Dunkel Schetter, C., Tanner, L., 2012. Anxiety, depression and stress in pregnancy: Implications
   for mothers, children, research, and practice. Curr. Opin. Psychiatry.
   https://doi.org/10.1097/YCO.0b013e3283503680
Dunn, O.J., 1961. Multiple Comparisons among Means. J. Am. Stat. Assoc. 56, 52–64.
   https://doi.org/10.1080/01621459.1961.10482090
Efron, B., Tibshirani, R.J., 1993. An introduction to Bootstrap. An Introd. to Bootstrap.
Elisseeff, A., 2005. Stability of Randomized Learning Algorithms. J. Mach. Learn. Res. 6, 55–79.
Fan, J., Lv, J., 2010. A Selective Overview of Variable Selection in High Dimensional Feature
     Space. Stat. Sin. 20, 101–148.
Fan, Y., Demirkaya, E., Lv, J., 2019. Nonuniformity of p-values can occur early in diverging
     dimensions. J. Mach. Learn. Res. 20, 1–33.
Fasanelli, F., Baglietto, L., Ponzi, E., Guida, F., Campanella, G., Johansson, Mattias, Grankvist,
     K., Johansson, Mikael, Assumma, M.B., Naccarati, A., Chadeau-Hyam, M., Ala, U., Faltus,
     C., Kaaks, R., Risch, A., De Stavola, B., Hodge, A., Giles, G.G., Southey, M.C., Relton, C.L.,
     Haycock, P.C., Lund, E., Polidoro, S., Sandanger, T.M., Severi, G., Vineis, P., 2015.
     Hypomethylation of smoking-related genes is associated with future lung cancer in four
     prospective cohorts. Nat. Commun. 6, 10192. https://doi.org/10.1038/ncomms10192
Feil, R., Fraga, M.F., 2012. Epigenetics and the environment: emerging patterns and implications.
      Nat. Rev. Genet. 13, 97–109. https://doi.org/10.1038/nrg3142
Finucane, M.M., Stevens, G.A., Cowan, M.J., Danaei, G., Lin, J.K., Paciorek, C.J., Singh, G.M.,
     Gutierrez, H.R., Lu, Y., Bahalim, A.N., Farzadfar, F., Riley, L.M., Ezzati, M., 2011. National,
     regional, and global trends in body-mass index since 1980: systematic analysis of health
     examination surveys and epidemiological studies with 960 country-years and 9·1 million
     participants. Lancet 377, 557–567. https://doi.org/10.1016/S0140-6736(10)62037-5
Forns, J., Mandal, S., Iszatt, N., Polder, A., Thomsen, C., Lyche, J.L., Stigum, H., Vermeulen, R.,
    Eggesbø, M., 2016. Novel application of statistical methods for analysis of multiple

                                                221


     toxicants identifies DDT as a risk factor for early child behavioral problems. Environ. Res.
     151, 91–100. https://doi.org/10.1016/j.envres.2016.07.014
Friedman, J., Hastie, T., Tibshirani, R., 2010. Regularization Paths for Generalized Linear Models
     via Coordinate Descent. J. Stat. Softw. 33, 1–22. https://doi.org/10.18637/jss.v033.i01
Friedman, J., Hastie, T., Tibshirani, R., Simon, N., Narasimhan, B., Qian, J., 2019. Package ‘
     glmnet .’
Gakidou, E., Afshin, A., Abajobir, A.A., Abate, K.H., Abbafati, C., Abbas, K.M., Abd-Allah, F.,
    Abdulle, A.M., Abera, S.F., Aboyans, V., Abu-Raddad, L.J., Abu-Rmeileh, N.M.E., Abyu,
    G.Y., Adedeji, I.A., Adetokunboh, O., Afarideh, M., Agrawal, A., Agrawal, S., Ahmad
    Kiadaliri, A., Ahmadieh, H., Ahmed, M.B., Aichour, A.N., Aichour, I., Aichour, M.T.E.,
    Akinyemi, R.O., Akseer, N., Alahdab, F., Al-Aly, Z., Alam, K., Alam, N., Alam, T.,
    Alasfoor, D., Alene, K.A., Ali, K., Alizadeh-Navaei, R., Alkerwi, A., Alla, F., Allebeck, P.,
    Al-Raddadi, R., Alsharif, U., Altirkawi, K.A., Alvis-Guzman, N., Amare, A.T., Amini, E.,
    Ammar, W., Amoako, Y.A., Ansari, H., Antó, J.M., Antonio, C.A.T., Anwari, P., Arian, N.,
    Ärnlöv, J., Artaman, A., Aryal, K.K., Asayesh, H., Asgedom, S.W., Atey, T.M., Avila-Burgos,
    L., Avokpaho, E.F.G.A., Awasthi, A., Azzopardi, P., Bacha, U., Badawi, A., Balakrishnan,
    K., Ballew, S.H., Barac, A., Barber, R.M., Barker-Collo, S.L., Bärnighausen, T., Barquera, S.,
    Barregard, L., Barrero, L.H., Batis, C., Battle, K.E., Baune, B.T., Beardsley, J., Bedi, N.,
    Beghi, E., Bell, M.L., Bennett, D.A., Bennett, J.R., Bensenor, I.M., Berhane, A., Berhe, D.F.,
    Bernabé, E., Betsu, B.D., Beuran, M., Beyene, A.S., Bhansali, A., Bhutta, Z.A., Bikbov, B.,
    Birungi, C., Biryukov, S., Blosser, C.D., Boneya, D.J., Bou-Orm, I.R., Brauer, M.,
    Breitborde, N.J.K., Brenner, H., Brugha, T.S., Bulto, L.N.B., Baumgarner, B.R., Butt, Z.A.,
    Cahuana-Hurtado, L., Cárdenas, R., Carrero, J.J., Castañeda-Orjuela, C.A., Catalá-López, F.,
    Cercy, K., Chang, H.Y., Charlson, F.J., Chimed-Ochir, O., Chisumpa, V.H., Chitheer, A.A.,
    Christensen, H., Christopher, D.J., Cirillo, M., Cohen, A.J., Comfort, H., Cooper, C.,
    Coresh, J., Cornaby, L., Cortesi, P.A., Criqui, M.H., Crump, J.A., Dandona, L., Dandona, R.,
    Das Neves, J., Davey, G., Davitoiu, D. V., Davletov, K., De Courten, B., Degenhardt, L.,
    Deiparine, S., Dellavalle, R.P., Deribe, K., Deshpande, A., Dharmaratne, S.D., Ding, E.L.,
    Djalalinia, S., Do, H.P., Dokova, K., Doku, D.T., Dorsey, E.R., Driscoll, T.R., Dubey, M.,
    Duncan, B.B., Duncan, S., Ebert, N., Ebrahimi, H., El-Khatib, Z.Z., Enayati, A., Endries,
    A.Y., Ermakov, S.P., Erskine, H.E., Eshrati, B., Eskandarieh, S., Esteghamati, A., Estep, K.,
    Faraon, E.J.A., Farinha, C.S.E.S., Faro, A., Farzadfar, F., Fay, K., Feigin, V.L.,
    Fereshtehnejad, S.M., Fernandes, J.C., Ferrari, A.J., Feyissa, T.R., Filip, I., Fischer, F.,
    Fitzmaurice, C., Flaxman, A.D., Foigt, N., Foreman, K.J., Frostad, J.J., Fullman, N., Fürst,
    T., Furtado, J.M., Ganji, M., Garcia-Basteiro, A.L., Gebrehiwot, T.T., Geleijnse, J.M.,
    Geleto, A., Gemechu, B.L., Gesesew, H.A., Gething, P.W., Ghajar, A., Gibney, K.B., Gill,
    P.S., Gillum, R.F., Giref, A.Z., Gishu, M.D., Giussani, G., Godwin, W.W., Gona, P.N.,
    Goodridge, A., Gopalani, S.V., Goryakin, Y., Goulart, A.C., Graetz, N., Gugnani, H.C.,
    Guo, J., Gupta, R., Gupta, T., Gupta, V., Gutiérrez, R.A., Hachinski, V., Hafezi-Nejad, N.,
    Hailu, G.B., Hamadeh, R.R., Hamidi, S., Hammami, M., Handal, A.J., Hankey, G.J., Harb,
    H.L., Hareri, H.A., Hassanvand, M.S., Havmoeller, R., Hawley, C., Hay, S.I., Hedayati, M.T.,
    Hendrie, D., Heredia-Pi, I.B., Hoek, H.W., Horita, N., Hosgood, H.D., Hostiuc, S., Hoy,
    D.G., Hsairi, M., Hu, G., Huang, H., Huang, J.J., Iburg, K.M., Ikeda, C., Inoue, M., Irvine,
    C.M.S., Jackson, M.D., Jacobsen, K.H., Jahanmehr, N., Jakovljevic, M.B., Jauregui, A.,
    Javanbakht, M., Jeemon, P., Johansson, L.R.K., Johnson, C.O., Jonas, J.B., Jürisson, M.,
    Kabir, Z., Kadel, R., Kahsay, A., Kamal, R., Karch, A., Karema, C.K., Kasaeian, A.,
    Kassebaum, N.J., Kastor, A., Katikireddi, S.V., Kawakami, N., Keiyoro, P.N., Kelbore, S.G.,
    Kemmer, L., Kengne, A.P., Kesavachandran, C.N., Khader, Y.S., Khalil, I.A., Khan, E.A.,
    Khang, Y.H., Khosravi, A., Khubchandani, J., Kieling, C., Kim, D., Kim, J.Y., Kim, Y.J.,
    Kimokoti, R.W., Kinfu, Y., Kisa, A., Kissimova-Skarbek, K.A., Kivimaki, M., Knibbs, L.D.,
                                                222


Knudsen, A.K., Kopec, J.A., Kosen, S., Koul, P.A., Koyanagi, A., Kravchenko, M., Krohn,
K.J., Kromhout, H., Kuate Defo, B., Kucuk Bicer, B., Kumar, G.A., Kutz, M., Kyu, H.H.,
Lal, D.K., Lalloo, R., Lallukka, T., Lan, Q., Lansingh, V.C., Larsson, A., Lee, A., Lee, P.H.,
Leigh, J., Leung, J., Levi, M., Li, Yichong, Li, Yongmei, Liang, X., Liben, M.L., Linn, S., Liu,
P., Lodha, R., Logroscino, G., Looker, K.J., Lopez, A.D., Lorkowski, S., Lotufo, P.A.,
Lozano, R., Lunevicius, R., Macarayan, E.R.K., Magdy Abd El Razek, H., Magdy Abd El
Razek, M., Majdan, M., Majdzadeh, R., Majeed, A., Malekzadeh, R., Malhotra, R., Malta,
D.C., Mamun, A.A., Manguerra, H., Mantovani, L.G., Mapoma, C.C., Martin, R. V.,
Martinez-Raga, J., Martins-Melo, F.R., Mathur, M.R., Matsushita, K., Matzopoulos, R.,
Mazidi, M., McAlinden, C., McGrath, J.J., Mehata, S., Mehndiratta, M.M., Meier, T., Melaku,
Y.A., Memiah, P., Memish, Z.A., Mendoza, W., Mengesha, M.M., Mensah, G.A., Mensink,
G.B.M., Mereta, S.T., Meretoja, A., Meretoja, T.J., Mezgebe, H.B., Micha, R., Millear, A.,
Miller, T.R., Minnig, S., Mirarefin, M., Mirrakhimov, E.M., Misganaw, A., Mishra, S.R.,
Mohammad, K.A., Mohammed, K.E., Mohammed, S., Mohamed Ibrahim, N., Mohan,
M.B.V., Mokdad, A.H., Monasta, L., Montañez Hernandez, J.C., Montico, M., Moradi-
Lakeh, M., Moraga, P., Morawska, L., Morrison, S.D., Mountjoy-Venning, C., Mueller, U.O.,
Mullany, E.C., Muller, K., Murthy, G.V.S., Musa, K.I., Naghavi, M., Naheed, A., Nangia, V.,
Natarajan, G., Negoi, I., Negoi, R.I., Nguyen, C.T., Nguyen, G., Nguyen, M., Nguyen, Q.
Le, Nguyen, T.H., Nichols, E., Ningrum, D.N.A., Nomura, M., Nong, V.M., Norheim,
O.F., Norrving, B., Noubiap, J.J.N., Obermeyer, C.M., Ogbo, F.A., Oh, I.H., Oladimeji, O.,
Olagunju, A.T., Olagunju, T.O., Olivares, P.R., Olsen, H.E., Olusanya, B.O., Olusanya, J.O.,
Opio, J.N., Oren, E., Ortiz, A., Ota, E., Owolabi, M.O., Pa, M., Pacella, R.E., Pana, A.,
Panda, B.K., Panda-Jonas, S., Pandian, J.D., Papachristou, C., Park, E.K., Parry, C.D.,
Patten, S.B., Patton, G.C., Pereira, D.M., Perico, N., Pesudovs, K., Petzold, M., Phillips,
M.R., Pillay, J.D., Piradov, M.A., Pishgar, F., Plass, D., Pletcher, M.A., Polinder, S., Popova,
S., Poulton, R.G., Pourmalek, F., Prasad, N., Purcell, C., Qorbani, M., Radfar, A., Rafay, A.,
Rahimi-Movaghar, A., Rahimi-Movaghar, V., Rahman, M., Rahman, M.H.U., Rahman,
M.A., Rai, R.K., Rajsic, S., Ram, U., Rawaf, S., Rehm, C.D., Rehm, J., Reiner, R.C., Reitsma,
M.B., Reynales-Shigematsu, L.M., Remuzzi, G., Renzaho, A.M.N., Resnikoff, S., Rezaei, S.,
Ribeiro, A.L., Rivera, J.A., Roba, K.T., Rojas-Rueda, D., Roman, Y., Room, R., Roshandel,
G., Roth, G.A., Rothenbacher, D., Rubagotti, E., Rushton, L., Sadat, N., Safdarian, M., Safi,
S., Safiri, S., Sahathevan, R., Salama, J., Salomon, J.A., Samy, A.M., Sanabria, J.R., Sanchez-
Niño, M.D., Sánchez-Pimienta, T.G., Santomauro, D., Santos, I.S., Santric Milicevic, M.M.,
Sartorius, B., Satpathy, M., Sawhney, M., Saxena, S., Schaeffner, E., Schmidt, M.I.,
Schneider, I.J.C., Schutte, A.E., Schwebel, D.C., Schwendicke, F., Seedat, S., Sepanlou, S.G.,
Serdar, B., Servan-Mori, E.E., Shaddick, G., Shaheen, A., Shahraz, S., Shaikh, M.A., Shamah
Levy, T., Shamsipour, M., Shamsizadeh, M., Shariful Islam, S.M., Sharma, J., Sharma, R.,
She, J., Shen, J., Shi, P., Shibuya, K., Shields, C., Shiferaw, M.S., Shigematsu, M., Shin, M.J.,
Shiri, R., Shirkoohi, R., Shishani, K., Shoman, H., Shrime, M.G., Sigfusdottir, I.D., Silva,
D.A.S., Silva, J.P., Silveira, D.G.A., Singh, J.A., Singh, V., Sinha, D.N., Skiadaresi, E., Slepak,
E.L., Smith, D.L., Smith, M., Sobaih, B.H.A., Sobngwi, E., Soneji, S., Sorensen, R.J.D.,
Sposato, L.A., Sreeramareddy, C.T., Srinivasan, V., Steel, N., Stein, D.J., Steiner, C., Steinke,
S., Stokes, M.A., Strub, B., Subart, M., Sufiyan, M.B., Suliankatchi, R.A., Sur, P.J.,
Swaminathan, S., Sykes, B.L., Szoeke, C.E.I., Tabarés-Seisdedos, R., Tadakamadla, S.K.,
Takahashi, K., Takala, J.S., Tandon, N., Tanner, M., Tarekegn, Y.L., Tavakkoli, M., Tegegne,
T.K., Tehrani-Banihashemi, A., Terkawi, A.S., Tesssema, B., Thakur, J.S., Thamsuwan, O.,
Thankappan, K.R., Theis, A.M., Thomas, M.L., Thomson, A.J., Thrift, A.G., Tillmann, T.,
Tobe-Gai, R., Tobollik, M., Tollanes, M.C., Tonelli, M., Topor-Madry, R., Torre, A.,
Tortajada, M., Touvier, M., Tran, B.X., Truelsen, T., Tuem, K.B., Tuzcu, E.M., Tyrovolas,
S., Ukwaja, K.N., Uneke, C.J., Updike, R., Uthman, O.A., Van Boven, J.F.M., Van
Donkelaar, A., Varughese, S., Vasankari, T., Veerman, L.J., Venkateswaran, V.,

                                            223


     Venketasubramanian, N., Violante, F.S., Vladimirov, S.K., Vlassov, V.V., Vollset, S.E., Vos,
     T., Wadilo, F., Wakayo, T., Wallin, M.T., Wang, Y.P., Weichenthal, S., Weiderpass, E.,
     Weintraub, R.G., Weiss, D.J., Werdecker, A., Westerman, R., Whiteford, H.A., Wiysonge,
     C.S., Woldeyes, B.G., Wolfe, C.D.A., Woodbrook, R., Workicho, A., Wulf Hanson, S.,
     Xavier, D., Xu, G., Yadgir, S., Yakob, B., Yan, L.L., Yaseri, M., Yimam, H.H., Yip, P.,
     Yonemoto, N., Yoon, S.J., Yotebieng, M., Younis, M.Z., Zaidi, Z., El Sayed Zaki, M.,
     Zavala-Arciniega, L., Zhang, X., Zimsen, S.R.M., Zipkin, B., Zodpey, S., Lim, S.S., Murray,
     C.J.L., 2017. Global, regional, and national comparative risk assessment of 84 behavioural,
     environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A
     systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1345–1422.
     https://doi.org/10.1016/S0140-6736(17)32366-8
Galhardi, C.M., Diniz, Y.S., Faine, L.A., Rodrigues, H.G., Burneiko, R.C.M., Ribas, B.O., Novelli,
    E.L.B., 2004. Toxicity of copper intake: Lipid profile, oxidative stress and susceptibility to
    renal dysfunction. Food Chem. Toxicol. https://doi.org/10.1016/j.fct.2004.07.020
Gängler, S., Waldenberger, M., Artati, A., Adamski, J., van Bolhuis, J.N., Sørgjerd, E.P., van
    Vliet-Ostaptchouk, J., Makris, K.C., 2019. Exposure to disinfection byproducts and risk of
    type 2 diabetes: a nested case–control study in the HUNT and Lifelines cohorts.
    Metabolomics 15. https://doi.org/10.1007/s11306-019-1519-0
Gascon, M., Sunyer, J., Casas, M., Martínez, D., Ballester, F., Basterrechea, M., Bonde, J.P.,
    Chatzi, L., Chevrier, C., Eggesbø, M., Esplugues, A., Govarts, E., Hannu, K., Ibarluzea, J.,
    Kasper-Sonnenberg, M., Klümper, C., Koppen, G., Nieuwenhuijsen, M.J., Palkovicova, L.,
    Pelé, F., Polder, A., Schoeters, G., Torrent, M., Trnovec, T., Vassilaki, M., Vrijheid, M.,
    2014. Prenatal exposure to DDE and PCB 153 and respiratory health in early childhood: A
    meta-analysis. Epidemiology 25, 544–553.
    https://doi.org/10.1097/EDE.0000000000000097
Gascon, M., Vrijheid, M., Nieuwenhuijsen, M.J., 2016. The Built Environment and Child Health:
    An Overview of Current Evidence. Curr. Environ. Heal. reports.
    https://doi.org/10.1007/s40572-016-0094-z
Ghiara, V., 2019. Inferring causation from big data in the social sciences. Doctor of Philosophy
    (PhD) thesis, University of Kent,.
Govarts, E., Iszatt, N., Trnovec, T., de Cock, M., Eggesbø, M., Palkovicova Murinova, L., van de
    Bor, M., Guxens, M., Chevrier, C., Koppen, G., Lamoree, M., Hertz-Picciotto, I., Lopez-
    Espinosa, M.J., Lertxundi, A., Grimalt, J.O., Torrent, M., Goñi-Irigoyen, F., Vermeulen, R.,
    Legler, J., Schoeters, G., 2018. Prenatal exposure to endocrine disrupting chemicals and risk
    of being born small for gestational age: Pooled analysis of seven European birth cohorts.
    Environ. Int. 115, 267–278. https://doi.org/10.1016/j.envint.2018.03.017
Govarts, E., Remy, S., Bruckers, L., Den Hond, E., Sioen, I., Nelen, V., Baeyens, W., Nawrot,
    T.S., Loots, I., Van Larebeke, N., Schoeters, G., 2016. Combined effects of prenatal
    exposures to environmental chemicals on birth weight. Int. J. Environ. Res. Public Health
    13. https://doi.org/10.3390/ijerph13050495
Grazuleviciene, R., Danileviciute, A., Dedele, A., Vencloviene, J., Andrusaityte, S., Uždanaviciute,
    I., Nieuwenhuijsen, M.J., 2015. Surrounding greenness, proximity to city parks and
    pregnancy outcomes in Kaunas cohort study. Int. J. Hyg. Environ. Health 218, 358–365.
    https://doi.org/10.1016/j.ijheh.2015.02.004
Greene, N.D.E., Leung, K.-Y., Copp, A.J., 2017. Inositol, neural tube closure and the prevention
    of neural tube defects. Birth Defects Res. 109, 68–80. https://doi.org/10.1002/bdra.23533

                                                224


Guxens, M., Ballester, F., Espada, M., Fernández, M.F., Grimalt, J.O., Ibarluzea, J., Olea, N.,
    Rebagliato, M., Tardón, A., Torrent, M., Vioque, J., Vrijheid, M., Sunyer, J., 2012. Cohort
    Profile: The INMA—INfancia y Medio Ambiente—(Environment and Childhood) Project.
    Int. J. Epidemiol. 41, 930–940. https://doi.org/10.1093/ije/dyr054
Guyon, I., Elisseeff, A., 2003. An Introduction to Variable and Feature Selection. J. Mach. Learn.
    Res. 1157–1182.
Han, J.C., Lawlor, D.A., Kimm, S.Y., 2010. Childhood obesity. Lancet.
    https://doi.org/10.1016/S0140-6736(10)60171-7
Hansen, S., Strøm, M., Olsen, S.F., Maslova, E., Rantakokko, P., Kiviranta, H., Rytter, D., Bech,
    B.H., Hansen, L. V., Halldorsson, T.I., 2014. Maternal concentrations of persistent
    organochlorine pollutants and the risk of asthma in offspring: Results from a prospective
    cohort with 20 years of follow-up. Environ. Health Perspect. 122, 93–99.
    https://doi.org/10.1289/ehp.1206397
Haug, L.S., Sakhi, A.K., Cequier, E., Casas, M., Maitre, L., Basagana, X., Andrusaityte, S.,
    Chalkiadaki, G., Chatzi, L., Coen, M., de Bont, J., Dedele, A., Ferrand, J., Grazuleviciene, R.,
    Gonzalez, J.R., Gutzkow, K.B., Keun, H., McEachan, R., Meltzer, H.M., Petraviciene, I.,
    Robinson, O., Saulnier, P.J., Slama, R., Sunyer, J., Urquiza, J., Vafeiadi, M., Wright, J.,
    Vrijheid, M., Thomsen, C., 2018. In-utero and childhood chemical exposome in six
    European mother-child cohorts. Environ. Int. 121, 751–763.
    https://doi.org/10.1016/j.envint.2018.09.056
Heindel, J.J., Balbus, J., Birnbaum, L., Brune-Drisse, M.N., Grandjean, P., Gray, K., Landrigan,
    P.J., Sly, P.D., Suk, W., Slechta, D.C., Thompson, C., Hanson, M., 2015. Developmental
    origins of health and disease: Integrating environmental influences. Endocrinology 156,
    3416–3421. https://doi.org/10.1210/EN.2015-1394
Hernán, M.A., Hernández-Díaz, S., Robins, J.M., 2004. A structural approach to selection bias.
    Epidemiology 15, 615–625. https://doi.org/10.1097/01.ede.0000135174.63482.43
Hernán, M.A., Hsu, J., Healy, B., 2019. A Second Chance to Get Causal Inference Right: A
    Classification of Data Science Tasks, Chance.
    https://doi.org/10.1080/09332480.2019.1579578
Heude, Barbara, Forhan, Anne, Slama, Rémy, Douhaud, L., Bedel, S., Saurel-Cubizolles, M.-J.,
    Hankard, Régis, Thiebaugeorges, Olivier, De Agostini, Maria, Annesi-Maesano, Isabella,
    Kaminski, Monique, Charles, Marie-Aline, Annesi-Maesano, I, Bernard, J., Botton, J.,
    Charles, M-A, Dargent-Molina, P., de Lauzon-Guillain, B., Ducimetière, P., de Agostini, M,
    Foliguet, B., Forhan, A, Fritel, X., Germa, A., Goua, V., Hankard, R, Heude, B, Kaminski,
    M, Larroque, B., Lelong, N., Lepeule, J., Magnin, G., Marchand, L., Nabet, C., Pierre, F.,
    Slama, R, Saurel-Cubizolles, M., Schweitzer, M., Thiebaugeorges, O, 2016. Cohort Profile:
    The EDEN mother-child cohort on the prenatal and early postnatal determinants of child
    health and development. Int. J. Epidemiol. 45, 353–363.
    https://doi.org/10.1093/ije/dyv151
Hill, A.B., Doll, R., 1950. Smoking and carcinoma of the lung preliminary report. Br. Med. J. 2,
      739–748. https://doi.org/10.1136/bmj.2.4682.739
Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., Leung, Y.-K., 2012.
     Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes.
     ILAR J. 53, 289–305. https://doi.org/10.1093/ilar.53.3-4.289
Hoerl, A.E., Kennard, R.W., 1970. Ridge Regression: Applications to Nonorthogonal Problems.

                                                225


     Technometrics 12, 69. https://doi.org/10.2307/1267352
Hofhuis, W., de Jongste, J.C., Merkus, P.J.F.M., 2003. Adverse health effects of prenatal and
    postnatal tobacco smoke exposure on children. Arch. Dis. Child. 88, 1086–1090.
    https://doi.org/10.1136/adc.88.12.1086
Holtcamp, W., 2012. Obesogens: an environmental link to obesity. Environ. Health Perspect.
     120, a62-8. https://doi.org/10.1289/ehp.120-a62
Höskuldsson, A., 1988. PLS regression methods. J. Chemom. 2, 211–228.
    https://doi.org/10.1002/cem.1180020306
Houle, M.E., Kriegel, H.P., Kröger, P., Schubert, E., Zimek, A., 2010. Can shared-neighbor
    distances defeat the curse of dimensionality?, in: Lecture Notes in Computer Science
    (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in
    Bioinformatics). Springer, Berlin, Heidelberg, pp. 482–500. https://doi.org/10.1007/978-3-
    642-13818-8_34
Huang, R., Chen, Q., Zhang, L., Luo, K., Chen, L., Zhao, S., Feng, L., Zhang, J., 2019. Prenatal
    exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive
    disorders of pregnancy. Environ. Heal. A Glob. Access Sci. Source 18, 5.
    https://doi.org/10.1186/s12940-018-0445-3
Hume, D., 1740. An Abstract of a Book lately Published: Entitled A Treatise of Human Nature.
Janesick, A., Blumberg, B., 2011. Endocrine disrupting chemicals and the developmental
     programming of adipogenesis and obesity. Birth Defects Res. Part C Embryo Today Rev.
     93, 34–50. https://doi.org/10.1002/bdrc.20197
Jeong, A., Fiorito, G., Keski-Rahkonen, P., Imboden, M., Kiss, A., Robinot, N., Gmuender, H.,
     Vlaanderen, J., Vermeulen, R., Kyrtopoulos, S., Herceg, Z., Ghantous, A., Lovison, G.,
     Galassi, C., Ranzi, A., Krogh, V., Grioni, S., Agnoli, C., Sacerdote, C., Mostafavi, N.,
     Naccarati, A., Scalbert, A., Vineis, P., Probst-Hensch, N., 2018. Perturbation of metabolic
     pathways mediates the association of air pollutants with asthma and cardiovascular diseases.
     Environ. Int. 119, 334–345. https://doi.org/10.1016/J.ENVINT.2018.06.025
Joubert, B.R., Felix, J.F., Yousefi, P., Bakulski, K.M., Just, A.C., Breton, C., Reese, S.E.,
    Markunas, C.A., Richmond, R.C., Xu, C.J., Küpers, L.K., Oh, S.S., Hoyo, C., Gruzieva, O.,
    Söderhäll, C., Salas, L.A., Baïz, N., Zhang, H., Lepeule, J., Ruiz, C., Ligthart, S., Wang, T.,
    Taylor, J.A., Duijts, L., Sharp, G.C., Jankipersadsing, S.A., Nilsen, R.M., Vaez, A., Fallin,
    M.D., Hu, D., Litonjua, A.A., Fuemmeler, B.F., Huen, K., Kere, J., Kull, I., Munthe-Kaas,
    M.C., Gehring, U., Bustamante, M., Saurel-Coubizolles, M.J., Quraishi, B.M., Ren, J., Tost,
    J., Gonzalez, J.R., Peters, M.J., Håberg, S.E., Xu, Z., Van Meurs, J.B., Gaunt, T.R., Kerkhof,
    M., Corpeleijn, E., Feinberg, A.P., Eng, C., Baccarelli, A.A., Benjamin Neelon, S.E.,
    Bradman, A., Merid, S.K., Bergström, A., Herceg, Z., Hernandez-Vargas, H., Brunekreef, B.,
    Pinart, M., Heude, B., Ewart, S., Yao, J., Lemonnier, N., Franco, O.H., Wu, M.C., Hofman,
    A., McArdle, W., Van Der Vlies, P., Falahi, F., Gillman, M.W., Barcellos, L.F., Kumar, A.,
    Wickman, M., Guerra, S., Charles, M.A., Holloway, J., Auffray, C., Tiemeier, H.W., Smith,
    G.D., Postma, D., Hivert, M.F., Eskenazi, B., Vrijheid, M., Arshad, H., Antó, J.M.,
    Dehghan, A., Karmaus, W., Annesi-Maesano, I., Sunyer, J., Ghantous, A., Pershagen, G.,
    Holland, N., Murphy, S.K., Demeo, D.L., Burchard, E.G., Ladd-Acosta, C., Snieder, H.,
    Nystad, W., Koppelman, G.H., Relton, C.L., Jaddoe, V.W.V., Wilcox, A., Melén, E.,
    London, S.J., 2016. DNA Methylation in Newborns and Maternal Smoking in Pregnancy:
    Genome-wide Consortium Meta-analysis. Am. J. Hum. Genet. 98, 680–696.
    https://doi.org/10.1016/j.ajhg.2016.02.019

                                               226


Khan, M.H.R., Bhadra, A., Howlader, T., 2016. Stability Selection for Lasso, Ridge and Elastic
    Net Implemented with AFT Models.
Kindlund, K., Thomsen, S.F., Stensballe, L.G., Skytthe, A., Kyvik, K.O., Backer, V., Bisgaard, H.,
    2010. Birth weight and risk of asthma in 3 - 9-year-old twins: Exploring the fetal origins
    hypothesis. Thorax 65, 146–149. https://doi.org/10.1136/thx.2009.117101
Kreiner-Møller, E., Bisgaard, H., Bønnelykke, K., 2014. Prenatal and postnatal genetic influence
     on lung function development. J. Allergy Clin. Immunol. 134, 1036-1042.e15.
     https://doi.org/10.1016/j.jaci.2014.04.003
Krstajic, D., Buturovic, L.J., Leahy, D.E., Thomas, S., 2014. Cross-validation pitfalls when
     selecting and assessing regression and classification models. J. Cheminform. 6, 1–15.
     https://doi.org/10.1186/1758-2946-6-10
Küpers, L.K., Monnereau, C., Sharp, G.C., Yousefi, P., Salas, L.A., Ghantous, A., Page, C.M.,
    Reese, S.E., Wilcox, A.J., Czamara, D., Starling, A.P., Novoloaca, A., Lent, S., Roy, R.,
    Hoyo, C., Breton, C. V., Allard, C., Just, A.C., Bakulski, K.M., Holloway, J.W., Everson,
    T.M., Xu, C.J., Huang, R.C., van der Plaat, D.A., Wielscher, M., Merid, S.K., Ullemar, V.,
    Rezwan, F.I., Lahti, J., van Dongen, J., Langie, S.A.S., Richardson, T.G., Magnus, M.C.,
    Nohr, E.A., Xu, Z., Duijts, L., Zhao, S., Zhang, W., Plusquin, M., DeMeo, D.L., Solomon,
    O., Heimovaara, J.H., Jima, D.D., Gao, L., Bustamante, M., Perron, P., Wright, R.O., Hertz-
    Picciotto, I., Zhang, H., Karagas, M.R., Gehring, U., Marsit, C.J., Beilin, L.J., Vonk, J.M.,
    Jarvelin, M.R., Bergström, A., Örtqvist, A.K., Ewart, S., Villa, P.M., Moore, S.E., Willemsen,
    G., Standaert, A.R.L., Håberg, S.E., Sørensen, T.I.A., Taylor, J.A., Räikkönen, K., Yang, I.
    V., Kechris, K., Nawrot, T.S., Silver, M.J., Gong, Y.Y., Richiardi, L., Kogevinas, M.,
    Litonjua, A.A., Eskenazi, B., Huen, K., Mbarek, H., Maguire, R.L., Dwyer, T., Vrijheid, M.,
    Bouchard, L., Baccarelli, A.A., Croen, L.A., Karmaus, W., Anderson, D., de Vries, M.,
    Sebert, S., Kere, J., Karlsson, R., Arshad, S.H., Hämäläinen, E., Routledge, M.N., Boomsma,
    D.I., Feinberg, A.P., Newschaffer, C.J., Govarts, E., Moisse, M., Fallin, M.D., Melén, E.,
    Prentice, A.M., Kajantie, E., Almqvist, C., Oken, E., Dabelea, D., Boezen, H.M., Melton,
    P.E., Wright, R.J., Koppelman, G.H., Trevisi, L., Hivert, M.F., Sunyer, J., Munthe-Kaas,
    M.C., Murphy, S.K., Corpeleijn, E., Wiemels, J., Holland, N., Herceg, Z., Binder, E.B.,
    Davey Smith, G., Jaddoe, V.W.V., Lie, R.T., Nystad, W., London, S.J., Lawlor, D.A., Relton,
    C.L., Snieder, H., Felix, J.F., 2019. Meta-analysis of epigenome-wide association studies in
    neonates reveals widespread differential DNA methylation associated with birthweight. Nat.
    Commun. 10, 1–11. https://doi.org/10.1038/s41467-019-09671-3
Küpers, L.K., Xu, X., Jankipersadsing, S.A., Vaez, A., La Bastide-van Gemert, S., Scholtens, S.,
    Nolte, I.M., Richmond, R.C., Relton, C.L., Felix, J.F., Duijts, L., Van Meurs, J.B., Tiemeier,
    H., Jaddoe, V.W., Wang, X., Corpeleijn, E., Snieder, H., 2015. DNA methylation mediates
    the effect of maternal smoking during pregnancy on birthweight of the offspring. Int. J.
    Epidemiol. 44, 1224–1237. https://doi.org/10.1093/ije/dyv048
Lachowycz, K., Jones, A.P., 2011. Greenspace and obesity: A systematic review of the evidence.
    Obes. Rev. 12. https://doi.org/10.1111/j.1467-789X.2010.00827.x
Landeira, D., Bagci, H., Malinowski, A.R., Brown, K.E., Soza-Ried, J., Feytout, A., Webster, Z.,
    Ndjetehe, E., Cantone, I., Asenjo, H.G., Brockdorff, N., Carroll, T., Merkenschlager, M.,
    Fisher, A.G., 2015. Jarid2 coordinates Nanog expression and PCP/Wnt signaling required
    for efficient ESC differentiation and early embryo development. Cell Rep. 12, 573–586.
    https://doi.org/10.1016/j.celrep.2015.06.060
Latzin, P., Röösli, M., Huss, A., Kuehni, C.E., Frey, U., 2009. Air pollution during pregnancy and
     lung function in newborns: A birth cohort study. Eur. Respir. J. 33, 594–603.
                                                227


     https://doi.org/10.1183/09031936.00084008
Lazarevic, N., Barnett, A.G., Sly, P.D., Knibbs, L.D., 2019. Statistical methodology in studies of
     prenatal exposure to mixtures of endocrine-disrupting chemicals: A review of existing
     approaches and new alternatives. Environ. Health Perspect. 127, 26001.
     https://doi.org/10.1289/EHP2207
Lee, H.W., Lawton, C., Na, Y.J., Yoon, S., 2013. Robustness of chemometrics-based feature
     selection methods in early cancer detection and biomarker discovery. Stat. Appl. Genet.
     Mol. Biol. 12, 207–223. https://doi.org/10.1515/sagmb-2012-0067
Leng, C., Lin, Y., Wahba, G., 2006. a Note on the Lasso and Related Procedures. Stat. Sin. 16,
    1273–1284.
Lenters, V., Portengen, L., Rignell-Hydbom, A., Jönsson, B.A.G., Lindh, C.H., Piersma, A.H.,
     Toft, G., Bonde, J.P., Heederik, D., Rylander, L., Vermeulen, R., 2016. Prenatal phthalate,
     perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth
     cohorts: Multi-pollutant models based on elastic net regression. Environ. Health Perspect.
     124, 365–372. https://doi.org/10.1289/ehp.1408933
Lenters, V., Portengen, L., Smit, L.A.M., Jönsson, B.A.G., Giwercman, A., Rylander, L., Lindh,
     C.H., Spanò, M., Pedersen, H.S., Ludwicki, J.K., Chumak, L., Piersma, A.H., Toft, G.,
     Bonde, J.P., Heederik, D., Vermeulen, R., 2015. Phthalates, perfluoroalkyl acids, metals and
     organochlorines and reproductive function: A multipollutant assessment in Greenlandic,
     Polish and Ukrainian men. Occup. Environ. Med. 72, 385–393.
     https://doi.org/10.1136/oemed-2014-102264
Lenters, V., Vermeulen, R., Portengen, L., 2018. Performance of variable selection methods for
     assessing the health effects of correlated exposures in case-control studies. Occup. Environ.
     Med. 75, 522–529. https://doi.org/10.1136/oemed-2016-104231
Leonelli, S., 2014. What difference does quantity make? On the epistemology of Big Data in
    biology. Big Data Soc. 1, 205395171453439. https://doi.org/10.1177/2053951714534395
Li, M.-X., Yeung, J.M.Y., Cherny, S.S., Sham, P.C., 2012. Evaluating the effective numbers of
     independent tests and significant p-value thresholds in commercial genotyping arrays and
     public imputation reference datasets. Hum. Genet. 131, 747–56.
     https://doi.org/10.1007/s00439-011-1118-2
Li, X., Hawkins, G.A., Ampleford, E.J., Moore, W.C., Li, H., Hastie, A.T., Howard, T.D.,
     Boushey, H.A., Busse, W.W., Calhoun, W.J., Castro, M., Erzurum, S.C., Israel, E.,
     Lemanske, R.F., Szefler, S.J., Wasserman, S.I., Wenzel, S.E., Peters, S.P., Meyers, D.A.,
     Bleecker, E.R., Bleecker, E.R., 2013. Genome-wide association study identifies TH1
     pathway genes associated with lung function in asthmatic patients. J. Allergy Clin. Immunol.
     132, 313–20.e15. https://doi.org/10.1016/j.jaci.2013.01.051
Lim, C., Yu, B., 2016. Estimation Stability With Cross-Validation (ESCV). J. Comput. Graph.
     Stat. 25, 464–492. https://doi.org/10.1080/10618600.2015.1020159
Little, R.E., 1977. Moderate alcohol use during pregnancy and decreased infant birth weight. Am.
      J. Public Health 67, 1154–1156. https://doi.org/10.2105/AJPH.67.12.1154
Louis, G.M.B., Sundaram, R., Schisterman, E.F., Sweeney, A.M., Lynch, C.D., Gore-Langton,
     R.E., Maisog, J., Kim, S., Chen, Z., Barr, D.B., 2013. Persistent Environmental Pollutants
     and Couple Fecundity: The LIFE Study. Environ. Health Perspect. 121, 231–236.
     https://doi.org/10.1289/ehp.1205301

                                                228


Lyon-Caen, S., Siroux, V., Lepeule, J., Lorimier, P., Hainaut, P., Mossuz, P., Quentin, J.,
    Supernant, K., Meary, D., Chaperot, L., Bayat, S., Cassee, F., Valentino, S., Couturier-
    Tarrade, A., Rousseau-Ralliard, D., Chavatte-Palmer, P., Philippat, C., Pin, I., Slama, R.,
    2019. Deciphering the impact of early-life exposures to highly variable environmental
    factors on foetal and child health: Design of SEPAGES couple-child cohort. Int. J. Environ.
    Res. Public Health 16. https://doi.org/10.3390/ijerph16203888
MacKinnon, D.P., Lockwood, C.M., Hoffman, J.M., West, S.G., Sheets, V., 2002. A comparison
   of methods to test mediation and other intervening variable effects. Psychol. Methods 7,
   83–104.
Magnus, P., Birke, C., Vejrup, K., Haugan, A., Alsaker, E., Daltveit, A.K., Handal, M., Haugen,
    M., Høiseth, G., Knudsen, G.P., Paltiel, L., Schreuder, P., Tambs, K., Vold, L., Stoltenberg,
    C., 2016. Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa).
    Int. J. Epidemiol. 45, 382–388. https://doi.org/10.1093/ije/dyw029
Magurran, A., 2004. Measuring biological diversity. Blackwell Publ. Oxford, UK.
Maitre, L., de Bont, J., Casas, M., Robinson, O., Aasvang, G.M., Agier, L., Andrušaitytė, S.,
     Ballester, F., Basagaña, X., Borràs, E., Brochot, C., Bustamante, M., Carracedo, A., de
     Castro, M., Dedele, A., Donaire-Gonzalez, D., Estivill, X., Evandt, J., Fossati, S., Giorgis-
     Allemand, L., R Gonzalez, J., Granum, B., Grazuleviciene, R., Bjerve Gützkow, K.,
     Småstuen Haug, L., Hernandez-Ferrer, C., Heude, B., Ibarluzea, J., Julvez, J., Karachaliou,
     M., Keun, H.C., Hjertager Krog, N., Lau, C.-H.E., Leventakou, V., Lyon-Caen, S.,
     Manzano, C., Mason, D., McEachan, R., Meltzer, H.M., Petraviciene, I., Quentin, J.,
     Roumeliotaki, T., Sabido, E., Saulnier, P.-J., Siskos, A.P., Siroux, V., Sunyer, J., Tamayo, I.,
     Urquiza, J., Vafeiadi, M., van Gent, D., Vives-Usano, M., Waiblinger, D., Warembourg, C.,
     Chatzi, L., Coen, M., van den Hazel, P., Nieuwenhuijsen, M.J., Slama, R., Thomsen, C.,
     Wright, J., Vrijheid, M., 2018. Human Early Life Exposome (HELIX) study: a European
     population-based exposome cohort. BMJ Open 8, e021311.
     https://doi.org/10.1136/bmjopen-2017-021311
Manrai, A.K., Cui, Y., Bushel, P.R., Hall, M., Karakitsios, S., Mattingly, C.J., Ritchie, M., Schmitt,
    C., Sarigiannis, D.A., Thomas, D.C., Wishart, D., Balshaw, D.M., Patel, C.J., 2017.
    Informatics and Data Analytics to Support Exposome-Based Discovery for Public Health.
    Annu. Rev. Public Heal. 38, 279–94. https://doi.org/10.1146/annurev-publhealth
Marioni, R.E., McRae, A.F., Bressler, J., Colicino, E., Hannon, E., Li, S., Prada, D., Smith, J.A.,
    Trevisi, L., Tsai, P.-C., Vojinovic, D., Simino, J., Levy, D., Liu, C., Mendelson, M., Satizabal,
    C.L., Yang, Q., Jhun, M.A., Kardia, S.L.R., Zhao, W., Bandinelli, S., Ferrucci, L., Hernandez,
    D.G., Singleton, A.B., Harris, S.E., Starr, J.M., Kiel, D.P., McLean, R.R., Just, A.C.,
    Schwartz, J., Spiro, A., Vokonas, P., Amin, N., Ikram, M.A., Uitterlinden, A.G., van Meurs,
    J.B.J., Spector, T.D., Steves, C., Baccarelli, A.A., Bell, J.T., van Duijn, C.M., Fornage, M.,
    Hsu, Y.-H., Mill, J., Mosley, T.H., Seshadri, S., Deary, I.J., 2018. Meta-analysis of
    epigenome-wide association studies of cognitive abilities. Mol. Psychiatry 1.
    https://doi.org/10.1038/s41380-017-0008-y
Mayer-Schönberger, V., Cukier, K., 2013. Big Data: A Revolution that Will Transform How We
    Live, Work and Think. London, UK John Murray.
McAllister, E.J., Dhurandhar, N. V., Keith, S.W., Aronne, L.J., Barger, J., Baskin, M., Benca,
   R.M., Biggio, J., Boggiano, M.M., Eisenmann, J.C., Elobeid, M., Fontaine, K.R., Gluckman,
   P., Hanlon, E.C., Katzmarzyk, P., Pietrobelli, A., Redden, D.T., Ruden, D.M., Wang, C.,
   Waterland, R.A., Wright, S.M., Allison, D.B., 2009. Ten putative contributors to the obesity
   epidemic. Crit. Rev. Food Sci. Nutr. 49, 868–913.
                                                 229


     https://doi.org/10.1080/10408390903372599
Meinshausen, N., Bühlmann, P., 2010. Stability selection. J. R. Stat. Soc. Ser. B Stat. Methodol.
    72, 417–473. https://doi.org/10.1111/j.1467-9868.2010.00740.x
Michalowsky, L.A., Jones, P.A., 1989. DNA methylation and differentiation. Environ. Health
    Perspect. 80, 189–197. https://doi.org/10.1289/ehp.8980189
Mills, J.L., Graubard, B.I., Harley, E.E., Rhoads, G.G., Berendes, H.W., 1984. Maternal Alcohol
      Consumption and Birth Weight: How Much Drinking During Pregnancy Is Safe? JAMA J.
      Am. Med. Assoc. 252, 1875–1879. https://doi.org/10.1001/jama.1984.03350140021018
Mubeen, S., Hoyt, C.T., Gemünd, A., Hofmann-Apitius, M., Fröhlich, H., Domingo-Fernández,
   D., 2019. The Impact of Pathway Database Choice on Statistical Enrichment Analysis and
   Predictive Modeling. Front. Genet. 10, 1203. https://doi.org/10.3389/fgene.2019.01203
Mustieles, V., Fernández, M.F., Martin-Olmedo, P., González-Alzaga, B., Fontalba-Navas, A.,
    Hauser, R., Olea, N., Arrebola, J.P., 2017. Human adipose tissue levels of persistent organic
    pollutants and metabolic syndrome components: Combining a cross-sectional with a 10-year
    longitudinal study using a multi-pollutant approach. Environ. Int. 104, 48–57.
    https://doi.org/10.1016/j.envint.2017.04.002
Nieuwenhuijsen, M.J., Agier, L., Basagaña, X., Urquiza, J., Tamayo-Uria, I., Giorgis-Allemand, L.,
    Robinson, O., Siroux, V., Maitre, L., de Castro, M., Valentin, A., Donaire, D., Dadvand, P.,
    Aasvang, G.M., Krog, N.H., Schwarze, P.E., Chatzi, L., Grazuleviciene, R., Andrusaityte, S.,
    Dedele, A., McEachan, R., Wright, J., West, J., Ibarluzea, J., Ballester, F., Vrijheid, M.,
    Slama, R., 2019. Influence of the Urban Exposome on Birth Weight. Environ. Health
    Perspect. 127, 047007. https://doi.org/10.1289/EHP3971
Nogueira, S., Sechidis, K., Brown, G., 2017. On the Stability of Feature Selection Algorithms. J.
    Mach. Learn. Res. 18, 6345–6398. https://doi.org/18(174):1−54
Park, M.H., Falconer, C., Viner, R.M., Kinra, S., 2012. The impact of childhood obesity on
     morbidity and mortality in adulthood: A systematic review. Obes. Rev. 13, 985–1000.
     https://doi.org/10.1111/j.1467-789X.2012.01015.x
Park, S.S., Skaar, D.A., Jirtle, R.L., Hoyo, C., 2017. Epigenetics, obesity and early-life cadmium or
     lead exposure. Epigenomics 9, 57–75. https://doi.org/10.2217/epi-2016-0047
Parker, J.D., Woodruff, T.J., Basu, R., Schoendorf, K.C., 2005. Air pollution and birth weight
     among term infants in California. Pediatrics 115, 121–128.
     https://doi.org/10.1542/peds.2004-0889
Parkhomenko, E., Tritchler, D., Beyene, J., 2007. Genome-wide sparse canonical correlation of
    gene expression with genotypes. BMC Proc. 1, S119. https://doi.org/10.1186/1753-6561-1-
    s1-s119
Patel, C.J., 2017. Analytic Complexity and Challenges in Identifying Mixtures of Exposures
     Associated with Phenotypes in the Exposome Era. Curr. Epidemiol. Reports 4, 22–30.
     https://doi.org/10.1007/s40471-017-0100-5
Patel, C.J., Bhattacharya, J., Butte, A.J., Zeggini, E., Freathy, R., 2010. An Environment-Wide
     Association Study (EWAS) on Type 2 Diabetes Mellitus. PLoS One 5, e10746.
     https://doi.org/10.1371/journal.pone.0010746
Patel, C.J., Rehkopf, D.H., Leppert, J.T., Bortz, W.M., Cullen, M.R., Chertow, G.M., Ioannidis,
     J.P.A., 2013. Systematic evaluation of environmental and behavioural factors associated with

                                                230


     all-cause mortality in the united states national health and nutrition examination survey. Int.
     J. Epidemiol. 42, 1795–1810. https://doi.org/10.1093/ije/dyt208
Patel, C.J., Sundaram, R., Buck Louis, G.M., 2017. A data-driven search for semen-related
     phenotypes in conception delay. Andrology 5, 95–102. https://doi.org/10.1111/andr.12288
Pavlidis, P., Qin, J., Arango, V., Mann, J.J., Sibille, E., 2004. Using the Gene Ontology for
     Microarray Data Mining: A Comparison of Methods and Application to Age Effects in
     Human Prefrontal Cortex. Neurochem. Res. 29, 1213–1222.
     https://doi.org/10.1023/B:NERE.0000023608.29741.45
Pearl, J., 2009. Causal inference in statistics: An overview. Stat. Surv. 3, 96–146.
     https://doi.org/10.1214/09-ss057
Pearl, J., 1995. Causal diagrams for empirical research. Biometrika 82, 669–688.
     https://doi.org/10.1093/biomet/82.4.669
Pedersen, M., Giorgis-Allemand, L., Bernard, C., Aguilera, I., Andersen, A.M.N., Ballester, F.,
    Beelen, R.M.J., Chatzi, L., Cirach, M., Danileviciute, A., Dedele, A., Eijsden, M. van,
    Estarlich, M., Fernández-Somoano, A., Fernández, M.F., Forastiere, F., Gehring, U.,
    Grazuleviciene, R., Gruzieva, O., Heude, B., Hoek, G., Hoogh, K. de, van den Hooven,
    E.H., Håberg, S.E., Jaddoe, V.W.V., Klümper, C., Korek, M., Krämer, U., Lerchundi, A.,
    Lepeule, J., Nafstad, P., Nystad, W., Patelarou, E., Porta, D., Postma, D., Raaschou-Nielsen,
    O., Rudnai, P., Sunyer, J., Stephanou, E., Sørensen, M., Thiering, E., Tuffnell, D., Varró,
    M.J., Vrijkotte, T.G.M., Wijga, A., Wilhelm, M., Wright, J., Nieuwenhuijsen, M.J., Pershagen,
    G., Brunekreef, B., Kogevinas, M., Slama, R., 2013. Ambient air pollution and low
    birthweight: A European cohort study (ESCAPE). Lancet Respir. Med. 1, 695–704.
    https://doi.org/10.1016/S2213-2600(13)70192-9
Pereira, T.C.B., Campos, M.M., Bogo, M.R., 2016. Copper toxicology, oxidative stress and
     inflammation using zebrafish as experimental model. J. Appl. Toxicol. 36, 876–885.
     https://doi.org/10.1002/jat.3303
Philippat, C., Heude, B., Botton, J., Alfaidy, N., Calafat, A.M., Slama, R., Group, the E.M.C.S.,
     2019. Prenatal Exposure to Select Phthalates and Phenols and Associations with Fetal and
     Placental Weight among Male Births in the EDEN Cohort (France). Environ. Health
     Perspect. 127, 017002. https://doi.org/10.1289/EHP3523
Poggio, T., Rifkin, R., Mukherjee, S., Niyogi, P., 2004. General conditions for predictivity in
    learning theory. Nature 428, 419–422. https://doi.org/10.1038/nature02341
Qin, X. Di, Qian, Z. (Min), Dharmage, S.C., Perret, J., Geiger, S.D., Rigdon, S.E., Howard, S.,
     Zeng, X.W., Hu, L.W., Yang, B.Y., Zhou, Y., Li, M., Xu, S.L., Bao, W.W., Zhang, Y.Z.,
     Yuan, P., Wang, J., Zhang, C., Tian, Y.P., Nian, M., Xiao, X., Chen, W., Lee, Y.L., Dong,
     G.H., 2017. Association of perfluoroalkyl substances exposure with impaired lung function
     in children. Environ. Res. 155, 15–21. https://doi.org/10.1016/j.envres.2017.01.025
Quanjer, P.H., Stanojevic, S., Cole, T.J., Baur, X., Hall, G.L., Culver, B.H., Enright, P.L.,
    Hankinson, J.L., Ip, M.S.M., Zheng, J., Stocks, J., Schindler, C., 2012. Multi-ethnic reference
    values for spirometry for the 3-95-yr age range: The global lung function 2012 equations.
    Eur. Respir. J. 40, 1324–1343. https://doi.org/10.1183/09031936.00080312
Quek, Y.H., Tam, W.W.S., Zhang, M.W.B., Ho, R.C.M., 2017. Exploring the association between
    childhood and adolescent obesity and depression: a meta-analysis. Obes. Rev.
    https://doi.org/10.1111/obr.12535


                                                 231


Rappaport, S.M., 2016. Genetic factors are not the major causes of chronic diseases. PLoS One
    11. https://doi.org/10.1371/journal.pone.0154387
Rappaport, S.M., 2012. Biomarkers intersect with the exposome. Biomarkers 17, 483–489.
    https://doi.org/10.3109/1354750X.2012.691553
Ratti, E., 2015. Big data biology: Between eliminative inferences and exploratory experiments.
      Philos. Sci. 82, 198–218. https://doi.org/10.1086/680332
Richmond, R.C., Sharp, G.C., Ward, M.E., Fraser, A., Lyttleton, O., McArdle, W.L., Ring, S.M.,
    Gaunt, T.R., Lawlor, D.A., Smith, G.D., Relton, C.L., 2016. DNA Methylation and BMI:
    Investigating Identified Methylation Sites at HIF3A in a Causal Framework. Diabetes 65,
    1231–1244. https://doi.org/10.2337/DB15-0996
Roberts, S., Nowak, G., 2014. Stabilizing the lasso against cross-validation variability. Comput.
    Stat. Data Anal. 70, 198–211. https://doi.org/10.1016/J.CSDA.2013.09.008
Rolland, M., Lyon-Caen, S., Sakhi, A.K., Pin, I., Sabaredzovic, A., Thomsen, C., Slama, R.,
     Philippat, C., 2020. Exposure to phenols during pregnancy and the first year of life in a new
     type of couple-child cohort relying on repeated urine biospecimens. Environ. Int. 139,
     105678. https://doi.org/10.1016/j.envint.2020.105678
Rothman, K., Greenland, S., Lash, T., 2012. Modern Epidemiology [WWW Document]. 3rd ed
    Philadelphia Lippincott Williams Wilkins. URL
    https://books.google.fr/books?hl=fr&lr=&id=Z3vjT9ALxHUC&oi=fnd&pg=PR7&dq=
    +rothman+modern+epidemiology+greenland&ots=aROIbIUL8W&sig=etZ2wtoFYJAi2T
    nE5gYzeIj-uBY&redir_esc=y#v=onepage&q=rothman modern epidemiology
    greenland&f=false (accessed 7.22.20).
Runge, J., Nowack, P., Kretschmer, M., Flaxman, S., Sejdinovic, D., 2019. Detecting and
    quantifying causal associations in large nonlinear time series datasets. Sci. Adv. 5.
    https://doi.org/10.1126/sciadv.aau4996
Russo, F., Williamson, J., 2007. Interpreting Causality in the Health Sciences. Int. Stud. Philos.
    Sci. 21, 157–170. https://doi.org/10.1080/02698590701498084
Samblas, M., Milagro, F.I., Mansego, M.L., Marti, A., Martinez, J.A., 2018. PTPRS and PER3
    methylation levels are associated with childhood obesity: results from a genome-wide
    methylation analysis. Pediatr. Obes. 13, 149–158. https://doi.org/10.1111/ijpo.12224
Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Larsson, H., Hultman, C.M., Reichenberg, A., 2014.
    The familial risk of autism. JAMA - J. Am. Med. Assoc. 311, 1770–1777.
    https://doi.org/10.1001/jama.2014.4144
Sang, Y., Zhang, R., Sun, L., Chen, K.K., Li, S.W., Xiong, L., Peng, Y., Zeng, L., Huang, G.,
     2019. MORF4L1 suppresses cell proliferation, migration and invasion by increasing p21 and
     E-cadherin expression in nasopharyngeal carcinoma. Oncol. Lett. 17, 294–302.
     https://doi.org/10.3892/ol.2018.9588
Shao, W., Liu, Q., He, X., Liu, H., Gu, A., Jiang, Z., 2017. Association between level of urinary
    trace heavy metals and obesity among children aged 6–19 years: NHANES 1999–2011.
    Environ. Sci. Pollut. Res. 24, 11573–11581. https://doi.org/10.1007/s11356-017-8803-1
Singh, A.S., Mulder, C., Twisk, J.W.R., Van Mechelen, W., Chinapaw, M.J.M., 2008. Tracking of
     childhood overweight into adulthood: A systematic review of the literature. Obes. Rev.
     https://doi.org/10.1111/j.1467-789X.2008.00475.x


                                                232


Sinisi, S.E., van der Laan, M.J., 2004. Deletion/Substitution/Addition Algorithm in Learning
      with Applications in Genomics. Stat. Appl. Genet. Mol. Biol. 3, 1–38.
      https://doi.org/10.2202/1544-6115.1069
Sinisi, S.E., Van Der Laan, M.J., 2004. Deletion/substitution/addition algorithm in learning with
      applications in genomics. Stat. Appl. Genet. Mol. Biol. 3, 1–38.
      https://doi.org/10.2202/1544-6115.1069
Siroux, V., Agier, L., Slama, R., 2016. The exposome concept: a challenge and a potential driver
     for environmental health research. Eur. Respir. Rev. 25, 124–9.
     https://doi.org/10.1183/16000617.0034-2016
Slama, R., Vrijheid, M., 2015. Some challenges of studies aiming to relate the Exposome to
    human health. Occup. Environ. Med. 72, 383–384. https://doi.org/10.1136/oemed-2014-
    102546
Sohn, M.B., Li, H., 2019. Compositional mediation analysis for microbiome studies. Ann. Appl.
    Stat. 13, 661–681. https://doi.org/10.1214/18-AOAS1210
Steckling, N., Gotti, A., Bose-O’Reilly, S., Chapizanis, D., Costopoulou, D., De Vocht, F., Garí,
     M., Grimalt, J.O., Heath, E., Hiscock, R., Jagodic, M., Karakitsios, S.P., Kedikoglou, K.,
     Kosjek, T., Leondiadis, L., Maggos, T., Mazej, D., Polańska, K., Povey, A., Rovira, J.,
     Schoierer, J., Schuhmacher, M., Špirić, Z., Stajnko, A., Stierum, R., Tratnik, J.S., Vassiliadou,
     I., Annesi-Maesano, I., Horvat, M., Sarigiannis, D.A., 2018. Biomarkers of exposure in
     environment-wide association studies – Opportunities to decode the exposome using
     human biomonitoring data. Environ. Res. https://doi.org/10.1016/j.envres.2018.02.041
Stein, A.D., Lumey, L.H., 2000. The Relationship between Maternal and Offspring Birth Weights
     after Maternal Prenatal Famine Exposure: The Dutch Famine Birth Cohort Study. Hum.
     Biol. https://doi.org/10.2307/41465863
Stieb, D.M., Chen, L., Eshoul, M., Judek, S., 2012. Ambient air pollution, birth weight and
     preterm birth: A systematic review and meta-analysis. Environ. Res.
     https://doi.org/10.1016/j.envres.2012.05.007
Strand, L.B., Barnett, A.G., Tong, S., 2011. The influence of season and ambient temperature on
     birth outcomes: A review of the epidemiological literature. Environ. Res.
     https://doi.org/10.1016/j.envres.2011.01.023
Strandberg-Larsen, K., Poulsen, G., Bech, B.H., Chatzi, L., Cordier, S., Dale, M.T.G., Fernandez,
     M., Henriksen, T.B., Jaddoe, V.W., Kogevinas, M., Kruithof, C.J., Lindhard, M.S., Magnus,
     P., Nohr, E.A., Richiardi, L., Rodriguez-Bernal, C.L., Rouget, F., Rusconi, F., Vrijheid, M.,
     Andersen, A.M.N., 2017. Association of light-to-moderate alcohol drinking in pregnancy
     with preterm birth and birth weight: elucidating bias by pooling data from nine European
     cohorts. Eur. J. Epidemiol. 32, 751–764. https://doi.org/10.1007/s10654-017-0323-2
Sur, P., Candès, E.J., 2019. A modern maximum-likelihood theory for high-dimensional logistic
     regression. Proc. Natl. Acad. Sci. U. S. A. 116, 14516–14525.
     https://doi.org/10.1073/pnas.1810420116
Tamayo-Uria, I., Maitre, L., Thomsen, C., Nieuwenhuijsen, M.J., Chatzi, L., Siroux, V., Aasvang,
    G.M., Agier, L., Andrusaityte, S., Casas, M., de Castro, M., Dedele, A., Haug, L.S., Heude,
    B., Grazuleviciene, R., Gutzkow, K.B., Krog, N.H., Mason, D., McEachan, R.R.C., Meltzer,
    H.M., Petraviciene, I., Robinson, O., Roumeliotaki, T., Sakhi, A.K., Urquiza, J., Vafeiadi, M.,
    Waiblinger, D., Warembourg, C., Wright, J., Slama, R., Vrijheid, M., Basagaña, X., 2019. The
    early-life exposome: Description and patterns in six European countries. Environ. Int. 123,

                                                 233


     189–200. https://doi.org/10.1016/j.envint.2018.11.067
Tamayo, I., Maitre, L., Thomsen, C., Nieuwenhuijsen, M.J., Chatzi, L., 2018. The early-life
    exposome: description and patterns in six European countries. Rev.
Tanabe, M., Kanehisa, M., 2012. Using the KEGG database resource. Curr. Protoc. Bioinforma.
    11, 1.12.1-1.12.54. https://doi.org/10.1002/0471250953.bi0112s38
Tenenhaus, M., Tenenhaus, A., Groenen, P.J.F., 2017. Regularized Generalized Canonical
    Correlation Analysis: A Framework for Sequential Multiblock Component Methods.
    Psychometrika 82, 737–777. https://doi.org/10.1007/s11336-017-9573-x
Ternès, N., Rotolo, F., Michiels, S., 2016. Empirical extensions of the lasso penalty to reduce the
    false discovery rate in high-dimensional Cox regression models. Stat. Med. 35, 2561–2573.
    https://doi.org/10.1002/sim.6927
Thayer, K.A., Heindel, J.J., Bucher, J.R., Gallo, M.A., 2012. Role of Environmental Chemicals in
    Diabetes and Obesity: A National Toxicology Program Workshop Review. Environ. Health
    Perspect. 120, 779. https://doi.org/10.1289/EHP.1104597
Tian, Y., Morris, T.J., Webster, A.P., Yang, Z., Beck, S., Feber, A., Teschendorff, A.E., 2017.
     ChAMP: Updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33,
     3982–3984. https://doi.org/10.1093/bioinformatics/btx513
Tibshirani, R., 1996. Regression Shrinkage and Selection via the Lasso. J. R. Stat. Soc. Ser. B 58,
     267–288. https://doi.org/10.2307/2346178
Titiunik, R., 2014. Can big data solve the fundamental problem of causal inference?, in: PS -
     Political Science and Politics. Cambridge University Press, pp. 75–79.
     https://doi.org/10.1017/S1049096514001772
Tobi, E.W., Zwet, E.W. van, Lumey, L., Heijmans, B.T., 2018. Why mediation analysis trumps
     Mendelian randomization in population epigenomics studies of the Dutch Famine. bioRxiv
     362392. https://doi.org/10.1101/362392
Tong, V.T., Dietz, P.M., Morrow, B., D’Angelo, D. V., Farr, S.L., Rockhill, K.M., England, L.J.,
    2013. Trends in smoking before, during, and after pregnancy - Pregnancy risk assessment
    monitoring system, United States, 40 Sites, 2000-2010. MMWR Surveill. Summ.
    https://doi.org/10.2307/24806088
Uriu-Adams, J.Y., Keen, C.L., 2005. Copper, oxidative stress, and human health. Mol. Aspects
     Med. 26, 268–98. https://doi.org/10.1016/j.mam.2005.07.015
Uusitalo, L., 2007. Advantages and challenges of Bayesian networks in environmental modelling.
     Ecol. Modell. 203, 312–318. https://doi.org/10.1016/j.ecolmodel.2006.11.033
van der Laan, M.J., Polley, E.C., Hubbard, A.E., 2007. Super Learner. Stat. Appl. Genet. Mol.
     Biol. 6. https://doi.org/10.2202/1544-6115.1309
van der Laan, M.J., Starmans, R.J.C.M., 2014. Entering the Era of Data Science: Targeted
     Learning and the Integration of Statistics and Computational Data Analysis. Adv. Stat. 2014,
     1–19. https://doi.org/10.1155/2014/502678
Van Der Maaten, L.J.P., Postma, E.O., Van Den Herik, H.J., 2009. Dimensionality Reduction: A
    Comparative Review. J. Mach. Learn. Res. 10, 1–41.
    https://doi.org/10.1080/13506280444000102
VanderWeele, T.J., 2011. Controlled direct and mediated effects: definition, identification and

                                                234


     bounds. Scand. Stat. Theory Appl. 38, 551. https://doi.org/10.1111/J.1467-
     9469.2010.00722.X
Vanderweele, T.J., Vansteelandt, S., 2009. Conceptual issues concerning mediation, interventions
    and composition. Stat. Interface 2, 457–468. https://doi.org/10.4310/SII.2009.v2.n4.a7
Vermeulen, R., Schymanski, E.L., Barabási, A.-L., Miller, G.W., 2020. The exposome and health:
    Where chemistry meets biology. Science (80-. ). 367, 392–396.
    https://doi.org/10.1126/science.aay3164
Vernet, C., Philippat, C., Agier, L., Calafat, A.M., Ye, X., Lyon-Caen, S., Hainaut, P., Siroux, V.,
    Schisterman, E.F., Slama, R., 2019. An Empirical Validation of the Within-subject
    Biospecimens Pooling Approach to Minimize Exposure Misclassification in Biomarker-
    based Studies. Epidemiology 30, 756–767. https://doi.org/10.1097/ede.0000000000001056
Vernet, C., Philippat, C., Calafat, A.M., Ye, X., Lyon-Caen, S., Siroux, V., Schisterman, E.F.,
    Slama, R., 2018. Within-day, between-day, and between-week variability of urinary
    concentrations of phenol biomarkers in pregnant women. Environ. Health Perspect. 126,
    037005. https://doi.org/10.1289/EHP1994
Vernet, C., Pin, I., Giorgis-Allemand, L., Philippat, C., Benmerad, M., Quentin, J., Calafat, A.M.,
    Ye, X., Annesi-Maesano, I., Siroux, V., Slama, Rémy, Botton, J., Charles, M.A., Dargent-
    Molina, P., de Lauzon-Guillain, B., Ducimetière, P., de Agostini, M., Foliguet, B., Forhan,
    A., Fritel, X., Germa, A., Goua, V., Hankard, R., Heude, B., Kaminski, M., Larroque, B.,
    Lelong, N., Lepeule, J., Magnin, G., Marchand, L., Nabet, C., Slama, R., Saurel-Cubizolles,
    M.J., Schweitzer, M., Thiebaugeorge, O., 2017. In utero exposure to select phenols and
    phthalates and respiratory health in five-year-old boys: A prospective study. Environ. Health
    Perspect. 125, 097006. https://doi.org/10.1289/EHP1015
Vineis, P., Chadeau-Hyam, M., Gmuender, H., Gulliver, J., Herceg, Z., Kleinjans, J., Kogevinas,
     M., Kyrtopoulos, S., Nieuwenhuijsen, M., Phillips, D.H.H., Probst-Hensch, N., Scalbert, A.,
     Vermeulen, R., Wild, C.P.P., 2017. The exposome in practice: Design of the EXPOsOMICS
     project. Int. J. Hyg. Environ. Health 220, 142–151.
     https://doi.org/10.1016/j.ijheh.2016.08.001
Vineis, P., Demetriou, C.A., Probst-Hensch, N., 2020. Long-term effects of air pollution: an
     exposome meet-in-the-middle approach. Int. J. Public Health.
     https://doi.org/10.1007/s00038-019-01329-7
Vineis, P., Perera, F., 2007. Molecular epidemiology and biomarkers in etiologic cancer research:
     The new in light of the old. Cancer Epidemiol. Biomarkers Prev.
     https://doi.org/10.1158/1055-9965.EPI-07-0457
Vineis, P., van Veldhoven, K., Chadeau-Hyam, M., Athersuch, T.J., 2013. Advancing the
     application of omics-based biomarkers in environmental epidemiology. Environ. Mol.
     Mutagen. 54, 461–467. https://doi.org/10.1002/em.21764
Visscher, P.M., Brown, M.A., McCarthy, M.I., Yang, J., 2012. Five years of GWAS discovery.
     Am. J. Hum. Genet. 90, 7–24. https://doi.org/10.1016/j.ajhg.2011.11.029
Von Kries, R., Toschke, A.M., Koletzko, B., Slikker, W., 2002. Maternal smoking during
    pregnancy and childhood obesity. Am. J. Epidemiol. 156, 954–961.
    https://doi.org/10.1093/aje/kwf128
Vrijheid, M., 2014. The exposome: A new paradigm to study the impact of environment on
     health. Thorax 69, 876–878. https://doi.org/10.1136/thoraxjnl-2013-204949

                                                235


Vrijheid, M., Casas, M., Gascon, M., Valvi, D., Nieuwenhuijsen, M., 2016. Environmental
     pollutants and child health—A review of recent concerns. Int. J. Hyg. Environ. Health 219,
     331–342. https://doi.org/10.1016/j.ijheh.2016.05.001
Vrijheid, M., Fossati, S., Maitre, L., Márquez, S., Roumeliotaki, T., Agier, L., Andrusaityte, S.,
     Cadiou, S., Casas, M., Dedele, A., Donaire-gonzalez, D., Grazuleviciene, R., Haug, L.S.,
     Mceachan, R., Meltzer, H.M., Papadopouplou, E., Robinson, O., Sakhi, A.K., Siroux, V.,
     Sunyer, J., Schwarze, P.E., Tamayo-uria, I., Urquiza, J., Vafeiadi, M., Valentin, A.,
     Warembourg, C., Wright, J., Nieuwenhuijsen, M.J., Thomsen, C., Basagaña, X., Slama, R.,
     Chatzi, L., 2020. Early-Life Environmental Exposures and Childhood Obesity : An
     Exposome-Wide Approach. Environ. Health Perspect. 128.
     https://doi.org/https://ehp.niehs.nih.gov/doi/10.1289/EHP5975
Vrijheid, M., Slama, R., Robinson, O., Chatzi, L., Coen, M., van den Hazel, P., Thomsen, C.,
     Wright, J., Athersuch, T.J., Avellana, N., Basagaña, X., Brochot, C., Bucchini, L.,
     Bustamante, M., Carracedo, A., Casas, M., Estivill, X., Fairley, L., van Gent, D., Gonzalez,
     J.R., Granum, B., Gražulevičienė, R., Gutzkow, K.B., Julvez, J., Keun, H.C., Kogevinas, M.,
     McEachan, R.R.C., Meltzer, H.M., Sabidó, E., Schwarze, P.E., Siroux, V., Sunyer, J., Want,
     E.J., Zeman, F., Nieuwenhuijsen, M.J., Gražulevičiene, R., Gutzkow, K.B., Julvez, J., Keun,
     H.C., Kogevinas, M., McEachan, R.R.C., Meltzer, H.M., Sabidó, E., Schwarze, P.E., Siroux,
     V., Sunyer, J., Want, E.J., Zeman, F., Nieuwenhuijsen, M.J., Gražulevičienė, R., Gutzkow,
     K.B., Julvez, J., Keun, H.C., Kogevinas, M., McEachan, R.R.C., Meltzer, H.M., Sabidó, E.,
     Schwarze, P.E., Siroux, V., Sunyer, J., Want, E.J., Zeman, F., Nieuwenhuijsen, M.J.,
     Gražulevičiene, R., Gutzkow, K.B., Julvez, J., Keun, H.C., Kogevinas, M., McEachan,
     R.R.C., Meltzer, H.M., Sabidó, E., Schwarze, P.E., Siroux, V., Sunyer, J., Want, E.J., Zeman,
     F., Nieuwenhuijsen, M.J., 2014. The human early-life exposome (HELIX): project rationale
     and design., Environmental Health Perspectives. National Institute of Environmental
     Health Science. https://doi.org/10.1289/ehp.1307204
Wang, L., Pinkerton, K.E., 2008. Detrimental effects of tobacco smoke exposure during
   development on postnatal lung function and asthma. Birth Defects Res. Part C - Embryo
   Today Rev. 84, 54–60. https://doi.org/10.1002/bdrc.20114
Warembourg, C., Maitre, L., Tamayo-Uria, I., Fossati, S., Roumeliotaki, T., Aasvang, G.M.,
    Andrusaityte, S., Casas, M., Cequier, E., Chatzi, L., Dedele, A., Gonzalez, J.-R.,
    Gražulevičienė, R., Haug, L.S., Hernandez-Ferrer, C., Heude, B., Karachaliou, M., Krog,
    N.H., McEachan, R., Nieuwenhuijsen, M., Petraviciene, I., Quentin, J., Robinson, O., Sakhi,
    A.K., Slama, R., Thomsen, C., Urquiza, J., Vafeiadi, M., West, J., Wright, J., Vrijheid, M.,
    Basagaña, X., 2019. Early-Life Environmental Exposures and Blood Pressure in Children. J.
    Am. Coll. Cardiol. 74, 1317–1328. https://doi.org/10.1016/j.jacc.2019.06.069
Weyde, K.V., Krog, N.H., Oftedal, B., Magnus, P., White, R., Stansfeld, S., Øverland, S.,
    Aasvang, G.M., 2018. A longitudinal study of road traffic noise and body mass index
    trajectories from birth to 8 Years. Epidemiology 29, 729–738.
    https://doi.org/10.1097/EDE.0000000000000868
Wild, C.P., 2012. The exposome: From concept to utility. Int. J. Epidemiol. 41, 24–32.
     https://doi.org/10.1093/ije/dyr236
Wild, C.P., 2005. Complementing the Genome with an “Exposome”: The Outstanding Challenge
     of Environmental Exposure Measurement in Molecular Epidemiology. Cancer Epidemiol.
     Prev. Biomarkers 14.
Winckelmans, E., Nawrot, T.S., Tsamou, M., Den Hond, E., Baeyens, W., Kleinjans, J., Lefebvre,
    W., Van Larebeke, N., Peusens, M., Plusquin, M., Reynders, H., Schoeters, G., Vanpoucke,
                                                236


     C., de Kok, T.M., Vrijens, K., 2017a. Transcriptome-wide analyses indicate mitochondrial
     responses to particulate air pollution exposure. Environ. Heal. 16, 87.
     https://doi.org/10.1186/s12940-017-0292-7
Winckelmans, E., Vrijens, K., Tsamou, M., Janssen, B.G., Saenen, N.D., Roels, H.A., Kleinjans,
    J., Lefebvre, W., Vanpoucke, C., De Kok, T.M., Nawrot, T.S., 2017b. Newborn sex-specific
    transcriptome signatures and gestational exposure to fine particles: findings from the
    ENVIRONAGE birth cohort. Environ. Heal. A Glob. Access Sci. Source 16, 52.
    https://doi.org/10.1186/s12940-017-0264-y
Windham, G.C., Hopkins, B., Fenster, L., Swan, S.H., 2000. Prenatal active or passive tobacco
    smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology.
    https://doi.org/10.1097/00001648-200007000-00011
Woods, M.M., Lanphear, B.P., Braun, J.M., McCandless, L.C., 2017. Gestational exposure to
   endocrine disrupting chemicals in relation to infant birth weight: A Bayesian analysis of the
   HOME Study. Environ. Heal. A Glob. Access Sci. Source 16.
   https://doi.org/10.1186/s12940-017-0332-3
Wright, J., Small, N., Raynor, P., Tuffnell, D., Bhopal, R., Cameron, N., Fairley, L., Lawlor, D.A.,
    Parslow, R., Petherick, E.S., Pickett, K.E., Waiblinger, D., West, J., 2013. Cohort Profile:
    The Born in Bradford multi-ethnic family cohort study. Int. J. Epidemiol. 42, 978–991.
    https://doi.org/10.1093/ije/dys112
Yamada, H., Masuko, H., Yatagai, Y., Sakamoto, T., Kaneko, Y., Iijima, H., Naito, T., Noguchi,
   E., Konno, S., Nishimura, M., Hirota, T., Tamari, M., Hizawa, N., 2016. Role of Lung
   Function Genes in the Development of Asthma. PLoS One 11, e0145832.
   https://doi.org/10.1371/journal.pone.0145832
Zhou, W., Lo, S.H., 2018. Analysis of genotype by methylation interactions through sparsity-
    inducing regularized regression 06 Biological Sciences 0604 Genetics, in: BMC Proceedings.
    BioMed Central Ltd., p. 40. https://doi.org/10.1186/s12919-018-0145-6
Zou, H., 2006. The adaptive lasso and its oracle properties. J. Am. Stat. Assoc. 101, 1418–1429.
     https://doi.org/10.1198/016214506000000735
Zou, H., Hastie, T., 2005. Regularization and variable selection via the elastic net. J. R. Stat. Soc.
     Ser. B Stat. Methodol. 67, 301–320. https://doi.org/10.1111/j.1467-9868.2005.00503.x




                                                  237


      APPENDIX I




238


APPENDIX I: Oral communications and publications; curriculum vitae


       Scientific production
Oral communications:
 Use of methylation marks to inform Association between Early-life Air pollution
   Exposures and child Body Mass Index: An analysis based on a priori selected
   pathways, Solène Cadiou; Bustamante, Mariona; Agier, Lydiane; Maitre, Lea; Gonzalez, Juan
   R.; Hernandez-Ferrer, Carles; Carracedo, Angel; Vives, Marta; Wright, John; Chatzi, Leda
   Grazuleviciene, Regina; Meltzer, Helle M.; Nieuwenhuijsen, Mark; Vrijheid, Martine; Slama,
   Rémy, ISEE-ISES 2018 congress, Ottawa.
 Using DNA methylation to characterize more efficiently associations between the
   exposome and child lung function, Solène Cadiou, Lydiane Agier, Mariona Bustamante,
   Léa Maitre, Xavier Basagana, Martine Vrijheid, Valérie Siroux, Rémy Slama, ISEE 2019
   congress, Utrecht

Manuscripts directly related to the PhD:
 Cadiou, S., Bustamante, M., Agier, L., Andrusaityte, S., Basagaña, X., Carracedo, A., Chatzi, L.,
  Grazuleviciene, R., Gonzalez, J.R., Gutzkow, K.B., Maitre, L., Mason, D., Millot, F.,
  Nieuwenhuijsen, M., Papadopoulou, E., Santorelli, G., Saulnier, P.-J., Vives, M., Wright, J.,
  Vrijheid, M., Slama, R., 2020. “Using methylome data to inform exposome-health
  association studies: An application to the identification of environmental drivers of
  child     body     mass      index.”      Environment        International.    138,     105622,
  https://doi.org/10.1016/j.envint.2020.105622
 Cadiou, S., Slama R., “Some insights regarding the instability of variable-selection
  algorithms used for causal inference purposes in epidemiology” (in review)
 Cadiou, S., Basagana, X., González, JR., Lepeule, J., Siroux, V., Vrijheid, M., Slama, R.,
  “Performance of approaches relying on multidimensional intermediary data to
  decipher causal relationships between the exposome and health: a simulation study
  under various causal structures” (in review)

Other manuscripts:
 Blum, M., Valeri, L., François, O., Cadiou, S., Siroux, V., Lepeule, J., Slama, R., 2020,
   “Challenges raised by mediation in a high dimension setting”, Environmental Health
   Perspectives 128, 055001. https://doi.org/10.1289/EHP6240
 Calvo, B., Lau, CH., Gutzkow, KB., Siskos, A., Maitre, L., … Cadiou, S.,..Coen, M., Vrihjeid,
   M., Keun, H., Escaramis, G., Bustamante, M., “Urinary metabolite quantitative trait loci in
   children and their interaction with dietary factors” (in review)
 Maitre, L., Bustamante, M.,Hernandez-Ferrer, C., Thiel, D., Lau, CH., Siskos, A., Vives-Usano,
   M., Robinson, O, Wright, J., …, Cadiou, S., Slama, R., .. Sunyer, J., Casas. M., Gutzkow, KB.,
   …, Grazuleviciene, R., …, Chatzi, L., Thomsen, C., Nieuwenhuijsen, M.,.., Basagana, X.,
   Tamayo, I., Sabido, E., Borras, E., Carracedo, A., Quintela, I, Estivill, X., Urquiza, J., Coren,
   M., Gonzalez, JR, Keun, H., Vrijheid, M, “The molecular signatures of the Human Early
   Life Exposome using multi-omics profiling” (in preparation)
 De Paro-Bert, P., Ruiz-Arenas, C;, Hernandez-Ferrer, C., …., Cadiou, S., Slama, R., …,
   Vrihjeid, M., Bustamante, M., “The early-life exposome and epigenetic age acceleration
   in children” (in preparation)
 Ruiz-Arenas, C., Hernandez-Ferrer, C., Vives-Usano, M., Quintela, I., Mason, D., Cadiou, S.,
   Casas, M., Andrusaityte, S., Gutzkow, K.B., Vafeiadi, M., Wright, J., Lepeule, J., Grazuleviciene,

                                                239


    R., Chatzi, L., Carracedo, A., Estivill, X., Martí, E., Escaramís, G., Vrijheid, M., González, JR.,
    Bustamante, M., “Identification of blood autosomal cis-expression quantitative trait
    methylation            (cis-eQTMs)               in          children”           (in        review)
    https://www.biorxiv.org/content/10.1101/2020.11.05.368076v1
   Vives-Usano, M., Hernandez-Ferrer, C., Maitre, L., Ruiz-Arena, C., Andrusaityte, S., Borràs,
    E., Cadiou, S., Carracedo, A., Casas, M., Chatzi, L., Coen, M., Estivill, X., González, JR.,
    Grazuleviciene, R., Gutzkow, KB., Keun, H., Lau, CH., Lepeule, J., Mason, D., Quintela, I.,
    Robinson, O., Sabidó, E., Santorelli, G., Schwarze, P., Siskos, A., Slama, R., Thomsen, C.,
    Vafeiadi, M., Martí, E., Vrijheid, M., Bustamante, M., “In utero and childhood exposure to
    tobacco smoke and multi-layer molecular signatures in children”, BMC Medicine.
    2020;18(1):1-19. https://doi.org/10.1186/s12916-020-01686-8
   Vrijheid, M., Fossati, S., Maitre, L., Márquez, S., Roumeliotaki, T., Agier, L., Andrusaityte, S.,
    Cadiou, S., Casas, M., de Castro, M, Dedele, A., Donaire, D., Grazuleviciene, R., Haug, L.,
    McEachan, R., Meltzer, HM., Papadopouplou, E., Robinson, E., Sakhi, AK., Siroux, V., Sunyer,
    J., Schwarze PE., Tamayo-Uria, I., Urquiza, J., Vafeiadi, M., Valentin A., Warembourg, C.,
    Wright, J., Nieuwenhuijsen, M., Thomsen, C., Basagaña, X., Slama R., Chatzi, L., 2020, “Early-
    life Environmental Exposures and Childhood Obesity: an Exposome-wide Approach”
    Environmental Health Perspectives 128. https://doi/10.1289/EHP5975




                                                 240


       Curriculum Vitae
Education:
2017-2020: Institute for Advanced Biosciences, Inserm U1209, (Grenoble, France)
Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health
PhD Student under the Supervision of Remy Slama,
2016-2017 École Nationale des Ponts and Chaussées and AgroParisTech (Paris, France)
Master2 « Public Policies for Sustainable development ».
2015-2016      Engineering school AgroParisTech (Paris, France)
Master2: METATOX: « From Assessment to politic management of toxicological risks for human
and environment ». Toxicology-statistics-public policies
Optional lessons from Master 2 Paris 5 University: Statistical methods for therapy assessment
2012-2015 Ecole Polytechnique (competitive scientific school) – Paris Saclay University (Palaiseau,
France)
Master 2: Sciences for sustainable development: informatics, mathematics, economy, mechanics,
human biology
Professional experience:
Since September 2020: French Ministry of Environment, Paris, France - in charge of data spaces
(“Green Data Hub”) and data sciences expert;
2017-2020 (September-August): Institute for Advanced Biosciences, Grenoble, France - PhD in
Environmental Epidemiology under the supervision of Rémy Slama;
2017 (March – July): Consulting mission for APHP (Paris Public Hospitals) to build a strategy to
apply European Directive on falsified drugs;
2016 (September-December): Consulting mission for the French Ministry of Health and
Agriculture on the governance of The National Council for Alimentation;
2016 (March –August): CRCHUM- Montreal University, Canada – Health Population Unit
Research internship: statistical description of occupational exposures national database;
2015 (March -August): Imperial College London, United-Kingdom –Bioengineering Department
Research internship: Development of new indicators to study local risks factors of atherosclerosis
2012: Compagnie de Gendarmerie Départementale de Lyon (Lyon, France) -Military service as a
police officer;


       Doctoral training (149 hours)
Scientific training (54 hours)
XP Exposome short course series: Advanced OMICS profiling and integration in Exposome
research M Chadeau-Hyam, London (28 hours)
Utilisation des données génétiques issues du séquençage haut débit dans l'étude des maladies :
méthodologie statistique et applications INSERM, Bordeaux (14 hours)
Doctoral school annual scientific day (12 hours)

Professional integration (60 hours)
Equivalence: professional contract as a high civil servant (60 hours)

Transversal training (35 hours)
Coding in PYTHON, introduction, UGA (26 hours)
Linux for scientific computation, UGA (9 hours)


                                                241


242


                                                                                                  APPENDIX II



APPENDIX II: Prenatal exposures and birthweight in SEPAGES mother-child study, an
  adapted oriented Meet-in-the-Middle approach
We present here preliminary results from a study performed on the French SEPAGES mother-child cohort, relating
a ‘small’ prenatal exposome to the birth weight of the child, relying on additional information from the mother blood
methylome during pregnancy. We used a third variation of our oMITM design: as a first step, we chose to perform
a supervised data-driven dimension reduction of the methylome using Partial Least Square (PLS) rather than an a
priori preselection of relevant CpGs based on external databases as done in chapter II. Moreover, to test the
association between the (reduced) exposome and the outcome, we used a multiple regression rather than ExWAS,
as this may be more efficient in the context of the small exposome considered here.

1.   Introduction
Low birth weight is known to be a predictor of later adverse health conditions (Belbasis et al.,

2016). Environmental and behavioral determinants of decreased birth weight have thus been

explored for many decades in epidemiology, leading to effective public health interventions, such

as limiting the alcohol consumptions and tobacco exposure during pregnancy (Burling et al., 1991;

Chersich et al., 2012; Tong et al., 2013). With the advent of the exposome paradigm (Wild, 2005),

various other prenatal exposures are now studied simultaneously within ambitious exposome

projects (Agier et al., 2020a). In the French Sepages cohort (Lyon-Caen et al., 2019), several

phenolic compounds and phthalates exposures have been characterized during pregnancy, with an

expected low measurement error due to reliance on the within-subject biospecimens pooling

approach (Vernet et al., 2019, 2018). In this study, we aimed to perform an exposome wide analysis

of the environmental drivers of the child birth weight in the Sepages cohort, relying on methylome

data and on the oMITM design that we previously developed (Cadiou et al., 2020, see Chapter II),

in an attempt to limit false positive signals. We adapted the implementation of oMITM chosen in

(Cadiou et al., 2020) to the dimension of our different layers: due to the limited size of our

exposome (see below), we chose to conduct multiple regression analysis instead of ExWAS for the

tests of association relating directly the exposome to the health outcome. We also chose to perform

a data-driven dimension reduction for the methylome, as the reliance on external heterogenous



                                                        243


                                                                                    APPENDIX II

database to preselect a part of the methylome could be questioned, as detailed in (Cadiou et al.,

2020) and (Mubeen et al., 2019).

2. Methods

2.1.    Study population and outcome
We relied on the SEPAGES parents-child cohort, in which the prenatal exposome, the mother

DNA methylome (from peripheral blood during pregnancy) and birthweight were assessed in 438

mother–single child pair recruited around the Grenoble (France) metropolitan area before 19

weeks of pregnancy between July 2014 and July 2017, in ultrasound medical center or after having

spontaneously contacted the study team (Lyon-Caen et al., 2019). Weight was measured at birth

and various relevant covariates were assessed during pregnancy and at birth: maternal weight before

pregnancy, maternal height, season of conception, maternal highest diploma, maternal smoking

before pregnancy, maternal smoking during pregnancy, maternal parity and gestational duration.

2.2.    Exposome assessment
As detailed elsewhere (Lyon-Caen et al., 2019), an extended personal exposure assessment was

conducted during pregnancy in the 484 women of the Sepages study. In this study, we considered

34 variables, available in 338 women, for the exposome. These environmental factors are detailed

in Table 0.1 and belong to 3 major groups: air pollutants, phenols and phthalates biomarkers and

behavioral factors. Air pollutants (2 variables) were measured by personal dosimeter carried during

the pregnancy by the mother during one follow up week taking place before the blood sampling

used for methylome assessment (see below). Phenols and phthalates (26 variables) were assessed

in pooled urine samples from three micturitions per day collecting during each follow-up week;

values below quantification limit were imputed using the fill-in method as detailed in Rolland et al.

(2020). Last, 5 parameters corresponding to behavior were built from the questionnaires. All

exposures were corrected for relevant protocol covariables to remove batch effects.




                                                244


                                                                                                                                    APPENDIX II

Table 0.1: Exposome components assessed in Sepages cohort during pregnancy, with mean and standard deviation for quantitative variables and
frequency for qualitative variables, and amount of missing data. (438 mothers recruited between 2014 and 2017).
                                                                                                     Mean +-                 Missing
Exposure group Exposure                                                   Modality                                 n (%)
                                                                                                     SD                      (%)           Unit
Air pollutant      PM2.5 - trimester 1                                                               13.9 (7.2)              132 (30.1)    ug/m
                                                                                                                                           3
Air pollutant      NO2 - trimester 1                                                                 20.9 (7.4)              12 (2.74)     ug/m
                                                                                                                                           3
Behaviour          Number of alcohol drinks per month during              No alcohol                               311 (71   69 (15.753)
                   pregnancy                                                                                       )
                                                                          Less than one glass per month            49 (11)   69 (15.753)
                                                                          More than one glass per month            9 (2)     69 (15.753)
Behaviour          More than 3 alcohol drinks                             Never                                    319 (73   72 (16.438)
                                                                                                                   )
                                                                          Less than one time per month             29 (7)    72 (16.438)
                                                                          One time per month                       14 (3)    72 (16.438)
                                                                          One time per week or more                4 (1)     72 (16.438)
Behaviour          Slimming diet during pregnancy                         No                                       374 (85   61 (13.927)
                                                                                                                   )
                                                                          Yes                                      3 (1)     61 (13.927)
Behaviour          Any slimming diet before pregnancy                     No                                       300 (68   60 (13.699)
                                                                                                                   )
                                                                          Yes                                      78 (18)   60 (13.699)
Behaviour          Self-assessed stress level                             Nervous most of the time                 6 (1)     82 (18.721)
                                                                          Often nervous                            59 (13)   82 (18.721)
                                                                          Sometimes nervous                        238 (54   82 (18.721)
                                                                                                                   )
                                                                          Never nervous                            53 (12)   82 (18.721)
Urinary            MnBP - Trimester 2                                                                13.2 (10.8)             -             µg/l
phthalates


                                                                      245


                                                                      APPENDIX II


Urinary           MEHHP - Trimester 2              9.6 (17.9)     -        µg/l
phthalates
Urinary           oomph - Trimester 2              1.2 (1.9)      -        µg/l
phthalates
Urinary           ohm INCH - Trimester 2           4.2 (10.8)     -        µg/l
phthalates
Urinary           MiBP - Trimester 2               18.8 (13.3)    -        µg/l
phthalates
Urinary           MEOHP - Trimester 2              6.9 (13.3)     -        µg/l
phthalates
Urinary           omen - Trimester 2               8.9 (12.5)     -        µg/l
phthalates
Urinary           oxo MINCH - Trimester 2          3 (6.6)        -        µg/l
phthalates
Urinary           MBzP - Trimester 2               6.6 (8.4)      -        µg/l
phthalates
Urinary           MECPP - Trimester 2              12.6 (19.4)    -        µg/l
phthalates
Urinary           oxolin - Trimester 2             4.1 (9.5)      -        µg/l
phthalates
Urinary           MEP - Trimester 2                38.3 (61.1)    -        µg/l
phthalates
Urinary           MEHP - Trimester 2               3.3 (6.9)      -        µg/l
phthalates
Urinary           MMCHP - Trimester 2              9.4 (12.5)     -        µg/l
phthalates
Urinary           cumin - Trimester 2              8.2 (16)       -        µg/l
phthalates
Urinary           MBzP - Trimester 2               6.6 (8.4)      -        µg/l
phthalates
Urinary phenols   MEPA - Trimester 2               97.7 (530.6)   -        µg/l
Urinary phenols   BPA - Trimester 2                2.4 (3.2)      -        µg/l
Urinary phenols   ETPA total - Trimester 2         8.4 (37.4)     -        µg/l

                                             246


                                                                                                                                                      APPENDIX II


Urinary phenols       OXBE total - Trimester 2                                                                     11.1 (80.3)              -                  µg/l
Urinary phenols       PRPA total - Trimester 2                                                                     19.8 (95.1)              -                  µg/l
Urinary phenols       Triclosan total - Trimester 2                                                                32.9 (149.7)             -                  µg/l
Urinary phenols       BUPA total - Trimester 2                                       <LOD                                           331 (76 -
                                                                                                                                    )
                                                                                     Between LOD and                                61 (14) -
                                                                                     LOQ
                                                                                     >LOQ                                           46 (11) -
Urinary phenols       BPS total - Trimester 2                                        <LOD                                           326 (74 -
                                                                                                                                    )
                                                                                     Between LOD and                                21 (5)  -
                                                                                     LOQ
                                                                                     >LOQ                                           91 (21)   -
Urinary phenols       BPF total - Trimester 2                                        <LOD                                           431 (98   -
                                                                                                                                    )
                                                                                     >LOQ                                           7 (2)     -
Urinary phenols       Trichlorobenzene total - Trimester 2                           <LOD                                           435 (99   -
                                                                                                                                    )
                                                                                     Between LOD and                                2 (0)     -
                                                                                     LOQ
                                                                                     >LOQ                                           1 (0)     -
BPA: bisphenol A; BPF: bisphenol F; BPS: bisphenol S; BUPA: butyl paraben; cxMiNP: Mono-4-methyl-7-carboxyoctyl-phthalate; ETPA: ethyl paraben; LOD: Limit of Detection;
LOQ: Limit of Quantification ; MBzP: mono benzyl phthalate; MECPP: mono-2-ethyl 5-carboxypentyl phthalate ; MEHHP: mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP:
Mono(2-éthylhexyl) phthalate; MEOHP: mono-2-ethyl-5-oxohexyl phthalate; MEP: monoethyl phthalate; MEPA: methyl paraben; MiBP: mono-iso-butyl phthalate; MMCHP: Mono-
2-carboxymethyl hexyl-phthalate ; MnBP: mono-n-butyl phthalate; ohMiNCH: 2-(((Hydroxy-4-methyloctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid;                  OHMiNP:
mono-4-methyl-7-hydroxyoctyl phthalate; ohMPHP: 6-Hydroxy Monopropylheptyl-phthalate; OXBE:oxybenzone/benzophenone-3; oxoMiNCH: 2-(((4-Methyl-7-
oxyooctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid; OXOMiNP: mono-4-methyl-7-oxooctyl phthalate; PRPA: propyl paraben




                                                                                 247


                                                                                     APPENDIX II



2.3.    DNA methylation
Peripheral blood was collected during the study visit taking place at the clinic around 19 gestational

weeks, using EDTA tubes. DNA extraction was performed at Quiagen, Heseilberg, Germany).

DNA was extracted from buffy coat; DNA methylation was assessed with the Infinium Human

Methylation 850K beadchip. A first filtering of probes was performed using ChAMP protocol

(Tian et al., 2017) to eliminate probes with detection p-values lower than 0.01, probes with a single-

nucleotide polymorphism (SNP), probes with beadcount lower than 3 in at least 5% of the samples

and unspecific probes, leading to 792,152 remaining CpG probes in 487 samples. Data were

normalized using Beta-Mixture Quantile and imputed using ChAMP (Tian et al., 2017). A final

filtering was performed to eliminate probes on sexual chromosomes and duplicate samples. Only

the samples corresponding to individuals for which at least one exposure variable from each of the

three groups of exposures assessed was available were considered. Finally, the remaining 774,172

CpGs were expressed as Beta-values for 438 subjects. Relevant “protocol” covariates (e.g. batch

and plate) were identified and added to all models including methylome data to avoid batch effects.

Correlation within the methylome was estimated by averaging the Pearson’s correlation within 1000

sets of 100 randomly selected CpGs to avoid computing all pairwise correlations between the

774,172 CpGs.

2.4.    Statistical analyses
We followed the oriented Meet-in-the-Middle (oMITM) design proposed by Cadiou et al. (2020)

using the methylome layer to reduce the dimension of the exposome. It follows three steps: a)

supervised dimension reduction of the methylome using the outcome of interest; b) tests of

association between the relevant dimension of the methylome defined at step a) and each

component of the exposome conditionally on the outcome; c) test of association between each

component of the exposome found associated with the reduced methylome at step b) (i.e. the

reduced exposome) and the outcome. For step a), we removed the linear effect of relevant


                                                 248


                                                                                          APPENDIX II

    covariates from the birthweight and used Partial-Least Square regression (Höskuldsson, 1988) to

    relate the whole methylome to the residual: this dimension reduction technique builds summary

    variables as linear combinations of the original set of variables, which are defined iteratively such

    that they explain as much of the remaining covariance between the predictors and the outcome as

    possible. The number of relevant components was determined by cross-validation using

    plsgenenomics package (Boulesteix et al., 2018), which was also used for the PLS analyses itself. For

    step b), we used an ExWAS-type approach, i.e. multiple univariate regressions corrected for

    multiple comparisons using the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995),

    adjusted on the relevant covariates (see IV.2.1.) and on birth weight. For step c), we used a multiple

    regression model adjusted on the same covariates and including simultaneously the whole reduced

    exposome. Considering the choice of adjustment covariates, season of measure was added to the

    set of covariates specified in IV.2.1. in the models including air pollutants variables. Missing values

    for exposures were single-imputed using MICE package (Buuren and Groothuis-Oudshoorn,

    2011),

    2.5.     Sensitivity analyses

    We performed 3 sensitivity analyses:


      Sensitivity analysis I: an ‘agnostic’ multiple linear regression ignoring the methylome: the whole

       exposome was related to the birth weight using a single multiple regression model as in step c).

      Sensitivity analysis II: an oMITM approach using ExWAS-type analysis at each step a), b) and

       c).

      Sensitivity analysis III: an oMITM approach repeating the oMITM implemented in Cadiou et

       al., 2020, using ExWAS type at each step and an a priori reduced methylome of only 2004 CpGs,

       representing the intersection of the CpGs available in our study and the 2284 CpGs selected in

       a priori reduced methylome relevant for the child BMI in Cadiou et al. (2020).



                                                     249


                                                                                     APPENDIX II

3. Results

3.1.   Study population
Among the 438 children for which both prenatal exposures and maternal methylome data were

available, mean birth weight was 3285 g (CI: 460) with 4 missing data. Detailed information about

the covariates and exposures levels in the study population are presented in Table 0.1 and Table

0.2.

Table 0.2: Characteristics of the 438 mother-child pairs included in the exposome analysis based
on Sepages study.
                                                                         Missing
Characteristic                Modality         Mean +- SD   n (%)        (%)           Unit
Preterm birth                 No                            418 (95)     3 (0.685)
                              Yes                           17 (4)       3 (0.685)
Season of conception          Jan-Feb-Mar                   112 (26)
                              Apr-May-Jun                   93 (21)
                              Jul-Aug-Sept                  105 (24)
                              Oct-Nov-Dec                   128 (29)
Maternal age                                   32.6 (3.8)                              year
Child sex                     Male                          229 (52)     4 (0.913)
                              Female                        205 (47)     4 (0.913)
Birth weight                                  3285 (460)                 4 (0.913)     g
Gestational duration                           39.7 (1.5)                3 (0.685)     week
Maternal height                                165.3 (6)                 4 (0.913)     cm
Maternal weight before pregnancy               61.2 (11)                               kg
Maternal highest diploma      Before high school            25 (6)       2 (0.457)
                              High school before bachelor   49 (11)      2 (0.457)
                              Between bachelor and master   115 (26)     2 (0.457)
                              Master or higher              247 (56)     2 (0.457)
                                                                                       cigarettes/
Maternal smoking before pregnancy            0.5 (2.3)                   43 (9.817)    day
Maternal smoking during any
trimester of pregnancy       No                             371 (85)     38 (8.676)
                             Yes                            29 (7)       38 (8.676)
                             No child
Parity                       before                         197 (45)
                             1 child                        196 (45)
                             2 children or more             45 (10)
Measurement season for air   Jan-Feb-Mar                    121 (28)     9 (2.055)
pollutants
                             Apr-May-Jun                    122 (28)     9 (2.055)
                             Jul-Aug-Sept                   101 (23)     9 (2.055)
                             Oct-Nov-Dec                    85 (19)      9 (2.055)



                                                250


                                                                                  APPENDIX II



3.2.    First step of the oMITM approach: relationship between methylome and birthweight


PLS analysis – step a) of the oMITM approach

One PLS component was enough to relate methylome to birth weight, as determined by cross

validation. The Pearson correlation of this component with birth weight was 0.29. The distribution

of the weights of the CpG in this component are presented in Figure 1. The 10 top CpGs belonged

to the following genes: PTPRS; ITPK1; JARID2; PDE4DIP-NBPF20-NBPF9; TBC1D24 and

MORF4L1.

Figure 1: Distribution of the weight of CpGs in the selected PLS component. Colors indicate the
corresponding gene for the top 500 CpGs and the top 10 are annotated.




Sensitivity analyses: ExWAS-type analyses on the methylome

No significant associations between the methylome and the birth weight were found when

correcting for multiple comparisons (Sensitivity analysis II, lowest corrected p-value: 0.38).

Without correction (lowest p-value: 1.11x10-6), 54090 associations were significant; the top 10


                                                   251


                                                                                    APPENDIX II

CpGs belonged to the following genes: TSSC4, GABRB3, ATP1A3, GIMD1, CCDC25, ZNF775,

COPE, DUSP16, AGBL3 and EPN2 (Sensitivity analysis II). Similarly, none of the 2004 CpGs of

the restricted methylome was associated with the birth weight neither with correction for multiple

testing (Sensitivity analysis III, lowest corrected p-value: 0.33) or without (lowest p-value:

3.23x10-4).

3.3.    Whole oMITM approach
None of the component of the exposome was associated with the PLS component with (lowest p-

value: 0.715) adjustment for multiple testing (see Table 0.3). The reduced exposome thus did not

contain any exposures and the whole oMITM approach did not point any association. Without the

correction for multiple tests, the association between the PLS component with the stress level self-

assessed by the mother was significant (p-value: 0.048).

3.4.    Agnostic multiple regression
An agnostic multivariate analysis showed no significant associations between the exposome and

birthweight (sensitivity analysis I, Table 0.4) with correction for multiple testing (lowest adjusted

p-value: 0.67) or without (lowest p-value: 0.062).




                                                252


                                                                                                                                         APPENDIX II

Table 0.3: Step b) of the oMITM approach: estimates, confidence intervals, uncorrected and corrected for multiple comparisons p-values of the tests
of association between exposome and PLS component adjusted on relevant covariates and birth weight (434 mother-child pairs from the Sepages
cohort). *: for qualitative exposures, p-values by level and the reference level are indicated.
                                                                                              Global
                                                                                                           Unadjusted p-value     p-value corrected for
        Exposure                 Modality        Estimate      CI2.5          CI97.5       unadjusted p-
                                                                                                               by level*            multiple testing
                                                                                              value
  Self-assessed stress level   Nervous most of        2.484       -2.844           7.811             0.048               0.360                     0.715
                                      the time
                                Often nervous         1.821       -0.032           3.673                                 0.054
                                Never nervous         2.316        0.324           4.308                                 0.023
                                    Sometimes                                                                   Reference level
                                       nervous
      MnBP - Trimester 2                              0.053        -0.014          0.121             0.119                                         0.715
    cxMiNP - Trimester 2                              0.069        -0.020          0.159             0.129                                         0.715
 ohMINCH - Trimester 2                                0.298        -0.141          0.737             0.182                                         0.715
   MEOHP - Trimester 2                                0.446        -0.221          1.113             0.190                                         0.715
     MEPA - Trimester 2                               0.001   -6.913x10-4          0.003             0.192                                         0.715
     Slimming diet during             Yes             2.773        -1.422          6.968             0.195               0.195                     0.715
               pregnancy
     Slimming diet during             No                                                                        Reference level
               pregnancy
  oxoMiNP - Trimester 2                              -0.090       -0.228           0.048             0.202                                         0.715
  oxoMINCH - Trimester                               -0.445       -1.159           0.270             0.222                                         0.715
                        2
   MMCHP - Trimester 2                               -0.220       -0.574           0.135             0.224                                         0.715
       MEP - Trimester 2                              0.006       -0.005           0.017             0.279                                         0.812
   ohMPHP - Trimester 2                              -0.168       -0.528           0.193             0.362                                         0.846
 TRCB total - Trimester 2 Between LOD and             6.583       -3.398          16.565             0.407               0.195                     0.846
                                     LOQ
                                    >LOQ              2.443      -11.080          15.966                                 0.723
 TRCB total - Trimester 2           <LOD                                                                        Reference level
      MBzP - Trimester 2                             -0.034       -0.120           0.052             0.431                                         0.846
 PRPA total - Trimester 2                            -0.004       -0.016           0.007             0.447                                         0.846

                                                                            253


                                                                                                        APPENDIX II

  MEHHP - Trimester 2                         -0.164   -0.590         0.262   0.451                           0.846
BUPA total - Trimester 2 Between LOD and       0.446   -1.547         2.439   0.483            0.660          0.846
                                       LOQ
                                     >LOQ     -1.193   -3.413         1.026                    0.291
                                     <LOD                                             Reference level
       BPA - Trimester 2                      -0.065   -0.271         0.140   0.533                           0.846
     MiBP - Trimester 2                       -0.017   -0.072         0.038   0.539                           0.846
  ohMiNP - Trimester 2                        -0.032   -0.136         0.072   0.544                           0.846
TRCS total - Trimester 2                      -0.001   -0.006         0.003   0.555                           0.846
 BPF total - Trimester 2             >LOQ      1.320   -3.998         6.638   0.626            0.626          0.910
                                     <LOD                                             Reference level
 OXBE total - Trimester                       -0.002   -0.012         0.008   0.738                           0.942
                        2
  How many times more Less than one time      1.150    -1.406         3.707   0.763            0.377          0.942
            than 3 drinks        per month
                               One time per   0.456    -2.848         3.760                    0.786
                                     month
                          One time per week   -1.813   -8.240         4.614                    0.579
                                    or more
                                      Never                                           Reference level
  BPS total - Trimester 2 Between LOD and     -1.058   -4.247         2.130   0.765            0.514          0.942
                                       LOQ
                                     >LOQ     -0.336   -1.998         1.326                    0.691
                                     <LOD                                             Reference level
ETPA total - Trimester 2                      -0.003   -0.021         0.015   0.765                           0.942
    MEHP - Trimester 2                        -0.054   -0.493         0.384   0.807                           0.957
Any slimming diet before                Yes   -0.161   -1.802         1.480   0.847            0.847          0.968
               pregnancy
                                        No                                            Reference level
   MECPP - Trimester 2                         0.017   -0.260         0.293   0.907                           0.975
        PM - Trimester 1                       0.003   -0.095         0.100   0.959                           0.975
      NO2 - Trimester 1                       -0.002   -0.099         0.094   0.961                           0.975



                                                                254


                                                                                                                                                       APPENDIX II

      Number of alcohol           Less than one            -0.037          -1.967         1.893               0.975                   0.970                       0.975
       drinks per month         glass per month
        during pregnancy
                                 More than one             0.416           -3.311         4.144                                       0.826
                                glass per month
                                     No alcohol                                                                             Reference level
BPA: bisphenol A; BPF: bisphenol F; BPS: bisphenol S; BUPA: butyl paraben; cxMiNP: Mono-4-methyl-7-carboxyoctyl-phthalate; ETPA: ethyl paraben; LOD : limit of detection:
LOQ: limit of quantification; MBzP: mono benzyl phthalate; MECPP: mono-2-ethyl 5-carboxypentyl phthalate ; MEHHP: mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP: Mono(2-
éthylhexyl) phthalate; MEOHP: mono-2-ethyl-5-oxohexyl phthalate; MEP: monoethyl phthalate; MEPA: methyl paraben; MiBP: mono-iso-butyl phthalate; MMCHP: Mono-2-
carboxymethyl hexyl-phthalate ; MnBP: mono-n-butyl phthalate; ohMiNCH: 2-(((Hydroxy-4-methyloctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid;                    OHMiNP:
mono-4-methyl-7-hydroxyoctyl phthalate; ohMPHP: 6-Hydroxy Monopropylheptyl-phthalate; OXBE:oxybenzone/benzophenone-3; oxoMiNCH: 2-(((4-Methyl-7-
oxyooctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid; OXOMiNP: mono-4-methyl-7-oxooctyl phthalate; PRPA: propyl paraben




                                                                                    255


                                                                                                                                     APPENDIX II

Table 0.4: Agnostic multiple regression relating the exposome to the birth weight: estimates, confidence intervals, uncorrected and corrected for
multiple comparisons p-values of the tests of association between exposome and birthweight adjusted on relevant covariates (434 mother-child pairs
from the Sepages cohort).
                   Exposure               Modality      Estimate       CI2.5    CI97.5       Unadjusted p-       Unadjusted p-     p-value corrected
                                                                                                     value        value by level        for multiple
                                                                                                                                             testing
        MEHP - Trimester 2                                 22.981      -1.162    47.124               0.062                                    0.672
      MEHHP - Trimester 2                                 -20.868     -44.191     2.454               0.079                                    0.672
       cxMiNP - Trimester 2                                 3.595      -1.258     8.448               0.146                                    0.672
      BPS total - Trimester 2    Between LOD and          -40.122    -216.375   136.131               0.158               0.655                0.672
                                            LOQ
                                           >LOQ            83.226      -7.062   173.514               0.158               0.071                0.672
                                           <LOD                                                       0.158                                    0.672
        MEPA - Trimester 2                                  0.078      -0.035     0.191               0.174                                    0.672
    Any slimming diet before                    Yes        62.935     -31.065   156.935               0.189               0.189                0.672
                  pregnancy
    Any slimming diet before                    No                                                    0.189                                    0.672
                  pregnancy
      MECPP - Trimester 2                                  -9.893     -25.341     5.555               0.209                                    0.672
     BPF total - Trimester 2                >LOQ         -182.968    -474.919   108.983               0.219               0.219                0.672
                                            <LOD                                                      0.219                                    0.672
        MiBP - Trimester 2                                  1.828      -1.148     4.803               0.228                                    0.672
     MMCHP - Trimester 2                                   11.790      -7.935    31.515               0.241                                    0.672
   OXBE total - Trimester 2                                -0.321      -0.878     0.235               0.257                                    0.672
   Number of alcohol drinks      Less than one glass      -10.993    -118.175    96.190               0.266               0.840                0.672
per month during pregnancy               per month
                                More than one glass       168.556     -38.200   375.312               0.266               0.110                0.672
                                         per month
                                         No alcohol                                                   0.266                                    0.672
    BUPA total - Trimester 2     Between LOD and           69.449     -41.058   179.956               0.273               0.217                0.672
                                              LOQ
                                            >LOQ          -55.957    -178.807    66.894               0.273               0.371                0.672
                                            <LOD                                                      0.273                                    0.672
     Self-assessed stress level Nervous most of the      -279.230    -573.150    14.689               0.317               0.063                0.723
                                               time

                                                                        256


                                                                                                                                                       APPENDIX II

                                     Often nervous                  6.631      -99.763     113.025                  0.317                  0.903                  0.723
                                     Never nervous                 -4.418     -117.370     108.534                  0.317                  0.939                  0.723
                                  Sometimes nervous                                                                 0.317                                         0.723
     MEOHP - Trimester 2                                           18.179      -19.164      55.522                  0.339                                         0.723
      ohMiNP - Trimester 2                                         -2.378       -8.038       3.282                  0.409                                         0.794
    PRPA total - Trimester 2                                       -0.249       -0.882       0.383                  0.438                                         0.794
          PM - Trimester 1                                         -2.183       -7.817       3.450                  0.446                                         0.794
  How many times more than     Less than one time                  41.458     -101.156     184.073                  0.606                  0.568                  0.935
                    3 drinks           per month
                              One time per month                  -58.308     -248.316     131.700                  0.606                  0.547                  0.935
                               One time per week                  191.093     -177.170     559.357                  0.606                  0.308                  0.935
                                          or more
                                            Never                                                                   0.606                                         0.935
        Slimming diet during                  Yes                 -53.197     -286.875     180.480                  0.655                  0.655                  0.935
                   pregnancy
                                               No                                                                   0.655                                         0.935
     TRCB total - Trimester 2  Between LOD and                   -176.696     -721.172     367.780                  0.665                  0.524                  0.935
                                             LOQ
                                           >LOQ                   241.056     -496.590     978.702                  0.665                  0.521                  0.935
                                           <LOD                                                                     0.665                                         0.935
         MnBP - Trimester 2                                        -0.747        -4.490      2.996                  0.695                                         0.935
    oxoMINCH - Trimester 2                                         -6.147       -46.086     33.793                  0.762                                         0.935
      ohMPHP - Trimester 2                                          2.760       -17.197     22.717                  0.786                                         0.935
      oxoMiNP - Trimester 2                                        -0.809        -8.355      6.738                  0.833                                         0.935
     ETPA total - Trimester 2                                       0.103        -0.889      1.095                  0.838                                         0.935
     TRCS total - Trimester 2                                      -0.025        -0.268      0.217                  0.838                                         0.935
     ohMINCH - Trimester 2                                          2.425       -22.059     26.909                  0.846                                         0.935
           BPA - Trimester 2                                        1.114       -10.248     12.476                  0.847                                         0.935
          MEP - Trimester 2                                         0.040        -0.564      0.643                  0.898                                         0.957
          NO2 - Trimester 1                                        -0.165        -5.618      5.289                  0.953                                         0.974
         MBzP - Trimester 2                                        -0.076        -4.770      4.617                  0.974                                         0.974
BPA: bisphenol A; BPF: bisphenol F; BPS: bisphenol S; BUPA: butyl paraben; cxMiNP: Mono-4-methyl-7-carboxyoctyl-phthalate; ETPA: ethyl paraben; LOD : limit of detection:
LOQ: limit of quantification; MBzP: mono benzyl phthalate; MECPP: mono-2-ethyl 5-carboxypentyl phthalate ; MEHHP: mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP: Mono(2-
éthylhexyl) phthalate; MEOHP: mono-2-ethyl-5-oxohexyl phthalate; MEP: monoethyl phthalate; MEPA: methyl paraben; MiBP: mono-iso-butyl phthalate; MMCHP: Mono-2-
carboxymethyl hexyl-phthalate ; MnBP: mono-n-butyl phthalate; ohMiNCH: 2-(((Hydroxy-4-methyloctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid;                    OHMiNP:



                                                                                  257


                                                                                                                                    APPENDIX II

mono-4-methyl-7-hydroxyoctyl phthalate; ohMPHP: 6-Hydroxy Monopropylheptyl-phthalate; OXBE:oxybenzone/benzophenone-3;   oxoMiNCH:    2-(((4-Methyl-7-
oxyooctyl)oxy)carbonyl)cyclohexanecarboxylic-Acid; OXOMiNP: mono-4-methyl-7-oxooctyl phthalate; PRPA: propyl paraben




                                                                      258


                                                                                  APPENDIX III

4. Discussion
Neither the novel implementation of our oMITM using PLS nor the implementation repeating the

oMITM applied in (Cadiou et al., 2020) did point any exposure of our small exposome as related

to child birthweight. The first step of oMITM, the supervised dimension reduction of the

methylome, gave plausible results: indeed, the genes on which the CpGs having the highest weight

in the PLS component built to predict birth weight were located seem relevant for birth weight

according to the literature. JARID2 and TBC1D24 methylation level have been linked to birth

weight in a meta-analysis of genome-wide methylation association studies (Küpers et al., 2019);

JARID2 is a gene expected to have an important role in fetal growth and cell differentiation

(Cervantes et al., 2017; Landeira et al., 2015). PTPRS methylation levels was found associated with

child obesity (Samblas et al., 2018) and is part of inflammation regulation pathways (Bunin et al.,

2015). Embryos with reduced expression of ITPK1 are more likely to show growth retardation and

adverse birth outcome such as neural tube defects (Chamberlain et al., 2007; Greene et al., 2017).

PDE4DIP is involved in hippocampal differential gene expression, which has been associated with

low birth weight (Buschdorf et al., 2016). Last, MORF4L1 has a role in embryonic development

via chromatin remodeling and transcriptional regulation (Sang et al., 2019). On the contrary, the

two sensitivity analyses involving methylome-wide type association tests with birth weight did not

point any specific CpG (sensitivity analysis II and III). Thus, PLS regression may be a relevant

alternative way to perform dimension reduction when the sample size makes the classical

methylome-wide analysis difficult to use due to a low power. Another possibility could have been

to perform an a priori selection of CpG specific to the birth weight instead of using the selection

made for child body mass index in (Cadiou et al., 2020)).

When correcting for multiple comparisons, no significant association was found between this PLS

component and any pregnancy exposure. Without this correction, the average level of stress self-

assessed by the mother (qualitative variable with 4 modalities) was the only exposure associated




                                               259


                                                                                       APPENDIX III

with the PLS component. Overall, as the reduced exposome was empty, the oMITM approach did

not point any association.

Regarding the agnostic analysis by multiple regression, no significant associations were found,

either with or without correction for multiple testing. In particular, the self-assessed level of stress,

which was the only exposure associated with the PLS component without correction for multiple

testing, was not associated with birth weight (unadjusted p-value: 0.32); among the three modalities

of the variable (which quantified the frequency of the feeling of stress) compared to the reference

level (the mother “sometimes felt stressed”), the most significant association with birth weight was

for the feeling of “almost always being stressed” (p-value: 0.06): the effect estimate was negative,

corresponding to a lower birth weight with higher level of self-assessed stress. The two other

modalities showed higher p-value (higher than 0.9). In past studies, high level of anxiety during

pregnancy was found associated with lower birth weight (Dunkel Schetter and Tanner, 2012) with

possible involvement of epigenetic mechanisms (DeSocio, 2018). This may be indicative of a lack

of a sensitivity both in the oMITM and in the agnostic approaches, supported by the fact that only

a very small number of women (7 among 434) declared a high level of stress. Similarly, in the

agnostic approach, we did not find any association of low birth weight with alcohol consumption

during pregnancy or air pollutants, which have been pointed by previous studies (Little, 1977; Mills

et al., 1984; Stieb et al., 2012; Strandberg-Larsen et al., 2017). Overall, these results put a new

perspective on our work on the oMITM design developed in (Cadiou et al., 2020) (see Chapter II).

The oMITM design was designed as a way to face the challenge of false-positive discoveries in

exposome study: it indeed allows to gain in specificity (see Chapter II and IV) and even in sensitivity

(see Chapter III and IV) when the intermediate layer carries some information. However, the

informed dimension reduction of the exposome that we proposed cannot go without a sample size

sufficient for assessing exposures effects without correction for multiple testing: in particular, if no

exposure is associated with the outcome without correction for multiple testing, the oMITM won’t

be able to point any exposures. Indeed, if the reduced exposome is empty, the oMITM cannot

                                                  260


                                                                                  APPENDIX III

point any exposure, and if the reduced exposome contains one exposure or more, a test corrected

for multiple testing of its association with the outcome would necessary provide associations p-

values equal or higher than the p-values of the agnostic analysis uncorrected for multiple testing.

This is true when ExWAS or multiple regression corrected for multiple comparisons are used to

relate the exposome to the health outcome. But this may also be true if more complex linear

algorithms such as DSA or LASSO would be used, as they are expected to give the same results as

a multiple regression when the dimension is low, which may be the case for the reduced exposome.

This underlined that the improvement of exposome studies may not only require the improvement

of methods, in the direction that we followed for this PhD, but also a sustained effort to build

larger exposome cohorts.




                                               261


                                                                          APPENDIX III

Acknowledgment

We acknowledge the input of Stephan Gabet and Johanna Lepeule, from IAB Grenoble, for the

processing of the methylation data.

The cohort was supported by the European Research Council (consolidator grantN◦311765-E-

DOHaD, PI, R. Slama), by the European Community’s Seventh Framework Programm

(FP7/2007-206, grant N◦308333-HELIX, PI, M. Vrijheid), by ANR, the French Research Agency

(PAPER project ANR-12-PDOC-0029-01, PI, J. Lepeule; SHALCOH project, 14-CE21-0007-01,

PI, R. Slama; GUMME project, PI, R. Slama; ETAPE ANR 18-CE36-005, PI, J. Lepeule; SYMER

project, ANR-15-IDEX-02, PI, U. Schlattner, Mobil’Air project, ANR-15-IDEX, PI, S. Mathy,

supported by University Grenoble-3Alpes), by ANSES (CNAP project, PI C. Philippat,

PENDORE project, PI, V. Siroux), by Plan Cancer (Canc’Air project, PI, P. Guénel), by

Association de Recherche sur le Cancer (ARC, PI, P. Guénel), by AGIR pour les maladies

chroniques (PI, R. Slama and PRENAPAR project, V. Siroux), and Fonds de Recherche pour la

Santé Respiratoire (FRSR, PI, I. Pin) and by Fondation de France (CLIMATHES—00081169, J.

Lepeule).




                                          262


                                                                                  APPENDIX III

APPENDIX III: Large supplementary materials
Supplementary Material II.10                                                                263
Supplementary Material IV.2                                                                 312
Supplementary Table V.3                                                                     381
Supplementary Material V.1                                                                  409
Supplementary Material II.10: Sensitivity analysis III - adjusted associations between the whole
methylome and zBMI in 1,173 children from the HELIX cohort (ExWAS model, step b of the
Meet-in-the-Middle approach applied to the whole methylome). Results are presented only for
CpGs with a (FDR - corrected for multiple hypothesis testing) p-value below 0.05 in ExWAS.



                                                  Effect      Uncorrected p-     FDR corrected
Gene                  CpG site     CI- 95%
                                                  estimate    Value              p –Value
                      cg02032125 -6.27    -3.28   -4.77       5.27x10-10         2.04x10-4
SFXN5                 cg10040131 3.55     7.26    5.41        1.42x10-8          2.74x10-3
                      cg16549957 3.27     7.08    5.18        1.15x10-7          0.01
CLK1                  cg21990144 4.18     9.01    6.59        1.01x10-7          0.01
ARHGEF3               cg25799109 -3.49    -1.60   -2.55       1.64x10-7          0.01
FAM107B               cg04638265 2.76     6.02    4.39        1.49x10-7          0.01
TMEM126B              cg21787323 -5.42    -2.46   -3.94       2.02x10-7          0.01
CBFA2T3               cg27061485 -5.57    -2.52   -4.05       2.34x10-7          0.01
PIK3CD                cg15701170 2.93     6.66    4.79        5.31x10-7          0.01
FGR                   cg09845000 -5.05    -2.20   -3.62       6.72x10-7          0.01
                      cg11532433 -3.87    -1.72   -2.79       4.05x10-7          0.01
DUSP2                 cg13725590 1.97     4.48    3.22        5.38x10-7          0.01
ATP2B2                cg09477124 4.21     9.63    6.92        6.02x10-7          0.01
ZNF620                cg07448319 -6.97    -3.02   -5.00       7.87x10-7          0.01
ACPL2                 cg22893494 -8.57    -3.76   -6.16       5.80x10-7          0.01
SLC12A7               cg04467119 -9.54    -4.14   -6.84       7.55x10-7          0.01
TAP1                  cg08818207 1.84     4.26    3.05        9.22x10-7          0.01
FOXK1                 cg11931953 3.08     7.14    5.11        9.13x10-7          0.01
                      cg06688910 -5.93    -2.59   -4.26       6.18x10-7          0.01
                      cg13514049 -5.45    -2.36   -3.90       8.41x10-7          0.01
DTX1                  cg19743522 3.98     9.21    6.59        8.64x10-7          0.01
                      cg26438942 2.26     5.22    3.74        8.10x10-7          0.01
ZNF710                cg00624799 4.54     10.30   7.42        4.90x10-7          0.01
                      cg09690072 -8.30    -3.63   -5.96       6.32x10-7          0.01
ITGB2                 cg13315706 2.68     6.08    4.38        4.96x10-7          0.01
                      cg20510033 1.94     4.55    3.25        1.15x10-6          0.02
                      cg00024471 -5.35    -2.29   -3.82       1.12x10-6          0.02


                                               263


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
            cg07708521 -8.79   -3.74   -6.26      1.30x10-6        0.02
NCALD       cg19308132 -9.55   -4.07   -6.81      1.24x10-6        0.02
KIAA0748    cg01874152 1.68    3.92    2.80       1.10x10-6        0.02
ARMC7       cg02186444 -6.11   -2.61   -4.36      1.22x10-6        0.02
PLEKHF1     cg14945937 3.18    7.47    5.33       1.28x10-6        0.02
ZCCHC3      cg10107382 -4.33   -1.85   -3.09      1.24x10-6        0.02
            cg26033520 2.96    6.97    4.97       1.35x10-6        0.02
CPEB2       cg07809027 -4.49   -1.90   -3.20      1.40x10-6        0.02
PIK3CD      cg01943221 2.47    5.85    4.16       1.51x10-6        0.02
ZNF250      cg10639435 2.33    5.51    3.92       1.51x10-6        0.02
                       -       -
            cg02381820                 -46.87     1.72x10-6        0.02
                       65.99   27.75
VEGFA       cg25343661 -4.45   -1.87   -3.16      1.68x10-6        0.02
PDE4D       cg09062288 2.81    6.70    4.75       1.77x10-6        0.02
ZFAT        cg16921643 3.64    8.67    6.15       1.82x10-6        0.02
CCDC88C     cg07112604 2.44    5.82    4.13       1.89x10-6        0.02
LGALS3BP    cg17836612 2.07    4.97    3.52       2.13x10-6        0.02
FAM100B     cg04912316 2.93    7.05    4.99       2.30x10-6        0.02
H2AFY       cg01874869 -5.42   -2.25   -3.84      2.40x10-6        0.02
LCN6        cg14611112 -4.89   -2.02   -3.46      2.57x10-6        0.02
PIK3CD      cg23098018 2.12    5.16    3.64       2.80x10-6        0.02
DHCR24      cg17901584 -2.98   -1.22   -2.10      2.97x10-6        0.02
ETS1        cg08452327 11.83   28.77   20.30      2.90x10-6        0.02
DGKA        cg06739462 2.19    5.33    3.76       2.86x10-6        0.02
DTX1        cg04456029 2.68    6.52    4.60       2.94x10-6        0.02
            cg26504467 1.81    4.41    3.11       2.97x10-6        0.02
ANKRD29     cg15393702 -5.09   -2.10   -3.60      2.70x10-6        0.02
CUTA        cg01300096 2.62    6.39    4.50       3.09x10-6        0.02
FGR         cg00404394 -6.17   -2.52   -4.34      3.40x10-6        0.02
DGKA        cg06915826 1.24    3.04    2.14       3.39x10-6        0.02
            cg10643916 -6.17   -2.52   -4.35      3.32x10-6        0.02
CDV3        cg21466315 1.57    3.85    2.71       3.54x10-6        0.02
PNPLA6      cg25025866 -9.38   -3.82   -6.60      3.54x10-6        0.02
FOXK1       cg11647481 3.22    7.92    5.57       3.67x10-6        0.02
PEAR1       cg13224583 1.58    3.89    2.73       3.82x10-6        0.02
FMNL3       cg04070601 2.23    5.49    3.86       3.86x10-6        0.02
            cg18232497 3.45    8.62    6.04       5.11x10-6        0.02
LOC284632   cg15571353 -7.04   -2.81   -4.93      5.23x10-6        0.02
            cg17945429 1.27    3.18    2.23       5.11x10-6        0.02


                                   264


                                                            APPENDIX III


                                  Effect     Uncorrected p- FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value          p –Value
                                                    -6
HPCAL1     cg04618171 3.46 8.62 6.04         4.83x10        0.02
                      -
           cg03765419       -4.32 -7.54      4.73x10-6     0.02
                      10.75
DUSP2      cg02431562 1.88 4.68 3.28         4.92x10-6     0.02
SPATA5     cg06695691 -5.70 -2.27 -3.99      5.65x10-6     0.02
                      -
PDLIM4     cg17852932       -4.06 -7.08      4.89x10-6     0.02
                      10.11
LY6G6E     cg13123009 3.28 8.14 5.71         4.30x10-6     0.02
                      -
FKBPL      cg18080528       -6.08 -10.58     4.33x10-6     0.02
                      15.07
LAMA4      cg11934419 -6.64 -2.65 -4.65      5.40x10-6     0.02
PHACTR2    cg10735015 -2.79 -1.11 -1.95      5.69x10-6     0.02
FOXK1      cg05066096 2.23 5.58 3.90         5.46x10-6     0.02
GIMAP8     cg12644845 1.79 4.47 3.13         5.19x10-6     0.02
LY96       cg13213009 1.27 3.18 2.22         5.37x10-6     0.02
EIF2C2     cg23731089 1.63 4.04 2.83         4.07x10-6     0.02
ALOX5      cg10909790 -5.62 -2.24 -3.93      5.62x10-6     0.02
           cg22648996 2.15 5.33 3.74         4.49x10-6     0.02
RNF141     cg07565042 -6.04 -2.42 -4.23      4.83x10-6     0.02
C11orf58   cg05512310 -7.56 -3.04 -5.30      4.54x10-6     0.02
                      -
ZNF259     cg12395125       -6.33 -11.01     4.26x10-6     0.02
                      15.68
DGKA       cg10782923 1.36 3.42 2.39         5.50x10-6     0.02
INTS6      cg21028785 3.73 9.28 6.50         4.81x10-6     0.02
TMX1       cg16565294 1.84 4.55 3.20         4.42x10-6     0.02
           cg23033518 -5.88 -2.34 -4.11      5.59x10-6     0.02
VAC14      cg00259097 2.15 5.33 3.74         4.64x10-6     0.02
COMP       cg15986030 -7.78 -3.12 -5.45      5.13x10-6     0.02
                      -
           cg00522276       -4.32 -7.59      5.81x10-6     0.02
                      10.86
           cg16522993 -6.81 -2.70 -4.75      6.01x10-6     0.03
GATS       cg23221013 2.30 5.79 4.05         6.11x10-6     0.03
C8orf73    cg11904266 -7.27 -2.89 -5.08      6.10x10-6     0.03
HADH       cg01150799 1.86 4.70 3.28         6.25x10-6     0.03
PSMB8      cg23750151 3.36 8.48 5.92         6.22x10-6     0.03
FGR        cg00065048 -3.51 -1.39 -2.45      6.52x10-6     0.03
PLEK       cg10812236 -5.81 -2.30 -4.05      6.54x10-6     0.03
                      -
CADPS      cg13716443       -4.54 -8.02      6.78x10-6     0.03
                      11.49
HNRNPAB    cg18428006 2.28 5.76 4.02         6.82x10-6     0.03


                                265


                                                                  APPENDIX III


                                     Effect     Uncorrected p-   FDR corrected
Gene      CpG site   CI- 95%
                                     estimate   Value            p –Value
CUTA      cg14021478 1.97    4.98    3.47       6.68x10-6        0.03
          cg04326499 1.63    4.13    2.88       6.86x10-6        0.03
SLC35C1   cg05151185 -6.72   -2.65   -4.68      6.98x10-6        0.03
TBK1      cg06092729 -6.68   -2.64   -4.66      6.92x10-6        0.03
TMC6      cg07313882 3.52    8.92    6.22       6.95x10-6        0.03
SBNO2     cg18608055 1.75    4.43    3.09       6.81x10-6        0.03
FAM111A   cg18529243 -7.06   -2.78   -4.92      7.13x10-6        0.03
                     -
LMNA      cg03946955         -6.67 -11.82       7.31x10-6        0.03
                     16.97
          cg19414383 1.73    4.40    3.06       7.53x10-6        0.03
HLA-E     cg21366673 1.29    3.29    2.29       7.51x10-6        0.03
HLA-E     cg13036546 1.26    3.22    2.24       7.76x10-6        0.03
GPER      cg10055222 -9.93   -3.89   -6.91      7.74x10-6        0.03
                     -
CUX1      cg10657965         -4.88 -8.66        7.64x10-6        0.03
                     12.44
SLC22A8   cg17945323 -5.14   -2.01   -3.57      7.74x10-6        0.03
ANKMY1    cg03978514 -7.26   -2.84   -5.05      8.21x10-6        0.03
CALHM2    cg23753748 -6.21   -2.43   -4.32      8.30x10-6        0.03
BNIP3     cg10206933 1.47    3.76    2.62       8.21x10-6        0.03
SLC48A1   cg16170936 -3.64   -1.42   -2.53      8.24x10-6        0.03
CHFR      cg21232015 1.57    4.01    2.79       8.30x10-6        0.03
                     -
SOCS1     cg05730996         -8.39 -14.93       8.31x10-6        0.03
                     21.48
NFATC2    cg18740175 2.17    5.53    3.85       7.92x10-6        0.03
TPST2     cg09856467 -5.19   -2.03   -3.61      8.12x10-6        0.03
          cg25918827 2.08    5.35    3.72       9.20x10-6        0.03
UXS1      cg00295485 1.92    4.94    3.43       8.98x10-6        0.03
CCRL2     cg16021018 -6.77   -2.63   -4.70      8.99x10-6        0.03
PPP1R2    cg27230534 1.96    5.04    3.50       8.76x10-6        0.03
NEU1      cg27645345 -8.25   -3.21   -5.73      9.03x10-6        0.03
TRIM8     cg06662132 7.75    19.91   13.83      8.92x10-6        0.03
GLB1L2    cg15868183 2.47    6.35    4.41       9.22x10-6        0.03
          cg12212198 -3.61   -1.41   -2.51      8.58x10-6        0.03
          cg13617812 -6.33   -2.46   -4.39      9.16x10-6        0.03
CORO1A    cg06038367 3.11    7.99    5.55       8.98x10-6        0.03
          cg15238325 1.62    4.15    2.88       8.55x10-6        0.03
                     -
CHD3      cg22695339         -7.24 -12.93       9.01x10-6        0.03
                     18.62
          cg13700939 -4.90   -1.90 -3.40        9.34x10-6        0.03
PMEPA1    cg26681770 -3.12   -1.21 -2.16        9.36x10-6        0.03

                                 266


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
C1orf126    cg05338397 2.04    5.36    3.70       1.31x10-5        0.03
ECE1        cg13551754 2.13    5.54    3.83       1.17x10-5        0.03
SLC9A1      cg17820878 1.73    4.55    3.14       1.32x10-5        0.03
RNF220      cg13573582 -2.55   -0.97   -1.76      1.27x10-5        0.03
LMO4        cg20633321 -4.82   -1.86   -3.34      1.11x10-5        0.03
CREB3L4     cg09895920 -2.34   -0.89   -1.62      1.28x10-5        0.03
                       -
            cg10421194         -4.95 -8.93        1.18x10-5        0.03
                       12.92
PLEK        cg02861056 -4.77   -1.82   -3.30      1.22x10-5        0.03
GLI2        cg08561286 3.14    8.16    5.65       1.09x10-5        0.03
            cg20402826 1.32    3.45    2.39       1.16x10-5        0.03
SF3B1       cg07204893 -6.84   -2.63   -4.74      1.09x10-5        0.03
SP140       cg05564251 1.89    4.88    3.38       9.96x10-6        0.03
SUSD5       cg13747145 -9.15   -3.49   -6.32      1.27x10-5        0.03
MGLL        cg03781224 -8.38   -3.20   -5.79      1.29x10-5        0.03
VWA5B2      cg00985388 -5.38   -2.07   -3.72      1.13x10-5        0.03
NFKB1       cg25905215 2.88    7.57    5.23       1.31x10-5        0.03
            cg13316433 1.73    4.50    3.12       1.13x10-5        0.03
PAM         cg17259761 -8.30   -3.20   -5.75      1.08x10-5        0.03
STARD4      cg11925263 -3.93   -1.51   -2.72      1.16x10-5        0.03
NEU1        cg02776448 -9.57   -3.70   -6.63      1.02x10-5        0.03
TCP11       cg09027493 2.41    6.28    4.35       1.16x10-5        0.03
            cg09009770 2.67    6.96    4.81       1.14x10-5        0.03
RAB11FIP1   cg19626138 -5.51   -2.12   -3.81      1.11x10-5        0.03
CHD7        cg14719959 3.08    8.04    5.56       1.22x10-5        0.03
EIF2C2      cg13157980 1.91    5.01    3.46       1.32x10-5        0.03
ZC3H3       cg11848483 1.12    2.93    2.03       1.19x10-5        0.03
BAT2L1      cg13637151 6.42    16.82   11.62      1.27x10-5        0.03
SEC31B      cg23599026 2.41    6.30    4.35       1.21x10-5        0.03
            cg12378753 -6.41   -2.45   -4.43      1.25x10-5        0.03
                       -       -
TRIM66      cg08926040                 -19.68     1.30x10-5        0.03
                       28.49   10.86
            cg22843803 2.87    7.51    5.19       1.24x10-5        0.03
PITPNM1     cg04383058 2.43    6.35    4.39       1.20x10-5        0.03
ALDH3B1     cg05620821 -4.93   -1.90   -3.42      1.06x10-5        0.03
DGKA        cg07679948 1.11    2.87    1.99       9.66x10-6        0.03
            cg03670162 -8.22   -3.15   -5.68      1.18x10-5        0.03
            cg26707718 1.92    4.96    3.44       9.79x10-6        0.03
            cg25936358 -3.96   -1.51   -2.74      1.27x10-5        0.03
MPP5        cg17327331 -4.86   -1.87   -3.37      1.06x10-5        0.03

                                   267


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
KIAA1199   cg17820039 -6.60   -2.53   -4.56      1.19x10-5        0.03
SLCO3A1    cg01794926 -3.62   -1.38   -2.50      1.23x10-5        0.03
           cg03854595 2.31    6.03    4.17       1.21x10-5        0.03
FAM38A     cg06007201 -6.10   -2.33   -4.22      1.28x10-5        0.03
           cg07435331 -3.96   -1.52   -2.74      1.13x10-5        0.03
TMEM49     cg01409343 1.61    4.17    2.89       1.05x10-5        0.03
SOCS3      cg18181703 2.59    6.70    4.64       1.03x10-5        0.03
TTC39C     cg05401069 1.63    4.21    2.92       9.61x10-6        0.03
NFATC1     cg13207250 2.51    6.58    4.55       1.30x10-5        0.03
           cg26853368 1.45    3.76    2.61       1.04x10-5        0.03
TMEM90B    cg24122922 -5.15   -1.99   -3.57      1.00x10-5        0.03
TGIF2      cg10566581 2.67    6.97    4.82       1.19x10-5        0.03
           cg12485727 1.96    5.14    3.55       1.32x10-5        0.03
PKIG       cg07097722 0.94    2.46    1.70       1.20x10-5        0.03
PMEPA1     cg08567517 -8.00   -3.07   -5.54      1.15x10-5        0.03
IL2RB      cg21307484 2.13    5.51    3.82       9.76x10-6        0.03
                      -
C11orf10   cg10669451         -7.04 -12.77       1.34x10-5        0.03
                      18.49
RERE       cg03610117 3.13    8.24    5.69       1.38x10-5        0.03
FDPS       cg06352803 -4.20   -1.59   -2.90      1.42x10-5        0.03
MAP4K4     cg13522882 1.30    3.41    2.36       1.40x10-5        0.03
ICOS       cg15344028 1.03    2.73    1.88       1.46x10-5        0.03
ARSK       cg09244244 -5.38   -2.04   -3.71      1.41x10-5        0.03
ITGB1      cg20545410 -4.12   -1.56   -2.84      1.46x10-5        0.03
SFXN3      cg15428620 -5.84   -2.22   -4.03      1.35x10-5        0.03
IFITM1     cg03038262 1.40    3.70    2.55       1.41x10-5        0.03
P4HA3      cg10408430 2.46    6.48    4.47       1.44x10-5        0.03
DGKA       cg25416125 1.49    3.92    2.70       1.45x10-5        0.03
ABCC4      cg05412028 -2.65   -1.01   -1.83      1.39x10-5        0.03
SLC25A29   cg14064024 -3.22   -1.22   -2.22      1.43x10-5        0.03
           cg06836102 1.60    4.23    2.92       1.45x10-5        0.03
CHD3       cg12353788 1.28    3.39    2.33       1.41x10-5        0.03
ORMDL3     cg08932654 -4.56   -1.73   -3.14      1.40x10-5        0.03
AXIN2      cg04239967 3.29    8.70    6.00       1.45x10-5        0.03
           cg01715745 -4.20   -1.59   -2.90      1.50x10-5        0.03
EPB49      cg03979241 -3.50   -1.32   -2.41      1.55x10-5        0.03
MIR1205    cg03611307 1.45    3.83    2.64       1.53x10-5        0.03
                      -
ASAP1      cg18822036         -3.82 -6.97        1.53x10-5        0.03
                      10.12
C11orf45   cg04468568 -6.60   -2.49 -4.55        1.54x10-5        0.03

                                  268


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
LIMA1      cg06817772 -4.38   -1.65   -3.01      1.54x10-5        0.03
           cg06329392 1.40    3.70    2.55       1.52x10-5        0.03
HSPA2      cg20014063 -7.42   -2.80   -5.11      1.52x10-5        0.03
SLC10A1    cg04227591 -7.74   -2.93   -5.33      1.51x10-5        0.03
                      -
           cg00430895         -4.41 -8.04        1.50x10-5        0.03
                      11.67
NFATC1     cg13608166 2.80    7.41    5.11       1.48x10-5        0.03
CTAGE5     cg18976418 -2.73   -1.03   -1.88      1.56x10-5        0.03
KCNG3      cg21129729 -4.25   -1.60   -2.93      1.58x10-5        0.03
ST3GAL5    cg09113070 -4.28   -1.61   -2.94      1.62x10-5        0.03
           cg20532925 1.98    5.26    3.62       1.60x10-5        0.03
PCCB       cg10109841 -5.16   -1.94   -3.55      1.60x10-5        0.03
CHD7       cg22822599 2.60    6.92    4.76       1.61x10-5        0.03
SH2D4B     cg14914442 -4.76   -1.79   -3.28      1.63x10-5        0.03
DPF2       cg09609051 1.64    4.37    3.01       1.62x10-5        0.03
                      -
PLA2G4E    cg03080639         -6.31 -11.54       1.63x10-5        0.03
                      16.77
CLUAP1     cg09934892 1.77    4.70    3.24       1.61x10-5        0.03
CLDND2     cg22065498 -5.84   -2.20   -4.02      1.64x10-5        0.03
ABCA5      cg09530790 -7.69   -2.89   -5.29      1.68x10-5        0.03
           cg08160085 -5.91   -2.22   -4.06      1.70x10-5        0.03
DTX1       cg18449739 2.17    5.79    3.98       1.74x10-5        0.03
VPS37B     cg05298628 -7.12   -2.67   -4.89      1.75x10-5        0.03
CHST11     cg16618104 -4.23   -1.58   -2.90      1.76x10-5        0.03
C1orf187   cg12403889 -7.15   -2.67   -4.91      1.83x10-5        0.03
                      -       -
           cg12426802                 -37.13     1.88x10-5        0.03
                      54.08   20.18
           cg12593793 -4.86   -1.82   -3.34      1.84x10-5        0.03
           cg27228986 1.50    4.01    2.75       1.87x10-5        0.03
SRGAP3     cg13475822 1.62    4.34    2.98       1.87x10-5        0.03
           cg17448336 -6.25   -2.34   -4.29      1.77x10-5        0.03
PTGER4     cg11821200 1.59    4.25    2.92       1.87x10-5        0.03
PHF15      cg05476182 -9.75   -3.65   -6.70      1.81x10-5        0.03
NEU1       cg26747317 -5.54   -2.07   -3.80      1.83x10-5        0.03
PTPRN2     cg09365094 1.70    4.55    3.12       1.83x10-5        0.03
           cg17841267 1.69    4.52    3.10       1.86x10-5        0.03
BATF       cg24673600 2.46    6.58    4.52       1.83x10-5        0.03
ZC3H18     cg04476070 -2.82   -1.05   -1.93      1.86x10-5        0.03
MAFG       cg09253473 -5.34   -1.99   -3.67      1.86x10-5        0.03
PLK1S1     cg23666170 -5.50   -2.05   -3.78      1.88x10-5        0.03

                                  269


                                                                        APPENDIX III


                                           Effect     Uncorrected p-   FDR corrected
Gene            CpG site   CI- 95%
                                           estimate   Value            p –Value
NAGLU           cg12280065 -9.08   -3.38   -6.23      1.89x10-5        0.03
PHACTR3         cg24334029 -3.80   -1.42   -2.61      1.91x10-5        0.03
MACF1           cg00352106 -3.78   -1.41   -2.60      1.91x10-5        0.03
LAMP3           cg18030943 1.29    3.47    2.38       1.94x10-5        0.03
                           -
C6orf27         cg05565809         -4.46 -8.22        1.93x10-5        0.03
                           11.98
ZNF589          cg05070273 1.58    4.24    2.91       1.94x10-5        0.03
                cg18146927 1.72    4.62    3.17       1.97x10-5        0.03
PEBP4           cg09423126 1.88    5.06    3.47       1.97x10-5        0.03
SLC22A8         cg16146033 -6.94   -2.58   -4.76      1.97x10-5        0.03
                cg10393508 3.61    9.72    6.66       1.98x10-5        0.03
NOSIP           cg21292909 3.44    9.26    6.35       1.98x10-5        0.03
LOC100130872-
                cg25002788 -5.21 -1.94 -3.57          2.00x10-5        0.03
SPON2
MXRA8           cg23973885 2.17    5.85 4.01          2.08x10-5        0.03
C1orf122        cg04299080 -6.32   -2.34 -4.33        2.17x10-5        0.03
CHI3L2          cg14414943 1.57    4.23 2.90          2.12x10-5        0.03
                           -
CD58            cg21039631         -6.19 -11.45       2.09x10-5        0.03
                           16.71
GALNT2          cg06801857 1.63    4.39    3.01       2.07x10-5        0.03
EML4            cg04741211 1.19    3.23    2.21       2.18x10-5        0.03
HECW2           cg22765299 1.12    3.03    2.07       2.05x10-5        0.03
TGFBR2          cg07285675 2.98    8.03    5.50       2.07x10-5        0.03
RAB43           cg05859076 1.72    4.63    3.17       2.13x10-5        0.03
RFC4            cg03852656 10.25   27.64   18.95      2.08x10-5        0.03
HES1            cg14475875 -5.22   -1.93   -3.57      2.14x10-5        0.03
                           -
C5orf56         cg05452391         -4.28 -7.91        2.15x10-5        0.03
                           11.55
SIT1            cg13876315 1.90    5.12 3.51          2.02x10-5        0.03
                           -
AKAP2           cg14488390         -3.84 -7.10        2.06x10-5        0.03
                           10.36
ABCC2           cg03381359 -3.96   -1.46   -2.71      2.15x10-5        0.03
                cg03558688 2.03    5.46    3.75       2.03x10-5        0.03
PTPRCAP         cg02685484 1.74    4.69    3.22       2.17x10-5        0.03
                cg13133835 -7.20   -2.66   -4.93      2.17x10-5        0.03
SNUPN           cg20630655 -5.53   -2.05   -3.79      2.14x10-5        0.03
                cg00103299 1.37    3.70    2.53       2.12x10-5        0.03
                cg26676129 1.40    3.77    2.58       2.09x10-5        0.03
                cg10334416 -3.75   -1.39   -2.57      2.09x10-5        0.03
YTHDF1          cg12589387 -8.40   -3.11   -5.76      2.12x10-5        0.03

                                       270


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
LIMK2       cg07713946 1.07    2.90    1.98       2.18x10-5        0.03
SPATA6      cg16965552 -2.59   -0.96   -1.77      2.19x10-5        0.03
FNIP1       cg21016699 -7.94   -2.93   -5.43      2.20x10-5        0.03
DENND2D     cg09826895 1.31    3.56    2.43       2.23x10-5        0.03
PHACTR4     cg00956142 -2.59   -0.96   -1.78      2.24x10-5        0.03
NEU1        cg19070159 -8.05   -2.97   -5.51      2.25x10-5        0.03
            cg15584070 -6.67   -2.46   -4.56      2.28x10-5        0.03
TP53INP2    cg15636879 1.65    4.47    3.06       2.29x10-5        0.03
SH3BP5      cg07078958 -5.58   -2.06   -3.82      2.30x10-5        0.03
CMKLR1      cg06933965 -7.24   -2.67   -4.95      2.35x10-5        0.03
PSMB8       cg25693349 1.92    5.21    3.56       2.37x10-5        0.03
            cg14343017 1.55    4.21    2.88       2.39x10-5        0.03
LOC349114   cg07437464 -6.79   -2.50   -4.64      2.38x10-5        0.03
CORO1B      cg17690322 2.75    7.47    5.11       2.37x10-5        0.03
CD7         cg11294761 2.66    7.25    4.96       2.39x10-5        0.03
PIK3CD      cg09706586 1.81    4.93    3.37       2.46x10-5        0.03
            cg12587087 -4.60   -1.69   -3.14      2.45x10-5        0.03
            cg22626683 -3.43   -1.26   -2.35      2.42x10-5        0.03
            cg03040292 1.16    3.18    2.17       2.53x10-5        0.03
PFKFB2      cg02233614 -3.99   -1.46   -2.73      2.49x10-5        0.03
            cg17163425 -4.65   -1.70   -3.17      2.53x10-5        0.03
CPS1        cg21967368 -3.06   -1.12   -2.09      2.49x10-5        0.03
OXNAD1      cg02255107 1.72    4.69    3.20       2.50x10-5        0.03
            cg23279756 -3.23   -1.19   -2.21      2.45x10-5        0.03
SMURF1      cg08486903 2.05    5.58    3.81       2.47x10-5        0.03
PEBP4       cg17836177 1.78    4.86    3.32       2.52x10-5        0.03
CDC42BPB    cg21057323 1.17    3.20    2.19       2.47x10-5        0.03
                       -
RAP1GAP2    cg12061069         -5.09 -9.48        2.50x10-5        0.03
                       13.88
            cg03834031 -4.92   -1.80   -3.36      2.46x10-5        0.03
RCAN3       cg01768001 2.02    5.53    3.78       2.59x10-5        0.03
ZNF619      cg12176605 -4.17   -1.52   -2.85      2.57x10-5        0.03
STX1A       cg01712428 -5.61   -2.05   -3.83      2.60x10-5        0.03
ARPC1B      cg02257708 3.23    8.83    6.03       2.60x10-5        0.03
CPEB3       cg24238409 -2.77   -1.01   -1.89      2.60x10-5        0.03
            cg26130090 -6.42   -2.35   -4.39      2.60x10-5        0.03
RAI1        cg06685437 2.15    5.88    4.02       2.59x10-5        0.03
                       -
PTPN7       cg07577934         -4.36 -8.16        2.67x10-5        0.03
                       11.95
C2orf68     cg24222817 -8.43   -3.08 -5.75        2.67x10-5        0.03

                                   271


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
ARID5B      cg16389209 1.74    4.78    3.26       2.67x10-5        0.03
            cg15227994 1.69    4.64    3.17       2.66x10-5        0.03
            cg02353048 -4.40   -1.60   -3.00      2.65x10-5        0.03
AZU1        cg24101283 -5.40   -1.97   -3.68      2.68x10-5        0.03
BLCAP       cg22378853 -6.94   -2.53   -4.74      2.64x10-5        0.03
            cg05945608 1.88    5.15    3.51       2.71x10-5        0.03
PIK3CD      cg19267205 2.50    6.87    4.68       2.75x10-5        0.03
SESN2       cg06754224 -6.07   -2.21   -4.14      2.74x10-5        0.03
RALY        cg19110982 3.07    8.43    5.75       2.76x10-5        0.03
DAND5       cg07782285 2.06    5.67    3.87       2.77x10-5        0.03
PIK3CD      cg11947782 1.63    4.48    3.05       2.80x10-5        0.03
NRM         cg11784631 -6.51   -2.37   -4.44      2.80x10-5        0.03
            cg05280814 -4.38   -1.59   -2.99      2.79x10-5        0.03
SLC35C1     cg24303076 -8.12   -2.95   -5.54      2.83x10-5        0.03
UBASH3A     cg27111890 1.01    2.77    1.89       2.83x10-5        0.03
MAN1C1      cg10555744 1.40    3.86    2.63       2.97x10-5        0.03
FBLN7       cg01154505 1.39    3.83    2.61       2.90x10-5        0.03
PASK        cg25488284 1.97    5.44    3.71       2.92x10-5        0.03
            cg15969804 -5.48   -1.99   -3.73      2.94x10-5        0.03
            cg06434490 -5.96   -2.16   -4.06      2.91x10-5        0.03
            cg01198111 -5.55   -2.02   -3.78      2.90x10-5        0.03
                       -
FLJ23834    cg00156506         -5.70 -10.71       2.97x10-5        0.03
                       15.72
CHD7        cg25011252 1.74    4.81    3.28       2.93x10-5        0.03
EFEMP2      cg20051715 -6.36   -2.31   -4.33      2.95x10-5        0.03
BCKDK       cg05299836 1.95    5.35    3.65       2.86x10-5        0.03
C17orf108   cg19001909 1.44    3.96    2.70       2.89x10-5        0.03
COL1A1      cg18618815 -5.25   -1.90   -3.58      2.96x10-5        0.03
TMEM49      cg18942579 1.59    4.38    2.98       2.95x10-5        0.03
SH2D3A      cg15055101 1.79    4.92    3.35       2.94x10-5        0.03
PGLYRP2     cg07408456 -5.59   -2.03   -3.81      2.94x10-5        0.03
                       -
            cg13556767         -4.77 -8.96        2.99x10-5        0.03
                       13.15
CHST11      cg06647068 -3.54   -1.28   -2.41      3.04x10-5        0.03
PTPRM       cg25279586 -4.84   -1.75   -3.30      3.04x10-5        0.03
SYDE1       cg22027399 -5.04   -1.82   -3.43      3.04x10-5        0.03
INPP5J      cg26373518 -6.07   -2.20   -4.13      3.05x10-5        0.03
PMEPA1      cg00138126 -5.12   -1.85   -3.49      3.06x10-5        0.03
IFFO2       cg09012001 -4.91   -1.77   -3.34      3.19x10-5        0.03
TMEM222     cg10239563 -6.21   -2.24   -4.22      3.27x10-5        0.03

                                   272


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
PTGFRN     cg08870281 1.64    4.57    3.11       3.32x10-5        0.03
           cg03388247 -7.01   -2.53   -4.77      3.08x10-5        0.03
           cg01100951 -6.98   -2.52   -4.75      3.22x10-5        0.03
PPARGC1B   cg26876242 -2.83   -1.02   -1.92      3.31x10-5        0.03
                      -
SLIT3      cg06007761         -3.74 -7.05        3.19x10-5        0.03
                      10.37
           cg12694224 -5.69   -2.06   -3.87      3.16x10-5        0.03
RNASET2    cg17991206 1.22    3.37    2.29       3.10x10-5        0.03
C7orf50    cg08973950 -3.03   -1.09   -2.06      3.33x10-5        0.03
SCRN1      cg10113101 -6.10   -2.20   -4.15      3.32x10-5        0.03
DDX56      cg13810644 -4.07   -1.47   -2.77      3.10x10-5        0.03
NCALD      cg27110054 -5.75   -2.07   -3.91      3.28x10-5        0.03
KIFC2      cg04794268 -5.05   -1.82   -3.44      3.15x10-5        0.03
SURF4      cg13660174 1.78    4.93    3.36       3.25x10-5        0.03
ELOVL3     cg18288462 -5.43   -1.96   -3.70      3.14x10-5        0.03
           cg14816825 2.00    5.56    3.78       3.24x10-5        0.03
           cg06640997 1.08    2.98    2.03       3.10x10-5        0.03
FAM113B    cg06547285 -6.04   -2.17   -4.11      3.31x10-5        0.03
MGC14436   cg00050496 2.48    6.88    4.68       3.28x10-5        0.03
DTX1       cg18567954 2.47    6.83    4.65       3.15x10-5        0.03
C12orf27   cg10969412 -7.62   -2.75   -5.18      3.25x10-5        0.03
           cg07899411 1.15    3.20    2.18       3.18x10-5        0.03
           cg25015038 -3.61   -1.30   -2.45      3.18x10-5        0.03
EVL        cg14245199 1.11    3.09    2.10       3.22x10-5        0.03
AKAP13     cg05239225 -2.51   -0.90   -1.71      3.31x10-5        0.03
                      -
UNKL       cg04928129         -5.06 -9.54        3.16x10-5        0.03
                      14.02
SF3B3      cg00864954 1.24    3.43 2.33          3.32x10-5        0.03
                      -
CUEDC1     cg08885409         -4.23 -7.98        3.17x10-5        0.03
                      11.73
HCN2       cg13470125 -6.15   -2.22   -4.18      3.18x10-5        0.03
HLCS       cg11638347 -6.11   -2.20   -4.15      3.29x10-5        0.03
GALNT2     cg01554316 4.20    11.69   7.94       3.34x10-5        0.03
GALNT2     cg15723468 1.48    4.13    2.81       3.42x10-5        0.03
           cg02424103 -9.22   -3.31   -6.27      3.42x10-5        0.03
CLNK       cg05582979 -9.79   -3.51   -6.65      3.42x10-5        0.03
FER        cg16174681 -4.11   -1.48   -2.80      3.43x10-5        0.03
STK17A     cg05415936 1.77    4.91    3.34       3.40x10-5        0.03
NEDD1      cg21721825 1.26    3.51    2.39       3.38x10-5        0.03
MAFG       cg07855221 -4.46   -1.60   -3.03      3.43x10-5        0.03

                                  273


                                                                APPENDIX III


                                   Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                   estimate   Value            p –Value
SMARCA4     cg15001636 2.31 6.42 4.37         3.38x10-5        0.03
ARID5B      cg07520810 2.24 6.25 4.25         3.45x10-5        0.03
MAP2K5      cg27219399 -5.77 -2.07 -3.92      3.45x10-5        0.03
                       -
MICA        cg02726263       -6.34 -12.00     3.47x10-5        0.03
                       17.67
ALDOA       cg00583733 -5.95 -2.13 -4.04      3.47x10-5        0.03
GRB2        cg27110374 1.41 3.94 2.68         3.48x10-5        0.03
SKI         cg24481594 1.52 4.25 2.88         3.50x10-5        0.03
CACNA1C     cg10031793 -3.56 -1.28 -2.42      3.51x10-5        0.03
            cg19061690 -7.98 -2.86 -5.42      3.51x10-5        0.03
PRDM2       cg24715767 -6.63 -2.37 -4.50      3.58x10-5        0.03
IL19        cg15392364 0.95 2.66 1.81         3.59x10-5        0.03
SPATS2L     cg08153883 -6.18 -2.21 -4.20      3.56x10-5        0.03
            cg10125599 -7.66 -2.74 -5.20      3.60x10-5        0.03
SHC3        cg13351583 6.02 16.83 11.43       3.59x10-5        0.03
                       -
LOC286359   cg21177384       -5.32 -10.10     3.60x10-5        0.03
                       14.88
EHD1        cg07019638 1.47 4.11 2.79         3.59x10-5        0.03
ITPK1       cg09257735 -4.48 -1.60 -3.04      3.53x10-5        0.03
VAC14       cg08329113 1.53 4.28 2.91         3.59x10-5        0.03
                       -
DLG4        cg12228229       -5.24 -9.94      3.58x10-5        0.03
                       14.63
RHEB        cg06603923 -3.98 -1.42 -2.70      3.63x10-5        0.03
ASAP1IT1    cg03295852 -5.57 -1.99 -3.78      3.64x10-5        0.03
C9orf139    cg02971262 -8.98 -3.21 -6.10      3.65x10-5        0.03
FAM107B     cg14295960 1.56 4.36 2.96         3.61x10-5        0.03
SDCBP2      cg05007126 1.84 5.14 3.49         3.63x10-5        0.03
RORA        cg23411013 -4.03 -1.44 -2.74      3.67x10-5        0.03
ORMDL3      cg19511844 -7.64 -2.73 -5.19      3.67x10-5        0.03
                       -
            cg21241675       -4.82 -9.17      3.69x10-5        0.03
                       13.51
                       -
LATS2       cg18151858       -5.56 -10.57     3.73x10-5        0.03
                       15.58
            cg03598938 -4.71 -1.68 -3.20      3.74x10-5        0.03
HLA-E       cg23235965 1.60 4.48 3.04         3.75x10-5        0.03
            cg11323439 -6.19 -2.21 -4.20      3.75x10-5        0.03
ADAR        cg00048381 2.03 5.70 3.87         3.77x10-5        0.03
            cg06699555 3.29 9.24 6.27         3.79x10-5        0.03
WDR82       cg12048331 1.10 3.09 2.10         3.80x10-5        0.03
PEBP4       cg01211283 1.79 5.03 3.41         3.81x10-5        0.03

                                 274


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
           cg24165921 -7.70   -2.74   -5.22      3.81x10-5        0.03
SLC7A7     cg10853566 -6.57   -2.34   -4.46      3.81x10-5        0.03
UACA       cg01918043 -4.11   -1.46   -2.79      3.80x10-5        0.03
           cg11945474 -3.07   -1.09   -2.08      3.84x10-5        0.03
LRRC33     cg02067535 -5.59   -1.99   -3.79      3.87x10-5        0.03
MIR429     cg06967105 2.05    5.78    3.92       4.05x10-5        0.03
S100A6     cg24375627 -4.22   -1.50   -2.86      4.13x10-5        0.03
           cg10154812 1.13    3.18    2.15       3.95x10-5        0.03
PSMB8      cg12048225 1.26    3.56    2.41       4.09x10-5        0.03
                      -
TRERF1     cg16597079         -3.80 -7.27        4.13x10-5        0.03
                      10.73
SND1       cg02538772 1.26    3.55    2.40       3.90x10-5        0.03
LZTS1      cg10121113 -7.17   -2.55   -4.86      3.98x10-5        0.03
RHOBTB1    cg05171195 -7.35   -2.61   -4.98      4.01x10-5        0.03
CD81       cg10504000 -4.38   -1.56   -2.97      3.90x10-5        0.03
KCNQ1      cg05438727 -6.25   -2.22   -4.23      4.07x10-5        0.03
           cg16981685 1.14    3.22    2.18       4.13x10-5        0.03
KCNJ1      cg25893560 1.39    3.90    2.64       3.95x10-5        0.03
           cg19369955 -2.70   -0.96   -1.83      4.10x10-5        0.03
NCOR2      cg02666020 -5.74   -2.03   -3.89      4.12x10-5        0.03
SLC25A30   cg20558112 -5.05   -1.79   -3.42      4.14x10-5        0.03
           cg10877241 -3.24   -1.15   -2.19      3.94x10-5        0.03
           cg01176433 -3.51   -1.25   -2.38      4.01x10-5        0.03
STARD5     cg05150327 -8.07   -2.86   -5.47      4.12x10-5        0.03
           cg08166214 1.96    5.52    3.74       3.94x10-5        0.03
RRN3P2     cg00525931 -5.22   -1.85   -3.54      4.03x10-5        0.03
                      -
CCL17      cg01100208         -4.22 -8.06        4.06x10-5        0.03
                      11.90
CMIP       cg03766174 -4.38   -1.56   -2.97      4.01x10-5        0.03
MSI2       cg21139312 1.88    5.31    3.60       4.12x10-5        0.03
AXIN2      cg26921093 1.21    3.42    2.32       4.11x10-5        0.03
SEPT9      cg27627381 2.19    6.15    4.17       3.95x10-5        0.03
NPLOC4     cg10954938 -7.08   -2.52   -4.80      3.96x10-5        0.03
                      -
BLVRB      cg06663644         -3.66 -6.98        4.02x10-5        0.03
                      10.31
           cg19344545 1.24    3.51    2.38       4.10x10-5        0.03
PATZ1      cg16369835 11.52   32.48   22.00      4.11x10-5        0.03
EIF4E3     cg22888463 1.46    4.12    2.79       4.15x10-5        0.03
EIF2C2     cg19352830 1.81    5.12    3.47       4.16x10-5        0.03
           cg05262463 1.34    3.79    2.56       4.19x10-5        0.03

                                  275


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
NMNAT3     cg03891318 -6.66   -2.36   -4.51      4.20x10-5        0.03
PIK3CD     cg03971555 1.47    4.15    2.81       4.33x10-5        0.03
ABCB6      cg19412109 -6.56   -2.32   -4.44      4.33x10-5        0.03
           cg05705140 1.01    2.86    1.94       4.30x10-5        0.03
DEPDC1B    cg08795084 -5.94   -2.10   -4.02      4.27x10-5        0.03
           cg11935041 -5.05   -1.79   -3.42      4.26x10-5        0.03
TTYH3      cg03590328 -6.85   -2.42   -4.64      4.30x10-5        0.03
CHRNA6     cg19352832 1.56    4.43    2.99       4.31x10-5        0.03
           cg14832378 0.87    2.47    1.67       4.23x10-5        0.03
SLC25A29   cg02540736 -4.10   -1.45   -2.78      4.26x10-5        0.03
GPR114     cg07877900 -6.75   -2.39   -4.57      4.27x10-5        0.03
           cg10371414 -2.15   -0.76   -1.46      4.33x10-5        0.03
TRAPPC1    cg13021301 -4.81   -1.70   -3.26      4.31x10-5        0.03
KSR1       cg10334489 1.72    4.88    3.30       4.26x10-5        0.03
MMP9       cg10505873 -5.55   -1.96   -3.76      4.30x10-5        0.03
THEMIS     cg11610626 1.21    3.41    2.31       4.35x10-5        0.03
           cg06771839 1.76    4.97    3.36       4.36x10-5        0.03
           cg15013544 -8.77   -3.10   -5.93      4.39x10-5        0.03
SH3PXD2A   cg00277384 -9.44   -3.33   -6.38      4.39x10-5        0.03
           cg07920381 -2.52   -0.89   -1.71      4.39x10-5        0.03
ACOT7      cg25165880 -4.70   -1.66   -3.18      4.46x10-5        0.03
                      -
FGGY       cg00581017         -6.54 -12.54       4.42x10-5        0.03
                      18.54
           cg06566627 2.26    6.41    4.34       4.45x10-5        0.03
CCND3      cg17159550 -7.82   -2.76   -5.29      4.47x10-5        0.03
HACE1      cg03002526 1.16    3.29    2.23       4.48x10-5        0.03
           cg13540411 1.98    5.61    3.79       4.44x10-5        0.03
           cg09488090 -5.28   -1.86   -3.57      4.44x10-5        0.03
RAB37      cg03469804 -3.19   -1.12   -2.15      4.46x10-5        0.03
C21orf57   cg11715092 -4.74   -1.67   -3.20      4.47x10-5        0.03
MTA3       cg02679503 1.59    4.52    3.05       4.51x10-5        0.03
KIAA1949   cg13357602 -4.14   -1.46   -2.80      4.54x10-5        0.03
UNKL       cg26728422 -5.72   -2.01   -3.87      4.52x10-5        0.03
TTYH2      cg23632849 -7.04   -2.48   -4.76      4.55x10-5        0.03
TTC39C     cg18719665 1.15    3.26    2.20       4.55x10-5        0.03
AIRE       cg26472802 1.19    3.38    2.28       4.53x10-5        0.03
           cg25989526 -2.99   -1.05   -2.02      4.57x10-5        0.04
CCHCR1     cg12044213 -4.67   -1.64   -3.15      4.59x10-5        0.04
PNPLA2     cg14689532 -5.12   -1.80   -3.46      4.64x10-5        0.04


                                  276


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
           cg09142405 -4.99   -1.75   -3.37      4.62x10-5        0.04
           cg19515108 1.98    5.62    3.80       4.64x10-5        0.04
ADPGK      cg12691651 2.02    5.74    3.88       4.62x10-5        0.04
IL24       cg16417028 1.39    3.97    2.68       4.66x10-5        0.04
JARID2     cg06487194 -2.26   -0.79   -1.52      4.67x10-5        0.04
                      -
BCAT1      cg07479001         -3.86 -7.42        4.68x10-5        0.04
                      10.98
CD58       cg26118759 -7.24   -2.54 -4.89        4.72x10-5        0.04
                      -
RFC1       cg12062995         -9.01 -17.33       4.71x10-5        0.04
                      25.65
CUEDC1     cg00968616 -4.02   -1.41   -2.71      4.72x10-5        0.04
HDAC4      cg05570654 -7.17   -2.52   -4.85      4.75x10-5        0.04
           cg21360910 -2.83   -0.99   -1.91      4.77x10-5        0.04
           cg02888518 -8.67   -3.04   -5.85      4.77x10-5        0.04
           cg12073436 0.92    2.61    1.76       4.80x10-5        0.04
DENND2C    cg11395799 -8.17   -2.86   -5.52      4.84x10-5        0.04
PDE4DIP    cg22712955 1.40    4.01    2.71       4.92x10-5        0.04
SLC27A3    cg21279955 -6.96   -2.44   -4.70      4.95x10-5        0.04
           cg12697139 -8.29   -2.89   -5.59      5.16x10-5        0.04
MRPL55     cg08158976 -4.35   -1.52   -2.94      4.89x10-5        0.04
           cg13693136 -4.84   -1.69   -3.27      5.11x10-5        0.04
           cg04335293 -6.39   -2.24   -4.31      4.96x10-5        0.04
PDCD1      cg25890838 1.83    5.24    3.54       5.21x10-5        0.04
CTNNB1     cg09678212 -5.45   -1.90   -3.67      5.22x10-5        0.04
SEC22C     cg25686812 4.01    11.47   7.74       5.03x10-5        0.04
                      -
FRMD4B     cg07164133         -4.85 -9.37        5.12x10-5        0.04
                      13.89
           cg10599446 1.17    3.36    2.26       5.17x10-5        0.04
           cg06012804 1.26    3.60    2.43       5.23x10-5        0.04
KIAA1530   cg25505570 3.86    11.04   7.45       5.06x10-5        0.04
N4BP2      cg21410980 2.85    8.18    5.52       5.19x10-5        0.04
TCF7       cg18338046 1.16    3.33    2.25       5.25x10-5        0.04
           cg17328407 1.55    4.45    3.00       5.19x10-5        0.04
ATXN1      cg03680932 7.93    22.74   15.33      5.18x10-5        0.04
ETV7       cg20447038 -4.67   -1.63   -3.15      5.25x10-5        0.04
PTK7       cg08558323 -6.78   -2.37   -4.58      5.09x10-5        0.04
                      -
MTHFD1L    cg22954978         -4.41 -8.52        5.04x10-5        0.04
                      12.63
JAZF1      cg22938901 -5.85   -2.04 -3.95        5.20x10-5        0.04


                                  277


                                                                APPENDIX III


                                      Effect     Uncorrected p- FDR corrected
Gene       CpG site     CI- 95%
                                      estimate   Value          p –Value
                      -
TMEM140    cg12577010         -4.02 -7.76        5.04x10-5     0.04
                      11.51
           cg00459992 1.50    4.28    2.89       4.98x10-5     0.04
NSMAF      cg25874782 -4.16   -1.46   -2.81      4.90x10-5     0.04
ZC3H3      cg24561207 3.03    8.65    5.84       4.82x10-5     0.04
           cg14554880 -5.70   -1.99   -3.85      5.21x10-5     0.04
INPP5A     cg13521018 0.77    2.21    1.49       5.18x10-5     0.04
APBB1      cg16230121 1.05    3.00    2.02       4.86x10-5     0.04
           cg24068972 1.77    5.06    3.42       4.97x10-5     0.04
BSCL2      cg23916044 -6.71   -2.35   -4.53      4.91x10-5     0.04
SNORD22    cg18159646 2.18    6.23    4.20       4.90x10-5     0.04
EHD1       cg14378925 1.48    4.25    2.87       5.25x10-5     0.04
SIK3       cg06928797 -4.88   -1.70   -3.29      5.18x10-5     0.04
HDAC7      cg15820955 1.89    5.42    3.66       5.11x10-5     0.04
CAB39L     cg02210115 -3.24   -1.13   -2.19      4.93x10-5     0.04
           cg11879741 -4.81   -1.68   -3.25      5.06x10-5     0.04
                      -
LTK        cg21867850         -6.33 -12.24       5.22x10-5     0.04
                      18.16
           cg21024495 -4.09   -1.43   -2.76      5.07x10-5     0.04
KSR1       cg05784862 1.31    3.74    2.52       5.11x10-5     0.04
RAB34      cg12873610 -5.33   -1.87   -3.60      4.94x10-5     0.04
TMC8       cg26003388 1.87    5.37    3.62       5.16x10-5     0.04
GNG7       cg22459924 1.28    3.68    2.48       5.04x10-5     0.04
FAM129C    cg12550597 -5.55   -1.94   -3.75      5.11x10-5     0.04
ITPKC      cg21202522 -7.89   -2.76   -5.32      4.91x10-5     0.04
OXT        cg13285174 -2.65   -0.92   -1.79      5.17x10-5     0.04
                      -
C21orf96   cg16071713         -3.62 -6.99        5.10x10-5     0.04
                      10.36
YPEL1      cg02774935 -3.71   -1.30   -2.50      5.05x10-5     0.04
TAP1       cg17626301 0.95    2.72    1.83       5.26x10-5     0.04
LGALS2     cg14711067 -8.76   -3.05   -5.91      5.28x10-5     0.04
FAM63A     cg21937128 -3.99   -1.38   -2.68      5.48x10-5     0.04
FAM179A    cg04304121 -3.26   -1.13   -2.19      5.52x10-5     0.04
SRBD1      cg12939390 -2.96   -1.03   -1.99      5.50x10-5     0.04
PLEK       cg04872689 -6.91   -2.40   -4.66      5.40x10-5     0.04
                      -
           cg24407086         -3.70 -7.18        5.61x10-5     0.04
                      10.67
ECEL1P2    cg09490371 1.32    3.81 2.56          5.62x10-5     0.04
           cg16033723 -7.87   -2.73 -5.30        5.62x10-5     0.04
ACAP2      cg05141059 -4.39   -1.53 -2.96        5.46x10-5     0.04

                                  278


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene           CpG site   CI- 95%
                                      estimate   Value            p –Value
PDGFC          cg18688704 -5.05 -1.75 -3.40      5.59x10-5        0.04
PALLD          cg08947774 -3.59 -1.25 -2.42      5.36x10-5        0.04
                          -
SLC6A18        cg12913587       -4.80 -9.31      5.57x10-5        0.04
                          13.83
               cg04505252 -5.78 -2.00 -3.89      5.57x10-5        0.04
DAXX           cg07607074 2.54 7.34 4.94         5.56x10-5        0.04
PRPH2          cg14517133 -8.71 -3.02 -5.86      5.52x10-5        0.04
               cg10794973 -6.15 -2.14 -4.15      5.31x10-5        0.04
BACH2          cg03035849 1.23 3.56 2.40         5.63x10-5        0.04
               cg22277485 1.14 3.29 2.22         5.49x10-5        0.04
                          -
LOC100287834   cg26948064       -5.74 -11.13     5.41x10-5        0.04
                          16.52
TPST1          cg03193328 -3.94 -1.37 -2.65      5.46x10-5        0.04
FGF17          cg08095204 -8.25 -2.86 -5.55      5.59x10-5        0.04
PPP3CC         cg19694519 1.09 3.14 2.12         5.58x10-5        0.04
CUGBP2         cg15777781 2.14 6.19 4.16         5.64x10-5        0.04
MGMT           cg04876500 1.77 5.10 3.43         5.38x10-5        0.04
AIP            cg20973735 1.31 3.77 2.54         5.60x10-5        0.04
UCP2           cg25429672 1.03 2.96 1.99         5.65x10-5        0.04
               cg26585452 1.29 3.72 2.51         5.32x10-5        0.04
               cg09232358 1.16 3.33 2.24         5.47x10-5        0.04
TTC7B          cg06937409 -6.21 -2.16 -4.18      5.37x10-5        0.04
PAK6           cg01965476 3.19 9.16 6.17         5.39x10-5        0.04
NTAN1          cg26629184 -6.55 -2.28 -4.41      5.44x10-5        0.04
CORO1A         cg02767068 2.98 8.61 5.80         5.65x10-5        0.04
MIR21          cg15759721 1.42 4.08 2.75         5.41x10-5        0.04
SLC16A5        cg08434692 3.15 9.05 6.10         5.38x10-5        0.04
FAM100B        cg16429214 2.16 6.22 4.19         5.56x10-5        0.04
TTC39C         cg12639429 1.43 4.12 2.78         5.58x10-5        0.04
               cg04638374 3.62 10.41 7.02        5.37x10-5        0.04
TIAM1          cg26648185 1.44 4.14 2.79         5.50x10-5        0.04
               cg05949181 1.12 3.21 2.16         5.51x10-5        0.04
KCNQ1          cg07556018 -3.41 -1.18 -2.29      5.68x10-5        0.04
                          -     -
LIMD2          cg20797699             -22.62     5.68x10-5        0.04
                          33.61 11.64
RNF186         cg17135423 2.63 7.61 5.12         5.81x10-5        0.04
INTS7          cg02451670 -5.98 -2.07 -4.02      5.82x10-5        0.04
                          -
ZNF620         cg14039773       -9.38 -18.25     5.79x10-5        0.04
                          27.12
GABBR1         cg09740560 -3.42 -1.18 -2.30      5.71x10-5        0.04

                                    279


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
PRKAG2     cg17192599 -3.85   -1.33   -2.59      5.79x10-5        0.04
LY6E       cg12110437 0.84    2.44    1.64       5.82x10-5        0.04
IFITM1     cg01886988 1.94    5.62    3.78       5.82x10-5        0.04
SNORD30    cg09448652 1.54    4.45    3.00       5.70x10-5        0.04
OAF        cg01146320 -6.39   -2.21   -4.30      5.79x10-5        0.04
SSH1       cg26663772 1.52    4.40    2.96       5.79x10-5        0.04
ZFP36L1    cg01424562 1.16    3.37    2.27       5.81x10-5        0.04
MYO5C      cg06192883 2.21    6.40    4.31       5.84x10-5        0.04
RORA       cg14720274 3.27    9.46    6.37       5.77x10-5        0.04
WDR7       cg26024874 1.23    3.57    2.40       5.80x10-5        0.04
ELOF1      cg23760945 0.95    2.76    1.86       5.84x10-5        0.04
PHLDB3     cg15664905 -5.75   -1.99   -3.87      5.83x10-5        0.04
ADORA2A    cg27381549 1.55    4.49    3.02       5.77x10-5        0.04
RERE       cg19679865 1.25    3.62    2.43       6.10x10-5        0.04
H6PD       cg09025327 2.15    6.23    4.19       6.06x10-5        0.04
                      -
C2orf62    cg27367952         -5.75 -11.21       6.06x10-5        0.04
                      16.68
PASK       cg10648547 3.85    11.15 7.50         6.02x10-5        0.04
                      -
           cg21413797         -3.50 -6.81        5.96x10-5        0.04
                      10.13
           cg15504461 -7.15   -2.47   -4.81      5.90x10-5        0.04
PLCH1      cg11932158 -6.99   -2.41   -4.70      6.08x10-5        0.04
HAVCR2     cg19646897 1.57    4.56    3.06       6.01x10-5        0.04
ZNF193     cg15407162 -3.65   -1.26   -2.45      5.88x10-5        0.04
SYNCRIP    cg00937359 1.78    5.15    3.46       5.93x10-5        0.04
HECA       cg08943714 -3.92   -1.35   -2.64      5.92x10-5        0.04
FOXK1      cg01974478 1.90    5.52    3.71       6.03x10-5        0.04
PTPRN2     cg01235172 1.74    5.04    3.39       6.10x10-5        0.04
PTGS1      cg00501774 -7.27   -2.50   -4.89      6.09x10-5        0.04
           cg07807026 -6.37   -2.20   -4.29      5.94x10-5        0.04
           cg24730612 -3.68   -1.27   -2.47      6.06x10-5        0.04
GCHFR      cg19433807 2.04    5.90    3.97       5.88x10-5        0.04
TRAPPC1    cg01837574 -3.75   -1.29   -2.52      6.01x10-5        0.04
ORMDL3     cg10444806 -3.55   -1.22   -2.39      6.07x10-5        0.04
LGALS3BP   cg04927537 1.45    4.20    2.83       5.92x10-5        0.04
CSNK1D     cg01807946 -4.99   -1.72   -3.35      6.09x10-5        0.04
APBA3      cg20366831 1.28    3.72    2.50       6.04x10-5        0.04
OXT        cg04731988 -4.37   -1.51   -2.94      5.91x10-5        0.04
OXT        cg26267561 -3.82   -1.32   -2.57      6.00x10-5        0.04
PYGB       cg04348305 1.54    4.47    3.01       6.05x10-5        0.04

                                  280


                                                            APPENDIX III


                                  Effect     Uncorrected p- FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value          p –Value
                                                    -5
WISP2      cg01750375 -5.03 -1.73 -3.38      5.99x10        0.04
                      -
           cg05941631       -4.22 -8.23      6.17x10-5     0.04
                      12.25
CHFR       cg02519218 1.28 3.71 2.49         6.19x10-5     0.04
ERC1       cg06708720 -4.61 -1.59 -3.10      6.23x10-5     0.04
           cg17098093 -6.13 -2.11 -4.12      6.27x10-5     0.04
ARAP2      cg22518157 2.32 6.73 4.52         6.26x10-5     0.04
CSPP1      cg24190223 -3.33 -1.14 -2.24      6.27x10-5     0.04
           cg07673979 -7.48 -2.57 -5.02      6.27x10-5     0.04
JARID2     cg13027183 -3.07 -1.05 -2.06      6.31x10-5     0.04
WIBG       cg08338281 0.69 2.01 1.35         6.34x10-5     0.04
                      -
TMEM53     cg10808027       -4.75 -9.29      6.40x10-5     0.04
                      13.83
LRRC33     cg15726700 -6.77 -2.32 -4.54      6.41x10-5     0.04
GPSM3      cg26301953 -5.40 -1.85 -3.62      6.41x10-5     0.04
C9orf167   cg13274149 1.39 4.05 2.72         6.37x10-5     0.04
BIRC2      cg26207239 1.32 3.84 2.58         6.41x10-5     0.04
ATP11A     cg27391403 -9.58 -3.29 -6.44      6.40x10-5     0.04
TNFRSF1B   cg15526535 1.18 3.44 2.31         6.48x10-5     0.04
           cg12646386 3.67 10.71 7.19        6.60x10-5     0.04
MAN1C1     cg04631202 -6.63 -2.27 -4.45      6.54x10-5     0.04
SPAG16     cg18859776 -4.77 -1.64 -3.21      6.45x10-5     0.04
                      -
           cg18727895       -4.37 -8.56      6.56x10-5     0.04
                      12.75
           cg10920316 4.30 12.56 8.43        6.50x10-5     0.04
PSMB8      cg11381564 1.30 3.78 2.54         6.55x10-5     0.04
           cg22273555 -7.04 -2.41 -4.73      6.59x10-5     0.04
NR4A3      cg13655635 -5.57 -1.91 -3.74      6.58x10-5     0.04
MYST4      cg07410339 -2.82 -0.97 -1.89      6.56x10-5     0.04
BTG4       cg09148270 -4.70 -1.61 -3.15      6.56x10-5     0.04
FLI1       cg02536065 -5.16 -1.77 -3.47      6.44x10-5     0.04
                      -
           cg25780735       -3.48 -6.82      6.59x10-5     0.04
                      10.16
LGALS3BP   cg25178683 1.49 4.36 2.93         6.45x10-5     0.04
PODNL1     cg26969888 -5.41 -1.85 -3.63      6.54x10-5     0.04
ASXL1      cg24727216 1.44 4.20 2.82         6.58x10-5     0.04
           cg01772743 1.00 2.92 1.96         6.51x10-5     0.04
TEF        cg13228442 -9.35 -3.21 -6.28      6.51x10-5     0.04
LYRM4      cg24686957 -5.79 -1.98 -3.88      6.62x10-5     0.04
           cg03984055 -5.47 -1.87 -3.67      6.68x10-5     0.04

                                281


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
WDR82      cg25236791 1.41    4.13    2.77       6.69x10-5        0.04
ITGAM      cg00833777 -6.08   -2.08   -4.08      6.70x10-5        0.04
           cg03324138 1.46    4.26    2.86       6.76x10-5        0.04
FOXN2      cg00032884 1.02    2.99    2.01       6.73x10-5        0.04
ADK        cg09299075 -3.21   -1.10   -2.15      6.76x10-5        0.04
IFIT1L     cg18044543 -2.59   -0.89   -1.74      6.74x10-5        0.04
           cg25514148 2.28    6.67    4.47       6.77x10-5        0.04
           cg07684519 -4.01   -1.37   -2.69      6.76x10-5        0.04
HIST1H3G   cg02481934 -7.48   -2.56   -5.02      6.82x10-5        0.04
VWA5B2     cg25447717 -5.57   -1.90   -3.74      6.85x10-5        0.04
           cg06875162 -3.82   -1.30   -2.56      6.87x10-5        0.04
SPTBN1     cg03017850 1.70    4.99    3.34       6.90x10-5        0.04
IFITM1     cg23570810 1.14    3.33    2.24       6.90x10-5        0.04
DST        cg15599182 1.03    3.01    2.02       6.93x10-5        0.04
UBAC2      cg24509225 1.71    5.00    3.35       6.95x10-5        0.04
SKI        cg01852476 2.43    7.14    4.79       7.06x10-5        0.04
RPS6KA1    cg09900893 -6.78   -2.31   -4.54      7.10x10-5        0.04
GBP1       cg07970007 2.30    6.74    4.52       7.03x10-5        0.04
C1orf9     cg00452835 -6.71   -2.29   -4.50      7.08x10-5        0.04
MRPL55     cg09462576 -3.75   -1.28   -2.52      6.99x10-5        0.04
           cg14915462 -8.53   -2.91   -5.72      7.03x10-5        0.04
CCDC12     cg00906812 -7.95   -2.71   -5.33      6.98x10-5        0.04
           cg16735495 -4.34   -1.48   -2.91      7.09x10-5        0.04
LY96       cg23732024 0.69    2.03    1.36       7.05x10-5        0.04
ENTPD7     cg12608633 -5.34   -1.82   -3.58      7.04x10-5        0.04
FLT3       cg20227511 -2.33   -0.79   -1.56      7.11x10-5        0.04
EPSTI1     cg09843907 1.25    3.66    2.45       7.07x10-5        0.04
ACSF3      cg06419212 7.11    20.89   14.00      7.11x10-5        0.04
HMHA1      cg16239536 1.20    3.52    2.36       7.03x10-5        0.04
WISP2      cg02481642 -3.69   -1.26   -2.48      7.06x10-5        0.04
MDS2       cg22613968 0.94    2.77    1.86       7.20x10-5        0.04
                      -
           cg27565650         -3.93 -7.74        7.13x10-5        0.04
                      11.55
           cg08056629 1.47    4.32    2.89       7.20x10-5        0.04
           cg05986288 -3.38   -1.15   -2.26      7.17x10-5        0.04
ZBTB43     cg14408428 1.58    4.65    3.11       7.20x10-5        0.04
           cg04384031 -5.23   -1.78   -3.51      7.18x10-5        0.04
STAT3      cg08652441 1.37    4.04    2.70       7.20x10-5        0.04
DNAH17     cg00735218 -7.52   -2.56   -5.04      7.21x10-5        0.04


                                  282


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
IL4I1      cg09767736 -6.35   -2.16   -4.25      7.18x10-5        0.04
MFSD2A     cg01869896 -3.59   -1.22   -2.41      7.24x10-5        0.04
           cg17850055 1.41    4.16    2.78       7.23x10-5        0.04
KSR1       cg17585031 2.07    6.10    4.09       7.24x10-5        0.04
ZNF697     cg15513620 -5.05   -1.71   -3.38      7.26x10-5        0.04
                      -
           cg08889234         -7.01 -13.83       7.28x10-5        0.04
                      20.64
           cg17631454 -6.30   -2.14   -4.22      7.27x10-5        0.04
IMMP2L     cg02729030 -6.96   -2.37   -4.66      7.28x10-5        0.04
TRIP4      cg18711535 1.11    3.26    2.19       7.29x10-5        0.04
SFXN5      cg17329648 -2.46   -0.83   -1.65      7.37x10-5        0.04
RAPGEF4    cg23622047 1.50    4.43    2.96       7.42x10-5        0.04
PDCD1      cg18096388 2.50    7.38    4.94       7.44x10-5        0.04
SLC6A6     cg16032408 -7.19   -2.44   -4.82      7.45x10-5        0.04
CD200R1    cg10708271 0.92    2.70    1.81       7.37x10-5        0.04
ADAMTS2    cg00329441 -5.83   -1.98   -3.90      7.45x10-5        0.04
           cg11630152 -3.45   -1.17   -2.31      7.38x10-5        0.04
ADRBK1     cg19905880 -9.39   -3.19   -6.29      7.42x10-5        0.04
           cg02259081 -3.74   -1.27   -2.51      7.39x10-5        0.04
                      -
TTC23      cg07470275         -4.79 -9.45        7.43x10-5        0.04
                      14.12
           cg03835547 3.55    10.45 7.00         7.42x10-5        0.04
GNB1L      cg15198068 -5.99   -2.03 -4.01        7.35x10-5        0.04
           cg18141622 -2.51   -0.85 -1.68        7.53x10-5        0.04
                      -
TADA2B     cg01220768         -4.12 -8.13        7.52x10-5        0.04
                      12.15
ARID5B     cg16401465 1.68    4.97    3.33       7.54x10-5        0.04
PRF1       cg23364656 1.61    4.76    3.18       7.53x10-5        0.04
AIP        cg13603599 1.00    2.95    1.97       7.50x10-5        0.04
           cg19697042 -5.12   -1.73   -3.43      7.51x10-5        0.04
HSH2D      cg02025270 -5.48   -1.86   -3.67      7.54x10-5        0.04
                      -
C19orf51   cg12018403         -5.63 -11.11       7.52x10-5        0.04
                      16.60
ITGB2      cg08422803 1.90    5.62 3.76          7.52x10-5        0.04
TGFBR3     cg08848903 -6.39   -2.16 -4.28        7.68x10-5        0.04
           cg22534374 -3.52   -1.19 -2.36        7.69x10-5        0.04
                      -
ULK4       cg06061536         -4.24 -8.39        7.66x10-5        0.04
                      12.54
           cg04451880 -3.52   -1.19 -2.36        7.64x10-5        0.04
SKIL       cg14612335 -4.16   -1.41 -2.79        7.60x10-5        0.04

                                  283


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
KIAA0922   cg20367304 1.16    3.43    2.29       7.57x10-5        0.04
ATP6V0E1   cg05201300 -5.03   -1.70   -3.37      7.67x10-5        0.04
INTS1      cg06942110 2.81    8.31    5.56       7.69x10-5        0.04
LRRN3      cg09837977 1.34    3.94    2.64       7.57x10-5        0.04
                      -
JPH1       cg05134476         -4.58 -9.05        7.64x10-5        0.04
                      13.53
DGKA       cg02330507 1.88    5.56    3.72       7.59x10-5        0.04
C14orf64   cg00263248 0.92    2.71    1.81       7.61x10-5        0.04
BCL11B     cg16452866 0.81    2.40    1.61       7.69x10-5        0.04
ISG20      cg00854314 2.03    5.98    4.00       7.62x10-5        0.04
C2orf88    cg05969591 -4.74   -1.60   -3.17      7.71x10-5        0.04
TNIP3      cg24215459 0.95    2.81    1.88       7.72x10-5        0.04
FBXO34     cg04853218 -3.70   -1.25   -2.47      7.74x10-5        0.04
CAPZB      cg16694480 1.59    4.71    3.15       7.78x10-5        0.04
NDUFS2     cg14382215 -6.74   -2.28   -4.51      7.79x10-5        0.04
TNNT3      cg02556649 4.92    14.56   9.74       7.77x10-5        0.04
MT2A       cg06663317 2.35    6.97    4.66       7.80x10-5        0.04
AXIN2      cg23475474 1.64    4.85    3.24       7.81x10-5        0.04
           cg02849956 -3.96   -1.34   -2.65      7.80x10-5        0.04
           cg17648076 1.05    3.11    2.08       7.83x10-5        0.04
PLEK       cg13060970 -4.32   -1.46   -2.89      7.87x10-5        0.04
                      -       -
PAM        cg04227789                 -39.37     7.88x10-5        0.04
                      58.87   19.88
SLC9A9     cg25945642 -2.24   -0.76   -1.50      7.89x10-5        0.04
PVT1       cg23896695 1.05    3.10    2.07       7.92x10-5        0.04
FNBP1L     cg22803510 -6.85   -2.31   -4.58      7.95x10-5        0.04
           cg07680505 2.21    6.55    4.38       7.95x10-5        0.04
FAM102B    cg21805788 -4.07   -1.37   -2.72      8.01x10-5        0.04
RNASET2    cg11301670 1.50    4.44    2.97       8.01x10-5        0.04
                      -
EXOC4      cg06070229         -4.18 -8.29        7.99x10-5        0.04
                      12.40
CCDC155    cg03100209 -3.26   -1.10   -2.18      7.98x10-5        0.04
           cg15569630 -6.59   -2.22   -4.41      8.05x10-5        0.04
           cg00058291 -3.94   -1.33   -2.64      8.06x10-5        0.04
           cg20155035 -4.24   -1.43   -2.84      8.07x10-5        0.04
LRRFIP1    cg12251803 -5.15   -1.74   -3.45      8.11x10-5        0.04
ZNF620     cg13461273 -6.12   -2.06   -4.09      8.09x10-5        0.04
UBA7       cg19381811 -4.41   -1.48   -2.95      8.08x10-5        0.04
ZBTB9      cg14999947 -2.90   -0.98   -1.94      8.11x10-5        0.04
ZMIZ1      cg11961495 -5.34   -1.80   -3.57      8.03x10-5        0.04

                                  284


                                                               APPENDIX III


                                  Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value            p –Value
C17orf75   cg17055821 -4.19 -1.41 -2.80      8.11x10-5        0.04
TNFAIP3    cg08919597 -3.98 -1.34 -2.66      8.12x10-5        0.04
                      -
HES2       cg00644814       -5.84 -11.59     8.17x10-5        0.04
                      17.35
                      -
PLXND1     cg15629311       -3.54 -7.03      8.17x10-5        0.04
                      10.52
ZNF589     cg01458495 1.64 4.87 3.25         8.19x10-5        0.04
TNFRSF8    cg22123711 -4.78 -1.61 -3.19      8.39x10-5        0.04
IFFO2      cg05626128 -5.37 -1.81 -3.59      8.40x10-5        0.04
C1orf21    cg22039357 -3.26 -1.10 -2.18      8.30x10-5        0.04
FAIM3      cg17100176 1.30 3.88 2.59         8.32x10-5        0.04
INPP1      cg15635368 -6.83 -2.29 -4.56      8.40x10-5        0.04
DOCK10     cg04168675 1.44 4.29 2.87         8.43x10-5        0.04
UBE2E1     cg19719475 -4.87 -1.64 -3.25      8.30x10-5        0.04
                      -
GNL3       cg18595196       -6.23 -12.39     8.43x10-5        0.04
                      18.54
FRMD4B     cg11377213 -2.84 -0.95 -1.89      8.43x10-5        0.04
EPGN       cg19747465 1.15 3.41 2.28         8.32x10-5        0.04
           cg21960364 1.69 5.04 3.37         8.34x10-5        0.04
           cg16230626 -3.33 -1.12 -2.22      8.29x10-5        0.04
LSM11      cg27117005 -9.72 -3.27 -6.49      8.28x10-5        0.04
           cg23127986 -6.26 -2.10 -4.18      8.42x10-5        0.04
           cg15758240 -4.23 -1.42 -2.83      8.23x10-5        0.04
           cg11107430 -8.19 -2.75 -5.47      8.32x10-5        0.04
KCNQ1      cg12141659 -5.50 -1.85 -3.68      8.39x10-5        0.04
           cg20907456 -5.51 -1.85 -3.68      8.41x10-5        0.04
           cg11465943 1.34 3.99 2.67         8.27x10-5        0.04
SERPINA1   cg01606800 -7.39 -2.48 -4.94      8.38x10-5        0.04
           cg08884974 -7.86 -2.64 -5.25      8.20x10-5        0.04
SYNGR3     cg26787199 -8.81 -2.97 -5.89      8.21x10-5        0.04
MIR193B    cg06273075 -4.41 -1.48 -2.95      8.42x10-5        0.04
C17orf75   cg04936619 -3.88 -1.30 -2.59      8.37x10-5        0.04
ERAP1      cg01142811 -5.62 -1.89 -3.76      8.48x10-5        0.04
CTNNBIP1   cg08934126 -5.87 -1.97 -3.92      8.56x10-5        0.04
PLK3       cg27583604 1.55 4.64 3.10         8.72x10-5        0.04
                      -
PIGC       cg16177739       -3.70 -7.36      8.60x10-5        0.04
                      11.03
ADCY3      cg26752663 1.06 3.15 2.10         8.58x10-5        0.04
           cg12542656 -4.44 -1.49 -2.97      8.60x10-5        0.04
DUSP2      cg04118190 1.98 5.89 3.93         8.53x10-5        0.04

                                285


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
CX3CR1     cg24130739 -4.44   -1.49   -2.96      8.69x10-5        0.04
EIF4G1     cg05677133 1.86    5.56    3.71       8.68x10-5        0.04
LEF1       cg12623364 2.38    7.08    4.73       8.55x10-5        0.04
SNX18      cg26118943 -3.41   -1.14   -2.28      8.64x10-5        0.04
LHFPL2     cg14114546 -2.70   -0.90   -1.80      8.73x10-5        0.04
C6orf154   cg01316923 -7.32   -2.45   -4.89      8.73x10-5        0.04
SMARCA2    cg13586038 2.79    8.33    5.56       8.73x10-5        0.04
GRK5       cg09337049 2.10    6.26    4.18       8.51x10-5        0.04
FAM53B     cg07081759 -5.21   -1.75   -3.48      8.59x10-5        0.04
SNORD30    cg03431111 1.25    3.72    2.49       8.64x10-5        0.04
                      -
ALDH3B1    cg00414166         -4.00 -7.96        8.57x10-5        0.04
                      11.93
CUX2       cg16721194 -6.71   -2.25   -4.48      8.60x10-5        0.04
           cg05899984 1.41    4.20    2.80       8.72x10-5        0.04
           cg00478326 1.28    3.81    2.55       8.73x10-5        0.04
RAB37      cg08661469 -6.21   -2.08   -4.14      8.69x10-5        0.04
           cg05850338 -2.78   -0.93   -1.85      8.73x10-5        0.04
IGLL1      cg02415431 -5.96   -2.00   -3.98      8.71x10-5        0.04
           cg14085060 -3.88   -1.30   -2.59      8.77x10-5        0.04
GATA3      cg00463367 2.61    7.80    5.20       8.77x10-5        0.04
           cg15514918 1.09    3.26    2.18       8.80x10-5        0.04
           cg10855531 -6.85   -2.29   -4.57      8.80x10-5        0.04
CEACAM3    cg15094920 -9.00   -3.01   -6.01      8.80x10-5        0.04
AGTRAP     cg21826784 -3.20   -1.07   -2.13      9.07x10-5        0.04
DDOST      cg14519150 1.62    4.83    3.23       8.91x10-5        0.04
FBXO11     cg09664186 -4.00   -1.33   -2.67      9.19x10-5        0.04
           cg27614178 -2.98   -0.99   -1.99      9.33x10-5        0.04
GPR55      cg19827923 3.10    9.27    6.18       8.93x10-5        0.04
FOXP1      cg21379733 1.14    3.41    2.28       9.23x10-5        0.04
           cg18772838 -5.63   -1.87   -3.75      9.34x10-5        0.04
BDH2       cg11469321 -9.43   -3.14   -6.29      9.12x10-5        0.04
                      -
C4orf39    cg00007239         -4.60 -9.19        8.97x10-5        0.04
                      13.78
SH3TC2     cg26474043 -5.24   -1.75   -3.49      9.16x10-5        0.04
           cg20892245 -4.76   -1.59   -3.17      9.23x10-5        0.04
JARID2     cg08757670 -7.21   -2.40   -4.80      9.23x10-5        0.04
C6orf27    cg15501231 -6.21   -2.07   -4.14      9.01x10-5        0.04
SYNGAP1    cg01468420 -6.26   -2.09   -4.18      9.08x10-5        0.04
                      -
ETV1       cg20909656         -6.42 -12.82       9.08x10-5        0.04
                      19.23

                                  286


                                                                APPENDIX III


                                   Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                   estimate   Value            p –Value
            cg15812586 -3.33 -1.11 -2.22      9.21x10-5        0.04
ZNF862      cg19507256 3.12 9.35 6.23         9.07x10-5        0.04
FAM167A     cg06551905 2.17 6.50 4.34         9.14x10-5        0.04
                       -
PGCP        cg11536940       -4.22 -8.42      8.95x10-5        0.04
                       12.62
NCALD       cg24023489 -2.98 -0.99 -1.99      9.27x10-5        0.04
            cg11263617 -7.53 -2.52 -5.02      9.05x10-5        0.04
NCOA4       cg13859860 -6.96 -2.32 -4.64      9.32x10-5        0.04
DLG5        cg19836471 -9.02 -3.01 -6.01      8.95x10-5        0.04
ZMIZ1       cg23865980 -3.22 -1.07 -2.15      9.28x10-5        0.04
                       -     -
HPSE2       cg24134845             -26.95     9.03x10-5        0.04
                       40.41 13.49
TNNI2       cg25623459 -6.05 -2.02 -4.04      8.89x10-5        0.04
KCNQ1       cg13428066 -3.77 -1.26 -2.52      8.88x10-5        0.04
UEVLD       cg15846482 -4.25 -1.42 -2.83      9.08x10-5        0.04
            cg24119798 2.41 7.25 4.83         9.31x10-5        0.04
RPS6KB2     cg03559915 1.42 4.26 2.84         8.96x10-5        0.04
TMEM133     cg06965373 1.17 3.50 2.33         9.18x10-5        0.04
FBXL14      cg17150898 1.66 5.00 3.33         9.30x10-5        0.04
RAPGEF3     cg14854517 -3.06 -1.02 -2.04      9.24x10-5        0.04
DGKA        cg26477856 1.33 3.97 2.65         9.04x10-5        0.04
            cg18038207 -3.63 -1.21 -2.42      9.21x10-5        0.04
LMO7        cg00902815 2.42 7.25 4.83         9.18x10-5        0.04
RASA3       cg03399609 -6.11 -2.04 -4.08      8.88x10-5        0.04
            cg26271776 1.29 3.87 2.58         9.15x10-5        0.04
MMP14       cg10418289 -5.65 -1.89 -3.77      8.98x10-5        0.04
BCL11B      cg08129129 1.33 3.97 2.65         8.93x10-5        0.04
EVL         cg17813891 0.90 2.69 1.80         9.04x10-5        0.04
SH2D7       cg02279625 -3.89 -1.30 -2.59      9.02x10-5        0.04
AXIN2       cg26308530 -6.16 -2.06 -4.11      8.91x10-5        0.04
LGALS3BP    cg11105610 1.50 4.50 3.00         9.29x10-5        0.04
NAPA        cg24009074 2.13 6.38 4.26         8.92x10-5        0.04
C20orf141   cg15013617 -3.15 -1.05 -2.10      9.30x10-5        0.04
EIF2S2      cg01562356 -8.43 -2.81 -5.62      9.28x10-5        0.04
MICAL3      cg04520704 1.33 3.98 2.65         9.25x10-5        0.04
ADSL        cg25636159 1.43 4.27 2.85         8.86x10-5        0.04
ADSL        cg13370427 2.48 7.43 4.96         8.90x10-5        0.04
            cg09978533 -3.43 -1.14 -2.29      9.18x10-5        0.04
HHLA2       cg02059214 2.12 6.36 4.24         9.36x10-5        0.04
RERE        cg17442683 1.11 3.32 2.22         9.43x10-5        0.04

                                 287


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
FYCO1      cg18682028 1.29    3.88    2.59       9.41x10-5        0.04
RAB6B      cg00448875 -5.31   -1.77   -3.54      9.40x10-5        0.04
TNRC18     cg09022230 -4.45   -1.48   -2.97      9.39x10-5        0.04
           cg14517126 -3.14   -1.04   -2.09      9.43x10-5        0.04
TSPO       cg00343092 -4.80   -1.60   -3.20      9.44x10-5        0.04
NUP210     cg06143615 1.60    4.82    3.21       9.46x10-5        0.04
           cg07974367 1.64    4.93    3.29       9.46x10-5        0.04
           cg06287548 -2.98   -0.99   -1.98      9.50x10-5        0.04
           cg24043628 -5.57   -1.85   -3.71      9.53x10-5        0.04
CHI3L2     cg09516523 1.16    3.49    2.33       9.56x10-5        0.04
                      -
GNL1       cg15789723         -3.40 -6.82        9.56x10-5        0.04
                      10.24
MAPKAPK2   cg06419268 -4.51   -1.50   -3.01      9.59x10-5        0.04
STRADA     cg20157577 1.33    4.01    2.67       9.59x10-5        0.04
PSMD13     cg05600342 1.43    4.31    2.87       9.62x10-5        0.04
           cg02033302 -4.36   -1.45   -2.90      9.62x10-5        0.04
           cg26600461 1.43    4.30    2.87       9.63x10-5        0.04
CA12       cg03036214 -3.89   -1.29   -2.59      9.67x10-5        0.04
EPN1       cg27573549 3.26    9.80    6.53       9.66x10-5        0.04
IFITM1     cg21686213 1.07    3.22    2.15       9.68x10-5        0.04
KIF26B     cg21301514 -9.05   -3.00   -6.03      9.71x10-5        0.04
PRPSAP1    cg00549574 -5.84   -1.94   -3.89      9.74x10-5        0.04
LGALS3BP   cg14870271 1.71    5.15    3.43       9.73x10-5        0.04
           cg08636638 -5.72   -1.90   -3.81      9.78x10-5        0.04
C12orf27   cg07545743 -2.33   -0.77   -1.55      9.78x10-5        0.04
FGR        cg09370867 -3.48   -1.15   -2.31      9.81x10-5        0.04
                      -
           cg05483875         -5.22 -10.48       9.81x10-5        0.04
                      15.74
IL6R       cg25135018 -4.20   -1.39   -2.80      9.83x10-5        0.04
           cg19634252 -5.38   -1.78   -3.58      9.83x10-5        0.04
CBX4       cg13475704 -6.75   -2.24   -4.50      9.85x10-5        0.04
IKZF1      cg07103517 1.39    4.20    2.79       9.89x10-5        0.04
IL21R      cg02656594 -2.70   -0.89   -1.79      9.88x10-5        0.04
SMG6       cg23698124 1.19    3.58    2.39       9.89x10-5        0.04
SLC9A8     cg02003117 -6.25   -2.07   -4.16      9.88x10-5        0.04
APBB1      cg27216937 1.95    5.88    3.91       9.91x10-5        0.04
ZNF608     cg26413942 -3.13   -1.04   -2.08      9.93x10-5        0.04
                      -
PTBP1      cg17357561         -8.03 -16.13       9.93x10-5        0.04
                      24.23
CYTH3      cg10950593 -4.20   -1.39 -2.79        9.98x10-5        0.04

                                  288


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
DGKA       cg21587469 0.99    2.98    1.98       9.98x10-5        0.04
CHD3       cg04674060 1.20    3.61    2.40       9.97x10-5        0.04
NDUFA4L2   cg02948264 -9.05   -2.99   -6.02      1.00x10-4        0.04
TERT       cg16429735 1.09    3.29    2.19       1.00x10-4        0.04
TUBA1C     cg16881676 -5.83   -1.93   -3.88      1.00x10-4        0.04
FAIM3      cg22945467 2.59    7.81    5.20       1.01x10-4        0.04
MAGEF1     cg26152983 -4.23   -1.40   -2.82      1.01x10-4        0.04
MFN2       cg09820729 -5.21   -1.72   -3.47      1.01x10-4        0.04
           cg16704158 -3.68   -1.22   -2.45      1.01x10-4        0.04
           cg17384323 3.09    9.34    6.21       1.02x10-4        0.04
C4orf41    cg21127184 -6.35   -2.10   -4.23      1.01x10-4        0.04
           cg16223546 -4.82   -1.59   -3.21      1.02x10-4        0.04
N4BP3      cg17343167 -7.29   -2.41   -4.85      1.02x10-4        0.04
PRDM1      cg17143179 1.03    3.13    2.08       1.02x10-4        0.04
           cg07276621 2.14    6.48    4.31       1.02x10-4        0.04
LRP6       cg00046744 -8.06   -2.66   -5.36      1.02x10-4        0.04
RAB21      cg02611240 -6.65   -2.20   -4.42      1.01x10-4        0.04
TESC       cg25598890 -6.04   -2.00   -4.02      1.01x10-4        0.04
NCOR2      cg11639950 -4.92   -1.63   -3.27      1.02x10-4        0.04
           cg11162888 1.09    3.31    2.20       1.02x10-4        0.04
ZSWIM1     cg13780718 2.42    7.30    4.86       1.01x10-4        0.04
           cg04957307 1.68    5.08    3.38       1.03x10-4        0.04
NAPSA      cg19901005 1.71    5.19    3.45       1.03x10-4        0.04
RREB1      cg12407685 -7.95   -2.63   -5.29      1.03x10-4        0.04
TREX1      cg21788755 1.99    6.02    4.00       1.03x10-4        0.04
           cg04892766 1.38    4.19    2.79       1.03x10-4        0.04
ABLIM1     cg00950497 -3.85   -1.27   -2.56      1.03x10-4        0.04
SEL1L      cg16379999 -3.09   -1.02   -2.06      1.03x10-4        0.04
MCTP2      cg02700491 -2.84   -0.94   -1.89      1.04x10-4        0.04
PAFAH1B1   cg08696470 -4.13   -1.36   -2.75      1.04x10-4        0.04
IQCE       cg04109092 -4.93   -1.63   -3.28      1.04x10-4        0.04
                      -       -
TRRAP      cg23151309                 -32.34     1.04x10-4        0.04
                      48.64   16.05
PRDM11     cg24904788 -3.50   -1.15   -2.32      1.04x10-4        0.04
FLJ23834   cg04215126 -8.22   -2.71   -5.46      1.04x10-4        0.04
TMEM49     cg16936953 1.22    3.71    2.47       1.05x10-4        0.04
TMEM49     cg12054453 1.23    3.72    2.47       1.05x10-4        0.04
RERE       cg21774136 1.06    3.22    2.14       1.05x10-4        0.04
MPHOSPH9   cg07732037 1.16    3.51    2.33       1.06x10-4        0.04


                                  289


                                                                  APPENDIX III


                                     Effect     Uncorrected p-   FDR corrected
Gene      CpG site   CI- 95%
                                     estimate   Value            p –Value
ZSWIM4    cg25751484 -7.00   -2.31   -4.66      1.06x10-4        0.04
RGS1      cg06357908 1.42    4.30    2.86       1.06x10-4        0.04
SKAP2     cg13081213 -6.46   -2.13   -4.29      1.06x10-4        0.04
RABL4     cg06235224 -7.45   -2.45   -4.95      1.06x10-4        0.04
FBP1      cg01210663 -6.64   -2.19   -4.41      1.06x10-4        0.04
                     -
ELN       cg25729687         -3.63 -7.32        1.06x10-4        0.04
                     11.01
          cg03412153 1.15    3.49    2.32       1.06x10-4        0.04
KCTD19    cg05762671 1.28    3.89    2.58       1.06x10-4        0.04
          cg26840889 1.66    5.04    3.35       1.07x10-4        0.04
TGIF1     cg07529654 -4.23   -1.39   -2.81      1.07x10-4        0.04
          cg26579986 -3.84   -1.26   -2.55      1.07x10-4        0.04
                     -
          cg00265360         -3.74 -7.55        1.08x10-4        0.04
                     11.36
BCL9      cg23014759 1.19    3.64    2.42       1.10x10-4        0.04
          cg06647600 -6.36   -2.09   -4.22      1.08x10-4        0.04
          cg11531339 2.13    6.50    4.32       1.11x10-4        0.04
          cg03834116 -3.97   -1.30   -2.63      1.11x10-4        0.04
          cg08009902 1.39    4.24    2.81       1.09x10-4        0.04
PLCL1     cg06734510 3.06    9.30    6.18       1.08x10-4        0.04
                     -
          cg17328631         -7.67 -15.52       1.11x10-4        0.04
                     23.38
                     -
SH3BP2    cg23746574         -7.32 -14.82       1.11x10-4        0.04
                     22.31
          cg04131890 1.15    3.51    2.33       1.11x10-4        0.04
          cg02381853 -3.28   -1.08   -2.18      1.08x10-4        0.04
ODZ2      cg01227558 -9.05   -2.98   -6.01      1.09x10-4        0.04
LRRC16A   cg09110394 -4.59   -1.51   -3.05      1.09x10-4        0.04
                     -
ARPC5L    cg14287565         -5.36 -10.84       1.10x10-4        0.04
                     16.31
          cg25500001 -5.95   -1.96 -3.95        1.08x10-4        0.04
          cg05482603 1.93    5.87 3.90          1.10x10-4        0.04
          cg18434560 1.23    3.74 2.48          1.08x10-4        0.04
                     -
          cg08214423         -6.98 -14.13       1.11x10-4        0.04
                     21.27
UBXN1     cg20140054 -5.72   -1.88 -3.80        1.10x10-4        0.04
AIP       cg19528654 1.11    3.39 2.25          1.09x10-4        0.04
                     -
          cg05592911         -9.41 -19.04       1.11x10-4        0.04
                     28.67
MLL       cg14242895 -4.89   -1.61 -3.25        1.10x10-4        0.04


                                 290


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
RPS26      cg25095951 -7.10   -2.33   -4.72      1.09x10-4        0.04
OBFC2B     cg10654546 -3.13   -1.03   -2.08      1.09x10-4        0.04
           cg09251317 -6.40   -2.10   -4.25      1.10x10-4        0.04
AKAP13     cg09874482 -3.50   -1.15   -2.32      1.11x10-4        0.04
SLCO3A1    cg25508605 1.89    5.77    3.83       1.10x10-4        0.04
LONP2      cg09539739 -5.00   -1.64   -3.32      1.10x10-4        0.04
                      -
WDR16      cg26976042         -4.82 -9.74        1.09x10-4        0.04
                      14.66
FCER2      cg12261095 -4.83   -1.59 -3.21        1.10x10-4        0.04
ZFP36      cg05209306 1.11    3.37 2.24          1.08x10-4        0.04
                      -
ZNF296     cg17769442         -3.36 -6.81        1.10x10-4        0.04
                      10.25
OXT        cg19592472 -2.50   -0.82 -1.66        1.09x10-4        0.04
                      -
           cg18908845         -3.86 -7.81        1.11x10-4        0.04
                      11.76
FAM38A     cg02610723 -6.51   -2.13   -4.32      1.12x10-4        0.04
AXIN2      cg18956355 2.49    7.61    5.05       1.12x10-4        0.04
CD44       cg19292760 1.12    3.41    2.26       1.12x10-4        0.04
IRS2       cg12085119 1.63    4.99    3.31       1.12x10-4        0.04
LPP        cg16464007 1.52    4.63    3.07       1.13x10-4        0.04
CAST       cg02291010 -2.86   -0.94   -1.90      1.12x10-4        0.04
RBPMS      cg26122129 -5.16   -1.69   -3.43      1.13x10-4        0.04
DCLK3      cg21113478 1.52    4.63    3.07       1.13x10-4        0.04
TMEM180    cg00122347 1.04    3.18    2.11       1.13x10-4        0.04
                      -
PRR5L      cg20934799         -5.55 -11.24       1.13x10-4        0.04
                      16.93
HLA-E      cg17615629 0.68    2.07    1.38       1.14x10-4        0.04
DUSP10     cg26562772 -2.85   -0.93   -1.89      1.14x10-4        0.04
RCSD1      cg01793445 2.69    8.20    5.44       1.14x10-4        0.04
KIAA1688   cg02340818 1.12    3.43    2.27       1.14x10-4        0.04
GUCY1B2    cg24013213 -3.35   -1.10   -2.22      1.14x10-4        0.04
           cg02393107 1.28    3.91    2.59       1.14x10-4        0.04
                      -
EGFL7      cg21184800         -3.44 -6.98        1.14x10-4        0.04
                      10.52
ITM2C      cg04293526 -8.53   -2.79   -5.66      1.15x10-4        0.04
ATP10B     cg13629358 1.65    5.03    3.34       1.15x10-4        0.04
TMEM8B     cg11825899 -3.45   -1.13   -2.29      1.15x10-4        0.04
DAPK1      cg08719486 -4.68   -1.53   -3.11      1.15x10-4        0.04
GRN        cg23570245 -3.66   -1.20   -2.43      1.15x10-4        0.04
PNPLA1     cg22027204 -3.71   -1.21   -2.46      1.16x10-4        0.04

                                  291


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
RAB32       cg12872357 -3.33   -1.09   -2.21      1.16x10-4        0.04
SLMO1       cg16498391 -4.15   -1.36   -2.76      1.15x10-4        0.04
ACSL3       cg23325384 -4.12   -1.35   -2.73      1.16x10-4        0.04
VIT         cg09154591 -3.50   -1.14   -2.32      1.16x10-4        0.04
            cg09333584 -7.97   -2.60   -5.29      1.17x10-4        0.04
CD34        cg21697512 -2.34   -0.76   -1.55      1.17x10-4        0.04
MARCH1      cg19400238 -7.32   -2.39   -4.85      1.17x10-4        0.04
            cg16994941 1.90    5.83    3.87       1.18x10-4        0.04
SLIT1       cg05265607 -5.13   -1.68   -3.41      1.18x10-4        0.04
COQ9        cg00247269 -4.70   -1.54   -3.12      1.17x10-4        0.04
MLC1        cg10854441 -4.59   -1.50   -3.05      1.18x10-4        0.04
PRKCZ       cg07693617 -5.67   -1.84   -3.76      1.23x10-4        0.04
            cg14217990 -8.71   -2.84   -5.77      1.21x10-4        0.04
            cg04991639 -7.79   -2.53   -5.16      1.23x10-4        0.04
KIAA0319L   cg10959672 1.11    3.40    2.26       1.19x10-4        0.04
FAM69A      cg22128645 1.48    4.52    3.00       1.19x10-4        0.04
KIRREL      cg11525252 1.31    4.04    2.68       1.23x10-4        0.04
RAB7L1      cg26418147 1.19    3.65    2.42       1.23x10-4        0.04
TRAF5       cg09825327 1.42    4.36    2.89       1.23x10-4        0.04
CPSF3       cg12057242 -3.47   -1.13   -2.30      1.23x10-4        0.04
GYPC        cg08129583 -2.94   -0.96   -1.95      1.22x10-4        0.04
                       -
TMEFF2      cg02288301         -5.39 -10.97       1.22x10-4        0.04
                       16.55
DGKD        cg00711795 2.45    7.50    4.98       1.20x10-4        0.04
            cg22856834 -4.10   -1.34   -2.72      1.18x10-4        0.04
            cg25616514 -4.87   -1.59   -3.23      1.21x10-4        0.04
PRICKLE2    cg18450254 -3.64   -1.19   -2.42      1.22x10-4        0.04
RBM47       cg20435896 -6.13   -2.00   -4.06      1.19x10-4        0.04
LNX1        cg06495586 -3.13   -1.02   -2.08      1.23x10-4        0.04
                       -       -
            cg01563714                 -21.42     1.18x10-4        0.04
                       32.30   10.54
JARID2      cg16362595 1.20    3.67    2.43       1.19x10-4        0.04
            cg19612068 -7.11   -2.31   -4.71      1.22x10-4        0.04
            cg03875496 -8.85   -2.88   -5.86      1.21x10-4        0.04
NOD1        cg09579281 -4.35   -1.42   -2.88      1.23x10-4        0.04
SLC25A13    cg27185510 1.46    4.47    2.97       1.18x10-4        0.04
GAL3ST4     cg24616382 1.02    3.15    2.09       1.22x10-4        0.04
FLJ23834    cg21586203 -8.76   -2.85   -5.81      1.21x10-4        0.04
EPHB6       cg12599168 1.38    4.24    2.81       1.19x10-4        0.04
GSR         cg06049177 -5.52   -1.80   -3.66      1.24x10-4        0.04

                                   292


                                                                       APPENDIX III


                                          Effect     Uncorrected p-   FDR corrected
Gene           CpG site   CI- 95%
                                          estimate   Value            p –Value
               cg14944923 -3.69   -1.20   -2.44      1.23x10-4        0.04
SLC25A25       cg14522718 0.97    2.97    1.97       1.22x10-4        0.04
LCN6           cg13544075 -4.55   -1.48   -3.02      1.20x10-4        0.04
               cg14480266 -7.50   -2.44   -4.97      1.22x10-4        0.04
DGKZ           cg18765542 2.85    8.75    5.80       1.20x10-4        0.04
MTCH2          cg22321327 -3.86   -1.26   -2.56      1.22x10-4        0.04
               cg25248213 -7.73   -2.52   -5.12      1.19x10-4        0.04
PTPRO          cg12601353 -9.00   -2.93   -5.97      1.20x10-4        0.04
BTBD11         cg01686739 -3.29   -1.07   -2.18      1.19x10-4        0.04
               cg19627549 1.68    5.15    3.42       1.20x10-4        0.04
CRIP1          cg07065217 -7.22   -2.35   -4.78      1.23x10-4        0.04
                          -
               cg14082893         -4.74 -9.65        1.21x10-4        0.04
                          14.56
CHD2           cg12644285 -2.95   -0.96   -1.96      1.20x10-4        0.04
SOCS1          cg03014241 1.11    3.40    2.25       1.20x10-4        0.04
MIR193B        cg03295417 -3.27   -1.06   -2.17      1.22x10-4        0.04
DLG4           cg03508063 -5.66   -1.84   -3.75      1.23x10-4        0.04
MSI2           cg05347965 1.21    3.72    2.46       1.21x10-4        0.04
               cg27112972 -4.97   -1.62   -3.29      1.23x10-4        0.04
RPTOR          cg01432609 -2.92   -0.95   -1.94      1.22x10-4        0.04
MAFG           cg00926657 -5.09   -1.66   -3.37      1.22x10-4        0.04
LAMA3          cg13270625 1.35    4.14    2.75       1.21x10-4        0.04
MBP            cg06773488 -4.70   -1.53   -3.12      1.19x10-4        0.04
FBXO46         cg09277709 -4.40   -1.43   -2.92      1.20x10-4        0.04
SIRPG          cg11061975 2.22    6.83    4.52       1.21x10-4        0.04
LOC100271722   cg23564243 -5.87   -1.91   -3.89      1.23x10-4        0.04
IL16           cg14898127 1.10    3.39    2.24       1.24x10-4        0.04
LOC100133612   cg09275693 0.83    2.56    1.69       1.25x10-4        0.04
               cg10582860 -4.93   -1.60   -3.27      1.24x10-4        0.04
               cg11690884 -3.02   -0.98   -2.00      1.24x10-4        0.04
ENTPD7         cg11736228 -5.58   -1.81   -3.70      1.24x10-4        0.04
               cg05302095 1.13    3.48    2.31       1.24x10-4        0.04
LTB4R          cg07042014 -4.22   -1.37   -2.80      1.24x10-4        0.04
               cg13152690 0.99    3.04    2.02       1.24x10-4        0.04
               cg07363543 -5.07   -1.65   -3.36      1.25x10-4        0.04
KCNIP1         cg02640147 1.03    3.17    2.10       1.25x10-4        0.04
               cg14114297 -3.07   -1.00   -2.03      1.25x10-4        0.04
CUTA           cg05352838 1.43    4.42    2.93       1.25x10-4        0.04
ICAM2          cg04034685 -4.81   -1.56   -3.19      1.25x10-4        0.04


                                      293


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
           cg18077387 3.40    10.47   6.93       1.26x10-4        0.04
FOXP1      cg15958828 -6.54   -2.12   -4.33      1.26x10-4        0.04
ATF6B      cg26539631 -8.57   -2.78   -5.67      1.26x10-4        0.04
KDM2B      cg21340621 -3.31   -1.07   -2.19      1.26x10-4        0.04
RSBN1      cg03469607 1.11    3.41    2.26       1.27x10-4        0.04
           cg07367601 -4.68   -1.52   -3.10      1.27x10-4        0.04
           cg03106207 2.53    7.79    5.16       1.27x10-4        0.04
RASGEF1A   cg24020157 -3.22   -1.04   -2.13      1.27x10-4        0.04
ENTPD7     cg26114100 -6.21   -2.01   -4.11      1.27x10-4        0.04
                      -
           cg09228327         -5.40 -11.02       1.27x10-4        0.04
                      16.65
REM2       cg24681208 -6.89   -2.23   -4.56      1.27x10-4        0.04
DOK4       cg16547186 -3.78   -1.23   -2.51      1.27x10-4        0.04
GNG7       cg19477361 1.68    5.18    3.43       1.27x10-4        0.04
           cg22726155 1.09    3.38    2.24       1.27x10-4        0.04
                      -
           cg07350631         -4.78 -9.76        1.28x10-4        0.04
                      14.75
PACS2      cg19769147 -6.79   -2.20   -4.49      1.28x10-4        0.04
MAD1L1     cg08972190 1.52    4.70    3.11       1.28x10-4        0.04
AXIN2      cg09231741 1.29    3.99    2.64       1.28x10-4        0.04
           cg09277256 -6.15   -1.99   -4.07      1.28x10-4        0.04
TBC1D4     cg00810292 0.81    2.50    1.66       1.28x10-4        0.04
                      -
           cg22490722         -3.71 -7.59        1.29x10-4        0.04
                      11.47
                      -
EHMT2      cg25202877         -4.46 -9.11        1.29x10-4        0.04
                      13.77
HYOU1      cg11962566 -5.50   -1.78 -3.64        1.29x10-4        0.04
                      -
MPND       cg25631746         -6.63 -13.56       1.28x10-4        0.04
                      20.48
TGFA       cg21346154 -3.59   -1.16   -2.38      1.29x10-4        0.04
CXCR6      cg25226014 0.95    2.93    1.94       1.29x10-4        0.04
SCARB1     cg01663970 -4.56   -1.48   -3.02      1.29x10-4        0.04
RORA       cg09879458 1.13    3.48    2.30       1.29x10-4        0.04
SNORA59A   cg22866430 1.32    4.08    2.70       1.31x10-4        0.04
FASLG      cg00071250 1.03    3.18    2.11       1.31x10-4        0.04
           cg08914730 -6.43   -2.08   -4.25      1.31x10-4        0.04
           cg07203767 1.08    3.35    2.21       1.31x10-4        0.04
RNF13      cg24105729 -8.47   -2.74   -5.61      1.30x10-4        0.04
SPATA5     cg05805445 1.29    4.00    2.64       1.31x10-4        0.04
F2RL2      cg00415993 -2.88   -0.93   -1.91      1.30x10-4        0.04

                                  294


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
DOCK4      cg11884089 -4.64   -1.50   -3.07      1.31x10-4        0.04
IL2RA      cg11127249 4.14    12.80   8.47       1.31x10-4        0.04
RPS6KB2    cg17375396 1.41    4.36    2.89       1.30x10-4        0.04
           cg21927426 -6.24   -2.02   -4.13      1.30x10-4        0.04
PACS2      cg06783197 2.31    7.14    4.72       1.31x10-4        0.04
                      -
PRPSAP1    cg24146586         -4.13 -8.45        1.30x10-4        0.04
                      12.77
KIAA1683   cg01087239 1.10    3.40    2.25       1.31x10-4        0.04
ZBTB32     cg09231418 0.94    2.90    1.92       1.31x10-4        0.04
ETFB       cg17110052 0.97    3.01    1.99       1.31x10-4        0.04
MTF1       cg13567986 -4.64   -1.50   -3.07      1.32x10-4        0.04
           cg01829632 -3.05   -0.99   -2.02      1.32x10-4        0.04
           cg04958236 -3.49   -1.13   -2.31      1.32x10-4        0.04
                      -
UNCX       cg17294725         -3.97 -8.12        1.32x10-4        0.04
                      12.28
MARK2      cg01102854 -5.27   -1.70   -3.49      1.32x10-4        0.04
SYT1       cg25193867 2.53    7.83    5.18       1.32x10-4        0.04
GPR81      cg22534509 1.11    3.43    2.27       1.32x10-4        0.04
LY9        cg01367992 0.79    2.44    1.61       1.35x10-4        0.04
                      -
           cg15711902         -7.91 -16.23       1.35x10-4        0.04
                      24.54
           cg17819732 1.33    4.14 2.74          1.37x10-4        0.04
SLC26A9    cg05122040 -3.96   -1.27 -2.62        1.37x10-4        0.04
C2orf29    cg21044433 -7.22   -2.33 -4.77        1.36x10-4        0.04
                      -
           cg06826886         -5.67 -11.63       1.36x10-4        0.04
                      17.59
HDAC4      cg11308319 1.44    4.47 2.95          1.36x10-4        0.04
CXCR6      cg08450017 0.76    2.36 1.56          1.37x10-4        0.04
                      -
PTH1R      cg16016506         -4.24 -8.68        1.34x10-4        0.04
                      13.13
           cg04322363 -9.27   -2.99 -6.13        1.35x10-4        0.04
                      -
           cg18157353         -4.57 -9.39        1.38x10-4        0.04
                      14.20
QRFPR      cg21631428 -3.17   -1.02   -2.10      1.37x10-4        0.04
MAML3      cg03180134 -5.62   -1.81   -3.72      1.33x10-4        0.04
CSNK1G3    cg27054084 1.43    4.42    2.92       1.34x10-4        0.04
ACSL6      cg14841483 1.37    4.24    2.80       1.35x10-4        0.04
TAP1       cg26234900 0.96    2.97    1.96       1.35x10-4        0.04
                      -
MCM7       cg22940022         -3.27 -6.71        1.35x10-4        0.04
                      10.15


                                  295


                                                                     APPENDIX III


                                        Effect     Uncorrected p-   FDR corrected
Gene         CpG site   CI- 95%
                                        estimate   Value            p –Value
CUX1         cg15755348 2.62    8.15    5.39       1.37x10-4        0.04
TNFRSF10D    cg14918744 0.94    2.91    1.92       1.34x10-4        0.04
RAB2A        cg14839134 -3.05   -0.98   -2.01      1.37x10-4        0.04
SIT1         cg15518883 1.11    3.46    2.29       1.36x10-4        0.04
NAA35        cg13727957 -6.70   -2.16   -4.43      1.35x10-4        0.04
NCRNA00092   cg05138681 -6.49   -2.09   -4.29      1.37x10-4        0.04
LZTS2        cg03271893 -4.81   -1.55   -3.18      1.34x10-4        0.04
                        -
TCF7L2       cg00831931         -4.13 -8.47        1.37x10-4        0.04
                        12.82
STK32C       cg13432205 -9.41   -3.03   -6.22      1.36x10-4        0.04
LGALS12      cg21964800 -2.38   -0.77   -1.57      1.34x10-4        0.04
PTPRO        cg13554714 1.46    4.53    3.00       1.37x10-4        0.04
GXYLT1       cg13431800 -5.17   -1.67   -3.42      1.35x10-4        0.04
ADCY6        cg02423534 -4.08   -1.31   -2.69      1.37x10-4        0.04
NCOR2        cg15085899 -2.49   -0.80   -1.64      1.35x10-4        0.04
             cg20749792 1.10    3.41    2.25       1.36x10-4        0.04
ZFP36L1      cg10099732 0.76    2.37    1.56       1.34x10-4        0.04
             cg22582617 -2.37   -0.76   -1.57      1.36x10-4        0.04
LMF1         cg08018572 2.11    6.56    4.34       1.38x10-4        0.04
ABCC1        cg16702014 -3.23   -1.04   -2.13      1.38x10-4        0.04
IL21R        cg02787852 0.86    2.66    1.76       1.37x10-4        0.04
PYCARD       cg12100791 -5.22   -1.69   -3.46      1.35x10-4        0.04
             cg03259887 2.81    8.70    5.75       1.33x10-4        0.04
GAS7         cg05558046 1.88    5.81    3.85       1.33x10-4        0.04
SLFN5        cg05897169 1.13    3.50    2.31       1.35x10-4        0.04
HEXIM2       cg08351131 -3.08   -0.99   -2.04      1.36x10-4        0.04
MSI2         cg10723617 -3.96   -1.27   -2.62      1.38x10-4        0.04
AZI1         cg05371735 3.38    10.47   6.93       1.33x10-4        0.04
                        -
MAPRE2       cg05735765         -4.55 -9.33        1.37x10-4        0.04
                        14.12
             cg12759166 2.14    6.65 4.40          1.36x10-4        0.04
CD97         cg08239297 -8.74   -2.82 -5.78        1.36x10-4        0.04
THEMIS       cg17113883 1.43    4.45 2.94          1.38x10-4        0.04
                        -
METTL10      cg16832958         -6.32 -12.97       1.38x10-4        0.04
                        19.63
LAMA3        cg01152726 1.32    4.09    2.70       1.39x10-4        0.04
             cg17756730 1.05    3.25    2.15       1.39x10-4        0.04
ZNF740       cg00078245 1.45    4.50    2.97       1.39x10-4        0.04
SKI          cg15007228 -9.58   -3.08   -6.33      1.39x10-4        0.04
PRDM16       cg10493186 -4.24   -1.36   -2.80      1.39x10-4        0.04

                                    296


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
ADAP1      cg20705627 -5.36   -1.72   -3.54      1.39x10-4        0.04
           cg26763394 0.96    2.99    1.98       1.39x10-4        0.04
SLC22A8    cg15572436 -8.90   -2.86   -5.88      1.40x10-4        0.04
OLFML3     cg13393917 -7.77   -2.50   -5.14      1.41x10-4        0.04
QSOX1      cg09505809 -4.36   -1.40   -2.88      1.40x10-4        0.04
                      -       -
CCRL2      cg13070763                 -25.46     1.40x10-4        0.04
                      38.53   12.39
INPP4B     cg03476007 -8.08   -2.60   -5.34      1.41x10-4        0.04
CUX1       cg20253855 -3.65   -1.17   -2.41      1.41x10-4        0.04
VPS37B     cg01832672 1.50    4.65    3.07       1.41x10-4        0.04
           cg09351315 -4.61   -1.48   -3.04      1.41x10-4        0.04
PLCG1      cg06493829 5.64    17.56   11.60      1.41x10-4        0.04
CLTCL1     cg24911827 1.83    5.70    3.77       1.40x10-4        0.04
MEI1       cg05023013 -9.07   -2.92   -5.99      1.41x10-4        0.04
CDC42BPB   cg04189326 -5.27   -1.69   -3.48      1.41x10-4        0.04
PHYH       cg19018267 -3.45   -1.11   -2.28      1.41x10-4        0.04
SSBP3      cg09417011 1.52    4.74    3.13       1.44x10-4        0.04
ITPKB      cg23717186 1.17    3.66    2.42       1.43x10-4        0.04
           cg16704560 -3.33   -1.07   -2.20      1.44x10-4        0.04
IP6K2      cg16180552 -6.93   -2.22   -4.57      1.43x10-4        0.04
DHX29      cg26464796 -2.87   -0.92   -1.90      1.42x10-4        0.04
LHFPL2     cg06759890 -3.30   -1.06   -2.18      1.43x10-4        0.04
HLA-E      cg27486585 0.93    2.91    1.92       1.43x10-4        0.04
CLIC1      cg11093373 -7.35   -2.36   -4.86      1.42x10-4        0.04
                      -
RGL2       cg05876591         -4.75 -9.77        1.43x10-4        0.04
                      14.79
MAMDC2     cg13870494 2.45    7.64    5.05       1.44x10-4        0.04
VAV2       cg14308466 -5.52   -1.77   -3.65      1.42x10-4        0.04
PFKFB3     cg14038949 1.34    4.17    2.75       1.43x10-4        0.04
           cg12999267 1.07    3.32    2.19       1.42x10-4        0.04
           cg04716447 1.53    4.78    3.15       1.44x10-4        0.04
TOMM20L    cg04728863 -5.17   -1.66   -3.41      1.44x10-4        0.04
                      -
PLEKHG3    cg11802553         -3.41 -7.01        1.42x10-4        0.04
                      10.62
C15orf61   cg22706883 -3.21   -1.03   -2.12      1.43x10-4        0.04
CREBBP     cg01312837 -6.27   -2.01   -4.14      1.44x10-4        0.04
MIR193B    cg07665535 -4.48   -1.44   -2.96      1.43x10-4        0.04
ABCC11     cg02938045 -3.13   -1.01   -2.07      1.42x10-4        0.04
TMEM93     cg13345380 -6.59   -2.12   -4.36      1.42x10-4        0.04
GNG7       cg23463608 1.04    3.25    2.15       1.43x10-4        0.04

                                  297


                                                            APPENDIX III


                                  Effect     Uncorrected p- FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value          p –Value
                                                    -4
POP4       cg06738169 2.21 6.88 4.54         1.44x10        0.04
                      -
           cg04447445       -3.82 -7.87      1.44x10-4     0.04
                      11.92
                      -
GRK5       cg13898290       -5.13 -10.57     1.45x10-4     0.04
                      16.01
           cg00021275 -4.04 -1.30 -2.67      1.45x10-4     0.04
           cg01894846 -5.84 -1.87 -3.86      1.45x10-4     0.04
           cg22627800 5.44 16.98 11.21       1.46x10-4     0.04
HDAC4      cg00144180 1.27 3.95 2.61         1.46x10-4     0.04
           cg18432806 -5.57 -1.78 -3.68      1.46x10-4     0.04
C11orf58   cg20474675 -7.51 -2.41 -4.96      1.46x10-4     0.04
SLC9A3R1   cg13896106 -6.14 -1.97 -4.05      1.46x10-4     0.04
SYT2       cg11071448 -3.53 -1.13 -2.33      1.47x10-4     0.04
           cg07586956 0.82 2.56 1.69         1.47x10-4     0.04
           cg03604731 2.81 8.78 5.79         1.47x10-4     0.04
SLMAP      cg00873919 -7.44 -2.38 -4.91      1.46x10-4     0.04
           cg25235205 1.40 4.36 2.88         1.47x10-4     0.04
PEBP4      cg20378690 -3.09 -0.99 -2.04      1.47x10-4     0.04
XPO6       cg00468395 1.30 4.06 2.68         1.47x10-4     0.04
HDAC5      cg19163395 1.04 3.26 2.15         1.47x10-4     0.04
MIR27A     cg02990289 -7.53 -2.41 -4.97      1.47x10-4     0.04
IGLL1      cg14902267 -4.16 -1.33 -2.75      1.47x10-4     0.04
           cg15321306 1.21 3.77 2.49         1.47x10-4     0.04
KLRG1      cg26806779 -2.68 -0.86 -1.77      1.48x10-4     0.04
           cg20244489 0.92 2.88 1.90         1.48x10-4     0.04
           cg12426870 -7.05 -2.25 -4.65      1.48x10-4     0.04
NEK7       cg12750917 -4.26 -1.36 -2.81      1.49x10-4     0.04
HHAT       cg22332066 -9.57 -3.06 -6.31      1.49x10-4     0.04
           cg03936870 -4.10 -1.31 -2.71      1.49x10-4     0.04
           cg17839366 -4.18 -1.34 -2.76      1.49x10-4     0.04
CD80       cg13458803 1.82 5.68 3.75         1.48x10-4     0.04
SNX25      cg04716478 -5.10 -1.63 -3.37      1.48x10-4     0.04
BRAF       cg12750675 -3.33 -1.07 -2.20      1.48x10-4     0.04
           cg02661764 1.20 3.76 2.48         1.49x10-4     0.04
LGALS12    cg11183156 -9.25 -2.96 -6.10      1.49x10-4     0.04
           cg19529621 -7.08 -2.26 -4.67      1.49x10-4     0.04
                      -
           cg25252598       -3.34 -6.89      1.48x10-4     0.04
                      10.43
                      -
GUCY2D     cg06079742       -4.16 -8.58      1.49x10-4     0.04
                      13.00

                                298


                                                              APPENDIX III


                                 Effect     Uncorrected p-   FDR corrected
Gene      CpG site   CI- 95%
                                 estimate   Value            p –Value
          cg26460530 2.23 6.98 4.60         1.49x10-4        0.04
PLEKHG5   cg21012139 1.12 3.49 2.31         1.50x10-4        0.04
                     -
          cg15681737       -5.16 -10.66     1.50x10-4        0.04
                     16.15
DICER1    cg24130561 1.10 3.45 2.28         1.50x10-4        0.04
ABCC2     cg17044311 -3.48 -1.11 -2.30      1.50x10-4        0.04
SPSB1     cg06779253 1.41 4.41 2.91         1.51x10-4        0.04
          cg19075787 -3.00 -0.96 -1.98      1.51x10-4        0.04
HLA-E     cg20105257 1.16 3.65 2.41         1.51x10-4        0.04
TRAF2     cg14003265 1.33 4.15 2.74         1.51x10-4        0.04
          cg22277154 -4.01 -1.28 -2.65      1.51x10-4        0.04
MEIS2     cg19010490 -5.19 -1.66 -3.43      1.51x10-4        0.04
          cg01231183 -2.35 -0.75 -1.55      1.51x10-4        0.04
          cg21565496 1.21 3.78 2.49         1.52x10-4        0.04
SLC9A1    cg25130381 2.16 6.77 4.46         1.52x10-4        0.04
          cg11236515 1.33 4.16 2.74         1.52x10-4        0.04
ESCO2     cg04425710 1.01 3.17 2.09         1.52x10-4        0.04
PRKCA     cg22435313 0.97 3.04 2.00         1.52x10-4        0.04
                     -
FAT1      cg02998591       -4.56 -9.44      1.53x10-4        0.04
                     14.31
ARSB      cg10864794 -3.91 -1.24 -2.58      1.53x10-4        0.04
TACC1     cg14773619 1.67 5.23 3.45         1.53x10-4        0.04
BCL11B    cg07025989 1.56 4.90 3.23         1.54x10-4        0.04
APBA2     cg08908089 1.04 3.26 2.15         1.53x10-4        0.04
GMEB2     cg10170269 -6.30 -2.01 -4.15      1.53x10-4        0.04
PDCD1     cg03889044 1.27 3.98 2.62         1.54x10-4        0.04
CCR1      cg10499974 -3.03 -0.97 -2.00      1.54x10-4        0.04
NACC2     cg14126392 -6.94 -2.21 -4.58      1.54x10-4        0.04
CORO1B    cg01525879 1.35 4.24 2.80         1.54x10-4        0.04
GIPR      cg02942825 -3.40 -1.08 -2.24      1.54x10-4        0.04
          cg01901101 -6.42 -2.05 -4.23      1.55x10-4        0.04
          cg18938313 -5.73 -1.83 -3.78      1.55x10-4        0.04
          cg26785220 -3.40 -1.08 -2.24      1.55x10-4        0.04
MAD1L1    cg15089567 1.62 5.08 3.35         1.55x10-4        0.04
          cg23934731 -3.53 -1.12 -2.32      1.55x10-4        0.04
MICAL3    cg12923994 1.94 6.09 4.02         1.55x10-4        0.04
FAM102A   cg13558912 1.78 5.60 3.69         1.55x10-4        0.04
ULK1      cg21649013 -5.21 -1.66 -3.44      1.55x10-4        0.04
SELO      cg24993400 -4.03 -1.28 -2.66      1.56x10-4        0.04
          cg20956594 -2.05 -0.65 -1.35      1.56x10-4        0.04

                               299


                                                                APPENDIX III


                                   Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                   estimate   Value            p –Value
ACSL6       cg09035699 1.23 3.86 2.55         1.56x10-4        0.04
ABHD4       cg06813554 -4.52 -1.44 -2.98      1.56x10-4        0.04
                       -
LDLR        cg07960944       -5.41 -11.22     1.56x10-4        0.04
                       17.02
GRB10       cg13879047 -6.96 -2.21 -4.58      1.57x10-4        0.04
S100A10     cg18348690 -6.58 -2.09 -4.34      1.57x10-4        0.04
LOC285780   cg12030031 1.11 3.48 2.29         1.57x10-4        0.04
MDFI        cg06688989 -9.06 -2.88 -5.97      1.57x10-4        0.04
MEIS2       cg25447144 -6.69 -2.13 -4.41      1.57x10-4        0.04
SH2D2A      cg09888330 2.34 7.35 4.85         1.58x10-4        0.05
            cg16173109 1.16 3.64 2.40         1.58x10-4        0.05
ANKRD33B    cg10581071 -5.96 -1.89 -3.93      1.58x10-4        0.05
HSD11B1     cg20941184 -3.78 -1.20 -2.49      1.58x10-4        0.05
ZHX2        cg26427777 1.44 4.53 2.99         1.58x10-4        0.05
LMO4        cg26801613 -3.98 -1.26 -2.62      1.58x10-4        0.05
                       -
            cg14426268       -3.45 -7.15      1.58x10-4        0.05
                       10.86
ACACB       cg08866695 -3.29 -1.05 -2.17      1.58x10-4        0.05
            cg07930673 0.90 2.82 1.86         1.59x10-4        0.05
                       -
KIFC1       cg13199639       -3.86 -8.00      1.59x10-4        0.05
                       12.14
KCNE3       cg18838431 -3.21 -1.02 -2.11      1.60x10-4        0.05
TAOK3       cg16301036 -2.53 -0.80 -1.67      1.60x10-4        0.05
ZBTB47      cg06399164 -4.48 -1.42 -2.95      1.60x10-4        0.05
                       -
EPHA3       cg04515667       -3.28 -6.81      1.60x10-4        0.05
                       10.33
C4BPB       cg19707677 1.28 4.04 2.66         1.62x10-4        0.05
TTC7A       cg25550753 -4.82 -1.53 -3.17      1.61x10-4        0.05
                       -
            cg08722695       -3.86 -8.02      1.61x10-4        0.05
                       12.17
TMEM185B    cg01109047 2.80 8.83 5.81         1.62x10-4        0.05
AGXT        cg17461448 -6.06 -1.92 -3.99      1.60x10-4        0.05
            cg02295156 -9.28 -2.94 -6.11      1.61x10-4        0.05
TXNDC15     cg14069412 2.22 6.99 4.60         1.62x10-4        0.05
            cg19930737 -4.08 -1.30 -2.69      1.61x10-4        0.05
BAIAP2L1    cg17341174 -2.66 -0.84 -1.75      1.62x10-4        0.05
FAM102A     cg13992008 0.94 2.97 1.95         1.62x10-4        0.05
                       -
            cg02845870       -3.24 -6.73      1.62x10-4        0.05
                       10.22
RARG        cg09107344 1.28 4.03 2.65         1.61x10-4        0.05


                                 300


                                                             APPENDIX III


                                   Effect     Uncorrected p- FDR corrected
Gene        CpG site   CI- 95%
                                   estimate   Value          p –Value
                                                     -4
            cg26345203 1.27  3.99 2.63        1.61x10        0.05
                       -     -
KCNK13      cg02136132             -24.05     1.60x10-4     0.05
                       36.51 11.59
BCL11B      cg07015803 0.78  2.44 1.61        1.61x10-4     0.05
UBASH3A     cg27280688 0.79  2.50 1.64        1.61x10-4     0.05
C17orf44    cg25228625 -5.99 -1.90 -3.94      1.62x10-4     0.05
            cg11314827 1.66  5.24 3.45        1.62x10-4     0.05
HCP5        cg01082299 1.16  3.65 2.40        1.62x10-4     0.05
C8orf73     cg24467290 -6.83 -2.16 -4.49      1.63x10-4     0.05
VPS53       cg06500079 -4.40 -1.39 -2.90      1.63x10-4     0.05
FCGRT       cg15528736 -4.23 -1.34 -2.78      1.63x10-4     0.05
            cg24527636 0.80  2.53 1.66        1.63x10-4     0.05
SULT1C2     cg25570328 -3.11 -0.99 -2.05      1.63x10-4     0.05
TOLLIP      cg01517832 -3.95 -1.25 -2.60      1.63x10-4     0.05
ARID2       cg23192604 -6.17 -1.96 -4.06      1.63x10-4     0.05
            cg25729350 -3.58 -1.13 -2.35      1.63x10-4     0.05
FHOD1       cg26719831 -4.63 -1.47 -3.05      1.64x10-4     0.05
KIAA1949    cg10145196 1.06  3.33 2.19        1.64x10-4     0.05
            cg03185794 1.15  3.64 2.40        1.64x10-4     0.05
CNR2        cg03611151 -4.05 -1.28 -2.67      1.64x10-4     0.05
CDC42BPA    cg03890680 -6.58 -2.08 -4.33      1.64x10-4     0.05
PITPNC1     cg15797314 1.32  4.15 2.74        1.64x10-4     0.05
EIF4E3      cg23333146 -2.57 -0.81 -1.69      1.65x10-4     0.05
            cg19107511 -3.65 -1.15 -2.40      1.65x10-4     0.05
SLC25A46    cg02061660 0.91  2.88 1.90        1.66x10-4     0.05
            cg13572592 -7.95 -2.52 -5.23      1.66x10-4     0.05
METTL9      cg06257110 0.86  2.73 1.79        1.66x10-4     0.05
KIAA1310    cg22057050 -5.42 -1.72 -3.57      1.66x10-4     0.05
PLCH1       cg18623216 -4.91 -1.55 -3.23      1.66x10-4     0.05
            cg16565528 -3.01 -0.95 -1.98      1.66x10-4     0.05
DDX6        cg05587627 0.87  2.76 1.81        1.66x10-4     0.05
CCR7        cg13504059 1.65  5.20 3.42        1.66x10-4     0.05
            cg19100292 -8.37 -2.65 -5.51      1.66x10-4     0.05
            cg06760077 1.83  5.79 3.81        1.67x10-4     0.05
CNR2        cg07967717 -3.69 -1.17 -2.43      1.68x10-4     0.05
ZCCHC11     cg05931551 2.30  7.27 4.79        1.67x10-4     0.05
                       -
LRPAP1      cg24789434       -3.54 -7.38      1.68x10-4     0.05
                       11.21
DAB2        cg25105652 -3.69 -1.17 -2.43      1.67x10-4     0.05
LOC728264   cg12675571 -7.49 -2.37 -4.93      1.68x10-4     0.05

                                 301


                                                               APPENDIX III


                                  Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value            p –Value
ZNF212     cg15320998 -3.40 -1.07 -2.24      1.68x10-4        0.05
SIT1       cg13832290 1.89 6.00 3.95         1.68x10-4        0.05
                      -
MON2       cg19781863       -3.41 -7.11      1.68x10-4        0.05
                      10.80
PPP2R5C    cg17904575 0.72 2.27 1.50         1.67x10-4        0.05
ZNF592     cg21253742 0.78 2.46 1.62         1.67x10-4        0.05
SEPT9      cg19654743 1.07 3.38 2.23         1.67x10-4        0.05
MARCH3     cg08975164 -2.59 -0.82 -1.70      1.68x10-4        0.05
                      -     -
           cg02368583             -38.08     1.68x10-4        0.05
                      57.88 18.29
           cg27332104 -4.60 -1.45 -3.03      1.69x10-4        0.05
           cg20554353 -4.72 -1.49 -3.11      1.70x10-4        0.05
PLD3       cg20513206 -7.01 -2.21 -4.61      1.70x10-4        0.05
DNAJB6     cg00114346 -8.50 -2.69 -5.59      1.70x10-4        0.05
CD3E       cg24612198 0.89 2.82 1.85         1.70x10-4        0.05
           cg22800884 1.90 6.03 3.97         1.71x10-4        0.05
           cg19619014 -2.40 -0.76 -1.58      1.71x10-4        0.05
RRAS2      cg11645556 -4.27 -1.35 -2.81      1.71x10-4        0.05
           cg05191839 1.16 3.67 2.42         1.71x10-4        0.05
PITPNC1    cg01599633 -5.96 -1.88 -3.92      1.71x10-4        0.05
FAIM3      cg23088126 1.09 3.46 2.27         1.73x10-4        0.05
PRKCE      cg22284398 -4.53 -1.43 -2.98      1.73x10-4        0.05
GTDC1      cg14768164 0.80 2.55 1.68         1.72x10-4        0.05
                      -
           cg15050753       -3.42 -7.13      1.73x10-4        0.05
                      10.85
F2RL1      cg18586277 -2.89 -0.91 -1.90      1.72x10-4        0.05
MICAL1     cg13206063 -4.27 -1.35 -2.81      1.72x10-4        0.05
                      -
TMEM200A   cg09301462       -4.85 -10.12     1.72x10-4        0.05
                      15.39
GNA12      cg03081478 -3.00 -0.94 -1.97      1.71x10-4        0.05
PSAT1      cg13740985 -3.26 -1.03 -2.15      1.73x10-4        0.05
NEK6       cg13505631 -4.57 -1.44 -3.01      1.73x10-4        0.05
FBXL14     cg17824906 1.30 4.14 2.72         1.72x10-4        0.05
CACNA1C    cg05824594 -3.52 -1.11 -2.31      1.72x10-4        0.05
           cg16340767 -5.04 -1.59 -3.32      1.72x10-4        0.05
LAMA3      cg26485825 1.03 3.28 2.16         1.71x10-4        0.05
CTSZ       cg12831034 -4.60 -1.45 -3.02      1.71x10-4        0.05
                      -
RUNX1      cg26360881       -7.24 -15.11     1.73x10-4        0.05
                      22.97
GPR157     cg20284891 0.89 2.84 1.87         1.74x10-4        0.05

                                302


                                                                    APPENDIX III


                                       Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                       estimate   Value            p –Value
            cg09337254 -5.23   -1.65   -3.44      1.74x10-4        0.05
ITPR1       cg02105211 -2.39   -0.75   -1.57      1.74x10-4        0.05
RAB11FIP1   cg07313709 -7.35   -2.32   -4.83      1.74x10-4        0.05
C10orf25    cg00899659 -2.76   -0.87   -1.82      1.74x10-4        0.05
            cg09287328 -2.61   -0.82   -1.72      1.74x10-4        0.05
PCCA        cg01165817 1.31    4.16    2.73       1.74x10-4        0.05
            cg04284196 1.39    4.43    2.91       1.73x10-4        0.05
LYRM1       cg08224563 -2.91   -0.92   -1.91      1.74x10-4        0.05
            cg13223043 -3.88   -1.22   -2.55      1.74x10-4        0.05
COL11A2     cg18651026 -7.40   -2.33   -4.87      1.75x10-4        0.05
FOXK1       cg10365743 2.10    6.66    4.38       1.75x10-4        0.05
            cg13424302 -2.77   -0.87   -1.82      1.75x10-4        0.05
            cg01191058 4.23    13.43   8.83       1.75x10-4        0.05
                       -
SLC10A7     cg05477920         -4.93 -10.29       1.75x10-4        0.05
                       15.66
            cg15335297 -7.17   -2.26   -4.71      1.75x10-4        0.05
LRP2        cg02361027 -9.00   -2.83   -5.92      1.76x10-4        0.05
UTP23       cg14355654 -5.84   -1.84   -3.84      1.76x10-4        0.05
FLJ42289    cg10933959 -2.34   -0.74   -1.54      1.76x10-4        0.05
            cg17581104 1.69    5.37    3.53       1.76x10-4        0.05
DOHH        cg03597940 1.98    6.28    4.13       1.76x10-4        0.05
CD37        cg07418126 1.65    5.23    3.44       1.76x10-4        0.05
ST6GAL1     cg25599673 1.17    3.73    2.45       1.77x10-4        0.05
FAM83D      cg04071118 -6.29   -1.98   -4.13      1.77x10-4        0.05
NOD1        cg12999366 -3.39   -1.06   -2.23      1.77x10-4        0.05
                       -
HSPB6       cg01080592         -6.51 -13.60       1.77x10-4        0.05
                       20.70
CTNNBIP1    cg16578549 -5.83   -1.83   -3.83      1.77x10-4        0.05
            cg20611272 0.93    2.96    1.95       1.77x10-4        0.05
KLRG1       cg14913610 -3.68   -1.16   -2.42      1.77x10-4        0.05
TMEM156     cg02131853 1.15    3.65    2.40       1.78x10-4        0.05
C20orf117   cg07556261 -6.37   -2.00   -4.18      1.78x10-4        0.05
NAALADL2    cg01379656 1.25    3.96    2.61       1.78x10-4        0.05
            cg09841889 -1.85   -0.58   -1.22      1.78x10-4        0.05
CLEC3B      cg10324158 -4.47   -1.40   -2.94      1.78x10-4        0.05
            cg06193328 1.05    3.33    2.19       1.79x10-4        0.05
EXT1        cg23554164 -7.31   -2.30   -4.80      1.79x10-4        0.05
LCOR        cg13918042 -5.22   -1.64   -3.43      1.78x10-4        0.05
                       -
KIF2B       cg10158151         -3.58 -7.49        1.79x10-4        0.05
                       11.40

                                   303


                                                                APPENDIX III


                                   Effect     Uncorrected p-   FDR corrected
Gene        CpG site   CI- 95%
                                   estimate   Value            p –Value
FLJ90757    cg23959115 -7.12 -2.24 -4.68      1.79x10-4        0.05
C10orf128   cg00142482 -3.97 -1.25 -2.61      1.79x10-4        0.05
                       -
HADH        cg01573501       -3.32 -6.94      1.80x10-4        0.05
                       10.57
ZC3H12D     cg04494800 -3.38 -1.06 -2.22      1.80x10-4        0.05
CORO1B      cg16408081 1.81 5.76 3.79         1.80x10-4        0.05
TRAPPC1     cg01667702 -3.93 -1.24 -2.59      1.80x10-4        0.05
FOSL2       cg25784219 -3.13 -0.98 -2.05      1.80x10-4        0.05
                       -
PARL        cg25686905       -4.73 -9.90      1.80x10-4        0.05
                       15.06
                       -
CNR2        cg00660272       -3.35 -7.01      1.80x10-4        0.05
                       10.68
CDYL        cg11935248 -3.65 -1.14 -2.40      1.81x10-4        0.05
GNG7        cg24723883 1.21 3.87 2.54         1.81x10-4        0.05
RHOU        cg07838098 3.91 12.47 8.19        1.81x10-4        0.05
            cg19362478 -3.79 -1.19 -2.49      1.81x10-4        0.05
RBMS1       cg17360854 -7.79 -2.44 -5.12      1.82x10-4        0.05
            cg03982897 -6.55 -2.06 -4.30      1.82x10-4        0.05
MICAL3      cg02610425 -7.42 -2.33 -4.88      1.82x10-4        0.05
DIP2C       cg23844018 15.04 47.97 31.51      1.82x10-4        0.05
BANP        cg05166473 2.36 7.51 4.93         1.82x10-4        0.05
                       -
SCRN1       cg11855325       -4.47 -9.36      1.83x10-4        0.05
                       14.25
CALCR       cg13916255 -5.73 -1.79 -3.76      1.83x10-4        0.05
TMCO3       cg25840538 -4.20 -1.32 -2.76      1.83x10-4        0.05
ZNF385A     cg17465423 -3.70 -1.16 -2.43      1.83x10-4        0.05
LZTS2       cg19499884 -2.76 -0.86 -1.81      1.84x10-4        0.05
            cg26200118 -3.45 -1.08 -2.26      1.84x10-4        0.05
PECAM1      cg20830994 1.21 3.86 2.53         1.84x10-4        0.05
WDR25       cg13529217 1.17 3.74 2.46         1.84x10-4        0.05
            cg16788865 -1.78 -0.56 -1.17      1.84x10-4        0.05
GYLTL1B     cg03994942 2.52 8.06 5.29         1.85x10-4        0.05
UBE2Q2      cg04346683 -4.07 -1.28 -2.67      1.85x10-4        0.05
IL21R       cg10454258 -3.58 -1.12 -2.35      1.85x10-4        0.05
FAM134A     cg03878190 -3.24 -1.01 -2.13      1.86x10-4        0.05
TSPAN13     cg11384744 -3.40 -1.06 -2.23      1.86x10-4        0.05
UBAC2       cg19635644 2.05 6.56 4.31         1.86x10-4        0.05
                       -
            cg18745279       -3.38 -7.09      1.86x10-4        0.05
                       10.80
RAP1GAP2    cg16037981 -6.34 -1.99 -4.16      1.86x10-4        0.05

                                 304


                                                               APPENDIX III


                                  Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value            p –Value
ARL5C      cg00808555 -5.94 -1.86 -3.90      1.86x10-4        0.05
           cg26611328 1.95 6.23 4.09         1.86x10-4        0.05
           cg10595031 1.42 4.54 2.98         1.87x10-4        0.05
                      -
EXPH5      cg10022155       -3.59 -7.53      1.87x10-4        0.05
                      11.47
TSC2       cg08404702 1.66 5.32 3.49         1.87x10-4        0.05
KIAA1257   cg01223011 0.95 3.05 2.00         1.87x10-4        0.05
           cg20657864 -4.69 -1.47 -3.08      1.87x10-4        0.05
KATNAL1    cg02788021 -2.47 -0.77 -1.62      1.87x10-4        0.05
NLRC5      cg16411857 1.32 4.21 2.76         1.87x10-4        0.05
MPZL1      cg04846203 -3.39 -1.06 -2.23      1.89x10-4        0.05
ZFP36L2    cg04920761 -8.25 -2.58 -5.41      1.89x10-4        0.05
           cg21394171 -4.62 -1.44 -3.03      1.89x10-4        0.05
NCEH1      cg02099877 -4.68 -1.46 -3.07      1.89x10-4        0.05
                      -
LETM1      cg08299791       -3.60 -7.56      1.89x10-4        0.05
                      11.53
MYOZ3      cg15699693 -2.39 -0.75 -1.57      1.88x10-4        0.05
FAM8A1     cg03068319 -5.31 -1.66 -3.48      1.89x10-4        0.05
           cg14560699 -5.62 -1.76 -3.69      1.89x10-4        0.05
UPP1       cg01092213 -3.03 -0.95 -1.99      1.88x10-4        0.05
IL23A      cg19951006 1.01 3.24 2.13         1.89x10-4        0.05
DZIP1      cg24328944 -5.28 -1.65 -3.46      1.88x10-4        0.05
           cg05859308 1.07 3.41 2.24         1.89x10-4        0.05
                      -
RIOK3      cg05812269       -3.66 -7.69      1.89x10-4        0.05
                      11.71
                      -
DOK5       cg09177519       -7.27 -15.26     1.89x10-4        0.05
                      23.26
ZBTB7B     cg01782486 1.58 5.07 3.32         1.91x10-4        0.05
ZIC1       cg05371578 -7.71 -2.41 -5.06      1.90x10-4        0.05
LHFPL2     cg04286455 -2.30 -0.72 -1.51      1.91x10-4        0.05
EGFL8      cg22101249 -6.57 -2.05 -4.31      1.91x10-4        0.05
           cg03957124 1.18 3.76 2.47         1.91x10-4        0.05
           cg26464586 -5.93 -1.85 -3.89      1.91x10-4        0.05
ZFAT       cg21672855 5.65 18.09 11.87       1.90x10-4        0.05
TET1       cg17817532 -5.97 -1.86 -3.92      1.89x10-4        0.05
           cg02345399 1.53 4.90 3.22         1.90x10-4        0.05
ETS1       cg25578781 -1.97 -0.62 -1.30      1.90x10-4        0.05
           cg17458693 0.85 2.73 1.79         1.91x10-4        0.05
C14orf45   cg18638434 -3.88 -1.21 -2.55      1.90x10-4        0.05
ANKRD11    cg02930721 1.39 4.44 2.91         1.90x10-4        0.05

                                305


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
PDE6G      cg16592596 -6.07   -1.90   -3.98      1.91x10-4        0.05
ID3        cg27518976 -2.63   -0.82   -1.72      1.93x10-4        0.05
           cg08468732 1.41    4.52    2.96       1.92x10-4        0.05
SERPINI1   cg18123677 -4.18   -1.30   -2.74      1.92x10-4        0.05
           cg04314624 -8.52   -2.66   -5.59      1.92x10-4        0.05
FBXL13     cg02508830 -3.14   -0.98   -2.06      1.93x10-4        0.05
PDIA4      cg02892367 2.03    6.52    4.28       1.93x10-4        0.05
C13orf15   cg23357533 1.01    3.22    2.11       1.93x10-4        0.05
LBXCOR1    cg26545918 -3.93   -1.23   -2.58      1.93x10-4        0.05
                      -
           cg16973527         -4.46 -9.37        1.92x10-4        0.05
                      14.29
ACACA      cg17939040 1.09    3.50    2.30       1.93x10-4        0.05
RIN2       cg19327615 -3.46   -1.08   -2.27      1.92x10-4        0.05
           cg27338353 -3.58   -1.12   -2.35      1.92x10-4        0.05
CCDC19     cg00950718 -3.74   -1.17   -2.45      1.94x10-4        0.05
LRIG1      cg25111284 -7.08   -2.21   -4.64      1.93x10-4        0.05
TIAL1      cg26164773 5.00    16.04   10.52      1.94x10-4        0.05
LRFN3      cg25289028 1.00    3.21    2.10       1.93x10-4        0.05
           cg15114607 1.09    3.49    2.29       1.94x10-4        0.05
                      -
ERBB2      cg26041593         -3.79 -7.97        1.94x10-4        0.05
                      12.15
           cg00122659 0.87    2.81    1.84       1.94x10-4        0.05
C4orf21    cg23692997 -4.87   -1.52   -3.19      1.95x10-4        0.05
MNAT1      cg13695076 -4.07   -1.27   -2.67      1.95x10-4        0.05
TGFBR3     cg21382567 -5.33   -1.66   -3.50      1.95x10-4        0.05
LGALS3BP   cg11202345 1.79    5.76    3.78       1.95x10-4        0.05
ADORA2A    cg04990420 1.86    5.98    3.92       1.95x10-4        0.05
                      -
SMOC2      cg16053651         -3.31 -6.98        1.96x10-4        0.05
                      10.65
PTPRN2     cg01462349 1.40    4.49    2.94       1.96x10-4        0.05
SYNPO2     cg12973294 -3.20   -1.00   -2.10      1.96x10-4        0.05
AHCY       cg05674199 -5.79   -1.80   -3.80      1.96x10-4        0.05
TRAF3IP2   cg15931839 1.91    6.15    4.03       1.97x10-4        0.05
GPR3       cg13380502 -3.82   -1.19   -2.51      1.97x10-4        0.05
LEPRE1     cg04118124 -4.36   -1.36   -2.86      1.97x10-4        0.05
ZC3H3      cg04180114 0.98    3.14    2.06       1.97x10-4        0.05
                      -
           cg16847800         -3.86 -8.13        1.97x10-4        0.05
                      12.40
SPOCK2     cg01861509 1.13    3.65 2.39          1.97x10-4        0.05
           cg11887996 3.51    11.27 7.39         1.97x10-4        0.05

                                  306


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
NKD1       cg16750777 1.87    6.01    3.94       1.97x10-4        0.05
INADL      cg13321661 -6.69   -2.08   -4.39      1.98x10-4        0.05
LTB        cg02249390 1.36    4.38    2.87       1.99x10-4        0.05
NEU1       cg13195955 -5.66   -1.76   -3.71      1.99x10-4        0.05
                      -       -
C6orf129   cg05758489                 -23.56     1.98x10-4        0.05
                      35.95   11.18
SORBS1     cg03190891 1.54    4.95    3.24       1.98x10-4        0.05
HSDL1      cg04006133 1.26    4.05    2.65       1.99x10-4        0.05
KCNJ4      cg20674521 2.73    8.77    5.75       1.99x10-4        0.05
CACNA1C    cg18806606 3.70    11.89   7.79       1.99x10-4        0.05
           cg14841601 -2.84   -0.88   -1.86      2.00x10-4        0.05
CEND1      cg09946142 3.89    12.52   8.21       2.00x10-4        0.05
GAB2       cg07780377 -3.03   -0.94   -1.98      2.00x10-4        0.05
RERE       cg00786138 2.06    6.62    4.34       2.01x10-4        0.05
RERE       cg13104185 1.24    4.01    2.63       2.01x10-4        0.05
           cg21417130 1.39    4.47    2.93       2.02x10-4        0.05
ZFAND2B    cg06753787 -4.17   -1.29   -2.73      2.01x10-4        0.05
GP5        cg14880079 -4.04   -1.26   -2.65      2.01x10-4        0.05
CDYL       cg27307183 -2.34   -0.73   -1.53      2.01x10-4        0.05
LY6G6E     cg14258501 -4.31   -1.34   -2.83      2.01x10-4        0.05
NELL1      cg22307471 -9.24   -2.87   -6.05      2.01x10-4        0.05
SECTM1     cg26312191 1.20    3.86    2.53       2.01x10-4        0.05
SBF1       cg01843272 1.37    4.41    2.89       2.01x10-4        0.05
PWWP2B     cg08751508 -3.45   -1.07   -2.26      2.02x10-4        0.05
PCNXL2     cg16371229 -7.80   -2.42   -5.11      2.02x10-4        0.05
PVT1       cg03481855 1.01    3.24    2.13       2.02x10-4        0.05
TBX21      cg06927323 -9.27   -2.88   -6.08      2.02x10-4        0.05
MTA3       cg25783099 2.54    8.17    5.36       2.02x10-4        0.05
CAMK2A     cg05004855 -5.86   -1.82   -3.84      2.03x10-4        0.05
H6PD       cg02276314 -3.33   -1.03   -2.18      2.03x10-4        0.05
                      -       -
           cg07873290                 -27.73     2.03x10-4        0.05
                      42.32   13.13
SEMA4B     cg20246851 -4.36   -1.35   -2.86      2.03x10-4        0.05
TBC1D16    cg02348119 -4.59   -1.42   -3.01      2.03x10-4        0.05
ALPK2      cg25407077 1.84    5.92    3.88       2.03x10-4        0.05
UBASH3A    cg09354050 0.88    2.84    1.86       2.03x10-4        0.05
RCAN3      cg01519464 0.97    3.14    2.05       2.05x10-4        0.05
           cg11550550 -8.66   -2.69   -5.67      2.04x10-4        0.05
KIAA1949   cg23672659 1.23    3.96    2.59       2.04x10-4        0.05
MAD2L1BP   cg02447620 1.48    4.77    3.12       2.04x10-4        0.05

                                  307


                                                                APPENDIX III


                                      Effect     Uncorrected p- FDR corrected
Gene       CpG site     CI- 95%
                                      estimate   Value          p –Value
                      -
ZMIZ1      cg17065712         -3.13 -6.62        2.04x10-4     0.05
                      10.11
BATF       cg21048162 1.26    4.05    2.65       2.04x10-4     0.05
           cg23444610 -8.32   -2.58   -5.45      2.04x10-4     0.05
TMEM62     cg12413346 -3.73   -1.16   -2.44      2.05x10-4     0.05
NSMCE1     cg02654449 -4.54   -1.41   -2.98      2.04x10-4     0.05
TMC8       cg05637296 1.66    5.37    3.52       2.05x10-4     0.05
TBRG4      cg26720010 1.05    3.38    2.22       2.05x10-4     0.05
TNFSF12    cg00031162 1.23    3.98    2.60       2.05x10-4     0.05
ID3        cg18150584 -2.58   -0.80   -1.69      2.08x10-4     0.05
PTP4A2     cg21545720 1.12    3.64    2.38       2.10x10-4     0.05
           cg03879180 -4.24   -1.31   -2.77      2.08x10-4     0.05
           cg09019635 -8.61   -2.66   -5.64      2.08x10-4     0.05
B3GNT7     cg06574960 -4.36   -1.35   -2.86      2.07x10-4     0.05
           cg21096907 -6.01   -1.86   -3.93      2.10x10-4     0.05
C4orf33    cg17707295 -4.84   -1.50   -3.17      2.06x10-4     0.05
           cg00525964 1.02    3.31    2.17       2.07x10-4     0.05
TTC33      cg15528722 -3.19   -0.99   -2.09      2.07x10-4     0.05
ACSL6      cg11010552 -3.72   -1.15   -2.44      2.08x10-4     0.05
HLA-E      cg09326440 4.56    14.75   9.66       2.09x10-4     0.05
           cg17423416 -7.72   -2.39   -5.05      2.09x10-4     0.05
REV3L      cg09365147 -1.80   -0.56   -1.18      2.09x10-4     0.05
C7orf36    cg01835368 -5.16   -1.60   -3.38      2.07x10-4     0.05
CDK6       cg09653641 -2.55   -0.79   -1.67      2.07x10-4     0.05
           cg22728904 -3.60   -1.11   -2.36      2.10x10-4     0.05
CCDC136    cg07611843 -3.80   -1.17   -2.48      2.08x10-4     0.05
EPB49      cg04662594 -5.73   -1.77   -3.75      2.08x10-4     0.05
NDRG1      cg08691775 -3.04   -0.94   -1.99      2.10x10-4     0.05
GSN        cg01136942 -7.36   -2.28   -4.82      2.08x10-4     0.05
SH2D4B     cg14104280 -4.32   -1.34   -2.83      2.10x10-4     0.05
LCOR       cg25589001 -2.89   -0.89   -1.89      2.09x10-4     0.05
UCP3       cg10859442 0.74    2.38    1.56       2.09x10-4     0.05
ARRB1      cg12041266 -6.14   -1.90   -4.02      2.08x10-4     0.05
NCOR2      cg17187521 -3.44   -1.06   -2.25      2.09x10-4     0.05
           cg15899743 1.19    3.84    2.52       2.08x10-4     0.05
           cg03035162 0.98    3.16    2.07       2.08x10-4     0.05
FBLN5      cg02082843 0.98    3.16    2.07       2.09x10-4     0.05
GRIN2C     cg19965023 -8.80   -2.72   -5.76      2.08x10-4     0.05
KIAA0427   cg18530324 -4.95   -1.53   -3.24      2.09x10-4     0.05


                                  308


                                                                   APPENDIX III


                                      Effect     Uncorrected p-   FDR corrected
Gene       CpG site   CI- 95%
                                      estimate   Value            p –Value
MBP        cg26457248 -6.32   -1.96   -4.14      2.06x10-4        0.05
C19orf35   cg01129847 -2.89   -0.89   -1.89      2.07x10-4        0.05
           cg20281375 -3.30   -1.02   -2.16      2.09x10-4        0.05
NOSIP      cg18734095 1.18    3.81    2.50       2.08x10-4        0.05
           cg26314722 2.31    7.49    4.90       2.11x10-4        0.05
SPARC      cg21877464 -2.99   -0.92   -1.96      2.11x10-4        0.05
FARS2      cg19689330 -3.31   -1.02   -2.17      2.11x10-4        0.05
C10orf99   cg04126866 1.59    5.16    3.38       2.11x10-4        0.05
           cg20626983 1.02    3.28    2.15       2.11x10-4        0.05
PIK3R5     cg16672810 2.28    7.37    4.82       2.11x10-4        0.05
MGST1      cg00609333 -4.46   -1.38   -2.92      2.11x10-4        0.05
NIN        cg08189198 1.19    3.84    2.51       2.12x10-4        0.05
           cg07820189 -3.81   -1.18   -2.49      2.12x10-4        0.05
CMTM8      cg01617750 -5.10   -1.58   -3.34      2.13x10-4        0.05
                      -
CDS1       cg21096050         -3.64 -7.71        2.13x10-4        0.05
                      11.77
DDAH2      cg03608520 -5.70   -1.76   -3.73      2.14x10-4        0.05
SRF        cg00537673 1.59    5.14    3.36       2.13x10-4        0.05
FAM91A1    cg20283107 -3.90   -1.20   -2.55      2.13x10-4        0.05
GPSM1      cg14164080 -7.02   -2.17   -4.60      2.13x10-4        0.05
GOLGA3     cg01230386 0.83    2.68    1.75       2.13x10-4        0.05
GMFB       cg02051941 -6.28   -1.94   -4.11      2.13x10-4        0.05
MPI        cg07630255 0.95    3.06    2.01       2.13x10-4        0.05
SMAD7      cg14283454 -4.91   -1.52   -3.21      2.13x10-4        0.05
RBM38      cg17799760 1.89    6.11    4.00       2.12x10-4        0.05
PMEPA1     cg04628369 -4.52   -1.39   -2.96      2.13x10-4        0.05
LIME1      cg12413156 1.05    3.41    2.23       2.13x10-4        0.05
LHFPL2     cg26951839 -6.12   -1.89   -4.00      2.14x10-4        0.05
SEC14L1    cg26477169 -6.60   -2.04   -4.32      2.14x10-4        0.05
AKAP8L     cg25533247 -4.96   -1.53   -3.25      2.14x10-4        0.05
DEPDC1     cg19916364 -3.59   -1.11   -2.35      2.15x10-4        0.05
CD1D       cg18234111 -2.69   -0.83   -1.76      2.15x10-4        0.05
           cg00017826 1.03    3.33    2.18       2.16x10-4        0.05
CCR1       cg11589536 -4.94   -1.52   -3.23      2.15x10-4        0.05
MED12L     cg19010441 1.17    3.78    2.47       2.16x10-4        0.05
           cg19118972 -3.80   -1.17   -2.49      2.16x10-4        0.05
TERT       cg13390570 1.10    3.58    2.34       2.16x10-4        0.05
WDFY4      cg07345108 -4.59   -1.41   -3.00      2.16x10-4        0.05
AMBRA1     cg01968525 -4.33   -1.33   -2.83      2.16x10-4        0.05


                                  309


                                                                       APPENDIX III


                                          Effect     Uncorrected p-   FDR corrected
Gene           CpG site   CI- 95%
                                          estimate   Value            p –Value
TBCD           cg15787636 0.84    2.72    1.78       2.16x10-4        0.05
MRPL16         cg08066376 -3.05   -0.94   -1.99      2.17x10-4        0.05
               cg12759387 1.34    4.34    2.84       2.18x10-4        0.05
               cg01479187 -2.60   -0.80   -1.70      2.18x10-4        0.05
                          -
TBX18          cg22496809         -4.86 -10.33       2.17x10-4        0.05
                          15.79
NACC2          cg03587907 -6.69   -2.06   -4.38      2.18x10-4        0.05
AMBRA1         cg20090290 -1.94   -0.60   -1.27      2.18x10-4        0.05
PHACTR4        cg23847017 -3.19   -0.98   -2.09      2.19x10-4        0.05
TRAPPC3        cg01747664 -5.25   -1.62   -3.43      2.19x10-4        0.05
                          -
NPY2R          cg06812991         -5.48 -11.64       2.19x10-4        0.05
                          17.80
                          -
CARD11         cg21516162         -6.31 -13.39       2.19x10-4        0.05
                          20.48
PRMT3          cg05914060 -3.50   -1.08   -2.29      2.19x10-4        0.05
ATP8B4         cg23671196 -3.03   -0.93   -1.98      2.19x10-4        0.05
OSGIN1         cg06190046 -2.60   -0.80   -1.70      2.19x10-4        0.05
AKAP8L         cg20222376 -4.93   -1.52   -3.22      2.19x10-4        0.05
                          -
TCIRG1         cg08932343         -6.11 -12.97       2.20x10-4        0.05
                          19.83
SKI            cg01938025 2.34    7.59    4.96       2.20x10-4        0.05
GP5            cg05323324 -2.52   -0.78   -1.65      2.20x10-4        0.05
APLP2          cg25354657 1.04    3.38    2.21       2.20x10-4        0.05
               cg05892030 -3.88   -1.19   -2.54      2.20x10-4        0.05
FAM38A         cg27004870 -5.91   -1.82   -3.86      2.20x10-4        0.05
SEPT9          cg10755077 -5.14   -1.58   -3.36      2.21x10-4        0.05
NFIX           cg25556035 1.52    4.96    3.24       2.21x10-4        0.05
NOL12          cg14398464 -6.64   -2.04   -4.34      2.21x10-4        0.05
               cg17511731 -7.64   -2.35   -5.00      2.21x10-4        0.05
FANCI          cg22813622 -3.86   -1.19   -2.52      2.21x10-4        0.05
                          -
BRD9           cg18277507         -4.11 -8.73        2.22x10-4        0.05
                          13.35
ARMC2          cg04642300 -2.98   -0.92 -1.95        2.22x10-4        0.05
PWWP2B         cg25303150 -4.27   -1.31 -2.79        2.22x10-4        0.05
GUK1           cg07366503 1.12    3.66 2.39          2.23x10-4        0.05
                          -
LOC100189589   cg06224721         -3.44 -7.32        2.23x10-4        0.05
                          11.19
               cg09122442 -5.28   -1.62 -3.45        2.24x10-4        0.05
                          -       -
GRPEL2         cg22725986               -61.94       2.23x10-4        0.05
                          94.76   29.12


                                      310


                                                            APPENDIX III


                                  Effect     Uncorrected p- FDR corrected
Gene       CpG site   CI- 95%
                                  estimate   Value          p –Value
                                                    -4
SLIT3      cg10165167 -6.96 -2.14 -4.55      2.23x10        0.05
                      -
BAT2       cg16278747       -4.20 -8.92      2.23x10-4     0.05
                      13.65
MAD1L1     cg18044113 1.25 4.08 2.67         2.22x10-4     0.05
MFHAS1     cg02049979 2.48 8.08 5.28         2.23x10-4     0.05
SNX16      cg17516635 -5.90 -1.81 -3.85      2.22x10-4     0.05
BLNK       cg07397033 -5.65 -1.74 -3.69      2.23x10-4     0.05
GPR81      cg17346246 1.31 4.25 2.78         2.23x10-4     0.05
           cg10414881 1.05 3.41 2.23         2.23x10-4     0.05
           cg26854588 0.87 2.82 1.85         2.23x10-4     0.05
                      -
LAIR1      cg06238491       -3.22 -6.85      2.23x10-4     0.05
                      10.48
           cg15138109 -6.58 -2.02 -4.30      2.24x10-4     0.05
                      -
ATP2B2     cg20235117       -3.51 -7.46      2.24x10-4     0.05
                      11.42
                      -
KIAA1161   cg14013337       -3.54 -7.52      2.24x10-4     0.05
                      11.51
FTO        cg10227678 1.23 4.01 2.62         2.24x10-4     0.05
TMIE       cg10775230 -7.30 -2.24 -4.77      2.25x10-4     0.05
                      -
CUX1       cg06294954       -3.48 -7.42      2.26x10-4     0.05
                      11.35
GSS        cg00352780 -4.84 -1.49 -3.17      2.26x10-4     0.05
                      -
           cg09356672       -3.67 -7.81      2.27x10-4     0.05
                      11.96
           cg14983236 -3.89 -1.19 -2.54      2.27x10-4     0.05
MTAP       cg25162921 -4.01 -1.23 -2.62      2.26x10-4     0.05
RASAL1     cg01616876 -3.22 -0.99 -2.10      2.27x10-4     0.05
           cg01207974 2.19 7.15 4.67         2.26x10-4     0.05
DAD1       cg07066907 -2.69 -0.83 -1.76      2.26x10-4     0.05
ZFP36L1    cg06617636 0.86 2.80 1.83         2.26x10-4     0.05
TGM5       cg25875049 -3.48 -1.07 -2.28      2.26x10-4     0.05
BLCAP      cg13591710 -6.27 -1.92 -4.10      2.27x10-4     0.05
CCT3       cg05532239 -4.15 -1.27 -2.71      2.28x10-4     0.05
CNIH4      cg18883472 3.32 10.84 7.08        2.28x10-4     0.05
ZAP70      cg14537825 1.36 4.43 2.89         2.28x10-4     0.05
ACTB       cg14145074 1.55 5.05 3.30         2.28x10-4     0.05
GRID2IP    cg07281318 -4.32 -1.32 -2.82      2.28x10-4     0.05
ARID5B     cg00928816 1.44 4.70 3.07         2.28x10-4     0.05
           cg11067407 -3.21 -0.98 -2.10      2.28x10-4     0.05
PLEKHA6    cg21581873 -8.39 -2.57 -5.48      2.29x10-4     0.05


                                311


                                                                                   APPENDIX III


                                             Effect           Uncorrected p- FDR corrected
Gene                  CpG site     CI- 95%
                                             estimate         Value          p –Value
                                                                     -4
                      cg14752089 -3.16 -0.97 -2.06            2.29x10        0.05
                                 -
ABLIM1                cg15294435       -3.79 -8.08            2.29x10-4         0.05
                                 12.36
C11orf16              cg14402562 -4.98 -1.53 -3.25            2.29x10-4         0.05
                                 -
C3                    cg11959387       -4.16 -8.88            2.29x10-4         0.05
                                 13.59
GPR77                 cg16734795 -3.89 -1.19 -2.54            2.29x10-4         0.05
                                 -
                      cg11963409       -4.05 -8.63            2.30x10-4         0.05
                                 13.21
                                 -
LRIG1                 cg25742035       -3.17 -6.76            2.30x10-4         0.05
                                 10.34
KIF26B                cg19368911 0.90 2.93 1.91               2.30x10-4         0.05
NECAB3                cg23687971 -3.29 -1.01 -2.15            2.31x10-4         0.05
F11R                  cg20012024 -3.58 -1.10 -2.34            2.31x10-4         0.05
                                 -
CLIP4                 cg07285673       -3.17 -6.75            2.31x10-4         0.05
                                 10.34
                      cg20661080 0.80 2.63 1.72               2.31x10-4         0.05
PTPRCAP               cg20792833 1.88 6.14 4.01               2.31x10-4         0.05


Supplementary Material IV.2: Simulation commented script
This script will be available on github (https://github.com/SoCadiou) once the corresponding
draft will be published.

    R script for causal structures A, B and C
##this code allows to perform a simulation to assess performance in terms of
## sensitivity and specificity of prespecified statistical methods
##used to find the true predictors of an health among the exposome under diverse
##causal structures involving a causal link from the exposome to an outcome.
##Some of them use an intermediary layer, some not. It contains 5 ##parts:

##1. defining the functions allowing to generate a realistic dataset of exposome
##intermediate layer and outcome. The three layers(E, M and Y) can be linearly
##related to simulate various causal structures.

#It needs real datasets (exposome/intermediate layer) as inputs, as well
##as parameters allowing to define the association within the three layers (number of
#predictors, variability explained, correlation..)

##2. defining the methods assessed

##3. defining some functions used to assess methods performance

##4. defining the simulation function, which, for a given scenario, generates

                                               312


                                                                                  APPENDIX III

##the datasets, applies the methods and assess their performance. This function
##allows to parallelize the simulation.

##5. runnning the simulation itself with parallelization, repeating X times the
##function defined in 4. for each scenario and saving the results.
########################################################
#######################

##load packages
library(mvtnorm)
library(boot)
library(parallel)
library(reshape)
library(glmnet)
library(DSA)

#####################################
##1. define the generating functions
####################################
simulator <-
  function(E_true, ##real exposome
        M_true, ## real intermediate layer, eg methylome
        R2_tot = 0.5, ##total varibility of the outcome explained by
        #the predictors of E and M
        propmE = 0, ##proportion of variables of M affected by E
        ##without affecting Y
        propmEY = 0.1, ##proportion of variables of M acting as mediators
        ##between E and Y
        propmY = 0, ##proportion of variables of M not affected by E
        ##but affecting Y.
        BetamEY = 0.1, ##coefficient of the effect of M on Y for variables
        ##of M acting as mediators between E and Y. It can be an unique value
        ##or a vector of length n_mEY
        BetamY = 0.1, ##coefficient of the effect of M on Y for variables
        ##of M acting as mediators between E and Y. It can be an unique value
        ##or a vector of length n_mY
        n_mE = NULL, ##alternative way to specify the three previous set
        ##of predictors: #directly giving the number of predictors
        n_mEY = NULL,
        n_mY = NULL,
        n_EmE = 0, ##number of exposures affecting variables of M without
        ##acting through M on the outcome
        n_EmEY = 3,##number of exposures having an effect on Y through M
        n_Ey = 0, ##number of exposures acting directly on M
        ##the 4 next variables specify the intersection between the different
        ## sets of predictors in E
        n_EmE_U_n_EmEY = 0,
        n_Ey_U_n_EmE = 0,
                                              313


                                                                             APPENDIX III

      n_Ey_U_n_EmEY = 0,
      n_Ey_U_n_EmE_U_n_EmEY = 0,
      ##the three next variables specify the coefficients of effects for
      ##the different sets of predictors in E. They can be an unique value
      ##or a vector of size respectively n_EmE, n_EmEY, n_Ey...
      BetaEmE = 0.1,
      BetaEmEY = 0.1,
      BetaEy = 0.1,
      test_and_training = TRUE ##generating only a training set or
      ##alternatively also a test set of same size
      ){
##check of consistency within the input
if ((BetaEmEY == 0 &
     n_EmEY != 0)) {
  stop("error: BetaEmEY and n_EmEY not compatible")
}
if ((n_mEY == 0 &
     n_EmEY != 0)) {
  stop("error: n_mEY and n_mEY not compatible")
}
if ((n_mEY != 0 &
     n_EmEY == 0)) {
  stop("error: n_mEY and n_mEY not compatible")
}
##sampling with replacemnt the real data for exposome
data.X <- as.data.frame(dataExp_true)
names_row <- rownames(data.X)
data.X <-
  data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),]
rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
dataExp <- data.X
remove(data.X)
##sampling with replacement the real intermediate data
data.X <- as.data.frame(M1_true)
names_row <- rownames(data.X)
data.X <-
  data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),]
rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
M1 <- data.X

##setting linear relationship between E and M

##E on variables on M having no effect on Y

##converting if necessary proportion of predictors to number of predictors
if (is.null(n_mE)) {
  n_mE <- floor(propmE * nrow(M1))
}
                                             314


                                                                                APPENDIX III

##multiplicity constraint: check if number of variables n_mE is a multiple of
##n_EmE
if (n_mE != 0){
n_pat_mE <- (n_mE / n_EmE)
if (trunc(n_pat_mE) != n_pat_mE) {
  stop("error: number of cpgs explained by E is not a multiple of
       the number of predictors from E")
}
}
###creating the vector of predictors
mE_predictors <- list()
##generating vector of effect coefficients
Npred_mE_E <- rep(list(n_EmE), n_mE)
Betapred_mE_E <- list()
for (t in seq(length.out = n_EmE)) {
  list_temp <- as.list(rep(0, n_EmE))
  if (length(BetaEmE) == 1) {
    list_temp[[t]] <- BetaEmE
  } else{
    if (length(BetaEmE) != n_EmE) {
      stop("error: Betas for E explaining M are not consistent
           with the number of predictors")
    }
    list_temp[[t]] <- BetaEmE[[t]]
  }
  list_Beta_pred_mE_E_by_pat <- rep(list(list_temp), n_pat_mE)
  Betapred_mE_E <- c(Betapred_mE_E, list_Beta_pred_mE_E_by_pat)
}
##random sampling of causal exposures
ind_mE_E <- sample(ncol(dataExp), n_EmE)
##random sampling of variables of M affected
ind_mE_M <- sample(ncol(M1), n_mE)
##adding a linear effect from E on each variable of M
for (k in seq(length.out = n_mE)) {
  list_temp <-
    list(ind_mE_M[k],
         colnames(M1)[ind_mE_M[k]],
         Npred_mE_E[[k]],
         Betapred_mE_E[[k]],
         ind_mE_E)
  list_temp <- c(list_temp, list(colnames(dataExp)[list_temp[[5]]]))
  names(list_temp) <-
    c(
      "indice_cpg",
      "cpg",
      "nb_exp_predictors",
      "Beta_exp_predictors",
      "ind_exp_predictors",
                                            315


                                                                              APPENDIX III

     "name_exp_predictors"
   )
 cpg_temp <-
   simResponseSimple(
     met = dataExp,
     Nmet = list_temp[[3]],
     beta = unlist(list_temp[[4]]),
     list_temp[[5]]
   )
 M1[, list_temp[[1]]] <-
   as.numeric(M1[, list_temp[[1]]] + cpg_temp$resp)
 list_temp[[7]] <-
   estimatedR2(dataExp, list_temp[[6]], M1[, list_temp[[1]], drop = FALSE])
 names(list_temp)[[7]] <- "R2"
 mE_predictors <- c(mE_predictors, list(list_temp))
 remove(list_temp)
 remove(cpg_temp)
}
##empirical estimation of mean R2 (mean variability of M affected by E
##explained by E)
if (n_mE != 0) {
  R2_mean_mE <-
    mean(unlist(lapply(mE_predictors, function(X)
     X$R2$r.squared)))
} else{
  R2_mean_mE = 0
}




##E on variables on M mediating effect on Y
##converting if necessary proportion of predictors to number of predictors
if (is.null(n_mEY)) {
  n_mEY <- floor(propmEY * nrow(M1))
}
##multiplicity constraint: check if number of variables n_mEY is a multiple of
##n_EmEY
if (n_mEY != 0){
n_pat_mEY <- (n_mEY / n_EmEY)
if (trunc(n_pat_mEY) != n_pat_mEY) {
  stop("error: number of cpgs explained by E explaining Y is not a
      multiple of the number of their predictors from E")
}
}
###creating the vector of predictors
mEY_predictors <- list()
##generating vector of effect coefficients
                                           316


                                                                        APPENDIX III

  Npred_mEY_E <- rep(list(n_EmEY), n_mEY)
  Betapred_mEY_E <- list()
  for (t in seq(length.out = n_EmEY)) {
    list_temp <- as.list(rep(0, n_EmEY))
    if (length(BetaEmEY) == 1) {
      list_temp[[t]] <- BetaEmEY
    } else{
      if (length(BetaEmEY) != n_EmEY) {
        stop("error: Betas for E explaining M are not consistent
            with the number of predictors")
      }
      list_temp[[t]] <- BetaEmEY[[t]]
    }
    list_Beta_pred_mEY_E_by_pat <- rep(list(list_temp), n_pat_mEY)
    Betapred_mEY_E <- c(Betapred_mEY_E, list_Beta_pred_mEY_E_by_pat)
  }
  ##random sampling of causal exposures
  if ((n_EmE) != 0) {
    ind_mEY_E_in_pred_mE = sample(ind_mE_E, n_EmE_U_n_EmEY)
    ind_mEY_E <-
      c(ind_mEY_E_in_pred_mE, sample((1:ncol(dataExp))[-ind_mE_E], n_EmEY -
n_EmE_U_n_EmEY))
  } else{
    ind_mEY_E <- sample(ncol(dataExp), n_EmEY)
  }
 ##random sampling of variables of M
  if (n_mE != 0) {
    ind_mEY_M <-
      sample((1:ncol(M1))[-ind_mE_M], n_mEY)
  } else{
    ind_mEY_M <- sample(ncol(M1), n_mEY)
  }

  ##adding a linear effect from E on each variable of M
     for (k in seq(length.out = n_mEY)) {
   list_temp <-
     list(ind_mEY_M[k],
         colnames(M1)[ind_mEY_M[k]],
         Npred_mEY_E[[k]],
         Betapred_mEY_E[[k]],
         ind_mEY_E)
   list_temp <- c(list_temp, list(colnames(dataExp)[list_temp[[5]]]))
   names(list_temp) <-
     c(
       "indice_cpg",
       "cpg",
       "nb_exp_predictors",
       "Beta_exp_predictors",
                                               317


                                                                                  APPENDIX III

      "ind_exp_predictors",
      "name_exp_predictors"
     )
   cpg_temp <-
     simResponseSimple(
       met = dataExp,
       Nmet = list_temp[[3]],
       beta = unlist(list_temp[[4]]),
       list_temp[[5]]
     )
   M1[, list_temp[[1]]] <-
     as.numeric(M1[, list_temp[[1]]] + cpg_temp$resp)
   list_temp[[7]] <-
     estimatedR2(dataExp, list_temp[[6]], M1[, list_temp[[1]], drop = FALSE])
   names(list_temp)[[7]] <- "R2"
   mEY_predictors <- c(mEY_predictors, list(list_temp))
   remove(list_temp)
   remove(cpg_temp)
  }
  ##empirical estimation of mean R2 (mean variability of M affected by E
  ##explained by E)
  if (n_mEY != 0) {
    R2_mean_mEY <-
      mean(unlist(lapply(mEY_predictors, function(X)
       X$R2$r.squared)))
  } else{
    R2_mean_mEY = 0
  }

   ##variables of M not affected by E having an effect on Y
   if (is.null(n_mY)) {
     n_mY <- floor(propmY * nrow(M1))
   }
   ##generating vector of effect coefficients
 if (length(BetamY) == 1) {
     Betapred_yM_M <- rep(BetamY, n_mY)
   } else{
     if (length(BetamY) != n_mY) {
       stop(
         "error: Betas for M explaining Y not explained by E are not consistent with the number of
predictors"
       )
     }
     Betapred_yM_M <- BetamY
   }
   ##if there is not effect of mY, generating an empty yM
   if (n_mY == 0) {
     yM = list(as.matrix(rep(0, nrow(M1)), ncol = 1), NULL, NULL)
                                               318


                                                                                 APPENDIX III

    names(yM) <- c("resp", "beta")
  } else{
    ##if there is an effect, generating yM: part of the outcome which is a
    ##linear combination of variables of M not affected by E
    if (n_mEY == 0 & n_mE == 0) {
      ind_yM_M <- sample(ncol(M1), n_mY)
    } else{
      ind_yM_M <- sample((1:ncol(M1))[-c(ind_mEY_M, ind_mE_M)], n_mY)
    }
    yM <-
      simResponseSimple(
        met = M1,
        Nmet = length(ind_yM_M),
        beta = Betapred_yM_M,
        cpg = ind_yM_M
      )
  }


 ##variables of M mediating an effect of E on Y
 ##generating vector of effect coefficients
  if (length(BetamEY) == 1) {
    Betapred_yME_M <- rep(BetamEY, n_mEY)
  } else{
    if (length(BetamEY) != n_mEY) {
      stop(
        "error: Betas for M explaining Y explained by E are not consistent with the number of
predictors"
      )
    }
    Betapred_yM_M <- BetamY
  }
#if there is an effect, generating yME: part of the outcome which is a
##linear combination of variables of M affected by E
  ind_yME_M <- ind_mEY_M
  if (n_mEY != 0) {
    yME <-
      simResponseSimple(
        met = M1,
        Nmet = length(ind_yME_M),
        beta = Betapred_yME_M,
        cpg = ind_yME_M
      )
  } else{
    yME = list(as.matrix(rep(0, nrow(M1)), ncol = 1), NULL, NULL)
    names(yME) <- c("resp", "beta")
  }


                                               319


                                                                  APPENDIX III

  ##direct effect of E on Y
  ##random sampling of exposures with respect to the specification of
  #intersections between the different groups of exposures having different
  ##effects
  if (n_EmE == 0 & n_EmEY == 0) {
    ind_yE_E <- sample(ncol(dataExp), n_Ey)
    ind_yE_E_shared_mEY <- integer(0)
    ind_yE_E_shared_mE <- integer(0)
    ind_yE_E_shared_mE_mEY <- integer(0)
  } else{
    ind_yE_E <-
      sample((1:ncol(dataExp))[-unique(c(ind_mE_E, ind_mEY_E))],
           n_Ey - n_Ey_U_n_EmE - n_Ey_U_n_EmEY + n_Ey_U_n_EmE_U_n_EmEY)
    if (n_Ey_U_n_EmE_U_n_EmEY != 0) {
      ind_yE_E_shared_mE_mEY <-
        sample(intersect(ind_mE_E, ind_mEY_E), n_Ey_U_n_EmE_U_n_EmEY)
    } else{
      ind_yE_E_shared_mE_mEY <- integer(0)
    }
    if (n_Ey_U_n_EmE != 0) {
      ind_yE_E_shared_mE <-
        sample(ind_mE_E[!ind_mE_E %in% intersect(ind_mE_E, ind_mEY_E)],
n_Ey_U_n_EmE -
             n_Ey_U_n_EmE_U_n_EmEY)
    } else{
      ind_yE_E_shared_mE <- integer(0)
    }
    if (n_Ey_U_n_EmEY != 0) {
      ind_yE_E_shared_mEY <-
        sample(ind_mEY_E[!ind_mEY_E %in% intersect(ind_mE_E, ind_mEY_E)],
n_Ey_U_n_EmEY -
             n_Ey_U_n_EmE_U_n_EmEY)

   } else{
     ind_yE_E_shared_mEY <- integer(0)
   }
   ind_yE_E <-
     c(ind_yE_E,
       ind_yE_E_shared_mE,
       ind_yE_E_shared_mEY,
       ind_yE_E_shared_mE_mEY)
  }
  ##generating vector of effects coefficients
  if (length(BetaEy) == 1) {
    Betapred_yE_E <- rep(BetaEy, n_Ey)
  } else{
    if (length(BetaEy) != n_Ey) {
      stop(
                                                320


                                                                             APPENDIX III

      "error: Betas for M explaining Y not explained by E are not
      consistent with the number of predictors"
  )
 }
 Betapred_yE_E <- BetaEy
}
##generating yE: part of the outcome which is a
##linear combination of exposures
yE <-
  simResponseSimple(
    met = dataExp,
    Nmet = length(ind_yE_E),
    beta = Betapred_yE_E,
    cpg = ind_yE_E
  )

##Creating the final Y by adding a gaussian according to the variability
##wanted to the differents parts of Y already created
Y <- yE$resp + yME$resp + yM$resp
if (!is.na(R2_tot)) {
  if (((R2_tot) != 0)) {
    sigma <- var(Y) * (1 / R2_tot - 1)
  } else{
    R2 = 0.00000001
    sigma <- var(Y) * (1 / R2_tot - 1)
  }
  Y <- as.matrix(Y + rnorm(length(Y), mean(Y), sqrt(sigma)), ncol = 1)
}

##extracting all indirect predictors of Y from E
##and computing the corresponding betas
datapred <- data.frame(exp = character(0), beta = numeric(0))
for (k in seq(length.out = n_mEY)) {
  datapred_temp <-
    cbind(
      exp = unlist(mEY_predictors[[k]]$name_exp_predictors),
      beta = unlist(mEY_predictors[[k]]$Beta_exp_predictors) * yME$beta[k]
    )
  datapred <- rbind(datapred, datapred_temp)
}
class(datapred$beta) <- "numeric"
yME_E <-
  list(
    resp = yME$resp,
    beta = sapply(unique(datapred$exp), function(X)
      sum(datapred[datapred$exp == X, ]$beta)),
    predictors = unique(datapred$exp)
  )
                                              321


                                                                         APPENDIX III

##extracting all predictors of Y from E (direct and indirect)
##and computing the corresponding betas
datapred <-
 data.frame(cbind(
   exp = c(
     as.character(yE$predictors),
     as.character(yME_E$predictors)
   ),
   beta = c(as.numeric(yE$beta), as.numeric(yME_E$beta))
 ))
datapred$beta <- as.numeric(as.character(datapred$beta))
yE_ME <-
 list(
   resp = Y,
   beta = sapply(unique(datapred$exp), function(X)
     sum(datapred[datapred$exp == X, ]$beta)),
   predictors = unique(datapred$exp)
 )
remove(datapred)
##extracting all predictors of Y from M
##and computing the corresponding betas
datapred <-
 data.frame(cbind(
   cpg = c(as.character(yM$predictors), as.character(yME$predictors)),
   beta = c(as.numeric(yM$beta), as.numeric(yME$beta))
 ))
datapred$beta <- as.numeric(as.character(datapred$beta))
yM_ME <-
 list(
   resp = Y,
   beta = sapply(unique(datapred$cpg), function(X)
     sum(datapred[datapred$cpg == X, ]$beta)),
   predictors = unique(datapred$cpg)
 )
remove(datapred)

##computing the effective R2
if ((n_mEY + n_mE) != 0) {
  R2_mean_M_E <-
    (n_mEY * R2_mean_mEY + n_mE * R2_mean_mE) / ((n_mEY + n_mE))
} else{
  R2_mean_M_E = 0
}
R2 <-
  list(
    BMI_all_exp = estimatedR2(dataExp, yE_ME$predictors, Y)$r.squared,
    BMI_all_M = estimatedR2(M1, yM_ME$predictors, Y)$r.squared,
    mean_M_E = R2_mean_M_E
                                            322


                                                                      APPENDIX III

      )

     ##creating a list to return

     resultats <-
      list(
        Y_train = Y[1:(nrow(M1) / 2), , drop = FALSE],
        E_train = dataExp[1:(nrow(M1) / 2), , drop = FALSE],
        M_train = M1[1:(nrow(M1) / 2), , drop = FALSE],
        Y_test = Y[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
        E_test = dataExp[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
        M_test = M1[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
        yM_E = yME_E,
        y_E = yE_ME,
        yE_E = yE,
        yM_M = yM_ME,
        R2 = R2,
        list_mY_predictor = as.character(yM$predictors),
        list_mE_Y_predictor = as.character(yME$predictors)
      )
     return(resultats)
 }

##function used to create a linear response
simResponseSimple <- function(met, ##matrix of potential predictors
                     Nmet = NA, ##number of predictors
                     beta = NULL, ##vector of effects
                     cpg = NULL) { ##optionnal: directly specifying
                    ##some of the indexes of predictors
  if (all(c(is.na(Nmet), is.na(cpg))) == TRUE) {
    return (list(
      resp = as.matrix(rep(0, nrow(met)), ncol = 1),
      beta = NA,
      predictors = NA
    ))
  }
  temp <- Nmet - length(cpg)
  if (temp != 0) {
    wh <- sample((1:ncol(met)[-cpg]), temp)
     wh <- c(cpg, wh)
  } else{
    wh <- cpg
  }
  CovMat <- as.matrix(met[, wh])
  colnames(CovMat) <- colnames(met)[wh]
  # computing the response
  mean <- CovMat %*% matrix(beta, ncol = 1)
  rownames(mean)<-rownames(met)
                                             323


                                                                                  APPENDIX III

    names(beta) <- colnames(CovMat)
    return (list(
      resp = mean,
      beta = beta,
      predictors = colnames(met)[wh]
    ))
}

##fonction to estimate R2 from a dataframe of potential predictors, a vector of
##predictors names and the outcome
estimatedR2 <- function(X, truepred, Y) {
 if ("y" %in% truepred) {
   stop("error: one of the true predictors is named y")
 }
 if (ncol(Y) != 1) {
   stop("error:Y is multidimensionnal")
 }
 if (nrow(X) != nrow(Y)) {
   stop("error not the same number of rows")
 }
 if (isTRUE(all.equal(rownames(X), rownames(Y))) == FALSE) {
   stop("error individuals are not ordered similarly in X and Y")
 }
 if (all(truepred %in% colnames(X))) {
   data <- X[, colnames(X) %in% truepred, drop = FALSE]
   data <- cbind(Y, data)
   colnames(data)[1] <- "y"
   mod <- lm(y ~ ., as.data.frame(data))
   toselect.x <- summary(mod)$coeff[-1, 4]
   r <-
     list(summary(mod)$r.squared,
         summary(mod)$adj.r.squared,
         names(toselect.x)[toselect.x == TRUE])
   names(r) <- c("r.squared", "adj.r.squared", "pred")
   return(r)
 } else{
   stop("error: X does not countain all true predictors")

    }
}


###########################################
##2. defining the methods to test
###########################################


###agnostic methods
                                              324


                                                                     APPENDIX III



##function to compute residuals of a linear model if covariates are specified
getresiduals_2df<-function(data_Y_in,data_covar_in,name_Y,covar){
  data_covar<-data_covar_in[,colnames(data_covar_in)%in%covar,drop=FALSE]
  data_Y<-
data_Y_in[rownames(data_Y_in)%in%rownames(data_covar),colnames(data_Y_in)==name_Y,d
rop=FALSE]
  data_covar<-data_covar[rownames(data_covar)%in%rownames(data_Y),,drop=FALSE]
  data_covar<-data_covar[rownames(data_Y),,drop=FALSE]
  data_output<-data_Y
  data<-cbind(data_Y,data_covar)
  mod<-lm(data=data)
  data_output[,1]<-as.data.frame(residuals(mod))
  return(data_output)
}

###ExWAS
ewas<-
function(data_Xs_in=NULL,data_Y_in=NULL,name_Y,data_covar_in=NULL,covar=character
(0),corr="BH"){
 require(parallel)
 if (length(covar)>0){
   data_covar<-
data_covar_in[rownames(data_covar_in)%in%rownames(data_Y_in)&rownames(data_covar_in)
%in%rownames(data_Xs_in),colnames(data_covar_in)%in%covar,drop=FALSE]
   data_Y<-
data_Y_in[rownames(data_Y_in)%in%rownames(data_covar)&rownames(data_Y_in)%in%rown
ames(data_Xs_in),colnames(data_Y_in)==name_Y,drop=FALSE]
   data_Xs<-
data_Xs_in[rownames(data_Xs_in)%in%rownames(data_covar)&rownames(data_Xs_in)%in%ro
wnames(data_Y),,drop=FALSE]
   data_covar<-data_covar[rownames(data_Y),,drop=FALSE]
   data_Xs<-data_Xs[rownames(data_Y),,drop=FALSE]
   data_Y<-getresiduals_2df(data_Y,data_covar,name_Y,covar)
 }else{
   data_Y<-
data_Y_in[rownames(data_Y_in)%in%rownames(data_Xs_in),colnames(data_Y_in)==name_Y,
drop=FALSE]
   data_Xs<-data_Xs_in[rownames(data_Xs_in)%in%rownames(data_Y_in),,drop=FALSE]
   data_Xs<-data_Xs[rownames(data_Y),,drop=FALSE]
 }
 if (is.null(data_Y)==TRUE |is.null(data_Xs)==TRUE|!(name_Y%in%colnames(data_Y))) {
   stop("Inconsistent data")
 }

 ##computing p.values
 p.values <- lapply(1:ncol(data_Xs), function(x,data_Xs){
  c(colnames(data_Xs)[x],confint(lm(Y~var1,
                                              325


                                                                               APPENDIX III

                         data=data.frame(cbind(var1=data_Xs[,x],Y=data_Y[,1]))))[2,],
     summary(lm(Y~var1,
data=data.frame(cbind(var1=data_Xs[,x],Y=data_Y[,1]))))$coefficients[2,])},
   data_Xs)
 if (length(p.values)>1){
   p.values <- cbind(matrix(unlist(p.values), ncol = 7, byrow = TRUE)[,-6])

  }else{
    p.values <- as.data.frame(t(as.data.frame(unlist(p.values)))[,-6,drop=FALSE])
  }
  p.values<-as.data.frame(p.values)
  colnames(p.values) <- c("var","conf - 2.5%","conf - 97.5%", "Est","Sd","pVal")
  p.values <- p.values[p.values$var!="Intercept",]
  p.values$pVal<-as.numeric(as.character(p.values$pVal))
  p.values.adj<-p.values
  pVal <- as.numeric(as.character(p.values$pVal))
  ##add correction for multiple testing
  if(corr=="None"){
    wh <- which(pVal<=0.05)
    p.values.adj$pVal_adj<-pVal}
  if(corr=="Bon"){ wh <- which(pVal<=0.05/nrow(p.values))
  p.values.adj$pVal_adj<-pVal*nrow(p.values)}
  if(corr=="BH") {wh <- which(p.adjust(pVal,"BH")<=0.05)
  p.values.adj$pVal_adj<-p.adjust(pVal,"BH")}
  if(corr=="BY") {wh <- which(p.adjust(pVal,"BY")<=0.05)
  p.values.adj$pVal_adj<-p.adjust(pVal,"BY")}
  if(!corr%in%c("Bon","BH","BY","","None")) stop("Please specify a known correction method
for
                                 multiple testing")
  wh <- p.values$var[wh]
  a<-list(wh,p.values.adj)
  names(a)<-c("selected","pval")
  return(a)
}

###LASSO
lasso <-
  function(data_Xs_in,
         data_Y_in,
         name_Y,
         data_covar_in = NULL,
         covar = character(0)) {
   if (length(covar) > 0) {
     data_covar <-
       data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                 rownames(data_covar_in) %in% rownames(data_Xs_in),
                colnames(data_covar_in) %in%
                 covar, drop = FALSE]
                                              326


                                                                          APPENDIX III

       data_Y <-
        data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
               rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) == name_Y, drop =
               FALSE]
       data_Xs <-
        data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                rownames(data_Xs_in) %in% rownames(data_Y_in), ,
               drop = FALSE]
       data_covar <- data_covar[rownames(data_Y), ]
       data_Xs <- data_Xs[rownames(data_Y), ]
       data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
     } else{
       data_Y <-
        data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) ==
               name_Y, drop = FALSE]
       data_Xs <-
        data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
       data_Xs <- data_Xs[rownames(data_Y), ]
     }
     data_Y <- data.matrix(data_Y)
     data_Xs <- data.matrix(data_Xs)
     model.enet <- cv.glmnet(data_Xs, data_Y, family = "gaussian",
                    alpha = 1)
     cvfit <- model.enet

    ##Calcul Y_predit
    Y_predit<-predict(cvfit,newx=data_Xs, s = "lambda.min")
    Y_predit<-Y_predit[rownames(Y_predit),]

 ##liste des CPG selectionnés
 tmp_coeffs <- coef(cvfit, s ="lambda.min")
 cg_select<-data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1], coefficient =
tmp_coeffs@x)

    cg_select<-cg_select$name[cg_select$name!="(Intercept)"]
    a<-list()
    if (length(cg_select)!=0){
      a<-list("selected"=cg_select,"prediction"=Y_predit)
    }else{
      a<-list("selected"=character(),"prediction"="no_prediction")
    }
    return(a)

}



                                                 327


                                                                             APPENDIX III

##DSA
DSAreg <- function(Exp,resp, family = gaussian,maxsize = 15, maxsumofpow = 2,
               maxorderint = 2){
 Exp <- data.frame(cbind(data.frame(Exp), resp=resp))
 res <- DSA(resp ~ 1, data = Exp, family = family, maxsize = maxsize, maxsumofpow
          = maxsumofpow, maxorderint = maxorderint ,nsplits=1,usersplits = NULL)
 form <- gsub("I[(]","",colnames(coefficients(res)))
 form <- gsub("[*]",":",gsub("[)]","",gsub("[:^:]1","",form)))
 if(length(grep(":",form))>0){
   nam <- strsplit(form[grep("[:]",form)],":")
   for(j in 1:length(nam)){
     nam[[j]] <- gsub("[[:space:]]","",nam[[j]])
     name <- nam[[j]][1]
     for(k in 2:length(nam[[j]]))
      name <- paste(name,":",nam[[j]][k],sep="")
     Exp <- cbind(Exp,name=apply(Exp[,nam[[j]]],1,prod))
   }}
 form2 <- "resp~1"
 if(length(form)>1)for(i in 2:length(form)) form2 <- paste(form2,"+",form[i])
 res2 <- lm(form2, data=data.frame(Exp))
 ##decomment next line and change "prediction" to pred in the return line
 ##if outcome predicted by DSA is needed (not used presently)
 #pred <- predict(res2,Exp)
 coef <- summary(res2)$coefficients
 coef <- as.character(rownames(coef)[rownames(coef)!="Intercept"])

    return(list(selected=coef[coef!="(Intercept)"], pred="prediction"))
}


########################################################
##########
####3. defining some functions used to assess methods performance
########################################################
#########

sensitivity<-function(truepred, predfound){
  return(length(truepred[truepred%in%predfound])/length(truepred))
}
fdp<-function(truepred, predfound){ ##false discovery proportion
  if (length(predfound)==0) {return(0)
  }else{
    return(length(predfound[!predfound%in%truepred])/length(predfound))}
}
specificity<-function(truepred, predfound,n_base){
  return(
    (n_base-length(truepred)-length(predfound[!predfound%in%truepred]))/(n_base-
length(truepred)))
                                                  328


                                                          APPENDIX III

}


########################################################
#########
##4. defining the simulation function which will be parallelized
########################################################
#########
##it first generates datasets, then applies methods and then assessed
##their performance
f0<-function(x){
 ##important: the parallelization is done on the seed
 set.seed(x)

    ##generating datasets
    simu <-
      simulator(
        E_true = dataExp_true,
        M_true = M1_true,
        R2_tot = R2_fixed,
        propmE = 0,
        propmEY = 0.1,
        propmY = 0,
        BetamEY = BetamEY,
        BetamY = 0,
        n_mE = 0,
        n_mEY = n_mEY,
        n_mY = 0,
        n_EmE = 0,
        n_EmEY = n_EmEY,
        n_Ey = n_Ey,
        n_EmE_U_n_EmEY = 0,
        n_Ey_U_n_EmE = 0,
        n_Ey_U_n_EmEY = n_Ey_U_n_EmEY,
        n_Ey_U_n_EmE_U_n_EmEY = 0,
        BetaEmE = 0,
        BetaEmEY = BetaEmEY,
        BetaEy = BetaEy,
        test_and_training = TRUE
      )
    ###################
    ###applying methods
    ####################
    ##ExWas on the intermediate layer
    predBMI_M <-
      list(ewas_BH = ewas(
        as.data.frame(simu$M_train),
        as.data.frame(simu$Y_train),
                                         329


                                                                        APPENDIX III

   colnames(as.data.frame(simu$Y_train)),
   corr = "BH"
 ))
##ExWAS on E
predBMI_E <-
 list(
   ewas_BH = ewas(
     as.data.frame(simu$E_train),
     as.data.frame(simu$Y_train),
     colnames(as.data.frame(simu$Y_train)),
     corr = "BH"
   ),
   ewas_Bon = ewas(
     as.data.frame(simu$E_train),
     as.data.frame(simu$Y_train),
     colnames(as.data.frame(simu$Y_train)),
     corr = "Bon"
   )
 )
 print("ewas done")

#########################
 #oMITM
 if (length(predBMI_M$ewas_BH$selected) != 0) {
   select_M <-
     as.data.frame(simu$M_train[,
                        colnames(simu$M_train) %in% predBMI_M$ewas_BH$selected,
                        drop = FALSE])
   print(ncol(select_M))
   rownames(select_M) <- rownames(simu$M_train)
   colnames(select_M) <- predBMI_M$ewas_BH$selected
   list <- list()
   list_exp <- list()
   list_nom <- list()
   list_ewas_signif <- list()
   ##step b using the exwas performed on M as step a
   for (i in (1:ncol(simu$E_train))) {
     predE_select_M <-
       ewas(
         as.data.frame(select_M),
         (simu$E_train[, i, drop = FALSE]),
         colnames(simu$E_train[, i, drop = FALSE]),
         corr = "None",
         data_covar_in = as.data.frame(simu$Y_train),
         covar = colnames(as.data.frame(simu$Y_train)[1])
       )

   list <- c(list, list(predE_select_M))
                                              330


                                                                      APPENDIX III

 list_nom <- c(list_nom, list(colnames(simu$E_train)[i]))


 list_exp <- c(list_exp, list(colnames(simu$E_train)[i]))
 temp_ewas <-
   cbind(predE_select_M$pval, rep(colnames(simu$E_train)[i],
                       nrow(predE_select_M$pval)))
 list_ewas_signif <- c(list_ewas_signif, list(temp_ewas))
 remove(temp_ewas)
 remove(predE_select_M)
}
df_all_ewas <- do.call("rbind", list_ewas_signif)
if (!is.null(df_all_ewas)) {
  df_all_ewas$pVal_adj <- p.adjust(df_all_ewas$pVal, "BH")
  colnames(df_all_ewas)[8] <- "exposures"
  names(list) <- as.vector(unlist(list_nom))
}
exp <- df_all_ewas$exposures[df_all_ewas$pVal_adj <= 0.05]
n_exp_select <- length(unique(exp))
##step c
if (length(exp) != 0) {
  select_E <- simu$E_train[, colnames(simu$E_train) %in% exp, drop = FALSE]
  ##ExWAS implementation for step c
  predBMI_E_MITM <-
    ewas(
      as.data.frame(select_E),
      as.data.frame(simu$Y_train),
      colnames(as.data.frame(simu$Y_train)),
      corr = "BH"
    )
  ##DSA implementation for step c
  predBMI_E_MITMdsa <-
    DSAreg(
      Exp = as.data.frame(select_E),
      resp = simu$Y_train,
      maxsize = floor(ncol(simu$E_train) / 10),
      maxsumofpow = 1,
      maxorderint = 1
    )
  predReducedExp <- list(selected = unique(exp), pred = "NULL")
} else{
  predReducedExp <- list(vector(), vector())
  names(predReducedExp) <- c("selected", "pred")
}
if (exists("predBMI_E_MITM")) {

} else{
 predBMI_E_MITM <- list(vector(), vector())
                                          331


                                                                                  APPENDIX III

       names(predBMI_E_MITM) <- c("selected", "pval")
     }
     if (exists("predBMI_E_MITMdsa")) {

     } else{
       predBMI_E_MITMdsa <- list(vector(), vector())
       names(predBMI_E_MITM) <- c("selected", "pred")
     }
    } else{
     predBMI_E_MITM <- list(vector(), vector())
     names(predBMI_E_MITM) <- c("selected", "pval")
     n_exp_select = 0
     predReducedExp <- list(vector(), vector())
     names(predReducedExp) <- c("selected", "pred")
     predBMI_E_MITMdsa <- list(vector(), vector())
     names(predBMI_E_MITMdsa) <- c("selected", "pred"
     )

}
    ##storing results in a list
    predBMI_E <-
     c(
       predBMI_E,
       MITM = list(predBMI_E_MITM),
       MITMdsa = list(predBMI_E_MITMdsa),
       ReducedExp = list(predReducedExp)
     )
    print("oMITM done")

    ###Control method : random sampling on a random set of exposures of same
    ##dimension as the reduced exposome of oMITM
    if (n_exp_select > 0) {
      tirage <-
        ewas(
          as.data.frame(simu$E_train)[, sample(colnames(as.data.frame(simu$E_train)),
                                  n_exp_select), drop =
                              FALSE],
          as.data.frame(simu$Y_train),
          colnames(as.data.frame(simu$Y_train)),
          corr = "BH"
        )
    } else{
      tirage <- list(selected = character(0), null = "null")
    }
    ##storing results in the same list
    predBMI_E <- c(predBMI_E, random_sampling = list(tirage))
    print(n_exp_select)


                                                332


                                                                        APPENDIX III

###################################
##mediation
if (length(predBMI_E$ewas_BH$selected) != 0) {
  select_E <-
    as.data.frame(simu$E_train[,
                       colnames(simu$E_train) %in% predBMI_E$ewas_BH$selected,
                       drop = FALSE])
  rownames(select_E) <- rownames(simu$E_train)
  colnames(select_E) <- predBMI_E$ewas_BH$selected
  #step a
  list_temp_ewas_med <- list()
  for (i in 1:ncol(simu$M_train)) {
    exp_affecting_M_all <-
      ewas(as.data.frame(select_E),
          (simu$M_train[, i, drop = FALSE]),
          colnames(simu$M_train[, i, drop = FALSE]),
          corr = "None")
    temp_ewas_med <-
      cbind(exp_affecting_M_all$pval, rep(colnames(simu$M_train)[i],
                              nrow(exp_affecting_M_all$pval)))
    list_temp_ewas_med <- c(list_temp_ewas_med, list(temp_ewas_med))
  }
  ewas_med <- do.call("rbind", list_temp_ewas_med)
  if (!is.null(ewas_med)) {
    ewas_med$pVal_adj_1 <- p.adjust(ewas_med$pVal, "BH")
    colnames(ewas_med)[8] <- "cpg"
    colnames(ewas_med)[1] <- "exp"
  }
  #step b
  list_temp_ewas_med_2 <- list()
  for (i in 1:ncol(select_E)) {
    M_affecting_Y_all <-
      ewas(
        as.data.frame(simu$M_train),
        as.data.frame(simu$Y_train),
        colnames(as.data.frame(simu$Y_train)),
        corr = "None",
        data_covar_in = (select_E[, i, drop = FALSE]),
        covar = colnames(select_E[, i, drop = FALSE])
      )
    temp_ewas_med_2 <-
      cbind(M_affecting_Y_all$pval, rep(colnames(select_E)[i],
                             nrow(M_affecting_Y_all$pval)))
    list_temp_ewas_med_2 <-
      c(list_temp_ewas_med_2, list(temp_ewas_med_2))
  }
  ewas_med_2 <- do.call("rbind", list_temp_ewas_med_2)
  if (!is.null(ewas_med_2)) {
                                         333


                                                                  APPENDIX III

      ewas_med_2$pVal_adj_2 <- p.adjust(ewas_med_2$pVal, "BH")
      colnames(ewas_med_2)[8] <- "exp"
      colnames(ewas_med_2)[1] <- "cpg"
  }

  ewas_med_tot <-
    merge(
      ewas_med,
      ewas_med_2,
      by.x = c("exp", "cpg"),
      by.y = c("exp", "cpg")
    )
  exp_med <-
    unique(ewas_med_tot$exp[ewas_med_tot$pVal_adj_2 <= 0.05 &
                      ewas_med_tot$pVal_adj_1 <= 0.05])
  exp_med <- exp_med[!is.na(exp_med)]
  if (length(exp_med) != 0) {
    predMediation <- list(selected = exp_med, pred = NULL)
  } else{
    predMediation <- list(selected = vector(), pred = vector())
  }

 } else{
   predMediation <- list(selected = vector(), pred = vector())
 }
 predBMI_E <- c(predBMI_E, mediation = list(predMediation))

#######################################
##applying agnostic methods
## lasso
predlasso <-
 lasso(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
predBMI_E <- c(predBMI_E, lasso_CV = list(predlasso))
print("lasso_ done")
##DSA
predDSA <-
 DSAreg(
   Exp = simu$E_train,
   resp = simu$Y_train,
   maxsize = floor(ncol(simu$E_train) / 10),
   maxsumofpow = 1,
   maxorderint = 1
 )
predBMI_E <- c(predBMI_E, DSA = list(predDSA))
                                           334


                                                                        APPENDIX III

print("DSA done")

##########################################
##assessing performance for ExWAS on M
truepred<-simu$yM_M$predictors
for (k1 in 1:length(predBMI_M)){
  truepred<-simu$yM_M$predictors
  predfound<-predBMI_M[[k1]]$selected
  if (exists("predfound")&exists("truepred")){
    if (length(predfound)==0) {print("no predictors found")}
    a<-sensitivity(truepred,predfound)
    b<-specificity(truepred,predfound,ncol(simu$M_train))
    c<-fdp(truepred,predfound)
    d<-estimatedR2(simu$M_test,predfound,simu$Y_test)$r.squared
    # print(a)
    # print(b)
    # print(c)
    # print(d)
    remove(predfound,truepred)
  }else{
    if(!exists("predfound")&exists("truepred")){
      a<-0
      b<-specificity(truepred,numeric(0),ncol(simu$M_train))
      c<-0
      d<-0
      remove(truepred)
    }else{
    if(!exists("truepred")&exists("predfound")){
      a<-1
      b<-specificity(numeric(0),predfound,ncol(simu$M_train))
      c<-fdp(numeric(0),predfound)
      d<-estimatedR2(simu$M_test,predfound,simu$Y_test)$r.squared
      remove(predfound)
    }else{
    if(!exists("truepred")&!exists("predfound")){
      a<-1
      b<-1
      c<-0
      d<-0
    }}}
  }
    predBMI_M[[k1]]<-c(predBMI_M[[k1]],sens=a,spec=b,fdp=c,R2_test=d)
    remove(a)
    remove(b)
    remove(c)
    remove(d)

 }
                                        335


                                                                                 APPENDIX III



##assessing performance for all methods on E
truepred<-simu$y_E$predictors
for (k1 in 1:length(predBMI_E)){
  truepred<-simu$y_E$predictors
  truepred<-simu$y_E$predictors
  predfound<-predBMI_E[[k1]]$selected
  if (exists("predfound")&exists("truepred")){
    if (length(predfound)==0) {print("no predictors found")}
    a<-sensitivity(truepred,predfound)
    b<-specificity(truepred,predfound,ncol(simu$E_train))
    c<-fdp(truepred,predfound)
    d<-estimatedR2(simu$E_test,predfound,simu$Y_test)$r.squared
    # print(a)
    # print(b)
    # print(c)
    # print(d)
    remove(predfound,truepred)
  }else{
    if(!exists("predfound")&exists("truepred")){
      a<-0
      b<-specificity(truepred,numeric(0),ncol(simu$E_train))
      c<-0
      d<-0
      remove(truepred)
    }else{
    if(!exists("truepred")&exists("predfound")){
      a<-1
      b<-specificity(numeric(0),predfound,ncol(simu$E_train))
      c<-fdp(numeric(0),predfound)
      d<-estimatedR2(simu$E_test,predfound,simu$Y_test)$r.squared
      remove(predfound)
    }else{
    if(!exists("truepred")&!exists("predfound")){
      a<-1
      b<-1
      c<-0
      d<-0
    }}}
  }
  predBMI_E[[k1]]<-c(predBMI_E[[k1]],sens=a,spec=b,fdp=c,R2_test=d)
  remove(a)
  remove(b)
  remove
  remove(d)
}

##assessing the performance considering only the predictors having an indirect
                                            336


                                                                       APPENDIX III

 ##effect
 truepred<-simu$yM_E$predictors
 for (k1 in 1:length(predBMI_E)){
   truepred<-simu$yM_E$predictors
   predfound<-predBMI_E[[k1]]$selected
   if (exists("predfound")&exists("truepred")){
     if (length(predfound)==0) {print("no predictors found")}
     a<-sensitivity(truepred,predfound)
     b<-specificity(truepred,predfound,ncol(simu$E_train))
     c<-fdp(truepred,predfound)
     d<-estimatedR2(simu$E_test,predfound,simu$Y_test)$r.squared
     # print(a)
     # print(b)
     # print(c)
     # print(d)

     remove(predfound,truepred)
   }else{
     if(!exists("predfound")&exists("truepred")){
       a<-0
       b<-specificity(truepred,numeric(0),ncol(simu$E_train))
       c<-0
       d<-0
       remove(truepred)
     }else{
     if(!exists("truepred")&exists("predfound")){
       a<-1
       b<-specificity(numeric(0),predfound,ncol(simu$E_train))
       c<-fdp(numeric(0),predfound)
       d<-estimatedR2(simu$E_test,predfound,simu$Y_test)$r.squared
       remove(predfound)
     }else{
     if(!exists("truepred")&!exists("predfound")){
       a<-1
       b<-1
       c<-0
       d<-0
     }}}
   }
 predBMI_E[[k1]]<-c(predBMI_E[[k1]],sens=a,spec=b,fdp=c,R2_test=d)
  remove(a)
  remove(b)
  remove
  remove(d)
}
  print("performance characterized")
  ##building the list with datasets generated + results of methods +
  ##performance to return
                                           337


                                                                                  APPENDIX III

    A<-list(simu=simu,predBMI_E=predBMI_E,predBMI_M=predBMI_M,
         nl_exp_select=n_exp_select)
    remove(simu)
    remove(select_M)
    remove(predBMI_M)
    remove(predBMI_E)
    remove(predBMI_E_MITM_WM)
    remove(predBMI_E_MITM)
    remove(predlasso)
    remove(n_exp_select)
    gc()
    return(A)

}

#################################
##5. Running simulations
#################################


##loading real datasets
dataExp_true <- readRDS("20190205 Exposome simu borne.rds")
M1_true <- readRDS("20191129 Methylome simu.Rds")
M1_true <- scale(M1_true)

##initialization
list_simulated_data <- list()
list_list_predBMI_E <- list()
list_list_predBMI_M <- list()
list_list_nl_exp_select <- list()

##setting simulations parameters
n_iter <- 100 ##number of iterations for one scenarios
##parameters for generating datasets
##all combinations will be tested (each combination allows to build a scenario)
##(adapt the code of the loop if multiple values instead of single values for
##some parameters)
c_n_my <- c(10, 18, 25, 100)
c_n_R2_fixed <- c(0.01, 0.05, 0.1, 0.4)
BetamEY = 0.01
c_BetaEy <- c(0.0001, 0.001, 0.01, 0.1, 0.5)
c_n_Ey <- c(1, 3, 10, 25)
c_BetaEmEY <- c(0.0001, 0.001, 0.01, 0.1, 0.5)
n_mE <- 0
n_mEY <- 0

##initialization of table of results
comp_method <-
                                              338


                                                                APPENDIX III

 data.frame(
   Methods = vector(),
   Association_tested = vector(),
   Nb_true_predictors_of_BMI_in_M = numeric(0),
   Nb_true_predictors_of_BMI_in_E = numeric(0),
   Total_variability_of_BMI_explained_by_EandM = numeric(0),
   Total_variability_of_BMI_explained_by_E = numeric(0),
   Total_variability_of_BMI_explained_by_M = numeric(0),
   Mean_variability_of_M_explained_by_E_for_Mey = numeric(0),
   Number_iterations = numeric(0),
   Mean_number_exp_selected_to_be_randomly_tested =
    numeric(0),
   Mean_number_predictors_found = numeric(0),
   Mean_sensitivity = numeric(0),
   Mean_specificity = numeric(0),
   Mean_fdp = numeric(0),
   Mean_R2_test = numeric(0),
   Mean_mediated_sensitivity = numeric(0),
   Mean_mediated_specificity = numeric(0),
   Mean_mediated_fdp = numeric(0),
   Mean_R2_test = numeric(0),
   SD_number_predictors_found = numeric(0),
   SD_sensitivity = numeric(0),
   SD_specificity = numeric(0),
   SD_fdp = numeric(0),
   SD_R2_test = numeric(0),
   SD_mediated_sensitivity = numeric(0),
   SD_mediated_specificity = numeric(0),
   SD_mediated_fdp = numeric(0),
   SD_R2_test = numeric(0),
   Which_iteration = numeric(0)
 )


##looping on the different vectors of parameters
n=1
for (i2 in 1:length(c_n_R2_fixed)) {
 R2_fixed <- c_n_R2_fixed[i2]
 for (i3 in 1:length(c_BetaEy)) {
   BetaEy <- c_BetaEy[i3]
   for (i4 in 1:length(c_n_Ey)) {
    n_Ey <- c_n_Ey[i4]
    n_Ey_U_n_EmEY <- n_Ey
    n_EmEY <- n_Ey
    for (i1 in 1:length(c_n_my)) {
      n_mEY <- c_n_my[i1]
      for (i5 in 1:length(c_BetaEmEY)) {
       BetaEmEY <- c_BetaEmEY[i5]
                                             339


                                                                     APPENDIX III

print(n)
iteration_OK <- TRUE

if (n < 1501) {
  n <- n + 1
} else{
  if (n_mEY != 0) {
    n_pat_mEY <- (n_mEY / n_EmEY)
    if (trunc(n_pat_mEY) != n_pat_mEY) {
      iteration_OK <- FALSE
    }
  }
  if (n_mE != 0) {
    n_pat_mE <- (n_mE / n_EmE)
    if (trunc(n_pat_mE) != n_pat_mE) {
      iteration_OK <- FALSE
    }
  }
  if (iteration_OK == TRUE) {
    n_row = nrow(comp_method)
    simulated_data <- list()
    list_predBMI_E <- list()
    list_predBMI_M <- list()
    list_nl_exp_select <- list()
    start_time <- Sys.time()
    ##parallelization of f0
    cl <- makeCluster(getOption("cl.cores", round(detectCores())))
    clusterExport(
      cl,
      list(
        "simulator",
        "simResponseSimple",
        "estimatedR2",
        "getresiduals_2df",
        "ewas",
        "lasso",
        "lasso_stab",
        "DSAreg",
        "sensitivity",
        "fdp",
        "specificity",
        "f0",
        "dataExp_true",
        "M1_true",
        "R2_fixed",
        "n_Ey",
        "n_mEY",
        "BetaEy",
                                        340


                                                              APPENDIX III

     "BetamEY",
     "n_Ey_U_n_EmEY",
     "n_EmEY",
     "BetaEmEY"
 )
)
clusterEvalQ(cl, list(library("boot"), library("reshape"),
              library("glmnet"), library("DSA")))
results_1_jeu <- clusterApply(cl, 1:n_iter, f0)
stopCluster(cl)
simulated_data <- lapply(results_1_jeu, function(x)
  x$simu)

##structure of results priorized by methods and not anymore
##priorized by datasets
list_predBMI_E <- lapply(results_1_jeu, function(x)
  x$predBMI_E)
list_predBMI_M <- lapply(results_1_jeu, function(x)
  x$predBMI_M)
list_nl_exp_select <-
  lapply(results_1_jeu, function(x)
    x$nl_exp_select)
remove(results_1_jeu)


###compilation of results for this scenario

##table describing the empirical characteristics of
##the simulated datasets
param_simu <-
 data.frame(
   Parameters = vector(),
   Fixed_or_measured = vector(),
   Value = numeric(0)
 )
param_simu[1, ] <-
 c(
   as.character("Nb_true predictors of BMI in M"),
   as.character("Fixed"),
   mean(unlist(
     lapply(simulated_data, function(X)
       length(X[[10]]$beta))
   ))
 )
param_simu[2, ] <-
 c("Nb_true predictors of BMI in E",
   "Measured",
   mean(unlist(
                                        341


                                                                    APPENDIX III

     lapply(simulated_data, function(X)
       length(X[[8]]$beta))
   )))
param_simu[3, ] <-
 c("Total variability of BMI explained by (E+M)",
   "Fixed",
   R2_fixed)
param_simu[4, ] <-
 c("Mean variability of BMI explained by E",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X[[11]]$BMI_all_exp))
   )))
param_simu[5, ] <-
 c("Mean variability of BMI explained by M",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X[[11]]$BMI_all_M))
   )))
param_simu[6, ] <-
 c(
   "Mean variability of part of M explained by E explained by E",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X[[11]]$mean_M_E))
   ))
 )
param_simu[7, ] <- c("Number_iterations", "Fixed", n_iter)
param_simu[8, ] <-
 c(
   "Mean_number_exp_selected_to_be_randomly_tested",
   "Measured",
   mean(unlist(list_nl_exp_select))
 )


##summarizing each method performance by a line in comp_method datadrame within
##this scenario

for (k1 in (1:length(list_predBMI_M[[1]]))) {
 comp_method[n_row + k1, ] <-
   c(
    names(list_predBMI_M[[1]][k1]),
    "BMI - M",
    param_simu[1, 3],
                                      342


                                       APPENDIX III

param_simu[2, 3],
R2_fixed,
param_simu[4, 3],
param_simu[5, 3],
param_simu[6, 3],
n_iter,
NA,
mean(unlist(
  lapply(list_predBMI_M, function(X)
    length(X[[k1]][[1]]))
)),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[3]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[4]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[5]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[6]]))
), na.rm = TRUE),
NA,
NA,
NA,
NA,
sd(unlist(
  lapply(list_predBMI_M, function(X)
    length(X[[k1]][[1]]))
)),
sd(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[3]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[4]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[5]]))
), na.rm = TRUE),
sd(unlist(
                                343


                                                APPENDIX III

          lapply(list_predBMI_M, function(X)
            (X[[k1]][[6]]))
        ), na.rm = TRUE),
        NA,
        NA,
        NA,
        NA,
        n
    )
}

for (k2 in (1:length(list_predBMI_E[[1]]))) {
 comp_method[n_row + k2 + k1, ] <-
   c(
    names(list_predBMI_E[[1]][k2]),
    "BMI - E",
    param_simu[1, 3],
    param_simu[2, 3],
    R2_fixed,
    param_simu[4, 3],
    param_simu[5, 3],
    param_simu[6, 3],
    n_iter,
    param_simu[8, 3],
    mean(unlist(
      lapply(list_predBMI_E, function(X)
        length(X[[k2]][[1]]))
    )),
    mean(unlist(
      lapply(list_predBMI_E, function(X)
        (X[[k2]][[3]]))
    )),
    mean(unlist(
      lapply(list_predBMI_E, function(X)
        (X[[k2]][[4]]))
    )),
    mean(unlist(
      lapply(list_predBMI_E, function(X)
        (X[[k2]][[5]]))
    )),
    mean(unlist(
      lapply(list_predBMI_E, function(X)
        (X[[k2]][[6]]))
    )),

        mean(unlist(
         lapply(list_predBMI_E, function(X)
           (X[[k2]][[7]]))
                                        344


                                       APPENDIX III

)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[8]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[9]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[10]]))
)),


sd(unlist(
  lapply(list_predBMI_E, function(X)
    length(X[[k2]][[1]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[3]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[4]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[5]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[6]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[7]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[8]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[9]]))
)),
sd(unlist(
                                345


                                                                                  APPENDIX III

                      lapply(list_predBMI_E, function(X)
                        (X[[k2]][[10]]))
                    )),
                    n
                )
            }


            ##storing generated datasets and methods results for this scenario
            list_list_predBMI_E <- c(list_list_predBMI_E, list(list_predBMI_E))
            list_list_predBMI_M <- c(list_list_predBMI_M, list(list_predBMI_M))
            list_list_nl_exp_select <-
              c(list_list_nl_exp_select,
                list(list_nl_exp_select))
            end_time <- Sys.time()
            end_time - start_time
            ##saving
            saveRDS(comp_method,
                    "comp_method_mediation_and_direct.Rds")
            saveRDS(
              simulated_data,
              file = paste(
                n,
                '_simulated_data_scenario_iteration_mediation_and_direct.Rds'
              )
            )
            saveRDS(
              list_list_predBMI_E,
              "list_list_predBMI_E_mediation_and_direct.rds"
            )
            saveRDS(
              list_list_predBMI_M,
              "list_list_predBMI_M_mediation_and_direct.rds"
            )
            saveRDS(
              list_list_nl_exp_select,
              "list_list_nl_exp_select_mediation_and_direct.rds"
            )

            remove(simulated_data)
            remove(list_predBMI_E)
            remove(list_predBMI_M)
            remove(list_nl_exp_select)
            }
            n=n+1
        }
    }
}
                                                    346


                                                                                   APPENDIX III

        }
    }
}


    R script for causal structure D and E
##this code allows to perform a simulation to assess performance in terms of
## sensitivity and specificity of prespecified statistical methods
##used to find the true predictors of an health among the exposome. The causal
##structures considered involve a reverse causative likn from the outcome on
##the exposome Some of them use an intermediary layer, some not.
##it contains 5 ##parts:

##1. defining the functions allowing to generate a realistic dataset of exposome
##intermediate layer and outcome. The three layers(E, M and Y) can be linearly
##related to simulate various causal structures.

#It needs real datasets (exposome/intermediate layer/outcome) as inputs, as well
##as parameters allowing to define the association within the three layers (number of
#predictors, #variability explained, correlation..)

##2. defining the methods assessed

##3. defining some functions used to assess methods performance

##4. defining the simulation function, which, for a given scenario, generates
##the datasets, applies the methods and assess their performance. This function
##allows to parallelize the simulation.

##5. runnning the simulation itself with parallelization, repeating X times the
##function defined in 4. for each scenario and saving the results.
########################################################
#######################

##load packages
library(mvtnorm)
library(boot)
library(parallel)
library(reshape)
library(glmnet)
library(DSA)


#####################################
##1. define the generating functions
####################################



                                              347


                                                                              APPENDIX III



simulator <-
  function(E_true,
        ##real exposome
        M_true,
        ## real intermediate layer, eg methylome
        Y_true,
        ##real outcome
        n_mY = 0,
        #variables of M not affected by E
        ##but affecting Y.
        R2_mY = 0,
        ##variability of M not affected by E affecting Y
        BetamY = 0.1,
        ##corresponding effect coefficient
        n_yM = 50,
        ##number of variables of M affected by Y
        Beta_yM = 0.001,
        ##corresponding effect coefficient
        n_yE = 5,
        ##number of variables of E affected by Y
        Beta_yE = 0.01,
        ##corresponding effect coefficient
        test_and_training = TRUE)#generating only a training set or
        ##alternatively also a test set of same size)
        {
        ##sampling with replacemnt the real data for exposome
        data.X <- as.data.frame(dataExp_true)
        names_row <- rownames(data.X)
        data.X <-
          data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),]
        rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
        dataExp <- data.X
        remove(data.X)
        ##sampling with replacement the real intermediate data
        data.X <- as.data.frame(M1_true)
        names_row <- rownames(data.X)
        data.X <-
          data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),]
        rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
        M1 <- data.X
        ##sampling with replacement the real outcome data
        data.X <- as.data.frame(Y_true)
        names_row <- rownames(data.X)
        data.X <-
          data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),
               , drop =
                 FALSE]
                                              348


                                                                   APPENDIX III

rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
Y_boot <- data.X
remove(data.X)

##setting if necessary linear relationship from M to Y
if (n_mY != 0) {
  if (R2_mY == 0) {
    stop("error: n_MY and R2_mY non consistent")
  }
  ##generating vector of effect coefficients
  if (length(BetamY) == 1) {
    Betapred_mY <- rep(BetamY, n_mY)
  } else{
    if (length(BetamY) != n_mY) {
      stop("error: Betas for M explaining Y are not consistent
    with the number of predictors")
    }
    Betapred_mY <- BetamY
  }
  ##random sampling of variables of M affecting Y
  ind_mY <- sample(ncol(M1), n_mY)
  ##generating yM: part of the outcome which is a
  ##linear combination of variables of M not affected by E
  yM <-
    simResponseSimple(
      met = M1,
      Nmet = length(ind_mY),
      beta = Betapred_mY,
      cpg = ind_mY
    )
  if (!is.na(R2_mY)) {
    if (((R2_mY) != 0)) {
      sigma <- var(yM$resp) * (1 / R2_mY - 1)
    } else{
      warning("R2 was not specified, automatic value")
      R2_mY = 0.00000001
      sigma <- var(Y$resp) * (1 / R2_mY - 1)
    }
    Y <-
      as.matrix(Y$resp + rnorm(length(Y$resp), mean(Y$resp),
                      sqrt(sigma)), ncol = 1)
    #standardiZation
    Y <- as.data.frame(scale(Y))

 }
 ##empirical estimation of R2 ( variability of Y explained by M)
 R2_mY_measured <- estimatedR2(M1, ind_mY, Y)$r.squared
} else{
                                        349


                                                                          APPENDIX III

    ##if no effect, creating an empty yM
    yM <- list(resp = Y_boot,
           beta = NULL,
           predictors = NULL)
    Y <- as.data.frame(Y_boot)
    R2_mY_measured <- 0
    ind_mY <- integer()
    Betapred_mY = NULL
}

##setting if necessary linear relationship from Y to M
if (n_yM != 0) {
  ##random sampling of variables of M affected by Y
  if (n_mY == 0) {
    ind_yM_M <- sample(ncol(M1), n_yM)
  } else{
    ind_yM_M <- sample((1:ncol(M1))[ind_mY], n_yM)
  }
  ##generating vector of effect coefficients
  if (length(BetayM) == 1) {
    Betapred_yM_M <- rep(BetayM, n_yM)
  } else{
    if (length(BetayM) != n_yM) {
      stop(
        "error: Betas for Y explaining M are not consistent with
        the number of predicted cpgs"
      )
    }
    Betapred_yM_M <- BetayM
  }
  ##adding a linear effect of Y on selected variables of M
  list_R2_M <- list()
  for (i in 1:n_yM) {
    M1[, ind_yM_M[i]] <- as.numeric(M1[, ind_yM_M[i]] +
                            simResponseSimple(
                              met = Y,
                              Nmet = 1,
                              beta = Betapred_yM_M[i],
                              cpg = 1
                            )$resp)

     list_R2_M <-
       c(list_R2_M, list(estimatedR2(Y, colnames(Y)[1], M1[,
                             ind_yM_M[i], drop = FALSE])))
    }
    ##empirical estimation of mean R2 (mean variability of M affected by Y)
    mean_R2_M <-
      mean(unlist(lapply(list_R2_M, function(x)
                                           350


                                                                           APPENDIX III

      x$r.squared)), na.rm = T)
  SD_R2_M <-
    sd(unlist(lapply(list_R2_M, function(x)
      x$r.squared)), na.rm = T)
} else{
  ind_yM_M <- integer()
  Betapred_yM_M = NULL
  list_R2_M = NULL
  mean_R2_M = 0
}
#setting if necessary linear relationship from Y to E
list_R2_E <- list()
if (n_yE != 0) {
  ##random sampling of variables of e affected by Y
  ind_yE_E <- sample(ncol(dataExp), n_yE)

 ##generating vector of effect coefficients
 if (length(BetayE) == 1) {
   Betapred_yE_E <- rep(BetayE, n_yE)
 } else{
   if (length(BetayE) != n_yE) {
     stop(
       "error: Betas for Y explaining E are not consistent with the
       number of predicted exposures"
     )
   }
   Betapred_yE_E <- BetayE
 }
 ##adding a linear effect of Y on selected variables of e
 for (i in 1:n_yE) {
   dataExp[, ind_yE_E] <- as.numeric(dataExp[, ind_yE_E[i]] +
                            simResponseSimple(
                              met = Y,
                              Nmet = 1,
                              beta = Betapred_yE_E[i],
                              cpg = 1
                            )$resp)

  list_R2_E <-
    c(list_R2_E, list(estimatedR2(Y, colnames(Y)[1], dataExp[,
                          ind_yE_E[i], drop = FALSE])))
 }
 ##empirical estimation of mean R2 (mean variability of e affected by Y)
 mean_R2_E <-
   mean(unlist(lapply(list_R2_E, function(x)
    x$r.squared)), na.rm = T)
 SD_R2_E <-
   sd(unlist(lapply(list_R2_E, function(x)
                                         351


                                                                APPENDIX III

      x$r.squared)), na.rm = T)
} else{
  ind_yE_E <- integer()
  Betapred_yE_E = NULL
  list_R2_E = NULL
  mean_R2_E = 0
}


##Building a result object with generated datesets;
##vector of predictors and effects
results <-

 list(
   Y_train = Y[1:(nrow(M1) / 2), , drop = FALSE],
   E_train = dataExp[1:(nrow(M1) / 2), , drop = FALSE],
   M_train = M1[1:(nrow(M1) / 2), , drop = FALSE],
   Y_test = Y[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
   E_test = dataExp[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
   M_test = M1[(nrow(M1) / 2):nrow(M1), , drop = FALSE],
   cpg_predictors = list(
     name = colnames(M1)[ind_mY],
     indices = ind_mY,
     betas = Betapred_mY,
     R2 = NULL
   ),
   cpg_predicted = list(
     name = colnames(M1)[ind_yM_M],
     indices = ind_yM_M,
     betas = Betapred_yM_M,
     R2 = list_R2_M
   ),
   exp_predicted = list(
     name = colnames(dataExp)[ind_yE_E],
     indices = ind_yE_E,
     betas = Betapred_yE_E,
     R2 = list_R2_E
   ),
   R2_mY_true = R2_mY,
   R2_mY_measured = R2_mY_measured,
   R2_yM_mean = mean_R2_M,
   R2_yM_SD = SD_R2_M,
   R2_yE_mean = mean_R2_E,
   R2_yE_SD = SD_R2_E
 )

return(results)
}
                                       352


                                                                                  APPENDIX III




##function used to create a linear response
simResponseSimple <- function(met,
                     ##matrix of potential predictors
                     Nmet = NA,
                     ##number of predictors
                     beta = NULL,
                     ##vector of effects
                     cpg = NULL) {
  ##optionnal: directly specifying
  ##some of the indexes of predictors
  if (all(c(is.na(Nmet), is.na(cpg))) == TRUE) {
    return (list(
      resp = as.matrix(rep(0, nrow(met)), ncol = 1),
      beta = NA,
      predictors = NA
    ))
  }
  temp <- Nmet - length(cpg)
  if (temp != 0) {
    wh <- sample((1:ncol(met)[-cpg]), temp)
    wh <- c(cpg, wh)
  } else{
    wh <- cpg
  }
  CovMat <- as.matrix(met[, wh])
  colnames(CovMat) <- colnames(met)[wh]
  # computing the response
  mean <- CovMat %*% matrix(beta, ncol = 1)
  rownames(mean) <- rownames(met)
  names(beta) <- colnames(CovMat)
  return (list(
    resp = mean,
    beta = beta,
    predictors = colnames(met)[wh]
  ))
}

##fonction to estimate R2 from a dataframe of potential predictors, a vector of
##predictors names and the outcome
estimatedR2 <- function(X, truepred, Y) {
 if ("y" %in% truepred) {
   stop("error: one of the true predictors is named y")
 }
 if (ncol(Y) != 1) {
   stop("error:Y is multidimensionnal")
 }
                                               353


                                                                        APPENDIX III

    if (nrow(X) != nrow(Y)) {
      stop("error not the same number of rows")
    }
    if (isTRUE(all.equal(rownames(X), rownames(Y))) == FALSE) {
      stop("error individuals are not ordered similarly in X and Y")
    }
    if (all(truepred %in% colnames(X))) {
      data <- X[, colnames(X) %in% truepred, drop = FALSE]
      data <- cbind(Y, data)
      colnames(data)[1] <- "y"
      mod <- lm(y ~ ., as.data.frame(data))
      toselect.x <- summary(mod)$coeff[-1, 4]
      r <-
        list(summary(mod)$r.squared,
            summary(mod)$adj.r.squared,
            names(toselect.x)[toselect.x == TRUE])
      names(r) <- c("r.squared", "adj.r.squared", "pred")
      return(r)
    } else{
      stop("error: X does not countain all true predictors")

    }
}

###########################################
##2. defining the methods to test
###########################################

###agnostic methods

##function to compute residuals of a linear model if covariates are specified
getresiduals_2df <- function(data_Y_in, data_covar_in, name_Y, covar) {
  data_covar <-
   data_covar_in[, colnames(data_covar_in) %in% covar, drop = FALSE]
  data_Y <-
   data_Y_in[rownames(data_Y_in) %in% rownames(data_covar), colnames(data_Y_in) ==
           name_Y, drop = FALSE]
  data_covar <-
   data_covar[rownames(data_covar) %in% rownames(data_Y), , drop = FALSE]
  data_covar <- data_covar[rownames(data_Y), , drop = FALSE]
  data_output <- data_Y
  data <- cbind(data_Y, data_covar)
  mod <- lm(data = data)
  data_output[, 1] <- as.data.frame(residuals(mod))
  return(data_output)
}

###ExWAS
                                                354


                                                                        APPENDIX III

ewas <-
 function(data_Xs_in = NULL,
         data_Y_in = NULL,
         name_Y,
         data_covar_in = NULL,
         covar = character(0),
         corr = "BH") {
  require(parallel)
  if (length(covar) > 0) {
    data_covar <-
      data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                  rownames(data_covar_in) %in% rownames(data_Xs_in),
                 colnames(data_covar_in) %in%
                  covar, drop = FALSE]
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
               rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) == name_Y, drop =
               FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                rownames(data_Xs_in) %in% rownames(data_Y), , drop = FALSE]
    data_covar <- data_covar[rownames(data_Y), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y), , drop = FALSE]
    data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
  } else{
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in), colnames(data_Y_in) ==
               name_Y, drop = FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y), , drop = FALSE]
  }
  if (is.null(data_Y) == TRUE |
      is.null(data_Xs) == TRUE | !(name_Y %in% colnames(data_Y))) {
    stop("Inconsistent data")
  }

  ##computing p.values
  p.values <- lapply(1:ncol(data_Xs), function(x, data_Xs) {
   c(colnames(data_Xs)[x],
     confint(lm(Y ~ var1,
            data = data.frame(
              cbind(var1 = data_Xs[, x], Y = data_Y[, 1])
            )))[2, ],
     summary(lm(Y ~ var1, data = data.frame(
       cbind(var1 = data_Xs[, x], Y = data_Y[, 1])
     )))$coefficients[2, ])
                                              355


                                                                                 APPENDIX III

     },
     data_Xs)
     if (length(p.values) > 1) {
       p.values <-
         cbind(matrix(unlist(p.values), ncol = 7, byrow = TRUE)[, -6])

     } else{
       p.values <-
         as.data.frame(t(as.data.frame(unlist(p.values)))[, -6, drop = FALSE])
     }
     p.values <- as.data.frame(p.values)
     colnames(p.values) <-
       c("var", "conf - 2.5%", "conf - 97.5%", "Est", "Sd", "pVal")
     p.values <- p.values[p.values$var != "Intercept", ]
     p.values$pVal <- as.numeric(as.character(p.values$pVal))
     p.values.adj <- p.values
     pVal <- as.numeric(as.character(p.values$pVal))
     ##add correction for multiple testing
     if (corr == "None") {
       wh <- which(pVal <= 0.05)
       p.values.adj$pVal_adj <- pVal
     }
     if (corr == "Bon") {
       wh <- which(pVal <= 0.05 / nrow(p.values))
       p.values.adj$pVal_adj <- pVal * nrow(p.values)
     }
     if (corr == "BH") {
       wh <- which(p.adjust(pVal, "BH") <= 0.05)
       p.values.adj$pVal_adj <- p.adjust(pVal, "BH")
     }
     if (corr == "BY") {
       wh <- which(p.adjust(pVal, "BY") <= 0.05)
       p.values.adj$pVal_adj <- p.adjust(pVal, "BY")
     }
     if (!corr %in% c("Bon", "BH", "BY", "", "None"))
       stop("Please specify a known correction method for
                                     multiple testing")
     wh <- p.values$var[wh]
     a <- list(wh, p.values.adj)
     names(a) <- c("selected", "pval")
     return(a)
 }

###LASSO
lasso <-
  function(data_Xs_in,
        data_Y_in,
        name_Y,
                                                   356


                                                                         APPENDIX III

        data_covar_in = NULL,
        covar = character(0)) {
  if (length(covar) > 0) {
    data_covar <-
      data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                 rownames(data_covar_in) %in% rownames(data_Xs_in),
                colnames(data_covar_in) %in%
                 covar, drop = FALSE]
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
              rownames(data_Y_in) %in% rownames(data_Xs_in),
            colnames(data_Y_in) == name_Y, drop =
              FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
               rownames(data_Xs_in) %in% rownames(data_Y_in), ,
             drop = FALSE]
    data_covar <- data_covar[rownames(data_Y),]
    data_Xs <- data_Xs[rownames(data_Y),]
    data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
  } else{
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
            colnames(data_Y_in) ==
              name_Y, drop = FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y),]
  }
  data_Y <- data.matrix(data_Y)
  data_Xs <- data.matrix(data_Xs)
  model.enet <- cv.glmnet(data_Xs, data_Y, family = "gaussian",
                    alpha = 1)
  cvfit <- model.enet

  ##Calcul Y_predit
  Y_predit <- predict(cvfit, newx = data_Xs, s = "lambda.min")
  Y_predit <- Y_predit[rownames(Y_predit), ]

  ##liste des CPG selectionnés
  tmp_coeffs <- coef(cvfit, s = "lambda.min")
  cg_select <-
   data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1], coefficient =
tmp_coeffs@x)

  cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
  a <- list()
  if (length(cg_select) != 0) {
                                             357


                                                                             APPENDIX III

       a <- list("selected" = cg_select, "prediction" = Y_predit)
     } else{
       a <- list("selected" = character(), "prediction" = "no_prediction")
     }
     return(a)

 }


##DSA
DSAreg <-
 function(Exp,
        resp,
        family = gaussian,
        maxsize = 15,
        maxsumofpow = 2,
        maxorderint = 2) {
  Exp <- data.frame(cbind(data.frame(Exp), resp = resp))
  res <-
    DSA(
      resp ~ 1,
      data = Exp,
      family = family,
      maxsize = maxsize,
      maxsumofpow
      = maxsumofpow,
      maxorderint = maxorderint ,
      nsplits = 1,
      usersplits = NULL
    )
  form <- gsub("I[(]", "", colnames(coefficients(res)))
  form <- gsub("[*]", ":", gsub("[)]", "", gsub("[:^:]1", "", form)))
  if (length(grep(":", form)) > 0) {
    nam <- strsplit(form[grep("[:]", form)], ":")
    for (j in 1:length(nam)) {
      nam[[j]] <- gsub("[[:space:]]", "", nam[[j]])
      name <- nam[[j]][1]
      for (k in 2:length(nam[[j]]))
       name <- paste(name, ":", nam[[j]][k], sep = "")
      Exp <- cbind(Exp, name = apply(Exp[, nam[[j]]], 1, prod))
    }
  }
  form2 <- "resp~1"
  if (length(form) > 1)
    for(i in 2:length(form))
      form2 <- paste(form2, "+", form[i])
  res2 <- lm(form2, data = data.frame(Exp))
  ##decomment next line and change "prediction" to pred in the return line
                                                  358


                                                                                 APPENDIX III

     ##if outcome predicted by DSA is needed (not used presently)
     #pred <- predict(res2,Exp)
     coef <- summary(res2)$coefficients
     coef <- as.character(rownames(coef)[rownames(coef) != "Intercept"])

     return(list(selected = coef[coef != "(Intercept)"], pred = "prediction"))
 }


########################################################
##########
####3. defining some functions used to assess methods performance
########################################################
#########

sensitivity <- function(truepred, predfound) {
  return(length(truepred[truepred %in% predfound]) / length(truepred))
}
fdp <- function(truepred, predfound) {
  ##false discovery proportion
  if (length(predfound) == 0) {
    return(0)
  } else{
    return(length(predfound[!predfound %in% truepred]) / length(predfound))
  }
}
specificity <- function(truepred, predfound, n_base) {
  return((n_base - length(truepred) - length(predfound[!predfound %in% truepred])) /
         (n_base - length(truepred)))
}


########################################################
#########
##4. defining the simulation function which will be parallelized
########################################################
#########
##it first generates datasets, then applies methods and then assessed
##their performance
##simulation d'un jeu, application des méthodes, évaluation des méthodes
f0 <- function(x) {
 ##important: the parallelization is made on the seed
 set.seed(x)
 ##generating datasets
 simu <- simulator(
   E_true = dataExp_true,
   M_true = M1_true,
   Y_true = Y_true,
                                                   359


                                                                APPENDIX III

     n_mY = n_mY,
     R2_mY = R2_mY,
     BetamY = BetamY,
     n_yM = n_yM,
     Beta_yM = Beta_yM,
     n_yE = n_yE,
     Beta_yE = Beta_yE,
     test_and_training = TRUE
 )

 #simulated_data<-c(simulated_data,list(simu))

 ###################
 ###applying methods
 ####################
 ##ExWas on the intermediate layer
 predBMI_M <-
  list(ewas_BH = ewas(
    as.data.frame(simu$M_train),
    as.data.frame(simu$Y_train),
    colnames(as.data.frame(simu$Y_train)),
    corr = "BH"
  ))
 predBMI_E <-
  list(
    ewas_BH = ewas(
      as.data.frame(simu$E_train),
      as.data.frame(simu$Y_train),
      colnames(as.data.frame(simu$Y_train)),
      corr = "BH"
    ),
    ewas_Bon = ewas(
      as.data.frame(simu$E_train),
      as.data.frame(simu$Y_train),
      colnames(as.data.frame(simu$Y_train)),
      corr = "Bon"
    )
  )
 print("ewas done")

 #########################
 #oMITM
 if (length(predBMI_M$ewas_BH$selected) != 0) {
   select_M <-
     as.data.frame(simu$M_train[, colnames(simu$M_train) %in%
predBMI_M$ewas_BH$selected,
                      drop =
                       FALSE])
                                               360


                                                                         APPENDIX III

print(ncol(select_M))
rownames(select_M) <- rownames(simu$M_train)
colnames(select_M) <- predBMI_M$ewas_BH$selected
list <- list()
list_exp <- list()
list_nom <- list()
list_ewas_signif <- list()
##step b using the exwas performed on M as step a
for (i in (1:ncol(simu$E_train))) {
  predE_select_M <-
    ewas(
      as.data.frame(select_M),
      (simu$E_train[, i, drop = FALSE]),
      colnames(simu$E_train[, i, drop = FALSE]),
      corr = "None",
      data_covar_in = as.data.frame(simu$Y_train),
      covar = colnames(as.data.frame(simu$Y_train)[1])
    )
  list <- c(list, list(predE_select_M))
  list_nom <- c(list_nom, list(colnames(simu$E_train)[i]))

 list_exp <- c(list_exp, list(colnames(simu$E_train)[i]))
 temp_ewas <-
   cbind(predE_select_M$pval, rep(colnames(simu$E_train)[i], nrow(predE_select_M$pval)))
 list_ewas_signif <- c(list_ewas_signif, list(temp_ewas))
 remove(temp_ewas)
 remove(predE_select_M)
}
df_all_ewas <- do.call("rbind", list_ewas_signif)
if (!is.null(df_all_ewas)) {
  df_all_ewas$pVal_adj <- p.adjust(df_all_ewas$pVal, "BH")
  colnames(df_all_ewas)[8] <- "exposures"
  names(list) <- as.vector(unlist(list_nom))
}
exp <- df_all_ewas$exposures[df_all_ewas$pVal_adj <= 0.05]
##step c
n_exp_select <-
  length(unique(exp)) ##nb of exposures in reduced exposome

if (length(exp) != 0) {
  select_E <- simu$E_train[, colnames(simu$E_train) %in% exp, drop = FALSE]
  ##ExWAS implementation for step c
  predBMI_E_MITM <-
    ewas(
     as.data.frame(select_E),
     as.data.frame(simu$Y_train),
     colnames(as.data.frame(simu$Y_train)),
     corr = "BH"
                                            361


                                                                           APPENDIX III

     )
   ##DSA implementation for step c
   predBMI_E_MITMdsa <-
     DSAreg(
       Exp = as.data.frame(select_E),
       resp = simu$Y_train,
       maxsize = floor(ncol(simu$E_train) / 10),
       maxsumofpow = 1,
       maxorderint = 1
     )
   predReducedExp <- list(selected = unique(exp), pred = "NULL")
 } else{
   predReducedExp <- list(vector(), vector())
   names(predReducedExp) <- c("selected", "pred")
 }
 if (exists("predBMI_E_MITM")) {

 } else{
   predBMI_E_MITM <- list(vector(), vector())
   names(predBMI_E_MITM) <- c("selected", "pval")
 }
 if (exists("predBMI_E_MITMdsa")) {

 } else{
   predBMI_E_MITMdsa <- list(vector(), vector())
   names(predBMI_E_MITM) <- c("selected", "pred")
 }
} else{
 predBMI_E_MITM <- list(vector(), vector())
 names(predBMI_E_MITM) <- c("selected", "pval")
 n_exp_select = 0
 predReducedExp <- list(vector(), vector())
 names(predReducedExp) <- c("selected", "pred")
 predBMI_E_MITMdsa <- list(vector(), vector())
 names(predBMI_E_MITMdsa) <- c("selected", "pred")

}
##storing results in a list
predBMI_E <-
  c(
    predBMI_E,
    MITM = list(predBMI_E_MITM),
    MITMdsa = list(predBMI_E_MITMdsa),
    ReducedExp = list(predReducedExp)
  )
print("oMITM")
###Control method : random sampling on a random set of exposures of same
##dimension as the reduced exposome of oMITM
                                          362


                                                                                APPENDIX III



 if (n_exp_select > 0) {
   tirage <-
     ewas(
       as.data.frame(simu$E_train)[, sample(colnames(as.data.frame(simu$E_train)), n_exp_select),
drop =
                           FALSE],
       as.data.frame(simu$Y_train),
       colnames(as.data.frame(simu$Y_train)),
       corr = "BH"
     )
 } else{
   tirage <- list(selected = character(0), null = "null")
 }
 ##storing results in the same list
 predBMI_E <- c(predBMI_E, random_sampling = list(tirage))
 print(n_exp_select)

 ###################################
 ##mediation
 if (length(predBMI_E$ewas_BH$selected) != 0) {
   select_E <-
     as.data.frame(simu$E_train[, colnames(simu$E_train) %in% predBMI_E$ewas_BH$selected,
drop =
                        FALSE])
   rownames(select_E) <- rownames(simu$E_train)
   colnames(select_E) <- predBMI_E$ewas_BH$selected
   #step a
   list_temp_ewas_med <- list()
   for (i in 1:ncol(simu$M_train)) {
     exp_affecting_M_all <-
       ewas(as.data.frame(select_E),
           (simu$M_train[, i, drop = FALSE]),
           colnames(simu$M_train[, i, drop = FALSE]),
           corr = "None")
     temp_ewas_med <-
       cbind(exp_affecting_M_all$pval, rep(
         colnames(simu$M_train)[i],
         nrow(exp_affecting_M_all$pval)
       ))
     list_temp_ewas_med <- c(list_temp_ewas_med, list(temp_ewas_med))
   }
   ewas_med <- do.call("rbind", list_temp_ewas_med)
   if (!is.null(ewas_med)) {
     ewas_med$pVal_adj_1 <- p.adjust(ewas_med$pVal, "BH")
     colnames(ewas_med)[8] <- "cpg"
     colnames(ewas_med)[1] <- "exp"
   }
                                              363


                                                                             APPENDIX III

 #step b
 list_temp_ewas_med_2 <- list()
 for (i in 1:ncol(select_E)) {
   M_affecting_Y_all <-
     ewas(
       as.data.frame(simu$M_train),
       as.data.frame(simu$Y_train),
       colnames(as.data.frame(simu$Y_train)),
       corr = "None",
       data_covar_in = (select_E[, i, drop = FALSE]),
       covar = colnames(select_E[, i, drop = FALSE])
     )
   temp_ewas_med_2 <-
     cbind(M_affecting_Y_all$pval, rep(colnames(select_E)[i], nrow(M_affecting_Y_all$pval)))
   list_temp_ewas_med_2 <-
     c(list_temp_ewas_med_2, list(temp_ewas_med_2))
 }
 ewas_med_2 <- do.call("rbind", list_temp_ewas_med_2)
 if (!is.null(ewas_med_2)) {
   ewas_med_2$pVal_adj_2 <- p.adjust(ewas_med_2$pVal, "BH")
   colnames(ewas_med_2)[8] <- "exp"
   colnames(ewas_med_2)[1] <- "cpg"
 }

 ewas_med_tot <-
   merge(
     ewas_med,
     ewas_med_2,
     by.x = c("exp", "cpg"),
     by.y = c("exp", "cpg")
   )
 exp_med <-
   ewas_med_tot$exp[ewas_med_tot$pVal_adj_2 <= 0.05 &
                ewas_med_tot$pVal_adj_1 <= 0.05]
 exp_med <- exp_med[!is.na(exp_med)]
 if (length(exp_med) != 0) {
   predMediation <- list(selected = exp_med, pred = NULL)
 } else{
   predMediation <- list(selected = vector(), pred = vector())
 }

} else{
  predMediation <- list(selected = vector(), pred = vector())
}
predBMI_E <- c(predBMI_E, mediation = list(predMediation))

#######################################
##applying agnostic methods
                                              364


                                                                      APPENDIX III

## lasso
predlasso <-
 lasso(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
predBMI_E <- c(predBMI_E, lasso_CV = list(predlasso))
print("lasso done")
##DSA
predDSA <-
 DSAreg(
   Exp = simu$E_train,
   resp = as.data.frame(simu$Y_train),
   maxsize = floor(ncol(simu$E_train) / 10),
   maxsumofpow = 1,
   maxorderint = 1
 )
predBMI_E <- c(predBMI_E, DSA = list(predDSA))
print("DSA done")

##########################################
##assessing performance linked to reverse causality between M and Y
##(sensitivity to predicted exposures) for all methods
truepred <- simu$cpg_predicted$name
for (k1 in 1:length(predBMI_M)) {
  truepred <- as.character(simu$cpg_predicted$name)
  predfound <- as.character(predBMI_M[[k1]]$selected)
  if (exists("predfound") & exists("truepred")) {
    if (length(predfound) == 0) {
      print("no predictors found")
    }
    a <- sensitivity(truepred, predfound)
    b <- specificity(truepred, predfound, ncol(simu$M_train))
    c <- fdp(truepred, predfound)
    d <- estimatedR2(simu$M_test, predfound, simu$Y_test)$r.squared
    # print(a)
    # print(b)
    # print(c)
    # print(d)
    remove(predfound, truepred)
  } else{
    if (!exists("predfound") & exists("truepred")) {
      a <- 0
      b <- specificity(truepred, numeric(0), ncol(simu$M_train))
      c <- 0
      d <- 0
      remove(truepred)
                                          365


                                                                        APPENDIX III

     } else{
       if (!exists("truepred") & exists("predfound")) {
         a <- 1
         b <- specificity(numeric(0), predfound, ncol(simu$M_train))
         c <- fdp(numeric(0), predfound)
         d <-
           estimatedR2(simu$M_test, predfound, simu$Y_test)$r.squared
         remove(predfound)
       } else{
         if (!exists("truepred") & !exists("predfound")) {
           a <- 1
           b <- 1
           c <- 0
           d <- 0
         }
       }
     }
    }
    predBMI_M[[k1]] <-
      c(
        predBMI_M[[k1]],
        sens_rev_caus = a,
        spec_rev_caus = b,
        fdp_rev_caus = c,
        R2_test_rev_caus = d
      )
    remove(a)
    remove(b)
    remove(c)
    remove(d)

}

##########################################
##assessing performance for ExWAS on M
truepred <- simu$cpg_predictors$name
for (k1 in 1:length(predBMI_M)) {
  truepred <- as.character(simu$cpg_predictors$name)
  predfound <- as.character(predBMI_M[[k1]]$selected)
  if (exists("predfound") & exists("truepred")) {
    if (length(predfound) == 0) {
      print("no predictors found")
    }
    a <- sensitivity(truepred, predfound)
    b <- specificity(truepred, predfound, ncol(simu$M_train))
    c <- fdp(truepred, predfound)
    d <- estimatedR2(simu$M_test, predfound, simu$Y_test)$r.squared
    # print(a)
                                              366


                                                                         APPENDIX III

      # print(b)
      # print(c)
      # print(d)
      remove(predfound, truepred)
    } else{
      if (!exists("predfound") & exists("truepred")) {
        a <- 0
        b <- specificity(truepred, numeric(0), ncol(simu$M_train))
        c <- 0
        d <- 0
        remove(truepred)
      } else{
        if (!exists("truepred") & exists("predfound")) {
          a <- 1
          b <- specificity(numeric(0), predfound, ncol(simu$M_train))
          c <- fdp(numeric(0), predfound)
          d <-
            estimatedR2(simu$M_test, predfound, simu$Y_test)$r.squared
          remove(predfound)
        } else{
          if (!exists("truepred") & !exists("predfound")) {
            a <- 1
            b <- 1
            c <- 0
            d <- 0
          }
        }
      }
    }
    predBMI_M[[k1]] <-
      c(
        predBMI_M[[k1]],
        sens = a,
        spec = b,
        fdp = c,
        R2_test = d
      )
    remove(a)
    remove(b)
    remove(c)
    remove(d)

}

##########################################
##assessing performance linked to reverse causality between E and Y
##( sensitivity to predicted exposures) for all methods
truepred <- simu$exp_predicted$name
                                               367


                                                                      APPENDIX III

for (k1 in 1:length(predBMI_E)) {
 truepred <- as.character(simu$exp_predicted$name)
 predfound <- as.character(predBMI_E[[k1]]$selected)
 if (exists("predfound") & exists("truepred")) {
   if (length(predfound) == 0) {
     print("no predictors found")
   }
   a <- sensitivity(truepred, predfound)
   b <- specificity(truepred, predfound, ncol(simu$E_train))
   c <- fdp(truepred, predfound)
   d <- estimatedR2(simu$E_test, predfound, simu$Y_test)$r.squared
   # print(a)
   # print(b)
   # print(c)
   # print(d)
   remove(predfound, truepred)
 } else{
   if (!exists("predfound") & exists("truepred")) {
     a <- 0
     b <- specificity(truepred, numeric(0), ncol(simu$E_train))
     c <- 0
     d <- 0
     remove(truepred)
   } else{
     if (!exists("truepred") & exists("predfound")) {
       a <- 1
       b <- specificity(numeric(0), predfound, ncol(simu$E_train))
       c <- fdp(numeric(0), predfound)
       d <-
         estimatedR2(simu$E_test, predfound, simu$Y_test)$r.squared
       remove(predfound)
     } else{
       if (!exists("truepred") & !exists("predfound")) {
         a <- 1
         b <- 1
         c <- 0
         d <- 0
       }
     }
   }
 }
 predBMI_E[[k1]] <-
   c(
     predBMI_E[[k1]],
     sens_rev_caus = a,
     spec_rev_caus = b,
     fdp_rev_caus = c,
     R2_test_rev_caus = d
                                           368


                                                                       APPENDIX III

     )
    remove(a)
    remove(b)
    remove
    remove(d)
}

##########################################
##assessing performance between E and Y (false detection)
truepred <- character()
for (k1 in 1:length(predBMI_E)) {
  truepred <- character()
  predfound <- as.character(predBMI_E[[k1]]$selected)
  if (exists("predfound") & exists("truepred")) {
    if (length(predfound) == 0) {
      print("no predictors found")
    }
    a <- sensitivity(truepred, predfound)
    b <- specificity(truepred, predfound, ncol(simu$E_train))
    c <- fdp(truepred, predfound)
    d <- estimatedR2(simu$E_test, predfound, simu$Y_test)$r.squared
    # print(a)
    # print(b)
    # print(c)
    # print(d)
    remove(predfound, truepred)
  } else{
    if (!exists("predfound") & exists("truepred")) {
      a <- 0
      b <- specificity(truepred, numeric(0), ncol(simu$E_train))
      c <- 0
      d <- 0
      remove(truepred)
    } else{
      if (!exists("truepred") & exists("predfound")) {
        a <- 1
        b <- specificity(numeric(0), predfound, ncol(simu$E_train))
        c <- fdp(numeric(0), predfound)
        d <-
          estimatedR2(simu$E_test, predfound, simu$Y_test)$r.squared
        remove(predfound)
      } else{
        if (!exists("truepred") & !exists("predfound")) {
          a <- 1
          b <- 1
          c <- 0
          d <- 0
        }
                                          369


                                                                         APPENDIX III

          }
      }
     }
     predBMI_E[[k1]] <-
       c(
         predBMI_E[[k1]],
         sens = a,
         spec = b,
         fdp = c,
         R2_test = d
       )
     remove(a)
     remove(b)
     remove(c)
     remove(d)

    }
    print("performance characterized")

    ##building the list with datasets generated + results of methods +
    ##performance to return
    A <-
     list(
       simu = simu,
       predBMI_E = predBMI_E,
       predBMI_M = predBMI_M,
       nl_exp_select = n_exp_select
     )
    remove(simu)
    remove(select_M)
    remove(predBMI_M)
    remove(predBMI_E)
    remove(predBMI_E_MITM_WM)
    remove(predBMI_E_MITM)
    remove(predlasso)
    remove(n_exp_select)


    gc()
    return(A)

}


#################################
##5. Running simulations
#################################


                                                 370


                                                                                  APPENDIX III



##loading real datasets

dataExp_true <- readRDS("20190205 Exposome simu borne.rds")
M1_true <- readRDS("20191129 Methylome simu.Rds")
Y_true <- readRDS("20190612_ZBMI_scaled_a_utiliser_pour_simu.rds")
M1_true <- scale(M1_true)

##initialization
list_simulated_data <- list()
list_list_predBMI_E <- list()
list_list_predBMI_M <- list()
list_list_nl_exp_select <- list()

##setting simulations parameters
n_iter <- 100 ##number of iterations for one scenarios
##parameters for generating datasets
##all combinations will be tested (each combination allows to build a scenario)
##(adapt the code of the loop if multiple values instead of single values for
##some parameters)
c_n_yM <- c(10, 18, 25, 100)

c_BetayM <- c(0.0001, 0.001, 0.01, 0.1, 0.5, 2)
c_BetayE <- c(0.0001, 0.001, 0.01, 0.1, 0.5, 2)
c_n_yE <- c(1, 3, 10, 25)
n_mY = 0
R2_mY = 0
BetamY = 0

##initialization of table of results

comp_method <-
 data.frame(
  Methods = vector(),
  Association_tested = vector(),
  Nb_true_predictors_of_BMI_in_M = numeric(0),
  Nb_predicted_by_BMI_in_M = numeric(0),
  Nb_predicted_by_BMI_in_E = numeric(0),
  Total_variability_of_BMI_explained_by_M = numeric(0),
  Total_variability_of_BMI_explained_by_M_measured =
   numeric(0),
  Mean_variability_of_M_explained_by_Y = numeric(0),
  Mean_variability_of_E_explained_by_Y = numeric(0),
  Mean_SD_variability_of_M_explained_by_Y = numeric(0),
  Mean_SD_variability_of_E_explained_by_Y = numeric(0),


  Number_iterations = numeric(0),
                                                  371


                                                                    APPENDIX III

     Mean_number_exp_selected_to_be_randomly_tested =
      numeric(0),
     Mean_number_predictors_found = numeric(0),
     Mean_sensitivity_rv = numeric(0),
     Mean_specificity_rv = numeric(0),
     Mean_fdp_rv = numeric(0),
     Mean_R2_test_rv = numeric(0),
     Mean_sensitivity_truepred = numeric(0),
     Mean_specificity_truepred = numeric(0),
     Mean_fdp_truepred = numeric(0),
     Mean_R2_test_truepred = numeric(0),
     SD_number_predictors_found = numeric(0),
     SD_sensitivity_rv = numeric(0),
     SD_specificity_rv = numeric(0),
     SD_fdp_rv = numeric(0),
     SD_R2_test_rv = numeric(0),
     SD_sensitivity_truepred = numeric(0),
     SD_specificity_truepred = numeric(0),
     SD_fdp_truepred = numeric(0),
     SD_R2_test_truepred = numeric(0),
     Which_iteration = numeric(0)
 )


n=1


##looping on the different vectors of parameters
for (i2 in 1:length(c_BetayE)) {
 BetayE <- c_BetayE[i2]
 for (i3 in 1:length(c_n_yE)) {
   n_yE <- c_n_yE[i3]
   for (i4 in 1:length(c_BetayM)) {
    BetayM <- c_BetayM[i4]
    for (i1 in 1:length(c_n_yM)) {
      n_yM <- c_n_yM[i1]


       n_row = nrow(comp_method)
       simulated_data <- list()
       list_predBMI_E <- list()
       list_predBMI_M <- list()
       list_nl_exp_select <- list()
       start_time <- Sys.time()
       ##parallelization of f0
       cl <-
         makeCluster(getOption("cl.cores", round(detectCores())))
       clusterExport(
                                                372


                                                              APPENDIX III

 cl,
 list(
   "simulator",
   "simResponseSimple",
   "estimatedR2",
   "getresiduals_2df",
   "ewas",
   "lasso",
   "lasso_stab",
   "DSAreg",
   "sensitivity",
   "fdp",
   "specificity",
   "f0",
   "dataExp_true",
   "M1_true",
   "Y_true",
   "BetayE",
   "n_yE",
   "n_yM",
   "BetayM",
   "n_mY",
   "R2_mY",
   "BetamY"
 )
)
clusterEvalQ(cl, list(library("boot"), library("reshape"),
                library("glmnet"), library("DSA")))
results_1_jeu <- clusterApply(cl, 1:n_iter, f0)
stopCluster(cl)
simulated_data <-
  lapply(results_1_jeu, function(x)
    x$simu)

##structure of results priorized by methods and not anymore
##priorized by datasets
list_predBMI_E <-
  lapply(results_1_jeu, function(x)
    x$predBMI_E)
list_predBMI_M <-
  lapply(results_1_jeu, function(x)
    x$predBMI_M)
list_nl_exp_select <-
  lapply(results_1_jeu, function(x)
    x$nl_exp_select)
remove(results_1_jeu)



                                            373


                                                       APPENDIX III




###compilation of results for this scenario

##table describing the empirical characteristics of
##the simulated datasets
param_simu <-
 data.frame(
   Parameters = vector(),
   Fixed_or_measured = vector(),
   Value = numeric(0)
 )
param_simu[1, ] <-
 c(
   as.character("Nb_true predictors of BMI in M"),
   as.character("Fixed"),
   mean(unlist(
     lapply(simulated_data, function(X)
       length(X$cpg_predictors$betas))
   ))
 )
param_simu[2, ] <-
 c("Nb_predicted_by_BMI_in_M", "Fixed", mean(unlist(
   lapply(simulated_data, function(X)
     length(X$cpg_predicted$betas))
 )))
param_simu[3, ] <-
 c("Nb_predicted_by_BMI_in_E", "Fixed", mean(unlist(
   lapply(simulated_data, function(X)
     length(X$exp_predicted$betas))
 )))
param_simu[4, ] <-
 c("Total_variability_of_BMI_explained_by_M",
   "Fixed",
   R2_mY)
param_simu[5, ] <-
 c("Total_variability_of_BMI_explained_by_M",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2_mY_measured))
   )))
param_simu[6, ] <-
 c("Mean_variability_of_M_explained_by_Y",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2_yM_mean))
                                         374


                                                                   APPENDIX III

   )))
param_simu[7, ] <-
 c("Mean_variability_of_E_explained_by_Y",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2_yE_mean))
   )))
param_simu[8, ] <-
 c("Mean_SD_variability_of_M_explained_by_Y",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2_yM_SD))
   )))
param_simu[9, ] <-
 c("Mean_SD_variability_of_E_explained_by_Y",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2_yE_SD))
   )))
param_simu[10, ] <- c("Number_iterations", "Fixed", n_iter)
param_simu[11, ] <-
 c(
   "Mean_number_exp_selected_to_be_randomly_tested",
   "Measured",
   mean(unlist(list_nl_exp_select))
 )

##summarizing each method performance by a line in comp_method datadrame
##within this scenario
for (k1 in (1:length(list_predBMI_M[[1]]))) {
 comp_method[n_row + k1, ] <-
   c(
    names(list_predBMI_M[[1]][k1]),
    "BMI - M",
    param_simu[1, 3],
    param_simu[2, 3],
    param_simu[3, 3],
    param_simu[4, 3],
    param_simu[5, 3],
    param_simu[6, 3],
    param_simu[7, 3],
    param_simu[8, 3],
    param_simu[9, 3],
    n_iter,
    NA,
                                        375


                                             APPENDIX III

mean(unlist(
  lapply(list_predBMI_M, function(X)
    length(X[[k1]][[1]]))
)),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[3]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[4]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[5]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[6]]))
), na.rm = TRUE),

mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[7]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[8]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[9]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[10]]))
), na.rm = TRUE),

sd(unlist(
  lapply(list_predBMI_M, function(X)
    length(X[[k1]][[1]]))
)),
sd(unlist(
  lapply(list_predBMI_M, function(X)
    (X[[k1]][[3]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_predBMI_M, function(X)
                                       376


                                                     APPENDIX III

            (X[[k1]][[4]]))
        ), na.rm = TRUE),
        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[5]]))
        ), na.rm = TRUE),
        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[6]]))
        ), na.rm = TRUE),

        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[7]]))
        ), na.rm = TRUE),
        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[8]]))
        ), na.rm = TRUE),
        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[9]]))
        ), na.rm = TRUE),
        sd(unlist(
          lapply(list_predBMI_M, function(X)
            (X[[k1]][[10]]))
        ), na.rm = TRUE),
        n
    )
}

for (k2 in (1:length(list_predBMI_E[[1]]))) {
 comp_method[n_row + k2 + k1, ] <-
   c(
    names(list_predBMI_E[[1]][k2]),
    "BMI - E",
    param_simu[1, 3],
    param_simu[2, 3],
    param_simu[3, 3],
    param_simu[4, 3],
    param_simu[5, 3],
    param_simu[6, 3],
    param_simu[7, 3],
    param_simu[8, 3],
    param_simu[9, 3],
    n_iter,
    param_simu[11, 3],
    mean(unlist(
                                               377


                                             APPENDIX III

  lapply(list_predBMI_E, function(X)
    length(X[[k2]][[1]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[3]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[4]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[5]]))
)),
mean(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[6]]))
)),

NA,
NA,
NA,
NA,


sd(unlist(
  lapply(list_predBMI_E, function(X)
    length(X[[k2]][[1]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[3]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[4]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[5]]))
)),
sd(unlist(
  lapply(list_predBMI_E, function(X)
    (X[[k2]][[6]]))
)),
NA,
NA,
                                       378


                                                                                     APPENDIX III

                    NA,
                    NA,
                    n
                   )
                }
                print(n)

                ##storing generated datasets and methods results for this scenario
                list_list_predBMI_E <-
                  c(list_list_predBMI_E, list(list_predBMI_E))
                list_list_predBMI_M <-
                  c(list_list_predBMI_M, list(list_predBMI_M))
                list_list_nl_exp_select <-
                  c(list_list_nl_exp_select, list(list_nl_exp_select))
                end_time <- Sys.time()
                end_time - start_time
                ##saving
                saveRDS(comp_method, "comp_method_rev_caus_sans_mY.Rds")
                saveRDS(
                  simulated_data,
                  file = paste(
                    n,
                    '_simulated_data_scenario_iteration_rev_caus_sans_mY.Rds'
                  )
                )
                saveRDS(list_list_predBMI_E,
                       "list_list_predBMI_E_rev_caus_sans_mY.rds")
                saveRDS(list_list_predBMI_M,
                       "list_list_predBMI_M_rev_caus_sans_mY.rds")
                saveRDS(list_list_nl_exp_select,
                       "list_list_nl_exp_select_rev_caus_sans_mY.rds")

                remove(simulated_data)
                remove(list_predBMI_E)
                remove(list_predBMI_M)
                remove(list_nl_exp_select)

                n=n+1

                print(n)
            }
        }
    }
}


##save
saveRDS(comp_method, "comp_method_rev_caus_sans_mY.Rds")
                                                        379


                                                                    APPENDIX III

#saveRDS(list_simulated_data,"list_simulated_data_mediation.Rds")
saveRDS(list_list_predBMI_E,
     "list_list_predBMI_E_rev_caus_sans_mY.Rds")
saveRDS(list_list_predBMI_M,
     "list_list_predBMI_M_rev_caus_sans_mY.Rds")
saveRDS(list_list_nl_exp_select,
     "list_list_nl_exp_select_rev_caus_sans_mY.Rds")




                                            380


                                                                                    APPENDIX III

Supplementary Table V.3: List of variables selected by default LASSO and all tested stabilized
LASSO for each of the 10 runs applied to relate an exposome of 173 prenatal and postnatal
quantitative exposures (A) or only the smaller exposome of 74 prenatal quantitative variables (B),
to zBMI in 1301 mother-child pairs of the Helix cohorts. For each run, the direction of
association with zBMI in a multivariate model including all exposures selected in the run and
adjusted for relevant covariates is also given.
A.
 Method      Run     Exposures selected and corresponding direction of association
 Default     1       Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
 LASSO               PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
                     (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
                     - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
                     Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
                     Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
                     Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
                     Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
                     (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
                     Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
                     Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
                     Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
                     Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
                     MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
                     - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
                     Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
                     Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
                     Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
                     Population density - Postnatal (+), Population density (school) - Postnatal
                     (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
                     m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
                     Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
                     Accessibility (bus stops 300m) - Postnatal (-)
 Default     2       Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+),
 LASSO               Temperature (preg) - Pregnancy (+), BPA - Pregnancy (+), BUPA -
                     Pregnancy (+), Cobalt - Postnatal (-), Cesium - Postnatal (+), Copper -
                     Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy
                     (+), DEP - Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-),
                     DMP - Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity
                     (day) - Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score -
                     Postnatal (+), Land use (300m - school) - Postnatal (-), Traffic noise (24h -
                     school) - Postnatal (-), MEHP - Postnatal (-), MEOHP - Pregnancy (-), MEP -
                     Postnatal (-), MEPA - Pregnancy (+), Manganese - Postnatal (+),
                     Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+), Moderate and
                     vigorous PA - Postnatal (-), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+),
                     Lead - Postnatal (+), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-), PCB
                     180 - Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
                     Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
                     Population density - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum) -
                     Pregnancy (+), Road traffic load (100 m) - Postnatal (+), Inverse distance to
                     nearest road (school) - Postnatal (+), Walkability index - Postnatal (-),


                                                381


                                                                             APPENDIX III

              Facility density (300m) - Postnatal (-), Accessibility (bus stops 300m) -
              Postnatal (-)
Default   3   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
              - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
              Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
              Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
              Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
              Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
              (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
              Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
              Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
              Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
              Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
              MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
              - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
              Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
              Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
              Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
              Population density - Postnatal (+), Population density (school) - Postnatal
              (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
              m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
              Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
              Accessibility (bus stops 300m) - Postnatal (-)
Default   4   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
              - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
              Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
              Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
              Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
              Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
              (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
              Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
              Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
              Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
              Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
              MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
              - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
              Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
              Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
              Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
              Population density - Postnatal (+), Population density (school) - Postnatal
              (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
              m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
              Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
              Accessibility (bus stops 300m) - Postnatal (-)
Default   5   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Cesium - Postnatal (+),
              Copper - Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-), DDE -

                                         382


                                                                             APPENDIX III

              Pregnancy (+), DEP - Postnatal (-), DEP - Pregnancy (+), Sleep duration -
              Postnatal (-), DMP - Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-),
              Humidity (day) - Postnatal (+), Humidity (month) - Postnatal (+), KIDMED
              score - Postnatal (+), Land use (300m - school) - Postnatal (-), Traffic noise
              (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP - Pregnancy (-),
              MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese - Postnatal (+),
              Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+), Moderate and
              vigorous PA - Postnatal (-), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+),
              OXBE - Pregnancy (-), Lead - Postnatal (+), PBDE 153 - Postnatal (-), PBDE
              47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
              Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Postnatal (-), PFUNDA -
              Pregnancy (+), PM10 (day) - Postnatal (+), Population density - Postnatal (+),
              Population density (school) - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum)
              - Pregnancy (+), Road traffic load (100 m) - Postnatal (+), Inverse distance to
              nearest road (school) - Postnatal (+), Walkability index - Postnatal (-),
              Facility density (300m) - Postnatal (-), Accessibility (bus stops 300m) -
              Postnatal (-)
Default   6   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
              - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
              Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
              Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
              Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
              Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
              (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
              Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
              Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
              Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
              Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
              MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
              - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
              Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
              Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
              Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
              Population density - Postnatal (+), Population density (school) - Postnatal
              (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
              m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
              Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
              Accessibility (bus stops 300m) - Postnatal (-)
Default   7   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
              - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
              Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
              Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
              Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
              Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
              (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
              Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
              Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
              Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),

                                         383


                                                                             APPENDIX III

              Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
              MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
              - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
              Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
              Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
              Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
              Population density - Postnatal (+), Population density (school) - Postnatal
              (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
              m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
              Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
              Accessibility (bus stops 300m) - Postnatal (-)
Default   8   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
              (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
              - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
              Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
              Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
              Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
              Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
              (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
              Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
              Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
              Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
              Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
              MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
              - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
              Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
              Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
              Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
              Population density - Postnatal (+), Population density (school) - Postnatal
              (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
              m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
              Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
              Accessibility (bus stops 300m) - Postnatal (-)
Default   9   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO         PM2.5 - Postnatal (+), PM2.5 (preg) - Pregnancy (-), Pressure (t1) -
              Pregnancy (-), Temperature (preg) - Pregnancy (+), BPA - Pregnancy (+),
              BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m -
              school) - Postnatal (-), Cotinine - Pregnancy (-), Cesium - Postnatal (+),
              Copper - Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-), DDE -
              Pregnancy (+), DEP - Postnatal (-), DEP - Pregnancy (+), Sleep duration -
              Postnatal (-), DMP - Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-),
              Mercury - Postnatal (+), Humidity (day) - Postnatal (+), Humidity (month) -
              Postnatal (+), KIDMED score - Postnatal (+), Land use (300m) - Postnatal (-),
              Land use (300m - school) - Postnatal (-), Traffic noise (24h - school) -
              Postnatal (-), MEHP - Postnatal (-), MEOHP - Pregnancy (-), MEP - Postnatal
              (-), MEPA - Pregnancy (+), MiBP - Postnatal (-), Manganese - Postnatal (+),
              MnBP - Pregnancy (-), Molybdenum - Postnatal (-), Molybdenum -
              Pregnancy (+), Moderate and vigorous PA - Postnatal (-), NO2 (year) -
              Postnatal (+), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE -
              Pregnancy (+), oxo-MiNP - Pregnancy (-), Lead - Postnatal (+), PBDE 153 -
              Postnatal (-), PBDE 47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 -

                                         384


                                                                                APPENDIX III

               Postnatal (+), PFNA - Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy
               (-), PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) -
               Postnatal (+), Population density - Postnatal (+), Population density (school)
               - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road
               traffic load (100 m) - Postnatal (+), Inverse distance to nearest road (school)
               - Postnatal (+), TRCS - Postnatal (-), Walkability index - Postnatal (-), Facility
               density (300m) - Postnatal (-), Accessibility (bus stops 300m) - Postnatal (-)
Default   10   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
               (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Cesium - Postnatal (+),
               Copper - Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-), DDE -
               Pregnancy (+), DEP - Postnatal (-), DEP - Pregnancy (+), Sleep duration -
               Postnatal (-), DMP - Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-),
               Humidity (day) - Postnatal (+), Humidity (month) - Postnatal (+), KIDMED
               score - Postnatal (+), Land use (300m - school) - Postnatal (-), Traffic noise
               (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP - Pregnancy (-),
               MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese - Postnatal (+),
               Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+), Moderate and
               vigorous PA - Postnatal (-), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+),
               OXBE - Pregnancy (-), Lead - Postnatal (+), PBDE 153 - Postnatal (-), PBDE
               47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
               Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Postnatal (-), PFUNDA -
               Pregnancy (+), PM10 (day) - Postnatal (+), Population density - Postnatal (+),
               Population density (school) - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum)
               - Pregnancy (+), Road traffic load (100 m) - Postnatal (+), Inverse distance to
               nearest road (school) - Postnatal (+), Walkability index - Postnatal (-),
               Facility density (300m) - Postnatal (-), Accessibility (bus stops 300m) -
               Postnatal (-)
Default   11   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
               (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
               - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
               Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
               Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
               Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
               Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
               (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
               Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
               Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
               Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
               Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
               MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
               - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
               Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
               Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
               Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
               Population density - Postnatal (+), Population density (school) - Postnatal
               (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
               m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
               Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
               Accessibility (bus stops 300m) - Postnatal (-)


                                           385


                                                                                APPENDIX III

Default   12   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), PM2.5 (preg) - Pregnancy (-), Pressure (t1) -
               Pregnancy (-), Temperature (preg) - Pregnancy (+), BPA - Pregnancy (+),
               BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m -
               school) - Postnatal (-), Cotinine - Pregnancy (-), Cesium - Postnatal (+),
               Copper - Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-), DDE -
               Pregnancy (+), DEP - Postnatal (-), DEP - Pregnancy (+), Sleep duration -
               Postnatal (-), DMP - Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-),
               Mercury - Postnatal (+), Humidity (day) - Postnatal (+), Humidity (month) -
               Postnatal (+), KIDMED score - Postnatal (+), Land use (300m) - Postnatal (-),
               Land use (300m - school) - Postnatal (-), Traffic noise (24h - school) -
               Postnatal (-), MEHP - Postnatal (-), MEOHP - Pregnancy (-), MEP - Postnatal
               (-), MEPA - Pregnancy (+), MiBP - Postnatal (-), Manganese - Postnatal (+),
               MnBP - Pregnancy (-), Molybdenum - Postnatal (-), Molybdenum -
               Pregnancy (+), Moderate and vigorous PA - Postnatal (-), NO2 (year) -
               Postnatal (+), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE -
               Pregnancy (+), oxo-MiNP - Pregnancy (-), Lead - Postnatal (+), PBDE 153 -
               Postnatal (-), PBDE 47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 -
               Postnatal (+), PFNA - Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy
               (-), PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) -
               Postnatal (+), Population density - Postnatal (+), Population density (school)
               - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road
               traffic load (100 m) - Postnatal (+), Inverse distance to nearest road (school)
               - Postnatal (+), TRCS - Postnatal (-), Walkability index - Postnatal (-), Facility
               density (300m) - Postnatal (-), Accessibility (bus stops 300m) - Postnatal (-)
Default   13   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
               (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
               - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
               Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
               Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
               Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
               Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
               (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
               Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
               Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
               Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
               Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
               MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
               - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
               Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
               Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
               Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
               Population density - Postnatal (+), Population density (school) - Postnatal
               (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
               m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
               Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
               Accessibility (bus stops 300m) - Postnatal (-)
Default   14   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), PM2.5 (preg) - Pregnancy (-), Pressure (t1) -
               Pregnancy (-), Temperature (preg) - Pregnancy (+), Road traffic load (100 m)
               - Pregnancy (+), BPA - Pregnancy (+), BUPA - Pregnancy (+), Cobalt -

                                           386


                                                                                APPENDIX III

               Postnatal (-), Connectivity density (300m - school) - Postnatal (-), Cotinine -
               Pregnancy (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
               Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP - Postnatal (-),
               DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP - Postnatal (-),
               DMP - Pregnancy (-), HCB - Postnatal (-), Mercury - Postnatal (+), Humidity
               (day) - Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score -
               Postnatal (+), Land use (300m) - Postnatal (-), Land use (300m - school) -
               Postnatal (-), Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-),
               MEOHP - Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), MiBP -
               Postnatal (-), Manganese - Postnatal (+), MnBP - Pregnancy (-),
               Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+), Moderate and
               vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-MiNP -
               Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (-), oxo-MiNP -
               Pregnancy (-), Lead - Postnatal (+), PBDE 153 - Postnatal (-), PBDE 47 -
               Postnatal (+), PCB 118 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 -
               Postnatal (+), PFNA - Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy
               (-), PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) -
               Postnatal (+), PM2.5 (week) - Postnatal (-), Population density - Postnatal
               (+), Population density (school) - Postnatal (+), PRPA - Pregnancy (-), PCBs
               (sum) - Pregnancy (+), Road traffic load (100 m) - Postnatal (+), Inverse
               distance to nearest road (school) - Postnatal (+), TRCS - Postnatal (-),
               Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
               Accessibility (bus stops 300m) - Postnatal (-)
Default   15   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
LASSO          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
               (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
               - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
               Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
               Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
               Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
               Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
               (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
               Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
               Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
               Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
               Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
               MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
               - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
               Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
               Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
               Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
               Population density - Postnatal (+), Population density (school) - Postnatal
               (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
               m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
               Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
               Accessibility (bus stops 300m) - Postnatal (-)
CV1       1    Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
               PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
               (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
               - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
               Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
               Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -

                                           387


                                                                         APPENDIX III

          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   2   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   3   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),

                                     388


                                                                         APPENDIX III

          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   4   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   5   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),

                                     389


                                                                         APPENDIX III

          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   6   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV1   7   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)


                                     390


                                                                          APPENDIX III

CV1   8    Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV1   9    Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), MiBP - Postnatal
           (-), Manganese - Postnatal (+), Molybdenum - Postnatal (-), Molybdenum -
           Pregnancy (+), Moderate and vigorous PA - Postnatal (-), NO2 (year) -
           Postnatal (+), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE -
           Pregnancy (+), oxo-MiNP - Pregnancy (-), Lead - Postnatal (-), PBDE 153 -
           Postnatal (-), PBDE 47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 -
           Postnatal (+), PFNA - Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy
           (-), PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) -
           Postnatal (+), Population density - Postnatal (+), Population density (school)
           - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road
           traffic load (100 m) - Postnatal (+), Inverse distance to nearest road (school)
           - Postnatal (+), Walkability index - Postnatal (-), Facility density (300m) -
           Postnatal (-), Accessibility (bus stops 300m) - Postnatal (-)
CV1   10   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -

                                      391


                                                                          APPENDIX III

           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV1   11   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), MiBP - Postnatal
           (-), Manganese - Postnatal (+), Molybdenum - Postnatal (-), Molybdenum -
           Pregnancy (+), Moderate and vigorous PA - Postnatal (-), NO2 (year) -
           Postnatal (+), OH-MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE -
           Pregnancy (+), oxo-MiNP - Pregnancy (-), Lead - Postnatal (-), PBDE 153 -
           Postnatal (-), PBDE 47 - Postnatal (+), PCB 170 - Postnatal (-), PCB 180 -
           Postnatal (+), PFNA - Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy
           (-), PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) -
           Postnatal (+), Population density - Postnatal (+), Population density (school)
           - Postnatal (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road
           traffic load (100 m) - Postnatal (+), Inverse distance to nearest road (school)
           - Postnatal (+), Walkability index - Postnatal (-), Facility density (300m) -
           Postnatal (-), Accessibility (bus stops 300m) - Postnatal (-)
CV1   12   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),

                                      392


                                                                          APPENDIX III

           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV1   13   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV1   14   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),

                                      393


                                                                          APPENDIX III

           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV1   15   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   1    Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)


                                      394


                                                                         APPENDIX III

CV2   2   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   3   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   4   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -

                                     395


                                                                         APPENDIX III

          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   5   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   6   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),

                                     396


                                                                         APPENDIX III

          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   7   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
          Population density - Postnatal (+), Population density (school) - Postnatal
          (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
          m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
          Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
          Accessibility (bus stops 300m) - Postnatal (-)
CV2   8   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
          PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
          (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
          - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
          Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
          Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
          Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
          Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
          (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
          Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
          Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
          Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
          Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
          MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
          - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
          Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
          Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
          Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),

                                     397


                                                                          APPENDIX III

           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   9    Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   10   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)


                                      398


                                                                          APPENDIX III

CV2   11   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   12   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   13   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -

                                      399


                                                                          APPENDIX III

           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   14   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),
           Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
           MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
           - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
           Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
           Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+), Population density (school) - Postnatal
           (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
           m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
           Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
           Accessibility (bus stops 300m) - Postnatal (-)
CV2   15   Cigarette - Pregnancy (-), Indoor PMabsorbance - Postnatal (+), Indoor
           PM2.5 - Postnatal (+), Temperature (preg) - Pregnancy (+), BPA - Pregnancy
           (+), BUPA - Pregnancy (+), Cobalt - Postnatal (-), Connectivity density (300m
           - school) - Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+),
           Copper - Pregnancy (-), DDE - Postnatal (-), DDE - Pregnancy (+), DEP -
           Postnatal (-), DEP - Pregnancy (+), Sleep duration - Postnatal (-), DMP -
           Postnatal (-), DMP - Pregnancy (-), HCB - Postnatal (-), Humidity (day) -
           Postnatal (+), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), Land use (300m) - Postnatal (+), Land use (300m - school) - Postnatal (-),
           Traffic noise (24h - school) - Postnatal (-), MEHP - Postnatal (-), MEOHP -
           Pregnancy (-), MEP - Postnatal (-), MEPA - Pregnancy (+), Manganese -
           Postnatal (+), Molybdenum - Postnatal (-), Molybdenum - Pregnancy (+),

                                      400


                                                                              APPENDIX III

                Moderate and vigorous PA - Postnatal (-), NO2 (year) - Postnatal (+), OH-
                MiNP - Pregnancy (-), OXBE - Postnatal (+), OXBE - Pregnancy (+), oxo-MiNP
                - Pregnancy (-), Lead - Postnatal (-), PBDE 153 - Postnatal (-), PBDE 47 -
                Postnatal (+), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFNA -
                Pregnancy (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
                Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
                Population density - Postnatal (+), Population density (school) - Postnatal
                (+), PRPA - Pregnancy (-), PCBs (sum) - Pregnancy (+), Road traffic load (100
                m) - Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+),
                Walkability index - Postnatal (-), Facility density (300m) - Postnatal (-),
                Accessibility (bus stops 300m) - Postnatal (-)
Meinshau   1    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   2    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   3    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   4    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   5    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   6    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   7    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   8    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   9    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   10   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   11   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   12   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   13   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   14   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   15   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
sen1            Postnatal (-), PCB 170 - Postnatal (-)
Meinshau   1    HCB - Postnatal (-)
sen2
Meinshau   2    HCB - Postnatal (-)
sen2
Meinshau   3
sen2
Meinshau   4    HCB - Postnatal (-)
sen2
Meinshau   5    HCB - Postnatal (-)
sen2


                                          401


                                                                              APPENDIX III

Meinshau   6
sen2
Meinshau   7    DDE - Postnatal (-), HCB - Postnatal (-)
sen2
Meinshau   8    DDE - Postnatal (-), HCB - Postnatal (-)
sen2
Meinshau   9
sen2
Meinshau   10   HCB - Postnatal (-)
sen2
Meinshau   11   DDE - Postnatal (-), HCB - Postnatal (-)
sen2
Meinshau   12
sen2
Meinshau   13   HCB - Postnatal (-)
sen2
Meinshau   14   DDE - Postnatal (-), HCB - Postnatal (-)
sen2
Meinshau   15   HCB - Postnatal (-)
sen2
Mix        1    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
                Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), DDE - Postnatal
                (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity (month) -
                Postnatal (+), KIDMED score - Postnatal (+), MEP - Postnatal (-),
                Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-
                ), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-),
                PFUNDA - Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal
                (+), Population density - Postnatal (+)
Mix        2    Temperature (preg) - Pregnancy (+), Accessibility (bus stops 300m) -
                Postnatal (-), BPA - Pregnancy (+), Cobalt - Postnatal (-), Cesium - Postnatal
                (+), Copper - Postnatal (+), Copper - Pregnancy (-), DDE - Postnatal (-),
                Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity (month) -
                Postnatal (+), KIDMED score - Postnatal (+), MEP - Postnatal (-),
                Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-
                ), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PM10
                (day) - Postnatal (+), Population density - Postnatal (+), Inverse distance to
                nearest road (school) - Postnatal (+)
Mix        3    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
                Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
                Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
                Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
                (+), Land use (300m - school) - Postnatal (-), MEP - Postnatal (-), Manganese
                - Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB
                170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
                Pregnancy (-), PM10 (day) - Postnatal (+), Population density - Postnatal (+)
Mix        4    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
                Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
                Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
                Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
                (+), MEP - Postnatal (-), Molybdenum - Postnatal (-), PBDE 153 - Postnatal
                (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-),


                                           402


                                                                          APPENDIX III

           PFOA - Pregnancy (-), PM10 (day) - Postnatal (+), Population density -
           Postnatal (+)
Mix   5    Accessibility (bus stops 300m) - Postnatal (-), Cobalt - Postnatal (-), Cesium -
           Postnatal (+), Copper - Postnatal (+), DDE - Postnatal (-), Sleep duration -
           Postnatal (-), HCB - Postnatal (-), Humidity (month) - Postnatal (+), MEP -
           Postnatal (-), Manganese - Postnatal (+), Molybdenum - Postnatal (-), PBDE
           153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
           Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Pregnancy (+), PM10 (day) -
           Postnatal (+), Population density - Postnatal (+)
Mix   6    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
           Pregnancy (-), DDE - Postnatal (-), DEP - Postnatal (-), Sleep duration -
           Postnatal (-), HCB - Postnatal (-), Humidity (month) - Postnatal (+), KIDMED
           score - Postnatal (+), MEP - Postnatal (-), Manganese - Postnatal (+),
           Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-
           ), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-),
           PFUNDA - Postnatal (-), PM10 (day) - Postnatal (+), Population density -
           Postnatal (+), Inverse distance to nearest road (school) - Postnatal (+)
Mix   7    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
           Pregnancy (-), DDE - Postnatal (-), DEP - Postnatal (-), Sleep duration -
           Postnatal (-), HCB - Postnatal (-), Humidity (month) - Postnatal (+), KIDMED
           score - Postnatal (+), MEP - Postnatal (-), Molybdenum - Postnatal (-), PBDE
           153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
           Postnatal (-), PFOA - Pregnancy (-), PM10 (day) - Postnatal (+), Population
           density - Postnatal (+)
Mix   8    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
           Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
           Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), MEP - Postnatal (-), Manganese - Postnatal (+), Molybdenum -
           Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 -
           Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
           Pregnancy (+), PM10 (day) - Postnatal (+), Population density - Postnatal (+)
Mix   9    Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
           Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
           Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
           (+), MEP - Postnatal (-), Molybdenum - Postnatal (-), PBDE 153 - Postnatal
           (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-),
           PFOA - Pregnancy (-), PFUNDA - Postnatal (-), PM10 (day) - Postnatal (+),
           Population density - Postnatal (+)
Mix   10   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
           Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
           Postnatal (-), Humidity (month) - Postnatal (+), MEP - Postnatal (+),
           Manganese - Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 -
           Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
           Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Postnatal (-), Population
           density - Postnatal (+)
Mix   11   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
           Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), DDE - Postnatal

                                      403


                                                                           APPENDIX III

             (-), DEP - Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-),
             Humidity (month) - Postnatal (+), KIDMED score - Postnatal (+), MEP -
             Postnatal (+), Manganese - Postnatal (+), Molybdenum - Postnatal (-), PBDE
             153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Postnatal (-), Population
             density - Postnatal (+)
Mix     12   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
             Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
             Pregnancy (-), DDE - Postnatal (-), DEP - Postnatal (-), Sleep duration -
             Postnatal (-), HCB - Postnatal (-), Humidity (month) - Postnatal (+), MEP -
             Postnatal (-), Manganese - Postnatal (+), Molybdenum - Postnatal (-), PBDE
             153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-), PFOA - Pregnancy (-), PFUNDA - Pregnancy (+), PM10 (day) -
             Postnatal (+), Population density - Postnatal (+)
Mix     13   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
             Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
             Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
             Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
             (+), MEP - Postnatal (-), Manganese - Postnatal (+), Molybdenum -
             Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 -
             Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
             Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
             Population density - Postnatal (+)
Mix     14   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
             Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
             Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
             Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
             (+), MEP - Postnatal (-), Manganese - Postnatal (+), Molybdenum -
             Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-), PCB 180 -
             Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PFUNDA -
             Postnatal (-), PFUNDA - Pregnancy (+), PM10 (day) - Postnatal (+),
             Population density - Postnatal (+), Road traffic load (100 m) - Postnatal (+),
             Inverse distance to nearest road (school) - Postnatal (+)
Mix     15   Accessibility (bus stops 300m) - Postnatal (-), BPA - Pregnancy (+), Cobalt -
             Postnatal (-), Cesium - Postnatal (+), Copper - Postnatal (+), Copper -
             Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
             Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
             (+), MEP - Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal
             (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-),
             PFOA - Pregnancy (-), PFUNDA - Postnatal (-), Population density -
             Postnatal (+)
LASSO   1    BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), Copper -
1SE          Pregnancy (-), DDE - Postnatal (-), Sleep duration - Postnatal (-), HCB -
             Postnatal (-), Humidity (month) - Postnatal (+), KIDMED score - Postnatal
             (+), Land use (300m - school) - Postnatal (-), MEP - Postnatal (-),
             Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 - Postnatal (-
             ), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA - Pregnancy (-), PM10
             (day) - Postnatal (+), Population density - Postnatal (+), Accessibility (bus
             stops 300m) - Postnatal (-)
LASSO   2    Cobalt - Postnatal (-), Copper - Postnatal (+), DDE - Postnatal (-), HCB -
1SE          Postnatal (-), Humidity (month) - Postnatal (+), PBDE 153 - Postnatal (-), PCB
             170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-)

                                       404


                                                                          APPENDIX III

LASSO   3    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
1SE          Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-)
LASSO   4    BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   5    Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
1SE          Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-)
LASSO   6    Cobalt - Postnatal (-), Copper - Postnatal (+), DDE - Postnatal (-), Sleep
1SE          duration - Postnatal (-), HCB - Postnatal (-), Humidity (month) - Postnatal
             (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 -
             Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-)
LASSO   7    BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   8    BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   9    BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   10   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
1SE          Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-)
LASSO   11   BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   12   DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170 -
1SE          Postnatal (-), PCB 180 - Postnatal (+)



                                       405


                                                                           APPENDIX III

LASSO   13   Copper - Postnatal (+), DDE - Postnatal (-), HCB - Postnatal (-), PBDE 153 -
1SE          Postnatal (-), PCB 170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA -
             Postnatal (-)
LASSO   14   BPA - Pregnancy (+), Cobalt - Postnatal (-), Copper - Postnatal (+), DDE -
1SE          Postnatal (-), Sleep duration - Postnatal (-), HCB - Postnatal (-), Humidity
             (month) - Postnatal (+), Land use (300m - school) - Postnatal (-), MEP -
             Postnatal (+), Molybdenum - Postnatal (-), PBDE 153 - Postnatal (-), PCB 170
             - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-), PFOA -
             Pregnancy (-), Population density - Postnatal (+), Accessibility (bus stops
             300m) - Postnatal (-)
LASSO   15   Cobalt - Postnatal (-), Copper - Postnatal (+), DDE - Postnatal (-), HCB -
1SE          Postnatal (-), Humidity (month) - Postnatal (+), PBDE 153 - Postnatal (-), PCB
             170 - Postnatal (-), PCB 180 - Postnatal (+), PFOA - Postnatal (-)




                                        406


                                                              APPENDIX III

B.

Method          Run Exposures selected and corresponding direction of
                    association
Default LASSO   1
Default LASSO   2
Default LASSO   3
Default LASSO   4
Default LASSO   5
Default LASSO   6
Default LASSO   7
Default LASSO   8
Default LASSO   9
Default LASSO   10
Default LASSO   11
Default LASSO   12
Default LASSO   13
Default LASSO   14
Default LASSO   15
CV1             1   Cigarette - Pregnancy (+)

CV1             2   Cigarette - Pregnancy (+)

CV1             3   Cigarette - Pregnancy (+)

CV1             4   Cigarette - Pregnancy (+)

CV1             5   Cigarette - Pregnancy (+)

CV1             6   Cigarette - Pregnancy (+)

CV1             7   Cigarette - Pregnancy (+)

CV1             8   Cigarette - Pregnancy (+)

CV1             9   Cigarette - Pregnancy (+)

CV1             10  Cigarette - Pregnancy (+)

CV1             11  Cigarette - Pregnancy (+)

CV1             12  Cigarette - Pregnancy (+)

CV1             13  Cigarette - Pregnancy (+)

CV1             14  Cigarette - Pregnancy (+)

CV1             15  Cigarette - Pregnancy (+)

CV2             1   Cigarette - Pregnancy (+)

CV2             2   Cigarette - Pregnancy (+)

CV2             3   Cigarette - Pregnancy (+)

CV2             4   Cigarette - Pregnancy (+)

CV2             5   Cigarette - Pregnancy (+)

CV2             6   Cigarette - Pregnancy (+)

CV2             7   Cigarette - Pregnancy (+)

CV2             8   Cigarette - Pregnancy (+)

CV2             9   Cigarette - Pregnancy (+)

CV2             10  Cigarette - Pregnancy (+)

CV2             11  Cigarette - Pregnancy (+)


                                 407


                                                                                       APPENDIX III


CV2            12   Cigarette - Pregnancy (+)

CV2            13   Cigarette - Pregnancy (+)

CV2            14   Cigarette - Pregnancy (+)

CV2            15   Cigarette - Pregnancy (+)

Meinshausen1   1    Facility density (300m) - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   2    DMP - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   3    OH-MiNP - Pregnancy (-)

Meinshausen1   4    Molybdenum - Pregnancy (+), OH-MiNP - Pregnancy (-)

Meinshausen1   5
Meinshausen1   6    Molybdenum - Pregnancy (+), OH-MiNP - Pregnancy (-)

Meinshausen1   7    Facility density (300m) - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   8    DMP - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   9    DMP - Pregnancy (-)

Meinshausen1   10   Molybdenum - Pregnancy (+), OH-MiNP - Pregnancy (-)

Meinshausen1   11   Facility density (300m) - Pregnancy (-), DMP - Pregnancy (-)

Meinshausen1   12   Facility density (300m) - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   13   Facility density (300m) - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   14   DMP - Pregnancy (-), OH-MiNP - Pregnancy (-)

Meinshausen1   15   OH-MiNP - Pregnancy (-)

Meinshausen2   1
Meinshausen2   2
Meinshausen2   3
Meinshausen2   4
Meinshausen2   5
Meinshausen2   6
Meinshausen2   7
Meinshausen2   8
Meinshausen2   9
Meinshausen2   10
Meinshausen2   11
Meinshausen2   12
Meinshausen2   13
Meinshausen2   14
Meinshausen2   15
Mix            1
Mix            2
Mix            3
Mix            4
Mix            5
Mix            6
Mix            7
Mix            8
Mix            9
Mix            10

                                      408


                                                                                   APPENDIX III


 Mix                       11
 Mix                       12
 Mix                       13
 Mix                       14
 Mix                       15
 LASSO 1SE                 1
 LASSO 1SE                 2
 LASSO 1SE                 3
 LASSO 1SE                 4
 LASSO 1SE                 5
 LASSO 1SE                 6
 LASSO 1SE                 7
 LASSO 1SE                 8
 LASSO 1SE                 9
 LASSO 1SE                 10
 LASSO 1SE                 11
 LASSO 1SE                 12
 LASSO 1SE                 13
 LASSO 1SE                 14
 LASSO 1SE                 15


Supplementary Material V.1: Commented Script
This script will be available on github (https://github.com/SoCadiou) once the corresponding
draft will be published.
########################################################
########################
##this code allows to perform a simulation to assess performance in terms of
##stability, sensitivity and specificity of prespecified statistical methods
##used to find the true predictors of an health among the exposome it contains 5
##parts:

##1. defining the functions allowing to generate a realistic dataset of exposome
#and an outcome linearly related to some variables of this exposome.

#It needs a real exposome dataset as input, as well as parameters allowing to
#define the #association between the exposome and the outcome (number of
#predictors, #variability explained, correlation..)

##2. defining the methods assessed

##3. defining some functions used to assess methods performance

##4. defining the simulation function, which, for a given scenario, generates
##the datasets, applies the methods and assess their performance. This function
##allows to parallelize the simulation.


                                               409


                                                                              APPENDIX III

##5. runnning the simulation itself with parallelization, repeating X times the
##function defined in 4. for each scenario and saving the results.
########################################################
########################

library(mvtnorm)
library(boot)
library(parallel)
library(reshape)
library(glmnet)
library(DSA)
library(OmicsMarkeR)
library(Rcpp)
library(stringr)

########################################################
###
######### 1. Generating datasets - functions ##############
########################################################
###

##Define functions used to generate datasets function which generates a
##dataset of exposures with same number of variables and individuals and similar
##correlation structure than a real exposome matrix provided and an outcome
##linearly generated

simulator_2layers <- function(E_true,
                   #real exposome data
                   R2_tot = 0.1 ,
                   #total variability explained all predictors
                   n_Ey = 5,
                   #number of predictors
                   BetaEy = 0.01,
                   #Beta coefficient for each predictors. Can be a
                   #vector of values or a unique value
                   test_and_training = TRUE,
                   #generate a dataset of the same size of E_true (if
                   #FALSE) or double the number of individuals (if
                   #TRUE)
                   pos_and_neg = FALSE,
                   #if FALSE, all effects are positive; if TRUE, half
                   #are negative
                   corr = F,
                   #if TRUE, the correlation between the predictors
                   #is controled
                   range_corr = c(0, 1)) {
                   #if corr = TRUE, range of correlation for true
                   #predictors

 ##creating a new exposome dataset by bootstraping
 data.X <- as.data.frame(E_true)

                                              410


                                                                                 APPENDIX III

names_row <- rownames(data.X)
data.X <- data.X[sample(1:nrow(data.X), 2 * nrow(data.X), replace = TRUE),]
rownames(data.X) <- c(names_row, sprintf('boot%s', names_row))
dataExp <- data.X

remove(data.X)


##creating a linearly generated outcome
##defining the vector of Beta coefficients
if (length(BetaEy) == 1) {
  if (pos_and_neg == FALSE) {
    Betapred_yE <- rep(BetaEy, n_Ey)
  } else{
    Betapred_yE <- rep(BetaEy, round(n_Ey / 2))
    Betapred_yE <- c(Betapred_yE, rep(-BetaEy, n_Ey - length(Betapred_yE)))
  }
} else{
  if (length(BetaEy) != n_Ey) {
    stop(
      "error: Betas for M explaining Y not explained by E are not
      consistent with the number of predictors"
    )
  }
  Betapred_yE <- BetaEy
}
##creating the linear combination
yE <- simResponseSimple(
    met = dataExp,
    Nmet = n_Ey,
    beta = Betapred_yE,
    corr = corr,
    range_corr = range_corr
  )

##adding a gaussian to Y to reach the wanted level of variability explained by
##the linear combination of predictors
Y <- yE$resp
if (!is.na(R2_tot)) {
  if (((R2_tot) != 0)) {
    sigma <- var(Y) * (1 / R2_tot - 1)
  } else{
    R2 = 0.00000001
    sigma <- var(Y) * (1 / R2_tot - 1)
  }
  Y <-
    as.matrix(Y + rnorm(length(Y), mean(Y), sqrt(sigma)), ncol = 1)
  Y <- as.data.frame(Y)
}

##estimating the R2

                                             411


                                                                               APPENDIX III

    R2 <- estimatedR2(dataExp, yE$predictors, Y)$r.squared
    ##results to return
    resultats <- list(
       Y_train = Y[1:(nrow(dataExp) / 2), , drop = FALSE],
       ##train part of the generated Y vector
       E_train = dataExp[1:(nrow(dataExp) / 2), , drop = FALSE],
       ##train part of the generated exposome dataset
       Y_test = Y[(nrow(dataExp) / 2):nrow(dataExp), , drop =
                FALSE],
       ##test part of the generated Y vector
       E_test = dataExp[(nrow(dataExp) / 2):nrow(dataExp), , drop = FALSE],
       ##test part of the generated exposome dataset
       yE = yE,
       ##yE (output of the simResponseSimple) object containing the list of
       ##predictors and the Betas
       R2 = R2,
       ##estimated R2
       list_predictor = as.character(yE$predictors) ##vectors of predictors
     )
    return(resultats)
}


####function to generate a linear response####
simResponseSimple <-function(met,
          ##dataframe of potential predictors
          Nmet = NA,
          ##number of predictors
          beta = NULL,
          ##Betas coefficient for predictors. Can be a vector of values or a
          ##unique value
          cpg = NULL,
          ##name of forced predictors if necessary
          corr = FALSE,
          #if TRUE, the correlation between the predictors is controled
          range_corr = c(0, 1)) {
   #if corr = TRUE, range of correlation for true predictors
   if (all(c(is.na(Nmet), is.null(cpg))) == TRUE) {
     ##case with no link between the response and the dataset of potential
     ##predictors
     return (list(
       resp = as.matrix(rep(0, nrow(met)), ncol = 1),
       beta = NA,
       predictors = NA
     ))
   }
   if (corr == FALSE | Nmet == 1) {
     ##case of only 1 predictors and no correlation cotnrol
     temp <- Nmet - length(cpg)
     if (temp != 0) {
       if (length(cpg) == 0) {

                                                412


                                                                             APPENDIX III

           wh <- sample((1:ncol(met)), temp) ##drawing predictors
         } else{
           ##drawing predictors while conserving those specified if some were
           ##specified as input
           wh <- sample((1:ncol(met)[-cpg]), temp)
           wh <- c(cpg, wh)
         }
       } else{
         wh <- cpg
       }
     } else{
       if (length(cpg) != 0) {
         stop("set corr to true is only possible when names of predictors
             are not provided")
       }
       ##if a specified correlation between predictors is set by the users,
       ##selecting the predictors to be in this specified range
       wh <- submatFindSimpl(Mat <- as.matrix(met), range = range_corr, Nvar = Nmet)
       wh <- which(colnames(met) %in% wh)
     }
     ##defining a matrix of predictors
     CovMat <- as.matrix(met[, wh])
     colnames(CovMat) <- colnames(met)[wh]
     # computing the response
     mean <- CovMat %*% matrix(beta, ncol = 1)
     rownames(mean) <- rownames(met)
     names(beta) <- colnames(CovMat)
     return (list(
       resp = mean,
       ##response vector
       beta = beta,
       ##Betas coefficient vector
       predictors = colnames(CovMat) ##vector of predictors
     ))
 }

####function to choose a set of predictors among a set of variables with a
####constraint on the correlation range between predictors####
submatFindSimpl <- function(Mat, range = c(0, 1), Nvar) {
 # verifying formats and values of inputs
 if (Nvar > ncol(Mat))
   stop("No matrix of the correct size meeting the range criterion")
 if (Nvar < 2)
   stop("Nvar must be at least 2")
 # computing the correlation matrix
 Mat <- abs(cor(Mat))
 diag(Mat) <- NA
 # removing rows with no correlation value in the given range
 wh <- which(apply(Mat, 1, min, na.rm = T) > range[2] |
           apply(Mat, 1, max, na.rm = T) < range[1])
 if (length(wh) > 0)

                                              413


                                                                                   APPENDIX III

     Mat <- Mat[-wh, -wh]
    # iteratively selecting and testing samples for the correct correlation
    Res <- NA
    samp1 <- sample(1:ncol(Mat), size = ncol(Mat))
    t1 <- 1
    while (t1 <= ncol(Mat) & all(is.na(Res))) {
     var <- array(NA, 0)
     t2 <- samp1[t1]
     while (all(is.na(Res)) & length(t2) > 0) {
       if (length(t2) == 1) var <- c(var, t2)
       if (length(t2) > 1) var <- c(var, sample(t2, size = 1))
       t2 <- (1:ncol(Mat))[-var]
       if (length(t2) > 1)
         t2 <- t2[which(apply(as.matrix(Mat[t2, var] <= range[2] &
                                Mat[t2, var] >= range[1] &
                                Mat[t2, var] < 1), 1, min) == 1)]
       if (length(t2) == 1){
         if (min(c(Mat[t2, var] <= range[2], Mat[t2, var] >= range[1],
                Mat[t2, var] < 1)) != 1)
           t2 <- NA
       }

      if (length(var) == Nvar)
        Res <- var
     }
     t1 <- t1 + 1
    }
    if (all(is.na(Res)))
      stop("Not enough variable with the given correlation range")
    return(colnames(Mat)[Res])
}

####function which estimates R2 from a dataset of potential predictors, the list
####of true predictors and a vector of outcome####
estimatedR2 <- function(X, truepred, Y) {
 if ("y" %in% truepred) {
   stop("error: one of the true predictors is named y")
 }
 if (ncol(Y) != 1) {
   stop("error:Y is multidimensionnal")
 }
 if (nrow(X) != nrow(Y)) {
   stop("error: not the same number of rows")
 }
 if (isTRUE(all.equal(rownames(X), rownames(Y))) == FALSE) {
   stop("error: individuals are not ordered similarly in X and Y")
 }
 if (all(truepred %in% colnames(X))) {
   data <- X[, colnames(X) %in% truepred, drop = FALSE]
   data <- cbind(Y, data)
   colnames(data)[1] <- "y"

                                                   414


                                                                   APPENDIX III

     mod <- lm(y ~ ., as.data.frame(data))
     toselect.x <- summary(mod)$coeff[-1, 4]
     r <- list(summary(mod)$r.squared,
          summary(mod)$adj.r.squared,
          names(toselect.x)[toselect.x == TRUE])
     names(r) <- c("r.squared", "adj.r.squared", "pred")
     return(r)
    } else{
     stop("error: X does not countain all true predictors")

    }
}

########################################################
########################
##an other function simulator_2layers can be used if one want to control the
##correlation of the overall dataset in this case, the simulated exposome matrix
##is no longer obtained by bootstrapping the real exposome but from a
##correlation matrix the correlation matrix must be provided by the user or
##specified as nulll uncomment the section below and adapt the input of
##functions f0 (section 4.) and clusterApply (section 5.) to use it

# simulator_2layers <-
# function(names_rows_true,
#        cormat,
#        R2_tot = 0.1 ,
#        n_Ey = 5,
#        BetaEy = 0.01,
#        test_and_training = TRUE,
#        pos_and_neg = FALSE,
#        corr_all = "real",
#        corr_pred = TRUE,
#        range_corr = c(0, 1)) {
# ##generation of exposome dataset DIFFERENT FROM THE OTHER FUNCTION
#    simulator_2layers
# if (corr_all == "real") {
#    data.X <- data.frame(rmvnorm(1173 * 2, rep(0, ncol(cormat)),
#                        cormat))
# } else{
#    if (corr_all == "null") {
#      cormat2 <- diag(ncol(cormat))
#      data.X <- data.frame(rmvnorm(1173 * 2, rep(0, ncol(cormat)),
#                          cormat2))
#    } else{
#      stop("Correlation for the whole exposome (null or real) must
#          be specifed")
#    }
# }
# colnames(data.X) <- colnames(cormat)
# rownames(data.X) <-
#    c(names_rows_true, sprintf('boot%s', (names_rows_true)))

                                                  415


                                                                              APPENDIX III

# dataExp <- data.X
# remove(data.X)
#
# ##FROM HERE, THE FUNCTION IS IDENTICAL TO THE OTHER
simulator_2layers
# function ##creating a linearly generated outcome ##defining the vector of
# Beta coefficients
#
# if (length(BetaEy) == 1) {
#     if (pos_and_neg == FALSE) {
#       Betapred_yE <- rep(BetaEy, n_Ey)
#     } else{
#       Betapred_yE <- rep(BetaEy, round(n_Ey / 2))
#       Betapred_yE <-
#         c(Betapred_yE, rep(-BetaEy, n_Ey - length(Betapred_yE)))
#     }
# } else{
#     if (length(BetaEy) != n_Ey) {
#       stop(
#         "error: Betas for M explaining Y not explained by E are not
#          consistent with the number of predictors"
#       )
#     }
#     Betapred_yE <- BetaEy
# }
# ##creating the linear combination
# yE <-
#     simResponseSimple(
#       met = dataExp,
#       Nmet = n_Ey,
#       beta = Betapred_yE,
#       corr = corr,
#       range_corr = range_corr
#     )
#
# ##adding a gaussian to Y to reach the wanted level of variability
# explained by the linear combination of predictors
# Y <- yE$resp
# if (!is.na(R2_tot)) {
#     if (((R2_tot) != 0)) {
#       sigma <- var(Y) * (1 / R2_tot - 1)
#     } else{
#       R2 = 0.00000001
#       sigma <- var(Y) * (1 / R2_tot - 1)
#     }
#     Y <-
#       as.matrix(Y + rnorm(length(Y), mean(Y), sqrt(sigma)), ncol = 1)
#     Y <- as.data.frame(Y)
# }
#
# ##estimating the R2

                                           416


                                                                             APPENDIX III

# R2 <- estimatedR2(dataExp, yE$predictors, Y)$r.squared
# ##results to return
# resultats <-
#   list(
#     Y_train = Y[1:(nrow(dataExp) / 2), , drop = FALSE],
#     ##train part of the generated Y vector
#     E_train = dataExp[1:(nrow(dataExp) / 2), , drop = FALSE],
#     ##train part of the generated exposome dataset
#     Y_test = Y[(nrow(dataExp) / 2):nrow(dataExp), , drop =
#              FALSE],
#     ##test part of the generated Y vector
#     E_test = dataExp[(nrow(dataExp) / 2):nrow(dataExp), , drop = FALSE],
#     ##test part of the generated exposome dataset
#     yE = yE,
#     ##yE (output of the simResponseSimple) object containing the list of
#     ##predictors and the Betas
#     R2 = R2,
#     ##estimated R2
#     list_predictor = as.character(yE$predictors) ##vectors of predictors
#   )
# return(resultats)
# }

########################################################
###
########### 2. Methods to be tested - functions ###########
########################################################
###


####a function used to compute residuals from a linear model if covariates are
####part of the inputs of any the function of the methods tested####
getresiduals_2df <-
 function(data_Y_in, data_covar_in, name_Y, covar) {
   data_covar <-
    data_covar_in[, colnames(data_covar_in) %in% covar, drop = FALSE]
   data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_covar),
           colnames(data_Y_in) ==
            name_Y, drop = FALSE]
   data_covar <-
    data_covar[rownames(data_covar) %in% rownames(data_Y), , drop = FALSE]
   data_covar <- data_covar[rownames(data_Y), , drop = FALSE]
   data_output <- data_Y
   data <- cbind(data_Y, data_covar)
   mod <- lm(data = data)
   data_output[, 1] <- as.data.frame(residuals(mod))
   return(data_output)
 }

####ExWAS####

                                            417


                                                                       APPENDIX III

ewas <-
 function(data_Xs_in,
         ##dataset of explanatory variables ("exposures")
         data_Y_in,
         ##dataset of univariate variable of interest ("outcome")
         name_Y,
         ##variable of interest name
         data_covar_in = NULL,
         ##if neccessary, dataset of covariates ("confounders")
         covar = character(0),
         ##if necessary, vector of covariates name
         corr = "BY",
         ##name of multiple testing correction to be applied ("BH" or "Bon" or
         ##"BY" or "None")
         ntest = NULL) {
  ##if ntest is a numeric, correction of multiple testing will be a Bonferroni
  ##correction considering ntest as the number of tests performed
  require(parallel)
  if (length(covar) > 0) {
    ##if necessary, computing residuals of the linear model explaining the
    ##variable of interest by the covariates
    data_covar<-data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                   rownames(data_covar_in) %in% rownames(data_Xs_in),
                   colnames(data_covar_in) %in% covar, drop = FALSE]
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
                rownames(data_Y_in) %in% rownames(data_Xs_in),
                colnames(data_Y_in) == name_Y, drop =
                FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                 rownames(data_Xs_in) %in% rownames(data_Y), , drop = FALSE]
    data_covar <- data_covar[rownames(data_Y), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y), , drop = FALSE]
    data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
  } else{
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) ==
                name_Y, drop = FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in),
               , drop = FALSE]
    data_Xs <- as.data.frame(data_Xs[rownames(data_Y), ])
    colnames(data_Xs) <- colnames(data_Xs_in)
  }
  ##checking consistency of the datasets
  if (is.null(data_Y) == TRUE |
      is.null(data_Xs) == TRUE |
      !(name_Y %in% colnames(data_Y))) {
    stop("Données incohérentes entre elles")

                                         418


                                                                                APPENDIX III

}

##applying univariate regression for each exposure outcome association
p.values <- mclapply(1:ncol(data_Xs), function(x, data_Xs) {
  c(colnames(data_Xs)[x], summary(lm(Y ~ .,
                          data = data.frame(
                            cbind(var1 = data_Xs[, x],
                                Y = data_Y[, 1])
                          )))$coefficients[2, ])
},
data_Xs)
if (length(p.values) == 1) {
  p.values <-
    as.matrix(as.vector(unlist(p.values[[1]])), ncol = 5, byrow = TRUE)[-4, ]
  p.values <- t(as.data.frame(p.values))
} else{
  p.values <-
    cbind(matrix(unlist(p.values), ncol = 5, byrow = TRUE)[, -4])
}
p.values <- as.data.frame(p.values)
colnames(p.values) <- c("var", "Est", "Sd", "pVal")
p.values <- p.values[p.values$var != "Intercept", ]
p.values$pVal <- as.numeric(as.character(p.values$pVal))
p.values.adj <- p.values
pVal <- as.numeric(as.character(p.values$pVal))
##applying correction for multiple testing
if (corr == "None") {
  wh <- which(pVal <= 0.05)
  p.values.adj$pVal_adj <- pVal
}
if (corr == "Bon") {
  wh <- which(pVal <= 0.05 / nrow(p.values))
  p.values.adj$pVal_adj <- pVal * nrow(p.values)
}
if (corr == "BH") {
  wh <- which(p.adjust(pVal, "BH") <= 0.05)
  p.values.adj$pVal_adj <- p.adjust(pVal, "BH")
}
if (corr == "BY") {
  wh <- which(p.adjust(pVal, "BY") <= 0.05)
  p.values.adj$pVal_adj <- p.adjust(pVal, "BY")
}
if (!corr %in% c("Bon", "BH", "BY", "", "None"))
  stop("Please specify a known correction method for
                                multiple testing")
if (!is.null(ntest)) {
  p.values.adj$pVal_adj <- pVal * ntest
}
wh_num <- wh
wh <- p.values$var[wh]
a <- list(wh, wh_num, p.values.adj)

                                              419


                                                                           APPENDIX III

     ##returning selected exposures and pvalues
     names(a) <- c("selected", "indices_selected", "pval")
     return(a)
 }


####lasso - basic implementation#### this includes a basic 10-fold cross
##validation process as implemented in the CVglmnet package
lasso <-
  function(data_Xs_in,
        ##dataset of explanatory variables ("exposures")
        data_Y_in,
        ##dataset of univariate variable of interest ("outcome")
        name_Y,
        ##variable of interest name
        data_covar_in = NULL,
        ##if neccessary, dataset of covariates ("confounders")
        covar = character(0)) {
   ##if necessary, vector of covariates name

     if (length(covar) > 0) {
       ##if necessary, computing residuals of the linear model explaining the
       ##variable of interest by the covariates
       data_covar <-
         data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                    rownames(data_covar_in) %in% rownames(data_Xs_in),
                   colnames(data_covar_in) %in%
                    covar, drop = FALSE]
       data_Y <-
         data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
                 rownames(data_Y_in) %in% rownames(data_Xs_in),
               colnames(data_Y_in) == name_Y, drop =
                 FALSE]
       data_Xs <-
         data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                  rownames(data_Xs_in) %in% rownames(data_Y_in),
                , drop = FALSE]
       data_covar <- data_covar[rownames(data_Y), ]
       data_Xs <- data_Xs[rownames(data_Y), ]
       data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
     } else{
       data_Y <-
         data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
               colnames(data_Y_in) == name_Y, drop = FALSE]
       data_Xs <-
         data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
       data_Xs <- data_Xs[rownames(data_Y), ]
     }
     data_Y <- data.matrix(data_Y)
     data_Xs <- data.matrix(data_Xs)
     ##applying lasso (as implemented in glmnet package, a path of penalization

                                                  420


                                                                              APPENDIX III

     ##parameter lambda according to the MSE computed is computed by 10-fold
     ##cross-validation)
     cvfit <- cv.glmnet(data_Xs, data_Y, family = "gaussian",
                  alpha = 1)

     ##Compute predicted Y "Y_predit"
     Y_predit <-
      predict(cvfit, newx = data_Xs, s = "lambda.min")
     ##selecting the model with the penalization parameter minimizing MSE
     Y_predit <- Y_predit[rownames(Y_predit), ]

     ##dataframe of predictors selected
     tmp_coeffs <-
      coef(cvfit, s = "lambda.min")
     ##selecting the model with the penalization parameter minimizing MSE
     cg_select <-
      data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1],
              coefficient = tmp_coeffs@x)

     cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
     a <- list()
     if (length(cg_select) != 0) {
       a <- list("selected" = cg_select,
               "prediction" = Y_predit,
               "null" = "nul")
     } else{
       a <-
         list(
           "selected" = character(),
           "prediction" = "pas_de_prediction",
           "null" = "nul"
         )
     }
     return(a)

 }

####lasso - basic implementation but using lambda.1se instead of lambda.min
#### this includes a basic 10-fold cross
##validation process as implemented in the CVglmnet package
lasso_1SE <-
  function(data_Xs_in,
        ##dataset of explanatory variables ("exposures")
        data_Y_in,
        ##dataset of univariate variable of interest ("outcome")
        name_Y,
        ##variable of interest name
        data_covar_in = NULL,
        ##if neccessary, dataset of covariates ("confounders")
        covar = character(0)) {
   ##if necessary, vector of covariates name

                                                421


                                                                       APPENDIX III



if (length(covar) > 0) {
  ##if necessary, computing residuals of the linear model explaining the
  ##variable of interest by the covariates
  data_covar <-
    data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                rownames(data_covar_in) %in% rownames(data_Xs_in),
              colnames(data_covar_in) %in%
                covar, drop = FALSE]
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
            rownames(data_Y_in) %in% rownames(data_Xs_in),
          colnames(data_Y_in) == name_Y, drop =
            FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
             rownames(data_Xs_in) %in% rownames(data_Y_in),
           , drop = FALSE]
  data_covar <- data_covar[rownames(data_Y), ]
  data_Xs <- data_Xs[rownames(data_Y), ]
  data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
} else{
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
          colnames(data_Y_in) == name_Y, drop = FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
  data_Xs <- data_Xs[rownames(data_Y), ]
}
data_Y <- data.matrix(data_Y)
data_Xs <- data.matrix(data_Xs)
##applying lasso (as implemented in glmnet package, a path of penalization
##parameter lambda according to the MSE computed is computed by 10-fold
##cross-validation)
cvfit <- cv.glmnet(data_Xs, data_Y, family = "gaussian",
               alpha = 1)

##Compute predicted Y "Y_predit"
Y_predit <-
 predict(cvfit, newx = data_Xs, s = "lambda.1se")
##selecting the model within 1MSE of the model using
##the penalization parameter minimizing MSE
Y_predit <- Y_predit[rownames(Y_predit), ]

##dataframe of predictors selected
tmp_coeffs <-
 coef(cvfit, s = "lambda.min")
##selecting the model with the penalization parameter minimizing MSE
cg_select <-
 data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1],
         coefficient = tmp_coeffs@x)

                                         422


                                                                              APPENDIX III



     cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
     a <- list()
     if (length(cg_select) != 0) {
       a <- list("selected" = cg_select,
               "prediction" = Y_predit,
               "null" = "nul")
     } else{
       a <-
         list(
           "selected" = character(),
           "prediction" = "pas_de_prediction",
           "null" = "nul"
         )
     }
     return(a)

 }


####lasso_stab : implementation of Meinshausen 2010
#### repeating lasso on
##subsamples and performing the selection according to empirical probability of
##selection computed over the repeated runs using a threshold specified by user
lasso_stab_Meinshausen <-
  function(data_Xs_in,
         ##dataset of explanatory variables ("exposures")
         data_Y_in,
         ##dataset of univariate variable of interest ("outcome")
         name_Y,
         ##variable of interest name
         data_covar_in = NULL,
         ##if neccessary, dataset of covariates ("confounders")
         covar = character(0),
         ##if necessary, vector of covariates name
         prop = 0.85) {
   #minimal threshold for an empirical probability to make the corresponding
   #variable selected
   if (length(covar) > 0) {
     ##if necessary, computing residuals of the linear model explaining the
     ##variable of interest by the covariates
     data_covar <-
       data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                 rownames(data_covar_in) %in% rownames(data_Xs_in),
                 colnames(data_covar_in) %in%
                 covar, drop = FALSE]
     data_Y <-
       data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
               rownames(data_Y_in) %in% rownames(data_Xs_in),
               colnames(data_Y_in) == name_Y, drop =
               FALSE]

                                                423


                                                                             APPENDIX III

  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
              rownames(data_Xs_in) %in% rownames(data_Y_in),
            , drop = FALSE]
  data_covar <- data_covar[rownames(data_Y), ]
  data_Xs <- data_Xs[rownames(data_Y), ]
  data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
} else{
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
           colnames(data_Y_in) ==
             name_Y, drop = FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y), , drop = FALSE]
  data_Xs <- data_Xs[rownames(data_Y), ]
}
if (is.null(data_Y)) {
  stop("Données incohérentes entre elles _ Y")
}
if (is.null(data_Xs)) {
  stop("Données incohérentes entre elles _ Xs")
}
if (!(name_Y %in% colnames(data_Y))) {
  stop("Données incohérentes entre elles _ nom Y")
}
data_Y <- data.matrix(data_Y)
data_Xs <- data.matrix(data_Xs)
list_iter <- list()

length_lambdas <- numeric()
n_iter_stab <- 100
##setting the number of repetitions from which the empirical probabilities
##will be computed
for (k2 in (1:n_iter_stab)) {
  #randomly selecting a subsample containing 50% of individuals
  selec <-
    sample(rownames(data_Xs), round(1 * nrow(data_Xs) / 2)) #
  i_df <- data.matrix(data_Xs[rownames(data_Xs) %in% selec, ])
  block_pheno <-
    data_Y[rownames(data_Y) %in% rownames(i_df), , drop = FALSE]
  block_pheno <- block_pheno[rownames(i_df), , drop = FALSE]
  ##applying lasso to the subsample
  model.lasso <-
    glmnet(
      x = i_df,
      y = data.matrix(block_pheno),
      family = "gaussian",
      alpha = 1
    )
  #saving the selection for each lambda in a dataframe
  selection_pour_une_iter <-

                                           424


                                                                                APPENDIX III

        as.data.frame(cbind(rownames(model.lasso$beta), as.numeric(tabulate(
          model.lasso$beta@i + 1
        ))))
      colnames(selection_pour_une_iter) <-
        c("variables", paste("iter", k2))
      ##adding this dataframe to the list of dataframes computed for all
      ##precedent subsamples
      list_iter <- c(list_iter, list(selection_pour_une_iter))
      ##saving the length of penalization path
      length_lambdas <-
        c(length_lambdas, length(model.lasso$lambda))
     }
     ##merging all dataframes of selection by variable
     M <-
       as.data.frame(Reduce(function(x, y)
         merge(x, y, by = "variables"), list_iter))
     M[, 2:ncol(M)] <-
       lapply(M[, 2:ncol(M)], function(x)
         as.numeric(as.character(x)))
     ##summing the frequencies of selection by variables
     M$sum <- rowSums(M[, 2:ncol(M)])
     M1 <- M[, c(1, ncol(M))]
     ##computing the empirical probabilities from the sum of frequencies of
     ##selection by variables and the number of possible selections
     M1$proba_estimee <- M1$sum / (sum(length_lambdas))
     ##selecting variables from the empirical probabilities and the threshold
     cg_select <- M1$variables[M1$proba_estimee >= prop]
     ##returning the selection
     a <- list()
     if (length(cg_select) != 0) {
       a <-
         list(
           "selected" = cg_select,
           "selection_iter" = list(M, M1),
           "iteration" = n_iter_stab
         )
     } else{
       a <-
         list(
           "selected" = character(0),
           "selection_iter" = list(M, M1),
           "iteration" = n_iter_stab
         )
     }
     return(a)

 }

####lasso_stab : second implementation of Meinshausen 2010
#### selection of a
##set of lambda parameters on a subsample then repeating lasso on subsamples

                                                425


                                                                           APPENDIX III

##with those lambdas and performing the selection according to empirical
##probability of selection computed over the repeated runs using a threshold
##specified by user
lasso_stab_Meinshausen2 <-
  function(data_Xs_in,
         ##dataset of explanatory variables ("exposures")
         data_Y_in,
         ##dataset of univariate variable of interest ("outcome")
         name_Y,
         ##variable of interest name
         data_covar_in = NULL,
         ##if neccessary, dataset of covariates ("confounders")
         covar = character(0),
         ##if necessary, vector of covariates names
         prop = 0.95) {
   #minimal threshold for an empirical probability to make the corresponding
   #variable selected
   if (length(covar) > 0) {
     ##if necessary, computing residuals of the linear model explaining the
     ##variable of interest by the covariates
     data_covar <-
       data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                   rownames(data_covar_in) %in% rownames(data_Xs_in),
                  colnames(data_covar_in) %in%
                   covar, drop = FALSE]
     data_Y <-
       data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
                rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) == name_Y, drop =
                FALSE]
     data_Xs <-
       data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                 rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
     data_covar <- data_covar[rownames(data_Y), ]
     data_Xs <- data_Xs[rownames(data_Y), ]
     data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
   } else{
     data_Y <-
       data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
              colnames(data_Y_in) ==
                name_Y, drop = FALSE]
     data_Xs <-
       data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y), , drop = FALSE]
     data_Xs <- data_Xs[rownames(data_Y), ]
   }
   if (is.null(data_Y)) {
     stop("Données incohérentes entre elles _ Y")
   }
   if (is.null(data_Xs)) {
     stop("Données incohérentes entre elles _ Xs")
   }

                                           426


                                                                             APPENDIX III

if (!(name_Y %in% colnames(data_Y))) {
  stop("Données incohérentes entre elles _ nom Y")
}
data_Y <- data.matrix(data_Y)
data_Xs <- data.matrix(data_Xs)


list_iter <- list()
###defining a vector of penalized parameters lambda on a subsample
selec <- sample(rownames(data_Xs), round(1 * nrow(data_Xs) / 2))
i_df <- data.matrix(data_Xs[rownames(data_Xs) %in% selec, ])
block_pheno <-
  data_Y[rownames(data_Y) %in% rownames(i_df), , drop = FALSE]
block_pheno <- block_pheno[rownames(i_df), , drop = FALSE]
temp <-
  glmnet(
    x = i_df,
    y = block_pheno,
    family = "gaussian",
    alpha = 1
  )
##lasso is applied; the path of lambdas will be used for all other
##subsamples
lambdas <- temp$lambda
###repeating lasso fo all subsamples
n_iter_stab <- 100
##setting the number of repetitions from which the empirical probabilities
##will be computed
for (k2 in (1:n_iter_stab)) {
  selec <-
    sample(rownames(data_Xs), round(1 * nrow(data_Xs) / 2))
  #randomly selecting a subsample containing 50% of individuals
  i_df <- data.matrix(data_Xs[rownames(data_Xs) %in% selec, ])
  block_pheno <-
    data_Y[rownames(data_Y) %in% rownames(i_df), , drop = FALSE]
  block_pheno <- block_pheno[rownames(i_df), , drop = FALSE]
  ##applying lasso to the subsample
  model.lasso <-
    glmnet(
      x = i_df,
      y = data.matrix(block_pheno),
      family = "gaussian",
      alpha = 1,
      lambda = as.numeric(lambdas)
    )
  #saving the selection for each lambda in a dataframe
  selection_pour_une_iter <-
    as.data.frame(cbind(rownames(model.lasso$beta), as.numeric(tabulate(
      model.lasso$beta@i + 1
    ))))
  colnames(selection_pour_une_iter) <-

                                           427


                                                                                APPENDIX III

        c("variables", paste("iter ", k2))
      ##adding this dataframe to the list of dataframes computed for all
      ##precedent subsamples
      list_iter <- c(list_iter, list(selection_pour_une_iter))
     }
     ##merging all dataframe of selection by variable
     M <-
       as.data.frame(Reduce(function(x, y)
         merge(x, y, by = "variables"), list_iter))
     M[, 2:ncol(M)] <-
       lapply(M[, 2:ncol(M)], function(x)
         as.numeric(as.character(x)))
     ##summing the frequencies of selection by variables
     M$sum <- rowSums(M[, 2:ncol(M)])
     M1 <- M[, c(1, ncol(M))]
     ##computing the empirical probabilities from the sum of frequencies of
     ##selection by variables and the number of possible selections
     M1$proba_estimee <- M1$sum / (length(lambdas) * n_iter_stab)
     M1$proba_estimee <- M1$sum / (sum(length_lambdas))
     ##selecting variables from the empirical probabilities and the threshold
     cg_select <- M1$variables[M1$proba_estimee >= prop]
     ##returning the selection
     a <- list()
     if (length(cg_select) != 0) {
       a <-
         list(
           "selected" = cg_select,
           "selection_iter" = list(M, M1),
           "iteration" = n_iter_stab
         )
     } else{
       a <-
         list(
           "selected" = character(0),
           "selection_iter" = list(M, M1),
           "iteration" = n_iter_stab
         )
     }
     return(a)

 }

####LASSO_CV2####

### loop applying 100 times lasso with the 10-fold validations procedures on the
### whole dataset the average of the mean error curves (MSE as a function of the
### MSE) gives the penalization parameter which minimizes this averaged MSE and
### which will be used in the final model
lasso_moy_MSE <-
  function(data_Xs_in,
        ##dataset of explanatory variables ("exposures")

                                                428


                                                                        APPENDIX III

       data_Y_in,
       ##dataset of univariate variable of interest ("outcome")
       name_Y,
       ##variable of interest name
       data_covar_in = NULL,
       ##if neccessary, dataset of covariates ("confounders")
       covar = character(0)) {
##if necessary, vector of covariates name
if (length(covar) > 0) {
  ##if necessary, computing residuals of the linear model explaining the
  ##variable of interest by the covariates
  data_covar <-
    data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                rownames(data_covar_in) %in% rownames(data_Xs_in),
               colnames(data_covar_in) %in%
                covar, drop = FALSE]
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
             rownames(data_Y_in) %in% rownames(data_Xs_in),
           colnames(data_Y_in) == name_Y, drop =
             FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
              rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
  data_covar <- data_covar[rownames(data_Y), ]
  data_Xs <- data_Xs[rownames(data_Y), ]
  data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
} else{
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
           colnames(data_Y_in) ==
             name_Y, drop = FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in),
            , drop = FALSE]
  data_Xs <- data_Xs[rownames(data_Y), ]
}
data_Y <- data.matrix(data_Y)
data_Xs <- data.matrix(data_Xs)
lambdas <- numeric(0)
MSEs <- data.frame(matrix(NA, nrow = 100, ncol = 100))
##repeating 100 times the cross-validation process
for (i in 1:100) {
  cv <- cv.glmnet(x = data_Xs, y = data_Y, alpha = 1) ##applying lasso
  MSEs[1:length(cv$lambda), i] <-
    cv$cvm
  ##saving the cross-validation path (ie MSE values for each lambdas) as a
  ##colum of MSEs dataframe
  if (length(cv$lambda) > length(lambdas)) {
    lambdas <-
      cv$lambda ##saving the vector of lambdas of maximum length

                                         429


                                                                              APPENDIX III

      }
      print(cv$lambda[1:10])

     }
     ##restricting MSEs to non empty rows
     MSEs <- MSEs[1:length(lambdas), ]
     rownames(MSEs) <- lambdas
     ##choosing the lambda minimimizing the mean of MSE computed across all
     ##lambdas
     lambda.min <-
       as.numeric(names(which.min(rowMeans(MSEs, na.rm = TRUE))))

     ##applying lasso with this lambda as forced penalization parameter
     model.enet <- glmnet(
       data_Xs,
       data_Y,
       family = "gaussian",
       alpha = 1,
       lambda = lambda.min
     )

     ##selecting variables
     tmp_coeffs <- coef(model.enet)
     cg_select <-
       data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1],
                coefficient = tmp_coeffs@x)
     cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
     ##returning selected variables
     a <- list()
     if (length(cg_select) != 0) {
       a <-
         list("selected" = cg_select,
             "prediction" = "prediction",
             "null" = "nul")
     } else{
       a <-
         list(
           "selected" = character(),
           "prediction" = "pas_de_prediction",
           "null" = "nul"
         )
     }
     return(a)

 }


####LASSO_CV1####
### loop applying 100 times lasso with the 10-fold validations procedures on the
### whole dataset the average of the penalization parameters minimizing the MSE
### for each run gives the penalization parameter which will be used in the

                                                430


                                                                         APPENDIX III

### final model

lasso_moy_lambda <-
  function(data_Xs_in,
         ##dataset of explanatory variables ("exposures")
         data_Y_in,
         ##dataset of univariate variable of interest ("outcome")
         name_Y,
         ##variable of interest name
         data_covar_in = NULL,
         ##if neccessary, dataset of covariates ("confounders")
         covar = character(0)) {
   ##if necessary, vector of covariates name
   if (length(covar) > 0) {
     ##if necessary, computing residuals of the linear model explaining the
     ##variable of interest by the covariates
     data_covar <-
       data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                  rownames(data_covar_in) %in% rownames(data_Xs_in),
                 colnames(data_covar_in) %in%
                  covar, drop = FALSE]
     data_Y <-
       data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
               rownames(data_Y_in) %in% rownames(data_Xs_in),
             colnames(data_Y_in) == name_Y, drop =
               FALSE]
     data_Xs <-
       data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
                rownames(data_Xs_in) %in% rownames(data_Y_in),
              , drop = FALSE]
     data_covar <- data_covar[rownames(data_Y), ]
     data_Xs <- data_Xs[rownames(data_Y), ]
     data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
   } else{
     data_Y <-
       data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
             colnames(data_Y_in) == name_Y, drop = FALSE]
     data_Xs <-
       data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
     data_Xs <- data_Xs[rownames(data_Y), ]
   }
   data_Y <- data.matrix(data_Y)
   data_Xs <- data.matrix(data_Xs)

  ##initialization
  lambdas <- NULL
  ##repeating 100 times the cross-validation process
  for (i in 1:100) {
    cv <- cv.glmnet(x = data_Xs, y = data_Y, alpha = 1)
    lambdas <- c(lambdas, cv$lambda.min)
  }

                                             431


                                                                              APPENDIX III

     ##averaging the optimal parameters across repetitions
     lambda_min <- mean(lambdas)
     ##applying lasso with this lambda as forced penalization parameter
     model.enet <- glmnet(
       data_Xs,
       data_Y,
       family = "gaussian",
       alpha = 1,
       lambda = lambda_min
     )

     ##selecting variables
     tmp_coeffs <- coef(model.enet)
     cg_select <-
      data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1],
              coefficient = tmp_coeffs@x)

     cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
     ##returning selected variables
     a <- list()
     if (length(cg_select) != 0) {
       a <-
         list("selected" = cg_select,
             "prediction" = "prediction",
             "null" = "nul")
     } else{
       a <-
         list(
           "selected" = character(),
           "prediction" = "pas_de_prediction",
           "null" = "nul"
         )
     }
     return(a)
 }




####Mix Method####
##Computing empirical probabilities derived from selection frequencies when
##running cross-validated lasso on subsamples
lasso_moy_Meinshausen <-
  function(data_Xs_in,
        ##dataset of explanatory variables ("exposures")
        data_Y_in,
        ##dataset of univariate variable of interest ("outcome")
        name_Y,
        ##variable of interest name
        data_covar_in = NULL,
        ##if neccessary, dataset of covariates ("confounders")

                                                432


                                                                      APPENDIX III

      covar = character(0),
      ##if necessary, vector of covariates name
      prop = 0.5) {
##threshold to select variables from their empirical probabilities
if (length(covar) > 0) {
  ##if necessary, computing residuals of the linear model explaining the
  ##variable of interest by the covariates
  data_covar <-
    data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                rownames(data_covar_in) %in% rownames(data_Xs_in),
               colnames(data_covar_in) %in%
                covar, drop = FALSE]
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
             rownames(data_Y_in) %in% rownames(data_Xs_in),
           colnames(data_Y_in) == name_Y, drop =
             FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
              rownames(data_Xs_in) %in% rownames(data_Y_in),
            , drop = FALSE]
  data_covar <- data_covar[rownames(data_Y), ]
  data_Xs <- data_Xs[rownames(data_Y), ]
  data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
} else{
  data_Y <-
    data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in),
           colnames(data_Y_in) == name_Y, drop = FALSE]
  data_Xs <-
    data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y), , drop = FALSE]
  data_Xs <- data_Xs[rownames(data_Y), ]
}
if (is.null(data_Y)) {
  stop("Données incohérentes entre elles _ Y")
}
if (is.null(data_Xs)) {
  stop("Données incohérentes entre elles _ Xs")
}
if (!(name_Y %in% colnames(data_Y))) {
  stop("Données incohérentes entre elles _ nom Y")
}
##initialization
data_Y <- data.matrix(data_Y)
data_Xs <- data.matrix(data_Xs)
vector_selected <- character()
n_iter_stab <- 100
#setting the number of repetitions from which the empirical probabilities
#will be computed
for (k2 in (1:n_iter_stab)) {
  #randomly selecting a subsample containing 50% of individuals
  selec <-

                                       433


                                                                          APPENDIX III

      sample(rownames(data_Xs), round(1 * nrow(data_Xs) / 2))
    i_df <- data.matrix(data_Xs[rownames(data_Xs) %in% selec, ])
    block_pheno <-
      data_Y[rownames(data_Y) %in% rownames(i_df), , drop = FALSE]
    block_pheno <- block_pheno[rownames(i_df), , drop = FALSE]
    ##applying cross_validated lasso to the subsample
    model.lasso <-
      cv.glmnet(
        x = i_df,
        y = data.matrix(block_pheno),
        family = "gaussian",
        alpha = 1
      )
    ##selecting the model minimizing the MSE
    tmp_coeffs <- coef(model.lasso, s = "lambda.min")
    cg_select <-
      data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1], coefficient =
tmp_coeffs@x)
    cg_select <- cg_select$name[cg_select$name != "(Intercept)"]
    #saving the variables selected for this iteration
    vector_selected <- c(vector_selected, as.character(cg_select))
  }
  ##computing frequencies of selection
  tab <- as.data.frame(table(vector_selected))
  colnames(tab) <- c("exp", "proba")
  ##computing empirical probabilities
  tab$proba <- tab$proba / n_iter_stab
  ###selecting variables from the empirical probabilities and the threshold
  cg_select_tot <- tab$exp[tab$proba >= prop]
  ##returning the selection
  a <- list()
  if (length(cg_select_tot) != 0) {
    a <-
      list("selected" = cg_select_tot,
          "freq" = tab,
          "iteration" = n_iter_stab)
  } else{
    a <- list(
      "selected" = character(0),
      "freq" = tab,
      "iteration" = n_iter_stab
    )
  }
  return(a)

 }


####Elastic-Net####
Enet <-
 function(data_Xs_in,

                                           434


                                                                           APPENDIX III

        ##dataset of explanatory variables ("exposures")
        data_Y_in,
        ##dataset of univariate variable of interest ("outcome")
        name_Y,
        ##variable of interest name
        data_covar_in = NULL,
        ##if neccessary, dataset of covariates ("confounders")
        covar = character(0)) {
  ##if necessary, vector of covariates name
  if (length(covar) > 0) {
    ##if necessary, computing residuals of the linear model explaining the
    ##variable of interest by the covariates
    data_covar <-
      data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
                 rownames(data_covar_in) %in% rownames(data_Xs_in),
colnames(data_covar_in) %in%
                 covar, drop = FALSE]
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
              rownames(data_Y_in) %in% rownames(data_Xs_in), colnames(data_Y_in) ==
name_Y, drop =
              FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
               rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_covar <- data_covar[rownames(data_Y), ]
    data_Xs <- data_Xs[rownames(data_Y), ]
    data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
  } else{
    data_Y <-
      data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in), colnames(data_Y_in) ==
              name_Y, drop = FALSE]
    data_Xs <-
      data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y), ]
  }
  data_Y <- data.matrix(data_Y)
  data_Xs <- data.matrix(data_Xs)
  ##preparation of CV folds (which must be the same for alpha and lambda CV)
  nfolds=10

  n <- nrow(data_Xs)
  folds <- rep(1:nfolds,length.out=n)[sample(n,n)]
  #step 1: do all crossvalidations for each alpha in range 0.1 - 1.0
  alphasOfInterest <- seq(1,0.1,-0.1)
  cvs <- lapply(alphasOfInterest,
           function(curAlpha){cv.glmnet(data_Xs,data_Y,alpha=curAlpha,
                               family="gaussian",nfolds=nfolds,
                               foldid=folds,standardize=FALSE)})
  #step 2: collect the optimum lambda for each alpha
  optimumPerAlpha <- sapply(seq_along(alphasOfInterest), function(curi){

                                           435


                                                                             APPENDIX III

      curcvs <- cvs[[curi]]
      curAlpha <- alphasOfInterest[curi]
      indOfMin <- match(curcvs$lambda.min, curcvs$lambda)
      return(c(lam=curcvs$lambda.min,alph=curAlpha,cvm=curcvs$cvm[indOfMin],
             cvup=curcvs$cvup[indOfMin])) })
     #step 3: find the overall optimum
     posOfOptimum <- which.min(optimumPerAlpha["cvm",])
     overall.alpha.min <- optimumPerAlpha["alph",posOfOptimum]
     overall.lambda.min <- optimumPerAlpha["lam",posOfOptimum]
     overall.criterionthreshold <- optimumPerAlpha["cvup",posOfOptimum]


  ##final model
  model <-
    glmnet(x=data_Xs,y=data_Y,alpha=overall.alpha.min,
         lambda=overall.lambda.min,family="gaussian",standardize=FALSE)
  ##selecting variables in the model minimizig the MSE
  tmp_coeffs <- coef(model, s =as.numeric(overall.lambda.min))
  cg_select<-data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1],
                  coefficient = tmp_coeffs@x)
  cg_select<-
cg_select$name[cg_select$name!="(Intercept)"&!is.na(cg_select$name)&cg_select$name!="<NA
>"]
  ##returning selection
  a<-list()
  if (length(cg_select)!=0){
    a<-list("selected"=cg_select,"alpha_final"=overall.alpha.min,
          "lambda_final"=overall.lambda.min)
  }else{
    a<-list("selected"=character(0),"alpha_final"=overall.alpha.min,
          "lambda_final"=overall.lambda.min)
  }
  return(a)

 }


####Elastic-Net stabilized by repeating the CV process####
Enet_CV <-
 function(data_Xs_in,
        ##dataset of explanatory variables ("exposures")
        data_Y_in,
        ##dataset of univariate variable of interest ("outcome")
        name_Y,
        ##variable of interest name
        data_covar_in = NULL,
        ##if neccessary, dataset of covariates ("confounders")
        covar = character(0)) {
  ##if necessary, vector of covariates name
  if (length(covar) > 0) {
    ##if necessary, computing residuals of the linear model explaining the

                                              436


                                                                         APPENDIX III

    ##variable of interest by the covariates
    data_covar <-
     data_covar_in[rownames(data_covar_in) %in% rownames(data_Y_in) &
               rownames(data_covar_in) %in% rownames(data_Xs_in),
colnames(data_covar_in) %in%
               covar, drop = FALSE]
    data_Y <-
     data_Y_in[rownames(data_Y_in) %in% rownames(data_covar) &
            rownames(data_Y_in) %in% rownames(data_Xs_in), colnames(data_Y_in) ==
name_Y, drop =
            FALSE]
    data_Xs <-
     data_Xs_in[rownames(data_Xs_in) %in% rownames(data_covar) &
             rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_covar <- data_covar[rownames(data_Y), ]
    data_Xs <- data_Xs[rownames(data_Y), ]
    data_Y <- getresiduals_2df(data_Y, data_covar, name_Y, covar)
  } else{
    data_Y <-
     data_Y_in[rownames(data_Y_in) %in% rownames(data_Xs_in), colnames(data_Y_in) ==
            name_Y, drop = FALSE]
    data_Xs <-
     data_Xs_in[rownames(data_Xs_in) %in% rownames(data_Y_in), , drop = FALSE]
    data_Xs <- data_Xs[rownames(data_Y), ]
  }
  data_Y <- data.matrix(data_Y)
  data_Xs <- data.matrix(data_Xs)


  nfolds=10

  ##the cross-validation process is repeated 100 times for alpha
  all_alpha_min<-numeric(0)
  n <- nrow(data_Xs)
  optimumAlpha<-NULL
  for (i in 1:100){
   print(i)
   ##preparation of CV folds (which must be the same for alpha and lambda CV)
   folds <- rep(1:nfolds,length.out=n)[sample(n,n)]
   #step 1: do all crossvalidations for each alpha in range 0.1 - 1.0
   alphasOfInterest <- seq(1,0.1,-0.1)
   cvs <- lapply(alphasOfInterest,
              function(curAlpha){cv.glmnet(data_Xs,data_Y,alpha=curAlpha,
                                family="gaussian",nfolds=nfolds,
                                foldid=folds,standardize=FALSE)})
   #step 2: collect the optimum lambda for each alpha
   optimumPerAlpha <- sapply(seq_along(alphasOfInterest), function(curi){
     curcvs <- cvs[[curi]]
     curAlpha <- alphasOfInterest[curi]
     indOfMin <- match(curcvs$lambda.min, curcvs$lambda)
     return(c(lam=curcvs$lambda.min,alph=curAlpha,cvm=curcvs$cvm[indOfMin],

                                          437


                                                                                     APPENDIX III

              cvup=curcvs$cvup[indOfMin])) })
      posOfOptimum <- which.min(optimumPerAlpha["cvm",])
      overall.alpha.min <- optimumPerAlpha["alph",posOfOptimum]
      #list_optimumPerAlpha<-cbind(list_optimumPerAlpha,list(optimumPerAlpha))
      optimumAlpha<-c(optimumAlpha,overall.alpha.min)
     }
     ##the final alpha value is computed
     alpha_final<-mean(optimumAlpha)
     ##comment : it is not possible to obtain simultaneously the average values of
     ##lambda and alpha, as lambda must be computed according to alpha

     ##the cross-validation process is repeated 100 times for lambda
     all_lambda_min<-numeric(0)
     for (i in 1:100){
      overall.lambda.min<-cv.glmnet(x=data_Xs,y=data_Y,alpha=alpha_final,family="gaussian")
      plot(overall.lambda.min)

      all_lambda_min<-c(all_lambda_min,overall.lambda.min)
     }
     lambda_final<-mean(all_lambda_min)

     ##final model
     model <-

glmnet(x=data_Xs,y=data_Y,alpha=alpha_final,lambda=lambda_final,family="gaussian",standar
dize=FALSE)
    ##selecting variables in the model minimizig the MSE
    tmp_coeffs <- coef(model, s =as.numeric(overall.lambda.min))
    cg_select<-data.frame(name = tmp_coeffs@Dimnames[[1]][tmp_coeffs@i + 1], coefficient =
tmp_coeffs@x)
    cg_select<-
cg_select$name[cg_select$name!="(Intercept)"&!is.na(cg_select$name)&cg_select$name!="<NA
>"]
    ##returning selection
    a<-list()
    if (length(cg_select)!=0){
      a<-
list("selected"=cg_select,"alpha_final"=overall.alpha.min,"lambda_final"=overall.lambda.min)
    }else{
      a<-
list("selected"=character(0),"alpha_final"=overall.alpha.min,"lambda_final"=overall.lambda.min)
    }
    return(a)

 }


####DSA####
##DSA is an iterative linear regression model search algorithm (Sinisi and van
##der Laan 2004) following three constraints: maximum order of interaction
##amongst predictors, the maximum power for a given predictor, and the maximum

                                                438


                                                                               APPENDIX III

##model size.
DSAreg <-
 function(Exp,
        ####dataset of explanatory variables ("exposures")
        resp,
        ##dataset of univariate variable of interest ("outcome")
        family = gaussian,
        ##family of the outcome
        maxsize = 15,
        ##maximum size of the model
        maxsumofpow = 2,
        ##maximum power for a given predictor
        maxorderint = 2) {
  ##maximum order of interaction
  Exp <-
    data.frame(cbind(resp = resp, data.frame(Exp)))
  ##merging exp and resp in a unique dataframe
  colnames(Exp)[1] <- "resp"
  ##applying DSA function with 5 fold split and 1 cross-validation process
  res <-
    DSA(
      resp ~ 1,
      data = Exp,
      family = family,
      maxsize = maxsize,
      maxsumofpow
      = maxsumofpow,
      maxorderint = maxorderint ,
      nsplits = 1,
      usersplits = NULL
    )
  ##extracting the selected variables in case there are power or interaction
  form <- gsub("I[(]", "", colnames(coefficients(res)))
  form <-
    gsub("[*]", ":", gsub("[)]", "", gsub("[:^:]1", "", form)))
  if (length(grep(":", form)) > 0) {
    nam <- strsplit(form[grep("[:]", form)], ":")
    for (j in 1:length(nam)) {
      nam[[j]] <- gsub("[[:space:]]", "", nam[[j]])
      name <- nam[[j]][1]
      for (k in 2:length(nam[[j]]))
       name <- paste(name, ":", nam[[j]][k], sep = "")
      Exp <- cbind(Exp, name = apply(Exp[, nam[[j]]], 1, prod))
    }
  }
  form2 <- "resp~1"
  if (length(form) > 1)
    for (i in 2:length(form))
      form2 <- paste(form2, "+", form[i])
  ##putting the selected variablesin a linear model
  res2 <- lm(form2, data = data.frame(Exp))

                                              439


                                                                              APPENDIX III

  #pred <- predict(res2,Exp)
  ##obtaining beta coefficients
  coef <- summary(res2)$coefficients
  coef <-
    as.character(rownames(coef)[rownames(coef) != "Intercept"])
  ##returning selecting
  return(list(
    selected = coef[coef != "(Intercept)"],
    pred = "prediction",
    null = "null"
  ))
  }
##multivariate regression
multi <- function(Exp, resp) {
  ##Exp is the dataset of potential predictors ("the exposome")
  ##resp is the variable to explain ("the outcome")
  var <- colnames(Exp)
  Exp <- data.frame(cbind(resp = resp, data.frame(Exp)))
  colnames(Exp)[1] <- "resp"
  formula <-
    as.formula(paste("resp ~", paste(var, collapse = " + ")))
  model <- lm(formula = formula, data = Exp)
  selection <- as.data.frame(summary(model)$coeff[-1, 4])
  colnames(selection) <- "pVal"
  selection$pVal_adj <- p.adjust(selection$pVal, "BH")
  selected <-
    as.character(unique(rownames(selection)[selection$pVal_adj <= 0.05]))
  return(list(
    selected = selected,
    pred = "prediction",
    null = "null"
  ))
}

########################################################
#
########### 3. Methods assessment - functions ###########
########################################################
#


####computing sensitivity####
sensitivity <- function(truepred, predfound) {
  return(length(truepred[truepred %in% predfound]) / length(truepred))
}
####computing false discovery proportion####
fdp <- function(truepred, predfound) {
  if (length(predfound) == 0) {
    return(0)
  } else{
    return(length(predfound[!predfound %in% truepred]) / length(predfound))

                                              440


                                                                               APPENDIX III

  }
}
####computing specificity####
specificity <- function(truepred, predfound, n_base) {
  return((n_base - length(truepred) - length(predfound[!predfound %in% truepred])) /
        (n_base - length(truepred)))
}

########################################################
########################
###### 4. Function to parallelize - performing simulation and assessment #######
########################################################
########################

##take only the iteration number as input and use it as a seed
f0 <- function(x) {
 ##setting seed
 set.seed(x)
 ##generating datasets
 simu <-
   simulator_2layers(
     E_true = dataExp_true,
     R2_tot = R2_fixed,
     n_Ey = n_Ey,
     BetaEy = 0.1,
     test_and_training = TRUE,
     pos_and_neg = pos_and_neg,
     corr = corr,
     range_corr = corr_range
   )
 simu$Y_train <- scale(simu$Y_train)
 simu$Y_test <- scale(simu$Y_test)
 list_predBMI_E <- list()
 ##creating a list where to save methods results
 predBMI_E <-
   lapply(1:n_method, function(i)
     lapply(1:7, function(x)
       list()))
 ###repeating methods on the datasets
 for (j_stab in (1:n_iter_stab)) {
   ##setting seed
   set.seed(x + j_stab)
   ##measuring computation time
   start_time_meth <- Sys.time()
   ##ExWAS
   pred_iter <-
     list(ewas_BH = ewas(
       as.data.frame(simu$E_train),
       as.data.frame(simu$Y_train),
       colnames(as.data.frame(simu$Y_train)),
       corr = "BH"

                                               441


                                                                             APPENDIX III

 ))
end_time_meth <- Sys.time()
pred_iter$ewas_BH[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth,   units = c("secs")))
print("ewas")
###LASSO
start_time_meth <- Sys.time()
predlasso <-
 lasso(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
end_time_meth <- Sys.time()
predlasso[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth,   units = c("secs")))
print("lasso")
###LASSO Meinshausen 1
start_time_meth <- Sys.time()
predlasso_stab_Meinshausen <-
 lasso_stab_Meinshausen(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train)),
   prop = 0.85
 )
end_time_meth <- Sys.time()
###LASSO Mix
predlasso_stab_Meinshausen[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth,   units = c("secs")))
print("lasso_stab")
start_time_meth <- Sys.time()
predlasso_moy_Meinshausen <-
 lasso_moy_Meinshausen(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train)),
   prop = 0.5
 )
end_time_meth <- Sys.time()
predlasso_moy_Meinshausen[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth,   units = c("secs")))

start_time_meth <- Sys.time()
###LASSO Meinshausen 2
predlasso_stab_Meinshausen2 <-
 lasso_stab_Meinshausen2(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train)),
   prop = 0.95

                                          442


                                                                           APPENDIX III

 )
end_time_meth <- Sys.time()
predlasso_stab_Meinshausen2[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth, units = c("secs")))

start_time_meth <- Sys.time()
###LASSO CV2
predlasso_moy_MSE <-
 lasso_moy_MSE(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
end_time_meth <- Sys.time()
predlasso_moy_MSE[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth, units = c("secs")))

###LASSO CV1
start_time_meth <- Sys.time()
predlasso_moy_lambda <-
 lasso_moy_lambda(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
end_time_meth <- Sys.time()
predlasso_moy_lambda[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth, units = c("secs")))


##ElasticNet
start_time_meth <- Sys.time()
predEnet <-
 Enet(
   data_Xs_in = as.data.frame(simu$E_train),
   data_Y_in = as.data.frame(simu$Y_train),
   colnames(as.data.frame(simu$Y_train))
 )
end_time_meth <- Sys.time()
predEnet[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth, units = c("secs")))
print("enet")

start_time_meth <- Sys.time()

predDSA <-
 DSAreg(
  Exp = simu$E_train,
  resp = simu$Y_train,
  maxsize = floor(ncol(simu$E_train) / 10),
  maxsumofpow = 1,

                                          443


                                                                           APPENDIX III

   maxorderint = 1
 )
end_time_meth <- Sys.time()
predDSA[[2]] <-
 as.numeric(difftime(end_time_meth, start_time_meth, units = c("secs")))
print("DSA effectué")
##combining results of the different methods for this iteration
pred_iter <-
 c(
   pred_iter,
   lasso = list(predlasso),
   lasso_stab_Meinshausen = list(predlasso_stab_Meinshausen),
   lasso_stab_Meinshausen2 = list(predlasso_stab_Meinshausen2),
   lasso_moy_Meinshausen = list(predlasso_moy_Meinshausen),
   lasso_moy_MSE = list(predlasso_moy_MSE),
   lasso_moy_lambda = list(predlasso_moy_lambda),
   Enet = list(predEnet,
           DSA = list(predDSA))
 )

#pred_iter<-c(pred_iter,lasso=list(predlasso),
#lasso_stab=list(predlasso_stab),
#lasso_stab_plus_spec=list(predlasso_stab_ps),
#Enet=list(predEnet),DSA=list(predDSA))
#pred_iter<-c(pred_iter,lasso=list(predlasso)) #assessing performance of
#each method
truepred <- simu$yE$predictors
for (k1 in (1:length(pred_iter))) {
  predfound <- pred_iter[[k1]]$selected
  if (exists("predfound") & exists("truepred")) {
    if (length(predfound) == 0) {
      print("no predictors found")
    }
    a <- sensitivity(truepred, predfound)
    b <- specificity(truepred, predfound, ncol(simu$E_train))
    c <- fdp(truepred, predfound)
    d <-
      estimatedR2(simu$E_test, predfound, simu$Y_test)$r.squared
    # print(a)
    # print(b)
    # print(c)
    # print(d)
    pred_iter[[k1]] <-
      c(
        pred_iter[[k1]],
        sens = a,
        spec = b,
        fdp = c,
        R2_test = d
      )
    remove(a)

                                           444


                                                                  APPENDIX III

   remove(b)
   remove
   remove(d)
   remove(predfound)
  }
  k1 <- k1 + 1
 }
 ##reshaping results saves
 for (k2 in (1:length(pred_iter))) {
   for (k3 in (1:length(pred_iter[[k2]]))) {
     predBMI_E[[k2]][[k3]] <-
      c(predBMI_E[[k2]][[k3]], list(pred_iter[[k2]][[k3]]))
     names(predBMI_E[[k2]]) <- names(pred_iter[[k2]])
   }
   names(predBMI_E) <- names(pred_iter)
 }
 print(j_stab)
 j_stab <- j_stab + 1

}
list_predBMI_E <- c(list_predBMI_E, list(predBMI_E))
performance <- list()
##Assessing stability
###Assessing the frequency of selection of each hits
for (k4 in (1:length(predBMI_E))) {
  tab_freq <-
    as.data.frame(table(table(as.character(
      unlist(predBMI_E[[k4]][[1]])
    ))))
  tab_freq$Var1 <-
    as.numeric(as.character(tab_freq$Var1)) / n_iter_stab
  colnames(tab_freq) <- c("freq", "nb_exp")
  tab_freq <- tab_freq[order(tab_freq$freq), ]
  ###Computing average Sorensen index as a measure of stability
  c_sor <- numeric(0)
  for (i1 in 1:(length(predBMI_E[[k4]][[1]]) - 1)) {
    for (i2 in (i1 + 1):length(predBMI_E[[k4]][[1]])) {
      if ((length(predBMI_E[[k4]][[1]][[i1]]) == 0) &
          length(predBMI_E[[k4]][[1]][[i2]]) == 0) {
        sor <- 1
      } else{
        sor <-
          sorensen(as.character(predBMI_E[[k4]][[1]][[i1]]),
                as.character((predBMI_E[[k4]][[1]][[i2]])))
      }
      c_sor <- c(c_sor, sor)
    }
  }

 sor_moy <- mean(c_sor)
 ##Saving performance measurement

                                                445


                                                                            APPENDIX III

 performance[[k4]] <-
  list(
    mean_nb_selec = mean(unlist(
      lapply(predBMI_E[[k4]][[1]], function(X)
        length(X))
    )),
    mean_sens = mean(unlist(predBMI_E[[k4]][[4]]), na.rm =
                 TRUE),
    mean_spec = mean(unlist(predBMI_E[[k4]][[5]]), na.rm =
                 TRUE),
    mean_fdp = mean(unlist(predBMI_E[[k4]][[6]]), na.rm =
                TRUE),
    mean_R2_test = mean(unlist(predBMI_E[[k4]][[7]]), na.rm =
                    TRUE),
    nb_sup_20percent = sum(tab_freq$nb_exp[(which(tab_freq$freq >=
                                   0.2))]),
    nb_sup_60percent = sum(tab_freq$nb_exp[(which(tab_freq$freq >=
                                   0.6))]),
    sorensen = sor_moy,
    sd_nb_selec = sd(unlist(
      lapply(predBMI_E[[k4]][[1]], function(X)
        length(X))
    ), na.rm = TRUE),
    sd_sens = sd(unlist(predBMI_E[[k4]][[4]]), na.rm =
               TRUE),
    sd_spec = sd(unlist(predBMI_E[[k4]][[5]]), na.rm =
                TRUE),
    sd_fdp = sd(unlist(predBMI_E[[k4]][[6]]), na.rm =
               TRUE),
    sd_R2_test = sd(unlist(predBMI_E[[k4]][[7]]), na.rm =
                   TRUE),
    run_time <-
      mean(unlist(predBMI_E[[k4]][[2]]), na.rm = TRUE)
  )


}
remove(sor_moy)
remove(tab_freq)
names(performance) = names(predBMI_E)
##returning an object containing the simulated datasets with their
##characteristics, the results of each method and the performance measurements
A <-
  list(simu = simu,
      performance = performance,
      list_predBMI_E = list_predBMI_E)
remove(simu)
remove(performance)
remove(list_predBMI_E)
gc()
return(A)

                                           446


                                                                            APPENDIX III




}

########################################################
################# 5. SIMULATIONS #######################
########################################################

####loading input needed to generate datasets#####
dataExp_true <- readRDS("20190205 Exposome simu borne.rds")
##initialization
list_list_list_predBMI_E <- list()
list_list_performance <- list()
n_iter <- 30 ##number of iterations for each scenarios
n_iter_stab <- 15 ##number of iterations for each dataset
n_method <- 8 ##number of methods tested
c_n_R2_fixed <-
  c(0.0001, 0.001, 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.6, 0.8)
##values tested for R2 (variability of the outcome explained)
c_n_Ey <-
  c(1, 3, 10, 25, 50, 100) ##values tested for the number of predictors

#list_corr<-list(all=c(0,1),low=c(0,0.2),middle=c(0.2,0.4),high=c(0.5,1))
list_corr <- list(all = c(0, 1))
neg <- FALSE
#neg<-c(FALSE,TRUE)

seed = 22
##initalizing the dataset in which the performance of each method will be
##summarized by scenarios
comp_stability_method <- data.frame(
 Methods = vector(),
 Nb_true_predictors_of_BMI_in_E = numeric(0),
 Total_variability_of_BMI_explained_by_E =
   numeric(0),
 Mean_measured_variability_of_BMI_explained_by_E =
   numeric(0),
 Number_iterations = numeric(0),
 Number_iterations_stab = numeric(0),
 Mean_mean_number_predictors_found = numeric(0),
 Mean_mean_sensitivity = numeric(0),
 Mean_mean_specificity = numeric(0),
 Mean_mean_fdp = numeric(0),
 Mean_mean_R2_test = numeric(0),
 Mean_nb_sup_20percent = numeric(0),
 Mean_nb_sup_60percent = numeric(0),
 Mean_Sorensen = numeric(0),
 Mean_sd_number_predictors_found = numeric(0),
 Mean_sd_sensitivity = numeric(0),
 Mean_sd_specificity = numeric(0),
 Mean_sd_fdp = numeric(0),

                                                447


                                                                                APPENDIX III

    Mean_sd_R2_test = numeric(0),
    SD_mean_number_predictors_found = numeric(0),
    SD_mean_sensitivity = numeric(0),
    SD_mean_specificity = numeric(0),
    SD_mean_fdp = numeric(0),
    SD_mean_R2_test = numeric(0),
    SD_nb_sup_20percent = numeric(0),
    SD_nb_sup_60percent = numeric(0),
    SD_sd_number_predictors_found = numeric(0),
    SD_sd_sensitivity = numeric(0),
    SD_sd_specificity = numeric(0),
    SD_sd_fdp = numeric(0),
    SD_sd_R2_test = numeric(0),
    SD_Sorensen = numeric(0),
    which_scenario = numeric(0),
    Correlation = vector(),
    Negative_coefficient = vector(),
    Run_time = numeric(0)
)

##############################
####Run of the simulation#####
##############################
n=1
##looping on each scenario ie looping on each list of parameters which define
##scenarios
for (i4 in 1:length(neg)) {
 pos_and_neg <- neg[i4]
 for (i3 in 1:length(list_corr)) {
   corr_range <- list_corr[[i3]]
   corr = TRUE
   if (corr_range[1] == 0 & corr_range[2] == 1) {
     corr = FALSE
   }
   for (i1 in 1:length(c_n_Ey)) {
     n_Ey <- c_n_Ey[i1]
     for (i2 in 1:length(c_n_R2_fixed)) {
       R2_fixed <- c_n_R2_fixed[i2]

       ##inside the loops a scenario is set

       test_correl <- tryCatch({
         simu <-
           simulator_2layers(
             E_true = dataExp_true,
             R2_tot = R2_fixed,
             n_Ey = n_Ey,
             BetaEy = 0.1,
             test_and_training = TRUE,
             pos_and_neg = pos_and_neg,
             corr = corr,

                                              448


                                                              APPENDIX III

      range_corr = corr_range
    )
}, silent = FALSE)
if (class(test_correl) == "try-error") {
  print(n)

} else{
 n_row = nrow(comp_stability_method)
 list_list_predBMI_E <- list()
 list_performance <- list()
 print("cluster")

 ##parallelization
 start_time <- Sys.time()
 cl <-
   makeCluster(getOption("cl.cores", round(detectCores())))
 clusterExport(
   cl,
   list(
     "dataExp_true",
     "simulator_2layers",
     "simResponseSimple",
     "estimatedR2",
     "getresiduals_2df",
     "ewas",
     "lasso",
     "lasso_stab_Meinshausen2",
     "lasso_moy_lambda",
     "lasso_moy_MSE",
     "lasso_moy_Meinshausen",
     "lasso_stab_Meinshausen",
     "Enet",
     "wqs",
     "sensitivity",
     "fdp",
     "specificity",
     "f0",
     "R2_fixed",
     "n_Ey",
     "n_iter_stab",
     "submatFindSimpl",
     "DSAreg",
     "corr",
     "corr_range",
     "pos_and_neg",
     "n_method"
   )
 )
 clusterEvalQ(
   cl,
   list(

                                           449


                                                             APPENDIX III

  library("boot"),
  library("reshape"),
  library("glmnet"),
  library("DSA"),
  library("mvtnorm"),
  library("gWQS"),
  library("OmicsMarkeR"),
  library("Rcpp")
  )
)
##applying f0 in parallel
results_1_jeu <- clusterApply(cl, 1:n_iter, f0)
stopCluster(cl)
##getting results for this scenario
simulated_data <- lapply(results_1_jeu, function(x)
  x$simu)
##formatting results for this scenario
list_list_predBMI_E <-
  lapply(results_1_jeu, function(x)
    x$list_predBMI_E)
list_performance <- lapply(results_1_jeu, function(x)
  x$performance)
remove(results_1_jeu)

##saving simulation parameters for this scenario
param_simu <-
 data.frame(
   Parameters = vector(),
   Fixed_or_measured = vector(),
   Value = numeric(0)
 )
param_simu[1, ] <-
 c("Nb_true predictors of BMI in E",
   "Fixed",
   mean(unlist(
     lapply(simulated_data, function(X)
       length(X$yE$beta))
   )))
param_simu[2, ] <-
 c("Total variability of BMI explained by E",
   "Fixed",
   R2_fixed)
param_simu[3, ] <-
 c("Mean variability of BMI explained by E",
   "Measured",
   mean(unlist(
     lapply(simulated_data, function(X)
       (X$R2))
   )))
param_simu[4, ] <- c("Number_iterations", "Fixed", n_iter)
param_simu[5, ] <-

                                        450


                                                      APPENDIX III

 c("Number_iterations_on_a_same_dataset",
  "Fixed",
  n_iter_stab)
param_simu[6, ] <-
 c("Correlation_range",
  "Fixed",
  str_c(
    as.character(corr_range[1]),
    as.character(corr_range[2])
  ))
param_simu[7, ] <-
 c("Negative_coefficients",
  "Fixed",
  ifelse(pos_and_neg == TRUE, "yes", "no"))

##saving methods performance for this scenario
for (i1 in (1:length(list_performance[[1]]))) {
 comp_stability_method[i1 + n_row, ] <-
   c(
    as.character(names(list_performance[[1]][i1])),
    param_simu[1, 3],
    R2_fixed,
    param_simu[3, 3],
    n_iter,
    n_iter_stab,
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[1]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[2]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[3]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[4]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[5]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)
        (X[[i1]][[6]]))
    ), na.rm = TRUE),
    mean(unlist(
      lapply(list_performance, function(X)

                                         451


                                          APPENDIX III

    (X[[i1]][[7]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[8]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[9]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[10]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[11]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[12]]))
), na.rm = TRUE),
mean(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[13]]))
), na.rm = TRUE),


sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[1]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[2]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[3]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[4]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[5]]))
), na.rm = TRUE),
sd(unlist(
  lapply(list_performance, function(X)
    (X[[i1]][[6]]))

                                    452


                                                  APPENDIX III

      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[7]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[8]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[9]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[10]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[11]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[12]]))
      ), na.rm = TRUE),
      sd(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[13]]))
      ), na.rm = TRUE),
      n,
      param_simu[6, 3],
      ifelse(pos_and_neg == TRUE, "yes", "no"),
      mean(unlist(
        lapply(list_performance, function(X)
          (X[[i1]][[14]]))
      ), na.rm = TRUE)


      )
    i1 <- i1 + 1
}

print(n)

list_list_list_predBMI_E <-
  c(list_list_list_predBMI_E,
    list(list_list_predBMI_E))
end_time <- Sys.time()
end_time - start_time
##saving results externaly
saveRDS(comp_stability_method,

                                       453


                                                                                         APPENDIX III

                       "comp_stability_method_n30_15.Rds")
                saveRDS(
                  simulated_data,
                  file = paste(n,
                            '_simulated_data_scenario_iteration_stability_n30_15.Rds')
                )
                saveRDS(
                  list_list_list_predBMI_E,
                  "list_list_list_predBMI_E_stability_n30_15.Rds"
                )
                saveRDS(list_list_performance,
                       "list_list_performance_stability_n30_15.Rds")
                remove(simulated_data)
                remove(list_list_predBMI_E)
                remove(list_performance)

                }
                n=n+1

            }
        }
    }
}




                                                         454
